"Molecule ChEMBL ID";"Molecule Name";"Molecule Max Phase";"Molecular Weight";"#RO5 Violations";"AlogP";"Compound Key";"Smiles";"Standard Type";"Standard Relation";"Standard Value";"Standard Units";"pChEMBL Value";"Data Validity Comment";"Comment";"Uo Units";"Ligand Efficiency BEI";"Ligand Efficiency LE";"Ligand Efficiency LLE";"Ligand Efficiency SEI";"Potential Duplicate";"Assay ChEMBL ID";"Assay Description";"Assay Type";"BAO Format ID";"BAO Label";"Assay Organism";"Assay Tissue ChEMBL ID";"Assay Tissue Name";"Assay Cell Type";"Assay Subcellular Fraction";"Assay Parameters";"Assay Variant Accession";"Assay Variant Mutation";"Target ChEMBL ID";"Target Name";"Target Organism";"Target Type";"Document ChEMBL ID";"Source ID";"Source Description";"Document Journal";"Document Year";"Cell ChEMBL ID";"Properties";"Action Type";"Standard Text Value"
"CHEMBL1169539";"";"None";"638.81";"1";"2.87";"8d";"CN1CCC([C@@H](O)[C@H](CC2CCCCC2)NC(=O)[C@H](Cc2c[nH]cn2)NC(=O)[C@H](Cc2ccccc2)NC(=O)OC(C)(C)C)C1=O";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL657351";"Inhibitory concentration against cathepsin D";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1125921";"1";"Scientific Literature";"J Med Chem";"1991";"None";"";"";""
"CHEMBL212357";"";"None";"624.87";"1";"3.35";"26";"CCCCNC(=O)[C@H](C)C[C@H](O)[C@@H]1CSCc2ccc(cc2)CSC[C@H](NC(=O)OC(C)(C)C)C(=O)N[C@@H](C)C(=O)N1";"IC50";"'='";"195.0";"nM";"6.71";"";"";"UO_0000065";"10.74";"0.22";"3.36";"4.60";"0";"CHEMBL866007";"Inhibition of Cathepsin D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1137429";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";"";""
"CHEMBL213858";"";"None";"532.77";"1";"1.43";"30";"CCCCNC(=O)[C@H](C)C[C@H](O)[C@@H]1CSCCCCCSC[C@H](NC(C)=O)C(=O)N[C@@H](C)C(=O)N1";"IC50";"'='";"1700.0";"nM";"5.77";"";"";"UO_0000065";"10.83";"0.23";"4.34";"4.22";"0";"CHEMBL866007";"Inhibition of Cathepsin D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1137429";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";"";""
"CHEMBL231325";"";"None";"574.72";"1";"3.55";"19c";"CCCN(CCC)C(=O)c1cc(C(N)=O)cc(C(=O)N[C@@H](Cc2ccccc2)[C@H](O)CNCc2cccc(OC)c2)c1";"IC50";"'='";"2800.0";"nM";"5.55";"";"";"UO_0000065";"9.66";"0.18";"2.00";"4.14";"0";"CHEMBL888969";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1144655";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"None";"";"";""
"CHEMBL1084432";"";"None";"535.77";"2";"5.10";"27";"CCC(=O)NC(C)(C)[C@H]1CCC[C@@H](C(=O)N[C@@H](Cc2ccccc2)[C@@H](O)CNCc2cccc(C(C)C)c2)C1";"IC50";"'='";"7100.0";"nM";"5.15";"";"";"UO_0000065";"9.61";"0.18";"0.05";"5.69";"0";"CHEMBL1107841";"Inhibition of Cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1155410";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL439148";"";"None";"496.72";"0";"1.59";"101";"CCCCNC(=O)[C@H](C)C[C@H](O)[C@@H]1CSC/C=C/CC[C@H]2CNCC[C@H]2C(=O)N[C@@H](C)C(=O)N1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL866007";"Inhibition of Cathepsin D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1137429";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";"";""
"CHEMBL209847";"";"None";"474.69";"0";"0.64";"102";"CCCCNC(=O)[C@H](C)C[C@H](O)[C@@H]1CSC/C=C/CSC[C@H](N)C(=O)N[C@@H](C)C(=O)N1";"IC50";"'='";"150.0";"nM";"6.82";"";"";"UO_0000065";"14.38";"0.30";"6.18";"5.11";"0";"CHEMBL866007";"Inhibition of Cathepsin D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1137429";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";"";""
"CHEMBL318803";"";"None";"805.98";"2";"4.53";"47";"COc1ccc(CN[C@@H](C(=O)N[C@H](C(=O)NCc2nc3ccccc3[nH]2)C(C)C)[C@H](O)[C@H](Cc2ccccc2)NC(=O)[C@@H](NC(=O)OCc2ccccc2)C(C)C)cc1";"IC50";"'='";"380.0";"nM";"6.42";"";"";"UO_0000065";"7.97";"0.15";"1.89";"3.28";"0";"CHEMBL657353";"Selectivity for their inhibitory potency against human cathepsin D.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1127464";"1";"Scientific Literature";"J Med Chem";"1994";"None";"";"";""
"CHEMBL211848";"";"None";"459.68";"0";"1.71";"34";"CCCCNC(=O)[C@H](C)C[C@H](O)[C@@H]1CSC/C=C\CSCCC(=O)N[C@@H](C)C(=O)N1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL866007";"Inhibition of Cathepsin D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1137429";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";"";""
"CHEMBL2349498";"";"None";"341.46";"0";"3.28";"28, rac-28";"CN1C(=O)C2(CC(C)(C)Oc3ccc(C4CCCCC4)cc32)N=C1N";"IC50";"'='";"2513.0";"nM";"5.60";"";"";"UO_0000065";"16.40";"0.31";"2.32";"8.24";"0";"CHEMBL2352017";"Inhibition of human spleen cathepsin D using 5-FAM/QXL as peptide substrate after 1 hr by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"CHEMBL3559722";"Spleen";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346596";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL2349496";"";"None";"401.41";"0";"3.50";"26, rac-26";"CN1C(=O)C2(CC(C)(C)Oc3ccc(-c4cccc(OC(F)F)c4)cc32)N=C1N";"IC50";"'='";"627.0";"nM";"6.20";"";"";"UO_0000065";"15.45";"0.29";"2.70";"8.04";"0";"CHEMBL2352017";"Inhibition of human spleen cathepsin D using 5-FAM/QXL as peptide substrate after 1 hr by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"CHEMBL3559722";"Spleen";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346596";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL2349492";"";"None";"393.49";"0";"3.68";"22, rac-22";"CC(C)Oc1cccc(-c2ccc3c(c2)C2(CC(C)(C)O3)N=C(N)N(C)C2=O)c1";"IC50";"'='";"430.0";"nM";"6.37";"";"";"UO_0000065";"16.18";"0.30";"2.69";"8.25";"0";"CHEMBL2352017";"Inhibition of human spleen cathepsin D using 5-FAM/QXL as peptide substrate after 1 hr by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"CHEMBL3559722";"Spleen";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346596";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL2349491";"";"None";"387.84";"0";"3.69";"21, rac-21";"CN1C(=O)C2(CC(C)(C)Oc3ccc(-c4cc(Cl)ccc4F)cc32)N=C1N";"IC50";"'='";"265.0";"nM";"6.58";"";"";"UO_0000065";"16.96";"0.33";"2.89";"9.68";"0";"CHEMBL2352017";"Inhibition of human spleen cathepsin D using 5-FAM/QXL as peptide substrate after 1 hr by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"CHEMBL3559722";"Spleen";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346596";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL449938";"";"None";"594.64";"1";"4.09";"20";"CCn1nnc2c(N3CCCC3=O)cc(C(=O)N[C@@H](Cc3ccccc3)[C@H](O)CNCc3cccc(C(F)(F)F)c3)cc21";"IC50";"'='";"11220.0";"nM";"4.95";"";"";"UO_0000065";"8.32";"0.16";"0.86";"4.40";"0";"CHEMBL1036847";"Inhibition of cathepsin-D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1137769";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL1092125";"";"None";"426.40";"0";"3.68";"4c";"CN1C(=O)C(c2ccncc2)(c2cccc(-c3cccc(OC(F)(F)F)c3)c2)N=C1N";"IC50";"'='";"14100.0";"nM";"4.85";"";"";"UO_0000065";"11.38";"0.21";"1.17";"6.00";"0";"CHEMBL1115170";"Inhibition of cathepsin D by FRET assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156304";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL598876";"";"None";"342.40";"0";"2.78";"4a";"CN1C(=O)C(c2ccncc2)(c2cccc(-c3ccccc3)c2)N=C1N";"IC50";"'='";"30100.0";"nM";"4.52";"";"";"UO_0000065";"13.21";"0.24";"1.74";"6.32";"0";"CHEMBL1115170";"Inhibition of cathepsin D by FRET assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156304";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL448939";"";"None";"571.68";"1";"2.98";"23";"CCn1c(=O)[nH]c2c(N3CCCC3=O)cc(C(=O)N[C@@H](Cc3ccccc3)[C@H](O)CNCc3cccc(OC)c3)cc21";"IC50";"'='";"23990.0";"nM";"4.62";"";"";"UO_0000065";"8.08";"0.15";"1.64";"3.59";"0";"CHEMBL1036847";"Inhibition of cathepsin-D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1137769";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL1257417";"";"None";"444.57";"0";"4.24";"55";"CC(=O)N[C@@H](Cc1cc(F)cc(F)c1)[C@H](O)CNC1(c2cccc(CC(C)(C)C)c2)CC1";"IC50";"'='";"379.0";"nM";"6.42";"";"";"UO_0000065";"14.44";"0.27";"2.18";"10.47";"0";"CHEMBL1260849";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1255191";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL1824144";"";"None";"378.41";"0";"2.13";"38";"CCn1cc(C2(c3cccc(-c4cccnc4F)c3)N=C(N)N(C)C2=O)cn1";"IC50";"'='";"12980.0";"nM";"4.89";"";"";"UO_0000065";"12.91";"0.24";"2.76";"5.47";"0";"CHEMBL1825607";"Inhibition of cathepsin D by FRET assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1821667";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL82907";"";"None";"640.16";"2";"7.25";"11";"CCOc1ccc2nc(Sc3ccc(NC(=O)c4cc(Cl)ccc4NS(=O)(=O)c4cccc(C(=O)O)c4)cc3)sc2c1";"IC50";"'='";"2200.0";"nM";"5.66";"";"";"UO_0000065";"8.84";"0.18";"-1.59";"4.20";"0";"CHEMBL657347";"Inhibitory activity against human liver Cathepsin D using Cathepsin D assay.";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1132101";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1999";"None";"";"";""
"CHEMBL84637";"";"None";"505.45";"2";"7.41";"40";"CCOc1ccc2nc(Sc3ccc(NC(=O)c4cc(Cl)cc(Cl)c4OC)cc3)sc2c1";"IC50";"'>'";"7000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL657347";"Inhibitory activity against human liver Cathepsin D using Cathepsin D assay.";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1132101";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1999";"None";"";"";""
"CHEMBL305635";"";"None";"621.82";"1";"2.43";"PS-429694";"CCCCNC(=O)CC(O)C(Cc1ccccc1)NC(=O)[C@@H](NC(=O)CN1CCC(C(N)=O)(c2ccccc2)CC1)[C@@H](C)CC";"IC50";"'='";"5500.0";"nM";"5.26";"";"";"UO_0000065";"8.46";"0.16";"2.83";"3.42";"0";"CHEMBL658686";"Inhibitory activity against cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1131370";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1998";"None";"";"";""
"CHEMBL1824336";"";"None";"396.40";"0";"2.27";"39";"CCn1cc(C2(c3ccc(F)c(-c4cccnc4F)c3)N=C(N)N(C)C2=O)cn1";"IC50";"'='";"4030.0";"nM";"5.39";"";"";"UO_0000065";"13.61";"0.25";"3.12";"6.03";"0";"CHEMBL1825607";"Inhibition of cathepsin D by FRET assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1821667";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL86237";"";"None";"461.40";"1";"7.02";"32";"Cc1cc(Sc2nc3ccccc3s2)ccc1NC(=O)c1cc(Cl)cc(Cl)c1O";"IC50";"'='";"1300.0";"nM";"5.89";"";"";"UO_0000065";"12.76";"0.28";"-1.13";"9.46";"0";"CHEMBL657347";"Inhibitory activity against human liver Cathepsin D using Cathepsin D assay.";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1132101";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1999";"None";"";"";""
"CHEMBL3763159";"";"None";"479.62";"1";"6.61";"rac-4e";"Nc1nc2cc(-c3ccc(C4CCCCC4)cc3)ccc2c(=O)n1C[C@@H]1CC[C@H](c2ccccc2)O1";"IC50";"'='";"8600.0";"nM";"5.07";"";"";"UO_0000065";"10.56";"0.19";"-1.54";"7.22";"0";"CHEMBL3767017";"Inhibition of CatD (unknown origin) preincubated for 30 mins followed by DABCYL-Glu-Arg-Nle-Phe-Leu-Ser-Phe-Pro-EDANS substrate addition by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3763050";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";""
"CHEMBL3764953";"";"None";"363.46";"0";"3.85";"rac-3d";"CC(C)[C@H]1CC[C@@H](Cn2c(N)nc3cc(-c4ccccc4)ccc3c2=O)O1";"IC50";"'='";"25000.0";"nM";"4.60";"";"";"UO_0000065";"12.66";"0.23";"0.75";"6.56";"0";"CHEMBL3767017";"Inhibition of CatD (unknown origin) preincubated for 30 mins followed by DABCYL-Glu-Arg-Nle-Phe-Leu-Ser-Phe-Pro-EDANS substrate addition by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3763050";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";""
"CHEMBL404500";"";"None";"530.67";"1";"3.75";"21";"CCNc1cc(C(=O)N[C@@H](Cc2ccccc2)[C@H](O)CNCc2ccc(OC)cc2)cc(N2CCCC2=O)c1";"IC50";"'='";"18620.0";"nM";"4.73";"";"";"UO_0000065";"8.91";"0.17";"0.98";"4.60";"0";"CHEMBL945833";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140837";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";"";"";""
"CHEMBL566403";"";"None";"402.45";"0";"2.80";"38";"COc1ccc(C2(c3cccc(-c4cccnc4)c3)N=C(N)N(C)C2=O)cc1OC";"IC50";"'='";"23100.0";"nM";"4.64";"";"";"UO_0000065";"11.52";"0.21";"1.84";"5.15";"0";"CHEMBL1044551";"Inhibition of human cathepsin D by FRET based peptide cleavage assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156789";"1";"Scientific Literature";"J Med Chem";"2010";"None";"";"";""
"CHEMBL258315";"";"None";"434.58";"0";"3.43";"36";"C[C@H](O)CN/C(N)=N\C(=O)Cn1c(-c2ccccc2)ccc1C12CC3CC(CC(C3)C1)C2";"IC50";"'='";"54100.0";"nM";"4.27";"";"";"UO_0000065";"9.82";"0.18";"0.84";"4.61";"0";"CHEMBL930552";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1142260";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";"";"";""
"CHEMBL461602";"";"None";"467.70";"0";"3.78";"2c";"CCCCNC(=O)[C@H](C)C[C@H](O)[C@@H]1C[C@H](C)CCCCCCCCC(=O)N(C)[C@@H](C)C(=O)N1";"IC50";"'='";"8100.0";"nM";"5.09";"";"";"UO_0000065";"10.89";"0.21";"1.31";"5.16";"0";"CHEMBL1030363";"Inhibition of human cathepsin D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1151821";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL2322611";"";"None";"491.07";"0";"4.04";"12a, (3S,4S)-12a";"COCCCOc1cc(C(=O)N(C[C@@H]2CNC[C@H]2Cc2ccccc2)C(C)C)ccc1OC.Cl";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2330925";"Inhibition of human recombinant cathepsin-D expressed in baculovirus-infected insect sf9 cells using Ac- E-D(EDANS)-KPILFFRLG-K(Dabcyl)-E-Amid as substrate incubated for 1 hr prior to substrate addition measured after 1 hr by FRET-based enzymatic assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2321868";"1";"Scientific Literature";"J Med Chem";"2013";"CHEMBL3308860";"";"";""
"CHEMBL315691";"";"None";"431.30";"1";"6.35";"20";"O=C(Nc1ccc(Oc2nc3ccccc3s2)cc1)c1cc(Cl)cc(Cl)c1O";"IC50";"'='";"2800.0";"nM";"5.55";"";"";"UO_0000065";"12.87";"0.27";"-0.80";"7.77";"0";"CHEMBL657347";"Inhibitory activity against human liver Cathepsin D using Cathepsin D assay.";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1132101";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1999";"None";"";"";""
"CHEMBL2349464";"";"None";"325.39";"0";"3.40";"61, rac-61";"CC1(C)Cc2ccc(-c3cncc(F)c3)cc2C2(COC(N)=N2)C1";"IC50";"'='";"48603.0";"nM";"4.31";"";"";"UO_0000065";"13.26";"0.25";"0.91";"7.13";"0";"CHEMBL2352017";"Inhibition of human spleen cathepsin D using 5-FAM/QXL as peptide substrate after 1 hr by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"CHEMBL3559722";"Spleen";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346596";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL4546797";"";"None";"616.80";"1";"4.29";"(S,R)-3f";"COCCNC(=O)c1cc(C(=O)N[C@@H](Cc2ccccc2)[C@H](O)CNC(C)(C)c2cccc(OC)c2)cc(N2CCCCC2)c1";"IC50";"'='";"750.0";"nM";"6.12";"";"";"UO_0000065";"9.93";"0.19";"1.83";"5.46";"0";"CHEMBL4331648";"Inhibition of human cathepsin D using DABCYL-Glu-Arg-Nle-Phe-Leu-Ser-Phe-Pro-EDANS as substrate preincubated for 30 mins followed by substrate addition and measured every min for 8 to 15 mins by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4330085";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";"";"";""
"CHEMBL4586892";"";"None";"627.75";"2";"6.20";"(S,R)-4e";"CCCN(CCC)C(=O)c1cc(C(=O)N[C@@H](Cc2ccccc2)[C@H](O)CNC(C)(C)c2cccc(OC)c2)cc(C(F)(F)F)c1";"IC50";"'='";"67.0";"nM";"7.17";"";"";"UO_0000065";"11.43";"0.22";"0.97";"7.89";"0";"CHEMBL4331648";"Inhibition of human cathepsin D using DABCYL-Glu-Arg-Nle-Phe-Leu-Ser-Phe-Pro-EDANS as substrate preincubated for 30 mins followed by substrate addition and measured every min for 8 to 15 mins by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4330085";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";"";"";""
"CHEMBL3127073";"";"None";"385.85";"0";"3.13";"79";"C[C@]12CCOC[C@@H]1[C@]1(COC(N)=N1)c1cc(-c3cncc(Cl)c3)ccc1O2";"IC50";"'='";"140000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3131975";"Inhibition of human liver cathepsin D measured for 1 hr by FRET assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124885";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL1257531";"";"None";"490.61";"1";"5.26";"9";"CC(=O)N[C@@H](Cc1cc(F)cc(F)c1)[C@H](O)CNC1(c2cc(F)cc(C(C)(C)C)c2)CCCCC1";"IC50";"'='";"24.0";"nM";"7.62";"";"";"UO_0000065";"15.53";"0.30";"2.36";"12.42";"0";"CHEMBL1260849";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1255191";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL1257892";"";"None";"487.64";"0";"4.70";"14";"CC(=O)N[C@@H](Cc1cc(F)cc(F)c1)[C@H](O)CNC1(c2cc(N)cc(C(C)(C)C)c2)CCCCC1";"IC50";"'='";"105.0";"nM";"6.98";"";"";"UO_0000065";"14.31";"0.27";"2.28";"7.99";"0";"CHEMBL1260849";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1255191";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL1257774";"";"None";"421.49";"0";"2.94";"62";"CC(=O)N[C@@H](Cc1cc(F)cc(F)c1)[C@H](O)CNC1(c2ncc(C(C)(C)C)o2)CC1";"IC50";"'='";"3470.0";"nM";"5.46";"";"";"UO_0000065";"12.95";"0.25";"2.52";"6.25";"0";"CHEMBL1260849";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1255191";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL416472";"";"None";"727.03";"2";"5.00";"14 (BILA 2157 BS)";"CC(C)C[C@H](O)[C@H](O)[C@H](CC1CCCCC1)NC(=O)[C@@H](CC(=O)N(CC(=O)N(C)CCc1ccccn1)CC1CCCCC1)Cc1csc(N)n1";"IC50";"'='";"550.0";"nM";"6.26";"";"";"UO_0000065";"8.61";"0.17";"1.26";"3.86";"0";"CHEMBL820309";"Inhibitory concentration against cathepsin D..";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133572";"1";"Scientific Literature";"J Med Chem";"2000";"None";"";"";""
"CHEMBL564530";"";"None";"566.65";"1";"3.23";"7";"CCn1cc2c3c(cc(C(=O)N[C@@H](Cc4ccccc4)[C@H](O)CNCCC(F)(F)F)cc31)N(C)S(=O)(=O)CC2";"IC50";"'='";"570.0";"nM";"6.24";"";"";"UO_0000065";"11.02";"0.22";"3.01";"6.02";"0";"CHEMBL725829";"Inhibition of cathepsin-D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1158411";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL170772";"";"None";"706.93";"1";"4.57";"36";"CC(C)(C)OC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC1CCCCC1)[C@@H](O)[C@@H]1CCN(C2CCCCC2)C1=O";"IC50";"'='";"500.0";"nM";"6.30";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL657351";"Inhibitory concentration against cathepsin D";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1125921";"1";"Scientific Literature";"J Med Chem";"1991";"None";"";"";""
"CHEMBL4444927";"";"None";"570.82";"2";"8.26";"47";"CCCCCc1ccc(C(=O)N(Cc2ccc(-c3ccc(OC)c(OC)c3)cc2)C2CCN(CCC(C)C)CC2)cc1";"IC50";"'='";"5200.0";"nM";"5.28";"";"";"UO_0000065";"9.26";"0.17";"-2.98";"12.58";"0";"CHEMBL4357658";"Inhibition of human cathepsin D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4354841";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";""
"CHEMBL211432";"";"None";"590.85";"1";"2.82";"24";"CCCCNC(=O)[C@H](C)C[C@H](O)[C@@H]1CSCCCCCSC[C@H](NC(=O)OC(C)(C)C)C(=O)N[C@@H](C)C(=O)N1";"IC50";"'='";"20.0";"nM";"7.70";"";"";"UO_0000065";"13.03";"0.27";"4.88";"5.28";"0";"CHEMBL866007";"Inhibition of Cathepsin D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1137429";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";"";""
"CHEMBL1093066";"";"None";"378.38";"0";"3.06";"(R)-4g";"CN1C(=O)[C@](c2ccncc2)(c2cccc(-c3cc(F)ccc3F)c2)N=C1N";"IC50";"'='";"26400.0";"nM";"4.58";"";"";"UO_0000065";"12.10";"0.22";"1.52";"6.40";"0";"CHEMBL1115170";"Inhibition of cathepsin D by FRET assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156304";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL3127102";"";"None";"393.44";"0";"2.14";"56";"COc1cccc(-c2ccc3c(c2)[C@]2(N=C(N)N(C)C2=O)[C@H]2COCC[C@@H]2O3)c1";"IC50";"'='";"1800.0";"nM";"5.75";"";"";"UO_0000065";"14.60";"0.27";"3.60";"6.65";"0";"CHEMBL3131975";"Inhibition of human liver cathepsin D measured for 1 hr by FRET assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124885";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL3127104";"";"None";"388.43";"0";"2.00";"58";"CN1C(=O)[C@]2(N=C1N)c1cc(-c3cccc(C#N)c3)ccc1O[C@H]1CCOC[C@@H]12";"IC50";"'='";"960.0";"nM";"6.02";"";"";"UO_0000065";"15.49";"0.28";"4.02";"5.96";"0";"CHEMBL3131975";"Inhibition of human liver cathepsin D measured for 1 hr by FRET assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124885";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL209795";"";"None";"484.68";"0";"1.88";"4";"CCCCNC(=O)[C@H](C)C[C@H](O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(C)=O";"IC50";"'='";"260.0";"nM";"6.58";"";"";"UO_0000065";"13.59";"0.26";"4.71";"4.82";"1";"CHEMBL1107841";"Inhibition of Cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1155410";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL1257775";"";"None";"421.49";"0";"2.94";"63";"CC(=O)N[C@@H](Cc1cc(F)cc(F)c1)[C@H](O)CNC1(c2nc(C(C)(C)C)co2)CC1";"IC50";"'>'";"200000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1260849";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1255191";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL190010";"";"None";"586.80";"2";"1.67";"36";"CSCC[C@H](NC(=O)[C@H](CC(C)C)NC(C)=O)C(=O)N[C@@H](CC(C)C)[C@@H](O)[C@@H]1CCC[C@H]1C(=O)N[C@@H](C)C(=O)O";"IC50";"'='";"90.0";"nM";"7.05";"";"";"UO_0000065";"12.01";"0.24";"5.38";"4.05";"0";"CHEMBL828480";"Inhibitory concentration against human Cathepsin D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1145163";"1";"Scientific Literature";"J Med Chem";"2005";"None";"";"";""
"CHEMBL419942";"";"None";"754.07";"1";"3.82";"29";"CCCC[C@@H](C(=O)N[C@@H](CC1CCCCC1)[C@@H](O)C[C@H](C(=O)NCCN(C)C)C(C)C)N1CCN(C(=O)N2CCN(C)CC2)[C@H](Cc2ccccc2)C1=O";"IC50";"'='";"58000.0";"nM";"4.24";"";"";"UO_0000065";"5.62";"0.11";"0.42";"3.29";"0";"CHEMBL658687";"Inhibitory concentration against cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133572";"1";"Scientific Literature";"J Med Chem";"2000";"None";"";"";""
"CHEMBL3961329";"";"None";"516.78";"1";"4.98";"BDBM214843";"NC1=N[C@](CF)(c2cc(NC(=O)c3ncc(C(F)(F)F)cc3Cl)ccc2F)C[C@@H](C(F)(F)F)O1";"IC50";"'>'";"400000.0";"nM";"";"Outside typical range";"377964";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3940040";"";"None";"468.38";"0";"3.51";"BDBM214999";"C#CCOc1ccc(C(=O)Nc2cc(F)c(F)c([C@]3(C)C[C@@H](C(F)(F)F)OC(N)=N3)c2)nc1";"IC50";"'='";"1330000.0";"nM";"";"Outside typical range";"377988";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3949268";"";"None";"471.82";"1";"5.19";"BDBM214983";"C[C@@]1(c2cc(Nc3nccc4cc(Cl)cnc34)cc(F)c2F)C[C@@H](C(F)(F)F)OC(N)=N1";"IC50";"'='";"104000.0";"nM";"";"Outside typical range";"378015";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3683831";"";"None";"402.34";"0";"1.93";"BDBM171441";"N#Cc1ccc(C(=O)Nc2cnc(F)c([C@]3(C(F)F)N=C(N)O[C@H]4C[C@H]43)c2)nc1";"IC50";"'='";"347610.0";"nM";"";"Outside typical range";"315850";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3693247";"";"None";"383.40";"0";"2.65";"BDBM171807";"CC#Cc1cncc(-c2cc(C3(CF)N=C(N)OC4CC43)c(F)cc2CO)c1";"IC50";"'='";"177690.0";"nM";"";"Outside typical range";"316203";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688790";"";"None";"430.39";"0";"3.11";"BDBM171737";"COc1cnc2c(Nc3ccc(F)c([C@@]4(C(F)F)N=C(N)O[C@@H]5C[C@@H]54)c3)nccc2n1";"IC50";"'='";"500520.0";"nM";"";"Outside typical range";"316218";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3955614";"";"None";"745.02";"2";"3.38";"BDBM232273";"CC[C@H](C)[C@H](NC(=O)C[C@H](N)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)CC(C)C)C(C)(C)C)C(=O)N[C@H](C(=O)OC)C(C)C";"IC50";"'='";"120.0";"nM";"6.92";"";"405047";"UO_0000065";"9.29";"0.18";"3.54";"3.50";"0";"CHEMBL3888498";"In-Vitro Fluorescence Assay: In order to identify modulators of cathepsin D activity, a continuous enzymatic test was carried out with a synthetic peptide which carries a fluorescent group (MCA=(7-methoxycoumarin-4-yl)acetyl) which is quenched by energy transfer from a Dpn (2,4 dinitrophenyl) group on the same molecule, in Greiner 384-well nb microtitre plates. Cleavage of the peptidic substrate by cathepsin D causes an increase in the fluorescence intensity. In order to determine the efficacy of substances, the time-dependent increase in the fluorescence intensity in the presence of the substance was compared with the time-dependent increase in fluorescence in the absence of substances. The reference substance used was pepstatin A (Sigma-Aldrich). The substrate used was MCAGKPILFFRLK(Dnp)d-R-NH2 (Enzo Life Sciences, Lorrach). The enzyme employed was cathepsin D isolated from the human liver (Sigma-Aldrich) in a final concentration of 1.4 nM. The test was carried out in 100 mM sodium acetate buffer, 1.25% (v/v) of DMSO, 0.25% (w/v) of Chaps, pH 5.5. 2 ul of each substance solution with serially diluted substance concentration were added to in each case 4 ul of cathepsin D solution and incubated at room temperature for 10 min. The reaction was started by addition of 2 ul of substrate solution (final concentration 5 uM). After carrying out a starting-point fluorescence measurement (excitation wavelength 340 nm/emission wavelength 450 nm) using an Envision multilabel reader (Perkin Elmer), the reaction was incubated at room temperature for 60 min. The amount of peptide fragment cleaved off during the reaction time was subsequently measured by determination of the increase in the fluorescence intensity at 450 nm (excitation wavelength 340 nm).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886733";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3898404";"";"None";"750.98";"2";"3.10";"BDBM232275";"CC[C@H](C)[C@H](NC(=O)C[C@H](N)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)CC(C)C)C(C)C)C(=O)N[C@H](C(=O)O)C(C)C";"IC50";"'='";"4.1";"nM";"8.39";"";"405049";"UO_0000065";"11.17";"0.21";"5.29";"4.02";"0";"CHEMBL3888498";"In-Vitro Fluorescence Assay: In order to identify modulators of cathepsin D activity, a continuous enzymatic test was carried out with a synthetic peptide which carries a fluorescent group (MCA=(7-methoxycoumarin-4-yl)acetyl) which is quenched by energy transfer from a Dpn (2,4 dinitrophenyl) group on the same molecule, in Greiner 384-well nb microtitre plates. Cleavage of the peptidic substrate by cathepsin D causes an increase in the fluorescence intensity. In order to determine the efficacy of substances, the time-dependent increase in the fluorescence intensity in the presence of the substance was compared with the time-dependent increase in fluorescence in the absence of substances. The reference substance used was pepstatin A (Sigma-Aldrich). The substrate used was MCAGKPILFFRLK(Dnp)d-R-NH2 (Enzo Life Sciences, Lorrach). The enzyme employed was cathepsin D isolated from the human liver (Sigma-Aldrich) in a final concentration of 1.4 nM. The test was carried out in 100 mM sodium acetate buffer, 1.25% (v/v) of DMSO, 0.25% (w/v) of Chaps, pH 5.5. 2 ul of each substance solution with serially diluted substance concentration were added to in each case 4 ul of cathepsin D solution and incubated at room temperature for 10 min. The reaction was started by addition of 2 ul of substrate solution (final concentration 5 uM). After carrying out a starting-point fluorescence measurement (excitation wavelength 340 nm/emission wavelength 450 nm) using an Envision multilabel reader (Perkin Elmer), the reaction was incubated at room temperature for 60 min. The amount of peptide fragment cleaved off during the reaction time was subsequently measured by determination of the increase in the fluorescence intensity at 450 nm (excitation wavelength 340 nm).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886733";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3936223";"";"None";"737.00";"2";"3.01";"BDBM232284";"CC[C@H](C)[C@H](NC(=O)C[C@H](N)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)CC(C)C)C(C)C)C(=O)N[C@H](CO)C(C)C";"IC50";"'='";"3.6";"nM";"8.44";"";"405058";"UO_0000065";"11.46";"0.22";"5.43";"4.40";"0";"CHEMBL3888498";"In-Vitro Fluorescence Assay: In order to identify modulators of cathepsin D activity, a continuous enzymatic test was carried out with a synthetic peptide which carries a fluorescent group (MCA=(7-methoxycoumarin-4-yl)acetyl) which is quenched by energy transfer from a Dpn (2,4 dinitrophenyl) group on the same molecule, in Greiner 384-well nb microtitre plates. Cleavage of the peptidic substrate by cathepsin D causes an increase in the fluorescence intensity. In order to determine the efficacy of substances, the time-dependent increase in the fluorescence intensity in the presence of the substance was compared with the time-dependent increase in fluorescence in the absence of substances. The reference substance used was pepstatin A (Sigma-Aldrich). The substrate used was MCAGKPILFFRLK(Dnp)d-R-NH2 (Enzo Life Sciences, Lorrach). The enzyme employed was cathepsin D isolated from the human liver (Sigma-Aldrich) in a final concentration of 1.4 nM. The test was carried out in 100 mM sodium acetate buffer, 1.25% (v/v) of DMSO, 0.25% (w/v) of Chaps, pH 5.5. 2 ul of each substance solution with serially diluted substance concentration were added to in each case 4 ul of cathepsin D solution and incubated at room temperature for 10 min. The reaction was started by addition of 2 ul of substrate solution (final concentration 5 uM). After carrying out a starting-point fluorescence measurement (excitation wavelength 340 nm/emission wavelength 450 nm) using an Envision multilabel reader (Perkin Elmer), the reaction was incubated at room temperature for 60 min. The amount of peptide fragment cleaved off during the reaction time was subsequently measured by determination of the increase in the fluorescence intensity at 450 nm (excitation wavelength 340 nm).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886733";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3264812";"";"None";"635.85";"2";"6.85";"18";"CCCN(CCC)C(=O)c1cc(C(=O)N[C@@H](Cc2ccccc2)[C@H](O)CNC(C)(C)c2cccc(OC)c2)cc(-c2ccccc2)c1";"IC50";"'='";"54.0";"nM";"7.27";"";"";"UO_0000065";"11.43";"0.21";"0.42";"8.00";"0";"CHEMBL3271470";"Inhibition of human cathepsin-D using DABCYL-Glu-Arg-Nle-Phe-Leu-Ser-Phe-Pro-EDANS as substrate preincubated for 30 mins by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3259525";"1";"Scientific Literature";"ACS Med Chem Lett";"2014";"None";"";"";""
"CHEMBL69980";"";"None";"489.62";"1";"5.64";"3f";"CCCc1c(COc2ccc(/C=C3\SC(=S)NC3=O)cc2)ccc(C(=O)c2ccccc2)c1O";"IC50";"'='";"210.0";"nM";"6.68";"";"";"UO_0000065";"13.64";"0.27";"1.04";"8.83";"0";"CHEMBL658685";"In vitro inhibition of cathepsin D.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1129769";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1996";"None";"";"";""
"CHEMBL561021";"";"None";"500.67";"1";"2.50";"17";"CCNc1cc(C(=O)N[C@@H](Cc2ccccc2)[C@H](O)CNC2CC2)cc(N2CCCCS2(=O)=O)c1";"IC50";"'='";"30200.0";"nM";"4.52";"";"";"UO_0000065";"9.03";"0.18";"2.02";"4.08";"0";"CHEMBL1035560";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1158445";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL211152";"";"None";"518.75";"1";"1.04";"29";"CCCCNC(=O)[C@H](C)C[C@H](O)[C@@H]1CSCCCCSC[C@H](NC(C)=O)C(=O)N[C@@H](C)C(=O)N1";"IC50";"'='";"9700.0";"nM";"5.01";"";"";"UO_0000065";"9.66";"0.20";"3.97";"3.67";"0";"CHEMBL866007";"Inhibition of Cathepsin D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1137429";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";"";""
"CHEMBL4062728";"";"None";"361.41";"0";"3.52";"6r";"C[C@@]1(c2cc(CNC3(C(F)F)CC3)c(F)cc2F)CCSC(N)=N1";"IC50";"'='";"65500.0";"nM";"4.18";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4042703";"Inhibition of Cathepsin D (unknown origin) by cell free assay";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4041533";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";"";""
"CHEMBL4077211";"";"None";"336.41";"0";"2.78";"6s";"C[C@@]1(c2cc(CNC3(C#N)CC3)c(F)cc2F)CCSC(N)=N1";"IC50";"'='";"71800.0";"nM";"4.14";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4042703";"Inhibition of Cathepsin D (unknown origin) by cell free assay";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4041533";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";"";""
"CHEMBL4098403";"";"None";"379.40";"0";"3.82";"6u";"C[C@@]1(c2cc(CNC3(C(F)(F)F)CC3)c(F)cc2F)CCSC(N)=N1";"IC50";"'='";"32400.0";"nM";"4.49";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4042703";"Inhibition of Cathepsin D (unknown origin) by cell free assay";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4041533";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";"";""
"CHEMBL1760729";"";"None";"403.54";"0";"2.62";"14e";"CC(C)c1cccc(CN[C@H]2CS(=O)(=O)C[C@@H](Cc3ccc(O)cc3)[C@@H]2O)c1";"IC50";"'='";"5400.0";"nM";"5.27";"";"";"UO_0000065";"13.05";"0.26";"2.65";"6.08";"0";"CHEMBL1764636";"Inhibition of human cathepsin D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1759891";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL70042";"";"None";"505.62";"2";"5.35";"8i";"CCCc1c(OCc2ccc(/C=C3\SC(=S)NC3=O)cc2)ccc(C(=O)c2ccccc2O)c1O";"IC50";"'='";"620.0";"nM";"6.21";"";"";"UO_0000065";"12.28";"0.24";"0.86";"6.48";"0";"CHEMBL658685";"In vitro inhibition of cathepsin D.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1129769";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1996";"None";"";"";""
"CHEMBL171236";"";"None";"682.86";"1";"2.88";"32";"COC[C@@H]1C[C@@H]([C@H](O)[C@H](CC2CCCCC2)NC(=O)[C@H](Cc2c[nH]cn2)NC(=O)[C@H](Cc2ccccc2)NC(=O)OC(C)(C)C)C(=O)N1C";"IC50";"'='";"280.0";"nM";"6.55";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL657351";"Inhibitory concentration against cathepsin D";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1125921";"1";"Scientific Literature";"J Med Chem";"1991";"None";"";"";""
"CHEMBL402171";"";"None";"518.66";"1";"2.95";"31";"CCNc1cc(C(=O)N[C@@H](Cc2ccccc2)[C@H](O)CNCc2cnn(CC)c2)cc(N2CCCC2=O)c1";"IC50";"'='";"46770.0";"nM";"4.33";"";"";"UO_0000065";"8.35";"0.16";"1.38";"3.88";"0";"CHEMBL945833";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140837";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";"";"";""
"CHEMBL231646";"";"None";"556.71";"1";"4.32";"19e";"CCCN(CCC)C(=O)c1cc(C#N)cc(C(=O)N[C@@H](Cc2ccccc2)[C@H](O)CNCc2cccc(OC)c2)c1";"IC50";"'='";"660.0";"nM";"6.18";"";"";"UO_0000065";"11.10";"0.21";"1.86";"5.39";"0";"CHEMBL888969";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1144655";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"None";"";"";""
"CHEMBL4642463";"";"None";"297.42";"0";"0.99";"17";"CCCCNC(=O)[C@@H]1C[C@H]1[C@]12COC[C@H]1CSC(N)=N2";"IC50";"'>'";"300000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4614137";"Inhibition of human cathepsin D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4613225";"1";"Scientific Literature";"Bioorg Med Chem";"2020";"None";"";"";""
"CHEMBL314359";"";"None";"663.44";"2";"9.96";"12";"CCOc1ccc2nc(Sc3ccc(NC(=O)c4cc(Cl)cc(Cl)c4NC(=O)c4cc(Cl)cc(Cl)c4)cc3)sc2c1";"IC50";"'='";"780.0";"nM";"6.11";"";"";"UO_0000065";"9.21";"0.20";"-3.85";"7.60";"0";"CHEMBL657347";"Inhibitory activity against human liver Cathepsin D using Cathepsin D assay.";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1132101";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1999";"None";"";"";""
"CHEMBL3321929";"";"None";"528.63";"1";"3.69";"28";"COc1ccc(CNC(=O)[C@@H](CC2CCCCC2)NC(=N)NC(=O)Cc2ccc(OC)c(OC)c2)cc1F";"IC50";"'='";"98.0";"nM";"7.01";"";"";"UO_0000065";"13.26";"0.25";"3.32";"5.76";"0";"CHEMBL3371146";"Inhibition of human liver cathepsin D using MCA-labeled GKPILFFRLK(Dnp)-D-R-NH2 peptide by fluorescence-based assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351526";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3321928";"";"None";"528.63";"1";"3.69";"27";"COc1cc(CNC(=O)[C@@H](CC2CCCCC2)NC(=N)NC(=O)Cc2ccc(OC)c(OC)c2)ccc1F";"IC50";"'='";"170.0";"nM";"6.77";"";"";"UO_0000065";"12.81";"0.24";"3.08";"5.56";"0";"CHEMBL3371146";"Inhibition of human liver cathepsin D using MCA-labeled GKPILFFRLK(Dnp)-D-R-NH2 peptide by fluorescence-based assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351526";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3763955";"";"None";"447.54";"1";"5.72";"rac-3e";"Nc1nc2cc(-c3ccccc3)ccc2c(=O)n1C[C@@H]1CC[C@H](c2ccc3ccccc3c2)O1";"IC50";"'='";"19500.0";"nM";"4.71";"";"";"UO_0000065";"10.52";"0.19";"-1.01";"6.72";"0";"CHEMBL3767017";"Inhibition of CatD (unknown origin) preincubated for 30 mins followed by DABCYL-Glu-Arg-Nle-Phe-Leu-Ser-Phe-Pro-EDANS substrate addition by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3763050";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";""
"CHEMBL47476";"";"None";"543.71";"1";"3.57";"9a";"CC(C)(C)OC(=O)N[C@@H](Cc1ccccc1)[C@H](O)CNC[C@@H](O)[C@H](Cc1ccccc1)NC(=O)OC(C)(C)C";"IC50";"'>'";"31000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL874520";"The inhibitory concentration value was measured on Human cathepsin D at 31000 nM";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1127539";"1";"Scientific Literature";"J Med Chem";"1994";"None";"";"";""
"CHEMBL566638";"";"None";"456.55";"0";"4.11";"43";"COc1ccc(C2(c3cccc(-c4cccnc4)c3)N=C(N)N(C)C2=O)cc1OC1CCCC1";"IC50";"'='";"8300.0";"nM";"5.08";"";"";"UO_0000065";"11.13";"0.20";"0.97";"5.64";"0";"CHEMBL1044551";"Inhibition of human cathepsin D by FRET based peptide cleavage assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156789";"1";"Scientific Literature";"J Med Chem";"2010";"None";"";"";""
"CHEMBL571319";"";"None";"353.47";"0";"2.89";"(R)-30";"COc1ccc([C@@]2(C34CC5CC(CC(C5)C3)C4)N=C(N)N(C)C2=O)cc1";"IC50";"'='";"20780.0";"nM";"4.68";"";"";"UO_0000065";"13.25";"0.25";"1.79";"6.89";"0";"CHEMBL1044551";"Inhibition of human cathepsin D by FRET based peptide cleavage assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156789";"1";"Scientific Literature";"J Med Chem";"2010";"None";"";"";""
"CHEMBL1210362";"";"None";"687.78";"2";"6.96";"44";"CS(=O)(=O)N(c1ccccc1)c1cc(C(=O)N[C@@H](Cc2ccccc2)[C@H](O)CNCc2cccc(C(F)(F)F)c2)cc(-c2ccccc2)c1";"IC50";"'='";"250.0";"nM";"6.60";"";"";"UO_0000065";"9.60";"0.18";"-0.36";"6.69";"0";"CHEMBL1211667";"Inhibition of Cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1208699";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL2425605";"";"None";"564.65";"1";"3.05";"17l";"COC[C@@H](Oc1cc(C[C@@H]2C[S@@+]([O-])C[C@H](NCc3cnn(CC(C)(C)C)c3)[C@H]2O)cc(F)c1N)C(F)(F)F";"IC50";"'='";"9680.0";"nM";"5.01";"";"";"UO_0000065";"8.88";"0.18";"1.96";"4.26";"0";"CHEMBL2427050";"Inhibition of human cathepsin-D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2424550";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"None";"";"";""
"CHEMBL2425601";"";"None";"576.65";"1";"3.07";"17h";"COC[C@@H](Oc1cc(C[C@@H]2C[S@@+]([O-])C[C@H](NCc3cccc(C(C)(C)CO)c3)[C@H]2O)cc(F)c1N)C(F)(F)F";"IC50";"'='";"3390.0";"nM";"5.47";"";"";"UO_0000065";"9.49";"0.19";"2.40";"4.56";"0";"CHEMBL2427050";"Inhibition of human cathepsin-D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2424550";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"None";"";"";""
"CHEMBL2425618";"";"None";"546.63";"1";"3.93";"17c";"COC[C@@H](Oc1cc(C[C@@H]2C[S@@+]([O-])C[C@H](NCc3cccc(C(C)C)c3)[C@H]2O)cc(F)c1N)C(F)(F)F";"IC50";"'='";"4030.0";"nM";"5.39";"";"";"UO_0000065";"9.87";"0.20";"1.46";"5.41";"0";"CHEMBL2427050";"Inhibition of human cathepsin-D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2424550";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"None";"";"";""
"CHEMBL211193";"";"None";"496.72";"0";"1.59";"99";"CCCCNC(=O)[C@H](C)C[C@H](O)[C@@H]1CSC/C=C/CC[C@@H]2CNCC[C@@H]2C(=O)N[C@@H](C)C(=O)N1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL866007";"Inhibition of Cathepsin D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1137429";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";"";""
"CHEMBL378897";"";"None";"574.81";"1";"2.21";"28";"CCCCNC(=O)[C@H](C)C[C@H](O)[C@@H]1CSC/C=C/CSC[C@H](NC(=O)OC(C)(C)C)C(=O)N[C@@H](C)C(=O)N1";"IC50";"'='";"190.0";"nM";"6.72";"";"";"UO_0000065";"11.69";"0.24";"4.51";"4.61";"0";"CHEMBL866007";"Inhibition of Cathepsin D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1137429";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";"";""
"CHEMBL211384";"";"None";"498.71";"0";"2.22";"104";"CCCCNC(=O)[C@H](C)C[C@H](O)[C@H](CC(C)C)NC(=O)[C@H](C)N(C)C(=O)[C@H](CC(C)C)NC(C)=O";"IC50";"'='";"190.0";"nM";"6.72";"";"";"UO_0000065";"13.48";"0.26";"4.50";"5.26";"0";"CHEMBL866007";"Inhibition of Cathepsin D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1137429";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";"";""
"CHEMBL3906250";"";"None";"471.82";"0";"5.00";"BDBM214807";"NC1=N[C@](CF)(c2cc(Nc3nccc4cc(Cl)cnc34)ccc2F)C[C@@H](C(F)(F)F)O1";"IC50";"'>'";"133000.0";"nM";"";"Outside typical range";"377857";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3977392";"";"None";"469.37";"0";"3.18";"BDBM214847";"COc1cc(C#N)cnc1C(=O)Nc1ccc(F)c([C@]2(CF)C[C@@H](C(F)(F)F)OC(N)=N2)c1";"IC50";"'>'";"400000.0";"nM";"";"Outside typical range";"377871";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3921965";"";"None";"436.37";"0";"2.93";"BDBM214866";"Cc1cc(C#N)cnc1C(=O)Nc1cnc(F)c([C@]2(C)C[C@@H](C(F)(F)F)OC(N)=N2)c1";"IC50";"'>'";"400000.0";"nM";"";"Outside typical range";"377881";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3943888";"";"None";"445.78";"1";"5.12";"BDBM214906";"NC1=N[C@](CF)(c2cc(-c3nc4ccc(Cl)cc4o3)ccc2F)C[C@@H](C(F)(F)F)O1";"IC50";"'>'";"44400.0";"nM";"";"";"377934";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3960610";"";"None";"469.37";"0";"2.71";"BDBM214835";"C#CCOc1cnc(C(=O)Nc2ccc(F)c([C@]3(CF)C[C@@H](C(F)(F)F)OC(N)=N3)c2)cn1";"IC50";"'>'";"400000.0";"nM";"";"Outside typical range";"377955";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3964525";"";"None";"464.34";"0";"4.24";"BDBM214841";"NC1=N[C@](CF)(c2cc(NC(=O)c3ccc(C(F)F)cn3)ccc2F)C[C@@H](C(F)(F)F)O1";"IC50";"'>'";"400000.0";"nM";"";"Outside typical range";"377962";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3927002";"";"None";"462.35";"0";"3.45";"BDBM214962";"COc1ccc(C(=O)Nc2cc(F)c(F)c([C@]3(CF)C[C@@H](C(F)(F)F)OC(N)=N3)c2)nc1";"IC50";"'>'";"400000.0";"nM";"";"Outside typical range";"377997";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL1934295";"";"None";"492.11";"1";"5.88";"12";"O=C([C@@H]1CNC[C@]12CCCc1nc(Cl)ccc12)N1CC[C@@H](c2ccccc2)C[C@H]1C1CCCCC1";"IC50";"'='";"6212.0";"nM";"5.21";"";"";"UO_0000065";"10.58";"0.20";"-0.67";"11.51";"0";"CHEMBL1937605";"Inhibition of Cat D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1933035";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL264322";"";"None";"598.74";"1";"3.69";"21";"CCNc1cc(C(=O)N[C@@H](Cc2ccccc2)[C@H](O)CNCc2cccc(OC)c2)c(F)c(N2CCCCS2(=O)=O)c1";"IC50";"'='";"6545.0";"nM";"5.18";"";"";"UO_0000065";"8.66";"0.17";"1.49";"4.32";"0";"CHEMBL945838";"Inhibition of Cathepsin D expressed in CHO cells by FRET assay";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140838";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"CHEMBL3308072";"";"";""
"CHEMBL74943";"";"None";"564.77";"1";"3.82";"PS-444035";"CCCCNC(=O)CC(O)C(Cc1ccccc1)NC(=O)[C@@H](NC(=O)c1ccc(CN2CCCC2)cc1)[C@@H](C)CC";"IC50";"'='";"1200.0";"nM";"5.92";"";"";"UO_0000065";"10.48";"0.20";"2.10";"5.35";"0";"CHEMBL658686";"Inhibitory activity against cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1131370";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1998";"None";"";"";""
"CHEMBL3127095";"";"None";"338.37";"0";"1.48";"73";"NC1=N[C@@]2(CO1)c1cc(-c3cncnc3)ccc1O[C@H]1CCOC[C@@H]12";"IC50";"'='";"76000.0";"nM";"4.12";"";"";"UO_0000065";"12.17";"0.23";"2.64";"4.48";"0";"CHEMBL3131974";"Inhibition of human spleen cathepsin D measured for 1 hr by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"CHEMBL3559722";"Spleen";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124885";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL3127094";"";"None";"355.37";"0";"2.23";"72";"NC1=N[C@@]2(CO1)c1cc(-c3cccnc3F)ccc1O[C@@H]1CCOC[C@H]12";"IC50";"'='";"170000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3131974";"Inhibition of human spleen cathepsin D measured for 1 hr by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"CHEMBL3559722";"Spleen";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124885";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL3127080";"";"None";"396.42";"0";"2.06";"87";"CN1C(=O)[C@]2(N=C1N)c1cc(-c3cccnc3F)ccc1O[C@H]1CCOC[C@@]12C";"IC50";"'='";"490.0";"nM";"6.31";"";"";"UO_0000065";"15.92";"0.30";"4.25";"7.01";"0";"CHEMBL3131975";"Inhibition of human liver cathepsin D measured for 1 hr by FRET assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124885";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL423112";"";"None";"382.46";"0";"2.86";"MDL-28170";"CC(C)[C@H](NC(=O)OCc1ccccc1)C(=O)NC(C=O)Cc1ccccc1";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1021961";"Inhibition of human liver cathepsin D after 30 mins by fluorometric end-point assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138527";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL296588";"PEPSTATIN";"2.0";"685.90";"2";"1.47";"Pepstatin A";"CC(C)CC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)[C@@H](O)CC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)[C@@H](O)CC(=O)O)C(C)C)C(C)C";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1021961";"Inhibition of human liver cathepsin D after 30 mins by fluorometric end-point assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138527";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL257871";"";"None";"562.76";"1";"3.89";"26";"CCCc1cc(C(=O)N[C@@H](Cc2ccccc2)[C@H](O)CN[C@@H](C)C(=O)NC2CCCCC2)cc(N2CCCC2=O)c1";"IC50";"'='";"4570.0";"nM";"5.34";"";"";"UO_0000065";"9.49";"0.18";"1.45";"4.82";"0";"CHEMBL931965";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1143153";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";"";"";""
"CHEMBL255964";"";"None";"591.80";"1";"4.01";"24";"CC(C)CNc1cc(C(=O)N[C@@H](Cc2ccccc2)[C@H](O)CN[C@@H](C)C(=O)NC2CCCCC2)cc(N2CCCC2=O)c1";"IC50";"'='";"3090.0";"nM";"5.51";"";"";"UO_0000065";"9.31";"0.18";"1.50";"4.49";"0";"CHEMBL931965";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1143153";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";"";"";""
"CHEMBL113208";"";"None";"596.73";"2";"0.84";"19";"CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)C[C@H](O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)c1ccccn1)C(C)C)C(N)=O";"IC50";"'='";"21.0";"nM";"7.68";"";"";"UO_0000065";"12.87";"0.24";"6.84";"3.99";"0";"CHEMBL658681";"Inhibitory concentration against Human cathepsin D.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133572";"1";"Scientific Literature";"J Med Chem";"2000";"None";"";"";""
"CHEMBL378015";"";"None";"471.51";"1";"5.11";"16";"COc1cc(C(=O)c2c(OCC(=O)Nc3ccccc3)ccc3ccccc23)cc(OC)c1OC";"IC50";"'='";"231500.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL869858";"Inhibition of human cathepsin D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149516";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"None";"";"";""
"CHEMBL490304";"";"None";"439.64";"0";"3.05";"2a";"CCCCNC(=O)[C@H](C)C[C@H](O)[C@@H]1C[C@H](C)CCCCCCCC(=O)N[C@@H](C)C(=O)N1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1030363";"Inhibition of human cathepsin D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1151821";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL187765";"";"None";"600.78";"2";"0.85";"35";"CSCC[C@H](NC(=O)[C@H](CC(C)C)NC(C)=O)C(=O)N[C@@H](CC(C)C)[C@@H](O)[C@@H]1CC(=O)C[C@H]1C(=O)N[C@@H](C)C(=O)O";"IC50";"'='";"1500.0";"nM";"5.82";"";"";"UO_0000065";"9.69";"0.19";"4.97";"3.05";"0";"CHEMBL828480";"Inhibitory concentration against human Cathepsin D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1145163";"1";"Scientific Literature";"J Med Chem";"2005";"None";"";"";""
"CHEMBL221454";"";"None";"578.74";"1";"3.03";"3";"C[C@@H](NC(=O)c1cc(C(=O)N[C@@H](Cc2ccccc2)C(O)CNC2CC2)cc(N(C)S(C)(=O)=O)c1)c1ccccc1";"IC50";"'='";"7620.0";"nM";"5.12";"";"";"UO_0000065";"8.84";"0.17";"2.09";"4.00";"0";"CHEMBL917723";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149268";"1";"Scientific Literature";"J Med Chem";"2004";"None";"";"";""
"CHEMBL425424";"";"None";"566.79";"1";"1.96";"32";"CCCCNC(=O)[C@H](C)C[C@H](O)[C@@H]1CSCc2ccc(cc2)CSC[C@H](NC(C)=O)C(=O)N[C@@H](C)C(=O)N1";"IC50";"'='";"3600.0";"nM";"5.44";"";"";"UO_0000065";"9.60";"0.20";"3.48";"3.98";"0";"CHEMBL866007";"Inhibition of Cathepsin D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1137429";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";"";""
"CHEMBL3765557";"";"None";"397.48";"0";"4.22";"rac-3g; mixture of diastereomers";"Nc1nc2cc(-c3ccccc3)ccc2c(=O)n1CC1CC(c2ccccc2)CO1";"IC50";"'>'";"200000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3767017";"Inhibition of CatD (unknown origin) preincubated for 30 mins followed by DABCYL-Glu-Arg-Nle-Phe-Leu-Ser-Phe-Pro-EDANS substrate addition by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3763050";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";""
"CHEMBL427719";"";"None";"580.75";"1";"3.55";"16";"CCNc1cc(C(=O)N[C@@H](Cc2ccccc2)[C@H](O)CNCc2cccc(OC)c2)cc(N2CCCCS2(=O)=O)c1";"IC50";"'='";"6760.0";"nM";"5.17";"";"";"UO_0000065";"8.90";"0.17";"1.62";"4.31";"0";"CHEMBL945838";"Inhibition of Cathepsin D expressed in CHO cells by FRET assay";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140838";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"CHEMBL3308072";"";"";""
"CHEMBL3321917";"";"None";"406.83";"0";"2.65";"9";"COc1cc(CC(=O)NC(=N)NCc2ccccc2Cl)c([N+](=O)[O-])cc1OC";"IC50";"'='";"3000.0";"nM";"5.52";"";"";"UO_0000065";"13.58";"0.27";"2.87";"4.36";"0";"CHEMBL3371146";"Inhibition of human liver cathepsin D using MCA-labeled GKPILFFRLK(Dnp)-D-R-NH2 peptide by fluorescence-based assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351526";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL2407489";"";"None";"632.80";"2";"5.55";"20";"CCc1ccc2c(c1)[C@@H](NC[C@@H](O)[C@@H]1Cc3cccc(c3)CCCCn3cc(cc(-c4ccccn4)c3=O)C(=O)N1)CC1(CCC1)O2";"IC50";"'='";"54.0";"nM";"7.27";"";"";"UO_0000065";"11.48";"0.21";"1.72";"6.89";"0";"CHEMBL2411009";"Inhibition of Cathepsin D (unknown origin) by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2406987";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"None";"";"";""
"CHEMBL2407488";"";"None";"555.72";"1";"4.49";"19";"CCc1ccc2c(c1)[C@@H](NC[C@@H](O)[C@@H]1Cc3cccc(c3)CCCCn3cc(ccc3=O)C(=O)N1)CC1(CCC1)O2";"IC50";"'='";"72.0";"nM";"7.14";"";"";"UO_0000065";"12.85";"0.24";"2.65";"7.71";"0";"CHEMBL2411009";"Inhibition of Cathepsin D (unknown origin) by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2406987";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"None";"";"";""
"CHEMBL1076905";"";"None";"835.97";"1";"4.87";"34-(R)";"CC(C)[C@H](NC(=O)[C@H](C)C[C@H](O)[C@H](COc1cc(F)cc(F)c1)NC(=O)c1cc(C(=O)N[C@H](C)c2ccccc2)cc(N(C)S(C)(=O)=O)c1)C(=O)NCc1ccccc1";"IC50";"'='";"59.0";"nM";"7.23";"";"";"UO_0000065";"8.65";"0.17";"2.36";"3.95";"0";"CHEMBL1106032";"Inhibition of human liver cathepsin D after 20 mins by homogeneous time resolved fluorescence assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1154862";"1";"Scientific Literature";"Eur J Med Chem";"2010";"None";"";"";""
"CHEMBL394595";"";"None";"575.71";"1";"4.15";"19l";"CCCN(CCC)C(=O)c1cc(C(=O)O)cc(C(=O)N[C@@H](Cc2ccccc2)[C@H](O)CNCc2cccc(OC)c2)c1";"IC50";"'='";"3600.0";"nM";"5.44";"";"";"UO_0000065";"9.46";"0.18";"1.29";"4.25";"0";"CHEMBL888969";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1144655";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"None";"";"";""
"CHEMBL397714";"";"None";"608.73";"1";"4.38";"19j";"CCCN(CCC)C(=O)c1cc(C(N)=O)cc(C(=O)N[C@@H](Cc2cc(F)cc(F)c2)[C@H](O)CNCc2cccc(CC)c2)c1";"IC50";"'='";"1600.0";"nM";"5.80";"";"";"UO_0000065";"9.52";"0.18";"1.42";"4.65";"0";"CHEMBL888969";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1144655";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"None";"";"";""
"CHEMBL230190";"";"None";"570.73";"1";"4.52";"19f";"CCCN(CCC)C(=O)c1cc(CC#N)cc(C(=O)N[C@@H](Cc2ccccc2)[C@H](O)CNCc2cccc(OC)c2)c1";"IC50";"'='";"570.0";"nM";"6.24";"";"";"UO_0000065";"10.94";"0.20";"1.72";"5.44";"0";"CHEMBL888969";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1144655";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"None";"";"";""
"CHEMBL315686";"";"None";"477.39";"1";"6.72";"24";"COc1ccc2sc(Sc3ccc(NC(=O)c4cc(Cl)cc(Cl)c4O)cc3)nc2c1";"IC50";"'='";"5000.0";"nM";"5.30";"";"";"UO_0000065";"11.10";"0.24";"-1.42";"7.42";"0";"CHEMBL657347";"Inhibitory activity against human liver Cathepsin D using Cathepsin D assay.";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1132101";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1999";"None";"";"";""
"CHEMBL85212";"";"None";"472.38";"1";"6.58";"33";"N#Cc1cc(Sc2nc3ccccc3s2)ccc1NC(=O)c1cc(Cl)cc(Cl)c1O";"IC50";"'='";"2400.0";"nM";"5.62";"";"";"UO_0000065";"11.90";"0.26";"-0.96";"6.53";"0";"CHEMBL657347";"Inhibitory activity against human liver Cathepsin D using Cathepsin D assay.";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1132101";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1999";"None";"";"";""
"CHEMBL208681";"";"None";"673.94";"2";"2.35";"41";"CCCCNC(=O)[C@@H](NC(=O)[C@H](C)C[C@H](O)[C@@H]1CSC/C=C\CSC[C@H](NC(=O)OC(C)(C)C)C(=O)N[C@@H](C)C(=O)N1)C(C)C";"IC50";"'='";"50.0";"nM";"7.30";"";"";"UO_0000065";"10.83";"0.22";"4.95";"4.17";"0";"CHEMBL866007";"Inhibition of Cathepsin D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1137429";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";"";""
"CHEMBL584109";"";"None";"381.52";"0";"3.46";"35";"CCc1cc(C2(C34CC5CC(CC(C5)C3)C4)N=C(N)N(C)C2=O)ccc1OC";"IC50";"'='";"14100.0";"nM";"4.85";"";"";"UO_0000065";"12.71";"0.24";"1.39";"7.14";"0";"CHEMBL1044551";"Inhibition of human cathepsin D by FRET based peptide cleavage assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156789";"1";"Scientific Literature";"J Med Chem";"2010";"None";"";"";""
"CHEMBL570298";"";"None";"487.59";"0";"3.07";"16, diastereomer";"CC(=O)N[C@@H](Cc1cc(F)cc(F)c1)[C@H](O)CNC1(c2cccc(C(C)(C)C)c2)CCNC(=O)C1";"IC50";"'='";"1100.0";"nM";"5.96";"";"";"UO_0000065";"12.22";"0.23";"2.89";"6.59";"0";"CHEMBL1045212";"Inhibition of cathepsin D assessed as reduction in polarization after 110 mins by oregon green based fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156090";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL572082";"";"None";"489.61";"0";"3.64";"19, mixture of epimers";"CC(=O)N[C@@H](Cc1cc(F)cc(F)c1)[C@H](O)CNC1(c2cccc(C(C)(C)C)c2)CCCN(O)C1";"IC50";"'='";"670.0";"nM";"6.17";"";"";"UO_0000065";"12.61";"0.24";"2.53";"7.28";"0";"CHEMBL1045212";"Inhibition of cathepsin D assessed as reduction in polarization after 110 mins by oregon green based fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156090";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL571860";"";"None";"472.62";"1";"5.12";"1, mixture of epimers";"CC(=O)N[C@@H](Cc1cc(F)cc(F)c1)[C@H](O)CNC1(c2cccc(C(C)(C)C)c2)CCCCC1";"IC50";"'='";"25.0";"nM";"7.60";"";"";"UO_0000065";"16.08";"0.31";"2.48";"12.39";"0";"CHEMBL1045212";"Inhibition of cathepsin D assessed as reduction in polarization after 110 mins by oregon green based fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156090";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL570556";"";"None";"474.59";"0";"3.97";"8, mixture of epimers";"CC(=O)N[C@@H](Cc1cc(F)cc(F)c1)[C@H](O)CNC1(c2cccc(C(C)(C)C)c2)CCOCC1";"IC50";"'='";"230.0";"nM";"6.64";"";"";"UO_0000065";"13.99";"0.27";"2.67";"9.40";"0";"CHEMBL1045212";"Inhibition of cathepsin D assessed as reduction in polarization after 110 mins by oregon green based fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156090";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL2408759";"";"None";"490.59";"0";"4.44";"54";"CC(=O)N[C@@H](Cc1cc(F)cc(F)c1)[C@H](O)CN[C@H]1CC(C)(C)Oc2ccc(OC(C)(C)C)cc21";"IC50";"'='";"374.0";"nM";"6.43";"";"";"UO_0000065";"13.10";"0.25";"1.99";"8.05";"0";"CHEMBL2410948";"Inhibition of cathepsin-D (unknown origin) using C-terminal biotinylated peptide substrate treated 30 mins before addition of peptide substrate measured after 110 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2406984";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"None";"";"";""
"CHEMBL508753";"";"None";"632.75";"1";"4.87";"10";"CCNc1cc(C(=O)N[C@@H](Cc2ccccc2)[C@H](O)CNCc2cccc(C(F)(F)F)c2)cc(N2CCCCS2(=O)=O)c1C";"IC50";"'='";"980.0";"nM";"6.01";"";"";"UO_0000065";"9.50";"0.19";"1.14";"5.42";"0";"CHEMBL1036847";"Inhibition of cathepsin-D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1137769";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL248699";"";"None";"549.74";"1";"4.76";"2a";"CCCN(c1cc2cc(c1)C(=O)N[C@@H](c1ccccc1)CCc1cccc(c1)C[C@@](C)(N)COC2)S(C)(=O)=O";"IC50";"'='";"275000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL886447";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1139967";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"None";"";"";""
"CHEMBL296588";"PEPSTATIN";"2.0";"685.90";"2";"1.47";"Pepstatin";"CC(C)CC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)[C@@H](O)CC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)[C@@H](O)CC(=O)O)C(C)C)C(C)C";"IC50";"'='";"2.0";"nM";"8.70";"";"";"UO_0000065";"12.68";"0.25";"7.23";"3.90";"0";"CHEMBL657347";"Inhibitory activity against human liver Cathepsin D using Cathepsin D assay.";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1132101";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1999";"None";"";"";""
"CHEMBL81963";"";"None";"436.56";"1";"6.11";"37";"CCOc1ccc2nc(Sc3ccc(NC(=O)c4cccc(C)c4O)cc3)sc2c1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL657347";"Inhibitory activity against human liver Cathepsin D using Cathepsin D assay.";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1132101";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1999";"None";"";"";""
"CHEMBL212102";"";"None";"500.66";"1";"0.10";"18";"CCCCNC(=O)[C@H](C)C[C@H](O)[C@@H]1COC/C=C/CSC[C@H](NC(C)=O)C(=O)N[C@@H](C)C(=O)N1";"IC50";"'='";"6000.0";"nM";"5.22";"";"";"UO_0000065";"10.43";"0.21";"5.12";"3.58";"0";"CHEMBL866007";"Inhibition of Cathepsin D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1137429";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";"";""
"CHEMBL212321";"";"None";"459.68";"0";"1.71";"35";"CCCCNC(=O)[C@H](C)C[C@H](O)[C@@H]1CSC/C=C/CSCCC(=O)N[C@@H](C)C(=O)N1";"IC50";"'='";"3900.0";"nM";"5.41";"";"";"UO_0000065";"11.77";"0.25";"3.70";"5.03";"0";"CHEMBL866007";"Inhibition of Cathepsin D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1137429";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";"";""
"CHEMBL317653";"";"None";"824.42";"3";"5.56";"49";"CC(C)[C@H](NC(=O)[C@H](NCc1ccc(Cl)cc1)[C@H](O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)OCc1ccccc1)C(C)(C)C)C(=O)NCc1nc2ccccc2[nH]1";"IC50";"'='";"1800.0";"nM";"5.75";"";"";"UO_0000065";"6.97";"0.13";"0.18";"3.08";"0";"CHEMBL657353";"Selectivity for their inhibitory potency against human cathepsin D.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1127464";"1";"Scientific Literature";"J Med Chem";"1994";"None";"";"";""
"CHEMBL2177340";"";"None";"360.37";"0";"2.85";"9u";"COc1ccc2c(c1)[C@]1(COC(N)=N1)c1cc(-c3cncnc3)ccc1O2";"IC50";"'='";"29700.0";"nM";"4.53";"";"";"UO_0000065";"12.56";"0.23";"1.68";"4.93";"0";"CHEMBL2183109";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2177044";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL2177315";"";"None";"363.39";"0";"3.48";"6";"COc1ccc(C2(c3cccc(-c4cccnc4F)c3)COC(N)=N2)cc1";"IC50";"'='";"12600.0";"nM";"4.90";"";"";"UO_0000065";"13.48";"0.25";"1.42";"7.03";"0";"CHEMBL2183109";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2177044";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL94797";"";"None";"573.78";"1";"2.31";"18";"CC(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)[C@@H](O)CN(CC1CCCCC1)NC(=O)[C@@H](NC(C)=O)C(C)C)C(C)C";"IC50";"'='";"7500.0";"nM";"5.12";"";"";"UO_0000065";"8.93";"0.17";"2.81";"3.66";"0";"CHEMBL662649";"The compound was tested for its inhibitory activity against human cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1127172";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1993";"None";"";"";""
"CHEMBL4229013";"";"None";"441.49";"0";"4.19";"2g";"Nc1nc2cc(-c3ccccc3)cc(-c3cccc(C(=O)O)c3)c2c(=O)n1CC1CCCO1";"IC50";"'='";"98000.0";"nM";"4.01";"";"";"UO_0000065";"9.08";"0.17";"-0.18";"3.73";"0";"CHEMBL4223547";"Inhibition of human cathepsin D using DABCYL-Glu-Arg-Nle-Phe-Leu-Ser-Phe-Pro-EDANS as substrate preincubated for 30 mins followed by substrate addition measured every 1 min within 8 to 15 mins by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4219216";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";"";""
"CHEMBL4227851";"";"None";"453.40";"0";"2.94";"22";"C[C@]1(c2cc(NC(=O)c3cnc(OCF)cn3)ccc2F)N=C(N)O[C@H](C2(F)CC2)[C@@H]1F";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4224430";"Inhibition of Cathepsin D (unknown origin)";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4219264";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL363783";"";"None";"771.87";"3";"-2.07";"4";"CC(C)C[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CCC(=O)O)C(C)C)[C@@H](O)[C@@H]1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)O";"IC50";"'='";"60.0";"nM";"7.22";"";"";"UO_0000065";"9.36";"0.18";"9.29";"2.08";"0";"CHEMBL828480";"Inhibitory concentration against human Cathepsin D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1145163";"1";"Scientific Literature";"J Med Chem";"2005";"None";"";"";""
"CHEMBL364446";"";"None";"614.85";"2";"2.31";"40";"CSCC[C@H](NC(=O)[C@H](CC(C)C)NC(C)=O)C(=O)N[C@@H](CC(C)C)[C@@H](O)[C@@H]1CCC[C@H]1C(=O)N[C@H](C(=O)O)C(C)C";"IC50";"'='";"25.0";"nM";"7.60";"";"";"UO_0000065";"12.36";"0.25";"5.29";"4.37";"0";"CHEMBL828480";"Inhibitory concentration against human Cathepsin D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1145163";"1";"Scientific Literature";"J Med Chem";"2005";"None";"";"";""
"CHEMBL1210358";"";"None";"612.67";"1";"4.69";"38";"CS(=O)(=O)N(c1cccnc1)c1cccc(C(=O)N[C@@H](Cc2ccccc2)[C@H](O)CNCc2cccc(C(F)(F)F)c2)c1";"IC50";"'='";"400.0";"nM";"6.40";"";"";"UO_0000065";"10.44";"0.20";"1.71";"5.73";"0";"CHEMBL1211667";"Inhibition of Cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1208699";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL1210433";"";"None";"493.63";"0";"3.24";"49";"CS(=O)(=O)N(c1ccccc1)c1cccc(C(=O)N[C@@H](Cc2ccccc2)[C@H](O)CNC2CC2)c1";"IC50";"'='";"9550.0";"nM";"5.02";"";"";"UO_0000065";"10.17";"0.20";"1.78";"5.08";"0";"CHEMBL1211667";"Inhibition of Cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1208699";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL454420";"";"None";"588.77";"1";"3.67";"9c";"CCNc1cc(C(=O)N[C@@H](Cc2ccccc2)[C@H](O)CNC2CCCCC2)cc(N2CCCCS2(=O)=O)c1.O=CO";"IC50";"'='";"5250.0";"nM";"5.28";"";"";"UO_0000065";"9.73";"0.19";"1.61";"4.77";"0";"CHEMBL959767";"Inhibition of cathepsin D expressed in CHO cells after 1 hrs by spectrophotometer";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1150334";"1";"Scientific Literature";"J Med Chem";"2008";"CHEMBL3308072";"";"";""
"CHEMBL211194";"";"None";"514.76";"1";"1.44";"54";"CCCCNC(=O)[C@H](C)C[C@H](O)[C@@H]1CSC/C=C/CS[C@@H]2CCCN[C@@H]2C(=O)N[C@@H](C)C(=O)N1";"IC50";"'='";"200.0";"nM";"6.70";"";"";"UO_0000065";"13.01";"0.27";"5.26";"5.60";"0";"CHEMBL866007";"Inhibition of Cathepsin D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1137429";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";"";""
"CHEMBL377548";"";"None";"558.74";"1";"1.49";"17";"CCCCNC(=O)[C@H](C)C[C@H](O)[C@@H]1COC/C=C/CSC[C@H](NC(=O)OC(C)(C)C)C(=O)N[C@@H](C)C(=O)N1";"IC50";"'='";"110.0";"nM";"6.96";"";"";"UO_0000065";"12.45";"0.25";"5.47";"4.49";"0";"CHEMBL866007";"Inhibition of Cathepsin D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1137429";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";"";""
"CHEMBL470707";"";"None";"515.00";"2";"5.76";"9";"CC(=O)c1c(Nc2ccc(Br)cc2)[nH]c2c(Br)ccc(Br)c2c1=O";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1021961";"Inhibition of human liver cathepsin D after 30 mins by fluorometric end-point assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138527";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL513042";"";"None";"426.10";"1";"5.54";"10";"CC(=O)c1c(Nc2ccc(Cl)cc2)[nH]c2c(Br)ccc(Cl)c2c1=O";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1021961";"Inhibition of human liver cathepsin D after 30 mins by fluorometric end-point assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138527";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL1092788";"";"None";"378.38";"0";"3.06";"(S)-4g";"CN1C(=O)[C@@](c2ccncc2)(c2cccc(-c3cc(F)ccc3F)c2)N=C1N";"IC50";"'='";"5500.0";"nM";"5.26";"";"";"UO_0000065";"13.90";"0.26";"2.20";"7.35";"0";"CHEMBL1115170";"Inhibition of cathepsin D by FRET assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156304";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL1092124";"";"None";"372.43";"0";"2.79";"4b";"COc1cccc(-c2cccc(C3(c4ccncc4)N=C(N)N(C)C3=O)c2)c1";"IC50";"'='";"12200.0";"nM";"4.91";"";"";"UO_0000065";"13.19";"0.24";"2.12";"6.08";"0";"CHEMBL1115170";"Inhibition of cathepsin D by FRET assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156304";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL70169";"";"None";"431.54";"0";"4.99";"3g";"O=C1NC(=S)S/C1=C\c1ccc(OCc2ccc(C(=O)c3ccccc3)cc2)cc1";"IC50";"'='";"1310.0";"nM";"5.88";"";"";"UO_0000065";"13.63";"0.27";"0.89";"10.62";"0";"CHEMBL658685";"In vitro inhibition of cathepsin D.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1129769";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1996";"None";"";"";""
"CHEMBL1760857";"";"None";"445.63";"0";"3.57";"20d";"CCCc1cc(C[C@@H]2CS(=O)(=O)C[C@H](NCc3cccc(C(C)C)c3)[C@H]2O)ccc1O";"IC50";"'='";"1800.0";"nM";"5.75";"";"";"UO_0000065";"12.89";"0.25";"2.17";"6.63";"0";"CHEMBL1764636";"Inhibition of human cathepsin D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1759891";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL1760861";"";"None";"390.47";"0";"3.29";"24";"CC(=O)N[C@@H](Cc1cc(F)cc(F)c1)[C@H](O)CNCc1cccc(C(C)C)c1";"IC50";"'='";"4700.0";"nM";"5.33";"";"";"UO_0000065";"13.64";"0.26";"2.04";"8.68";"0";"CHEMBL1764636";"Inhibition of human cathepsin D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1759891";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL3900409";"BRENSOCATIB";"3.0";"420.47";"0";"1.73";"30; AZD7986";"Cn1c(=O)oc2ccc(-c3ccc(C[C@@H](C#N)NC(=O)[C@@H]4CNCCCO4)cc3)cc21";"IC50";"'>'";"20000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3859657";"Inhibition of human recombinant cathepsin D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3856275";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";""
"CHEMBL4591760";"";"None";"528.69";"2";"1.19";"2";"CC(C)CC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)[C@@H](O)CC(=O)N[C@@H](C)C(=O)O)C(C)C)C(C)C";"IC50";"'='";"40.0";"nM";"7.40";"";"";"UO_0000065";"13.99";"0.27";"6.21";"4.25";"0";"CHEMBL4325791";"Inhibition of human placenta CatD using Abz-Lys-Pro-Ala-Glu-Phe-Nph-Ala-Leu as substrate preincubated for 10 mins followed by substrate addition and measured by FRET assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4321885";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";""
"CHEMBL4465469";"";"None";"459.63";"0";"3.00";"8";"C[C@@H]1NC(=O)C[C@H](O)[C@H](Cc2ccccc2)NC(=O)CCCCCCCCCCCNC1=O";"IC50";"'='";"68.0";"nM";"7.17";"";"";"UO_0000065";"15.59";"0.30";"4.17";"6.67";"0";"CHEMBL4325791";"Inhibition of human placenta CatD using Abz-Lys-Pro-Ala-Glu-Phe-Nph-Ala-Leu as substrate preincubated for 10 mins followed by substrate addition and measured by FRET assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4321885";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";""
"CHEMBL4582805";"";"None";"533.78";"1";"4.33";"19";"CC(C)[C@@H]1NC(=O)C[C@H](O)[C@H](CSCc2ccccc2)NC(=O)CCCCCCCCCCCNC1=O";"IC50";"'='";"20.0";"nM";"7.70";"";"";"UO_0000065";"14.42";"0.28";"3.37";"7.16";"0";"CHEMBL4325791";"Inhibition of human placenta CatD using Abz-Lys-Pro-Ala-Glu-Phe-Nph-Ala-Leu as substrate preincubated for 10 mins followed by substrate addition and measured by FRET assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4321885";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";""
"CHEMBL4455141";"";"None";"503.68";"1";"3.34";"20";"CC(C)[C@@H]1NC(=O)C[C@H](O)[C@H](Cc2ccc(O)cc2)NC(=O)CCCCCCCCCCCNC1=O";"IC50";"'='";"39.0";"nM";"7.41";"";"";"UO_0000065";"14.71";"0.28";"4.07";"5.80";"0";"CHEMBL4325791";"Inhibition of human placenta CatD using Abz-Lys-Pro-Ala-Glu-Phe-Nph-Ala-Leu as substrate preincubated for 10 mins followed by substrate addition and measured by FRET assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4321885";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";""
"CHEMBL4213486";"";"None";"383.36";"0";"2.76";"15";"C[C@@]1(c2cc(NC(=O)c3ccc(C#N)cn3)ccc2F)C=C(CF)OC(N)=N1";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4195233";"Inhibition of cathepsin D (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4190390";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL3963645";"";"None";"460.82";"0";"4.02";"BDBM215017";"COc1ccc(C(=O)Nc2cc(Cl)c(F)c([C@]3(C)C[C@@H](C(F)(F)F)OC(N)=N3)c2)nc1";"IC50";"'='";"622000.0";"nM";"";"Outside typical range";"378077";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3891152";"";"None";"529.80";"1";"4.34";"BDBM215022";"C[C@@]1(c2cc(NC(=O)c3cnc(OCC(F)(F)F)cn3)cc(Cl)c2F)C[C@@H](C(F)(F)F)OC(N)=N1";"IC50";"'>'";"400000.0";"nM";"";"Outside typical range";"378083";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3943162";"";"None";"463.37";"0";"4.29";"BDBM214822";"[C-]#[N+]c1cnc2c(Nc3ccc(F)c([C@]4(CF)C[C@@H](C(F)(F)F)OC(N)=N4)c3)ncnc2c1";"IC50";"'>'";"400000.0";"nM";"";"Outside typical range";"377876";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3982006";"";"None";"446.37";"0";"3.06";"BDBM214874";"C[C@@]1(c2cc(Nc3ncnc4cc(C#N)cnc34)cnc2F)C[C@@H](C(F)(F)F)OC(N)=N1";"IC50";"'>'";"400000.0";"nM";"";"Outside typical range";"377884";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3909660";"";"None";"310.23";"0";"1.63";"BDBM214941";"NC1=N[C@](CF)(c2cc(N)cnc2F)C[C@@H](C(F)(F)F)O1";"IC50";"'>'";"400000.0";"nM";"";"Outside typical range";"377915";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3915000";"";"None";"449.77";"0";"3.35";"BDBM214943";"NC1=N[C@](CF)(c2cc(NC(=O)c3ccc(Cl)cn3)cnc2F)C[C@@H](C(F)(F)F)O1";"IC50";"'>'";"400000.0";"nM";"";"Outside typical range";"377916";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3927936";"";"None";"440.33";"0";"2.57";"BDBM214945";"N#Cc1ccc(C(=O)Nc2cnc(F)c([C@]3(CF)C[C@@H](C(F)(F)F)OC(N)=N3)c2)nc1";"IC50";"'='";"1790000.0";"nM";"";"Outside typical range";"377918";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3972761";"";"None";"421.35";"0";"3.04";"BDBM214949";"N#Cc1ccc(C(=O)Nc2cccc([C@]3(CF)C[C@@H](C(F)(F)F)OC(N)=N3)c2)nc1";"IC50";"'='";"665000.0";"nM";"";"Outside typical range";"377921";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3911790";"";"None";"409.36";"0";"4.09";"BDBM214914";"CC#Cc1ccc(-c2ccc(F)c([C@]3(CF)C[C@@H](C(F)(F)F)OC(N)=N3)c2)cn1";"IC50";"'='";"170000.0";"nM";"";"Outside typical range";"377938";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3894342";"";"None";"420.77";"0";"4.45";"BDBM214815";"NC1=N[C@](CF)(c2cc(Nc3cc(Cl)ccn3)ccc2F)C[C@@H](C(F)(F)F)O1";"IC50";"'='";"1630000.0";"nM";"";"Outside typical range";"377947";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3906242";"";"None";"462.42";"1";"5.46";"BDBM214916";"NC1=N[C@](CF)(c2cc(Nc3cc(-c4ccccc4)ccn3)ccc2F)C[C@@H](C(F)(F)F)O1";"IC50";"'='";"316000.0";"nM";"";"Outside typical range";"377949";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3921416";"";"None";"421.75";"0";"4.50";"BDBM214901";"NC1=N[C@](CF)(c2cc(Oc3cccc(Cl)n3)ccc2F)C[C@@H](C(F)(F)F)O1";"IC50";"'='";"1930000.0";"nM";"";"Outside typical range";"377950";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3891585";"";"None";"466.77";"0";"4.10";"BDBM214834";"NC1=N[C@](CF)(c2cc(NC(=O)c3ncc(Cl)cc3F)ccc2F)C[C@@H](C(F)(F)F)O1";"IC50";"'>'";"400000.0";"nM";"";"Outside typical range";"377954";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3903133";"";"None";"439.34";"0";"4.04";"BDBM214970";"[C-]#[N+]c1ccc(C(=O)Nc2cc(F)c(F)c([C@]3(C)C[C@@H](C(F)(F)F)OC(N)=N3)c2)nc1";"IC50";"'='";"901000.0";"nM";"";"Outside typical range";"378004";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3688824";"";"None";"417.80";"0";"2.90";"BDBM171775";"N#Cc1cnc(C(=O)Nc2ccc(Cl)c([C@@]3(CF)N=C(N)O[C@@H]4C[C@@H]43)c2)c(F)c1";"IC50";"'>'";"400000.0";"nM";"";"Outside typical range";"316221";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3683853";"";"None";"427.24";"0";"3.83";"BDBM171463";"NC1=N[C@@](c2cc(NC(=O)c3ccc(Cl)cn3)ccc2Cl)(C(F)F)[C@H]2C[C@H]2O1";"IC50";"'='";"1053000.0";"nM";"";"Outside typical range";"315874";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3683866";"";"None";"419.34";"0";"2.68";"BDBM171479";"N#Cc1ccc(C(=O)Nc2cc(F)c(F)c([C@@]3(C(F)F)N=C(N)O[C@@H]4C[C@@H]43)c2)nc1";"IC50";"'>'";"618000.0";"nM";"";"Outside typical range";"315888";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3683869";"";"None";"392.79";"0";"3.02";"BDBM171483";"NC1=N[C@](CF)(c2cc(NC(=O)c3ccc(Cl)cn3)ccc2F)[C@H]2C[C@H]2O1";"IC50";"'='";"471710.0";"nM";"";"Outside typical range";"315892";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3683878";"";"None";"434.26";"0";"3.41";"BDBM171493";"N#Cc1cnc(C(=O)Nc2ccc(Cl)c([C@@]3(CF)N=C(N)O[C@@H]4C[C@@H]43)c2)c(Cl)c1";"IC50";"'='";"996820.0";"nM";"";"Outside typical range";"315902";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3683906";"";"None";"505.83";"1";"3.67";"BDBM171525";"Cc1nc(OCC(F)(F)F)cnc1C(=O)Nc1cc(F)c(Cl)c([C@]2(CF)N=C(N)O[C@H]3C[C@H]32)c1";"IC50";"'='";"1047200.0";"nM";"";"Outside typical range";"315934";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3683920";"";"None";"474.40";"0";"2.63";"BDBM171540";"NC1=N[C@@](c2cc(NC(=O)c3cnc(OCc4cocn4)cn3)ccc2F)(C(F)F)[C@H]2C[C@H]2O1";"IC50";"'='";"925020.0";"nM";"";"Outside typical range";"315949";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3967607";"";"None";"425.85";"0";"4.41";"BDBM220792";"Cc1cccnc1Nc1ccc2c(c1)[C@@]1(CCOC(N)=N1)c1cc(Cl)nc(F)c1O2";"IC50";"'='";"386300.0";"nM";"";"Outside typical range";"386475";"UO_0000065";"";"";"";"";"0";"CHEMBL3888270";"Fluorescence Resonance Energy Transfer (FRET) Assay: Recombinant CathepsinD was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The CathepsinD enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for CathepsinD) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886633";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3937998";"";"None";"466.54";"1";"5.17";"BDBM220793";"CCOc1cccnc1Nc1ccc2c(c1)C1(CCSC(N)=N1)c1cc(OC)cc(F)c1O2";"IC50";"'='";"262500.0";"nM";"";"Outside typical range";"386476";"UO_0000065";"";"";"";"";"0";"CHEMBL3888270";"Fluorescence Resonance Energy Transfer (FRET) Assay: Recombinant CathepsinD was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The CathepsinD enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for CathepsinD) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886633";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3899000";"";"None";"503.95";"1";"4.27";"BDBM220806";"NC1=NC2(CCO1)c1cc(NC(=O)c3ccc(Cl)cn3)ccc1Oc1cnc(C3=CCCOC3)cc12";"IC50";"'='";"400000.0";"nM";"";"Outside typical range";"386492";"UO_0000065";"";"";"";"";"0";"CHEMBL3888270";"Fluorescence Resonance Energy Transfer (FRET) Assay: Recombinant CathepsinD was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The CathepsinD enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for CathepsinD) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886633";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3936359";"";"None";"745.02";"2";"3.38";"BDBM232256";"CC[C@H](C)[C@H](NC(=O)C[C@H](N)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)CC(C)C)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)OC";"IC50";"'='";"160.0";"nM";"6.80";"";"405033";"UO_0000065";"9.12";"0.18";"3.42";"3.44";"0";"CHEMBL3888498";"In-Vitro Fluorescence Assay: In order to identify modulators of cathepsin D activity, a continuous enzymatic test was carried out with a synthetic peptide which carries a fluorescent group (MCA=(7-methoxycoumarin-4-yl)acetyl) which is quenched by energy transfer from a Dpn (2,4 dinitrophenyl) group on the same molecule, in Greiner 384-well nb microtitre plates. Cleavage of the peptidic substrate by cathepsin D causes an increase in the fluorescence intensity. In order to determine the efficacy of substances, the time-dependent increase in the fluorescence intensity in the presence of the substance was compared with the time-dependent increase in fluorescence in the absence of substances. The reference substance used was pepstatin A (Sigma-Aldrich). The substrate used was MCAGKPILFFRLK(Dnp)d-R-NH2 (Enzo Life Sciences, Lorrach). The enzyme employed was cathepsin D isolated from the human liver (Sigma-Aldrich) in a final concentration of 1.4 nM. The test was carried out in 100 mM sodium acetate buffer, 1.25% (v/v) of DMSO, 0.25% (w/v) of Chaps, pH 5.5. 2 ul of each substance solution with serially diluted substance concentration were added to in each case 4 ul of cathepsin D solution and incubated at room temperature for 10 min. The reaction was started by addition of 2 ul of substrate solution (final concentration 5 uM). After carrying out a starting-point fluorescence measurement (excitation wavelength 340 nm/emission wavelength 450 nm) using an Envision multilabel reader (Perkin Elmer), the reaction was incubated at room temperature for 60 min. The amount of peptide fragment cleaved off during the reaction time was subsequently measured by determination of the increase in the fluorescence intensity at 450 nm (excitation wavelength 340 nm).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886733";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3939441";"";"None";"781.01";"2";"3.55";"BDBM232262";"CC[C@H](C)[C@H](NC(=O)C[C@H](N)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)OC(C)(C)C)C(C)C)C(=O)N[C@H](C(=O)OC)C(C)C";"IC50";"'='";"1.0";"nM";"9.00";"";"405037";"UO_0000065";"11.52";"0.22";"5.45";"4.35";"0";"CHEMBL3888498";"In-Vitro Fluorescence Assay: In order to identify modulators of cathepsin D activity, a continuous enzymatic test was carried out with a synthetic peptide which carries a fluorescent group (MCA=(7-methoxycoumarin-4-yl)acetyl) which is quenched by energy transfer from a Dpn (2,4 dinitrophenyl) group on the same molecule, in Greiner 384-well nb microtitre plates. Cleavage of the peptidic substrate by cathepsin D causes an increase in the fluorescence intensity. In order to determine the efficacy of substances, the time-dependent increase in the fluorescence intensity in the presence of the substance was compared with the time-dependent increase in fluorescence in the absence of substances. The reference substance used was pepstatin A (Sigma-Aldrich). The substrate used was MCAGKPILFFRLK(Dnp)d-R-NH2 (Enzo Life Sciences, Lorrach). The enzyme employed was cathepsin D isolated from the human liver (Sigma-Aldrich) in a final concentration of 1.4 nM. The test was carried out in 100 mM sodium acetate buffer, 1.25% (v/v) of DMSO, 0.25% (w/v) of Chaps, pH 5.5. 2 ul of each substance solution with serially diluted substance concentration were added to in each case 4 ul of cathepsin D solution and incubated at room temperature for 10 min. The reaction was started by addition of 2 ul of substrate solution (final concentration 5 uM). After carrying out a starting-point fluorescence measurement (excitation wavelength 340 nm/emission wavelength 450 nm) using an Envision multilabel reader (Perkin Elmer), the reaction was incubated at room temperature for 60 min. The amount of peptide fragment cleaved off during the reaction time was subsequently measured by determination of the increase in the fluorescence intensity at 450 nm (excitation wavelength 340 nm).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886733";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL244347";"";"None";"502.70";"2";"6.76";"3a";"CN(C(=O)CC[C@@H](C1CCCCC1)N1Cc2cc(Oc3ccccc3)ccc2N=C1N)C1CCCCC1";"IC50";"'='";"110.0";"nM";"6.96";"";"";"UO_0000065";"13.84";"0.26";"0.20";"9.78";"0";"CHEMBL895730";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1148753";"1";"Scientific Literature";"J Med Chem";"2007";"None";"";"";""
"CHEMBL377149";"";"None";"673.94";"2";"2.35";"42";"CCCCNC(=O)[C@@H](NC(=O)[C@H](C)C[C@H](O)[C@@H]1CSC/C=C/CSC[C@H](NC(=O)OC(C)(C)C)C(=O)N[C@@H](C)C(=O)N1)C(C)C";"IC50";"'='";"11.0";"nM";"7.96";"";"";"UO_0000065";"11.81";"0.24";"5.61";"4.55";"0";"CHEMBL866007";"Inhibition of Cathepsin D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1137429";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";"";""
"CHEMBL3747766";"";"None";"502.59";"2";"5.99";"11a";"CC(C)(C)OC(=O)N1C[C@H](Nc2nc3cc(F)ccc3[nH]2)[C@@H](OCc2ccc(-c3ccccc3)cc2)C1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3749955";"Inhibition of cathepsin D (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3745702";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";"";""
"CHEMBL401338";"";"None";"505.68";"1";"2.23";"26";"COc1cccc(CNC[C@@H](O)[C@H](Cc2ccccc2)NC(=O)CCS(=O)(=O)NCCC(C)C)c1";"IC50";"'='";"2116.0";"nM";"5.67";"";"";"UO_0000065";"11.22";"0.22";"3.44";"4.86";"0";"CHEMBL942098";"Inhibition of human recombinant cathepsin D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140593";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"None";"";"";""
"CHEMBL252755";"";"None";"490.67";"0";"2.87";"22";"CCCC(C)S(=O)(=O)CCC(=O)N[C@@H](Cc1ccccc1)[C@H](O)CNCc1cccc(OC)c1";"IC50";"'='";"10986.0";"nM";"4.96";"";"";"UO_0000065";"10.11";"0.20";"2.09";"4.74";"0";"CHEMBL942098";"Inhibition of human recombinant cathepsin D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140593";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"None";"";"";""
"CHEMBL2058868";"";"None";"383.52";"1";"6.10";"3";"O[C@H](CSc1ccc2ccccc2c1)Cn1c2ccccc2c2ccccc21";"IC50";"'>'";"300000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2061980";"Inhibition of cathepsin D by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2057073";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL2058869";"";"None";"383.52";"1";"6.10";"4";"O[C@@H](CSc1ccc2ccccc2c1)Cn1c2ccccc2c2ccccc21";"IC50";"'>'";"300000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2061980";"Inhibition of cathepsin D by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2057073";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL1824344";"";"None";"406.47";"0";"2.91";"47";"CCCCn1cc(C2(c3cccc(-c4cccnc4F)c3)N=C(N)N(C)C2=O)cn1";"IC50";"'='";"1910.0";"nM";"5.72";"";"";"UO_0000065";"14.07";"0.26";"2.81";"6.40";"0";"CHEMBL1825607";"Inhibition of cathepsin D by FRET assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1821667";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL1824347";"";"None";"363.45";"0";"2.54";"50";"Cc1cc(C2(c3cccc(-c4cncnc4)c3)N=C(N)N(C)C2=O)cs1";"IC50";"'='";"30500.0";"nM";"4.52";"";"";"UO_0000065";"12.42";"0.24";"1.98";"5.35";"0";"CHEMBL1825607";"Inhibition of cathepsin D by FRET assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1821667";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL1824360";"";"None";"422.49";"0";"3.57";"63";"CCC(=O)c1cc(C2(c3cccc(-c4cccnc4F)c3)N=C(N)N(C)C2=O)cs1";"IC50";"'='";"4100.0";"nM";"5.39";"";"";"UO_0000065";"12.75";"0.25";"1.82";"6.08";"0";"CHEMBL1825607";"Inhibition of cathepsin D by FRET assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1821667";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL3414703";"";"None";"286.35";"0";"2.50";"14a";"COC[C@H]1CSC(N)=N[C@]1(C)c1ccc(F)cc1F";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3420009";"Inhibition of CatD (unknown origin) by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3414451";"1";"Scientific Literature";"J Med Chem";"2015";"None";"";"";""
"CHEMBL2408739";"";"None";"466.55";"0";"2.19";"17";"CCc1ccc2c(c1)[C@@H](NC[C@@H](O)[C@H](Cc1cc(F)cc(F)c1)NC(C)=O)CS(=O)(=O)C2";"IC50";"'='";"2844.0";"nM";"5.55";"";"";"UO_0000065";"11.89";"0.24";"3.36";"5.81";"0";"CHEMBL2410948";"Inhibition of cathepsin-D (unknown origin) using C-terminal biotinylated peptide substrate treated 30 mins before addition of peptide substrate measured after 110 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2406984";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"None";"";"";""
"CHEMBL2408745";"";"None";"496.55";"0";"4.32";"33";"CC(=O)N[C@@H](Cc1cc(F)cc(F)c1)[C@H](O)CN[C@H]1CCOc2ccc(CC(C)(C)C(F)F)cc21";"IC50";"'='";"478.0";"nM";"6.32";"";"";"UO_0000065";"12.73";"0.25";"2.00";"8.95";"0";"CHEMBL2410948";"Inhibition of cathepsin-D (unknown origin) using C-terminal biotinylated peptide substrate treated 30 mins before addition of peptide substrate measured after 110 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2406984";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"None";"";"";""
"CHEMBL2408746";"";"None";"448.51";"0";"3.27";"35";"CC(=O)N[C@@H](Cc1cc(F)cc(F)c1)[C@H](O)CN[C@H]1CCOc2ccc(OC(C)C)cc21";"IC50";"'='";"429.0";"nM";"6.37";"";"";"UO_0000065";"14.20";"0.27";"3.10";"7.98";"0";"CHEMBL2410948";"Inhibition of cathepsin-D (unknown origin) using C-terminal biotinylated peptide substrate treated 30 mins before addition of peptide substrate measured after 110 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2406984";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"None";"";"";""
"CHEMBL1098670";"";"None";"620.75";"2";"0.84";"8";"C#CC[C@H](NC(=O)C[C@H](O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)c1ccccn1)C(C)C)C(=O)N[C@@H](CC(C)C)C(N)=O";"IC50";"'='";"50.0";"nM";"7.30";"";"";"UO_0000065";"11.76";"0.22";"6.46";"3.79";"0";"CHEMBL1114767";"Inhibition of human cathepsin D after 30 mins by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1157812";"1";"Scientific Literature";"J Med Chem";"2010";"None";"";"";""
"CHEMBL3403995";"";"None";"513.64";"1";"3.48";"24";"COCCCOc1cc(C(=O)N(C[C@@H]2CNC[C@H]2OC(=O)NCc2ccccc2)C(C)C)ccc1OC";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3406668";"Inhibition of cathepsin D (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3400053";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";""
"CHEMBL1270262";"";"None";"468.47";"0";"4.23";"14";"C=C(c1cccc(C2(NC[C@@H](O)[C@H](Cc3cc(F)cc(F)c3)NC(C)=O)CC2)c1)C(F)(F)F";"IC50";"'='";"1200.0";"nM";"5.92";"";"";"UO_0000065";"12.64";"0.25";"1.69";"9.65";"0";"CHEMBL1274834";"Inhibition of cathepsin-D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1268878";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL1270164";"";"None";"444.52";"0";"3.16";"13";"CC(=O)N[C@@H](Cc1cc(F)cc(F)c1)[C@H](O)CNC1(c2cccc(C3CCOC3)c2)CC1";"IC50";"'='";"480.0";"nM";"6.32";"";"";"UO_0000065";"14.21";"0.27";"3.16";"8.95";"0";"CHEMBL1274834";"Inhibition of cathepsin-D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1268878";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL1270163";"";"None";"440.49";"0";"2.84";"12";"CC(=O)N[C@@H](Cc1cc(F)cc(F)c1)[C@H](O)CNC1(c2cccc(-n3cccn3)c2)CC1";"IC50";"'='";"750.0";"nM";"6.12";"";"";"UO_0000065";"13.90";"0.26";"3.28";"7.74";"0";"CHEMBL1274834";"Inhibition of cathepsin-D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1268878";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL1270458";"";"None";"444.57";"0";"4.34";"18";"CC(=O)N[C@@H](Cc1cc(F)cc(F)c1)[C@H](O)CNC1(c2cccc(C(C)(C)C)c2)CCC1";"IC50";"'='";"380.0";"nM";"6.42";"";"";"UO_0000065";"14.44";"0.27";"2.08";"10.46";"0";"CHEMBL1274834";"Inhibition of cathepsin-D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1268878";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL1270263";"";"None";"448.53";"0";"3.90";"15";"CC(=O)N[C@@H](Cc1cc(F)cc(F)c1)[C@H](O)CNC1(c2cccc(C(C)(C)CF)c2)CC1";"IC50";"'='";"480.0";"nM";"6.32";"";"";"UO_0000065";"14.09";"0.27";"2.42";"10.30";"0";"CHEMBL1274834";"Inhibition of cathepsin-D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1268878";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL158033";"";"None";"587.72";"1";"2.89";"9 (Qc-Asn-Phe-psi-[(R,S)-cis-epoxide]Gly-NH-CH(isopropyl)2)";"CC(C)C(NC(=O)C[C@@H]1O[C@@H]1[C@H](Cc1ccccc1)NC(=O)C(CC(N)=O)NC(=O)c1ccc2ccccc2n1)C(C)C";"IC50";"'='";"12500.0";"nM";"4.90";"";"";"UO_0000065";"8.34";"0.16";"2.01";"3.15";"0";"CHEMBL657346";"Inhibitory activity against human cathepsin D was determined";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1128990";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1996";"None";"";"";""
"CHEMBL4458461";"";"None";"102.14";"0";"-0.22";"33-1";"CCCC(=O)NN";"IC50";"'='";"1000.0";"nM";"6.00";"";"";"UO_0000065";"58.74";"1.17";"6.22";"10.89";"0";"CHEMBL4355299";"Inhibition of human liver cathepsin D using DABCYL-Glu-Arg-Nle-Phe-Leu-Ser-Phe-Pro-EDANS as substrate by FRET assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4354799";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";""
"CHEMBL1210354";"";"None";"625.71";"2";"5.60";"33";"Cc1c(C(=O)N[C@@H](Cc2ccccc2)[C@H](O)CNCc2cccc(C(F)(F)F)c2)cccc1N(c1ccccc1)S(C)(=O)=O";"IC50";"'='";"110.0";"nM";"6.96";"";"";"UO_0000065";"11.12";"0.22";"1.36";"7.05";"0";"CHEMBL1211667";"Inhibition of Cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1208699";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL1210336";"";"None";"607.77";"1";"3.72";"11";"C[C@H](NC[C@@H](O)[C@H](Cc1ccccc1)NC(=O)c1cccc(OS(=O)(=O)Cc2ccccc2)c1)C(=O)NC1CCCCC1";"IC50";"'='";"3500.0";"nM";"5.46";"";"";"UO_0000065";"8.98";"0.17";"1.74";"4.08";"0";"CHEMBL1211667";"Inhibition of Cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1208699";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL1210431";"";"None";"565.78";"2";"5.29";"47";"CC(C)CCCC(C)NC[C@@H](O)[C@H](Cc1ccccc1)NC(=O)c1cccc(N(c2ccccc2)S(C)(=O)=O)c1";"IC50";"'='";"207.0";"nM";"6.68";"";"";"UO_0000065";"11.81";"0.23";"1.39";"6.77";"0";"CHEMBL1211667";"Inhibition of Cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1208699";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL4470195";"";"None";"648.85";"2";"5.84";"(S,R)-3k";"COc1cccc(C(C)(C)NC[C@@H](O)[C@H](Cc2ccccc2)NC(=O)c2cc(C(=O)NCc3ccccc3)cc(N3CCCCC3)c2)c1";"IC50";"'='";"220.0";"nM";"6.66";"";"";"UO_0000065";"10.26";"0.19";"0.82";"6.47";"0";"CHEMBL4331648";"Inhibition of human cathepsin D using DABCYL-Glu-Arg-Nle-Phe-Leu-Ser-Phe-Pro-EDANS as substrate preincubated for 30 mins followed by substrate addition and measured every min for 8 to 15 mins by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4330085";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";"";"";""
"CHEMBL434943";"CARBOCYCLIC PEPTIDOMIMETIC";"None";"919.04";"3";"-1.35";"3";"CC(C)C[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CCC(=O)O)C(C)C)[C@@H](O)[C@@H]1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)O";"IC50";"'<'";"10.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL828480";"Inhibitory concentration against human Cathepsin D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1145163";"1";"Scientific Literature";"J Med Chem";"2005";"None";"";"";""
"CHEMBL213301";"";"None";"576.83";"1";"2.43";"23";"CCCCNC(=O)[C@H](C)C[C@H](O)[C@@H]1CSCCCCSC[C@H](NC(=O)OC(C)(C)C)C(=O)N[C@@H](C)C(=O)N1";"IC50";"'='";"180.0";"nM";"6.75";"";"";"UO_0000065";"11.69";"0.24";"4.31";"4.62";"0";"CHEMBL866007";"Inhibition of Cathepsin D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1137429";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";"";""
"CHEMBL3746261";"";"None";"482.56";"1";"5.08";"7g";"CC(C)c1ccc(C(=O)O[C@H]2CN(C(=O)OC(C)(C)C)C[C@@H]2Nc2nc3cc(F)ccc3[nH]2)cc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3749955";"Inhibition of cathepsin D (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3745702";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";"";""
"CHEMBL3394056";"";"None";"439.45";"0";"4.35";"27";"Cc1cc(-c2cc3c(cn2)Oc2ccc(-c4cccnc4F)cc2[C@@]32COC(N)=N2)ccn1";"IC50";"'='";"3870.0";"nM";"5.41";"";"";"UO_0000065";"12.32";"0.22";"1.06";"5.67";"0";"CHEMBL3395116";"Inhibition of cathepsin D (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3393054";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";""
"CHEMBL1271140";"";"None";"444.39";"0";"3.82";"29";"CN1C(=O)[C@@](c2ccc(OC(F)(F)F)cc2)(c2cccc(-c3cccnc3F)c2)N=C1N";"IC50";"'='";"3150.0";"nM";"5.50";"";"";"UO_0000065";"12.38";"0.23";"1.68";"6.81";"0";"CHEMBL1273977";"Inhibition of cathepsin D by FRET assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1268920";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL1258233";"";"None";"422.54";"0";"3.88";"23";"CC(=O)N[C@@H](Cc1cc(F)cc(F)c1)[C@H](O)CNC1(c2cccs2)CCCCC1";"IC50";"'='";"4420.0";"nM";"5.36";"";"";"UO_0000065";"12.67";"0.25";"1.47";"8.73";"0";"CHEMBL1260849";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1255191";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL1257185";"";"None";"541.69";"1";"4.34";"35";"CC(=O)N[C@@H](Cc1cc(F)cc(F)c1)[C@H](O)CNC1(c2cn(C34CC5CC(CC(C5)C3)C4)nn2)CCCCC1";"IC50";"'='";"8.0";"nM";"8.10";"";"";"UO_0000065";"14.95";"0.28";"3.76";"8.79";"0";"CHEMBL1260849";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1255191";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL1257651";"";"None";"450.60";"0";"4.30";"60";"CC(=O)N[C@@H](Cc1cc(F)cc(F)c1)[C@H](O)CNC1(c2ccc(CC(C)(C)C)s2)CC1";"IC50";"'='";"1720.0";"nM";"5.76";"";"";"UO_0000065";"12.79";"0.25";"1.46";"9.39";"0";"CHEMBL1260849";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1255191";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL1230648";"";"None";"450.60";"0";"4.30";"53";"CC(=O)N[C@@H](Cc1cc(F)cc(F)c1)[C@H](O)CNC1(c2cc(CC(C)(C)C)cs2)CC1";"IC50";"'='";"395.0";"nM";"6.40";"";"";"UO_0000065";"14.21";"0.28";"2.10";"10.44";"0";"CHEMBL1260849";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1255191";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL582044";"";"None";"290.37";"0";"2.36";"1";"NC1=NC(c2ccccc2)(c2ccccc2)C2=NCCCN12";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1071582";"Inhibition of human cathepsin D by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1159096";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL213744";"";"None";"587.63";"2";"5.70";"23";"COc1cc(NC(=O)/C=C/COc2ccc3ccccc3c2C(=O)c2cc(OC)c(OC)c(OC)c2)cc(OC)c1OC";"IC50";"'='";"12290.0";"nM";"4.91";"";"";"UO_0000065";"8.36";"0.16";"-0.79";"4.43";"0";"CHEMBL869858";"Inhibition of human cathepsin D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149516";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"None";"";"";""
"CHEMBL212436";"";"None";"533.67";"2";"6.51";"20";"CCCCCCCCNC(=O)/C=C/COc1ccc2ccccc2c1C(=O)c1cc(OC)c(OC)c(OC)c1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL869858";"Inhibition of human cathepsin D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149516";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"None";"";"";""
"CHEMBL213899";"";"None";"395.41";"0";"2.96";"14";"COc1cc(C(=O)c2c(OCC(N)=O)ccc3ccccc23)cc(OC)c1OC";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL869858";"Inhibition of human cathepsin D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149516";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"None";"";"";""
"CHEMBL215401";"";"None";"424.45";"0";"4.04";"10";"CCOC(=O)COc1ccc2ccccc2c1C(=O)c1cc(OC)c(OC)c(OC)c1";"IC50";"'>'";"1000000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL869858";"Inhibition of human cathepsin D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149516";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"None";"";"";""
"CHEMBL364664";"";"None";"671.95";"2";"2.13";"59";"CCCCNC(=O)[C@@H](NC(=O)[C@@H]1OCC[C@H]1[C@H](O)[C@H](CC(C)C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(C)C)NC(C)=O)C(C)C";"IC50";"'='";"28.0";"nM";"7.55";"";"";"UO_0000065";"11.24";"0.22";"5.42";"4.32";"0";"CHEMBL828480";"Inhibitory concentration against human Cathepsin D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1145163";"1";"Scientific Literature";"J Med Chem";"2005";"None";"";"";""
"CHEMBL566112";"";"None";"455.42";"0";"4.07";"42";"NC1=NC(c2ccc(OC(F)(F)F)cc2)(c2cccc(-c3cccnc3F)c2)C2=NCCN12";"IC50";"'='";"10700.0";"nM";"4.97";"";"";"UO_0000065";"10.91";"0.21";"0.90";"6.53";"0";"CHEMBL1061266";"Inhibition of human cathepsin D by FRET";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1155232";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL583888";"";"None";"442.49";"0";"4.60";"33";"NC1=NC(c2ccc(OC(F)(F)F)cc2)(c2cccc(CCC3CC3)c2)C2=NCCCN12";"IC50";"'='";"16440.0";"nM";"4.78";"";"";"UO_0000065";"10.81";"0.20";"0.18";"7.57";"0";"CHEMBL1061266";"Inhibition of human cathepsin D by FRET";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1155232";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL567654";"";"None";"453.26";"0";"4.02";"31";"NC1=NC(c2ccc(OC(F)(F)F)cc2)(c2cccc(Br)c2)C2=NCCCN12";"IC50";"'='";"47400.0";"nM";"4.32";"";"";"UO_0000065";"9.54";"0.21";"0.30";"6.84";"0";"CHEMBL1061266";"Inhibition of human cathepsin D by FRET";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1155232";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL253165";"";"None";"547.76";"1";"3.50";"29";"CCCCN(CCCC)S(=O)(=O)CCC(=O)N[C@@H](Cc1ccccc1)[C@H](O)CNCc1cccc(OC)c1";"IC50";"'='";"4880.0";"nM";"5.31";"";"";"UO_0000065";"9.70";"0.19";"1.81";"4.92";"0";"CHEMBL942098";"Inhibition of human recombinant cathepsin D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140593";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"None";"";"";""
"CHEMBL566011";"";"None";"404.45";"0";"3.24";"3a";"COc1ccc(C2(c3cccc(-c4cccnc4F)c3)N=C(N)N(C)C2=O)cc1C";"IC50";"'='";"2600.0";"nM";"5.58";"";"";"UO_0000065";"13.81";"0.25";"2.35";"6.91";"0";"CHEMBL1071582";"Inhibition of human cathepsin D by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1159096";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL609987";"";"None";"510.63";"1";"4.07";"56, mixture of epimers";"CC(=O)N[C@@H](Cc1cc(F)cc(F)c1)[C@H](O)CNC1(c2cccc(C(C)(C)C)c2)CCc2n[nH]cc2C1";"IC50";"'='";"300.0";"nM";"6.52";"";"";"UO_0000065";"12.77";"0.24";"2.45";"7.24";"0";"CHEMBL1045212";"Inhibition of cathepsin D assessed as reduction in polarization after 110 mins by oregon green based fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156090";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL404394";"";"None";"355.44";"1";"5.07";"Nar103";"Cc1cccc(C(=O)NNc2c3ccccc3nc3c(C)c(C)ccc23)c1";"IC50";"'='";"9.0";"nM";"8.05";"";"";"UO_0000065";"22.64";"0.41";"2.98";"14.89";"0";"CHEMBL929232";"Inhibition of human cathepsin D by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1145617";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";"";"";""
"CHEMBL257594";"";"None";"357.41";"0";"4.47";"Nar110";"Cc1ccc2c(NNC(=O)c3ccccc3O)c3ccccc3nc2c1C";"IC50";"'='";"0.5";"nM";"9.30";"";"";"UO_0000065";"26.02";"0.47";"4.83";"12.53";"0";"CHEMBL929232";"Inhibition of human cathepsin D by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1145617";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";"";"";""
"CHEMBL1270339";"";"None";"429.35";"0";"3.10";"79";"CN1C(=O)[C@@](c2ccc(OC(F)F)cc2)(c2ccc(F)c(OCC(F)F)c2)N=C1N";"IC50";"'='";"2600.0";"nM";"5.58";"";"";"UO_0000065";"13.01";"0.25";"2.49";"7.24";"0";"CHEMBL1273977";"Inhibition of cathepsin D by FRET assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1268920";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL567893";"GRASSYSTATIN A";"None";"1174.44";"None";"None";"1";"COC(=O)[C@@H]1CCCN1C(=O)[C@@H](Cc1ccccc1)N(C)C(=O)[C@H](C)NC(=O)[C@@H](NC(=O)C[C@H](O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](OC(=O)[C@@H](OC(=O)[C@H](C(C)C)N(C)C)C(C)C)C(C)C)[C@@H](C)O";"IC50";"'='";"1000.0";"nM";"6.00";"";"";"UO_0000065";"5.11";"None";"None";"None";"0";"CHEMBL1043702";"Inhibition of cathepsin D in human MCF7 cells by fluorescence assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"MCF7";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156023";"1";"Scientific Literature";"J Med Chem";"2009";"CHEMBL3308403";"";"";""
"CHEMBL2380821";"";"None";"471.03";"1";"5.11";"8";"CCCc1scc(-c2cn[nH]c2)c1CC(NC1=NC(C)(C)Cc2cc(Cl)ccc21)C(=O)O";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2384470";"Inhibition of cathepsin-D (unknown origin) after 110 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2380283";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"None";"";"";""
"CHEMBL69148";"";"None";"490.61";"1";"5.04";"20b";"CCCc1c(OCc2ccc(/C=C3\SC(=S)NC3=O)cc2)ccc(C(=O)c2ccncc2)c1O";"IC50";"'='";"7940.0";"nM";"5.10";"";"";"UO_0000065";"10.40";"0.20";"0.06";"5.76";"0";"CHEMBL658685";"In vitro inhibition of cathepsin D.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1129769";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1996";"None";"";"";""
"CHEMBL1270459";"";"None";"480.55";"0";"4.44";"19";"CC(=O)N[C@@H](Cc1cc(F)cc(F)c1)[C@H](O)CN[C@]1(c2cccc(C(C)(C)C(F)F)c2)C[C@H]1C";"IC50";"";"";"";"";"";"Not Active";"";"";"";"";"";"0";"CHEMBL1274834";"Inhibition of cathepsin-D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1268878";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL448592";"";"None";"593.65";"1";"4.69";"19";"CCn1ncc2c(N3CCCC3=O)cc(C(=O)N[C@@H](Cc3ccccc3)[C@H](O)CNCc3cccc(C(F)(F)F)c3)cc21";"IC50";"'='";"14130.0";"nM";"4.85";"";"";"UO_0000065";"8.17";"0.15";"0.16";"4.87";"0";"CHEMBL1036847";"Inhibition of cathepsin-D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1137769";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL1824133";"";"None";"347.38";"0";"0.91";"27";"CN1C(=O)C(c2cccc(-c3cncnc3)c2)(c2cnn(C)c2)N=C1N";"IC50";"'='";"54400.0";"nM";"4.26";"";"";"UO_0000065";"12.28";"0.22";"3.35";"4.17";"0";"CHEMBL1825607";"Inhibition of cathepsin D by FRET assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1821667";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL3344265";"";"None";"753.82";"2";"2.21";"55";"CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)OCc1ccccc1)[C@@H](O)CC(=O)NC(C)c1ccccc1.O=C(O)C(F)(F)F";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3370435";"Inhibition of human cathepsin D assessed as cleavage of wtKAHRP fluorogenic substrate";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3352063";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL2047891";"";"None";"521.40";"1";"3.39";"14d";"CC(F)(F)c1cccc(CN[C@H]2CS(=O)(=O)C[C@@H](Cc3cc(F)c(N)c(Br)c3)[C@@H]2O)c1";"IC50";"'='";"4160.0";"nM";"5.38";"";"";"UO_0000065";"10.32";"0.24";"1.99";"5.82";"0";"CHEMBL2049562";"Inhibition of human recombinant CatD using Mca-GKPILFFRLK(DNP)-dR-NH2 as substrate after 1 hr by fluorescence analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2046351";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL2047892";"";"None";"500.58";"1";"3.57";"14e";"CC(C)(C)c1cccc(CN[C@H]2CS(=O)(=O)C[C@@H](Cc3ccc(N)c(OC(F)(F)F)c3)[C@@H]2O)c1";"IC50";"'='";"7990.0";"nM";"5.10";"";"";"UO_0000065";"10.18";"0.20";"1.53";"5.01";"0";"CHEMBL2049562";"Inhibition of human recombinant CatD using Mca-GKPILFFRLK(DNP)-dR-NH2 as substrate after 1 hr by fluorescence analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2046351";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL2181018";"";"None";"868.04";"2";"0.27";"5";"CC(C)C[C@H](NC(=O)C[C@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(N)=O)N(C)C(=O)[C@@H](NC(=O)[C@H](C)O)C(C)C)C(=O)N[C@@H](C)C(=O)N(C)[C@H](Cc1ccccc1)C(=O)O";"IC50";"'='";"54.1";"nM";"7.27";"";"";"UO_0000065";"8.37";"0.16";"7.00";"2.62";"0";"CHEMBL2185513";"Inhibition of cathepsin D by fluorescence assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2176894";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL2181015";"";"None";"979.19";"3";"0.35";"2";"COC(=O)[C@@H]1CCCN1C(=O)[C@@H](Cc1ccccc1)N(C)C(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)C[C@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(N)=O)N(C)C(=O)[C@@H](NC(=O)[C@H](C)O)C(C)C";"IC50";"'='";"182.0";"nM";"6.74";"";"";"UO_0000065";"6.88";"0.13";"6.39";"2.35";"0";"CHEMBL2185513";"Inhibition of cathepsin D by fluorescence assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2176894";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL3264809";"";"None";"558.72";"1";"4.01";"15";"COc1cccc(C(C)(C)NC[C@@H](O)[C@H](Cc2ccccc2)NC(=O)c2cc(C(N)=O)cc(N3CCCCC3)c2)c1";"IC50";"'='";"500.0";"nM";"6.30";"";"";"UO_0000065";"11.28";"0.21";"2.29";"5.39";"0";"CHEMBL3271470";"Inhibition of human cathepsin-D using DABCYL-Glu-Arg-Nle-Phe-Leu-Ser-Phe-Pro-EDANS as substrate preincubated for 30 mins by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3259525";"1";"Scientific Literature";"ACS Med Chem Lett";"2014";"None";"";"";""
"CHEMBL598876";"";"None";"342.40";"0";"2.78";"29";"CN1C(=O)C(c2ccncc2)(c2cccc(-c3ccccc3)c2)N=C1N";"IC50";"'='";"30000.0";"nM";"4.52";"";"";"UO_0000065";"13.21";"0.24";"1.74";"6.32";"0";"CHEMBL1071582";"Inhibition of human cathepsin D by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1159096";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL2177343";"";"None";"402.45";"0";"3.87";"11a";"CC(C)COc1ccc2c(c1)[C@]1(COC(N)=N1)c1cc(-c3cncnc3)ccc1O2";"IC50";"'='";"4470.0";"nM";"5.35";"";"";"UO_0000065";"13.29";"0.24";"1.48";"5.82";"0";"CHEMBL2183109";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2177044";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL2177331";"";"None";"410.83";"0";"4.85";"9l";"COc1ccc2c(c1)C1(COC(N)=N1)c1cc(-c3cc(Cl)ccc3F)ccc1O2";"IC50";"'='";"3700.0";"nM";"5.43";"";"";"UO_0000065";"13.22";"0.26";"0.58";"8.22";"0";"CHEMBL2183109";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2177044";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL2177325";"";"None";"392.84";"0";"4.71";"9f";"COc1ccc2c(c1)C1(COC(N)=N1)c1cc(-c3cccc(Cl)c3)ccc1O2";"IC50";"'='";"35700.0";"nM";"4.45";"";"";"UO_0000065";"11.32";"0.22";"-0.26";"6.73";"0";"CHEMBL2183109";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2177044";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL2177329";"";"None";"410.83";"0";"4.85";"9j";"COc1ccc2c(c1)C1(COC(N)=N1)c1cc(-c3cccc(Cl)c3F)ccc1O2";"IC50";"'='";"13700.0";"nM";"4.86";"";"";"UO_0000065";"11.84";"0.23";"0.01";"7.36";"0";"CHEMBL2183109";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2177044";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL3127090";"";"None";"365.39";"0";"0.92";"68";"CN1C(=O)[C@]2(N=C1N)c1cc(-c3cncnc3)ccc1O[C@H]1CCOC[C@@H]12";"IC50";"'='";"11000.0";"nM";"4.96";"";"";"UO_0000065";"13.57";"0.25";"4.04";"4.82";"0";"CHEMBL3131975";"Inhibition of human liver cathepsin D measured for 1 hr by FRET assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124885";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL68538";"";"None";"431.54";"0";"4.99";"8e";"O=C1NC(=S)S/C1=C\c1ccc(COc2ccc(C(=O)c3ccccc3)cc2)cc1";"IC50";"'='";"780.0";"nM";"6.11";"";"";"UO_0000065";"14.15";"0.28";"1.12";"11.03";"0";"CHEMBL658685";"In vitro inhibition of cathepsin D.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1129769";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1996";"None";"";"";""
"CHEMBL165";"RESVERATROL";"3.0";"228.25";"0";"2.97";"Resveratrol";"Oc1ccc(/C=C/c2cc(O)cc(O)c2)cc1";"IC50";"'='";"138000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4223547";"Inhibition of human cathepsin D using DABCYL-Glu-Arg-Nle-Phe-Leu-Ser-Phe-Pro-EDANS as substrate preincubated for 30 mins followed by substrate addition measured every 1 min within 8 to 15 mins by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4219216";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";"";""
"CHEMBL173204";"";"None";"666.86";"1";"3.65";"10";"CN1CCCCC([C@@H](O)[C@H](CC2CCCCC2)NC(=O)[C@H](Cc2c[nH]cn2)NC(=O)[C@H](Cc2ccccc2)NC(=O)OC(C)(C)C)C1=O";"IC50";"'='";"135.0";"nM";"6.87";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL657351";"Inhibitory concentration against cathepsin D";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1125921";"1";"Scientific Literature";"J Med Chem";"1991";"None";"";"";""
"CHEMBL4290822";"";"None";"466.50";"0";"2.99";"17";"NC1=N[C@@]2(CO1)c1cc(-c3cncc(C#CCO)c3)ccc1Oc1cnc(C3=CCOCC3)cc12";"IC50";"'='";"4400.0";"nM";"5.36";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4262564";"Inhibition of recombinant human CatD using fluorophore/quencher-tagged peptide as substrate pretreated for 60 mins followed by substrate addition and measured after 60 mins by FRET assay";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261519";"1";"Scientific Literature";"Medchemcomm";"2017";"None";"";"";""
"CHEMBL4279064";"";"None";"447.88";"0";"3.95";"28";"NC1=N[C@@]2(CO1)c1cc(NC(=O)c3ccc(Cl)cn3)ccc1Oc1cnc(C3CC3)cc12";"IC50";"'='";"310000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4262564";"Inhibition of recombinant human CatD using fluorophore/quencher-tagged peptide as substrate pretreated for 60 mins followed by substrate addition and measured after 60 mins by FRET assay";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261519";"1";"Scientific Literature";"Medchemcomm";"2017";"None";"";"";""
"CHEMBL4066885";"";"None";"335.37";"0";"2.99";"6l";"C[C@@]1(c2cc(CNCC(F)F)c(F)cc2F)CCSC(N)=N1";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4042703";"Inhibition of Cathepsin D (unknown origin) by cell free assay";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4041533";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";"";""
"CHEMBL4091480";"";"None";"362.45";"0";"3.95";"6a";"Cc1ccc(NCc2cc([C@]3(C)CCSC(N)=N3)c(F)cc2F)nc1";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4042703";"Inhibition of Cathepsin D (unknown origin) by cell free assay";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4041533";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";"";""
"CHEMBL572081";"";"None";"482.58";"0";"4.01";"4";"CC(=O)N[C@@H](Cc1cc(F)cc(F)c1)[C@H](O)CNC1(c2cccc(-n3cccn3)c2)CCCCC1";"IC50";"'='";"22.0";"nM";"7.66";"";"";"UO_0000065";"15.87";"0.30";"3.65";"9.67";"1";"CHEMBL1274834";"Inhibition of cathepsin-D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1268878";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL1210353";"";"None";"612.67";"1";"4.69";"32";"CS(=O)(=O)N(c1ccncc1)c1cccc(C(=O)N[C@@H](Cc2ccccc2)[C@H](O)CNCc2cccc(C(F)(F)F)c2)c1";"IC50";"'='";"25700.0";"nM";"4.59";"";"";"UO_0000065";"7.49";"0.15";"-0.10";"4.11";"0";"CHEMBL1211667";"Inhibition of Cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1208699";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL213595";"";"None";"542.67";"1";"0.78";"15";"CCCCNC(=O)[C@H](C)C[C@H](O)[C@@H]1COC/C=C/COC[C@H](NC(=O)OC(C)(C)C)C(=O)N[C@@H](C)C(=O)N1";"IC50";"'='";"910.0";"nM";"6.04";"";"";"UO_0000065";"11.13";"0.22";"5.26";"3.68";"0";"CHEMBL866007";"Inhibition of Cathepsin D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1137429";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";"";""
"CHEMBL3394043";"";"None";"432.46";"0";"3.87";"14";"NC1=N[C@@]2(CO1)c1cc(-c3cccnc3F)ccc1Oc1cnc(C3CCCOC3)cc12";"IC50";"'='";"5800.0";"nM";"5.24";"";"";"UO_0000065";"12.11";"0.22";"1.37";"5.70";"0";"CHEMBL3395116";"Inhibition of cathepsin D (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3393054";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";""
"CHEMBL2349467";"";"None";"370.84";"0";"2.95";"(R)-34";"CN1C(=O)[C@]2(CC(C)(C)Oc3ccc(-c4cncc(Cl)c4)cc32)N=C1N";"IC50";"'='";"1717.0";"nM";"5.76";"";"";"UO_0000065";"15.55";"0.30";"2.82";"7.13";"0";"CHEMBL2352017";"Inhibition of human spleen cathepsin D using 5-FAM/QXL as peptide substrate after 1 hr by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"CHEMBL3559722";"Spleen";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346596";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL2349476";"";"None";"352.41";"0";"2.84";"46, rac-46";"CN1C(=O)C2(CC(C)(C)Cc3ccc(-c4cccnc4F)cc32)N=C1N";"IC50";"'='";"1760.0";"nM";"5.75";"";"";"UO_0000065";"16.33";"0.30";"2.91";"8.04";"0";"CHEMBL2352017";"Inhibition of human spleen cathepsin D using 5-FAM/QXL as peptide substrate after 1 hr by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"CHEMBL3559722";"Spleen";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346596";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL2349616";"";"None";"365.43";"0";"2.91";"16, rac-16";"COc1ccc(-c2ccc3c(c2)C2(CC(C)(C)O3)N=C(N)N(C)C2=O)cc1";"IC50";"'='";"6340.0";"nM";"5.20";"";"";"UO_0000065";"14.22";"0.26";"2.29";"6.74";"0";"CHEMBL2352017";"Inhibition of human spleen cathepsin D using 5-FAM/QXL as peptide substrate after 1 hr by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"CHEMBL3559722";"Spleen";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346596";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL2349615";"";"None";"365.43";"0";"2.91";"15, rac-15";"COc1ccccc1-c1ccc2c(c1)C1(CC(C)(C)O2)N=C(N)N(C)C1=O";"IC50";"'='";"3462.0";"nM";"5.46";"";"";"UO_0000065";"14.94";"0.28";"2.55";"7.08";"0";"CHEMBL2352017";"Inhibition of human spleen cathepsin D using 5-FAM/QXL as peptide substrate after 1 hr by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"CHEMBL3559722";"Spleen";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346596";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL2349614";"";"None";"365.43";"0";"2.91";"14, rac-14";"COc1cccc(-c2ccc3c(c2)C2(CC(C)(C)O3)N=C(N)N(C)C2=O)c1";"IC50";"'='";"295.0";"nM";"6.53";"";"";"UO_0000065";"17.87";"0.33";"3.62";"8.46";"0";"CHEMBL2352017";"Inhibition of human spleen cathepsin D using 5-FAM/QXL as peptide substrate after 1 hr by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"CHEMBL3559722";"Spleen";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346596";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL2349611";"";"None";"335.41";"0";"2.90";"11, rac-11";"CN1C(=O)C2(CC(C)(C)Oc3ccc(-c4ccccc4)cc32)N=C1N";"IC50";"'='";"4368.0";"nM";"5.36";"";"";"UO_0000065";"15.98";"0.29";"2.46";"7.89";"0";"CHEMBL2352017";"Inhibition of human spleen cathepsin D using 5-FAM/QXL as peptide substrate after 1 hr by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"CHEMBL3559722";"Spleen";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346596";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL3917530";"";"None";"457.50";"0";"3.49";"60";"C[C@H]1C[C@H]2CSC(N)=N[C@@]2(c2nc(NC(=O)c3ccc(C(F)(F)F)cn3)cs2)CO1";"IC50";"'>'";"300000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4183115";"Inhibition of Cathepsin D (unknown origin) by fluorescence polarization assay";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4177751";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4214785";"";"None";"269.39";"0";"1.82";"47";"C[C@H]1C[C@H]2CSC(N)=N[C@@]2(c2nccs2)CO1";"IC50";"'>'";"64000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4183115";"Inhibition of Cathepsin D (unknown origin) by fluorescence polarization assay";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4177751";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4204215";"";"None";"268.41";"0";"2.43";"46";"C[C@H]1C[C@H]2CSC(N)=N[C@@]2(c2cccs2)CO1";"IC50";"'>'";"98000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4183115";"Inhibition of Cathepsin D (unknown origin) by fluorescence polarization assay";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4177751";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4214603";"";"None";"281.36";"0";"1.90";"44";"C[C@H]1C[C@H]2CSC(N)=N[C@@]2(c2ncccc2F)CO1";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4183115";"Inhibition of Cathepsin D (unknown origin) by fluorescence polarization assay";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4177751";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL2047903";"";"None";"519.68";"1";"2.73";"42";"CN(C)CC(=O)Nc1ccc(C[C@@H]2CS(=O)(=O)C[C@H](NCc3cccc(C(C)(C)C)c3)[C@H]2O)cc1F";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2049562";"Inhibition of human recombinant CatD using Mca-GKPILFFRLK(DNP)-dR-NH2 as substrate after 1 hr by fluorescence analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2046351";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL2047907";"";"None";"474.64";"0";"3.69";"44";"CC(C)(C)c1cccc(CN[C@H]2CS(=O)(=O)C[C@@H](Cc3cc(F)c(N)c(C4CC4)c3)[C@@H]2O)c1";"IC50";"'='";"1740.0";"nM";"5.76";"";"";"UO_0000065";"12.13";"0.24";"2.07";"6.23";"0";"CHEMBL2049562";"Inhibition of human recombinant CatD using Mca-GKPILFFRLK(DNP)-dR-NH2 as substrate after 1 hr by fluorescence analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2046351";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL2048045";"";"None";"532.60";"1";"3.75";"60h";"CC(C)(C)c1cccc(CN[C@H]2CS(=O)(=O)C[C@@H](Cc3cc(F)c(N)c(OCC(F)(F)F)c3)[C@@H]2O)c1";"IC50";"'='";"690.0";"nM";"6.16";"";"";"UO_0000065";"11.57";"0.23";"2.41";"6.06";"0";"CHEMBL2049562";"Inhibition of human recombinant CatD using Mca-GKPILFFRLK(DNP)-dR-NH2 as substrate after 1 hr by fluorescence analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2046351";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL437496";"";"None";"496.72";"0";"1.73";"82";"CCCCNC(=O)[C@H](C)C[C@H](O)[C@@H]1CSC/C=C/CC[C@@H]2CCCN[C@@H]2C(=O)N[C@@H](C)C(=O)N1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL866007";"Inhibition of Cathepsin D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1137429";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";"";""
"CHEMBL3127077";"";"None";"396.42";"0";"2.06";"83";"C[C@H]1OCC[C@H]2Oc3ccc(-c4cccnc4F)cc3[C@]3(N=C(N)N(C)C3=O)[C@H]12";"IC50";"'='";"4600.0";"nM";"5.34";"";"";"UO_0000065";"13.46";"0.25";"3.28";"5.93";"0";"CHEMBL3131975";"Inhibition of human liver cathepsin D measured for 1 hr by FRET assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124885";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL2048044";"";"None";"514.61";"1";"3.46";"60g";"CC(C)(C)c1cccc(CN[C@H]2CS(=O)(=O)C[C@@H](Cc3cc(F)c(N)c(OCC(F)F)c3)[C@@H]2O)c1";"IC50";"'='";"680.0";"nM";"6.17";"";"";"UO_0000065";"11.98";"0.24";"2.71";"6.07";"0";"CHEMBL2049562";"Inhibition of human recombinant CatD using Mca-GKPILFFRLK(DNP)-dR-NH2 as substrate after 1 hr by fluorescence analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2046351";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL2048046";"";"None";"546.63";"1";"4.14";"60i";"CC(C)(C)c1cccc(CN[C@H]2CS(=O)(=O)C[C@@H](Cc3cc(F)c(N)c(OCCC(F)(F)F)c3)[C@@H]2O)c1";"IC50";"'='";"2400.0";"nM";"5.62";"";"";"UO_0000065";"10.28";"0.21";"1.48";"5.53";"0";"CHEMBL2049562";"Inhibition of human recombinant CatD using Mca-GKPILFFRLK(DNP)-dR-NH2 as substrate after 1 hr by fluorescence analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2046351";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL2349610";"";"None";"338.20";"0";"1.99";"1a, rac-1a";"CN1C(=O)C2(CC(C)(C)Oc3ccc(Br)cc32)N=C1N";"IC50";"'='";"97740.0";"nM";"4.01";"";"";"UO_0000065";"11.86";"0.27";"2.02";"5.90";"0";"CHEMBL2352017";"Inhibition of human spleen cathepsin D using 5-FAM/QXL as peptide substrate after 1 hr by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"CHEMBL3559722";"Spleen";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346596";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL567893";"GRASSYSTATIN A";"None";"1174.44";"None";"None";"1";"COC(=O)[C@@H]1CCCN1C(=O)[C@@H](Cc1ccccc1)N(C)C(=O)[C@H](C)NC(=O)[C@@H](NC(=O)C[C@H](O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](OC(=O)[C@@H](OC(=O)[C@H](C(C)C)N(C)C)C(C)C)C(C)C)[C@@H](C)O";"IC50";"'='";"40.0";"nM";"7.40";"";"";"UO_0000065";"6.30";"None";"None";"None";"0";"CHEMBL2064999";"Inhibition of cathepsin D using MCA-KPILFFRLK(Dnp)-D-R-NH2 as substrate incubated for 10 to 15 mins prior to substrate addition measured every 5 min for 2 hrs by fluorometry";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2062495";"1";"Scientific Literature";"Bioorg Med Chem";"2012";"None";"";"";""
"CHEMBL2349468";"";"None";"358.45";"0";"3.18";"(R)-45";"CN1C(=O)[C@]2(CC(C)(C)Cc3ccc(-c4cccc(C#N)c4)cc32)N=C1N";"IC50";"'='";"1259.0";"nM";"5.90";"";"";"UO_0000065";"16.46";"0.30";"2.72";"7.15";"0";"CHEMBL2352017";"Inhibition of human spleen cathepsin D using 5-FAM/QXL as peptide substrate after 1 hr by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"CHEMBL3559722";"Spleen";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346596";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL2349480";"";"None";"335.41";"0";"2.10";"50, rac-50";"CN1C(=O)C2(CC(C)(C)Cc3ccc(-c4cncnc4)cc32)N=C1N";"IC50";"'='";"10144.0";"nM";"4.99";"";"";"UO_0000065";"14.89";"0.27";"2.89";"5.91";"0";"CHEMBL2352017";"Inhibition of human spleen cathepsin D using 5-FAM/QXL as peptide substrate after 1 hr by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"CHEMBL3559722";"Spleen";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346596";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL319672";"";"None";"735.93";"2";"4.64";"6";"CC(C)[C@H](NC(=O)OCc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)[C@@H](O)[C@@H](NCc1ccccc1)C(=O)N[C@H](C(=O)NCc1ccccc1)C(C)C";"IC50";"'='";"35.0";"nM";"7.46";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL657354";"Selectivity for their inhibitory potency against human cathepsin D.";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1127464";"1";"Scientific Literature";"J Med Chem";"1994";"None";"";"";""
"CHEMBL1210330";"";"None";"528.70";"1";"4.56";"5";"C[C@H](NC[C@@H](O)[C@H](Cc1ccccc1)NC(=O)c1cccc(Nc2ccccc2)c1)C(=O)NC1CCCCC1";"IC50";"'='";"1700.0";"nM";"5.77";"";"";"UO_0000065";"10.91";"0.20";"1.21";"5.63";"0";"CHEMBL1211667";"Inhibition of Cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1208699";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL1210360";"";"None";"655.74";"2";"5.69";"42";"CCOc1cc(C(=O)N[C@@H](Cc2ccccc2)[C@H](O)CNCc2cccc(C(F)(F)F)c2)cc(N(c2ccccc2)S(C)(=O)=O)c1";"IC50";"'='";"680.0";"nM";"6.17";"";"";"UO_0000065";"9.41";"0.18";"0.48";"5.71";"0";"CHEMBL1211667";"Inhibition of Cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1208699";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL1941010";"";"None";"331.35";"0";"4.12";"7";"O=C(Cn1c(-c2ccccn2)nc2ccccc21)c1ccc(F)cc1";"IC50";"'='";"31900.0";"nM";"4.50";"";"";"UO_0000065";"13.57";"0.25";"0.38";"9.41";"0";"CHEMBL1942416";"Inhibition of human cathepsin D using DABCYL-Glu-Arg-Nle-Phe-Leu-Ser-Phe-Pro-EDANS as substrate by FRET analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1938395";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL67585";"";"None";"441.57";"0";"4.92";"17c";"CCCc1c(COc2ccc(/C=C3\SC(=S)NC3=O)cc2)ccc(C(C)=O)c1OC";"IC50";"'='";"1860.0";"nM";"5.73";"";"";"UO_0000065";"12.98";"0.26";"0.81";"8.87";"0";"CHEMBL658685";"In vitro inhibition of cathepsin D.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1129769";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1996";"None";"";"";""
"CHEMBL2059329";"";"None";"333.46";"0";"4.95";"E2T18";"OC(CSc1ccc2ccccc2c1)Cn1ccc2ccccc21";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL2061980";"Inhibition of cathepsin D by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2057073";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL3422242";"";"None";"379.43";"0";"3.68";"1; PF-9238";"Cc1cc([C@H]2C[C@H]3[C@@H](C)SC(N)=N[C@@]3(c3ccc(F)cc3F)CO2)on1";"IC50";"'='";"140.0";"nM";"6.85";"";"";"UO_0000065";"18.06";"0.36";"3.17";"9.31";"0";"CHEMBL4026418";"Inhibition of cathepsin D (unknown origin) by cell based assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4024745";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4207711";"";"None";"262.38";"0";"2.37";"42";"C[C@H]1C[C@H]2CSC(N)=N[C@@]2(c2ccccc2)CO1";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4183115";"Inhibition of Cathepsin D (unknown origin) by fluorescence polarization assay";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4177751";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL585128";"";"None";"353.47";"0";"2.89";"(S)-30";"COc1ccc([C@]2(C34CC5CC(CC(C5)C3)C4)N=C(N)N(C)C2=O)cc1";"IC50";"'='";"13370.0";"nM";"4.87";"";"";"UO_0000065";"13.79";"0.26";"1.98";"7.18";"0";"CHEMBL1044551";"Inhibition of human cathepsin D by FRET based peptide cleavage assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156789";"1";"Scientific Literature";"J Med Chem";"2010";"None";"";"";""
"CHEMBL3764174";"";"None";"467.61";"1";"6.30";"rac-4b";"CCCCCc1ccc(-c2ccc3c(=O)n(C[C@@H]4CC[C@H](c5ccccc5)O4)c(N)nc3c2)cc1";"IC50";"'='";"5000.0";"nM";"5.30";"";"";"UO_0000065";"11.34";"0.21";"-1.00";"7.56";"0";"CHEMBL3767017";"Inhibition of CatD (unknown origin) preincubated for 30 mins followed by DABCYL-Glu-Arg-Nle-Phe-Leu-Ser-Phe-Pro-EDANS substrate addition by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3763050";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";""
"CHEMBL461815";"";"None";"425.61";"0";"2.66";"3a";"CCCCNC(=O)[C@H](C)C[C@H](O)[C@@H]1C[C@H](C)CCCCCCC(=O)N[C@@H](C)C(=O)N1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL963292";"Inhibition of human cathepsin D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1153267";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL1169539";"";"None";"638.81";"1";"2.87";"8d";"CN1CCC([C@@H](O)[C@H](CC2CCCCC2)NC(=O)[C@H](Cc2c[nH]cn2)NC(=O)[C@H](Cc2ccccc2)NC(=O)OC(C)(C)C)C1=O";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL657351";"Inhibitory concentration against cathepsin D";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1125921";"1";"Scientific Literature";"J Med Chem";"1991";"None";"";"";""
"CHEMBL4590201";"";"None";"342.37";"0";"1.68";"8e";"O=C(CF)CNC(=O)[C@H](Cc1ccccc1)NC(=O)c1ccccc1";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4480320";"Inhibition of recombinant human cathepsin D (400 residues) expressed in CHO cells using 5-FAM/QXL 520 FRET peptide as substrate preincubated for 20 mins followed by substrate addition by fluorescence plate reader analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4477275";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3959278";"";"None";"466.49";"0";"3.99";"BDBM220841";"COc1ccc(C(=O)Nc2ccc3c(c2)C2(CCSC(N)=N2)c2cc(O)cc(F)c2O3)nc1";"IC50";"'='";"225000.0";"nM";"";"Outside typical range";"386527";"UO_0000065";"";"";"";"";"0";"CHEMBL3888270";"Fluorescence Resonance Energy Transfer (FRET) Assay: Recombinant CathepsinD was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The CathepsinD enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for CathepsinD) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886633";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3971627";"";"None";"491.94";"0";"4.35";"BDBM220786";"COc1nc(C2CC2)cc2c1Oc1ccc(NC(=O)c3ccc(Cl)cn3)cc1C21CCOC(N)=N1";"IC50";"'>'";"400000.0";"nM";"";"Outside typical range";"386469";"UO_0000065";"";"";"";"";"0";"CHEMBL3888270";"Fluorescence Resonance Energy Transfer (FRET) Assay: Recombinant CathepsinD was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The CathepsinD enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for CathepsinD) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886633";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3948791";"";"None";"520.52";"1";"4.52";"BDBM220834";"Cc1nc(C(=O)Nc2ccc3c(c2)C2(CCOC(N)=N2)c2cc(-c4ccnc(F)c4)nc(F)c2O3)cs1";"IC50";"'='";"400000.0";"nM";"";"Outside typical range";"386520";"UO_0000065";"";"";"";"";"0";"CHEMBL3888270";"Fluorescence Resonance Energy Transfer (FRET) Assay: Recombinant CathepsinD was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The CathepsinD enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for CathepsinD) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886633";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL562555";"";"None";"568.74";"1";"2.84";"35";"CCc1cn2c3c(cc(C(=O)N[C@@H](Cc4ccccc4)[C@H](O)CNC4CCOCC4)cc13)N(CC)S(=O)(=O)CC2";"IC50";"'='";"1620.0";"nM";"5.79";"";"";"UO_0000065";"10.18";"0.20";"2.95";"5.13";"0";"CHEMBL1035560";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1158445";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL3891240";"";"None";"533.59";"1";"4.48";"BDBM220836";"COc1ccc(C(=O)Nc2ccc3c(c2)C2(CCSC(N)=N2)c2cc(C4=CCOCC4)nc(F)c2O3)nc1";"IC50";"'='";"197600.0";"nM";"";"Outside typical range";"386522";"UO_0000065";"";"";"";"";"0";"CHEMBL3888270";"Fluorescence Resonance Energy Transfer (FRET) Assay: Recombinant CathepsinD was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The CathepsinD enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for CathepsinD) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886633";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL566978";"";"None";"473.55";"0";"4.36";"41";"CCOc1ccc(C2(c3cccc(-c4cccnc4F)c3)N=C(N)N3CCCN=C32)cc1OCC";"IC50";"'='";"63400.0";"nM";"4.20";"";"";"UO_0000065";"8.86";"0.16";"-0.16";"4.92";"0";"CHEMBL1061266";"Inhibition of human cathepsin D by FRET";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1155232";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL86182";"";"None";"515.37";"2";"7.73";"27";"O=C(Nc1ccc(Sc2nc3ccccc3s2)c(C(F)(F)F)c1)c1cc(Cl)cc(Cl)c1O";"IC50";"'='";"1100.0";"nM";"5.96";"";"";"UO_0000065";"11.56";"0.25";"-1.77";"9.58";"0";"CHEMBL657347";"Inhibitory activity against human liver Cathepsin D using Cathepsin D assay.";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1132101";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1999";"None";"";"";""
"CHEMBL314703";"";"None";"477.39";"1";"6.72";"31";"COc1cc(NC(=O)c2cc(Cl)cc(Cl)c2O)ccc1Sc1nc2ccccc2s1";"IC50";"'='";"2000.0";"nM";"5.70";"";"";"UO_0000065";"11.94";"0.26";"-1.02";"7.98";"0";"CHEMBL657347";"Inhibitory activity against human liver Cathepsin D using Cathepsin D assay.";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1132101";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1999";"None";"";"";""
"CHEMBL1760854";"";"None";"433.57";"0";"2.11";"20a";"CC(C)c1cccc(CN[C@H]2CS(=O)(=O)C[C@@H](Cc3ccc(O)c(CO)c3)[C@@H]2O)c1";"IC50";"'='";"2100.0";"nM";"5.68";"";"";"UO_0000065";"13.10";"0.26";"3.57";"5.31";"0";"CHEMBL1764636";"Inhibition of human cathepsin D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1759891";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL1760865";"";"None";"496.47";"0";"3.56";"22c";"CC(C)(C)c1cccc(CN[C@H]2CS(=O)(=O)C[C@@H](Cc3ccc(O)c(Br)c3)[C@@H]2O)c1";"IC50";"'='";"420.0";"nM";"6.38";"";"";"UO_0000065";"12.84";"0.29";"2.82";"7.36";"0";"CHEMBL1764636";"Inhibition of human cathepsin D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1759891";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL1077237";"";"None";"561.81";"2";"5.59";"25";"CC(C)c1cccc(CNC[C@H](O)[C@H](Cc2ccccc2)NC(=O)[C@@H]2CCC[C@H](C(C)(C)N3CCCCC3=O)C2)c1";"IC50";"'='";"120.0";"nM";"6.92";"";"";"UO_0000065";"12.32";"0.23";"1.33";"8.47";"0";"CHEMBL1107841";"Inhibition of Cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1155410";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL3127099";"";"None";"375.43";"0";"2.95";"77";"C[C@]12CCOC[C@@H]1[C@]1(COC(N)=N1)c1cc(-c3cccc(C#N)c3)ccc1O2";"IC50";"'='";"69000.0";"nM";"4.16";"";"";"UO_0000065";"11.08";"0.20";"1.21";"4.63";"0";"CHEMBL3131975";"Inhibition of human liver cathepsin D measured for 1 hr by FRET assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124885";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL3127071";"";"None";"403.84";"0";"3.27";"92";"C[C@]12CCOC[C@@H]1[C@]1(COC(N)=N1)c1cc(-c3cncc(Cl)c3)c(F)cc1O2";"IC50";"'='";"11000.0";"nM";"4.96";"";"";"UO_0000065";"12.28";"0.24";"1.69";"6.28";"0";"CHEMBL3131975";"Inhibition of human liver cathepsin D measured for 1 hr by FRET assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124885";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL209795";"";"None";"484.68";"0";"1.88";"103";"CCCCNC(=O)[C@H](C)C[C@H](O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(C)=O";"IC50";"'='";"260.0";"nM";"6.58";"";"";"UO_0000065";"13.59";"0.26";"4.71";"4.82";"0";"CHEMBL866007";"Inhibition of Cathepsin D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1137429";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";"";""
"CHEMBL4094377";"";"None";"381.41";"0";"4.06";"6m";"CC(C)(NCc1cc([C@]2(C)CCSC(N)=N2)c(F)cc1F)C(F)(F)F";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4042703";"Inhibition of Cathepsin D (unknown origin) by cell free assay";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4041533";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";"";""
"CHEMBL4084170";"";"None";"367.39";"0";"3.67";"6o";"C[C@@]1(c2cc(CNCCC(F)(F)F)c(F)cc2F)CCSC(N)=N1";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4042703";"Inhibition of Cathepsin D (unknown origin) by cell free assay";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4041533";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";"";""
"CHEMBL4102593";"";"None";"337.44";"0";"3.27";"6i";"C[C@@]1(c2cc(CNC34CC(C3)C4)c(F)cc2F)CCSC(N)=N1";"IC50";"'='";"95300.0";"nM";"4.02";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4042703";"Inhibition of Cathepsin D (unknown origin) by cell free assay";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4041533";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";"";""
"CHEMBL4100140";"";"None";"299.39";"0";"2.69";"6d";"CN(C)Cc1cc([C@]2(C)CCSC(N)=N2)c(F)cc1F";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4042703";"Inhibition of Cathepsin D (unknown origin) by cell free assay";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4041533";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";"";""
"CHEMBL4061944";"";"None";"299.39";"0";"2.74";"6b";"CCNCc1cc([C@]2(C)CCSC(N)=N2)c(F)cc1F";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4042703";"Inhibition of Cathepsin D (unknown origin) by cell free assay";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4041533";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";"";""
"CHEMBL3414707";"";"None";"298.36";"0";"2.65";"42";"C[C@H]1C[C@H]2CSC(N)=N[C@@]2(c2ccc(F)cc2F)CO1";"IC50";"'='";"72000.0";"nM";"4.14";"";"";"UO_0000065";"13.88";"0.28";"1.49";"8.70";"0";"CHEMBL3420009";"Inhibition of CatD (unknown origin) by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3414451";"1";"Scientific Literature";"J Med Chem";"2015";"None";"";"";""
"CHEMBL3422236";"";"None";"365.41";"0";"3.30";"3";"Cc1coc([C@H]2C[C@H]3CSC(N)=N[C@@]3(c3ccc(F)cc3F)CO2)n1";"IC50";"'='";"13900.0";"nM";"4.86";"";"";"UO_0000065";"13.29";"0.27";"1.56";"6.60";"0";"CHEMBL3423725";"Inhibition of CatD (unknown origin) assessed as fluorescence polarization by cell free assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3421534";"1";"Scientific Literature";"J Med Chem";"2015";"None";"";"";""
"CHEMBL562290";"";"None";"508.64";"1";"1.91";"12";"C#CCNC[C@@H](O)[C@H](Cc1ccccc1)NC(=O)c1cc2c3c(c1)c(CC)cn3CCS(=O)(=O)N2C";"IC50";"'='";"75500.0";"nM";"4.12";"";"";"UO_0000065";"8.10";"0.16";"2.21";"3.98";"0";"CHEMBL725829";"Inhibition of cathepsin-D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1158411";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL3394050";"";"None";"435.43";"0";"3.53";"21";"NC1=N[C@@]2(CO1)c1cc(-c3cccnc3F)ccc1Oc1cnc(N3CC[C@H](F)C3)cc12";"IC50";"'='";"2220.0";"nM";"5.65";"";"";"UO_0000065";"12.98";"0.24";"2.12";"6.58";"0";"CHEMBL3395116";"Inhibition of cathepsin D (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3393054";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";""
"CHEMBL3935967";"";"None";"481.46";"0";"4.32";"BDBM220811";"COc1ccc(C(=O)Nc2ccc3c(c2)C2(CCOC(N)=N2)c2cc(OC)cc(F)c2O3)c(F)c1";"IC50";"'='";"331100.0";"nM";"";"Outside typical range";"386497";"UO_0000065";"";"";"";"";"0";"CHEMBL3888270";"Fluorescence Resonance Energy Transfer (FRET) Assay: Recombinant CathepsinD was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The CathepsinD enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for CathepsinD) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886633";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3980947";"";"None";"512.50";"1";"3.63";"BDBM220796";"N#Cc1ccc(C(=O)Nc2ccc3c(c2)C2(CCOC(N)=N2)c2cc(C4=CCOCC4)nc(F)c2O3)nc1";"IC50";"'='";"400000.0";"nM";"";"Outside typical range";"386482";"UO_0000065";"";"";"";"";"0";"CHEMBL3888270";"Fluorescence Resonance Energy Transfer (FRET) Assay: Recombinant CathepsinD was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The CathepsinD enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for CathepsinD) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886633";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3899306";"";"None";"468.39";"0";"3.94";"BDBM214985";"COc1cnc2c(Nc3cc(F)c(F)c([C@]4(C)C[C@@H](C(F)(F)F)OC(N)=N4)c3)nccc2n1";"IC50";"'='";"519000.0";"nM";"";"Outside typical range";"378018";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3972152";"";"None";"494.37";"0";"4.40";"BDBM214981";"Cc1cc(OC(F)F)cnc1C(=O)Nc1cc(F)c(F)c([C@]2(C)C[C@@H](C(F)(F)F)OC(N)=N2)c1";"IC50";"'>'";"400000.0";"nM";"";"Outside typical range";"378021";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3964372";"";"None";"469.37";"0";"2.90";"BDBM214997";"C#CCOc1cnc(C(=O)Nc2cc(F)c(F)c([C@]3(C)C[C@@H](C(F)(F)F)OC(N)=N3)c2)cn1";"IC50";"'='";"504900.0";"nM";"";"Outside typical range";"378063";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3959106";"";"None";"525.48";"1";"4.03";"BDBM220801";"N#Cc1ccc(C(=O)Nc2ccc3c(c2)C2(CCOC(N)=N2)c2cc(-c4cncc(F)c4)nc(F)c2O3)nc1";"IC50";"'='";"133000.0";"nM";"";"Outside typical range";"386487";"UO_0000065";"";"";"";"";"0";"CHEMBL3888270";"Fluorescence Resonance Energy Transfer (FRET) Assay: Recombinant CathepsinD was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The CathepsinD enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for CathepsinD) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886633";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL78946";"";"None";"893.01";"3";"-1.74";"1";"CC(C)C[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CCC(=O)O)C(C)C)[C@@H](O)C[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)O";"IC50";"'='";"6.0";"nM";"8.22";"";"";"UO_0000065";"9.21";"0.18";"9.96";"2.19";"0";"CHEMBL828480";"Inhibitory concentration against human Cathepsin D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1145163";"1";"Scientific Literature";"J Med Chem";"2005";"None";"";"";""
"CHEMBL3969876";"IMARIKIREN HYDROCHLORIDE";"2.0";"536.12";"0";"2.40";"10; TAK-272";"COCCCCn1c(C(=O)N(CC(C)C)[C@@H]2CNC[C@H](C(=O)N3CCOCC3)C2)nc2ccccc21.Cl";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3859994";"Inhibition of cathepsin D (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3856290";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"";"";""
"CHEMBL3947677";"";"None";"503.95";"1";"4.27";"BDBM220779";"NC1=NC2(CCO1)c1cc(NC(=O)c3ccc(Cl)cn3)ccc1Oc1ncc(C3=CCOCC3)cc12";"IC50";"'='";"341500.0";"nM";"";"Outside typical range";"386462";"UO_0000065";"";"";"";"";"0";"CHEMBL3888270";"Fluorescence Resonance Energy Transfer (FRET) Assay: Recombinant CathepsinD was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The CathepsinD enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for CathepsinD) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886633";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3962966";"";"None";"513.49";"1";"3.42";"BDBM220827";"COc1cnc(C(=O)Nc2ccc3c(c2)C2(CCOC(N)=N2)c2cc(-c4ccnc(F)c4)ncc2O3)cn1";"IC50";"'='";"400000.0";"nM";"";"Outside typical range";"386513";"UO_0000065";"";"";"";"";"0";"CHEMBL3888270";"Fluorescence Resonance Energy Transfer (FRET) Assay: Recombinant CathepsinD was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The CathepsinD enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for CathepsinD) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886633";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3902974";"";"None";"516.92";"1";"4.67";"BDBM220828";"NC1=NC2(CCO1)c1cc(NC(=O)c3ccc(Cl)cn3)ccc1Oc1cnc(-c3ccnc(F)c3)cc12";"IC50";"'='";"400000.0";"nM";"";"Outside typical range";"386514";"UO_0000065";"";"";"";"";"0";"CHEMBL3888270";"Fluorescence Resonance Energy Transfer (FRET) Assay: Recombinant CathepsinD was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The CathepsinD enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for CathepsinD) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886633";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3978473";"";"None";"500.74";"1";"4.23";"BDBM220769";"NC1=NC2(CCO1)c1cc(NC(=O)c3ccc(Cl)cn3)ccc1Oc1ncc(Br)cc12";"IC50";"'='";"245100.0";"nM";"";"Outside typical range";"386452";"UO_0000065";"";"";"";"";"0";"CHEMBL3888270";"Fluorescence Resonance Energy Transfer (FRET) Assay: Recombinant CathepsinD was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The CathepsinD enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for CathepsinD) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886633";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3948764";"";"None";"474.28";"0";"4.26";"BDBM220772";"NC1=NC2(CCO1)c1cc(NC(=O)c3ccc(Cl)cn3)ccc1Oc1c2cc(Cl)nc1F";"IC50";"'>'";"400000.0";"nM";"";"Outside typical range";"386455";"UO_0000065";"";"";"";"";"0";"CHEMBL3888270";"Fluorescence Resonance Energy Transfer (FRET) Assay: Recombinant CathepsinD was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The CathepsinD enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for CathepsinD) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886633";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL537797";"";"None";"538.71";"1";"3.57";"25";"CCc1cn2c3c(cc(C(=O)N[C@@H](Cc4ccccc4)[C@H](O)CNC4CCCCC4)cc13)N(C)S(=O)(=O)C2";"IC50";"'='";"300.0";"nM";"6.52";"";"";"UO_0000065";"12.11";"0.23";"2.95";"6.29";"0";"CHEMBL1035560";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1158445";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL500275";"";"None";"642.86";"1";"4.88";"8d";"CCc1cn2c3c(cc(C(=O)N[C@@H](Cc4ccccc4)[C@H](O)CNC(C)(C)CCCC(C)C)cc13)N(C)S(=O)(=O)CC2.O=CO";"IC50";"'='";"660.0";"nM";"6.18";"";"";"UO_0000065";"10.36";"0.20";"1.30";"5.96";"0";"CHEMBL959767";"Inhibition of cathepsin D expressed in CHO cells after 1 hrs by spectrophotometer";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1150334";"1";"Scientific Literature";"J Med Chem";"2008";"CHEMBL3308072";"";"";""
"CHEMBL2322207";"";"None";"577.75";"1";"4.28";"(3S,5R)-12";"COCCCCC1(CNC(=O)[C@@H]2CNC[C@H](NS(=O)(=O)c3ccc(C)cc3)C2)c2ccccc2Oc2ccccc21";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2329599";"Inhibition of human recombinant cathepsin D expressed in baculovirus-infected SF9 cells using fluorescence-quenched Ac-E-D(EDANS)-KPILFFRLG-K(Dabcyl)-E-Amid as substrate incubated for 1 hr prior to substrate addition measured after 1 hr by fluorescence polarization assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2321871";"1";"Scientific Literature";"J Med Chem";"2013";"CHEMBL3308860";"";"";""
"CHEMBL2349606";"";"None";"354.39";"0";"2.43";"38, rac-38";"CN1C(=O)C2(CC(C)(C)Oc3ccc(-c4cncc(F)c4)cc32)N=C1N";"IC50";"'='";"6760.0";"nM";"5.17";"";"";"UO_0000065";"14.59";"0.27";"2.74";"6.40";"0";"CHEMBL2352017";"Inhibition of human spleen cathepsin D using 5-FAM/QXL as peptide substrate after 1 hr by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"CHEMBL3559722";"Spleen";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346596";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL2048059";"";"None";"616.60";"1";"3.66";"62e";"CC(C)(CO)c1cccc(CN[C@H]2CS(=O)(=O)C[C@@H](Cc3cc(F)c(N)c(OC(C(F)(F)F)C(F)(F)F)c3)[C@@H]2O)c1";"IC50";"'='";"600.0";"nM";"6.22";"";"";"UO_0000065";"10.09";"0.21";"2.56";"5.10";"0";"CHEMBL2049562";"Inhibition of human recombinant CatD using Mca-GKPILFFRLK(DNP)-dR-NH2 as substrate after 1 hr by fluorescence analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2046351";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL296588";"PEPSTATIN";"2.0";"685.90";"2";"1.47";"Pepstatin A";"CC(C)CC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)[C@@H](O)CC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)[C@@H](O)CC(=O)O)C(C)C)C(C)C";"IC50";"'='";"5000.0";"nM";"5.30";"";"";"UO_0000065";"7.73";"0.15";"3.83";"2.37";"0";"CHEMBL1043707";"Inhibition of cathepsin D in human MCF7 cells treated for 1 hr measured after washout and trypsin treatment by fluorescence assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"MCF7";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156023";"1";"Scientific Literature";"J Med Chem";"2009";"CHEMBL3308403";"";"";""
"CHEMBL3394052";"";"None";"424.44";"0";"4.64";"23";"NC1=N[C@@]2(CO1)c1cc(-c3cccnc3F)ccc1Oc1cnc(-c3ccccc3)cc12";"IC50";"'='";"650.0";"nM";"6.19";"";"";"UO_0000065";"14.58";"0.26";"1.55";"7.49";"0";"CHEMBL3395116";"Inhibition of cathepsin D (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3393054";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";""
"CHEMBL3394047";"";"None";"461.50";"0";"3.59";"18";"CC1(C)CN(c2cc3c(cn2)Oc2ccc(-c4cccnc4F)cc2[C@@]32COC(N)=N2)CCO1";"IC50";"'='";"530.0";"nM";"6.28";"";"";"UO_0000065";"13.60";"0.25";"2.69";"6.60";"0";"CHEMBL3395116";"Inhibition of cathepsin D (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3393054";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";""
"CHEMBL3264796";"";"None";"692.92";"2";"5.11";"1SS";"CCCN(CCC)C(=O)c1cc(C(=O)N[C@@H](Cc2ccccc2)[C@@H](O)CNC(C)(C)c2cccc(OC)c2)cc(N2CCCCS2(=O)=O)c1";"IC50";"'='";"4400.0";"nM";"5.36";"";"";"UO_0000065";"7.73";"0.15";"0.25";"4.18";"0";"CHEMBL3271470";"Inhibition of human cathepsin-D using DABCYL-Glu-Arg-Nle-Phe-Leu-Ser-Phe-Pro-EDANS as substrate preincubated for 30 mins by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3259525";"1";"Scientific Literature";"ACS Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3264800";"";"None";"628.86";"2";"5.87";"4";"CCCN(CCC)C(=O)c1cc(C(=O)N[C@@H](Cc2ccccc2)[C@H](O)CNC(C)(C)c2cccc(O)c2)cc(N2CCCCC2)c1";"IC50";"'='";"40.0";"nM";"7.40";"";"";"UO_0000065";"11.76";"0.22";"1.53";"7.04";"0";"CHEMBL3271470";"Inhibition of human cathepsin-D using DABCYL-Glu-Arg-Nle-Phe-Leu-Ser-Phe-Pro-EDANS as substrate preincubated for 30 mins by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3259525";"1";"Scientific Literature";"ACS Med Chem Lett";"2014";"None";"";"";""
"CHEMBL2407345";"";"None";"504.72";"2";"5.57";"14";"CCc1ccc2c(c1)[C@@H](NC[C@@H](O)[C@@H]1Cc3cccc(c3)CCCCCCCC(=O)N1)CC1(CCC1)O2";"IC50";"'='";"890.0";"nM";"6.05";"";"";"UO_0000065";"11.99";"0.22";"0.48";"8.57";"0";"CHEMBL2411009";"Inhibition of Cathepsin D (unknown origin) by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2406987";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"None";"";"";""
"CHEMBL4104527";"";"None";"367.39";"0";"3.63";"6j";"CN(Cc1cc([C@]2(C)CCSC(N)=N2)c(F)cc1F)CC(F)(F)F";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4042703";"Inhibition of Cathepsin D (unknown origin) by cell free assay";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4041533";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";"";""
"CHEMBL4064708";"";"None";"343.44";"0";"2.76";"6g";"COCCCNCc1cc([C@]2(C)CCSC(N)=N2)c(F)cc1F";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4042703";"Inhibition of Cathepsin D (unknown origin) by cell free assay";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4041533";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";"";""
"CHEMBL68617";"";"None";"537.66";"2";"6.28";"8h";"O=C1NC(=S)S/C1=C\c1ccc(COc2ccc(C(=O)c3ccccc3)c(O)c2Cc2ccccc2)cc1";"IC50";"'='";"820.0";"nM";"6.09";"";"";"UO_0000065";"11.32";"0.22";"-0.19";"8.05";"0";"CHEMBL658685";"In vitro inhibition of cathepsin D.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1129769";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1996";"None";"";"";""
"CHEMBL1210358";"";"None";"612.67";"1";"4.69";"31";"CS(=O)(=O)N(c1cccnc1)c1cccc(C(=O)N[C@@H](Cc2ccccc2)[C@H](O)CNCc2cccc(C(F)(F)F)c2)c1";"IC50";"'='";"470.0";"nM";"6.33";"";"";"UO_0000065";"10.33";"0.20";"1.64";"5.67";"0";"CHEMBL1211667";"Inhibition of Cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1208699";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL2425607";"";"None";"561.64";"1";"3.50";"17n";"COC[C@@H](Oc1cc(C[C@@H]2C[S@@+]([O-])C[C@H](NCc3cc(C(C)(C)C)ccn3)[C@H]2O)cc(F)c1N)C(F)(F)F";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2427050";"Inhibition of human cathepsin-D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2424550";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"None";"";"";""
"CHEMBL2425598";"";"None";"548.64";"1";"3.93";"17d";"[2H]C([2H])(N[C@H]1C[S@+]([O-])C[C@@H](Cc2cc(F)c(N)c(O[C@H](COC)C(F)(F)F)c2)[C@@H]1O)c1cccc(C(C)C)c1";"IC50";"'='";"3290.0";"nM";"5.48";"";"";"UO_0000065";"10.03";"0.20";"1.55";"5.49";"0";"CHEMBL2427050";"Inhibition of human cathepsin-D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2424550";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"None";"";"";""
"CHEMBL502289";"";"None";"576.72";"1";"2.81";"27";"CCNc1cc(C(=O)N[C@@H](Cc2ccccc2)[C@H](O)CNCc2cncc(C#N)c2)cc(N2CCCCS2(=O)=O)c1";"IC50";"'='";"35480.0";"nM";"4.45";"";"";"UO_0000065";"7.72";"0.15";"1.64";"3.02";"0";"CHEMBL1036847";"Inhibition of cathepsin-D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1137769";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL3936498";"";"None";"498.54";"0";"3.61";"BDBM220820";"COc1cnc(C(=O)Nc2ccc3c(c2)C2(CCOC(N)=N2)c2cc(C#CC(C)(C)C)ncc2O3)cn1";"IC50";"'='";"452300.0";"nM";"";"Outside typical range";"386506";"UO_0000065";"";"";"";"";"0";"CHEMBL3888270";"Fluorescence Resonance Energy Transfer (FRET) Assay: Recombinant CathepsinD was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The CathepsinD enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for CathepsinD) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886633";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL397275";"";"None";"579.73";"2";"5.59";"19a";"CCCN(CCC)C(=O)c1cc(C)cc(C(=O)N[C@@H](Cc2cc(F)cc(F)c2)[C@H](O)CNCc2cccc(CC)c2)c1";"IC50";"'='";"150.0";"nM";"6.82";"";"";"UO_0000065";"11.77";"0.22";"1.23";"8.36";"0";"CHEMBL888969";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1144655";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"None";"";"";""
"CHEMBL4080380";"";"None";"395.40";"0";"3.05";"6t";"C[C@@]1(c2cc(CNC3(C(F)(F)F)COC3)c(F)cc2F)CCSC(N)=N1";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4042703";"Inhibition of Cathepsin D (unknown origin) by cell free assay";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4041533";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";"";""
"CHEMBL3344262";"";"None";"739.79";"2";"1.65";"52";"CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)OCc1ccccc1)[C@@H](O)CC(=O)NCc1ccccc1.O=C(O)C(F)(F)F";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3370435";"Inhibition of human cathepsin D assessed as cleavage of wtKAHRP fluorogenic substrate";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3352063";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL252655";"";"None";"538.73";"1";"3.99";"15";"CCNc1cc(C(=O)N[C@@H](Cc2ccccc2)[C@H](O)CNC(C)(C)COCC(C)C)cc(N2CCCC2=O)c1";"IC50";"'='";"22325.0";"nM";"4.65";"";"";"UO_0000065";"8.63";"0.16";"0.66";"4.52";"0";"CHEMBL945833";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140837";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";"";"";""
"CHEMBL296588";"PEPSTATIN";"2.0";"685.90";"2";"1.47";"pepstatin-A";"CC(C)CC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)[C@@H](O)CC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)[C@@H](O)CC(=O)O)C(C)C)C(C)C";"IC50";"'='";"0.55";"nM";"9.26";"";"";"UO_0000065";"13.50";"0.26";"7.79";"4.15";"0";"CHEMBL929232";"Inhibition of human cathepsin D by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1145617";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";"";"";""
"CHEMBL490920";"";"None";"383.45";"0";"-0.11";"CA 074";"CCCNC(=O)[C@H]1O[C@@H]1C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)O)[C@@H](C)CC";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1021961";"Inhibition of human liver cathepsin D after 30 mins by fluorometric end-point assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138527";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL1271244";"";"None";"426.40";"0";"3.52";"31";"CN1C(=O)[C@@](c2ccc(OC(F)F)cc2)(c2cccc(-c3cccnc3F)c2)N=C1N";"IC50";"'='";"300.0";"nM";"6.52";"";"";"UO_0000065";"15.30";"0.29";"3.00";"8.07";"0";"CHEMBL1273977";"Inhibition of cathepsin D by FRET assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1268920";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL1269918";"";"None";"327.36";"0";"2.07";"37";"CN1C(=O)[C@](c2ccccc2)(c2ccc(OCCF)cc2)N=C1N";"IC50";"'='";"116710.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1273977";"Inhibition of cathepsin D by FRET assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1268920";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL3764405";"";"None";"397.48";"0";"4.57";"2S,5R-3b";"Nc1nc2cc(-c3ccccc3)ccc2c(=O)n1C[C@@H]1CC[C@H](c2ccccc2)O1";"IC50";"'='";"22000.0";"nM";"4.66";"";"";"UO_0000065";"11.72";"0.21";"0.09";"6.64";"0";"CHEMBL3767017";"Inhibition of CatD (unknown origin) preincubated for 30 mins followed by DABCYL-Glu-Arg-Nle-Phe-Leu-Ser-Phe-Pro-EDANS substrate addition by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3763050";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";""
"CHEMBL3764744";"";"None";"321.38";"0";"2.82";"rac-3a";"Nc1nc2cc(-c3ccccc3)ccc2c(=O)n1C[C@@H]1CCCO1";"IC50";"'='";"53400.0";"nM";"4.27";"";"";"UO_0000065";"13.29";"0.24";"1.45";"6.09";"0";"CHEMBL3767017";"Inhibition of CatD (unknown origin) preincubated for 30 mins followed by DABCYL-Glu-Arg-Nle-Phe-Leu-Ser-Phe-Pro-EDANS substrate addition by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3763050";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";""
"CHEMBL404897";"";"None";"448.61";"0";"3.83";"34";"N/C(=N/C(=O)Cn1c(-c2ccccc2)ccc1C12CC3CC(CC(C3)C1)C2)NCCCCO";"IC50";"'='";"6450.0";"nM";"5.19";"";"";"UO_0000065";"11.57";"0.21";"1.36";"5.60";"0";"CHEMBL930552";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1142260";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";"";"";""
"CHEMBL2349478";"";"None";"368.87";"0";"3.36";"48, rac-48";"CN1C(=O)C2(CC(C)(C)Cc3ccc(-c4cncc(Cl)c4)cc32)N=C1N";"IC50";"'='";"1665.0";"nM";"5.78";"";"";"UO_0000065";"15.67";"0.30";"2.42";"8.07";"0";"CHEMBL2352017";"Inhibition of human spleen cathepsin D using 5-FAM/QXL as peptide substrate after 1 hr by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"CHEMBL3559722";"Spleen";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346596";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL2349506";"";"None";"374.44";"0";"2.66";"36, rac-36";"CC#Cc1cncc(-c2ccc3c(c2)C2(CC(C)(C)O3)N=C(N)N(C)C2=O)c1";"IC50";"'='";"973.0";"nM";"6.01";"";"";"UO_0000065";"16.06";"0.29";"3.35";"7.44";"0";"CHEMBL2352017";"Inhibition of human spleen cathepsin D using 5-FAM/QXL as peptide substrate after 1 hr by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"CHEMBL3559722";"Spleen";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346596";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL2407496";"";"None";"516.73";"2";"5.76";"9";"C=CCCCC(=O)N[C@@H](Cc1cccc(CC=C)c1)[C@H](O)CN[C@H]1CC2(CCC2)Oc2ccc(CC)cc21";"IC50";"'='";"6.3";"nM";"8.20";"";"";"UO_0000065";"15.87";"0.29";"2.44";"11.62";"0";"CHEMBL2411009";"Inhibition of Cathepsin D (unknown origin) by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2406987";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"None";"";"";""
"CHEMBL394596";"";"None";"603.76";"1";"4.63";"19n";"CCCN(CCC)C(=O)c1cc(C(=O)N[C@@H](Cc2ccccc2)[C@H](O)CNCc2cccc(OC)c2)cc(C(=O)OCC)c1";"IC50";"'='";"866.0";"nM";"6.06";"";"";"UO_0000065";"10.04";"0.19";"1.43";"5.17";"0";"CHEMBL888969";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1144655";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"None";"";"";""
"CHEMBL2059624";"";"None";"384.93";"1";"5.46";"E10T5";"OC(COc1ccc(Cc2ccccc2)cc1)CSc1ccccc1Cl";"IC50";"'>'";"300000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2061980";"Inhibition of cathepsin D by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2057073";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL2031151";"";"None";"431.58";"0";"2.42";"47";"C=CC[C@H](NC(C)=O)[C@H](O)CN[C@H]1C[C@]2(C[C@H](O)C2)Oc2ncc(CC(C)(C)C)cc21";"IC50";"'>'";"40000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2033077";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2029322";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL242315";"";"None";"970.02";"3";"0.37";"5a";"CC(C)C[C@H](NC(=O)[C@@H](N)CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)P(=O)(O)CC(C)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C";"IC50";"'='";"28.0";"nM";"7.55";"";"";"UO_0000065";"7.79";"0.15";"7.18";"1.95";"0";"CHEMBL893254";"Inhibition of cathepsin D expressed in HEK293 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147996";"1";"Scientific Literature";"Bioorg Med Chem";"2007";"CHEMBL3307715";"";"";""
"CHEMBL4557670";"";"None";"425.44";"0";"3.18";"5";"C[C@H]1SC(N)=N[C@](C)(c2cc(NC(=O)c3cnc(OCF)cn3)ccc2F)[C@H]1F";"IC50";"'>='";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4322975";"Inhibition of Cathepsin D (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4321815";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";""
"CHEMBL1941015";"";"None";"373.41";"0";"4.00";"12";"COc1ccc(OC)c(C(=O)Cn2c(-c3ccccn3)nc3ccccc32)c1";"IC50";"'='";"21200.0";"nM";"4.67";"";"";"UO_0000065";"12.52";"0.23";"0.67";"7.06";"0";"CHEMBL1942416";"Inhibition of human cathepsin D using DABCYL-Glu-Arg-Nle-Phe-Leu-Ser-Phe-Pro-EDANS as substrate by FRET analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1938395";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL582044";"";"None";"290.37";"0";"2.36";"1, HTS Hit";"NC1=NC(c2ccccc2)(c2ccccc2)C2=NCCCN12";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"1";"CHEMBL1825607";"Inhibition of cathepsin D by FRET assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1821667";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL3917242";"";"None";"499.77";"0";"4.42";"BDBM214880";"C[C@@]1(c2nc(NC(=O)c3ncc(C(F)(F)F)cc3Cl)ccc2F)C[C@@H](C(F)(F)F)OC(N)=N1";"IC50";"'>'";"400000.0";"nM";"";"Outside typical range";"377890";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3934911";"";"None";"396.32";"0";"3.59";"BDBM214904";"N#Cc1cncc(-c2ccc(F)c([C@]3(CF)C[C@@H](C(F)(F)F)OC(N)=N3)c2)c1";"IC50";"'='";"129000.0";"nM";"";"Outside typical range";"377898";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3925742";"";"None";"462.81";"0";"4.46";"BDBM214977";"Cc1cc(Cl)cnc1C(=O)Nc1cc(F)c(F)c([C@]2(C)C[C@@H](C(F)(F)F)OC(N)=N2)c1";"IC50";"'='";"733000.0";"nM";"";"Outside typical range";"378011";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3943708";"";"None";"433.38";"0";"4.54";"BDBM214931";"NC1=N[C@](CF)(c2cc(C#Cc3cccc4[nH]ccc34)ccc2F)C[C@@H](C(F)(F)F)O1";"IC50";"'='";"578000.0";"nM";"";"Outside typical range";"378031";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3952431";"";"None";"433.38";"0";"4.54";"BDBM214933";"NC1=N[C@](CF)(c2cc(C#Cc3ccc4cc[nH]c4c3)ccc2F)C[C@@H](C(F)(F)F)O1";"IC50";"'='";"721000.0";"nM";"";"Outside typical range";"378033";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3926914";"";"None";"484.76";"0";"4.24";"BDBM215041";"NC1=N[C@](CF)(c2cc(NC(=O)c3ncc(Cl)cc3F)cc(F)c2F)C[C@@H](C(F)(F)F)O1";"IC50";"'>'";"400000.0";"nM";"";"Outside typical range";"378037";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL4741771";"";"None";"757.87";"1";"4.98";"2b";"COc1ccc(CC(=O)NC(=N)N[C@H](CC2CCCCC2)C(=O)Nc2cc(S(=O)(=O)N(C(C)C)C(C)C)ccc2C)cc1OC.O=C(O)C(F)(F)F";"IC50";"'='";"11.0";"nM";"7.96";"";"";"UO_0000065";"12.36";"0.24";"2.98";"5.31";"0";"CHEMBL4706202";"Inhibition of human liver Cathepsin D preincubated for 10 mins followed by substrate addition and further incubated for 2 hrs in dark by fluorimetric analysis";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699662";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"TIME = 2.167 hr";"INHIBITOR";""
"CHEMBL4746206";"";"None";"605.59";"0";"1.13";"6c";"CNS(=O)(=O)c1ccc(C)c(NC(=O)[C@@H](C)NC(=N)NC(=O)Cc2ccc(OC)c(OC)c2)c1.O=C(O)C(F)(F)F";"IC50";"'='";"5947.0";"nM";"5.23";"";"";"UO_0000065";"10.63";"0.21";"4.10";"3.29";"0";"CHEMBL4706202";"Inhibition of human liver Cathepsin D preincubated for 10 mins followed by substrate addition and further incubated for 2 hrs in dark by fluorimetric analysis";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699662";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"TIME = 2.167 hr";"INHIBITOR";""
"CHEMBL4797663";"";"None";"763.68";"2";"5.10";"6d";"CNS(=O)(=O)c1ccc(C)c(NC(=O)[C@@H](CC2CCCCC2)NC(=N)NC(=O)Cc2cc(C(F)(F)F)cc(C(F)(F)F)c2)c1.O=C(O)C(F)(F)F";"IC50";"'='";"110.0";"nM";"6.96";"";"";"UO_0000065";"10.71";"0.22";"1.86";"4.96";"0";"CHEMBL4706202";"Inhibition of human liver Cathepsin D preincubated for 10 mins followed by substrate addition and further incubated for 2 hrs in dark by fluorimetric analysis";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699662";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"TIME = 2.167 hr";"INHIBITOR";""
"CHEMBL83114";"";"None";"715.49";"2";"9.22";"4";"CCOc1ccc2nc(Sc3ccc(NC(=O)c4cc(Cl)cc(Cl)c4NS(=O)(=O)c4cc(Cl)cc(Cl)c4O)cc3)sc2c1";"IC50";"'='";"250.0";"nM";"6.60";"";"";"UO_0000065";"9.23";"0.21";"-2.62";"5.61";"1";"CHEMBL3371144";"Inhibition of cathepsin D (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351526";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL2151149";"";"None";"422.57";"0";"3.69";"Page no 4460, R13C1, 5-1";"CCc1ccc2c(c1)[C@@H](NC[C@@H](O)[C@H](Cc1ccccc1)NC(C)=O)CC1(CCC1)O2";"IC50";"'='";"700.0";"nM";"6.16";"";"";"UO_0000065";"14.57";"0.27";"2.46";"8.72";"0";"CHEMBL2411009";"Inhibition of Cathepsin D (unknown origin) by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2406987";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"None";"";"";""
"CHEMBL3688795";"";"None";"339.36";"0";"3.23";"BDBM171742";"NC1=N[C@@](c2cc(NCC3CCC3)ccc2F)(C(F)F)[C@H]2C[C@H]2O1";"IC50";"'='";"121000.0";"nM";"";"Outside typical range";"316142";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688825";"";"None";"413.40";"0";"4.06";"BDBM171776";"[C-]#[N+]c1cnc2c(c1)CC[C@H]2Nc1ccc(F)c([C@@]2(C(F)F)N=C(N)O[C@@H]3C[C@@H]32)c1";"IC50";"'='";"555020.0";"nM";"";"Outside typical range";"316173";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3693245";"";"None";"371.36";"0";"3.45";"BDBM171804";"CC#Cc1cncc(-c2ccc(F)c([C@@]3(C(F)F)N=C(N)O[C@@H]4C[C@@H]43)c2)c1";"IC50";"'='";"91600.0";"nM";"4.04";"";"316202";"UO_0000065";"10.87";"0.20";"0.59";"6.67";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL2048043";"";"None";"496.62";"0";"3.16";"60f";"CC(C)(C)c1cccc(CN[C@H]2CS(=O)(=O)C[C@@H](Cc3cc(F)c(N)c(OCCF)c3)[C@@H]2O)c1";"IC50";"'='";"2000.0";"nM";"5.70";"";"";"UO_0000065";"11.48";"0.23";"2.54";"5.61";"0";"CHEMBL2049562";"Inhibition of human recombinant CatD using Mca-GKPILFFRLK(DNP)-dR-NH2 as substrate after 1 hr by fluorescence analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2046351";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL2048047";"";"None";"600.60";"1";"4.68";"60j";"CC(C)(C)c1cccc(CN[C@H]2CS(=O)(=O)C[C@@H](Cc3cc(F)c(N)c(OC(C(F)(F)F)C(F)(F)F)c3)[C@@H]2O)c1";"IC50";"'='";"450.0";"nM";"6.35";"";"";"UO_0000065";"10.57";"0.22";"1.67";"6.24";"0";"CHEMBL2049562";"Inhibition of human recombinant CatD using Mca-GKPILFFRLK(DNP)-dR-NH2 as substrate after 1 hr by fluorescence analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2046351";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL2048056";"";"None";"580.56";"1";"3.39";"62b, mixture of diastereomers";"CC(C)(C)O[C@H]1C[C@@H]1CN[C@H]1CS(=O)(=O)C[C@@H](Cc2cc(F)c(N)c(OC(C(F)(F)F)C(F)(F)F)c2)[C@@H]1O";"IC50";"'='";"3710.0";"nM";"5.43";"";"";"UO_0000065";"9.35";"0.20";"2.04";"4.90";"0";"CHEMBL2049562";"Inhibition of human recombinant CatD using Mca-GKPILFFRLK(DNP)-dR-NH2 as substrate after 1 hr by fluorescence analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2046351";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL2048063";"";"None";"605.57";"1";"3.96";"62i";"CC(C)(C)Cc1cc(CN[C@H]2CS(=O)(=O)C[C@@H](Cc3cc(F)c(N)c(OC(C(F)(F)F)C(F)(F)F)c3)[C@@H]2O)no1";"IC50";"'='";"510.0";"nM";"6.29";"";"";"UO_0000065";"10.39";"0.21";"2.33";"4.93";"0";"CHEMBL2049562";"Inhibition of human recombinant CatD using Mca-GKPILFFRLK(DNP)-dR-NH2 as substrate after 1 hr by fluorescence analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2046351";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL257594";"";"None";"357.41";"0";"4.47";"73";"Cc1ccc2c(NNC(=O)c3ccccc3O)c3ccccc3nc2c1C";"IC50";"'='";"9.0";"nM";"8.05";"";"";"UO_0000065";"22.51";"0.41";"3.58";"10.84";"0";"CHEMBL4357658";"Inhibition of human cathepsin D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4354841";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";""
"CHEMBL3764738";"";"None";"467.61";"1";"6.15";"rac-4h";"CC(C)CCc1ccc(-c2ccc3c(=O)n(C[C@@H]4CC[C@H](c5ccccc5)O4)c(N)nc3c2)cc1";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3767017";"Inhibition of CatD (unknown origin) preincubated for 30 mins followed by DABCYL-Glu-Arg-Nle-Phe-Leu-Ser-Phe-Pro-EDANS substrate addition by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3763050";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";""
"CHEMBL2031141";"";"None";"497.66";"0";"4.50";"35";"CC(=O)N[C@@H](Cc1ccc(F)cc1)[C@H](O)CN[C@H]1C[C@]2(C[C@H](C)C2)Oc2ncc(CC(C)(C)C)cc21";"IC50";"'='";"38.0";"nM";"7.42";"";"";"UO_0000065";"14.91";"0.28";"2.92";"8.89";"0";"CHEMBL2033077";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2029322";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL2031146";"";"None";"519.61";"1";"4.50";"42";"CC(=O)N[C@@H](Cc1ccc(F)cc1)[C@H](O)CN[C@H]1CC2(CC(F)(F)C2)Oc2ncc(CC(C)(C)C)cc21";"IC50";"'='";"11.0";"nM";"7.96";"";"";"UO_0000065";"15.32";"0.29";"3.46";"9.53";"0";"CHEMBL2033077";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2029322";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL2031148";"";"None";"499.63";"0";"3.22";"44";"CC(=O)N[C@@H](Cc1ccc(F)cc1)[C@H](O)CN[C@H]1C[C@]2(C[C@H](O)C2)Oc2ncc(CC(C)(C)C)cc21";"IC50";"'='";"577.0";"nM";"6.24";"";"";"UO_0000065";"12.49";"0.24";"3.02";"6.02";"0";"CHEMBL2033077";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2029322";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL604590";"";"None";"343.39";"0";"2.17";"4l";"CN1C(=O)C(c2ccncc2)(c2cccc(-c3cccnc3)c2)N=C1N";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1115170";"Inhibition of cathepsin D by FRET assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156304";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL307641";"";"None";"441.57";"1";"5.01";"3e";"CCCc1c(COc2ccc(/C=C3\SC(=S)NC3=O)cc2)ccc(C(=O)CC)c1O";"IC50";"'='";"3690.0";"nM";"5.43";"";"";"UO_0000065";"12.30";"0.25";"0.42";"7.18";"0";"CHEMBL658685";"In vitro inhibition of cathepsin D.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1129769";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1996";"None";"";"";""
"CHEMBL4083698";"";"None";"313.42";"0";"3.13";"6c";"CC(C)NCc1cc([C@]2(C)CCSC(N)=N2)c(F)cc1F";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4042703";"Inhibition of Cathepsin D (unknown origin) by cell free assay";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4041533";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";"";""
"CHEMBL3764174";"";"None";"467.61";"1";"6.30";"1b";"CCCCCc1ccc(-c2ccc3c(=O)n(C[C@@H]4CC[C@H](c5ccccc5)O4)c(N)nc3c2)cc1";"IC50";"'='";"5000.0";"nM";"5.30";"";"";"UO_0000065";"11.34";"0.21";"-1.00";"7.56";"1";"CHEMBL4223547";"Inhibition of human cathepsin D using DABCYL-Glu-Arg-Nle-Phe-Leu-Ser-Phe-Pro-EDANS as substrate preincubated for 30 mins followed by substrate addition measured every 1 min within 8 to 15 mins by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4219216";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";"";""
"CHEMBL67206";"";"None";"427.55";"0";"4.62";"3h";"CCCc1c(COc2cccc(/C=C3/SC(=S)NC3=O)c2)ccc(C(C)=O)c1O";"IC50";"'='";"6640.0";"nM";"5.18";"";"";"UO_0000065";"12.11";"0.24";"0.56";"6.85";"0";"CHEMBL658685";"In vitro inhibition of cathepsin D.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1129769";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1996";"None";"";"";""
"CHEMBL1824352";"";"None";"397.89";"0";"3.20";"55";"Cc1cc(C2(c3cccc(-c4cncnc4)c3)N=C(N)N(C)C2=O)c(Cl)s1";"IC50";"'='";"31650.0";"nM";"4.50";"";"";"UO_0000065";"11.31";"0.23";"1.30";"5.33";"0";"CHEMBL1825607";"Inhibition of cathepsin D by FRET assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1821667";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL2047905";"";"None";"504.67";"1";"3.75";"46b";"CCc1cc(C[C@@H]2CS(=O)(=O)C[C@H](NCc3cccc(C(C)(C)C)c3)[C@H]2O)cc(F)c1NC(C)=O";"IC50";"'='";"2300.0";"nM";"5.64";"";"";"UO_0000065";"11.17";"0.22";"1.89";"5.90";"0";"CHEMBL2049562";"Inhibition of human recombinant CatD using Mca-GKPILFFRLK(DNP)-dR-NH2 as substrate after 1 hr by fluorescence analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2046351";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL2048040";"";"None";"504.67";"1";"3.74";"60c";"CC(C)(C)c1cccc(CN[C@H]2CS(=O)(=O)C[C@@H](Cc3cc(F)c(N)c(OC4CCC4)c3)[C@@H]2O)c1";"IC50";"'='";"390.0";"nM";"6.41";"";"";"UO_0000065";"12.70";"0.25";"2.67";"6.30";"0";"CHEMBL2049562";"Inhibition of human recombinant CatD using Mca-GKPILFFRLK(DNP)-dR-NH2 as substrate after 1 hr by fluorescence analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2046351";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL436104";"";"None";"698.97";"2";"1.57";"57";"CCCCNC(=O)[C@@H](NC(=O)[C@H]1[C@H]([C@H](O)[C@H](CC(C)C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(C)C)NC(C)=O)CC(=O)N1C)C(C)C";"IC50";"'='";"70.0";"nM";"7.16";"";"";"UO_0000065";"10.24";"0.20";"5.58";"3.85";"0";"CHEMBL828480";"Inhibitory concentration against human Cathepsin D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1145163";"1";"Scientific Literature";"J Med Chem";"2005";"None";"";"";""
"CHEMBL2048039";"";"None";"478.63";"0";"3.21";"60b";"CCOc1cc(C[C@@H]2CS(=O)(=O)C[C@H](NCc3cccc(C(C)(C)C)c3)[C@H]2O)cc(F)c1N";"IC50";"'='";"1030.0";"nM";"5.99";"";"";"UO_0000065";"12.51";"0.25";"2.78";"5.89";"0";"CHEMBL2049562";"Inhibition of human recombinant CatD using Mca-GKPILFFRLK(DNP)-dR-NH2 as substrate after 1 hr by fluorescence analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2046351";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL4795135";"";"None";"577.54";"0";"0.48";"19e";"COc1ccc(CC(=O)NC(=N)NCC(=O)Nc2cc(S(N)(=O)=O)ccc2C)cc1OC.O=C(O)C(F)(F)F";"IC50";"'='";"18340.0";"nM";"4.74";"";"";"UO_0000065";"10.22";"0.20";"4.26";"2.74";"0";"CHEMBL4706202";"Inhibition of human liver Cathepsin D preincubated for 10 mins followed by substrate addition and further incubated for 2 hrs in dark by fluorimetric analysis";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699662";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"TIME = 2.167 hr";"INHIBITOR";""
"CHEMBL4745248";"";"None";"607.56";"1";"-0.16";"25e";"COc1ccc(CC(=O)NC(=N)N[C@H](CO)C(=O)Nc2cc(S(N)(=O)=O)ccc2C)cc1OC.O=C(O)C(F)(F)F";"IC50";"'='";"7513.0";"nM";"5.12";"";"";"UO_0000065";"10.38";"0.21";"5.28";"2.66";"0";"CHEMBL4706202";"Inhibition of human liver Cathepsin D preincubated for 10 mins followed by substrate addition and further incubated for 2 hrs in dark by fluorimetric analysis";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699662";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"TIME = 2.167 hr";"INHIBITOR";""
"CHEMBL1824354";"";"None";"348.43";"0";"2.84";"57";"CN1C(=O)C(c2ccsc2)(c2cccc(-c3cccnc3)c2)N=C1N";"IC50";"'='";"22000.0";"nM";"4.66";"";"";"UO_0000065";"13.37";"0.25";"1.82";"6.51";"0";"CHEMBL1825607";"Inhibition of cathepsin D by FRET assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1821667";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL1824145";"";"None";"378.41";"0";"2.13";"(S)-38";"CCn1cc([C@]2(c3cccc(-c4cccnc4F)c3)N=C(N)N(C)C2=O)cn1";"IC50";"'='";"6690.0";"nM";"5.17";"";"";"UO_0000065";"13.67";"0.25";"3.04";"5.79";"0";"CHEMBL1825607";"Inhibition of cathepsin D by FRET assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1821667";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL255977";"";"None";"578.75";"1";"3.73";"18";"CC(C)Oc1cc(C(=O)N[C@@H](Cc2ccccc2)[C@H](O)CN[C@@H](C)C(=O)NC2CCCCC2)cc(N2CCCC2=O)c1";"IC50";"'='";"12300.0";"nM";"4.91";"";"";"UO_0000065";"8.48";"0.16";"1.18";"4.09";"0";"CHEMBL931965";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1143153";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";"";"";""
"CHEMBL258068";"";"None";"564.73";"1";"3.34";"17";"CCOc1cc(C(=O)N[C@@H](Cc2ccccc2)[C@H](O)CN[C@@H](C)C(=O)NC2CCCCC2)cc(N2CCCC2=O)c1";"IC50";"'='";"7940.0";"nM";"5.10";"";"";"UO_0000065";"9.03";"0.17";"1.76";"4.25";"0";"CHEMBL931965";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1143153";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";"";"";""
"CHEMBL2349493";"";"None";"379.46";"0";"3.30";"23, rac-23";"CCOc1cccc(-c2ccc3c(c2)C2(CC(C)(C)O3)N=C(N)N(C)C2=O)c1";"IC50";"'='";"1085.0";"nM";"5.96";"";"";"UO_0000065";"15.72";"0.29";"2.66";"7.73";"0";"CHEMBL2352017";"Inhibition of human spleen cathepsin D using 5-FAM/QXL as peptide substrate after 1 hr by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"CHEMBL3559722";"Spleen";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346596";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL2047901";"";"None";"564.71";"2";"5.10";"39a";"CC(C)(C)c1cccc(CN[C@H]2CS(=O)(=O)C[C@@H](Cc3cc(F)c4c(c3)C3(CCC(F)(F)CC3)CN4)[C@@H]2O)c1";"IC50";"'='";"1750.0";"nM";"5.76";"";"";"UO_0000065";"10.19";"0.20";"0.66";"7.34";"0";"CHEMBL2049562";"Inhibition of human recombinant CatD using Mca-GKPILFFRLK(DNP)-dR-NH2 as substrate after 1 hr by fluorescence analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2046351";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL2048050";"";"None";"546.63";"1";"4.14";"60m";"C[C@@H](Oc1cc(C[C@@H]2CS(=O)(=O)C[C@H](NCc3cccc(C(C)(C)C)c3)[C@H]2O)cc(F)c1N)C(F)(F)F";"IC50";"'='";"480.0";"nM";"6.32";"";"";"UO_0000065";"11.56";"0.23";"2.18";"6.22";"0";"CHEMBL2049562";"Inhibition of human recombinant CatD using Mca-GKPILFFRLK(DNP)-dR-NH2 as substrate after 1 hr by fluorescence analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2046351";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL4228456";"";"None";"391.52";"0";"4.56";"4a";"CCCCCc1ccc(-c2ccc3c(=O)n(CC4CCCO4)c(N)nc3c2)cc1";"IC50";"'='";"3200.0";"nM";"5.50";"";"";"UO_0000065";"14.03";"0.26";"0.93";"7.83";"0";"CHEMBL4223547";"Inhibition of human cathepsin D using DABCYL-Glu-Arg-Nle-Phe-Leu-Ser-Phe-Pro-EDANS as substrate preincubated for 30 mins followed by substrate addition measured every 1 min within 8 to 15 mins by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4219216";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";"";""
"CHEMBL4225038";"";"None";"441.49";"0";"4.19";"2a";"Nc1nc2cc(-c3ccccc3)cc(-c3ccc(C(=O)O)cc3)c2c(=O)n1CC1CCCO1";"IC50";"'='";"100000.0";"nM";"4.00";"";"";"UO_0000065";"9.06";"0.17";"-0.19";"3.72";"0";"CHEMBL4223547";"Inhibition of human cathepsin D using DABCYL-Glu-Arg-Nle-Phe-Leu-Ser-Phe-Pro-EDANS as substrate preincubated for 30 mins followed by substrate addition measured every 1 min within 8 to 15 mins by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4219216";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";"";""
"CHEMBL2177335";"";"None";"377.38";"0";"3.59";"9p";"COc1ccc2c(c1)C1(COC(N)=N1)c1cc(-c3cccnc3F)ccc1O2";"IC50";"'='";"16000.0";"nM";"4.80";"";"";"UO_0000065";"12.71";"0.23";"1.21";"6.07";"0";"CHEMBL2183109";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2177044";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL2177336";"";"None";"377.38";"0";"3.59";"9q";"COc1ccc2c(c1)C1(COC(N)=N1)c1cc(-c3cnccc3F)ccc1O2";"IC50";"'>'";"40000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2183109";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2177044";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL1271344";"";"None";"390.42";"0";"2.93";"33";"COc1ccc([C@]2(c3cccc(-c4cccnc4F)c3)N=C(N)N(C)C2=O)cc1";"IC50";"'='";"1170.0";"nM";"5.93";"";"";"UO_0000065";"15.19";"0.28";"3.00";"7.34";"0";"CHEMBL1273977";"Inhibition of cathepsin D by FRET assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1268920";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL1271450";"";"None";"422.44";"0";"3.27";"35";"CN1C(=O)[C@@](c2ccc(OCCF)cc2)(c2cccc(-c3cccnc3F)c2)N=C1N";"IC50";"'='";"2360.0";"nM";"5.63";"";"";"UO_0000065";"13.32";"0.25";"2.36";"6.96";"0";"CHEMBL1273977";"Inhibition of cathepsin D by FRET assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1268920";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL1270335";"";"None";"413.40";"0";"3.22";"84";"CN1C(=O)[C@@](c2ccc(OC(F)F)cc2)(c2ccc(F)c(C#CC3CC3)c2)N=C1N";"IC50";"'='";"1500.0";"nM";"5.82";"";"";"UO_0000065";"14.09";"0.27";"2.60";"8.57";"0";"CHEMBL1273977";"Inhibition of cathepsin D by FRET assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1268920";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL401475";"";"None";"606.79";"1";"4.04";"14";"CCNc1cc(C(=O)N[C@@H](Cc2ccccc2)[C@H](O)CNC2CCc3ccc(OC)cc32)cc(N2CCCCS2(=O)=O)c1";"IC50";"'='";"1070.0";"nM";"5.97";"";"";"UO_0000065";"9.84";"0.19";"1.93";"4.98";"0";"CHEMBL945838";"Inhibition of Cathepsin D expressed in CHO cells by FRET assay";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140838";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"CHEMBL3308072";"";"";""
"CHEMBL564712";"";"None";"544.72";"1";"2.30";"14";"CCNc1cc(C(=O)N[C@@H](Cc2ccccc2)[C@H](O)CNC2CCOCC2)cc2c1CCCS(=O)(=O)N2C";"IC50";"'='";"4100.0";"nM";"5.39";"";"";"UO_0000065";"9.89";"0.19";"3.09";"4.49";"0";"CHEMBL1035560";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1158445";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL560497";"";"None";"544.72";"1";"2.52";"12";"CCNc1cc(C(=O)N[C@@H](Cc2ccccc2)[C@H](O)CNC2CCOCC2)cc(N2CCCCS2(=O)=O)c1";"IC50";"'='";"19950.0";"nM";"4.70";"";"";"UO_0000065";"8.63";"0.17";"2.18";"3.92";"0";"CHEMBL1035560";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1158445";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL4455398";"";"None";"186.22";"0";"1.92";"32-2";"c1cc(NNc2ccncc2)ccn1";"IC50";"'='";"1000.0";"nM";"6.00";"";"";"UO_0000065";"32.22";"0.59";"4.08";"12.04";"0";"CHEMBL4355299";"Inhibition of human liver cathepsin D using DABCYL-Glu-Arg-Nle-Phe-Leu-Ser-Phe-Pro-EDANS as substrate by FRET assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4354799";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";""
"CHEMBL3982565";"";"None";"686.98";"2";"3.98";"BDBM232281";"CCC(CC)NC(=O)[C@@H](NC(=O)C[C@H](N)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)CC(C)C)C(C)C)[C@@H](C)CC";"IC50";"'='";"9.9";"nM";"8.00";"";"405055";"UO_0000065";"11.65";"0.22";"4.02";"4.67";"0";"CHEMBL3888498";"In-Vitro Fluorescence Assay: In order to identify modulators of cathepsin D activity, a continuous enzymatic test was carried out with a synthetic peptide which carries a fluorescent group (MCA=(7-methoxycoumarin-4-yl)acetyl) which is quenched by energy transfer from a Dpn (2,4 dinitrophenyl) group on the same molecule, in Greiner 384-well nb microtitre plates. Cleavage of the peptidic substrate by cathepsin D causes an increase in the fluorescence intensity. In order to determine the efficacy of substances, the time-dependent increase in the fluorescence intensity in the presence of the substance was compared with the time-dependent increase in fluorescence in the absence of substances. The reference substance used was pepstatin A (Sigma-Aldrich). The substrate used was MCAGKPILFFRLK(Dnp)d-R-NH2 (Enzo Life Sciences, Lorrach). The enzyme employed was cathepsin D isolated from the human liver (Sigma-Aldrich) in a final concentration of 1.4 nM. The test was carried out in 100 mM sodium acetate buffer, 1.25% (v/v) of DMSO, 0.25% (w/v) of Chaps, pH 5.5. 2 ul of each substance solution with serially diluted substance concentration were added to in each case 4 ul of cathepsin D solution and incubated at room temperature for 10 min. The reaction was started by addition of 2 ul of substrate solution (final concentration 5 uM). After carrying out a starting-point fluorescence measurement (excitation wavelength 340 nm/emission wavelength 450 nm) using an Envision multilabel reader (Perkin Elmer), the reaction was incubated at room temperature for 60 min. The amount of peptide fragment cleaved off during the reaction time was subsequently measured by determination of the increase in the fluorescence intensity at 450 nm (excitation wavelength 340 nm).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886733";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3969366";"";"None";"666.91";"1";"3.76";"BDBM232285";"CC(C)CC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)[C@@H](N)CC(=O)N[C@H](COc1cccnc1)C(C)C)C(C)C";"IC50";"'='";"240.0";"nM";"6.62";"";"405059";"UO_0000065";"9.93";"0.19";"2.86";"4.02";"0";"CHEMBL3888498";"In-Vitro Fluorescence Assay: In order to identify modulators of cathepsin D activity, a continuous enzymatic test was carried out with a synthetic peptide which carries a fluorescent group (MCA=(7-methoxycoumarin-4-yl)acetyl) which is quenched by energy transfer from a Dpn (2,4 dinitrophenyl) group on the same molecule, in Greiner 384-well nb microtitre plates. Cleavage of the peptidic substrate by cathepsin D causes an increase in the fluorescence intensity. In order to determine the efficacy of substances, the time-dependent increase in the fluorescence intensity in the presence of the substance was compared with the time-dependent increase in fluorescence in the absence of substances. The reference substance used was pepstatin A (Sigma-Aldrich). The substrate used was MCAGKPILFFRLK(Dnp)d-R-NH2 (Enzo Life Sciences, Lorrach). The enzyme employed was cathepsin D isolated from the human liver (Sigma-Aldrich) in a final concentration of 1.4 nM. The test was carried out in 100 mM sodium acetate buffer, 1.25% (v/v) of DMSO, 0.25% (w/v) of Chaps, pH 5.5. 2 ul of each substance solution with serially diluted substance concentration were added to in each case 4 ul of cathepsin D solution and incubated at room temperature for 10 min. The reaction was started by addition of 2 ul of substrate solution (final concentration 5 uM). After carrying out a starting-point fluorescence measurement (excitation wavelength 340 nm/emission wavelength 450 nm) using an Envision multilabel reader (Perkin Elmer), the reaction was incubated at room temperature for 60 min. The amount of peptide fragment cleaved off during the reaction time was subsequently measured by determination of the increase in the fluorescence intensity at 450 nm (excitation wavelength 340 nm).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886733";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3958289";"";"None";"666.91";"1";"3.76";"BDBM232287";"CC(C)CC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)[C@@H](N)CC(=O)N[C@@H](COc1cccnc1)C(C)C)C(C)C";"IC50";"'='";"280.0";"nM";"6.55";"";"405061";"UO_0000065";"9.83";"0.19";"2.79";"3.98";"0";"CHEMBL3888498";"In-Vitro Fluorescence Assay: In order to identify modulators of cathepsin D activity, a continuous enzymatic test was carried out with a synthetic peptide which carries a fluorescent group (MCA=(7-methoxycoumarin-4-yl)acetyl) which is quenched by energy transfer from a Dpn (2,4 dinitrophenyl) group on the same molecule, in Greiner 384-well nb microtitre plates. Cleavage of the peptidic substrate by cathepsin D causes an increase in the fluorescence intensity. In order to determine the efficacy of substances, the time-dependent increase in the fluorescence intensity in the presence of the substance was compared with the time-dependent increase in fluorescence in the absence of substances. The reference substance used was pepstatin A (Sigma-Aldrich). The substrate used was MCAGKPILFFRLK(Dnp)d-R-NH2 (Enzo Life Sciences, Lorrach). The enzyme employed was cathepsin D isolated from the human liver (Sigma-Aldrich) in a final concentration of 1.4 nM. The test was carried out in 100 mM sodium acetate buffer, 1.25% (v/v) of DMSO, 0.25% (w/v) of Chaps, pH 5.5. 2 ul of each substance solution with serially diluted substance concentration were added to in each case 4 ul of cathepsin D solution and incubated at room temperature for 10 min. The reaction was started by addition of 2 ul of substrate solution (final concentration 5 uM). After carrying out a starting-point fluorescence measurement (excitation wavelength 340 nm/emission wavelength 450 nm) using an Envision multilabel reader (Perkin Elmer), the reaction was incubated at room temperature for 60 min. The amount of peptide fragment cleaved off during the reaction time was subsequently measured by determination of the increase in the fluorescence intensity at 450 nm (excitation wavelength 340 nm).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886733";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3763489";"";"None";"529.68";"2";"7.13";"rac-4k";"Nc1nc2cc(-c3ccc(CCCCc4ccccc4)cc3)ccc2c(=O)n1C[C@@H]1CC[C@H](c2ccccc2)O1";"IC50";"'='";"91000.0";"nM";"4.04";"";"";"UO_0000065";"7.63";"0.14";"-3.09";"5.76";"0";"CHEMBL3767017";"Inhibition of CatD (unknown origin) preincubated for 30 mins followed by DABCYL-Glu-Arg-Nle-Phe-Leu-Ser-Phe-Pro-EDANS substrate addition by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3763050";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";""
"CHEMBL3763523";"";"None";"515.66";"2";"6.74";"rac-4j";"Nc1nc2cc(-c3ccc(CCCc4ccccc4)cc3)ccc2c(=O)n1C[C@@H]1CC[C@H](c2ccccc2)O1";"IC50";"'='";"6000.0";"nM";"5.22";"";"";"UO_0000065";"10.13";"0.18";"-1.52";"7.44";"0";"CHEMBL3767017";"Inhibition of CatD (unknown origin) preincubated for 30 mins followed by DABCYL-Glu-Arg-Nle-Phe-Leu-Ser-Phe-Pro-EDANS substrate addition by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3763050";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";""
"CHEMBL3765238";"";"None";"453.59";"1";"5.91";"rac-4c";"CCCCc1cccc(-c2ccc3c(=O)n(C[C@@H]4CC[C@H](c5ccccc5)O4)c(N)nc3c2)c1";"IC50";"'='";"3000.0";"nM";"5.52";"";"";"UO_0000065";"12.18";"0.22";"-0.39";"7.87";"0";"CHEMBL3767017";"Inhibition of CatD (unknown origin) preincubated for 30 mins followed by DABCYL-Glu-Arg-Nle-Phe-Leu-Ser-Phe-Pro-EDANS substrate addition by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3763050";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";""
"CHEMBL4279496";"";"None";"506.56";"1";"4.03";"18";"CC1(C#Cc2cncc(-c3ccc4c(c3)[C@@]3(COC(N)=N3)c3cc(C5=CCOCC5)ncc3O4)c2)COC1";"IC50";"'='";"12000.0";"nM";"4.92";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4262564";"Inhibition of recombinant human CatD using fluorophore/quencher-tagged peptide as substrate pretreated for 60 mins followed by substrate addition and measured after 60 mins by FRET assay";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261519";"1";"Scientific Literature";"Medchemcomm";"2017";"None";"";"";""
"CHEMBL3914456";"";"None";"662.70";"1";"4.57";"BDBM232248";"CC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)CC(C)C)C(=O)N[C@@H](Cc1ccccc1)[C@@H](N)CC(=O)NCCc1ccc(Cl)c(Cl)c1";"IC50";"'='";"1200.0";"nM";"5.92";"";"405025";"UO_0000065";"8.93";"0.18";"1.35";"4.16";"0";"CHEMBL3888498";"In-Vitro Fluorescence Assay: In order to identify modulators of cathepsin D activity, a continuous enzymatic test was carried out with a synthetic peptide which carries a fluorescent group (MCA=(7-methoxycoumarin-4-yl)acetyl) which is quenched by energy transfer from a Dpn (2,4 dinitrophenyl) group on the same molecule, in Greiner 384-well nb microtitre plates. Cleavage of the peptidic substrate by cathepsin D causes an increase in the fluorescence intensity. In order to determine the efficacy of substances, the time-dependent increase in the fluorescence intensity in the presence of the substance was compared with the time-dependent increase in fluorescence in the absence of substances. The reference substance used was pepstatin A (Sigma-Aldrich). The substrate used was MCAGKPILFFRLK(Dnp)d-R-NH2 (Enzo Life Sciences, Lorrach). The enzyme employed was cathepsin D isolated from the human liver (Sigma-Aldrich) in a final concentration of 1.4 nM. The test was carried out in 100 mM sodium acetate buffer, 1.25% (v/v) of DMSO, 0.25% (w/v) of Chaps, pH 5.5. 2 ul of each substance solution with serially diluted substance concentration were added to in each case 4 ul of cathepsin D solution and incubated at room temperature for 10 min. The reaction was started by addition of 2 ul of substrate solution (final concentration 5 uM). After carrying out a starting-point fluorescence measurement (excitation wavelength 340 nm/emission wavelength 450 nm) using an Envision multilabel reader (Perkin Elmer), the reaction was incubated at room temperature for 60 min. The amount of peptide fragment cleaved off during the reaction time was subsequently measured by determination of the increase in the fluorescence intensity at 450 nm (excitation wavelength 340 nm).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886733";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3942349";"";"None";"746.99";"2";"3.36";"BDBM232258";"CC[C@H](C)[C@H](NC(=O)C[C@H](N)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)OC(C)(C)C)C(C)C)C(=O)N[C@H](C(=O)OC)C(C)C";"IC50";"'='";"36.0";"nM";"7.44";"";"405035";"UO_0000065";"9.96";"0.19";"4.08";"3.60";"0";"CHEMBL3888498";"In-Vitro Fluorescence Assay: In order to identify modulators of cathepsin D activity, a continuous enzymatic test was carried out with a synthetic peptide which carries a fluorescent group (MCA=(7-methoxycoumarin-4-yl)acetyl) which is quenched by energy transfer from a Dpn (2,4 dinitrophenyl) group on the same molecule, in Greiner 384-well nb microtitre plates. Cleavage of the peptidic substrate by cathepsin D causes an increase in the fluorescence intensity. In order to determine the efficacy of substances, the time-dependent increase in the fluorescence intensity in the presence of the substance was compared with the time-dependent increase in fluorescence in the absence of substances. The reference substance used was pepstatin A (Sigma-Aldrich). The substrate used was MCAGKPILFFRLK(Dnp)d-R-NH2 (Enzo Life Sciences, Lorrach). The enzyme employed was cathepsin D isolated from the human liver (Sigma-Aldrich) in a final concentration of 1.4 nM. The test was carried out in 100 mM sodium acetate buffer, 1.25% (v/v) of DMSO, 0.25% (w/v) of Chaps, pH 5.5. 2 ul of each substance solution with serially diluted substance concentration were added to in each case 4 ul of cathepsin D solution and incubated at room temperature for 10 min. The reaction was started by addition of 2 ul of substrate solution (final concentration 5 uM). After carrying out a starting-point fluorescence measurement (excitation wavelength 340 nm/emission wavelength 450 nm) using an Envision multilabel reader (Perkin Elmer), the reaction was incubated at room temperature for 60 min. The amount of peptide fragment cleaved off during the reaction time was subsequently measured by determination of the increase in the fluorescence intensity at 450 nm (excitation wavelength 340 nm).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886733";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3693226";"";"None";"470.45";"0";"3.05";"BDBM171784";"CC1(C#Cc2ccc(C(=O)Nc3ccc(F)c([C@@]4(C(F)F)N=C(N)O[C@@H]5C[C@@H]54)c3)nc2)COC1";"IC50";"'='";"748150.0";"nM";"";"Outside typical range";"316181";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3693229";"";"None";"477.44";"0";"2.48";"BDBM171788";"NC1=N[C@@](c2cc(NC(=O)c3cnc(OCC4CCOC4)cn3)ccc2F)(C(F)F)[C@H]2C[C@H]2O1";"IC50";"'>'";"400000.0";"nM";"";"Outside typical range";"316184";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3422242";"";"None";"379.43";"0";"3.68";"1; PF-9238";"Cc1cc([C@H]2C[C@H]3[C@@H](C)SC(N)=N[C@@]3(c3ccc(F)cc3F)CO2)on1";"IC50";"'='";"12000.0";"nM";"4.92";"";"";"UO_0000065";"12.97";"0.26";"1.24";"6.68";"0";"CHEMBL4026417";"Inhibition of recombinant cathepsin D (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4024745";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL89076";"";"None";"672.87";"1";"3.10";"2";"CCN(C(C)C)S(=O)(=O)CC[C@@H]1O[C@@H]1[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)c1ccc2ccccc2n1)C(C)(C)S(C)(=O)=O";"IC50";"'='";"8200.0";"nM";"5.09";"";"";"UO_0000065";"7.56";"0.15";"1.99";"3.28";"0";"CHEMBL657345";"Inhibition against human cathepsin D was determined";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1130577";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1997";"None";"";"";""
"CHEMBL558078";"";"None";"495.60";"0";"1.85";"20";"C#CCNC[C@@H](O)[C@H](Cc1ccccc1)NC(=O)c1cc2c3c(c1)c(CC)cn3CCS(=O)(=O)O2";"IC50";"'='";"15140.0";"nM";"4.82";"";"";"UO_0000065";"9.73";"0.19";"2.97";"4.40";"0";"CHEMBL725829";"Inhibition of cathepsin-D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1158411";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL554349";"";"None";"628.72";"1";"4.49";"17";"CCc1cn2c3c(cc(C(=O)N[C@@H](Cc4ccccc4)[C@H](O)CNCc4cccc(C(F)(F)F)c4)cc13)N(C)S(=O)(=O)CC2";"IC50";"'='";"1260.0";"nM";"5.90";"";"";"UO_0000065";"9.38";"0.18";"1.41";"5.69";"0";"CHEMBL725829";"Inhibition of cathepsin-D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1158411";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL3906250";"";"None";"471.82";"0";"5.00";"BDBM214807";"NC1=N[C@](CF)(c2cc(Nc3nccc4cc(Cl)cnc34)ccc2F)C[C@@H](C(F)(F)F)O1";"IC50";"'>'";"400000.0";"nM";"";"Outside typical range";"377851";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3914387";"";"None";"457.33";"0";"3.99";"BDBM214957";"[C-]#[N+]c1ccc(C(=O)Nc2cc(F)c(F)c([C@]3(CF)C[C@@H](C(F)(F)F)OC(N)=N3)c2)nc1";"IC50";"'='";"3120000.0";"nM";"";"Outside typical range";"377994";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3943009";"";"None";"462.81";"0";"4.27";"BDBM215032";"Cc1cc(NC(=O)c2ccc(Cl)cn2)cc([C@]2(CF)C[C@@H](C(F)(F)F)OC(N)=N2)c1F";"IC50";"'='";"515200.0";"nM";"";"Outside typical range";"378049";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3972614";"";"None";"453.37";"0";"3.48";"BDBM215033";"Cc1cc(NC(=O)c2ccc(C#N)cn2)cc([C@]2(CF)C[C@@H](C(F)(F)F)OC(N)=N2)c1F";"IC50";"'>'";"400000.0";"nM";"";"Outside typical range";"378050";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3985357";"";"None";"466.77";"0";"4.29";"BDBM215012";"C[C@@]1(c2cc(NC(=O)c3ncc(Cl)cc3F)cc(F)c2F)C[C@@H](C(F)(F)F)OC(N)=N1";"IC50";"'>'";"400000.0";"nM";"";"Outside typical range";"378057";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3926156";"";"None";"527.37";"1";"4.14";"BDBM215004";"Cc1nc(OCC(F)(F)F)cnc1C(=O)Nc1cc(F)c(F)c([C@]2(C)C[C@@H](C(F)(F)F)OC(N)=N2)c1";"IC50";"'>'";"400000.0";"nM";"";"Outside typical range";"378071";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3934414";"";"None";"461.80";"0";"3.41";"BDBM214879";"COc1cnc(C(=O)Nc2ccc(F)c([C@]3(C)C[C@@H](C(F)(F)F)OC(N)=N3)n2)c(Cl)c1";"IC50";"'='";"658000.0";"nM";"";"Outside typical range";"377980";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL570298";"";"None";"487.59";"0";"3.07";"16, diastereomer";"CC(=O)N[C@@H](Cc1cc(F)cc(F)c1)[C@H](O)CNC1(c2cccc(C(C)(C)C)c2)CCNC(=O)C1";"IC50";"'='";"330.0";"nM";"6.48";"";"";"UO_0000065";"13.29";"0.25";"3.41";"7.17";"0";"CHEMBL1045212";"Inhibition of cathepsin D assessed as reduction in polarization after 110 mins by oregon green based fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156090";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL2181024";"";"None";"1007.24";"None";"None";"11";"COC(=O)[C@@H]1CCCN1C(=O)[C@@H](Cc1ccccc1)N(C)C(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)C[C@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(N)=O)N(C)C(=O)[C@@H](NC(=O)OC(C)(C)C)C(C)C";"IC50";"'='";"0.126";"nM";"9.90";"";"";"UO_0000065";"9.83";"None";"None";"None";"0";"CHEMBL2185513";"Inhibition of cathepsin D by fluorescence assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2176894";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL501578";"TASIAMIDE B";"None";"979.19";"3";"0.35";"1";"COC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)N(C)C(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)C[C@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(N)=O)N(C)C(=O)[C@@H](NC(=O)[C@H](C)O)C(C)C";"IC50";"'='";"251.0";"nM";"6.60";"";"";"UO_0000065";"6.74";"0.13";"6.25";"2.30";"0";"CHEMBL2185513";"Inhibition of cathepsin D by fluorescence assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2176894";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL2177334";"";"None";"424.86";"1";"5.16";"9o";"COc1ccc2c(c1)C1(COC(N)=N1)c1cc(-c3cc(Cl)c(C)cc3F)ccc1O2";"IC50";"'='";"13800.0";"nM";"4.86";"";"";"UO_0000065";"11.44";"0.22";"-0.30";"7.36";"0";"CHEMBL2183109";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2177044";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL2177324";"";"None";"392.84";"0";"4.71";"9e";"COc1ccc2c(c1)C1(COC(N)=N1)c1cc(-c3ccccc3Cl)ccc1O2";"IC50";"'='";"16800.0";"nM";"4.78";"";"";"UO_0000065";"12.15";"0.23";"0.06";"7.23";"0";"CHEMBL2183109";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2177044";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL2177310";"";"None";"396.85";"0";"4.74";"1";"COc1ccc(C2(c3cccc(-c4cc(Cl)ccc4F)c3)COC(N)=N2)cc1";"IC50";"'='";"10700.0";"nM";"4.97";"";"";"UO_0000065";"12.53";"0.24";"0.23";"8.74";"0";"CHEMBL2183109";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2177044";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL2177316";"";"None";"399.37";"0";"4.08";"7";"NC1=N[C@](c2ccc(OC(F)F)cc2)(c2cccc(-c3cccnc3F)c2)CO1";"IC50";"'='";"7650.0";"nM";"5.12";"";"";"UO_0000065";"12.81";"0.24";"1.04";"7.34";"0";"CHEMBL2183109";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2177044";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL252960";"";"None";"503.67";"1";"2.08";"25";"COc1cccc(CNC[C@@H](O)[C@H](Cc2ccccc2)NC(=O)CCS(=O)(=O)N2CCCCC2)c1";"IC50";"'>'";"20000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL942098";"Inhibition of human recombinant cathepsin D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140593";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"None";"";"";""
"CHEMBL252756";"";"None";"517.69";"1";"2.47";"24";"COc1cccc(CNC[C@@H](O)[C@H](Cc2ccccc2)NC(=O)CCCS(=O)(=O)N2CCCCC2)c1";"IC50";"'>'";"20000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL942098";"Inhibition of human recombinant cathepsin D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140593";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"None";"";"";""
"CHEMBL252548";"";"None";"516.70";"1";"3.40";"18";"COc1cccc(CNC[C@@H](O)[C@H](Cc2ccccc2)NC(=O)CCCS(=O)(=O)C2CCCCC2)c1";"IC50";"'>'";"20000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL942098";"Inhibition of human recombinant cathepsin D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140593";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"None";"";"";""
"CHEMBL271437";"";"None";"556.73";"1";"2.36";"11";"C[C@H](NC[C@@H](O)[C@H](Cc1ccccc1)NC(=O)c1cccc(N2CCCS2(=O)=O)c1)C(=O)NC1CCCCC1";"IC50";"'='";"10000.0";"nM";"5.00";"";"";"UO_0000065";"8.98";"0.18";"2.64";"3.91";"0";"CHEMBL931965";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1143153";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";"";"";""
"CHEMBL560894";"";"None";"556.65";"1";"3.07";"16";"CCNc1cc(C(=O)N[C@@H](Cc2ccccc2)[C@H](O)CNCCC(F)(F)F)cc2c1CCCS(=O)(=O)N2C";"IC50";"'='";"1070.0";"nM";"5.97";"";"";"UO_0000065";"10.73";"0.21";"2.90";"5.39";"0";"CHEMBL1035560";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1158445";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL4799250";"";"None";"701.77";"1";"3.42";"1a";"COc1ccc(CC(=O)NC(=N)N[C@H](CC2CCCCC2)C(=O)Nc2cc(S(=O)(=O)N(C)C)ccc2C)cc1OC.O=C(O)C(F)(F)F";"IC50";"'='";"29.0";"nM";"7.54";"";"";"UO_0000065";"12.82";"0.25";"4.12";"5.03";"0";"CHEMBL4706202";"Inhibition of human liver Cathepsin D preincubated for 10 mins followed by substrate addition and further incubated for 2 hrs in dark by fluorimetric analysis";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699662";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"TIME = 2.167 hr";"INHIBITOR";""
"CHEMBL4759490";"";"None";"677.69";"1";"3.68";"3a";"Cc1ccc(S(=O)(=O)N(C)C)cc1NC(=O)[C@@H](CC1CCCCC1)NC(=N)NC(=O)Cc1ccc(F)c(F)c1.O=C(O)C(F)(F)F";"IC50";"'='";"63.0";"nM";"7.20";"";"";"UO_0000065";"12.77";"0.25";"3.52";"5.48";"0";"CHEMBL4706202";"Inhibition of human liver Cathepsin D preincubated for 10 mins followed by substrate addition and further incubated for 2 hrs in dark by fluorimetric analysis";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699662";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"TIME = 2.167 hr";"INHIBITOR";""
"CHEMBL4792598";"";"None";"777.71";"2";"5.44";"9a";"Cc1ccc(S(=O)(=O)N(C)C)cc1NC(=O)[C@@H](CC1CCCCC1)NC(=N)NC(=O)Cc1cc(C(F)(F)F)cc(C(F)(F)F)c1.O=C(O)C(F)(F)F";"IC50";"'='";"180.0";"nM";"6.75";"";"";"UO_0000065";"10.16";"0.20";"1.30";"5.13";"0";"CHEMBL4706202";"Inhibition of human liver Cathepsin D preincubated for 10 mins followed by substrate addition and further incubated for 2 hrs in dark by fluorimetric analysis";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699662";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"TIME = 2.167 hr";"INHIBITOR";""
"CHEMBL3890269";"";"None";"521.94";"1";"4.41";"BDBM220783";"NC1=NC2(CCO1)c1cc(NC(=O)c3ccc(Cl)cn3)ccc1Oc1c2cc(C2=CCCOC2)nc1F";"IC50";"'>'";"400000.0";"nM";"";"Outside typical range";"386466";"UO_0000065";"";"";"";"";"0";"CHEMBL3888270";"Fluorescence Resonance Energy Transfer (FRET) Assay: Recombinant CathepsinD was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The CathepsinD enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for CathepsinD) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886633";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3688807";"";"None";"467.29";"0";"4.28";"BDBM171754";"NC1=N[C@@](c2cc(N[C@H]3CCc4cc(Br)cnc43)ccc2F)(C(F)F)[C@H]2C[C@H]2O1";"IC50";"'='";"336160.0";"nM";"";"Outside typical range";"316154";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688815";"";"None";"415.38";"0";"2.85";"BDBM171764";"Cc1cc(NC(=O)c2ccc(C#N)cn2)cc([C@@]2(C(F)F)N=C(N)O[C@@H]3C[C@@H]32)c1F";"IC50";"'='";"441280.0";"nM";"";"Outside typical range";"316164";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688826";"";"None";"413.40";"0";"3.39";"BDBM171777";"N#Cc1cnc2c(c1)CC[C@@H]2Nc1ccc(F)c([C@@]2(C(F)F)N=C(N)O[C@@H]3C[C@@H]32)c1";"IC50";"'='";"205500.0";"nM";"";"Outside typical range";"316174";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3693232";"";"None";"489.50";"0";"4.02";"BDBM171791";"NC1=N[C@@](c2cc(NC(=O)c3cnc(OCC4CCCCC4)cn3)ccc2F)(C(F)F)[C@H]2C[C@H]2O1";"IC50";"'='";"228150.0";"nM";"";"Outside typical range";"316187";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3693241";"";"None";"407.78";"0";"4.48";"BDBM171800";"NC1=N[C@](c2cc(-c3nc4ccc(Cl)cc4o3)ccc2F)(C(F)F)[C@@H]2C[C@@H]2O1";"IC50";"'='";"240270.0";"nM";"";"Outside typical range";"316196";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3693251";"";"None";"451.38";"0";"3.20";"BDBM171811";"COC(=O)c1ccc(C(=O)Nc2cc(F)c(F)c([C@]3(C(F)F)N=C(N)O[C@H]4C[C@H]43)c2)cc1";"IC50";"'='";"343180.0";"nM";"";"Outside typical range";"316207";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688742";"";"None";"427.24";"0";"3.68";"BDBM171686";"NC1=N[C@](CF)(c2cc(NC(=O)c3ncc(Cl)cc3F)ccc2Cl)[C@H]2C[C@H]2O1";"IC50";"'='";"1137400.0";"nM";"";"Outside typical range";"316213";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688671";"";"None";"379.38";"0";"3.46";"BDBM171609";"NC1=N[C@@](c2cc(NC(=O)C3=CCCCC3)ccc2F)(C(F)F)[C@H]2C[C@H]2O1";"IC50";"'='";"1026300.0";"nM";"";"Outside typical range";"316018";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688749";"";"None";"372.36";"0";"1.22";"BDBM171693";"COc1cnc(C(=O)Nc2ccc(F)c([C@]3(C)N=C(N)O[C@H]4C[C@H]43)n2)cn1";"IC50";"'>'";"400000.0";"nM";"";"Outside typical range";"316097";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688751";"";"None";"366.36";"0";"1.69";"BDBM171695";"C[C@@]1(c2nc(NC(=O)c3ccc(C#N)cn3)ccc2F)N=C(N)O[C@H]2C[C@H]21";"IC50";"'='";"1294400.0";"nM";"";"Outside typical range";"316099";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688754";"";"None";"410.24";"0";"3.12";"BDBM171698";"C[C@]1(c2nc(NC(=O)c3ncc(Cl)cc3Cl)ccc2F)N=C(N)O[C@@H]2C[C@@H]21";"IC50";"'='";"511670.0";"nM";"";"Outside typical range";"316102";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688773";"";"None";"458.83";"0";"4.23";"BDBM171719";"N#Cc1cnc2c(Nc3ccc(Cl)c([C@]4(C(F)F)N=C(N)O[C@H]5C[C@H]54)c3)ncc(F)c2c1";"IC50";"'='";"88357.0";"nM";"4.05";"";"316123";"UO_0000065";"8.83";"0.17";"-0.18";"3.71";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688775";"";"None";"442.38";"0";"3.72";"BDBM171722";"N#Cc1cnc2c(Nc3ccc(F)c([C@@]4(C(F)F)N=C(N)O[C@@H]5C[C@@H]54)c3)ncc(F)c2c1";"IC50";"'='";"192210.0";"nM";"";"Outside typical range";"316126";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688784";"";"None";"451.81";"0";"4.50";"BDBM171731";"NC1=N[C@@](c2cc(Nc3ncc(F)c4cc(Cl)cnc34)ccc2F)(C(F)F)[C@H]2C[C@H]2O1";"IC50";"'>'";"400000.0";"nM";"";"Outside typical range";"316135";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL568960";"";"None";"497.50";"1";"5.24";"44";"NC1=NC(c2ccc(OC(F)(F)F)cc2)(c2cccc(-c3cccnc3F)c2)/C2=N/CCCCCN12";"IC50";"'='";"11300.0";"nM";"4.95";"";"";"UO_0000065";"9.94";"0.19";"-0.29";"6.50";"0";"CHEMBL1061266";"Inhibition of human cathepsin D by FRET";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1155232";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL583608";"";"None";"429.46";"0";"3.29";"38";"NC1=NC(c2cccc(-c3cccnc3F)c2)(c2ccc3c(c2)OCO3)C2=NCCCN12";"IC50";"'='";"15400.0";"nM";"4.81";"";"";"UO_0000065";"11.21";"0.21";"1.52";"5.64";"0";"CHEMBL1061266";"Inhibition of human cathepsin D by FRET";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1155232";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL582828";"";"None";"398.47";"0";"2.83";"34";"COc1ccc(C2(c3cccc(-c4cncnc4)c3)N=C(N)N3CCCN=C32)cc1";"IC50";"'='";"69500.0";"nM";"4.16";"";"";"UO_0000065";"10.43";"0.19";"1.33";"4.67";"0";"CHEMBL1061266";"Inhibition of human cathepsin D by FRET";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1155232";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL566977";"";"None";"380.50";"0";"3.95";"28";"NC1=NC(c2ccccc2)(c2cccc(Cc3ccccc3)c2)C2=NCCCN12";"IC50";"'='";"52500.0";"nM";"4.28";"";"";"UO_0000065";"11.25";"0.20";"0.33";"7.93";"0";"CHEMBL1061266";"Inhibition of human cathepsin D by FRET";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1155232";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL582045";"";"None";"452.44";"0";"3.72";"(R)-35";"NC1=N[C@](c2ccc(OC(F)(F)F)cc2)(c2cccc(-c3cncnc3)c2)C2=NCCCN12";"IC50";"'='";"36200.0";"nM";"4.44";"";"";"UO_0000065";"9.82";"0.18";"0.72";"4.99";"0";"CHEMBL1061266";"Inhibition of human cathepsin D by FRET";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1155232";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL567653";"";"None";"398.49";"0";"4.09";"30";"NC1=NC(c2ccccc2)(c2cccc(Cc3ccc(F)cc3)c2)C2=NCCCN12";"IC50";"'='";"9200.0";"nM";"5.04";"";"";"UO_0000065";"12.64";"0.23";"0.95";"9.33";"0";"CHEMBL1061266";"Inhibition of human cathepsin D by FRET";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1155232";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL2349466";"";"None";"308.39";"0";"2.66";"63, rac-63";"CC1(C)Cc2ccc(-c3cncnc3)cc2C2(COC(N)=N2)C1";"IC50";"'='";"59798.0";"nM";"4.22";"";"";"UO_0000065";"13.69";"0.25";"1.56";"5.75";"0";"CHEMBL2352017";"Inhibition of human spleen cathepsin D using 5-FAM/QXL as peptide substrate after 1 hr by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"CHEMBL3559722";"Spleen";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346596";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL2349473";"";"None";"385.87";"0";"4.10";"43, rac-43";"CN1C(=O)C2(CC(C)(C)Cc3ccc(-c4cc(F)cc(Cl)c4)cc32)N=C1N";"IC50";"'='";"624.0";"nM";"6.21";"";"";"UO_0000065";"16.08";"0.31";"2.10";"10.57";"0";"CHEMBL2352017";"Inhibition of human spleen cathepsin D using 5-FAM/QXL as peptide substrate after 1 hr by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"CHEMBL3559722";"Spleen";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346596";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL4576319";"";"None";"487.69";"0";"3.64";"9";"CC(C)[C@@H]1NC(=O)C[C@H](O)[C@H](Cc2ccccc2)NC(=O)CCCCCCCCCCCNC1=O";"IC50";"'='";"5.8";"nM";"8.24";"";"";"UO_0000065";"16.89";"0.32";"4.60";"7.66";"0";"CHEMBL4325791";"Inhibition of human placenta CatD using Abz-Lys-Pro-Ala-Glu-Phe-Nph-Ala-Leu as substrate preincubated for 10 mins followed by substrate addition and measured by FRET assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4321885";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";""
"CHEMBL4560400";"";"None";"501.71";"1";"4.03";"11";"CC(C)[C@@H]1NC(=O)C[C@H](O)[C@H](Cc2ccccc2)NC(=O)CCCCCCCCCCCCNC1=O";"IC50";"'='";"3.5";"nM";"8.46";"";"";"UO_0000065";"16.85";"0.32";"4.43";"7.86";"0";"CHEMBL4325791";"Inhibition of human placenta CatD using Abz-Lys-Pro-Ala-Glu-Phe-Nph-Ala-Leu as substrate preincubated for 10 mins followed by substrate addition and measured by FRET assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4321885";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";""
"CHEMBL4444244";"";"None";"523.67";"1";"3.91";"15";"CC(C)[C@@H]1NC(=O)C[C@H](O)[C@H](Cc2ccc(F)c(F)c2)NC(=O)CCCCCCCCCCCNC1=O";"IC50";"'='";"3.1";"nM";"8.51";"";"";"UO_0000065";"16.25";"0.31";"4.60";"7.91";"0";"CHEMBL4325791";"Inhibition of human placenta CatD using Abz-Lys-Pro-Ala-Glu-Phe-Nph-Ala-Leu as substrate preincubated for 10 mins followed by substrate addition and measured by FRET assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4321885";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";""
"CHEMBL4514021";"";"None";"503.68";"1";"3.86";"33";"CC(C)[C@@H]1NC(=O)C[C@H](O)[C@H](Cc2ccccc2)NC(=O)OCCCCCCCCCCCNC1=O";"IC50";"'='";"2.5";"nM";"8.60";"";"";"UO_0000065";"17.08";"0.33";"4.74";"7.37";"0";"CHEMBL4325791";"Inhibition of human placenta CatD using Abz-Lys-Pro-Ala-Glu-Phe-Nph-Ala-Leu as substrate preincubated for 10 mins followed by substrate addition and measured by FRET assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4321885";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";""
"CHEMBL2368566";"";"None";"462.52";"0";"3.79";"Z-FF-FMK";"O=C(N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)CF)OCc1ccccc1";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1021961";"Inhibition of human liver cathepsin D after 30 mins by fluorometric end-point assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138527";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL570982";"";"None";"518.65";"1";"3.02";"45";"CON[C@H]1CC[C@@](NC[C@@H](O)[C@H](Cc2cc(F)cc(F)c2)NC(C)=O)(c2cccc(C(C)(C)C)c2)CN1";"IC50";"'='";"530.0";"nM";"6.28";"";"";"UO_0000065";"12.10";"0.23";"3.26";"6.63";"0";"CHEMBL1045212";"Inhibition of cathepsin D assessed as reduction in polarization after 110 mins by oregon green based fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156090";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL572047";"";"None";"516.63";"1";"2.61";"47";"CC(=O)N[C@@H](Cc1cc(F)cc(F)c1)[C@H](O)CN[C@@]1(c2cccc(C(C)(C)C)c2)CC[C@H](NC=O)NC1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1045212";"Inhibition of cathepsin D assessed as reduction in polarization after 110 mins by oregon green based fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156090";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL572048";"";"None";"470.52";"0";"2.46";"11, mixture of epimers";"CC(=O)N[C@@H](Cc1cc(F)cc(F)c1)[C@H](O)CNC1(c2cccc(-n3cccn3)c2)CCOC1";"IC50";"'='";"4900.0";"nM";"5.31";"";"";"UO_0000065";"11.28";"0.21";"2.85";"6.01";"0";"CHEMBL1045212";"Inhibition of cathepsin D assessed as reduction in polarization after 110 mins by oregon green based fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156090";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL566809";"";"None";"473.61";"0";"3.54";"13";"CC(=O)N[C@@H](Cc1cc(F)cc(F)c1)[C@H](O)CNC1(c2cccc(C(C)(C)C)c2)CCNCC1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1045212";"Inhibition of cathepsin D assessed as reduction in polarization after 110 mins by oregon green based fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156090";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL257099";"";"None";"481.64";"0";"4.84";"44";"N/C(=N/C(=O)Cn1c(-c2ccccc2)ccc1C12CC3CC(CC(C3)C1)C2)NCc1cccc(N)c1";"IC50";"'='";"1380.0";"nM";"5.86";"";"";"UO_0000065";"12.17";"0.22";"1.02";"5.95";"0";"CHEMBL930552";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1142260";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";"";"";""
"CHEMBL258356";"";"None";"429.57";"0";"3.97";"33";"N#CCCN/C(N)=N\C(=O)Cn1c(-c2ccccc2)ccc1C12CC3CC(CC(C3)C1)C2";"IC50";"'='";"12200.0";"nM";"4.91";"";"";"UO_0000065";"11.44";"0.21";"0.94";"5.11";"0";"CHEMBL930552";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1142260";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";"";"";""
"CHEMBL4743293";"";"None";"709.71";"1";"4.42";"8a";"Cc1ccc(S(=O)(=O)N(C)C)cc1NC(=O)[C@@H](CC1CCCCC1)NC(=N)NC(=O)Cc1ccc(C(F)(F)F)cc1.O=C(O)C(F)(F)F";"IC50";"'='";"54.0";"nM";"7.27";"";"";"UO_0000065";"12.20";"0.24";"2.85";"5.53";"0";"CHEMBL4706202";"Inhibition of human liver Cathepsin D preincubated for 10 mins followed by substrate addition and further incubated for 2 hrs in dark by fluorimetric analysis";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699662";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"TIME = 2.167 hr";"INHIBITOR";""
"CHEMBL4779266";"";"None";"729.82";"1";"4.20";"1b";"CCN(CC)S(=O)(=O)c1ccc(C)c(NC(=O)[C@@H](CC2CCCCC2)NC(=N)NC(=O)Cc2ccc(OC)c(OC)c2)c1.O=C(O)C(F)(F)F";"IC50";"'='";"8.0";"nM";"8.10";"";"";"UO_0000065";"13.15";"0.26";"3.90";"5.40";"0";"CHEMBL4706202";"Inhibition of human liver Cathepsin D preincubated for 10 mins followed by substrate addition and further incubated for 2 hrs in dark by fluorimetric analysis";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699662";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"TIME = 2.167 hr";"INHIBITOR";""
"CHEMBL4788968";"";"None";"673.71";"1";"2.69";"1c";"CNS(=O)(=O)c1ccc(C)c(NC(=O)[C@H](NC(=N)NC(=O)Cc2ccc(OC)c(OC)c2)C2CCCCC2)c1.O=C(O)C(F)(F)F";"IC50";"'='";"57.0";"nM";"7.24";"";"";"UO_0000065";"12.94";"0.25";"4.55";"4.56";"0";"CHEMBL4706202";"Inhibition of human liver Cathepsin D preincubated for 10 mins followed by substrate addition and further incubated for 2 hrs in dark by fluorimetric analysis";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699662";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"TIME = 2.167 hr";"INHIBITOR";""
"CHEMBL4746757";"";"None";"725.71";"1";"4.09";"7d";"CNS(=O)(=O)c1ccc(C)c(NC(=O)[C@@H](CC2CCCCC2)NC(=N)NC(=O)Cc2ccc(OC)c(C(F)(F)F)c2)c1.O=C(O)C(F)(F)F";"IC50";"'='";"16.0";"nM";"7.80";"";"";"UO_0000065";"12.74";"0.25";"3.71";"5.22";"0";"CHEMBL4706202";"Inhibition of human liver Cathepsin D preincubated for 10 mins followed by substrate addition and further incubated for 2 hrs in dark by fluorimetric analysis";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699662";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"TIME = 2.167 hr";"INHIBITOR";""
"CHEMBL4229080";"";"None";"440.50";"0";"3.59";"2f";"NC(=O)c1ccc(-c2cc(-c3ccccc3)cc3nc(N)n(CC4CCCO4)c(=O)c23)cc1";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4223547";"Inhibition of human cathepsin D using DABCYL-Glu-Arg-Nle-Phe-Leu-Ser-Phe-Pro-EDANS as substrate preincubated for 30 mins followed by substrate addition measured every 1 min within 8 to 15 mins by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4219216";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";"";""
"CHEMBL4228400";"";"None";"398.47";"0";"3.89";"2c";"Nc1nc2cc(-c3ccccc3)cc(-c3ccncc3)c2c(=O)n1CC1CCCO1";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4223547";"Inhibition of human cathepsin D using DABCYL-Glu-Arg-Nle-Phe-Leu-Ser-Phe-Pro-EDANS as substrate preincubated for 30 mins followed by substrate addition measured every 1 min within 8 to 15 mins by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4219216";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";"";""
"CHEMBL3952809";"";"None";"521.94";"1";"4.41";"BDBM220768";"NC1=N[C@@]2(CCO1)c1cc(NC(=O)c3ccc(Cl)cn3)ccc1Oc1c2cc(C2=CCOCC2)nc1F";"IC50";"'='";"400000.0";"nM";"";"Outside typical range";"386481";"UO_0000065";"";"";"";"";"0";"CHEMBL3888270";"Fluorescence Resonance Energy Transfer (FRET) Assay: Recombinant CathepsinD was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The CathepsinD enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for CathepsinD) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886633";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL535008";"";"None";"582.81";"1";"4.84";"23";"CCc1cn2c3c(cc(C(=O)N[C@@H](Cc4ccccc4)[C@H](O)CNC(C)(C)CCCC(C)C)cc13)N(C)S(=O)(=O)C2";"IC50";"'='";"780.0";"nM";"6.11";"";"";"UO_0000065";"10.48";"0.20";"1.27";"5.89";"0";"CHEMBL1035560";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1158445";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL560092";"";"None";"566.65";"1";"3.23";"15";"CCc1cn2c3c(cc(C(=O)N[C@@H](Cc4ccccc4)[C@H](O)CNCCC(F)(F)F)cc13)N(C)S(=O)(=O)CC2";"IC50";"'='";"890.0";"nM";"6.05";"";"";"UO_0000065";"10.68";"0.21";"2.82";"5.84";"0";"CHEMBL1035560";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1158445";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL401587";"";"None";"468.99";"0";"4.08";"10d";"CCCOc1ccc(-c2ccc(-c3ccccc3Cl)n2CC(=O)/N=C(/N)NCCCO)cc1";"IC50";"'='";"5900.0";"nM";"5.23";"";"";"UO_0000065";"11.15";"0.22";"1.15";"5.13";"0";"CHEMBL855558";"Inhibition of cathepsin D by FRET based peptide cleavage assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1137408";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";"";""
"CHEMBL402330";"";"None";"376.50";"0";"3.42";"7b";"NC(N)=NC(=O)Cn1c(-c2ccccc2)ccc1C12CC3CC(CC(C3)C1)C2";"IC50";"'='";"30200.0";"nM";"4.52";"";"";"UO_0000065";"12.01";"0.22";"1.10";"5.23";"0";"CHEMBL855558";"Inhibition of cathepsin D by FRET based peptide cleavage assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1137408";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";"";""
"CHEMBL4740385";"";"None";"755.86";"1";"4.78";"6b";"COc1ccc(CC(=O)NC(=N)N[C@H](CC2CCCCC2)C(=O)Nc2cc(S(=O)(=O)NC3CCCCC3)ccc2C)cc1OC.O=C(O)C(F)(F)F";"IC50";"'='";"163.0";"nM";"6.79";"";"";"UO_0000065";"10.58";"0.21";"2.01";"4.28";"0";"CHEMBL4706202";"Inhibition of human liver Cathepsin D preincubated for 10 mins followed by substrate addition and further incubated for 2 hrs in dark by fluorimetric analysis";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699662";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"TIME = 2.167 hr";"INHIBITOR";""
"CHEMBL4756722";"";"None";"756.84";"1";"3.11";"8b";"COc1ccc(CC(=O)NC(=N)N[C@H](CC2CCCCC2)C(=O)Nc2cc(S(=O)(=O)N3CCN(C)CC3)ccc2C)cc1OC.O=C(O)C(F)(F)F";"IC50";"'='";"86.0";"nM";"7.07";"";"";"UO_0000065";"10.99";"0.21";"3.96";"4.61";"0";"CHEMBL4706202";"Inhibition of human liver Cathepsin D preincubated for 10 mins followed by substrate addition and further incubated for 2 hrs in dark by fluorimetric analysis";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699662";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"TIME = 2.167 hr";"INHIBITOR";""
"CHEMBL4741258";"";"None";"734.71";"1";"1.81";"5e";"COc1ccc(CC(=O)NC(=N)N[C@H](Cn2cc(-c3ccccc3)nn2)C(=O)Nc2cc(S(N)(=O)=O)ccc2C)cc1OC.O=C(O)C(F)(F)F";"IC50";"'='";"677.0";"nM";"6.17";"";"";"UO_0000065";"9.94";"0.19";"4.36";"3.03";"0";"CHEMBL4706202";"Inhibition of human liver Cathepsin D preincubated for 10 mins followed by substrate addition and further incubated for 2 hrs in dark by fluorimetric analysis";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699662";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"TIME = 2.167 hr";"INHIBITOR";""
"CHEMBL296588";"PEPSTATIN";"2.0";"685.90";"2";"1.47";"1";"CC(C)CC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)[C@@H](O)CC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)[C@@H](O)CC(=O)O)C(C)C)C(C)C";"IC50";"'='";"0.0016";"ug.mL-1";"";"";"";"UO_0000274";"";"";"";"";"0";"CHEMBL3072144";"Inhibition of cathepsin D (unknown origin) using hemoglobin as substrate after 30 min by spectrophotometric analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3045990";"1";"Scientific Literature";"Med Chem Res";"2013";"None";"";"";""
"CHEMBL2177339";"";"None";"360.37";"0";"2.85";"9t";"COc1ccc2c(c1)C1(COC(N)=N1)c1cc(-c3cncnc3)ccc1O2";"IC50";"'='";"37000.0";"nM";"4.43";"";"";"UO_0000065";"12.30";"0.22";"1.58";"4.83";"0";"CHEMBL2183109";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2177044";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL2177327";"";"None";"442.39";"0";"4.96";"9h";"COc1ccc2c(c1)C1(COC(N)=N1)c1cc(-c3ccc(OC(F)(F)F)cc3)ccc1O2";"IC50";"'>'";"40000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2183109";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2177044";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL2177326";"";"None";"392.84";"0";"4.71";"9g";"COc1ccc2c(c1)C1(COC(N)=N1)c1cc(-c3ccc(Cl)cc3)ccc1O2";"IC50";"'>'";"40000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2183109";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2177044";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL1270835";"";"None";"433.41";"0";"3.56";"102";"CN1C(=O)[C@@](c2ccc(OC(F)F)cc2)(c2ccc(F)c(C#CCCCF)c2)N=C1N";"IC50";"'='";"1150.0";"nM";"5.94";"";"";"UO_0000065";"13.70";"0.26";"2.38";"8.74";"0";"CHEMBL1273977";"Inhibition of cathepsin D by FRET assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1268920";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL1269948";"";"None";"404.50";"0";"3.46";"8";"CC(=O)N[C@@H](Cc1cc(F)cc(F)c1)[C@H](O)CNCc1cccc(C(C)(C)C)c1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1274834";"Inhibition of cathepsin-D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1268878";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL2031149";"";"None";"529.65";"1";"2.85";"45";"COCC(=O)N[C@@H](Cc1ccc(F)cc1)[C@H](O)CN[C@H]1C[C@]2(C[C@H](O)C2)Oc2ncc(CC(C)(C)C)cc21";"IC50";"'='";"695.0";"nM";"6.16";"";"";"UO_0000065";"11.63";"0.22";"3.31";"5.45";"0";"CHEMBL2033077";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2029322";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL315139";"";"None";"481.81";"1";"7.37";"25";"O=C(Nc1ccc(Sc2nc3ccccc3s2)c(Cl)c1)c1cc(Cl)cc(Cl)c1O";"IC50";"'='";"1800.0";"nM";"5.75";"";"";"UO_0000065";"11.92";"0.27";"-1.63";"9.23";"0";"CHEMBL657347";"Inhibitory activity against human liver Cathepsin D using Cathepsin D assay.";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1132101";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1999";"None";"";"";""
"CHEMBL409766";"";"None";"616.73";"1";"3.83";"17";"CCNc1cc(C(=O)N[C@@H](Cc2cc(F)cc(F)c2)[C@H](O)CNCc2cccc(OC)c2)cc(N2CCCCS2(=O)=O)c1";"IC50";"'='";"2400.0";"nM";"5.62";"";"";"UO_0000065";"9.11";"0.18";"1.79";"4.68";"0";"CHEMBL945838";"Inhibition of Cathepsin D expressed in CHO cells by FRET assay";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140838";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"CHEMBL3308072";"";"";""
"CHEMBL4456863";"";"None";"452.91";"0";"3.95";"8";"COC[C@]12C[C@H]1[C@@](C)(c1cc(NC(=O)c3ccc(Cl)cn3)cc(F)c1F)N=C(N)S2";"IC50";"'='";"281000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4343401";"Inhibition of recombinant CatD (unknown origin) expressed in CHO cells using FRET peptide substrate preincubated for 1 hr followed by substrate addition and measured after 1 hr by FRET assay";"A";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4342420";"1";"Scientific Literature";"J Med Chem";"2020";"CHEMBL3308072";"";"";""
"CHEMBL85006";"";"None";"752.53";"2";"8.73";"7";"CCOc1ccc2nc(Sc3ccc(NS(=O)(=O)c4cc(Cl)cc(Cl)c4OS(=O)(=O)c4cc(Cl)cc(Cl)c4O)cc3)sc2c1";"IC50";"'='";"460.0";"nM";"6.34";"";"";"UO_0000065";"8.42";"0.20";"-2.39";"4.80";"0";"CHEMBL657347";"Inhibitory activity against human liver Cathepsin D using Cathepsin D assay.";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1132101";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1999";"None";"";"";""
"CHEMBL314144";"";"None";"640.16";"2";"7.25";"44";"CCOc1ccc2nc(Sc3ccc(NC(=O)c4cc(Cl)ccc4NC(=O)c4ccccc4S(=O)(=O)O)cc3)sc2c1";"IC50";"'='";"2000.0";"nM";"5.70";"";"";"UO_0000065";"8.90";"0.19";"-1.55";"4.23";"0";"CHEMBL657347";"Inhibitory activity against human liver Cathepsin D using Cathepsin D assay.";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1132101";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1999";"None";"";"";""
"CHEMBL2349607";"";"None";"337.38";"0";"1.69";"39, rac-39";"CN1C(=O)C2(CC(C)(C)Oc3ccc(-c4cncnc4)cc32)N=C1N";"IC50";"'='";"14704.0";"nM";"4.83";"";"";"UO_0000065";"14.32";"0.26";"3.14";"5.16";"0";"CHEMBL2352017";"Inhibition of human spleen cathepsin D using 5-FAM/QXL as peptide substrate after 1 hr by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"CHEMBL3559722";"Spleen";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346596";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL2349507";"";"None";"354.39";"0";"2.43";"37, rac-37";"CN1C(=O)C2(CC(C)(C)Oc3ccc(-c4cccnc4F)cc32)N=C1N";"IC50";"'='";"3709.0";"nM";"5.43";"";"";"UO_0000065";"15.32";"0.29";"3.00";"6.72";"0";"CHEMBL2352017";"Inhibition of human spleen cathepsin D using 5-FAM/QXL as peptide substrate after 1 hr by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"CHEMBL3559722";"Spleen";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346596";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL87758";"";"None";"481.81";"1";"7.37";"21";"O=C(Nc1ccc(Sc2nc3ccc(Cl)cc3s2)cc1)c1cc(Cl)cc(Cl)c1O";"IC50";"'='";"1200.0";"nM";"5.92";"";"";"UO_0000065";"12.29";"0.28";"-1.45";"9.52";"0";"CHEMBL657347";"Inhibitory activity against human liver Cathepsin D using Cathepsin D assay.";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1132101";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1999";"None";"";"";""
"CHEMBL252189";"";"None";"516.40";"1";"4.85";"6g";"N=C(N)NC(=O)Cn1c(-c2ccccc2)ccc1-c1ccc(NC(=O)c2cccc(Br)c2)cc1";"IC50";"'='";"2100.0";"nM";"5.68";"";"";"UO_0000065";"10.99";"0.23";"0.83";"5.02";"0";"CHEMBL944849";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140831";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";"";"";""
"CHEMBL572081";"";"None";"482.58";"0";"4.01";"7, mixture of epimers";"CC(=O)N[C@@H](Cc1cc(F)cc(F)c1)[C@H](O)CNC1(c2cccc(-n3cccn3)c2)CCCCC1";"IC50";"'='";"22.0";"nM";"7.66";"";"";"UO_0000065";"15.87";"0.30";"3.65";"9.67";"0";"CHEMBL1045212";"Inhibition of cathepsin D assessed as reduction in polarization after 110 mins by oregon green based fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156090";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL571833";"";"None";"458.59";"0";"4.73";"10, mixture of epimers";"CC(=O)N[C@@H](Cc1cc(F)cc(F)c1)[C@H](O)CNC1(c2cccc(C(C)(C)C)c2)CCCC1";"IC50";"'='";"130.0";"nM";"6.89";"";"";"UO_0000065";"15.02";"0.28";"2.16";"11.22";"0";"CHEMBL1045212";"Inhibition of cathepsin D assessed as reduction in polarization after 110 mins by oregon green based fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156090";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL584547";"";"None";"485.62";"0";"4.05";"36";"C=C1CCC(NC[C@@H](O)[C@H](Cc2cc(F)cc(F)c2)NC(C)=O)(c2cccc(C(C)(C)C)c2)CN1";"IC50";"'='";"22.0";"nM";"7.66";"";"";"UO_0000065";"15.77";"0.30";"3.61";"10.43";"0";"CHEMBL1045212";"Inhibition of cathepsin D assessed as reduction in polarization after 110 mins by oregon green based fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156090";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL583688";"";"None";"530.66";"1";"3.00";"50";"CC(=O)N[C@H]1CC[C@@](NC[C@@H](O)[C@H](Cc2cc(F)cc(F)c2)NC(C)=O)(c2cccc(C(C)(C)C)c2)CN1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1045212";"Inhibition of cathepsin D assessed as reduction in polarization after 110 mins by oregon green based fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156090";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL540685";"";"None";"576.72";"1";"3.46";"34";"CCc1cn2c3c(cc(C(=O)N[C@@H](Cc4ccccc4)[C@H](O)CNCc4cccc(OC)c4)cc13)NS(=O)(=O)CC2";"IC50";"'='";"14120.0";"nM";"4.85";"";"";"UO_0000065";"8.41";"0.16";"1.39";"3.99";"0";"CHEMBL1035560";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1158445";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL1090025";"";"None";"332.36";"0";"2.37";"4j";"CN1C(=O)C(c2ccncc2)(c2cccc(-c3ccoc3)c2)N=C1N";"IC50";"'='";"46800.0";"nM";"4.33";"";"";"UO_0000065";"13.03";"0.24";"1.96";"5.11";"0";"CHEMBL1115170";"Inhibition of cathepsin D by FRET assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156304";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL3321923";"";"None";"557.61";"1";"1.91";"22";"COc1ccc(CC(=O)NC(=N)N[C@H](Cc2ccccc2)C(=O)NCCN2C(=O)c3ccccc3C2=O)cc1OC";"IC50";"'='";"320.0";"nM";"6.50";"";"";"UO_0000065";"11.65";"0.22";"4.58";"4.33";"0";"CHEMBL3371146";"Inhibition of human liver cathepsin D using MCA-labeled GKPILFFRLK(Dnp)-D-R-NH2 peptide by fluorescence-based assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351526";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL1076901";"";"None";"814.02";"1";"4.73";"33";"CC(C)[C@H](NC(=O)[C@H](C)C[C@H](O)[C@H](COCc1ccccc1)NC(=O)c1cc(C(=O)N[C@H](C)c2ccccc2)cc(N(C)S(C)(=O)=O)c1)C(=O)NCc1ccccc1";"IC50";"'='";"41.0";"nM";"7.39";"";"";"UO_0000065";"9.07";"0.17";"2.66";"4.03";"0";"CHEMBL1106032";"Inhibition of human liver cathepsin D after 20 mins by homogeneous time resolved fluorescence assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1154862";"1";"Scientific Literature";"Eur J Med Chem";"2010";"None";"";"";""
"CHEMBL3321925";"";"None";"534.61";"1";"2.83";"24";"COc1ccc(CNC(=O)[C@@H](Cc2ccccc2)NC(=N)NC(=O)Cc2ccc(OC)c(OC)c2)cc1OC";"IC50";"'='";"58.0";"nM";"7.24";"";"";"UO_0000065";"13.54";"0.25";"4.41";"5.52";"0";"CHEMBL3371146";"Inhibition of human liver cathepsin D using MCA-labeled GKPILFFRLK(Dnp)-D-R-NH2 peptide by fluorescence-based assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351526";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3321915";"";"None";"341.41";"0";"2.40";"7";"COc1ccc(CC(=O)NC(=N)NCc2ccc(C)cc2)cc1OC";"IC50";"'='";"1900.0";"nM";"5.72";"";"";"UO_0000065";"16.76";"0.31";"3.32";"6.86";"0";"CHEMBL3371146";"Inhibition of human liver cathepsin D using MCA-labeled GKPILFFRLK(Dnp)-D-R-NH2 peptide by fluorescence-based assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351526";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3321914";"";"None";"406.83";"0";"2.65";"6";"COc1cc(CC(=O)NC(=N)NCc2ccc(Cl)cc2)c([N+](=O)[O-])cc1OC";"IC50";"'='";"1500.0";"nM";"5.82";"";"";"UO_0000065";"14.32";"0.28";"3.17";"4.60";"0";"CHEMBL3371146";"Inhibition of human liver cathepsin D using MCA-labeled GKPILFFRLK(Dnp)-D-R-NH2 peptide by fluorescence-based assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351526";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL566632";"";"None";"445.38";"0";"3.21";"(S)-61";"CN1C(=O)[C@](c2ccc(OC(F)(F)F)cc2)(c2ccc(F)c(-c3cncnc3)c2)N=C1N";"IC50";"'='";"11570.0";"nM";"4.94";"";"";"UO_0000065";"11.08";"0.21";"1.73";"5.27";"0";"CHEMBL1044551";"Inhibition of human cathepsin D by FRET based peptide cleavage assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156789";"1";"Scientific Literature";"J Med Chem";"2010";"None";"";"";""
"CHEMBL566223";"";"None";"390.42";"0";"2.93";"45";"COc1ccc(C2(c3cccc(-c4cccnc4)c3)N=C(N)N(C)C2=O)cc1F";"IC50";"'='";"5200.0";"nM";"5.28";"";"";"UO_0000065";"13.53";"0.25";"2.35";"6.54";"0";"CHEMBL1044551";"Inhibition of human cathepsin D by FRET based peptide cleavage assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156789";"1";"Scientific Literature";"J Med Chem";"2010";"None";"";"";""
"CHEMBL567061";"";"None";"444.54";"0";"3.97";"41";"CCCCOc1cc(C2(c3cccc(-c4cccnc4)c3)N=C(N)N(C)C2=O)ccc1OC";"IC50";"'='";"8180.0";"nM";"5.09";"";"";"UO_0000065";"11.44";"0.21";"1.12";"5.65";"0";"CHEMBL1044551";"Inhibition of human cathepsin D by FRET based peptide cleavage assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156789";"1";"Scientific Literature";"J Med Chem";"2010";"None";"";"";""
"CHEMBL566407";"";"None";"430.51";"0";"3.58";"40";"CCCOc1cc(C2(c3cccc(-c4cccnc4)c3)N=C(N)N(C)C2=O)ccc1OC";"IC50";"'='";"10100.0";"nM";"5.00";"";"";"UO_0000065";"11.60";"0.21";"1.42";"5.55";"0";"CHEMBL1044551";"Inhibition of human cathepsin D by FRET based peptide cleavage assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156789";"1";"Scientific Literature";"J Med Chem";"2010";"None";"";"";""
"CHEMBL584284";"";"None";"367.49";"0";"3.20";"34";"COc1ccc(C2(C34CC5CC(CC(C5)C3)C4)N=C(N)N(C)C2=O)cc1C";"IC50";"'='";"11100.0";"nM";"4.96";"";"";"UO_0000065";"13.48";"0.25";"1.75";"7.29";"0";"CHEMBL1044551";"Inhibition of human cathepsin D by FRET based peptide cleavage assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156789";"1";"Scientific Literature";"J Med Chem";"2010";"None";"";"";""
"CHEMBL566012";"";"None";"387.44";"0";"2.49";"59";"COc1ccc(C2(c3cccc(-c4cncnc4)c3)N=C(N)N(C)C2=O)cc1C";"IC50";"'='";"14300.0";"nM";"4.84";"";"";"UO_0000065";"12.50";"0.23";"2.35";"5.17";"0";"CHEMBL1044551";"Inhibition of human cathepsin D by FRET based peptide cleavage assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156789";"1";"Scientific Literature";"J Med Chem";"2010";"None";"";"";""
"CHEMBL567258";"";"None";"444.39";"0";"3.82";"56";"CN1C(=O)C(c2ccc(OC(F)(F)F)cc2)(c2cccc(-c3cccnc3F)c2)N=C1N";"IC50";"'='";"3150.0";"nM";"5.50";"";"";"UO_0000065";"12.38";"0.23";"1.68";"6.81";"0";"CHEMBL1044551";"Inhibition of human cathepsin D by FRET based peptide cleavage assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156789";"1";"Scientific Literature";"J Med Chem";"2010";"None";"";"";""
"CHEMBL504438";"";"None";"664.75";"1";"4.56";"1";"CCNc1cc(C(=O)N[C@@H](Cc2ccccc2)[C@H](O)CNCc2cccc(C(F)(F)F)c2)cc(N2CCCCS2(=O)=O)c1.O=CO";"IC50";"'='";"3900.0";"nM";"5.41";"";"";"UO_0000065";"8.74";"0.17";"0.85";"4.88";"0";"CHEMBL959767";"Inhibition of cathepsin D expressed in CHO cells after 1 hrs by spectrophotometer";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1150334";"1";"Scientific Literature";"J Med Chem";"2008";"CHEMBL3308072";"";"";""
"CHEMBL4225824";"";"None";"463.58";"0";"4.57";"6a";"CCCCCc1ccc(-c2cc(CCC(=O)O)c3c(=O)n(CC4CCCO4)c(N)nc3c2)cc1";"IC50";"'='";"21000.0";"nM";"4.68";"";"";"UO_0000065";"10.09";"0.19";"0.11";"4.35";"0";"CHEMBL4223547";"Inhibition of human cathepsin D using DABCYL-Glu-Arg-Nle-Phe-Leu-Ser-Phe-Pro-EDANS as substrate preincubated for 30 mins followed by substrate addition measured every 1 min within 8 to 15 mins by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4219216";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";"";""
"CHEMBL493637";"";"None";"546.69";"1";"2.50";"9e";"CCNc1cc(C(=O)N[C@@H](Cc2ccccc2)[C@H](O)CNC2CC2)cc(N2CCCCS2(=O)=O)c1.O=CO";"IC50";"'='";"30200.0";"nM";"4.52";"";"";"UO_0000065";"9.03";"0.18";"2.02";"4.08";"0";"CHEMBL959767";"Inhibition of cathepsin D expressed in CHO cells after 1 hrs by spectrophotometer";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1150334";"1";"Scientific Literature";"J Med Chem";"2008";"CHEMBL3308072";"";"";""
"CHEMBL2181023";"";"None";"907.12";"3";"0.81";"10";"COC(=O)[C@@H]1CCCN1C(=O)[C@@H](Cc1ccccc1)N(C)C(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)C[C@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(N)=O)N(C)C(=O)[C@@H](N)C(C)C";"IC50";"'='";"17.3";"nM";"7.76";"";"";"UO_0000065";"8.56";"0.16";"6.95";"2.94";"0";"CHEMBL2185513";"Inhibition of cathepsin D by fluorescence assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2176894";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL2181021";"";"None";"965.16";"3";"0.01";"8";"COC(=O)[C@@H]1CCCN1C(=O)[C@@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)C[C@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(N)=O)N(C)C(=O)[C@@H](NC(=O)[C@H](C)O)C(C)C";"IC50";"'='";"89.3";"nM";"7.05";"";"";"UO_0000065";"7.30";"0.14";"7.04";"2.38";"0";"CHEMBL2185513";"Inhibition of cathepsin D by fluorescence assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2176894";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL2181020";"";"None";"909.14";"2";"0.71";"7";"CC(C)C[C@H](NC(=O)C[C@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(N)=O)N(C)C(=O)[C@@H](NC(=O)[C@H](C)O)C(C)C)C(=O)N[C@@H](C)C(=O)N(C)[C@H](Cc1ccccc1)C(=O)NC(C)C";"IC50";"'='";"254.0";"nM";"6.59";"";"";"UO_0000065";"7.25";"0.14";"5.89";"2.45";"0";"CHEMBL2185513";"Inhibition of cathepsin D by fluorescence assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2176894";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL3264804";"";"None";"613.85";"2";"5.56";"8";"CCCN(CCC)C(=O)c1cc(C(=O)N[C@@H](Cc2ccccc2)[C@H](O)CNC(C)(C)c2ccncc2)cc(N2CCCCC2)c1";"IC50";"'='";"170.0";"nM";"6.77";"";"";"UO_0000065";"11.03";"0.21";"1.21";"6.92";"0";"CHEMBL3271470";"Inhibition of human cathepsin-D using DABCYL-Glu-Arg-Nle-Phe-Leu-Ser-Phe-Pro-EDANS as substrate preincubated for 30 mins by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3259525";"1";"Scientific Literature";"ACS Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3683792";"";"None";"410.78";"0";"3.16";"BDBM171397";"NC1=N[C@@](CF)(c2cc(NC(=O)c3ccc(Cl)cn3)cc(F)c2F)[C@@H]2C[C@@H]2O1";"IC50";"'='";"1021900.0";"nM";"";"Outside typical range";"315807";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3683793";"";"None";"431.37";"0";"1.92";"BDBM171399";"C#CCOc1cnc(C(=O)Nc2cc(F)c(F)c([C@@]3(CF)N=C(N)O[C@@H]4C[C@@H]43)c2)cn1";"IC50";"'='";"116000.0";"nM";"";"Outside typical range";"315808";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3683840";"";"None";"437.38";"0";"2.08";"BDBM171450";"COc1cnc(C(=O)Nc2ccc(F)c([C@@]3(C(F)F)N=C(N)O[C@@H]4C[C@@H]43)c2)c(OC)n1";"IC50";"'>'";"400000.0";"nM";"";"Outside typical range";"315859";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688694";"";"None";"456.22";"0";"2.82";"BDBM171633";"NC1=N[C@@](c2cc(NC(=O)c3ncc(Br)cn3)ccc2F)(C(F)F)[C@H]2C[C@H]2O1";"IC50";"'='";"1015200.0";"nM";"";"Outside typical range";"316042";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688768";"";"None";"429.40";"0";"3.56";"BDBM171714";"COc1cnc2c(Nc3ccc(F)c([C@@]4(CF)N=C(N)O[C@@H]5C[C@@H]54)c3)ncc(F)c2c1";"IC50";"'='";"596190.0";"nM";"";"Outside typical range";"316118";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688800";"";"None";"417.79";"0";"3.58";"BDBM171747";"NC1=N[C@](CF)(c2cc(NCc3nn(C(F)F)cc3Cl)ccc2F)[C@H]2C[C@H]2O1";"IC50";"'='";"234000.0";"nM";"";"Outside typical range";"316147";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3693236";"";"None";"439.27";"0";"3.03";"BDBM171795";"NC1=N[C@](CF)(c2cc(NC(=O)c3ncc(Cl)cc3CO)ccc2Cl)[C@H]2C[C@H]2O1";"IC50";"'='";"532830.0";"nM";"";"Outside typical range";"316191";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3683794";"";"None";"431.37";"0";"1.92";"BDBM171400";"C#CCOc1cnc(C(=O)Nc2cc(F)c(F)c([C@]3(CF)N=C(N)O[C@H]4C[C@H]43)c2)cn1";"IC50";"'='";"622600.0";"nM";"";"Outside typical range";"315809";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3683797";"";"None";"401.35";"0";"2.38";"BDBM171403";"N#Cc1ccc(C(=O)Nc2cc(F)c(F)c([C@@]3(CF)N=C(N)O[C@@H]4C[C@@H]43)c2)nc1";"IC50";"'='";"364120.0";"nM";"";"Outside typical range";"315812";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3683813";"";"None";"425.80";"0";"3.02";"BDBM171419";"Cc1nc(Cl)cnc1C(=O)Nc1ccc(F)c([C@]2(C(F)F)N=C(N)O[C@H]3C[C@H]32)c1";"IC50";"'='";"577310.0";"nM";"";"Outside typical range";"315828";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3683889";"";"None";"431.83";"0";"3.20";"BDBM171504";"Cc1cc(C#N)cnc1C(=O)Nc1cc(F)c(Cl)c([C@@]2(CF)N=C(N)O[C@@H]3C[C@@H]32)c1";"IC50";"'='";"662080.0";"nM";"";"Outside typical range";"315913";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL584509";"";"None";"469.44";"0";"4.46";"(S)-37";"NC1=N[C@@](c2ccc(OC(F)(F)F)cc2)(c2cccc(-c3cccnc3F)c2)C2=NCCCN12";"IC50";"'='";"56900.0";"nM";"4.25";"";"";"UO_0000065";"9.04";"0.17";"-0.22";"5.58";"0";"CHEMBL1061266";"Inhibition of human cathepsin D by FRET";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1155232";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL3394054";"";"None";"425.42";"0";"4.04";"25";"NC1=N[C@@]2(CO1)c1cc(-c3cccnc3F)ccc1Oc1cnc(-c3cccnc3)cc12";"IC50";"'='";"1000.0";"nM";"6.00";"";"";"UO_0000065";"14.10";"0.26";"1.96";"6.28";"0";"CHEMBL3395116";"Inhibition of cathepsin D (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3393054";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";""
"CHEMBL3915646";"";"None";"445.35";"0";"2.90";"BDBM214972";"COc1cnc(C(=O)Nc2cc(F)c(F)c([C@]3(C)C[C@@H](C(F)(F)F)OC(N)=N3)c2)cn1";"IC50";"'='";"5350000.0";"nM";"";"Outside typical range";"378006";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3957027";"";"None";"508.39";"1";"4.52";"BDBM215036";"Cc1cc(OC(F)F)cnc1C(=O)Nc1cc(C)c(F)c([C@]2(CF)C[C@@H](C(F)(F)F)OC(N)=N2)c1";"IC50";"'='";"775000.0";"nM";"";"Outside typical range";"378054";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3933535";"";"None";"465.23";"0";"4.66";"BDBM215045";"C[C@@]1(c2cc(NC(=O)c3ccc(Cl)cn3)cc(F)c2Cl)C[C@@H](C(F)(F)F)OC(N)=N1";"IC50";"'='";"407900.0";"nM";"";"Outside typical range";"378084";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL254138";"";"None";"531.66";"1";"3.14";"30";"CCNc1cc(C(=O)N[C@@H](Cc2ccccc2)[C@H](O)CNCc2cccc(OC)n2)cc(N2CCCC2=O)c1";"IC50";"'='";"26300.0";"nM";"4.58";"";"";"UO_0000065";"8.61";"0.16";"1.44";"3.95";"0";"CHEMBL945833";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140837";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";"";"";""
"CHEMBL253719";"";"None";"535.09";"1";"4.39";"28";"CCNc1cc(C(=O)N[C@@H](Cc2ccccc2)[C@H](O)CNCc2cccc(Cl)c2)cc(N2CCCC2=O)c1";"IC50";"'='";"5620.0";"nM";"5.25";"";"";"UO_0000065";"9.81";"0.19";"0.86";"5.60";"0";"CHEMBL945833";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140837";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";"";"";""
"CHEMBL1210343";"";"None";"636.82";"1";"3.92";"22";"COc1cccc(N(c2cccc(C(=O)N[C@@H](Cc3ccccc3)[C@H](O)CN[C@@H](C)C(=O)NC3CCCCC3)c2)S(C)(=O)=O)c1";"IC50";"'='";"640.0";"nM";"6.19";"";"";"UO_0000065";"9.73";"0.19";"2.27";"4.52";"0";"CHEMBL1211667";"Inhibition of Cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1208699";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL1210432";"";"None";"535.71";"1";"4.41";"48";"CS(=O)(=O)N(c1ccccc1)c1cccc(C(=O)N[C@@H](Cc2ccccc2)[C@H](O)CNC2CCCCC2)c1";"IC50";"'='";"193.0";"nM";"6.71";"";"";"UO_0000065";"12.53";"0.24";"2.30";"6.80";"0";"CHEMBL1211667";"Inhibition of Cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1208699";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL4451023";"";"None";"494.70";"0";"3.09";"24";"CC(C)[C@@H]1NC(=O)C[C@H](O)[C@H](Cc2cscn2)NC(=O)CCCCCCCCCCCNC1=O";"IC50";"'='";"600.0";"nM";"6.22";"";"";"UO_0000065";"12.58";"0.25";"3.13";"5.17";"0";"CHEMBL4325791";"Inhibition of human placenta CatD using Abz-Lys-Pro-Ala-Glu-Phe-Nph-Ala-Leu as substrate preincubated for 10 mins followed by substrate addition and measured by FRET assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4321885";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";""
"CHEMBL4532529";"";"None";"501.71";"1";"4.03";"26";"CC[C@@H](C)[C@@H]1NC(=O)C[C@H](O)[C@H](Cc2ccccc2)NC(=O)CCCCCCCCCCCNC1=O";"IC50";"'='";"3.8";"nM";"8.42";"";"";"UO_0000065";"16.78";"0.32";"4.39";"7.83";"0";"CHEMBL4325791";"Inhibition of human placenta CatD using Abz-Lys-Pro-Ala-Glu-Phe-Nph-Ala-Leu as substrate preincubated for 10 mins followed by substrate addition and measured by FRET assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4321885";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";""
"CHEMBL403533";"";"None";"550.74";"1";"3.81";"20";"CCOc1cc(C(=O)N[C@@H](Cc2ccccc2)[C@H](O)CN[C@@H](C)C(=O)NC2CCCCC2)cc(N2CCCC2)c1";"IC50";"'='";"6170.0";"nM";"5.21";"";"";"UO_0000065";"9.46";"0.18";"1.40";"5.06";"0";"CHEMBL931965";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1143153";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";"";"";""
"CHEMBL116";"AMPRENAVIR";"4.0";"505.64";"1";"2.40";"APV";"CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CCOC1)S(=O)(=O)c1ccc(N)cc1";"IC50";"'='";"15200.0";"nM";"4.82";"";"";"UO_0000065";"9.53";"0.19";"2.42";"3.67";"0";"CHEMBL996242";"Inhibition of human cathepsin D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1137017";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2007";"None";"";"";""
"CHEMBL566826";"";"None";"486.60";"0";"4.30";"28";"CC(=O)N[C@@H](Cc1cc(F)cc(F)c1)[C@H](O)CNC1(c2cccc(C(C)(C)C)c2)CCC(=O)CC1";"IC50";"'='";"450.0";"nM";"6.35";"";"";"UO_0000065";"13.04";"0.25";"2.05";"8.09";"0";"CHEMBL1045212";"Inhibition of cathepsin D assessed as reduction in polarization after 110 mins by oregon green based fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156090";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL566404";"";"None";"445.38";"0";"3.21";"63";"CN1C(=O)C(c2ccc(OC(F)(F)F)cc2)(c2cccc(-c3cncnc3)c2F)N=C1N";"IC50";"'='";"26180.0";"nM";"4.58";"";"";"UO_0000065";"10.29";"0.20";"1.37";"4.89";"0";"CHEMBL1044551";"Inhibition of human cathepsin D by FRET based peptide cleavage assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156789";"1";"Scientific Literature";"J Med Chem";"2010";"None";"";"";""
"CHEMBL314896";"";"None";"640.16";"2";"7.25";"46";"CCOc1ccc2nc(Sc3ccc(NC(=O)c4cc(Cl)ccc4NS(=O)(=O)c4ccccc4C(=O)O)cc3)sc2c1";"IC50";"'='";"1800.0";"nM";"5.75";"";"";"UO_0000065";"8.97";"0.19";"-1.51";"4.27";"0";"CHEMBL657347";"Inhibitory activity against human liver Cathepsin D using Cathepsin D assay.";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1132101";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1999";"None";"";"";""
"CHEMBL1097007";"";"None";"530.78";"1";"2.22";"2";"CCCCNC(=O)[C@H](C)C[C@H](O)[C@H](CC(C)C)NC(=O)[C@H](CCSC)NC(=O)[C@@H](NC(C)=O)C(C)C";"IC50";"'='";"48.0";"nM";"7.32";"";"";"UO_0000065";"13.79";"0.28";"5.10";"5.36";"0";"CHEMBL1107841";"Inhibition of Cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1155410";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL2408750";"";"None";"488.62";"0";"4.85";"45";"CC(=O)N[C@@H](Cc1cc(F)cc(F)c1)[C@H](O)CN[C@H]1CC(C)(C)Oc2ccc(CC(C)(C)C)cc21";"IC50";"'='";"18.0";"nM";"7.75";"";"";"UO_0000065";"15.85";"0.30";"2.89";"10.97";"0";"CHEMBL2410948";"Inhibition of cathepsin-D (unknown origin) using C-terminal biotinylated peptide substrate treated 30 mins before addition of peptide substrate measured after 110 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2406984";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"None";"";"";""
"CHEMBL2408757";"";"None";"499.60";"0";"4.36";"52";"CC(=O)N[C@@H](Cc1cc(F)cc(F)c1)[C@H](O)CN[C@H]1CC(C)(C)Oc2ccc(CC(C)(C)C#N)cc21";"IC50";"'='";"8.0";"nM";"8.10";"";"";"UO_0000065";"16.21";"0.31";"3.74";"8.58";"0";"CHEMBL2410948";"Inhibition of cathepsin-D (unknown origin) using C-terminal biotinylated peptide substrate treated 30 mins before addition of peptide substrate measured after 110 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2406984";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"None";"";"";""
"CHEMBL1270362";"";"None";"466.52";"0";"4.19";"16";"CC(=O)N[C@@H](Cc1cc(F)cc(F)c1)[C@H](O)CNC1(c2cccc(C(C)(C)C(F)F)c2)CC1";"IC50";"'='";"490.0";"nM";"6.31";"";"";"UO_0000065";"13.53";"0.26";"2.12";"10.28";"0";"CHEMBL1274834";"Inhibition of cathepsin-D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1268878";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL537300";"";"None";"622.71";"1";"3.39";"37";"CCc1cn2c3c(cc(C(=O)N[C@@H](Cc4ccccc4)[C@H](O)CNC4CCOCC4)cc13)N(CC(F)(F)F)S(=O)(=O)CC2";"IC50";"'='";"5010.0";"nM";"5.30";"";"";"UO_0000065";"8.51";"0.17";"1.91";"4.69";"0";"CHEMBL1035560";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1158445";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL583887";"";"None";"416.45";"0";"4.21";"32";"CCCc1cccc(C2(c3ccc(OC(F)(F)F)cc3)N=C(N)N3CCCN=C32)c1";"IC50";"'='";"93700.0";"nM";"4.03";"";"";"UO_0000065";"9.67";"0.18";"-0.18";"6.37";"0";"CHEMBL1061266";"Inhibition of human cathepsin D by FRET";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1155232";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL1092475";"";"None";"367.41";"0";"2.65";"4d";"CN1C(=O)C(c2ccncc2)(c2cccc(-c3cccc(C#N)c3)c2)N=C1N";"IC50";"'='";"24200.0";"nM";"4.62";"";"";"UO_0000065";"12.56";"0.23";"1.97";"4.84";"0";"CHEMBL1115170";"Inhibition of cathepsin D by FRET assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156304";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL2030995";"";"None";"501.62";"1";"4.20";"39";"CC(=O)N[C@@H](Cc1ccc(F)cc1)[C@H](O)CN[C@H]1C[C@]2(C[C@H](F)C2)Oc2ncc(CC(C)(C)C)cc21";"IC50";"'='";"14.0";"nM";"7.85";"";"";"UO_0000065";"15.66";"0.30";"3.65";"9.41";"0";"CHEMBL2033077";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2029322";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL252962";"";"None";"533.74";"1";"3.11";"28";"CCCN(CCC)S(=O)(=O)CCCC(=O)N[C@@H](Cc1ccccc1)[C@H](O)CNCc1cccc(OC)c1";"IC50";"'='";"11700.0";"nM";"4.93";"";"";"UO_0000065";"9.24";"0.18";"1.82";"4.57";"0";"CHEMBL942098";"Inhibition of human recombinant cathepsin D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140593";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"None";"";"";""
"CHEMBL398925";"";"None";"502.68";"1";"3.01";"19";"COc1cccc(CNC[C@@H](O)[C@H](Cc2ccccc2)NC(=O)CCS(=O)(=O)C2CCCCC2)c1";"IC50";"'='";"6946.0";"nM";"5.16";"";"";"UO_0000065";"10.26";"0.20";"2.15";"4.93";"0";"CHEMBL942098";"Inhibition of human recombinant cathepsin D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140593";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"None";"";"";""
"CHEMBL3321930";"";"None";"516.59";"1";"3.82";"29";"COc1ccc(CC(=O)NC(=N)N[C@H](CC2CCCCC2)C(=O)NCc2ccc(F)c(F)c2)cc1OC";"IC50";"'='";"170.0";"nM";"6.77";"";"";"UO_0000065";"13.10";"0.25";"2.95";"6.02";"0";"CHEMBL3371146";"Inhibition of human liver cathepsin D using MCA-labeled GKPILFFRLK(Dnp)-D-R-NH2 peptide by fluorescence-based assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351526";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3321913";"";"None";"441.27";"0";"3.30";"5";"COc1cc(CC(=O)NC(=N)NCc2ccc(Cl)c(Cl)c2)c([N+](=O)[O-])cc1OC";"IC50";"'='";"440.0";"nM";"6.36";"";"";"UO_0000065";"14.41";"0.30";"3.06";"5.02";"0";"CHEMBL3371146";"Inhibition of human liver cathepsin D using MCA-labeled GKPILFFRLK(Dnp)-D-R-NH2 peptide by fluorescence-based assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351526";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL227053";"";"None";"577.77";"1";"3.76";"23";"CC(C)Nc1cc(C(=O)N[C@@H](Cc2ccccc2)[C@H](O)CN[C@@H](C)C(=O)NC2CCCCC2)cc(N2CCCC2=O)c1";"IC50";"'='";"5413.0";"nM";"5.27";"";"";"UO_0000065";"9.12";"0.17";"1.51";"4.29";"0";"CHEMBL931965";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1143153";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";"";"";""
"CHEMBL2059593";"";"None";"371.93";"1";"5.33";"E6T5";"OC(CSc1ccccc1Cl)Cn1c2c(c3ccccc31)CCCC2";"IC50";"'>'";"300000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2061980";"Inhibition of cathepsin D by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2057073";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL3901700";"";"None";"765.01";"2";"3.19";"BDBM232257";"COC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)C[C@H](N)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)CC(C)C)C(C)C)C(C)C";"IC50";"'='";"5.7";"nM";"8.24";"";"405034";"UO_0000065";"10.78";"0.20";"5.05";"4.17";"0";"CHEMBL3888498";"In-Vitro Fluorescence Assay: In order to identify modulators of cathepsin D activity, a continuous enzymatic test was carried out with a synthetic peptide which carries a fluorescent group (MCA=(7-methoxycoumarin-4-yl)acetyl) which is quenched by energy transfer from a Dpn (2,4 dinitrophenyl) group on the same molecule, in Greiner 384-well nb microtitre plates. Cleavage of the peptidic substrate by cathepsin D causes an increase in the fluorescence intensity. In order to determine the efficacy of substances, the time-dependent increase in the fluorescence intensity in the presence of the substance was compared with the time-dependent increase in fluorescence in the absence of substances. The reference substance used was pepstatin A (Sigma-Aldrich). The substrate used was MCAGKPILFFRLK(Dnp)d-R-NH2 (Enzo Life Sciences, Lorrach). The enzyme employed was cathepsin D isolated from the human liver (Sigma-Aldrich) in a final concentration of 1.4 nM. The test was carried out in 100 mM sodium acetate buffer, 1.25% (v/v) of DMSO, 0.25% (w/v) of Chaps, pH 5.5. 2 ul of each substance solution with serially diluted substance concentration were added to in each case 4 ul of cathepsin D solution and incubated at room temperature for 10 min. The reaction was started by addition of 2 ul of substrate solution (final concentration 5 uM). After carrying out a starting-point fluorescence measurement (excitation wavelength 340 nm/emission wavelength 450 nm) using an Envision multilabel reader (Perkin Elmer), the reaction was incubated at room temperature for 60 min. The amount of peptide fragment cleaved off during the reaction time was subsequently measured by determination of the increase in the fluorescence intensity at 450 nm (excitation wavelength 340 nm).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886733";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL570556";"";"None";"474.59";"0";"3.97";"2";"CC(=O)N[C@@H](Cc1cc(F)cc(F)c1)[C@H](O)CNC1(c2cccc(C(C)(C)C)c2)CCOCC1";"IC50";"'='";"230.0";"nM";"6.64";"";"";"UO_0000065";"13.99";"0.27";"2.67";"9.40";"1";"CHEMBL1274834";"Inhibition of cathepsin-D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1268878";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL566810";"";"None";"487.59";"0";"3.07";"23, mixture of epimers";"CC(=O)N[C@@H](Cc1cc(F)cc(F)c1)[C@H](O)CNC1(c2cccc(C(C)(C)C)c2)CCC(=O)NC1";"IC50";"'='";"180.0";"nM";"6.75";"";"";"UO_0000065";"13.83";"0.26";"3.67";"7.46";"0";"CHEMBL1045212";"Inhibition of cathepsin D assessed as reduction in polarization after 110 mins by oregon green based fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156090";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL3414707";"";"None";"298.36";"0";"2.65";"40";"C[C@H]1C[C@H]2CSC(N)=N[C@@]2(c2ccc(F)cc2F)CO1";"IC50";"'>'";"72000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4183115";"Inhibition of Cathepsin D (unknown origin) by fluorescence polarization assay";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4177751";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL583899";"";"None";"407.44";"0";"3.78";"33";"CN1C(=O)C(c2ccc(OC(F)(F)F)cc2)(C23CC4CC(CC(C4)C2)C3)N=C1N";"IC50";"'='";"6220.0";"nM";"5.21";"";"";"UO_0000065";"12.78";"0.25";"1.43";"7.67";"0";"CHEMBL1044551";"Inhibition of human cathepsin D by FRET based peptide cleavage assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156789";"1";"Scientific Literature";"J Med Chem";"2010";"None";"";"";""
"CHEMBL566414";"";"None";"384.44";"0";"2.71";"51";"CN1C(=O)C(c2cccc(-c3cccnc3)c2)(c2ccc3c(c2)CCO3)N=C1N";"IC50";"'='";"23920.0";"nM";"4.62";"";"";"UO_0000065";"12.02";"0.22";"1.91";"5.72";"0";"CHEMBL1044551";"Inhibition of human cathepsin D by FRET based peptide cleavage assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156789";"1";"Scientific Literature";"J Med Chem";"2010";"None";"";"";""
"CHEMBL568114";"";"None";"397.44";"0";"2.66";"48";"COc1ccc(C2(c3cccc(-c4cccnc4)c3)N=C(N)N(C)C2=O)cc1C#N";"IC50";"'='";"7300.0";"nM";"5.14";"";"";"UO_0000065";"12.92";"0.23";"2.48";"4.91";"0";"CHEMBL1044551";"Inhibition of human cathepsin D by FRET based peptide cleavage assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156789";"1";"Scientific Literature";"J Med Chem";"2010";"None";"";"";""
"CHEMBL3683819";"";"None";"401.35";"0";"2.54";"BDBM171425";"N#Cc1ccc(C(=O)Nc2ccc(F)c([C@]3(C(F)F)N=C(N)O[C@H]4C[C@H]43)c2)nc1";"IC50";"'='";"899100.0";"nM";"";"Outside typical range";"315834";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3683835";"";"None";"406.36";"0";"2.52";"BDBM171445";"COc1ccc(C(=O)Nc2ccc(F)c([C@@]3(CF)N=C(N)O[C@@H]4C[C@@H]43)c2F)nc1";"IC50";"'='";"941650.0";"nM";"";"Outside typical range";"315854";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3683842";"";"None";"447.83";"0";"2.90";"BDBM171452";"COc1cc(C#N)cnc1C(=O)Nc1cc(Cl)c(F)c([C@@]2(CF)N=C(N)O[C@@H]3C[C@@H]32)c1";"IC50";"'='";"891600.0";"nM";"";"Outside typical range";"315861";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3683894";"";"None";"422.82";"0";"3.03";"BDBM171511";"COc1c(F)cc(NC(=O)c2ccc(Cl)cn2)cc1[C@@]1(CF)N=C(N)O[C@@H]2C[C@@H]21";"IC50";"'='";"220000.0";"nM";"";"Outside typical range";"315920";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688611";"";"None";"415.82";"0";"3.99";"BDBM171545";"NC1=N[C@@](c2cc(NC(=O)c3ccc(Cl)s3)ccc2F)(C(F)F)[C@H]2C[C@H]2O1";"IC50";"'='";"474390.0";"nM";"";"Outside typical range";"315954";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688616";"";"None";"404.39";"0";"3.28";"BDBM171551";"Cc1cnc(C(=O)Nc2ccc(F)c([C@@]3(C(F)F)N=C(N)O[C@@H]4C[C@@H]43)c2)c(C)c1";"IC50";"'='";"752560.0";"nM";"";"Outside typical range";"315960";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688624";"";"None";"427.24";"0";"3.68";"BDBM171559";"NC1=N[C@](CF)(c2cc(NC(=O)c3ncc(Cl)cc3Cl)ccc2F)[C@H]2C[C@H]2O1";"IC50";"'='";"875420.0";"nM";"";"Outside typical range";"315968";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688637";"";"None";"414.37";"0";"1.17";"BDBM171572";"C#CCOc1cnc(C(=O)Nc2cnc(F)c([C@@]3(CF)N=C(N)O[C@@H]4C[C@@H]43)c2)cn1";"IC50";"'='";"310790.0";"nM";"";"Outside typical range";"315981";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688661";"";"None";"444.41";"0";"3.07";"BDBM171599";"CC#CCOc1ccc(C(=O)Nc2ccc(F)c([C@@]3(C(F)F)N=C(N)O[C@@H]4C[C@@H]43)c2)nc1";"IC50";"'='";"243500.0";"nM";"";"Outside typical range";"316008";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688664";"";"None";"474.36";"0";"3.61";"BDBM171602";"NC1=N[C@@](c2cc(NC(=O)c3ccc(OCC(F)(F)F)cn3)ccc2F)(C(F)F)[C@H]2C[C@H]2O1";"IC50";"'='";"4249400.0";"nM";"";"Outside typical range";"316011";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688686";"";"None";"367.33";"0";"1.94";"BDBM171624";"NC1=N[C@@](c2cc(NC(=O)C3CC(=O)C3)ccc2F)(C(F)F)[C@H]2C[C@H]2O1";"IC50";"'='";"117000.0";"nM";"";"Outside typical range";"316033";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688695";"";"None";"397.39";"0";"2.71";"BDBM171635";"Cc1ccc(NC(=O)c2ccc(C#N)cn2)cc1[C@@]1(C(F)F)N=C(N)O[C@@H]2C[C@@H]21";"IC50";"'='";"715760.0";"nM";"";"Outside typical range";"316043";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688720";"";"None";"455.23";"0";"3.43";"BDBM171662";"NC1=N[C@](c2cc(NC(=O)c3ccc(Br)cn3)ccc2F)(C(F)F)[C@@H]2C[C@@H]2O1";"IC50";"'='";"1859400.0";"nM";"";"Outside typical range";"316070";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688736";"";"None";"400.36";"0";"2.65";"BDBM171679";"C#Cc1ccc(C(=O)Nc2ccc(F)c([C@@]3(C(F)F)N=C(N)O[C@@H]4C[C@@H]43)c2)nc1";"IC50";"'='";"466880.0";"nM";"";"Outside typical range";"316087";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688737";"";"None";"414.39";"0";"3.04";"BDBM171680";"CC#Cc1ccc(C(=O)Nc2ccc(F)c([C@@]3(C(F)F)N=C(N)O[C@@H]4C[C@@H]43)c2)nc1";"IC50";"'='";"420550.0";"nM";"";"Outside typical range";"316088";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688739";"";"None";"447.83";"0";"2.43";"BDBM171683";"C#CCOc1cnc(C(=O)Nc2cc(F)c(Cl)c([C@@]3(CF)N=C(N)O[C@@H]4C[C@@H]43)c2)cn1";"IC50";"'='";"41000.0";"nM";"4.39";"";"316091";"UO_0000065";"9.80";"0.19";"1.96";"3.93";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688762";"";"None";"393.42";"0";"3.47";"BDBM171708";"COc1cnc2c(Nc3ccc(F)c([C@]4(C)N=C(N)O[C@@H]5C[C@@H]54)c3)nccc2c1";"IC50";"'='";"56550.0";"nM";"4.25";"";"316112";"UO_0000065";"10.80";"0.20";"0.78";"4.49";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688634";"";"None";"426.42";"0";"2.77";"BDBM171569";"CC#CCOc1ccc(C(=O)Nc2ccc(F)c([C@@]3(CF)N=C(N)O[C@@H]4C[C@@H]43)c2)nc1";"IC50";"'='";"303020.0";"nM";"";"Outside typical range";"315978";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688693";"";"None";"391.35";"0";"2.37";"BDBM171632";"Cc1cnc(C(=O)Nc2ccc(F)c([C@@]3(C(F)F)N=C(N)O[C@@H]4C[C@@H]43)c2)cn1";"IC50";"'='";"1164700.0";"nM";"";"Outside typical range";"316041";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3683864";"";"None";"449.36";"0";"2.21";"BDBM171477";"C#CCOc1cnc(C(=O)Nc2cc(F)c(F)c([C@@]3(C(F)F)N=C(N)O[C@@H]4C[C@@H]43)c2)cn1";"IC50";"'='";"1001000.0";"nM";"";"Outside typical range";"315886";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3683873";"";"None";"424.35";"0";"2.81";"BDBM171487";"COc1ccc(C(=O)Nc2cc(F)c(F)c([C@@]3(C(F)F)N=C(N)O[C@@H]4C[C@@H]43)c2)nc1";"IC50";"'='";"206000.0";"nM";"";"Outside typical range";"315896";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3683907";"";"None";"441.84";"0";"3.70";"BDBM171527";"CC(C)n1cc(Cl)c(C(=O)Nc2ccc(F)c([C@@]3(C(F)F)N=C(N)O[C@@H]4C[C@@H]43)c2)n1";"IC50";"'='";"294980.0";"nM";"";"Outside typical range";"315936";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688610";"";"None";"406.39";"0";"3.20";"BDBM171544";"N#Cc1csc(C(=O)Nc2ccc(F)c([C@@]3(C(F)F)N=C(N)O[C@@H]4C[C@@H]43)c2)c1";"IC50";"'='";"534110.0";"nM";"";"Outside typical range";"315953";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688614";"";"None";"454.43";"0";"2.07";"BDBM171548";"CS(=O)(=O)c1ccc(C(=O)Nc2ccc(F)c([C@@]3(C(F)F)N=C(N)O[C@@H]4C[C@@H]43)c2)nc1";"IC50";"'='";"565490.0";"nM";"";"Outside typical range";"315957";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688642";"";"None";"461.68";"0";"4.49";"BDBM171577";"NC1=N[C@@](c2cc(NC(=O)c3ncc(Cl)cc3Cl)ccc2Cl)(C(F)F)[C@H]2C[C@H]2O1";"IC50";"'>'";"400000.0";"nM";"";"Outside typical range";"315986";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL508663";"";"None";"606.69";"2";"5.38";"18b";"CCc1cn(C)c2c(N3CCCC3=O)cc(C(=O)N[C@@H](Cc3ccccc3)[C@H](O)CNCc3cccc(C(F)(F)F)c3)cc12";"IC50";"'='";"3720.0";"nM";"5.43";"";"";"UO_0000065";"8.95";"0.17";"0.05";"6.27";"0";"CHEMBL1036847";"Inhibition of cathepsin-D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1137769";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL426717";"";"None";"571.67";"1";"3.85";"5";"C[C@@H](NC(=O)c1cc(OCC(=O)NCCCCCN)cc(OS(=O)(=O)Cc2ccccc2)c1)c1ccc(F)cc1";"IC50";"'>'";"500000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL918067";"Inhibition of Cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149241";"1";"Scientific Literature";"J Med Chem";"2004";"None";"";"";""
"CHEMBL1824341";"";"None";"420.49";"0";"3.16";"44";"CC(C)CCn1cc(C2(c3cccc(-c4cccnc4F)c3)N=C(N)N(C)C2=O)cn1";"IC50";"'='";"830.0";"nM";"6.08";"";"";"UO_0000065";"14.46";"0.27";"2.92";"6.80";"0";"CHEMBL1825607";"Inhibition of cathepsin D by FRET assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1821667";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL1824346";"";"None";"349.42";"0";"2.24";"49";"CN1C(=O)C(c2ccsc2)(c2cccc(-c3cncnc3)c2)N=C1N";"IC50";"'='";"26400.0";"nM";"4.58";"";"";"UO_0000065";"13.10";"0.25";"2.34";"5.42";"0";"CHEMBL1825607";"Inhibition of cathepsin D by FRET assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1821667";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL403819";"";"None";"434.58";"0";"3.44";"10b";"N/C(=N/C(=O)Cn1c(-c2ccccc2)ccc1C12CC3CC(CC(C3)C1)C2)NCCCO";"IC50";"'='";"19400.0";"nM";"4.71";"";"";"UO_0000065";"10.84";"0.20";"1.27";"5.09";"0";"CHEMBL855558";"Inhibition of cathepsin D by FRET based peptide cleavage assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1137408";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";"";""
"CHEMBL2349481";"";"None";"349.39";"0";"1.74";"51, rac-51";"CN1C(=O)C2(CC(C)(C)C(=O)c3ccc(-c4cncnc4)cc32)N=C1N";"IC50";"'='";"9034.0";"nM";"5.04";"";"";"UO_0000065";"14.44";"0.26";"3.30";"4.97";"0";"CHEMBL2352017";"Inhibition of human spleen cathepsin D using 5-FAM/QXL as peptide substrate after 1 hr by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"CHEMBL3559722";"Spleen";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346596";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL2349505";"";"None";"404.39";"0";"3.31";"35, rac-35";"CN1C(=O)C2(CC(C)(C)Oc3ccc(-c4cncc(C(F)(F)F)c4)cc32)N=C1N";"IC50";"'='";"2069.0";"nM";"5.68";"";"";"UO_0000065";"14.06";"0.27";"2.37";"7.03";"0";"CHEMBL2352017";"Inhibition of human spleen cathepsin D using 5-FAM/QXL as peptide substrate after 1 hr by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"CHEMBL3559722";"Spleen";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346596";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL2349613";"";"None";"360.42";"0";"2.77";"13, rac-13";"CN1C(=O)C2(CC(C)(C)Oc3ccc(-c4cccc(C#N)c4)cc32)N=C1N";"IC50";"'='";"1176.0";"nM";"5.93";"";"";"UO_0000065";"16.45";"0.30";"3.16";"6.47";"0";"CHEMBL2352017";"Inhibition of human spleen cathepsin D using 5-FAM/QXL as peptide substrate after 1 hr by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"CHEMBL3559722";"Spleen";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346596";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL4648644";"";"None";"297.42";"0";"1.13";"20";"CCCCC(=O)N[C@@H]1C[C@H]1[C@]12COC[C@H]1CSC(N)=N2";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4614137";"Inhibition of human cathepsin D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4613225";"1";"Scientific Literature";"Bioorg Med Chem";"2020";"None";"";"";""
"CHEMBL1258002";"";"None";"434.53";"0";"2.89";"11";"CC(=O)N[C@@H](Cc1cc(F)cc(F)c1)[C@H](O)CNC1(c2cnn(CC(C)(C)C)c2)CC1";"IC50";"'='";"720.0";"nM";"6.14";"";"";"UO_0000065";"14.14";"0.27";"3.25";"7.76";"1";"CHEMBL1274834";"Inhibition of cathepsin-D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1268878";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL598290";"";"None";"417.49";"0";"3.44";"S-39";"CCc1cc([C@]2(c3cccc(-c4cccnc4F)c3)N=C(N)N(C)C2=O)cc(CC)n1";"IC50";"'='";"54000.0";"nM";"4.27";"";"";"UO_0000065";"10.22";"0.19";"0.83";"5.05";"0";"CHEMBL1071582";"Inhibition of human cathepsin D by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1159096";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL169";"URSOLIC ACID";"2.0";"456.71";"1";"7.09";"4";"C[C@H]1[C@H](C)CC[C@]2(C(=O)O)CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@H]12";"IC50";"'='";"18200.0";"nM";"4.74";"";"";"UO_0000065";"10.38";"0.20";"-2.35";"8.24";"0";"CHEMBL3072144";"Inhibition of cathepsin D (unknown origin) using hemoglobin as substrate after 30 min by spectrophotometric analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3045990";"1";"Scientific Literature";"Med Chem Res";"2013";"None";"";"";""
"CHEMBL2048061";"";"None";"628.49";"1";"4.28";"62g";"Nc1c(F)cc(C[C@@H]2CS(=O)(=O)C[C@H](NCc3cccc(OC(F)(F)F)c3)[C@H]2O)cc1OC(C(F)(F)F)C(F)(F)F";"IC50";"'='";"2530.0";"nM";"5.60";"";"";"UO_0000065";"8.91";"0.19";"1.32";"5.05";"0";"CHEMBL2049562";"Inhibition of human recombinant CatD using Mca-GKPILFFRLK(DNP)-dR-NH2 as substrate after 1 hr by fluorescence analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2046351";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL296588";"PEPSTATIN";"2.0";"685.90";"2";"1.47";"Pepstatin A";"CC(C)CC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)[C@@H](O)CC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)[C@@H](O)CC(=O)O)C(C)C)C(C)C";"IC50";"'='";"0.173";"nM";"9.76";"";"";"UO_0000065";"14.23";"0.28";"8.29";"4.37";"0";"CHEMBL1043695";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156023";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL1093388";"";"None";"501.71";"1";"3.74";"10";"CCCCNC(=O)[C@H](C)C[C@H](O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCC[C@H](C(C)(C)NC(C)=O)C1";"IC50";"'='";"240.0";"nM";"6.62";"";"";"UO_0000065";"13.19";"0.25";"2.88";"6.16";"0";"CHEMBL1107841";"Inhibition of Cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1155410";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL3957241";"";"None";"635.89";"1";"4.91";"BDBM232280";"CCc1cccc(CC)c1NC(=O)C[C@H](N)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)CC(C)C)C(C)C";"IC50";"'='";"230.0";"nM";"6.64";"";"405054";"UO_0000065";"10.44";"0.20";"1.73";"4.66";"0";"CHEMBL3888498";"In-Vitro Fluorescence Assay: In order to identify modulators of cathepsin D activity, a continuous enzymatic test was carried out with a synthetic peptide which carries a fluorescent group (MCA=(7-methoxycoumarin-4-yl)acetyl) which is quenched by energy transfer from a Dpn (2,4 dinitrophenyl) group on the same molecule, in Greiner 384-well nb microtitre plates. Cleavage of the peptidic substrate by cathepsin D causes an increase in the fluorescence intensity. In order to determine the efficacy of substances, the time-dependent increase in the fluorescence intensity in the presence of the substance was compared with the time-dependent increase in fluorescence in the absence of substances. The reference substance used was pepstatin A (Sigma-Aldrich). The substrate used was MCAGKPILFFRLK(Dnp)d-R-NH2 (Enzo Life Sciences, Lorrach). The enzyme employed was cathepsin D isolated from the human liver (Sigma-Aldrich) in a final concentration of 1.4 nM. The test was carried out in 100 mM sodium acetate buffer, 1.25% (v/v) of DMSO, 0.25% (w/v) of Chaps, pH 5.5. 2 ul of each substance solution with serially diluted substance concentration were added to in each case 4 ul of cathepsin D solution and incubated at room temperature for 10 min. The reaction was started by addition of 2 ul of substrate solution (final concentration 5 uM). After carrying out a starting-point fluorescence measurement (excitation wavelength 340 nm/emission wavelength 450 nm) using an Envision multilabel reader (Perkin Elmer), the reaction was incubated at room temperature for 60 min. The amount of peptide fragment cleaved off during the reaction time was subsequently measured by determination of the increase in the fluorescence intensity at 450 nm (excitation wavelength 340 nm).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886733";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL85889";"";"None";"604.11";"2";"7.70";"10";"CCOc1ccc2nc(Sc3ccc(NC(=O)c4cc(Cl)ccc4NC(=O)c4ccccc4C(=O)O)cc3)sc2c1";"IC50";"'='";"3800.0";"nM";"5.42";"";"";"UO_0000065";"8.97";"0.18";"-2.28";"4.61";"0";"CHEMBL657347";"Inhibitory activity against human liver Cathepsin D using Cathepsin D assay.";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1132101";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1999";"None";"";"";""
"CHEMBL3688704";"";"None";"429.84";"0";"2.29";"BDBM171645";"C#CCOc1cnc(C(=O)Nc2ccc(Cl)c([C@@]3(CF)N=C(N)O[C@@H]4C[C@@H]43)c2)cn1";"IC50";"'='";"123500.0";"nM";"";"Outside typical range";"316053";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688765";"";"None";"432.83";"0";"4.73";"BDBM171711";"NC1=C[C@@](CF)(c2cc(Nc3nccc4cc(Cl)cnc34)cc(F)c2F)[C@@H]2C[C@@H]2O1";"IC50";"'='";"2885600.0";"nM";"";"Outside typical range";"316115";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL325739";"";"None";"708.86";"2";"3.97";"2";"COc1ccc(CN[C@@H](C(=O)NC2c3ccccc3C[C@H]2O)[C@H](O)[C@H](Cc2ccccc2)NC(=O)[C@@H](NC(=O)OCc2ccccc2)C(C)C)cc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL662648";"The compound was tested for inhibition of Human Cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1129607";"1";"Scientific Literature";"J Med Chem";"1996";"None";"";"";""
"CHEMBL3683844";"";"None";"417.80";"0";"2.90";"BDBM171454";"N#Cc1ccc(C(=O)Nc2cc(Cl)c(F)c([C@@]3(CF)N=C(N)O[C@@H]4C[C@@H]43)c2)nc1";"IC50";"'='";"301500.0";"nM";"";"Outside typical range";"315863";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3683904";"";"None";"423.81";"0";"2.43";"BDBM171522";"COc1cnc(C(=O)Nc2cc(F)c(Cl)c([C@@]3(CF)N=C(N)O[C@@H]4C[C@@H]43)c2)cn1";"IC50";"'='";"896760.0";"nM";"";"Outside typical range";"315931";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688618";"";"None";"407.35";"0";"2.07";"BDBM171553";"COc1ccc(C(=O)Nc2ccc(F)c([C@@]3(C(F)F)N=C(N)O[C@@H]4C[C@@H]43)c2)nn1";"IC50";"'='";"667110.0";"nM";"";"Outside typical range";"315962";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL85682";"";"None";"441.34";"1";"6.65";"22";"O=C(Nc1ccc(Sc2ccc3ccccc3n2)cc1)c1cc(Cl)cc(Cl)c1O";"IC50";"'='";"2500.0";"nM";"5.60";"";"";"UO_0000065";"12.69";"0.26";"-1.05";"9.00";"0";"CHEMBL657347";"Inhibitory activity against human liver Cathepsin D using Cathepsin D assay.";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1132101";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1999";"None";"";"";""
"CHEMBL314030";"";"None";"682.03";"2";"8.53";"43";"CCOc1ccc2nc(Sc3ccc(NC(=O)c4cc(Cl)ccc4OS(=O)(=O)c4cc(Cl)cc(Cl)c4O)cc3)sc2c1";"IC50";"'='";"700.0";"nM";"6.16";"";"";"UO_0000065";"9.02";"0.20";"-2.38";"5.36";"0";"CHEMBL657347";"Inhibitory activity against human liver Cathepsin D using Cathepsin D assay.";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1132101";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1999";"None";"";"";""
"CHEMBL1824141";"";"None";"389.46";"0";"2.17";"35";"CCCCn1cc(C2(c3cccc(-c4cncnc4)c3)N=C(N)N(C)C2=O)cn1";"IC50";"'='";"11900.0";"nM";"4.92";"";"";"UO_0000065";"12.64";"0.23";"2.75";"4.81";"0";"CHEMBL1825607";"Inhibition of cathepsin D by FRET assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1821667";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL4637568";"";"None";"336.39";"0";"0.79";"3";"NC1=N[C@@]2([C@H]3C[C@@H]3NC(=O)c3ccc(F)cn3)COC[C@H]2CS1";"IC50";"'>'";"300000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4614137";"Inhibition of human cathepsin D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4613225";"1";"Scientific Literature";"Bioorg Med Chem";"2020";"None";"";"";""
"CHEMBL1760856";"";"None";"459.65";"0";"3.96";"20c";"CCCCc1cc(C[C@@H]2CS(=O)(=O)C[C@H](NCc3cccc(C(C)C)c3)[C@H]2O)ccc1O";"IC50";"'='";"1900.0";"nM";"5.72";"";"";"UO_0000065";"12.45";"0.24";"1.76";"6.60";"0";"CHEMBL1764636";"Inhibition of human cathepsin D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1759891";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL1210357";"";"None";"649.14";"1";"4.69";"37";"CS(=O)(=O)N(c1ccncc1)c1cccc(C(=O)N[C@@H](Cc2ccccc2)[C@H](O)CNCc2cccc(C(F)(F)F)c2)c1.Cl";"IC50";"'='";"280.0";"nM";"6.55";"";"";"UO_0000065";"10.70";"0.21";"1.86";"5.87";"0";"CHEMBL1211667";"Inhibition of Cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1208699";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL1210355";"";"None";"625.71";"2";"5.60";"34";"Cc1ccc(C(=O)N[C@@H](Cc2ccccc2)[C@H](O)CNCc2cccc(C(F)(F)F)c2)cc1N(c1ccccc1)S(C)(=O)=O";"IC50";"'='";"2140.0";"nM";"5.67";"";"";"UO_0000065";"9.06";"0.18";"0.07";"5.74";"0";"CHEMBL1211667";"Inhibition of Cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1208699";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL1210341";"";"None";"636.82";"1";"3.92";"20";"COc1ccccc1N(c1cccc(C(=O)N[C@@H](Cc2ccccc2)[C@H](O)CN[C@@H](C)C(=O)NC2CCCCC2)c1)S(C)(=O)=O";"IC50";"'='";"405.0";"nM";"6.39";"";"";"UO_0000065";"10.04";"0.19";"2.47";"4.66";"0";"CHEMBL1211667";"Inhibition of Cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1208699";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL1210339";"";"None";"620.82";"1";"3.64";"14";"C[C@H](NC[C@@H](O)[C@H](Cc1ccccc1)NC(=O)c1cccc(S(=O)(=O)N(C)Cc2ccccc2)c1)C(=O)NC1CCCCC1";"IC50";"'='";"2200.0";"nM";"5.66";"";"";"UO_0000065";"9.11";"0.18";"2.02";"4.43";"0";"CHEMBL1211667";"Inhibition of Cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1208699";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL1210332";"";"None";"612.84";"1";"3.91";"7";"C[C@H](NC[C@@H](O)[C@H](Cc1ccccc1)NC(=O)c1cccc(N(C2CCCCC2)S(C)(=O)=O)c1)C(=O)NC1CCCCC1";"IC50";"'='";"2400.0";"nM";"5.62";"";"";"UO_0000065";"9.17";"0.18";"1.71";"4.40";"0";"CHEMBL1211667";"Inhibition of Cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1208699";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL1210329";"";"None";"606.79";"1";"3.91";"4";"C[C@H](NC[C@@H](O)[C@H](Cc1ccccc1)NC(=O)c1cccc(N(c2ccccc2)S(C)(=O)=O)c1)C(=O)NC1CCCCC1";"IC50";"'='";"660.0";"nM";"6.18";"";"";"UO_0000065";"10.19";"0.20";"2.27";"4.83";"0";"CHEMBL1211667";"Inhibition of Cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1208699";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL217068";"";"None";"318.38";"0";"2.83";"7a";"N=C(N)NC(=O)Cn1c(-c2ccccc2)ccc1-c1ccccc1";"IC50";"'='";"60000.0";"nM";"4.22";"";"";"UO_0000065";"13.26";"0.24";"1.39";"5.03";"0";"CHEMBL855558";"Inhibition of cathepsin D by FRET based peptide cleavage assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1137408";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";"";""
"CHEMBL212088";"";"None";"561.59";"2";"5.14";"18";"COc1cc(NC(=O)COc2ccc3ccccc3c2C(=O)c2cc(OC)c(OC)c(OC)c2)cc(OC)c1OC";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL869858";"Inhibition of human cathepsin D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149516";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"None";"";"";""
"CHEMBL1258576";"";"None";"450.60";"0";"4.45";"29";"CCc1csc(C2(NC[C@@H](O)[C@H](Cc3cc(F)cc(F)c3)NC(C)=O)CCCCC2)c1";"IC50";"'='";"228.0";"nM";"6.64";"";"";"UO_0000065";"14.74";"0.29";"2.19";"10.82";"0";"CHEMBL1260849";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1255191";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL1257184";"";"None";"493.68";"None";"None";"34";"CC(=O)N[C@@H](Cc1cc(F)cc(F)c1)[C@H](O)CNC1(c2cn(C[Si](C)(C)C)nn2)CCCCC1";"IC50";"'='";"12.0";"nM";"7.92";"";"";"UO_0000065";"16.04";"None";"None";"None";"0";"CHEMBL1260849";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1255191";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL1257532";"";"None";"445.55";"0";"3.64";"57";"CC(=O)N[C@@H](Cc1cc(F)cc(F)c1)[C@H](O)CNC1(c2cncc(CC(C)(C)C)c2)CC1";"IC50";"'='";"530.0";"nM";"6.28";"";"";"UO_0000065";"14.09";"0.27";"2.64";"8.45";"0";"CHEMBL1260849";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1255191";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL1258002";"";"None";"434.53";"0";"2.89";"67";"CC(=O)N[C@@H](Cc1cc(F)cc(F)c1)[C@H](O)CNC1(c2cnn(CC(C)(C)C)c2)CC1";"IC50";"'='";"720.0";"nM";"6.14";"";"";"UO_0000065";"14.14";"0.27";"3.25";"7.76";"0";"CHEMBL1260849";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1255191";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL1258121";"";"None";"435.52";"0";"2.29";"69";"CC(=O)N[C@@H](Cc1cc(F)cc(F)c1)[C@H](O)CNC1(c2cn(CC(C)(C)C)nn2)CC1";"IC50";"'='";"200.0";"nM";"6.70";"";"";"UO_0000065";"15.38";"0.30";"4.41";"7.28";"0";"CHEMBL1260849";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1255191";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL169870";"";"None";"664.85";"1";"3.42";"28";"C=C[C@H]1C[C@@H]([C@H](O)[C@H](CC2CCCCC2)NC(=O)[C@H](Cc2c[nH]cn2)NC(=O)[C@H](Cc2ccccc2)NC(=O)OC(C)(C)C)C(=O)N1C";"IC50";"'='";"250.0";"nM";"6.60";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL657348";"Inhibitory concentration against Cathepsin D";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1125921";"1";"Scientific Literature";"J Med Chem";"1991";"None";"";"";""
"CHEMBL296588";"PEPSTATIN";"2.0";"685.90";"2";"1.47";"pepstatin A";"CC(C)CC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)[C@@H](O)CC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)[C@@H](O)CC(=O)O)C(C)C)C(C)C";"IC50";"'='";"2.3";"nM";"8.64";"";"";"UO_0000065";"12.59";"0.25";"7.17";"3.87";"0";"CHEMBL869858";"Inhibition of human cathepsin D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149516";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"None";"";"";""
"CHEMBL271230";"";"None";"520.67";"1";"2.94";"12";"C[C@H](NC[C@@H](O)[C@H](Cc1ccccc1)NC(=O)c1cccc(N2CCCC2=O)c1)C(=O)NC1CCCCC1";"IC50";"'='";"25630.0";"nM";"4.59";"";"";"UO_0000065";"8.82";"0.17";"1.65";"4.14";"0";"CHEMBL931965";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1143153";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";"";"";""
"CHEMBL84561";"";"None";"447.37";"1";"6.71";"17";"O=C(Nc1ccc(Sc2nc3ccccc3s2)cc1)c1cc(Cl)cc(Cl)c1O";"IC50";"'='";"3000.0";"nM";"5.52";"";"";"UO_0000065";"12.35";"0.27";"-1.19";"8.88";"0";"CHEMBL657347";"Inhibitory activity against human liver Cathepsin D using Cathepsin D assay.";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1132101";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1999";"None";"";"";""
"CHEMBL84317";"";"None";"490.53";"1";"6.82";"35";"CCOc1ccc2nc(Sc3ccc(NC(=O)c4ccc(C(F)(F)F)cc4O)cc3)sc2c1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL657347";"Inhibitory activity against human liver Cathepsin D using Cathepsin D assay.";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1132101";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1999";"None";"";"";""
"CHEMBL1090026";"";"None";"344.38";"0";"1.57";"4k";"CN1C(=O)C(c2ccncc2)(c2cccc(-c3cnccn3)c2)N=C1N";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1115170";"Inhibition of cathepsin D by FRET assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156304";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL2181015";"";"None";"979.19";"3";"0.35";"2";"COC(=O)[C@@H]1CCCN1C(=O)[C@@H](Cc1ccccc1)N(C)C(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)C[C@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(N)=O)N(C)C(=O)[C@@H](NC(=O)[C@H](C)O)C(C)C";"IC50";"'='";"50.0";"nM";"7.30";"";"";"UO_0000065";"7.46";"0.14";"6.95";"2.54";"0";"CHEMBL3816585";"Inhibition of human liver cathepsin D using Mca-Gly-Lys-Pro-Ile-Leu-Phe-Phe-Arg-Leu-Lys-(Dnp)-D-Arg-NH2 as substrate preincubated for 15 mins followed by substrate addition measured every 5 mins for 120 mins by fluorescence analysis";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3813591";"1";"Scientific Literature";"Bioorg Med Chem";"2016";"None";"";"";""
"CHEMBL4760681";"";"None";"723.75";"1";"3.31";"4e";"COc1ccc(CC(=O)NC(=N)N[C@H](Cc2cc3ccccc3s2)C(=O)Nc2cc(S(N)(=O)=O)ccc2C)cc1OC.O=C(O)C(F)(F)F";"IC50";"'='";"123.0";"nM";"6.91";"";"";"UO_0000065";"11.33";"0.22";"3.60";"4.00";"0";"CHEMBL4706202";"Inhibition of human liver Cathepsin D preincubated for 10 mins followed by substrate addition and further incubated for 2 hrs in dark by fluorimetric analysis";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699662";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"TIME = 2.167 hr";"INHIBITOR";""
"CHEMBL501927";"";"None";"648.75";"1";"4.57";"11";"CCNc1cc(C(=O)N[C@@H](Cc2ccccc2)[C@H](O)CNCc2cccc(C(F)(F)F)c2)cc(N2CCCCS2(=O)=O)c1OC";"IC50";"'='";"600.0";"nM";"6.22";"";"";"UO_0000065";"9.59";"0.19";"1.65";"5.18";"0";"CHEMBL1036847";"Inhibition of cathepsin-D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1137769";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL401475";"";"None";"606.79";"1";"4.04";"26";"CCNc1cc(C(=O)N[C@@H](Cc2ccccc2)[C@H](O)CNC2CCc3ccc(OC)cc32)cc(N2CCCCS2(=O)=O)c1";"IC50";"'='";"1070.0";"nM";"5.97";"";"";"UO_0000065";"9.84";"0.19";"1.93";"4.98";"1";"CHEMBL1036847";"Inhibition of cathepsin-D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1137769";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL68595";"";"None";"489.62";"1";"5.64";"8d";"CCCc1c(OCc2ccc(/C=C3\SC(=S)NC3=O)cc2)ccc(C(=O)c2ccccc2)c1O";"IC50";"'='";"340.0";"nM";"6.47";"";"";"UO_0000065";"13.21";"0.26";"0.83";"8.55";"0";"CHEMBL658685";"In vitro inhibition of cathepsin D.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1129769";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1996";"None";"";"";""
"CHEMBL4565858";"";"None";"425.61";"0";"2.80";"6";"CC(C)C[C@@H]1NC(=O)CCCCCCCCCCCNC(=O)[C@H](C)NC(=O)C[C@@H]1O";"IC50";"'='";"310.0";"nM";"6.51";"";"";"UO_0000065";"15.29";"0.30";"3.71";"6.05";"0";"CHEMBL4325791";"Inhibition of human placenta CatD using Abz-Lys-Pro-Ala-Glu-Phe-Nph-Ala-Leu as substrate preincubated for 10 mins followed by substrate addition and measured by FRET assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4321885";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";""
"CHEMBL1760860";"";"None";"539.49";"1";"3.40";"20g";"CNC(=O)Oc1ccc(C[C@@H]2CS(=O)(=O)C[C@H](NCc3cccc(C(C)C)c3)[C@H]2O)cc1Br";"IC50";"'='";"370.0";"nM";"6.43";"";"";"UO_0000065";"11.92";"0.27";"3.03";"6.14";"0";"CHEMBL1764636";"Inhibition of human cathepsin D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1759891";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL1760866";"";"None";"498.44";"0";"3.05";"22d";"CC(C)Oc1cccc(CN[C@H]2CS(=O)(=O)C[C@@H](Cc3ccc(O)c(Br)c3)[C@@H]2O)c1";"IC50";"'='";"670.0";"nM";"6.17";"";"";"UO_0000065";"12.39";"0.28";"3.12";"6.44";"0";"CHEMBL1764636";"Inhibition of human cathepsin D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1759891";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL1824351";"";"None";"383.86";"0";"2.89";"54";"CN1C(=O)C(c2cccc(-c3cncnc3)c2)(c2csc(Cl)c2)N=C1N";"IC50";"'='";"29920.0";"nM";"4.52";"";"";"UO_0000065";"11.79";"0.24";"1.63";"5.36";"0";"CHEMBL1825607";"Inhibition of cathepsin D by FRET assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1821667";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL3688809";"";"None";"429.40";"0";"3.22";"BDBM171757";"N#Cc1cnc2c(c1)OCC[C@@H]2Nc1ccc(F)c([C@@]2(C(F)F)N=C(N)O[C@@H]3C[C@@H]32)c1";"IC50";"'='";"206000.0";"nM";"";"Outside typical range";"316157";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL1258119";"";"None";"514.66";"2";"5.32";"16";"CC(=O)N[C@@H](Cc1cc(F)cc(F)c1)[C@H](O)CNC1(c2cc(C(C)=O)cc(C(C)(C)C)c2)CCCCC1";"IC50";"'='";"45.0";"nM";"7.35";"";"";"UO_0000065";"14.28";"0.27";"2.03";"9.37";"0";"CHEMBL1260849";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1255191";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL1271343";"";"None";"331.32";"0";"2.32";"32";"CN1C(=O)[C@](c2ccccc2)(c2ccc(OC(F)F)cc2)N=C1N";"IC50";"'='";"53000.0";"nM";"4.28";"";"";"UO_0000065";"12.91";"0.24";"1.96";"6.30";"0";"CHEMBL1273977";"Inhibition of cathepsin D by FRET assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1268920";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL1271451";"";"None";"349.31";"0";"2.62";"36";"CN1C(=O)[C@](c2ccccc2)(c2ccc(OC(F)(F)F)cc2)N=C1N";"IC50";"'='";"31560.0";"nM";"4.50";"";"";"UO_0000065";"12.89";"0.25";"1.88";"6.63";"0";"CHEMBL1273977";"Inhibition of cathepsin D by FRET assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1268920";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL1271245";"";"None";"397.43";"0";"3.33";"64";"CC(C)C#Cc1cccc([C@@]2(c3ccc(OC(F)F)cc3)N=C(N)N(C)C2=O)c1";"IC50";"'='";"4800.0";"nM";"5.32";"";"";"UO_0000065";"13.38";"0.25";"1.99";"7.83";"0";"CHEMBL1273977";"Inhibition of cathepsin D by FRET assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1268920";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL1270432";"";"None";"427.43";"0";"3.53";"85";"Cc1cc([C@]2(c3ccc(F)c(C#CC4CC4)c3)N=C(N)N(C)C2=O)ccc1OC(F)F";"IC50";"'='";"1800.0";"nM";"5.75";"";"";"UO_0000065";"13.44";"0.25";"2.21";"8.46";"0";"CHEMBL1273977";"Inhibition of cathepsin D by FRET assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1268920";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL1270630";"";"None";"409.44";"0";"3.39";"92";"Cc1cc([C@]2(c3cccc(C#CC4CC4)c3)N=C(N)N(C)C2=O)ccc1OC(F)F";"IC50";"'='";"2000.0";"nM";"5.70";"";"";"UO_0000065";"13.92";"0.26";"2.31";"8.39";"0";"CHEMBL1273977";"Inhibition of cathepsin D by FRET assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1268920";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL1091463";"";"None";"378.38";"0";"3.06";"4h";"CN1C(=O)C(c2ccncc2)(c2cccc(-c3cc(F)cc(F)c3)c2)N=C1N";"IC50";"'='";"34100.0";"nM";"4.47";"";"";"UO_0000065";"11.81";"0.22";"1.41";"6.24";"0";"CHEMBL1115170";"Inhibition of cathepsin D by FRET assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156304";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL1258467";"";"None";"492.68";"1";"5.47";"22";"CC(=O)N[C@@H](Cc1cc(F)cc(F)c1)[C@H](O)CNC1(c2cc(CC(C)(C)C)cs2)CCCCC1";"IC50";"'='";"9.0";"nM";"8.05";"";"";"UO_0000065";"16.33";"0.32";"2.58";"13.11";"0";"CHEMBL1260849";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1255191";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL1257302";"";"None";"474.60";"0";"3.91";"59";"CC(=O)N[C@@H](Cc1cc(F)cc(F)c1)[C@H](O)CNC1(c2cc(C(C)(C)C)ncn2)CCCCC1";"IC50";"'='";"245.0";"nM";"6.61";"";"";"UO_0000065";"13.93";"0.27";"2.70";"7.59";"0";"CHEMBL1260849";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1255191";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL558582";"";"None";"566.77";"1";"4.00";"38";"CCc1cn2c3c(cc(C(=O)N[C@@H](Cc4ccccc4)[C@H](O)CNC4CCCCC4)cc13)N(CC)S(=O)(=O)CC2";"IC50";"'='";"150.0";"nM";"6.82";"";"";"UO_0000065";"12.04";"0.23";"2.82";"6.58";"0";"CHEMBL1035560";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1158445";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL3707005";"";"None";"500.67";"1";"2.28";"20";"CCNc1cc(C(=O)N[C@@H](Cc2ccccc2)[C@H](O)CNC2CC2)cc2c1CCCS(=O)(=O)N2C";"IC50";"'='";"8150.0";"nM";"5.09";"";"";"UO_0000065";"10.16";"0.20";"2.81";"4.59";"0";"CHEMBL1035560";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1158445";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL355128";"";"None";"638.81";"1";"2.87";"8c";"CN1CC[C@@H]([C@H](O)[C@H](CC2CCCCC2)NC(=O)[C@H](Cc2c[nH]cn2)NC(=O)[C@H](Cc2ccccc2)NC(=O)OC(C)(C)C)C1=O";"IC50";"'='";"600.0";"nM";"6.22";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL657351";"Inhibitory concentration against cathepsin D";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1125921";"1";"Scientific Literature";"J Med Chem";"1991";"None";"";"";""
"CHEMBL461602";"";"None";"467.70";"0";"3.78";"3h";"CCCCNC(=O)[C@H](C)C[C@H](O)[C@@H]1C[C@H](C)CCCCCCCCC(=O)N(C)[C@@H](C)C(=O)N1";"IC50";"'='";"8.1";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL963292";"Inhibition of human cathepsin D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1153267";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL3683814";"";"None";"425.80";"0";"3.02";"BDBM171420";"Cc1ncc(Cl)nc1C(=O)Nc1ccc(F)c([C@]2(C(F)F)N=C(N)O[C@H]3C[C@H]32)c1";"IC50";"'='";"459520.0";"nM";"";"Outside typical range";"315829";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3683823";"";"None";"435.79";"0";"3.19";"BDBM171432";"N#Cc1cnc(C(=O)Nc2ccc(F)c([C@@]3(C(F)F)N=C(N)O[C@@H]4C[C@@H]43)c2)c(Cl)c1";"IC50";"'='";"825020.0";"nM";"";"Outside typical range";"315841";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3683922";"";"None";"395.41";"0";"3.64";"BDBM171542";"Cc1csc(C(=O)Nc2ccc(F)c([C@@]3(C(F)F)N=C(N)O[C@@H]4C[C@@H]43)c2)c1";"IC50";"'='";"834710.0";"nM";"";"Outside typical range";"315951";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL254485";"";"None";"586.73";"1";"2.90";"22";"CCNc1cc(C(=O)N[C@@H](Cc2ccccc2)[C@H](O)CNCc2cnn(CC)c2)c(F)c(N2CCCCS2(=O)=O)c1";"IC50";"'='";"87100.0";"nM";"4.06";"";"";"UO_0000065";"6.92";"0.14";"1.16";"3.16";"0";"CHEMBL945838";"Inhibition of Cathepsin D expressed in CHO cells by FRET assay";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140838";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"CHEMBL3308072";"";"";""
"CHEMBL409753";"";"None";"634.72";"1";"4.44";"11";"CCNc1cc(C(=O)N[C@@H](Cc2ccccc2)[C@H](O)CNCc2cccc(OC(F)(F)F)c2)cc(N2CCCCS2(=O)=O)c1";"IC50";"'='";"2570.0";"nM";"5.59";"";"";"UO_0000065";"8.81";"0.17";"1.15";"4.66";"0";"CHEMBL945838";"Inhibition of Cathepsin D expressed in CHO cells by FRET assay";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140838";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"CHEMBL3308072";"";"";""
"CHEMBL409752";"";"None";"635.71";"1";"4.41";"10";"CCOc1cc(C(=O)N[C@@H](Cc2ccccc2)[C@H](O)CNCc2cccc(OC(F)(F)F)c2)cc(N2CCCCS2(=O)=O)c1";"IC50";"'='";"6170.0";"nM";"5.21";"";"";"UO_0000065";"8.20";"0.16";"0.80";"4.45";"0";"CHEMBL945838";"Inhibition of Cathepsin D expressed in CHO cells by FRET assay";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140838";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"CHEMBL3308072";"";"";""
"CHEMBL254272";"";"None";"570.71";"1";"3.14";"18";"CCNc1cc(C(=O)N[C@@H](Cc2ccco2)[C@H](O)CNCc2cccc(OC)c2)cc(N2CCCCS2(=O)=O)c1";"IC50";"'='";"15140.0";"nM";"4.82";"";"";"UO_0000065";"8.45";"0.16";"1.68";"3.62";"0";"CHEMBL945838";"Inhibition of Cathepsin D expressed in CHO cells by FRET assay";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140838";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"CHEMBL3308072";"";"";""
"CHEMBL401473";"";"None";"618.72";"1";"4.56";"7";"CCNc1cc(C(=O)N[C@@H](Cc2ccccc2)[C@H](O)CNCc2cccc(C(F)(F)F)c2)cc(N2CCCCS2(=O)=O)c1";"IC50";"'='";"3900.0";"nM";"5.41";"";"";"UO_0000065";"8.74";"0.17";"0.85";"4.88";"0";"CHEMBL945838";"Inhibition of Cathepsin D expressed in CHO cells by FRET assay";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140838";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"CHEMBL3308072";"";"";""
"CHEMBL264110";"";"None";"605.68";"1";"4.14";"5";"CCOc1cc(C(=O)N[C@@H](Cc2ccccc2)[C@H](O)CNCc2cccc(C(F)(F)F)c2)cc(N2CCCS2(=O)=O)c1";"IC50";"'='";"8510.0";"nM";"5.07";"";"";"UO_0000065";"8.37";"0.16";"0.93";"4.70";"0";"CHEMBL945838";"Inhibition of Cathepsin D expressed in CHO cells by FRET assay";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140838";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"CHEMBL3308072";"";"";""
"CHEMBL191122";"";"None";"642.75";"2";"-1.42";"5";"CC(C)C[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CCC(=O)O)C(C)C)[C@@H](O)[C@@H]1CCC[C@H]1C(=O)N[C@@H](C)C(=O)O";"IC50";"'='";"6000.0";"nM";"5.22";"";"";"UO_0000065";"8.12";"0.16";"6.64";"1.86";"0";"CHEMBL828480";"Inhibitory concentration against human Cathepsin D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1145163";"1";"Scientific Literature";"J Med Chem";"2005";"None";"";"";""
"CHEMBL191123";"";"None";"598.81";"2";"1.84";"34";"C=C1C[C@@H]([C@H](O)[C@H](CC(C)C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(C)C)NC(C)=O)[C@H](C(=O)N[C@@H](C)C(=O)O)C1";"IC50";"'='";"430.0";"nM";"6.37";"";"";"UO_0000065";"10.63";"0.21";"4.53";"3.66";"0";"CHEMBL828480";"Inhibitory concentration against human Cathepsin D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1145163";"1";"Scientific Literature";"J Med Chem";"2005";"None";"";"";""
"CHEMBL3913444";"";"None";"489.81";"1";"5.14";"BDBM214967";"NC1=N[C@](CF)(c2cc(Nc3nccc4cc(Cl)cnc34)cc(F)c2F)C[C@@H](C(F)(F)F)O1";"IC50";"'>'";"400000.0";"nM";"";"Outside typical range";"378001";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3922335";"";"None";"478.81";"0";"4.16";"BDBM214976";"COc1cnc(C(=O)Nc2cc(F)c(F)c([C@]3(C)C[C@@H](C(F)(F)F)OC(N)=N3)c2)c(Cl)c1";"IC50";"'>'";"400000.0";"nM";"";"Outside typical range";"378010";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3923385";"";"None";"483.22";"0";"4.80";"BDBM214979";"C[C@@]1(c2cc(NC(=O)c3ncc(Cl)cc3Cl)cc(F)c2F)C[C@@H](C(F)(F)F)OC(N)=N1";"IC50";"'='";"394000.0";"nM";"";"Outside typical range";"378013";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL252754";"";"None";"504.69";"1";"3.11";"21";"COc1cccc(CNC[C@@H](O)[C@H](Cc2ccccc2)NC(=O)CCCS(=O)(=O)CCC(C)C)c1";"IC50";"'>'";"20000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL942098";"Inhibition of human recombinant cathepsin D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140593";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"None";"";"";""
"CHEMBL252549";"";"None";"434.56";"0";"1.31";"20";"COc1cccc(CNC[C@@H](O)[C@H](Cc2ccccc2)NC(=O)CCS(C)(=O)=O)c1";"IC50";"'='";"7593.0";"nM";"5.12";"";"";"UO_0000065";"11.78";"0.23";"3.81";"4.89";"0";"CHEMBL942098";"Inhibition of human recombinant cathepsin D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140593";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"None";"";"";""
"CHEMBL256399";"";"None";"606.81";"1";"4.51";"19";"CCCCCOc1cc(C(=O)N[C@@H](Cc2ccccc2)[C@H](O)CN[C@@H](C)C(=O)NC2CCCCC2)cc(N2CCCC2=O)c1";"IC50";"'='";"430.0";"nM";"6.37";"";"";"UO_0000065";"10.49";"0.20";"1.86";"5.31";"0";"CHEMBL931965";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1143153";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";"";"";""
"CHEMBL1090146";"";"None";"410.52";"0";"4.99";"34";"CCCNC(=O)c1ccc(-c2ccc(-c3ccccc3)n2Cc2cccc(N)n2)cc1";"IC50";"'='";"44300.0";"nM";"4.35";"";"";"UO_0000065";"10.61";"0.19";"-0.64";"5.97";"0";"CHEMBL1108758";"Inhibition of cathepsin D by FRET assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156953";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL396765";"";"None";"610.70";"1";"3.83";"19d";"CCCN(CCC)C(=O)c1cc(C(N)=O)cc(C(=O)N[C@@H](Cc2cc(F)cc(F)c2)[C@H](O)CNCc2cccc(OC)c2)c1";"IC50";"'='";"2400.0";"nM";"5.62";"";"";"UO_0000065";"9.20";"0.17";"1.79";"4.19";"0";"CHEMBL888969";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1144655";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"None";"";"";""
"CHEMBL94762";"";"None";"701.91";"2";"2.84";"38";"NC1CCN(C(=O)C[C@@H](Cc2ccccc2)C(=O)N[C@@H](Cc2c[nH]cn2)C(=O)N[C@@H](CC2CCCCC2)[C@@H](O)[C@@H](O)CCc2ccccn2)CC1";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL657355";"Selectivity against human cathepsin D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1127052";"1";"Scientific Literature";"J Med Chem";"1993";"None";"";"";""
"CHEMBL3586133";"";"None";"438.86";"0";"3.10";"31.TFA";"NC1=NC2CCC(OC(=O)c3cccc(Cl)c3)CC2CS1.O=C(O)C(F)(F)F";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3588066";"Inhibition of human cathepsin D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3585284";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL3586132";"";"None";"402.35";"0";"2.44";"(+/-)-8.HCl";"Cl.NC1=NC23CCC(NC(=O)c4cccc(Cl)c4)CC2(COC3)CS1";"IC50";"'='";"277000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3588066";"Inhibition of human cathepsin D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3585284";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL461606";"";"None";"487.75";"0";"3.49";"1";"CCCCNC(=O)[C@H](C)C[C@H](O)[C@H](CC(C)C)NC(=O)[C@H](CCSC)NC(=O)CCC(C)C";"IC50";"'='";"370.0";"nM";"6.43";"";"";"UO_0000065";"13.19";"0.27";"2.94";"5.98";"0";"CHEMBL963292";"Inhibition of human cathepsin D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1153267";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL3688710";"";"None";"443.87";"0";"2.68";"58";"CC#CCOc1cnc(C(=O)Nc2ccc(Cl)c([C@@]3(CF)N=C(N)O[C@@H]4C[C@@H]43)c2)cn1";"IC50";"'='";"1835.0";"nM";"5.74";"";"";"UO_0000065";"12.92";"0.25";"3.06";"5.13";"0";"CHEMBL4342626";"Inhibition of recombinant Cathepsin D (unknown origin) expressed in CHO cells preincubated for 1 hr followed by substrate addition and measured after 1 hr by FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4342403";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"CHEMBL3308072";"";"";""
"CHEMBL4447037";"";"None";"750.83";"2";"7.26";"(S,R)-2e";"COc1cccc(C(C)(C)NC[C@@H](O)[C@H](Cc2ccccc2)NC(=O)c2cc(C(=O)N(CCC(F)(F)F)CCC(F)(F)F)cc(N3CCCCC3)c2)c1";"IC50";"'='";"120.0";"nM";"6.92";"";"";"UO_0000065";"9.22";"0.18";"-0.34";"7.35";"0";"CHEMBL4331648";"Inhibition of human cathepsin D using DABCYL-Glu-Arg-Nle-Phe-Leu-Ser-Phe-Pro-EDANS as substrate preincubated for 30 mins followed by substrate addition and measured every min for 8 to 15 mins by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4330085";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";"";"";""
"CHEMBL4163078";"";"None";"1134.43";"None";"None";"3";"CC[C@H](C)[C@H](NC(=O)C[C@H](O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)N(C)C(=O)[C@H](CC(C)C)NC(=O)[C@H](C)OC(=O)[C@H](Cc1ccccc1)N(C)C)C(=O)N[C@@H](C)C(=O)N(C)[C@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)OC";"IC50";"'='";"50.0";"nM";"7.30";"";"";"UO_0000065";"6.44";"None";"None";"None";"0";"CHEMBL4141000";"Inhibition of human liver cathepsin D using Mca-Gly-Lys-Pro-Ile-Leu-PhePhe-Arg-Leu-Lys-(Dnp)-D-Arg-NH2 as substrate pretreated for 15 mins followed by substrate addition measured at 5 mins interval for 120 mins by fluorescence assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4138143";"1";"Scientific Literature";"J Nat Prod";"2017";"None";"";"";""
"CHEMBL217068";"";"None";"318.38";"0";"2.83";"3.a.1";"N=C(N)NC(=O)Cn1c(-c2ccccc2)ccc1-c1ccccc1";"IC50";"'='";"60000.0";"nM";"4.22";"";"";"UO_0000065";"13.26";"0.24";"1.39";"5.03";"1";"CHEMBL944849";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140831";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";"";"";""
"CHEMBL430400";"";"None";"506.69";"1";"4.26";"7";"CCNc1cc(C(=O)N[C@@H](Cc2ccccc2)[C@H](O)CNC2CCCCCC2)cc(N2CCCC2=O)c1";"IC50";"'='";"2400.0";"nM";"5.62";"";"";"UO_0000065";"11.09";"0.21";"1.36";"6.00";"0";"CHEMBL945833";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140837";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";"";"";""
"CHEMBL3394046";"";"None";"433.44";"0";"2.81";"17";"NC1=N[C@@]2(CO1)c1cc(-c3cccnc3F)ccc1Oc1cnc(N3CCOCC3)cc12";"IC50";"'='";"600.0";"nM";"6.22";"";"";"UO_0000065";"14.35";"0.27";"3.41";"6.54";"0";"CHEMBL3395116";"Inhibition of cathepsin D (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3393054";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";""
"CHEMBL3394044";"";"None";"432.46";"0";"4.22";"15";"NC1=N[C@@]2(CO1)c1cc(-c3cccnc3F)ccc1Oc1cnc([C@@H]3CCCCO3)cc12";"IC50";"'='";"11600.0";"nM";"4.94";"";"";"UO_0000065";"11.41";"0.21";"0.72";"5.37";"0";"CHEMBL3395116";"Inhibition of cathepsin D (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3393054";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";""
"CHEMBL318803";"";"None";"805.98";"2";"4.53";"1";"COc1ccc(CN[C@@H](C(=O)N[C@H](C(=O)NCc2nc3ccccc3[nH]2)C(C)C)[C@H](O)[C@H](Cc2ccccc2)NC(=O)[C@@H](NC(=O)OCc2ccccc2)C(C)C)cc1";"IC50";"'='";"380.0";"nM";"6.42";"";"";"UO_0000065";"7.97";"0.15";"1.89";"3.28";"1";"CHEMBL662648";"The compound was tested for inhibition of Human Cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1129607";"1";"Scientific Literature";"J Med Chem";"1996";"None";"";"";""
"CHEMBL253237";"";"None";"486.96";"1";"5.48";"7c";"CC(=O)c1ccc(Oc2ccc(-c3ccc(-c4ccccc4Cl)n3CC(=O)NC(=N)N)cc2)cc1";"IC50";"'='";"8200.0";"nM";"5.09";"";"";"UO_0000065";"10.44";"0.20";"-0.39";"4.62";"0";"CHEMBL855558";"Inhibition of cathepsin D by FRET based peptide cleavage assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1137408";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";"";""
"CHEMBL559358";"";"None";"588.23";"1";"3.29";"46";"COCCCOc1cc(C[C@@H](C[C@H](N)[C@@H](O)C[C@H](C(=O)NCC(C)(C)C(N)=O)C(C)C)C(C)C)ccc1OC.Cl";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL895267";"Inhibition human cathepsin D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1148801";"1";"Scientific Literature";"J Med Chem";"2007";"None";"";"";""
"CHEMBL3914230";"";"None";"538.00";"2";"5.13";"BDBM220800";"NC1=NC2(CCS1)c1cc(NC(=O)c3ccc(Cl)cn3)ccc1Oc1c2cc(C2=CCCOC2)nc1F";"IC50";"'='";"217000.0";"nM";"";"Outside typical range";"386486";"UO_0000065";"";"";"";"";"0";"CHEMBL3888270";"Fluorescence Resonance Energy Transfer (FRET) Assay: Recombinant CathepsinD was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The CathepsinD enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for CathepsinD) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886633";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL2031000";"";"None";"497.66";"0";"4.50";"30";"CC(=O)N[C@@H](Cc1ccc(F)cc1)[C@H](O)CN[C@H]1C[C@]2(CC[C@@H]2C)Oc2ncc(CC(C)(C)C)cc21";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"16.68";"0.31";"3.80";"9.94";"0";"CHEMBL2033077";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2029322";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL2031139";"";"None";"497.66";"0";"4.50";"33";"CC(=O)N[C@@H](Cc1ccc(F)cc1)[C@H](O)CN[C@H]1C[C@@]2(CC[C@@H]2C)Oc2ncc(CC(C)(C)C)cc21";"IC50";"'>'";"40000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2033077";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2029322";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL2031144";"";"None";"501.62";"1";"4.20";"38";"CC(=O)N[C@@H](Cc1ccc(F)cc1)[C@H](O)CN[C@H]1C[C@]2(C[C@@H](F)C2)Oc2ncc(CC(C)(C)C)cc21";"IC50";"'='";"8.0";"nM";"8.10";"";"";"UO_0000065";"16.14";"0.31";"3.90";"9.70";"0";"CHEMBL2033077";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2029322";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL2031145";"";"None";"501.62";"1";"4.20";"41";"CC(=O)N[C@@H](Cc1cccc(F)c1)[C@H](O)CN[C@H]1C[C@]2(C[C@H](F)C2)Oc2ncc(CC(C)(C)C)cc21";"IC50";"'='";"22.0";"nM";"7.66";"";"";"UO_0000065";"15.27";"0.29";"3.46";"9.17";"0";"CHEMBL2033077";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2029322";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL3916241";"";"None";"465.42";"0";"4.38";"BDBM214929";"NC1=N[C@](CF)(c2cc(C#Cc3ccc(OC4CCC4)cn3)ccc2F)C[C@@H](C(F)(F)F)O1";"IC50";"'='";"1060000.0";"nM";"";"Outside typical range";"378029";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3896202";"";"None";"448.78";"0";"3.96";"BDBM214802";"NC1=N[C@](CF)(c2cc(NC(=O)c3ccc(Cl)cn3)ccc2F)C[C@@H](C(F)(F)F)O1";"IC50";"'>'";"400000.0";"nM";"";"Outside typical range";"377850";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3920732";"";"None";"462.81";"0";"4.27";"BDBM214803";"Cc1cc(Cl)cnc1C(=O)Nc1ccc(F)c([C@]2(CF)C[C@@H](C(F)(F)F)OC(N)=N2)c1";"IC50";"'>'";"400000.0";"nM";"";"Outside typical range";"377853";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3897411";"";"None";"512.36";"1";"4.24";"BDBM214804";"NC1=N[C@](CF)(c2cc(NC(=O)c3ccc(OCC(F)(F)F)cn3)ccc2F)C[C@@H](C(F)(F)F)O1";"IC50";"'>'";"400000.0";"nM";"";"Outside typical range";"377856";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL568553";"GRASSYSTATIN B";"None";"1188.47";"None";"None";"Grassystatin B";"CC[C@H](NC(=O)[C@@H](NC(=O)C[C@H](O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](OC(=O)[C@@H](OC(=O)[C@H](C(C)C)N(C)C)C(C)C)C(C)C)[C@@H](C)O)C(=O)N(C)[C@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)OC";"IC50";"'='";"7.3";"nM";"8.14";"";"";"UO_0000065";"6.85";"None";"None";"None";"0";"CHEMBL4141000";"Inhibition of human liver cathepsin D using Mca-Gly-Lys-Pro-Ile-Leu-PhePhe-Arg-Leu-Lys-(Dnp)-D-Arg-NH2 as substrate pretreated for 15 mins followed by substrate addition measured at 5 mins interval for 120 mins by fluorescence assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4138143";"1";"Scientific Literature";"J Nat Prod";"2017";"None";"";"";""
"CHEMBL3688738";"";"None";"505.83";"1";"3.67";"BDBM171681";"Cc1nc(OCC(F)(F)F)cnc1C(=O)Nc1cc(F)c(Cl)c([C@@]2(CF)N=C(N)O[C@@H]3C[C@@H]32)c1";"IC50";"'='";"556390.0";"nM";"";"Outside typical range";"316089";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3951015";"";"None";"506.36";"1";"4.76";"BDBM214817";"NC1=N[C@](CF)(c2cc(Nc3nccc4nc(C(F)(F)F)cnc34)ccc2F)C[C@@H](C(F)(F)F)O1";"IC50";"'>'";"14800.0";"nM";"";"";"377965";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3946502";"";"None";"519.45";"2";"5.24";"BDBM214853";"NC1=N[C@](CF)(c2cc(Nc3ncc(F)c4cc(C#CC5CC5)cnc34)ccc2F)C[C@@H](C(F)(F)F)O1";"IC50";"'>'";"133000.0";"nM";"";"Outside typical range";"377967";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3926622";"";"None";"494.40";"0";"4.74";"BDBM214820";"NC1=N[C@](CF)(c2cc(Nc3ncnc4sc(C(F)F)nc34)ccc2F)C[C@@H](C(F)(F)F)O1";"IC50";"'>'";"400000.0";"nM";"";"Outside typical range";"377973";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3901027";"";"None";"459.38";"0";"3.21";"BDBM214980";"COc1cnc(C(=O)Nc2cc(F)c(F)c([C@]3(C)C[C@@H](C(F)(F)F)OC(N)=N3)c2)c(C)n1";"IC50";"'>'";"400000.0";"nM";"";"Outside typical range";"378020";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3938609";"";"None";"433.38";"0";"4.54";"BDBM214934";"NC1=N[C@](CF)(c2cc(C#Cc3cccc4cc[nH]c34)ccc2F)C[C@@H](C(F)(F)F)O1";"IC50";"'='";"1130000.0";"nM";"";"Outside typical range";"378034";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3902895";"";"None";"632.85";"2";"1.54";"BDBM232244";"CC[C@H](NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](Cc1ccccc1)[C@@H](N)CC(=O)N[C@H](C(=O)N[C@H](C(=O)OC)C(C)C)[C@@H](C)CC";"IC50";"'='";"2000.0";"nM";"5.70";"";"405021";"UO_0000065";"9.01";"0.17";"4.16";"2.93";"0";"CHEMBL3888498";"In-Vitro Fluorescence Assay: In order to identify modulators of cathepsin D activity, a continuous enzymatic test was carried out with a synthetic peptide which carries a fluorescent group (MCA=(7-methoxycoumarin-4-yl)acetyl) which is quenched by energy transfer from a Dpn (2,4 dinitrophenyl) group on the same molecule, in Greiner 384-well nb microtitre plates. Cleavage of the peptidic substrate by cathepsin D causes an increase in the fluorescence intensity. In order to determine the efficacy of substances, the time-dependent increase in the fluorescence intensity in the presence of the substance was compared with the time-dependent increase in fluorescence in the absence of substances. The reference substance used was pepstatin A (Sigma-Aldrich). The substrate used was MCAGKPILFFRLK(Dnp)d-R-NH2 (Enzo Life Sciences, Lorrach). The enzyme employed was cathepsin D isolated from the human liver (Sigma-Aldrich) in a final concentration of 1.4 nM. The test was carried out in 100 mM sodium acetate buffer, 1.25% (v/v) of DMSO, 0.25% (w/v) of Chaps, pH 5.5. 2 ul of each substance solution with serially diluted substance concentration were added to in each case 4 ul of cathepsin D solution and incubated at room temperature for 10 min. The reaction was started by addition of 2 ul of substrate solution (final concentration 5 uM). After carrying out a starting-point fluorescence measurement (excitation wavelength 340 nm/emission wavelength 450 nm) using an Envision multilabel reader (Perkin Elmer), the reaction was incubated at room temperature for 60 min. The amount of peptide fragment cleaved off during the reaction time was subsequently measured by determination of the increase in the fluorescence intensity at 450 nm (excitation wavelength 340 nm).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886733";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3961078";"";"None";"744.96";"2";"2.03";"BDBM232251";"CC[C@H](C)[C@H](NC(=O)C[C@H](N)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)Cc1cccc(NS(C)(=O)=O)c1)C(C)C)C(=O)N[C@H](C(=O)OC)C(C)C";"IC50";"'='";"81.0";"nM";"7.09";"";"405028";"UO_0000065";"9.52";"0.19";"5.06";"3.30";"0";"CHEMBL3888498";"In-Vitro Fluorescence Assay: In order to identify modulators of cathepsin D activity, a continuous enzymatic test was carried out with a synthetic peptide which carries a fluorescent group (MCA=(7-methoxycoumarin-4-yl)acetyl) which is quenched by energy transfer from a Dpn (2,4 dinitrophenyl) group on the same molecule, in Greiner 384-well nb microtitre plates. Cleavage of the peptidic substrate by cathepsin D causes an increase in the fluorescence intensity. In order to determine the efficacy of substances, the time-dependent increase in the fluorescence intensity in the presence of the substance was compared with the time-dependent increase in fluorescence in the absence of substances. The reference substance used was pepstatin A (Sigma-Aldrich). The substrate used was MCAGKPILFFRLK(Dnp)d-R-NH2 (Enzo Life Sciences, Lorrach). The enzyme employed was cathepsin D isolated from the human liver (Sigma-Aldrich) in a final concentration of 1.4 nM. The test was carried out in 100 mM sodium acetate buffer, 1.25% (v/v) of DMSO, 0.25% (w/v) of Chaps, pH 5.5. 2 ul of each substance solution with serially diluted substance concentration were added to in each case 4 ul of cathepsin D solution and incubated at room temperature for 10 min. The reaction was started by addition of 2 ul of substrate solution (final concentration 5 uM). After carrying out a starting-point fluorescence measurement (excitation wavelength 340 nm/emission wavelength 450 nm) using an Envision multilabel reader (Perkin Elmer), the reaction was incubated at room temperature for 60 min. The amount of peptide fragment cleaved off during the reaction time was subsequently measured by determination of the increase in the fluorescence intensity at 450 nm (excitation wavelength 340 nm).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886733";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3945386";"";"None";"520.52";"1";"4.52";"BDBM220822";"Cc1nc(C(=O)Nc2ccc3c(c2)C2(CCOC(N)=N2)c2cc(-c4cncc(F)c4)nc(F)c2O3)cs1";"IC50";"'='";"361600.0";"nM";"";"Outside typical range";"386508";"UO_0000065";"";"";"";"";"0";"CHEMBL3888270";"Fluorescence Resonance Energy Transfer (FRET) Assay: Recombinant CathepsinD was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The CathepsinD enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for CathepsinD) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886633";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3955960";"";"None";"525.48";"1";"4.03";"BDBM220835";"N#Cc1ccc(C(=O)Nc2ccc3c(c2)C2(CCOC(N)=N2)c2cc(-c4ccnc(F)c4)nc(F)c2O3)nc1";"IC50";"'='";"517700.0";"nM";"";"Outside typical range";"386521";"UO_0000065";"";"";"";"";"0";"CHEMBL3888270";"Fluorescence Resonance Energy Transfer (FRET) Assay: Recombinant CathepsinD was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The CathepsinD enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for CathepsinD) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886633";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3960345";"";"None";"536.59";"1";"3.51";"BDBM220846";"COc1cnc(C(=O)Nc2ccc3c(c2)C2(CCSC(N)=N2)c2cc(N4CCOCC4)cc(F)c2O3)cn1";"IC50";"'='";"229500.0";"nM";"";"Outside typical range";"386532";"UO_0000065";"";"";"";"";"0";"CHEMBL3888270";"Fluorescence Resonance Energy Transfer (FRET) Assay: Recombinant CathepsinD was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The CathepsinD enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for CathepsinD) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886633";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3917597";"";"None";"596.48";"2";"5.54";"BDBM220857";"Cc1cc(Br)cnc1C(=O)Nc1ccc2c(c1)C1(CCSC(N)=N1)c1cc(C3=CCOCC3)nc(F)c1O2";"IC50";"'='";"88300.0";"nM";"4.05";"";"386543";"UO_0000065";"6.80";"0.15";"-1.49";"3.63";"0";"CHEMBL3888270";"Fluorescence Resonance Energy Transfer (FRET) Assay: Recombinant CathepsinD was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The CathepsinD enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for CathepsinD) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886633";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL2347187";"";"None";"439.34";"0";"3.18";"BDBM50432603";"N#Cc1ccc(C(=O)Nc2ccc(F)c([C@]3(CF)C[C@@H](C(F)(F)F)OC(N)=N3)c2)nc1";"IC50";"'>'";"400000.0";"nM";"";"Outside typical range";"377859";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3954148";"";"None";"473.79";"0";"3.83";"BDBM214832";"N#Cc1cnc(C(=O)Nc2ccc(F)c([C@]3(CF)C[C@@H](C(F)(F)F)OC(N)=N3)c2)c(Cl)c1";"IC50";"'>'";"400000.0";"nM";"";"Outside typical range";"377861";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3974975";"";"None";"498.45";"0";"4.40";"BDBM214837";"Cc1cc(OCC2CC2)cnc1C(=O)Nc1ccc(F)c([C@]2(CF)C[C@@H](C(F)(F)F)OC(N)=N2)c1";"IC50";"'>'";"400000.0";"nM";"";"Outside typical range";"377870";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3958391";"";"None";"456.79";"0";"3.27";"BDBM214865";"C[C@@]1(c2cc(NC(=O)c3ncc(C#N)cc3Cl)cnc2F)C[C@@H](C(F)(F)F)OC(N)=N1";"IC50";"'>'";"400000.0";"nM";"";"Outside typical range";"377873";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3915277";"";"None";"461.80";"0";"3.41";"BDBM214868";"COc1cnc(C(=O)Nc2cnc(F)c([C@]3(C)C[C@@H](C(F)(F)F)OC(N)=N3)c2)c(Cl)c1";"IC50";"'>'";"400000.0";"nM";"";"Outside typical range";"377882";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3937663";"";"None";"527.68";"1";"4.72";"BDBM214855";"NC1=N[C@](CF)(c2cc(NC(=O)c3ncc(Br)cc3Cl)ccc2F)C[C@@H](C(F)(F)F)O1";"IC50";"'>'";"400000.0";"nM";"";"Outside typical range";"377896";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3985595";"";"None";"388.30";"0";"3.24";"BDBM214909";"NC1=N[C@](CF)(c2cc(Oc3ncccn3)ccc2F)C[C@@H](C(F)(F)F)O1";"IC50";"'>'";"400000.0";"nM";"";"Outside typical range";"377907";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3899615";"";"None";"439.36";"1";"5.01";"BDBM214918";"NC1=N[C@](CF)(c2cc(-c3ccc4ccc(F)cc4n3)ccc2F)C[C@@H](C(F)(F)F)O1";"IC50";"'>'";"133000.0";"nM";"";"Outside typical range";"377941";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3896886";"";"None";"459.38";"0";"3.02";"BDBM215035";"COc1cnc(C(=O)Nc2cc(C)c(F)c([C@]3(CF)C[C@@H](C(F)(F)F)OC(N)=N3)c2)cn1";"IC50";"'>'";"400000.0";"nM";"";"Outside typical range";"378053";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3985686";"";"None";"458.39";"0";"3.62";"BDBM215037";"COc1ccc(C(=O)Nc2cc(C)c(F)c([C@]3(CF)C[C@@H](C(F)(F)F)OC(N)=N3)c2)nc1";"IC50";"'='";"1119000.0";"nM";"";"Outside typical range";"378055";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3940796";"";"None";"486.83";"0";"4.70";"BDBM215038";"Cc1cc(Nc2ncnc3cc(Cl)cnc23)cc([C@]2(CF)C[C@@H](C(F)(F)F)OC(N)=N2)c1F";"IC50";"'>'";"400000.0";"nM";"";"Outside typical range";"378056";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3965367";"";"None";"455.80";"0";"3.88";"BDBM215014";"C[C@@]1(c2cc(NC(=O)c3ccc(C#N)cn3)cc(Cl)c2F)C[C@@H](C(F)(F)F)OC(N)=N1";"IC50";"'='";"487900.0";"nM";"";"Outside typical range";"378059";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL556087";"";"None";"497.62";"0";"2.38";"21";"CCc1cn2c3c(cc(C(=O)N[C@@H](Cc4ccccc4)[C@H](O)CNC4CC4)cc13)OS(=O)(=O)CC2";"IC50";"'='";"2970.0";"nM";"5.53";"";"";"UO_0000065";"11.11";"0.22";"3.15";"5.04";"0";"CHEMBL725829";"Inhibition of cathepsin-D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1158411";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL549458";"";"None";"498.65";"0";"2.29";"13";"CCNC[C@@H](O)[C@H](Cc1ccccc1)NC(=O)c1cc2c3c(cn(CC)c3c1)CCS(=O)(=O)N2C";"IC50";"'='";"19540.0";"nM";"4.71";"";"";"UO_0000065";"9.44";"0.18";"2.42";"4.54";"0";"CHEMBL725829";"Inhibition of cathepsin-D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1158411";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL556453";"";"None";"526.70";"1";"3.07";"9";"CC[C@@H](C)NC[C@@H](O)[C@H](Cc1ccccc1)NC(=O)c1cc2c3c(cn(CC)c3c1)CCS(=O)(=O)N2C";"IC50";"'='";"1190.0";"nM";"5.92";"";"";"UO_0000065";"11.25";"0.22";"2.85";"5.71";"0";"CHEMBL725829";"Inhibition of cathepsin-D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1158411";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL550208";"";"None";"510.66";"1";"2.44";"15";"CCn1cc2c3c(cc(C(=O)N[C@@H](Cc4ccccc4)[C@H](O)CNC4CC4)cc31)N(C)S(=O)(=O)CC2";"IC50";"'='";"6790.0";"nM";"5.17";"";"";"UO_0000065";"10.12";"0.20";"2.73";"4.99";"0";"CHEMBL725829";"Inhibition of cathepsin-D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1158411";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL560092";"";"None";"566.65";"1";"3.23";"8";"CCc1cn2c3c(cc(C(=O)N[C@@H](Cc4ccccc4)[C@H](O)CNCCC(F)(F)F)cc13)N(C)S(=O)(=O)CC2";"IC50";"'='";"890.0";"nM";"6.05";"";"";"UO_0000065";"10.68";"0.21";"2.82";"5.84";"1";"CHEMBL725829";"Inhibition of cathepsin-D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1158411";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL560612";"";"None";"554.71";"1";"2.45";"6";"CCc1cn2c3c(cc(C(=O)N[C@@H](Cc4ccccc4)[C@H](O)CNC4CCOCC4)cc13)N(C)S(=O)(=O)CC2";"IC50";"'='";"60.0";"nM";"7.22";"";"";"UO_0000065";"13.02";"0.25";"4.77";"6.40";"0";"CHEMBL725829";"Inhibition of cathepsin-D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1158411";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL3586130";"";"None";"360.31";"0";"2.67";"6.HCl";"Cl.NC1=NC2CCC(NC(=O)c3cccc(Cl)c3)CC2CS1";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3588066";"Inhibition of human cathepsin D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3585284";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL2425613";"";"None";"546.63";"1";"3.45";"11f";"CC(C)(C)c1cccc(CN[C@H]2C[S@+]([O-])C[C@@H](Cc3cc(F)c(N)c(O[C@H](CO)C(F)(F)F)c3)[C@@H]2O)c1";"IC50";"'='";"2450.0";"nM";"5.61";"";"";"UO_0000065";"10.26";"0.21";"2.16";"5.06";"0";"CHEMBL2427050";"Inhibition of human cathepsin-D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2424550";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"None";"";"";""
"CHEMBL354505";"";"None";"664.85";"1";"3.42";"26";"C=C[C@@H]1C[C@@H]([C@H](O)[C@H](CC2CCCCC2)NC(=O)[C@H](Cc2c[nH]cn2)NC(=O)[C@H](Cc2ccccc2)NC(=O)OC(C)(C)C)C(=O)N1C";"IC50";"'='";"175.0";"nM";"6.76";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL657351";"Inhibitory concentration against cathepsin D";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1125921";"1";"Scientific Literature";"J Med Chem";"1991";"None";"";"";""
"CHEMBL3688702";"";"None";"399.81";"0";"2.76";"BDBM171643";"N#Cc1ccc(C(=O)Nc2ccc(Cl)c([C@@]3(CF)N=C(N)O[C@@H]4C[C@@H]43)c2)nc1";"IC50";"'='";"1561600.0";"nM";"";"Outside typical range";"316051";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL4454293";"";"None";"654.77";"2";"5.59";"(S,R)-3d";"COc1cccc(C(C)(C)NC[C@@H](O)[C@H](Cc2ccccc2)NC(=O)c2cc(C(=O)NCCC(F)(F)F)cc(N3CCCCC3)c2)c1";"IC50";"'='";"580.0";"nM";"6.24";"";"";"UO_0000065";"9.52";"0.18";"0.65";"6.06";"0";"CHEMBL4331648";"Inhibition of human cathepsin D using DABCYL-Glu-Arg-Nle-Phe-Leu-Ser-Phe-Pro-EDANS as substrate preincubated for 30 mins followed by substrate addition and measured every min for 8 to 15 mins by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4330085";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";"";"";""
"CHEMBL4452552";"";"None";"630.83";"1";"4.41";"(S,R)-3i";"COc1cccc(C(C)(C)NC[C@@H](O)[C@H](Cc2ccccc2)NC(=O)c2cc(C(=O)NC(C)(C)CO)cc(N3CCCCC3)c2)c1";"IC50";"'='";"1460.0";"nM";"5.84";"";"";"UO_0000065";"9.25";"0.17";"1.43";"4.74";"0";"CHEMBL4331648";"Inhibition of human cathepsin D using DABCYL-Glu-Arg-Nle-Phe-Leu-Ser-Phe-Pro-EDANS as substrate preincubated for 30 mins followed by substrate addition and measured every min for 8 to 15 mins by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4330085";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";"";"";""
"CHEMBL4516259";"";"None";"658.88";"2";"5.46";"(S,R)-3l";"COc1cccc(C(C)(C)NC[C@@H](O)[C@H](Cc2ccccc2)NC(=O)c2cc(C(=O)NCCOC(C)(C)C)cc(N3CCCCC3)c2)c1";"IC50";"'='";"150.0";"nM";"6.82";"";"";"UO_0000065";"10.36";"0.19";"1.36";"6.08";"0";"CHEMBL4331648";"Inhibition of human cathepsin D using DABCYL-Glu-Arg-Nle-Phe-Leu-Ser-Phe-Pro-EDANS as substrate preincubated for 30 mins followed by substrate addition and measured every min for 8 to 15 mins by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4330085";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";"";"";""
"CHEMBL4449532";"";"None";"577.74";"2";"5.32";"(S,R)-4c";"CCCN(CCC)C(=O)c1cc(F)cc(C(=O)N[C@@H](Cc2ccccc2)[C@H](O)CNC(C)(C)c2cccc(OC)c2)c1";"IC50";"'='";"1000.0";"nM";"6.00";"";"";"UO_0000065";"10.39";"0.20";"0.68";"6.60";"0";"CHEMBL4331648";"Inhibition of human cathepsin D using DABCYL-Glu-Arg-Nle-Phe-Leu-Ser-Phe-Pro-EDANS as substrate preincubated for 30 mins followed by substrate addition and measured every min for 8 to 15 mins by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4330085";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";"";"";""
"CHEMBL4449824";"";"None";"686.94";"2";"6.45";"(S,R)-4g";"CCCN(CCC)C(=O)c1cc(C(=O)N[C@@H](Cc2ccccc2)[C@H](O)CNC(C)(C)c2cccc(OC)c2)cc(C(=O)N(CCC)CCC)c1";"IC50";"'='";"700.0";"nM";"6.16";"";"";"UO_0000065";"8.96";"0.17";"-0.30";"5.53";"0";"CHEMBL4331648";"Inhibition of human cathepsin D using DABCYL-Glu-Arg-Nle-Phe-Leu-Ser-Phe-Pro-EDANS as substrate preincubated for 30 mins followed by substrate addition and measured every min for 8 to 15 mins by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4330085";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";"";"";""
"CHEMBL509903";"";"None";"646.99";"2";"7.22";"51";"O=C(C1=C(c2ccc(CCCOc3c(F)ccc(F)c3Cl)cc2)C[C@@H]2CNC[C@H]1N2)N(Cc1cccc(Cl)c1Cl)C1CC1";"IC50";"'='";"2700.0";"nM";"5.57";"";"";"UO_0000065";"8.61";"0.18";"-1.65";"10.39";"0";"CHEMBL1285370";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1275274";"1";"Scientific Literature";"J Med Chem";"2010";"None";"";"";""
"CHEMBL2408747";"";"None";"474.55";"0";"3.81";"36";"CC(=O)N[C@@H](Cc1cc(F)cc(F)c1)[C@H](O)CN[C@H]1CCOc2ccc(OC3CCCC3)cc21";"IC50";"'='";"145.0";"nM";"6.84";"";"";"UO_0000065";"14.41";"0.27";"3.03";"8.57";"0";"CHEMBL2410948";"Inhibition of cathepsin-D (unknown origin) using C-terminal biotinylated peptide substrate treated 30 mins before addition of peptide substrate measured after 110 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2406984";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"None";"";"";""
"CHEMBL2407490";"";"None";"624.83";"2";"5.09";"21";"CCc1ccc2c(c1)[C@@H](NC[C@@H](O)[C@@H]1Cc3cccc(c3)CCCCn3cc(cc(N4CCCC4)c3=O)C(=O)N1)CC1(CCC1)O2";"IC50";"'='";"8.1";"nM";"8.09";"";"";"UO_0000065";"12.95";"0.24";"3.00";"8.44";"0";"CHEMBL2411009";"Inhibition of Cathepsin D (unknown origin) by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2406987";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"None";"";"";""
"CHEMBL2407487";"";"None";"533.76";"2";"5.60";"15";"CC(C)(C)Cc1cnc2c(c1)[C@@H](NC[C@@H](O)[C@@H]1Cc3cccc(c3)CCCCCCC(=O)N1)CC1(CCC1)O2";"IC50";"'='";"4.3";"nM";"8.37";"";"";"UO_0000065";"15.67";"0.29";"2.77";"10.02";"0";"CHEMBL2411009";"Inhibition of Cathepsin D (unknown origin) by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2406987";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"None";"";"";""
"CHEMBL2407338";"";"None";"530.75";"2";"6.15";"10";"C=CCCCCC(=O)N[C@@H](Cc1cccc(CC=C)c1)[C@H](O)CN[C@H]1CC2(CCC2)Oc2ccc(CC)cc21";"IC50";"'='";"36.0";"nM";"7.44";"";"";"UO_0000065";"14.02";"0.26";"1.29";"10.54";"0";"CHEMBL2411009";"Inhibition of Cathepsin D (unknown origin) by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2406987";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"None";"";"";""
"CHEMBL1271452";"";"None";"413.42";"0";"2.71";"68";"COCCC#Cc1cccc([C@@]2(c3ccc(OC(F)F)cc3)N=C(N)N(C)C2=O)c1";"IC50";"'='";"9900.0";"nM";"5.00";"";"";"UO_0000065";"12.10";"0.23";"2.29";"6.49";"0";"CHEMBL1273977";"Inhibition of cathepsin D by FRET assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1268920";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL3975637";"";"None";"518.46";"1";"4.29";"BDBM220832";"NC1=NC2(CCO1)c1cc(NC(=O)c3ccc(F)cn3)ccc1Oc1c2cc(-c2ccnc(F)c2)nc1F";"IC50";"'='";"400000.0";"nM";"";"Outside typical range";"386518";"UO_0000065";"";"";"";"";"0";"CHEMBL3888270";"Fluorescence Resonance Energy Transfer (FRET) Assay: Recombinant CathepsinD was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The CathepsinD enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for CathepsinD) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886633";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3958580";"";"None";"493.23";"0";"4.07";"BDBM214851";"NC1=N[C@](CF)(c2cc(NC(=O)c3ccc(Br)cn3)ccc2F)C[C@@H](C(F)(F)F)O1";"IC50";"'>'";"400000.0";"nM";"";"Outside typical range";"377872";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3975091";"";"None";"472.81";"0";"4.39";"BDBM214810";"NC1=N[C@](CF)(c2cc(Nc3ncnc4cc(Cl)cnc34)ccc2F)C[C@@H](C(F)(F)F)O1";"IC50";"'='";"54400.0";"nM";"4.26";"";"377875";"UO_0000065";"9.02";"0.18";"-0.13";"4.34";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3893892";"";"None";"483.40";"0";"3.10";"BDBM214839";"CC#CCOc1cnc(C(=O)Nc2ccc(F)c([C@]3(CF)C[C@@H](C(F)(F)F)OC(N)=N3)c2)cn1";"IC50";"'>'";"400000.0";"nM";"";"Outside typical range";"377960";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3968817";"";"None";"466.77";"0";"4.10";"BDBM214958";"NC1=N[C@](CF)(c2cc(NC(=O)c3ccc(Cl)cn3)cc(F)c2F)C[C@@H](C(F)(F)F)O1";"IC50";"'='";"2750000.0";"nM";"";"Outside typical range";"377992";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3963410";"";"None";"462.35";"0";"3.64";"BDBM215048";"COc1cnc(C(=O)Nc2cc(F)c(F)c([C@]3(C)C[C@@H](C(F)(F)F)OC(N)=N3)c2)c(F)c1";"IC50";"'='";"1185000.0";"nM";"";"Outside typical range";"378087";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL401180";"";"None";"529.64";"2";"5.65";"6b";"C[C@@]1(N)Cc2cccc(c2)CC[C@H](c2ccccc2)NC(=O)c2cc(cc(-c3ccccc3C#N)c2)COC1=O";"IC50";"'='";"48000.0";"nM";"4.32";"";"";"UO_0000065";"8.15";"0.15";"-1.33";"4.10";"0";"CHEMBL886447";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1139967";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"None";"";"";""
"CHEMBL325071";"";"None";"725.03";"1";"4.67";"28, pepstatin, A-70450";"CCCC[C@@H](C(=O)N[C@@H](CC1CCCCC1)[C@@H](O)C[C@H](C(=O)NCCC)C(C)C)N1CCN(C(=O)N2CCN(C)CC2)[C@H](Cc2ccccc2)C1=O";"IC50";"'='";"770.0";"nM";"6.11";"";"";"UO_0000065";"8.43";"0.16";"1.44";"4.87";"0";"CHEMBL658687";"Inhibitory concentration against cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133572";"1";"Scientific Literature";"J Med Chem";"2000";"None";"";"";""
"CHEMBL3940163";"";"None";"453.37";"0";"3.67";"BDBM214973";"Cc1cc(C#N)cnc1C(=O)Nc1cc(F)c(F)c([C@]2(C)C[C@@H](C(F)(F)F)OC(N)=N2)c1";"IC50";"'='";"1070000.0";"nM";"";"Outside typical range";"378007";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3895405";"";"None";"478.37";"0";"4.74";"BDBM214978";"Cc1cc(C(F)F)cnc1C(=O)Nc1cc(F)c(F)c([C@]2(C)C[C@@H](C(F)(F)F)OC(N)=N2)c1";"IC50";"'='";"2060000.0";"nM";"";"Outside typical range";"378012";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3914410";"";"None";"475.32";"0";"3.45";"BDBM215042";"N#Cc1cnc(C(=O)Nc2cc(F)c(F)c([C@]3(CF)C[C@@H](C(F)(F)F)OC(N)=N3)c2)c(F)c1";"IC50";"'>'";"400000.0";"nM";"";"Outside typical range";"378036";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3948355";"";"None";"492.83";"0";"4.27";"BDBM215030";"COc1cc(Cl)cnc1C(=O)Nc1cc(C)c(F)c([C@]2(CF)C[C@@H](C(F)(F)F)OC(N)=N2)c1";"IC50";"'>'";"400000.0";"nM";"";"Outside typical range";"378046";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3688794";"";"None";"460.37";"0";"3.86";"BDBM171741";"N#Cc1cnc2c(Nc3cc(F)c(F)c([C@@]4(C(F)F)N=C(N)O[C@@H]5C[C@@H]54)c3)ncc(F)c2c1";"IC50";"'='";"102630.0";"nM";"";"Outside typical range";"316141";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688796";"";"None";"385.39";"0";"3.48";"BDBM171743";"NC1=N[C@@](c2cc(NCC#Cc3ccccc3)ccc2F)(C(F)F)[C@H]2C[C@H]2O1";"IC50";"'='";"19200.0";"nM";"4.72";"";"316143";"UO_0000065";"12.24";"0.23";"1.24";"7.91";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3707004";"";"None";"527.69";"1";"1.57";"19";"CCN1CCN2CCS(=O)(=O)N(C)c3cc(C(=O)N[C@@H](Cc4ccccc4)[C@H](O)CNC4CC4)cc1c32";"IC50";"'='";"26300.0";"nM";"4.58";"";"";"UO_0000065";"8.68";"0.17";"3.01";"4.35";"0";"CHEMBL1035560";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1158445";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL68540";"";"None";"441.57";"0";"4.92";"17a";"CCCc1c(OCc2ccc(/C=C3\SC(=S)NC3=O)cc2)ccc(C(C)=O)c1OC";"IC50";"'='";"48400.0";"nM";"4.32";"";"";"UO_0000065";"9.77";"0.20";"-0.60";"6.68";"0";"CHEMBL658685";"In vitro inhibition of cathepsin D.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1129769";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1996";"None";"";"";""
"CHEMBL1092786";"";"None";"378.38";"0";"3.06";"4f";"CN1C(=O)C(c2ccncc2)(c2cccc(-c3cccc(F)c3F)c2)N=C1N";"IC50";"'='";"13100.0";"nM";"4.88";"";"";"UO_0000065";"12.90";"0.24";"1.82";"6.82";"0";"CHEMBL1115170";"Inhibition of cathepsin D by FRET assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156304";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL438355";"";"None";"443.60";"0";"4.36";"30";"N#CCCCN/C(N)=N\C(=O)Cn1c(-c2ccccc2)ccc1C12CC3CC(CC(C3)C1)C2";"IC50";"'='";"4250.0";"nM";"5.37";"";"";"UO_0000065";"12.11";"0.22";"1.01";"5.58";"0";"CHEMBL930552";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1142260";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";"";"";""
"CHEMBL74974";"";"None";"561.72";"1";"4.14";"PS-189863";"CCCCNC(=O)CC(O)C(Cc1ccccc1)NC(=O)[C@@H](NC(=O)COc1ccc2ccccc2c1)[C@@H](C)CC";"IC50";"'='";"500.0";"nM";"6.30";"";"";"UO_0000065";"11.22";"0.21";"2.16";"5.40";"0";"CHEMBL658686";"Inhibitory activity against cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1131370";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1998";"None";"";"";""
"CHEMBL2425604";"";"None";"588.54";"1";"3.70";"17k";"COC[C@@H](Oc1cc(C[C@@H]2C[S@@+]([O-])C[C@H](NCc3cccc(OC(F)(F)F)c3)[C@H]2O)cc(F)c1N)C(F)(F)F";"IC50";"'='";"6830.0";"nM";"5.17";"";"";"UO_0000065";"8.78";"0.18";"1.47";"4.74";"0";"CHEMBL2427050";"Inhibition of human cathepsin-D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2424550";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"None";"";"";""
"CHEMBL2425610";"";"None";"448.60";"0";"3.15";"11b";"COc1cc(C[C@@H]2C[S@@+]([O-])C[C@H](NCc3cccc(C(C)(C)C)c3)[C@H]2O)cc(F)c1N";"IC50";"'='";"1240.0";"nM";"5.91";"";"";"UO_0000065";"13.17";"0.26";"2.76";"6.52";"0";"CHEMBL2427050";"Inhibition of human cathepsin-D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2424550";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"None";"";"";""
"CHEMBL2425609";"";"None";"584.60";"2";"5.02";"12a";"CC(C)(C)c1cccc(CN[C@H]2C[S@@+]([O-])C[C@@H](Cc3cc(F)c(N)c(OC(C(F)(F)F)C(F)(F)F)c3)[C@@H]2O)c1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2427050";"Inhibition of human cathepsin-D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2424550";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"None";"";"";""
"CHEMBL433335";"";"None";"679.43";"2";"9.67";"41";"CCOc1ccc2nc(Sc3ccc(NC(=O)c4cc(Cl)cc(Cl)c4NC(=O)c4cc(Cl)cc(Cl)c4O)cc3)sc2c1";"IC50";"'='";"1500.0";"nM";"5.82";"";"";"UO_0000065";"8.57";"0.19";"-3.85";"5.79";"0";"CHEMBL657347";"Inhibitory activity against human liver Cathepsin D using Cathepsin D assay.";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1132101";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1999";"None";"";"";""
"CHEMBL304801";"";"None";"429.52";"0";"4.11";"8j";"CCCc1c(OCc2ccc(/C=C3\SC(=S)NC3=O)cc2)ccc(C(=O)O)c1O";"IC50";"'='";"5130.0";"nM";"5.29";"";"";"UO_0000065";"12.32";"0.25";"1.18";"5.52";"0";"CHEMBL658685";"In vitro inhibition of cathepsin D.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1129769";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1996";"None";"";"";""
"CHEMBL1098668";"";"None";"631.17";"2";"1.05";"6";"CC(C)C[C@H](NC(=O)[C@H](CCl)NC(=O)C[C@H](O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)c1ccccn1)C(C)C)C(N)=O";"IC50";"'='";"50.0";"nM";"7.30";"";"";"UO_0000065";"11.57";"0.23";"6.25";"3.79";"0";"CHEMBL1114767";"Inhibition of human cathepsin D after 30 mins by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1157812";"1";"Scientific Literature";"J Med Chem";"2010";"None";"";"";""
"CHEMBL567893";"GRASSYSTATIN A";"None";"1174.44";"None";"None";"1";"COC(=O)[C@@H]1CCCN1C(=O)[C@@H](Cc1ccccc1)N(C)C(=O)[C@H](C)NC(=O)[C@@H](NC(=O)C[C@H](O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](OC(=O)[C@@H](OC(=O)[C@H](C(C)C)N(C)C)C(C)C)C(C)C)[C@@H](C)O";"IC50";"'='";"10000.0";"nM";"5.00";"";"";"UO_0000065";"4.26";"None";"None";"None";"0";"CHEMBL1039244";"Inhibition of cathepsin D after 10 to 15 mins by fluorescence assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156023";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL585289";"";"None";"440.43";"0";"3.81";"47";"COc1ccc(C2(c3cccc(-c4cccnc4)c3)N=C(N)N(C)C2=O)cc1C(F)(F)F";"IC50";"'='";"3510.0";"nM";"5.46";"";"";"UO_0000065";"12.38";"0.23";"1.64";"6.75";"0";"CHEMBL1044551";"Inhibition of human cathepsin D by FRET based peptide cleavage assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156789";"1";"Scientific Literature";"J Med Chem";"2010";"None";"";"";""
"CHEMBL566212";"";"None";"456.42";"0";"3.69";"58";"COc1ccc(-c2cccc(C3(c4ccc(OC(F)(F)F)cc4)N=C(N)N(C)C3=O)c2)cn1";"IC50";"'='";"4430.0";"nM";"5.35";"";"";"UO_0000065";"11.73";"0.22";"1.66";"5.95";"0";"CHEMBL1044551";"Inhibition of human cathepsin D by FRET based peptide cleavage assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156789";"1";"Scientific Literature";"J Med Chem";"2010";"None";"";"";""
"CHEMBL1091441";"";"None";"348.43";"0";"2.84";"4i";"CN1C(=O)C(c2ccncc2)(c2cccc(-c3ccsc3)c2)N=C1N";"IC50";"'='";"31600.0";"nM";"4.50";"";"";"UO_0000065";"12.92";"0.25";"1.66";"6.29";"0";"CHEMBL1115170";"Inhibition of cathepsin D by FRET assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156304";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL510798";"";"None";"646.78";"2";"5.29";"25";"CCNc1cc(C(=O)N[C@@H](Cc2ccccc2)[C@H](O)CNC(C)(C)c2cccc(C(F)(F)F)c2)cc(N2CCCCS2(=O)=O)c1";"IC50";"'='";"600.0";"nM";"6.22";"";"";"UO_0000065";"9.62";"0.19";"0.93";"5.62";"0";"CHEMBL1036847";"Inhibition of cathepsin-D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1137769";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL2030999";"";"None";"415.58";"0";"3.45";"4";"C=CC[C@H](NC(C)=O)[C@H](O)CN[C@H]1CC2(CCC2)Oc2ncc(CC(C)(C)C)cc21";"IC50";"'='";"465.0";"nM";"6.33";"";"";"UO_0000065";"15.24";"0.29";"2.88";"7.59";"0";"CHEMBL2033077";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2029322";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL2031140";"";"None";"497.66";"0";"4.50";"34";"CC(=O)N[C@@H](Cc1ccc(F)cc1)[C@H](O)CN[C@H]1C[C@]2(C[C@@H](C)C2)Oc2ncc(CC(C)(C)C)cc21";"IC50";"'='";"8.0";"nM";"8.10";"";"";"UO_0000065";"16.27";"0.31";"3.60";"9.70";"0";"CHEMBL2033077";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2029322";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL2031150";"";"None";"517.62";"1";"3.17";"46";"CC(C)(C)Cc1cnc2c(c1)[C@@H](NC[C@@H](O)[C@H](Cc1ccc(F)cc1)NC(=O)CF)C[C@]1(C[C@H](O)C1)O2";"IC50";"'='";"347.0";"nM";"6.46";"";"";"UO_0000065";"12.48";"0.24";"3.29";"6.23";"0";"CHEMBL2033077";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2029322";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL1824349";"";"None";"377.47";"0";"2.80";"52";"CCc1cc(C2(c3cccc(-c4cncnc4)c3)N=C(N)N(C)C2=O)cs1";"IC50";"'='";"23800.0";"nM";"4.62";"";"";"UO_0000065";"12.25";"0.23";"1.82";"5.47";"0";"CHEMBL1825607";"Inhibition of cathepsin D by FRET assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1821667";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL1824359";"";"None";"349.42";"0";"2.24";"62";"CN1C(=O)C(c2ccsc2)(c2cccc(-c3cnccn3)c2)N=C1N";"IC50";"'='";"33000.0";"nM";"4.48";"";"";"UO_0000065";"12.83";"0.24";"2.24";"5.31";"0";"CHEMBL1825607";"Inhibition of cathepsin D by FRET assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1821667";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL3963996";"";"None";"507.55";"1";"4.13";"BDBM220819";"Cc1nc(C(=O)Nc2ccc3c(c2)C2(CCOC(N)=N2)c2cc(C4=CCCOC4)nc(F)c2O3)cs1";"IC50";"'='";"411100.0";"nM";"";"Outside typical range";"386505";"UO_0000065";"";"";"";"";"0";"CHEMBL3888270";"Fluorescence Resonance Energy Transfer (FRET) Assay: Recombinant CathepsinD was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The CathepsinD enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for CathepsinD) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886633";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3954566";"";"None";"765.01";"2";"3.19";"BDBM232261";"CC[C@H](C)[C@H](NC(=O)C[C@H](N)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)CC(C)C)C(C)C)C(=O)N[C@H](C(=O)OC)C(C)C";"IC50";"'='";"3.9";"nM";"8.41";"";"405036";"UO_0000065";"10.99";"0.21";"5.22";"4.25";"0";"CHEMBL3888498";"In-Vitro Fluorescence Assay: In order to identify modulators of cathepsin D activity, a continuous enzymatic test was carried out with a synthetic peptide which carries a fluorescent group (MCA=(7-methoxycoumarin-4-yl)acetyl) which is quenched by energy transfer from a Dpn (2,4 dinitrophenyl) group on the same molecule, in Greiner 384-well nb microtitre plates. Cleavage of the peptidic substrate by cathepsin D causes an increase in the fluorescence intensity. In order to determine the efficacy of substances, the time-dependent increase in the fluorescence intensity in the presence of the substance was compared with the time-dependent increase in fluorescence in the absence of substances. The reference substance used was pepstatin A (Sigma-Aldrich). The substrate used was MCAGKPILFFRLK(Dnp)d-R-NH2 (Enzo Life Sciences, Lorrach). The enzyme employed was cathepsin D isolated from the human liver (Sigma-Aldrich) in a final concentration of 1.4 nM. The test was carried out in 100 mM sodium acetate buffer, 1.25% (v/v) of DMSO, 0.25% (w/v) of Chaps, pH 5.5. 2 ul of each substance solution with serially diluted substance concentration were added to in each case 4 ul of cathepsin D solution and incubated at room temperature for 10 min. The reaction was started by addition of 2 ul of substrate solution (final concentration 5 uM). After carrying out a starting-point fluorescence measurement (excitation wavelength 340 nm/emission wavelength 450 nm) using an Envision multilabel reader (Perkin Elmer), the reaction was incubated at room temperature for 60 min. The amount of peptide fragment cleaved off during the reaction time was subsequently measured by determination of the increase in the fluorescence intensity at 450 nm (excitation wavelength 340 nm).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886733";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3899185";"";"None";"721.82";"2";"3.47";"BDBM232274";"CC[C@H](C)[C@H](NC(=O)C[C@H](N)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)Cc1cccc(OC(F)(F)F)c1)C(C)C)C(=O)N[C@H](C(=O)O)C(C)C";"IC50";"'='";"12.0";"nM";"7.92";"";"405048";"UO_0000065";"10.97";"0.21";"4.45";"4.19";"0";"CHEMBL3888498";"In-Vitro Fluorescence Assay: In order to identify modulators of cathepsin D activity, a continuous enzymatic test was carried out with a synthetic peptide which carries a fluorescent group (MCA=(7-methoxycoumarin-4-yl)acetyl) which is quenched by energy transfer from a Dpn (2,4 dinitrophenyl) group on the same molecule, in Greiner 384-well nb microtitre plates. Cleavage of the peptidic substrate by cathepsin D causes an increase in the fluorescence intensity. In order to determine the efficacy of substances, the time-dependent increase in the fluorescence intensity in the presence of the substance was compared with the time-dependent increase in fluorescence in the absence of substances. The reference substance used was pepstatin A (Sigma-Aldrich). The substrate used was MCAGKPILFFRLK(Dnp)d-R-NH2 (Enzo Life Sciences, Lorrach). The enzyme employed was cathepsin D isolated from the human liver (Sigma-Aldrich) in a final concentration of 1.4 nM. The test was carried out in 100 mM sodium acetate buffer, 1.25% (v/v) of DMSO, 0.25% (w/v) of Chaps, pH 5.5. 2 ul of each substance solution with serially diluted substance concentration were added to in each case 4 ul of cathepsin D solution and incubated at room temperature for 10 min. The reaction was started by addition of 2 ul of substrate solution (final concentration 5 uM). After carrying out a starting-point fluorescence measurement (excitation wavelength 340 nm/emission wavelength 450 nm) using an Envision multilabel reader (Perkin Elmer), the reaction was incubated at room temperature for 60 min. The amount of peptide fragment cleaved off during the reaction time was subsequently measured by determination of the increase in the fluorescence intensity at 450 nm (excitation wavelength 340 nm).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886733";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3928780";"";"None";"702.98";"2";"2.81";"BDBM232276";"CC[C@H](C)[C@H](NC(=O)C[C@H](N)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)CC(C)C)C(C)C)C(=O)N[C@H](CO)C(C)C";"IC50";"'='";"6.2";"nM";"8.21";"";"405050";"UO_0000065";"11.68";"0.22";"5.40";"4.28";"0";"CHEMBL3888498";"In-Vitro Fluorescence Assay: In order to identify modulators of cathepsin D activity, a continuous enzymatic test was carried out with a synthetic peptide which carries a fluorescent group (MCA=(7-methoxycoumarin-4-yl)acetyl) which is quenched by energy transfer from a Dpn (2,4 dinitrophenyl) group on the same molecule, in Greiner 384-well nb microtitre plates. Cleavage of the peptidic substrate by cathepsin D causes an increase in the fluorescence intensity. In order to determine the efficacy of substances, the time-dependent increase in the fluorescence intensity in the presence of the substance was compared with the time-dependent increase in fluorescence in the absence of substances. The reference substance used was pepstatin A (Sigma-Aldrich). The substrate used was MCAGKPILFFRLK(Dnp)d-R-NH2 (Enzo Life Sciences, Lorrach). The enzyme employed was cathepsin D isolated from the human liver (Sigma-Aldrich) in a final concentration of 1.4 nM. The test was carried out in 100 mM sodium acetate buffer, 1.25% (v/v) of DMSO, 0.25% (w/v) of Chaps, pH 5.5. 2 ul of each substance solution with serially diluted substance concentration were added to in each case 4 ul of cathepsin D solution and incubated at room temperature for 10 min. The reaction was started by addition of 2 ul of substrate solution (final concentration 5 uM). After carrying out a starting-point fluorescence measurement (excitation wavelength 340 nm/emission wavelength 450 nm) using an Envision multilabel reader (Perkin Elmer), the reaction was incubated at room temperature for 60 min. The amount of peptide fragment cleaved off during the reaction time was subsequently measured by determination of the increase in the fluorescence intensity at 450 nm (excitation wavelength 340 nm).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886733";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3945144";"";"None";"584.81";"2";"5.36";"BDBM232282";"CCc1cccc(CC)c1NC(=O)C[C@H](N)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CCCc1ccccc1)C(C)C";"IC50";"'='";"800.0";"nM";"6.10";"";"405056";"UO_0000065";"10.43";"0.19";"0.74";"5.38";"0";"CHEMBL3888498";"In-Vitro Fluorescence Assay: In order to identify modulators of cathepsin D activity, a continuous enzymatic test was carried out with a synthetic peptide which carries a fluorescent group (MCA=(7-methoxycoumarin-4-yl)acetyl) which is quenched by energy transfer from a Dpn (2,4 dinitrophenyl) group on the same molecule, in Greiner 384-well nb microtitre plates. Cleavage of the peptidic substrate by cathepsin D causes an increase in the fluorescence intensity. In order to determine the efficacy of substances, the time-dependent increase in the fluorescence intensity in the presence of the substance was compared with the time-dependent increase in fluorescence in the absence of substances. The reference substance used was pepstatin A (Sigma-Aldrich). The substrate used was MCAGKPILFFRLK(Dnp)d-R-NH2 (Enzo Life Sciences, Lorrach). The enzyme employed was cathepsin D isolated from the human liver (Sigma-Aldrich) in a final concentration of 1.4 nM. The test was carried out in 100 mM sodium acetate buffer, 1.25% (v/v) of DMSO, 0.25% (w/v) of Chaps, pH 5.5. 2 ul of each substance solution with serially diluted substance concentration were added to in each case 4 ul of cathepsin D solution and incubated at room temperature for 10 min. The reaction was started by addition of 2 ul of substrate solution (final concentration 5 uM). After carrying out a starting-point fluorescence measurement (excitation wavelength 340 nm/emission wavelength 450 nm) using an Envision multilabel reader (Perkin Elmer), the reaction was incubated at room temperature for 60 min. The amount of peptide fragment cleaved off during the reaction time was subsequently measured by determination of the increase in the fluorescence intensity at 450 nm (excitation wavelength 340 nm).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886733";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3939817";"";"None";"470.76";"0";"3.60";"BDBM214887";"C[C@@]1(c2nc(NC(=O)c3nn(C(F)F)cc3Cl)ccc2F)C[C@@H](C(F)(F)F)OC(N)=N1";"IC50";"'='";"712000.0";"nM";"";"Outside typical range";"377953";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3897736";"";"None";"452.40";"0";"4.22";"BDBM214923";"C[C@@]1(c2cc(NC(=O)N3CCC(C(F)F)CC3)ccc2F)C[C@@H](C(F)(F)F)OC(N)=N1";"IC50";"'>'";"14800.0";"nM";"";"";"377977";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3904724";"";"None";"483.28";"0";"2.68";"BDBM220770";"NC1=NC2(CCO1)c1cc(NC(=O)c3cnc(O)cn3)ccc1Oc1ncc(Br)cc12";"IC50";"'>'";"4940.0";"nM";"";"";"386453";"UO_0000065";"";"";"";"";"0";"CHEMBL3888270";"Fluorescence Resonance Energy Transfer (FRET) Assay: Recombinant CathepsinD was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The CathepsinD enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for CathepsinD) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886633";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3927120";"";"None";"459.44";"0";"3.44";"BDBM220808";"COc1cc(F)c2c(c1)C1(CCOC(N)=N1)c1cc(NC(=O)c3ccc(C#N)cn3)ccc1O2";"IC50";"'='";"147000.0";"nM";"";"Outside typical range";"386494";"UO_0000065";"";"";"";"";"0";"CHEMBL3888270";"Fluorescence Resonance Energy Transfer (FRET) Assay: Recombinant CathepsinD was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The CathepsinD enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for CathepsinD) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886633";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3930557";"";"None";"505.48";"1";"3.90";"BDBM220817";"NC1=NC2(CCO1)c1cc(NC(=O)c3ccc(F)cn3)ccc1Oc1c2cc(C2=CCCOC2)nc1F";"IC50";"'='";"255000.0";"nM";"";"Outside typical range";"386503";"UO_0000065";"";"";"";"";"0";"CHEMBL3888270";"Fluorescence Resonance Energy Transfer (FRET) Assay: Recombinant CathepsinD was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The CathepsinD enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for CathepsinD) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886633";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3976114";"";"None";"486.92";"0";"3.73";"BDBM220790";"COc1cnc(C(=O)Nc2ccc3c(c2)C2(CCSC(N)=N2)c2cc(Cl)nc(F)c2O3)cn1";"IC50";"'='";"69900.0";"nM";"4.16";"";"386473";"UO_0000065";"8.53";"0.17";"0.43";"3.33";"0";"CHEMBL3888270";"Fluorescence Resonance Energy Transfer (FRET) Assay: Recombinant CathepsinD was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The CathepsinD enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for CathepsinD) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886633";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3917445";"";"None";"534.57";"1";"3.88";"BDBM220799";"COc1cnc(C(=O)Nc2ccc3c(c2)C2(CCSC(N)=N2)c2cc(C4=CCOCC4)nc(F)c2O3)cn1";"IC50";"'='";"159800.0";"nM";"";"Outside typical range";"386485";"UO_0000065";"";"";"";"";"0";"CHEMBL3888270";"Fluorescence Resonance Energy Transfer (FRET) Assay: Recombinant CathepsinD was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The CathepsinD enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for CathepsinD) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886633";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3910114";"";"None";"531.48";"1";"3.56";"BDBM220802";"COc1cnc(C(=O)Nc2ccc3c(c2)C2(CCOC(N)=N2)c2cc(-c4cncc(F)c4)nc(F)c2O3)cn1";"IC50";"'='";"400000.0";"nM";"";"Outside typical range";"386488";"UO_0000065";"";"";"";"";"0";"CHEMBL3888270";"Fluorescence Resonance Energy Transfer (FRET) Assay: Recombinant CathepsinD was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The CathepsinD enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for CathepsinD) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886633";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3981595";"";"None";"500.52";"1";"3.02";"BDBM220805";"COc1cnc(C(=O)Nc2ccc3c(c2)C2(CCOC(N)=N2)c2cc(C4=CCCOC4)ncc2O3)cn1";"IC50";"'='";"480000.0";"nM";"";"Outside typical range";"386491";"UO_0000065";"";"";"";"";"0";"CHEMBL3888270";"Fluorescence Resonance Energy Transfer (FRET) Assay: Recombinant CathepsinD was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The CathepsinD enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for CathepsinD) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886633";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3688706";"";"None";"443.69";"0";"4.19";"BDBM171647";"NC1=N[C@](CF)(c2cc(NC(=O)c3ncc(Cl)cc3Cl)ccc2Cl)[C@H]2C[C@H]2O1";"IC50";"'='";"2867000.0";"nM";"";"Outside typical range";"316055";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688744";"";"None";"455.84";"0";"4.70";"BDBM171688";"Cc1cc(NC(=O)c2ccc(Cl)cc2CF)cc([C@@]2(C(F)F)N=C(N)O[C@@H]3C[C@@H]32)c1F";"IC50";"'='";"171000.0";"nM";"";"Outside typical range";"316215";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3949134";"";"None";"449.77";"0";"3.35";"BDBM214938";"NC1=N[C@](CF)(c2nc(NC(=O)c3ccc(Cl)cn3)ccc2F)C[C@@H](C(F)(F)F)O1";"IC50";"'>'";"400000.0";"nM";"";"Outside typical range";"377897";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3954714";"";"None";"466.20";"0";"4.61";"BDBM214893";"NC1=N[C@](CF)(c2cc(Oc3cc(Br)ccn3)ccc2F)C[C@@H](C(F)(F)F)O1";"IC50";"'='";"557000.0";"nM";"";"Outside typical range";"377902";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3969211";"";"None";"450.44";"0";"4.30";"BDBM214922";"C[C@@]1(c2cc(NC(=O)N3CCc4ccccc4C3)ccc2F)C[C@@H](C(F)(F)F)OC(N)=N1";"IC50";"'='";"3610000.0";"nM";"";"Outside typical range";"377976";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL4167618";"";"None";"965.16";"3";"0.26";"Tasiamide B";"CC(C)C[C@H](NC(=O)C[C@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(N)=O)N(C)C(=O)[C@@H](NC(=O)[C@H](C)O)C(C)C)C(=O)N[C@@H](C)C(=O)N(C)[C@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)O";"IC50";"'='";"50.0";"nM";"7.30";"";"";"UO_0000065";"7.56";"0.14";"7.04";"2.45";"0";"CHEMBL4141000";"Inhibition of human liver cathepsin D using Mca-Gly-Lys-Pro-Ile-Leu-PhePhe-Arg-Leu-Lys-(Dnp)-D-Arg-NH2 as substrate pretreated for 15 mins followed by substrate addition measured at 5 mins interval for 120 mins by fluorescence assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4138143";"1";"Scientific Literature";"J Nat Prod";"2017";"None";"";"";""
"CHEMBL4173516";"";"None";"959.20";"3";"0.54";"1";"CC[C@H](C)[C@H](NC(=O)C[C@H](O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)N(C)C(=O)[C@H](CC(C)C)NC(=O)[C@H](C)O)C(=O)N[C@@H](C)C(=O)N(C)[C@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)OC";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"7.30";"0.14";"6.46";"2.44";"0";"CHEMBL4140999";"Inhibition of secreted cathepsin D in human MDA-MB-231 cells using Mca-Gly-Lys-Pro-Ile-Leu-PhePhe-Arg-Leu-Lys-(Dnp)-D-Arg-NH2 as substrate pretreated for 3 days under pH 6.6 conditioned media followed by substrate addition measured at 5 mins interval for 2 hrs by fluorescence assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"MDA-MB-231";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4138143";"1";"Scientific Literature";"J Nat Prod";"2017";"None";"";"";""
"CHEMBL2181012";"";"None";"707.87";"1";"1.75";"14";"COC(=O)[C@@H]1CCCN1C(=O)[C@@H](Cc1ccccc1)N(C)C(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)C[C@H](O)[C@H](Cc1ccccc1)NC(C)=O";"IC50";"'='";"71.7";"nM";"7.14";"";"";"UO_0000065";"10.09";"0.19";"5.39";"4.10";"0";"CHEMBL2185513";"Inhibition of cathepsin D by fluorescence assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2176894";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL2407343";"";"None";"476.66";"0";"4.79";"12";"CCc1ccc2c(c1)[C@@H](NC[C@@H](O)[C@@H]1Cc3cccc(c3)CCCCCC(=O)N1)CC1(CCC1)O2";"IC50";"'='";"230.0";"nM";"6.64";"";"";"UO_0000065";"13.93";"0.26";"1.85";"9.40";"0";"CHEMBL2411009";"Inhibition of Cathepsin D (unknown origin) by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2406987";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"None";"";"";""
"CHEMBL2047899";"";"None";"522.63";"1";"4.68";"32b";"CC(C)(C)c1cccc(CN[C@H]2CS(=O)(=O)C[C@@H](Cc3ccc4[nH]cc(CC(F)(F)F)c4c3)[C@@H]2O)c1";"IC50";"'='";"1490.0";"nM";"5.83";"";"";"UO_0000065";"11.15";"0.22";"1.15";"7.09";"0";"CHEMBL2049562";"Inhibition of human recombinant CatD using Mca-GKPILFFRLK(DNP)-dR-NH2 as substrate after 1 hr by fluorescence analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2046351";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL2047908";"";"None";"500.64";"1";"3.20";"45a";"CC(C)(C)c1cccc(CN[C@H]2CS(=O)(=O)C[C@@H](Cc3cc(F)c(N)c(-c4cc[nH]n4)c3)[C@@H]2O)c1";"IC50";"'='";"600.0";"nM";"6.22";"";"";"UO_0000065";"12.43";"0.24";"3.02";"5.14";"0";"CHEMBL2049562";"Inhibition of human recombinant CatD using Mca-GKPILFFRLK(DNP)-dR-NH2 as substrate after 1 hr by fluorescence analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2046351";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL2048054";"";"None";"620.71";"1";"3.78";"60q";"COCCOC[C@@H](Oc1cc(C[C@@H]2CS(=O)(=O)C[C@H](NCc3cccc(C(C)(C)C)c3)[C@H]2O)cc(F)c1N)C(F)(F)F";"IC50";"'='";"250.0";"nM";"6.60";"";"";"UO_0000065";"10.64";"0.21";"2.82";"5.50";"0";"CHEMBL2049562";"Inhibition of human recombinant CatD using Mca-GKPILFFRLK(DNP)-dR-NH2 as substrate after 1 hr by fluorescence analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2046351";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL3906965";"";"None";"409.36";"0";"4.09";"BDBM214905";"CC#Cc1cncc(-c2ccc(F)c([C@]3(CF)C[C@@H](C(F)(F)F)OC(N)=N3)c2)c1";"IC50";"'='";"220000.0";"nM";"";"Outside typical range";"377935";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3948514";"";"None";"395.33";"0";"3.70";"BDBM214913";"C#Cc1ccc(-c2ccc(F)c([C@]3(CF)C[C@@H](C(F)(F)F)OC(N)=N3)c2)cn1";"IC50";"'>'";"400000.0";"nM";"";"Outside typical range";"377937";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3908739";"";"None";"432.42";"0";"3.35";"BDBM214920";"COC1CCN(C(=O)Nc2ccc(F)c([C@]3(C)C[C@@H](C(F)(F)F)OC(N)=N3)c2)CC1";"IC50";"'>'";"400000.0";"nM";"";"Outside typical range";"377974";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3910073";"";"None";"493.23";"0";"4.26";"BDBM214982";"C[C@@]1(c2cc(NC(=O)c3ccc(Br)cn3)cc(F)c2F)C[C@@H](C(F)(F)F)OC(N)=N1";"IC50";"'='";"424000.0";"nM";"";"Outside typical range";"378022";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3952931";"";"None";"420.34";"0";"3.32";"BDBM214926";"N#Cc1ccc(C#Cc2ccc(F)c([C@]3(CF)C[C@@H](C(F)(F)F)OC(N)=N3)c2)nc1";"IC50";"'>'";"400000.0";"nM";"";"Outside typical range";"378026";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3964029";"";"None";"471.36";"0";"3.62";"BDBM215040";"Cc1cc(C#N)cnc1C(=O)Nc1cc(F)c(F)c([C@]2(CF)C[C@@H](C(F)(F)F)OC(N)=N2)c1";"IC50";"'='";"568100.0";"nM";"";"Outside typical range";"378038";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3966537";"";"None";"473.40";"0";"3.32";"BDBM215025";"COc1cnc(C(=O)Nc2cc(C)c(F)c([C@]3(CF)C[C@@H](C(F)(F)F)OC(N)=N3)c2)c(C)n1";"IC50";"'='";"634000.0";"nM";"";"Outside typical range";"378041";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL399862";"";"None";"570.72";"1";"2.20";"19";"CCNc1cc(C(=O)N[C@@H](Cn2cccn2)[C@H](O)CNCc2cccc(OC)c2)cc(N2CCCCS2(=O)=O)c1";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL945838";"Inhibition of Cathepsin D expressed in CHO cells by FRET assay";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140838";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"CHEMBL3308072";"";"";""
"CHEMBL252459";"";"None";"522.73";"1";"4.90";"14";"CCCCCC(C)(C)NC[C@@H](O)[C@H](Cc1ccccc1)NC(=O)c1cc(NCC)cc(N2CCCC2=O)c1";"IC50";"'='";"10720.0";"nM";"4.97";"";"";"UO_0000065";"9.51";"0.18";"0.07";"5.30";"0";"CHEMBL945833";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140837";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";"";"";""
"CHEMBL252263";"";"None";"522.73";"1";"4.75";"11";"CCNc1cc(C(=O)N[C@@H](Cc2ccccc2)[C@H](O)CNC(C)CCCC(C)C)cc(N2CCCC2=O)c1";"IC50";"'='";"1095.0";"nM";"5.96";"";"";"UO_0000065";"11.40";"0.21";"1.21";"6.36";"0";"CHEMBL945833";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140837";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";"";"";""
"CHEMBL4755672";"";"None";"651.69";"1";"1.60";"22e";"COc1ccc(CC(=O)NC(=N)N[C@H](CCSC)C(=O)Nc2cc(S(N)(=O)=O)ccc2C)cc1OC.O=C(O)C(F)(F)F";"IC50";"'='";"127.0";"nM";"6.90";"";"";"UO_0000065";"12.83";"0.26";"5.30";"3.99";"0";"CHEMBL4706202";"Inhibition of human liver Cathepsin D preincubated for 10 mins followed by substrate addition and further incubated for 2 hrs in dark by fluorimetric analysis";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699662";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"TIME = 2.167 hr";"INHIBITOR";""
"CHEMBL3919475";"";"None";"416.40";"0";"4.32";"BDBM202620";"C[C@@]1(c2cc(Nc3cccc4cc(OC(F)F)cnc34)ccc2F)COCC(N)=N1";"IC50";"'='";"21100.0";"nM";"4.68";"";"359419";"UO_0000065";"11.23";"0.21";"0.36";"5.72";"0";"CHEMBL3887877";"Fluorescent Substrate Kinetic Assay: A substrate peptide is labeled at the N-terminus with tryptophan and at the C-terminus with the fluorophore MR121 (for cathepsin D the 10 amino acid peptide WTSVLMAAPC-MR121 was used; for cathepsin E, MR121-CKLVFFAEDW was used). The fluorescent substrate cathepsin D and cathepsin E kinetic assays were performed at room temperature in 384-well microtiter plates (black with clear flat bottom, non binding surface plates from Corning) in a final volume of 51 ul. The test compounds were serially diluted in DMSO (15 concentrations, 1/3 dilution steps) and 1 ul of diluted compounds were mixed for 10 min with 40 ul of cathepsin D (from human liver, Calbiochem) diluted in assay buffer (100 mM sodium acetate, 0.05% BSA, pH 5.5; final concentration: 200 nM) or with 40 ul of recombinant human cathepsin E (R&D Systems) diluted in assay buffer (100 mM sodium acetate, 0.05% BSA, pH 4.5; final concentration: 0.01 nM). After addition of 10 ul of the cathepsin D substrate WTSVLMAAPC-MR121 diluted in cathepsin D assay buffer (final concentration: 300 nM) or 10 ul of the cathepsin E substrate MR121-CKLVFFAEDW diluted in cathepsin E assay buffer (final concentration: 300 nM), the plates were strongly shaken for 2 minutes. The enzymatic reaction was followed in a plate: vision reader (Perkin Elmer) (excitation wavelength: 630 nm; emission: 695 nm) for at least 30 minutes in a kinetic measurement detecting an increase of MR121 fluorescence during the reaction time.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886483";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3981834";"";"None";"497.31";"0";"2.98";"BDBM220771";"COc1cnc(C(=O)Nc2ccc3c(c2)C2(CCOC(N)=N2)c2cc(Br)cnc2O3)cn1";"IC50";"'>'";"1650.0";"nM";"";"";"386454";"UO_0000065";"";"";"";"";"0";"CHEMBL3888270";"Fluorescence Resonance Energy Transfer (FRET) Assay: Recombinant CathepsinD was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The CathepsinD enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for CathepsinD) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886633";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3893589";"";"None";"458.48";"0";"3.09";"BDBM220814";"COc1cnc(C(=O)Nc2ccc3c(c2)C2(CCOC(N)=N2)c2cc(C4CC4)ncc2O3)cn1";"IC50";"'='";"962700.0";"nM";"";"Outside typical range";"386500";"UO_0000065";"";"";"";"";"0";"CHEMBL3888270";"Fluorescence Resonance Energy Transfer (FRET) Assay: Recombinant CathepsinD was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The CathepsinD enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for CathepsinD) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886633";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3913825";"";"None";"517.52";"1";"3.76";"BDBM220831";"COc1nc(C2=CCOCC2)cc2c1Oc1ccc(NC(=O)c3ccc(F)cn3)cc1C21CCOC(N)=N1";"IC50";"'='";"400000.0";"nM";"";"Outside typical range";"386517";"UO_0000065";"";"";"";"";"0";"CHEMBL3888270";"Fluorescence Resonance Energy Transfer (FRET) Assay: Recombinant CathepsinD was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The CathepsinD enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for CathepsinD) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886633";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3965056";"";"None";"468.39";"0";"3.75";"BDBM214808";"COc1cnc2c(Nc3ccc(F)c([C@]4(CF)C[C@@H](C(F)(F)F)OC(N)=N4)c3)nccc2n1";"IC50";"'>'";"400000.0";"nM";"";"Outside typical range";"377852";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL2069613";"";"None";"872.51";"3";"6.76";"3";"CCCCNC(=O)C[C@H](O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)c1ccc(Oc2ccc(C(=O)N[C@@H](C)C(=O)NCCCNc3ccnc4cc(Cl)ccc34)cc2)cc1)[C@@H](C)CC";"IC50";"'='";"540.0";"nM";"6.27";"";"";"UO_0000065";"7.18";"0.14";"-0.49";"3.14";"0";"CHEMBL2072160";"Inhibition of human cathepsin D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2069175";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL4854306";"";"None";"404.90";"0";"2.07";"29";"Cc1ccc(Cl)cc1N1CCN(C(=O)CCC2(C3CC3)NC(=O)NC2=O)CC1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4835182";"Inhibition of Cathepsin D (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4834410";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"";""
"CHEMBL3683824";"";"None";"374.80";"0";"3.08";"BDBM171434";"C[C@]1(c2cc(NC(=O)c3ccc(Cl)cn3)ccc2F)N=C(N)O[C@@H]2C[C@@H]21";"IC50";"'='";"476180.0";"nM";"";"Outside typical range";"315843";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3683885";"";"None";"454.84";"0";"3.64";"BDBM171500";"COc1cc(Cl)cnc1C(=O)Nc1cc(C)c(F)c([C@@]2(C(F)F)N=C(N)O[C@@H]3C[C@@H]32)c1";"IC50";"'='";"1109400.0";"nM";"";"Outside typical range";"315909";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3683888";"";"None";"431.83";"0";"3.20";"BDBM171503";"Cc1cc(C#N)cnc1C(=O)Nc1cc(F)c(Cl)c([C@]2(CF)N=C(N)O[C@H]3C[C@H]32)c1";"IC50";"'='";"539090.0";"nM";"";"Outside typical range";"315912";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688662";"";"None";"423.37";"0";"3.01";"BDBM171600";"Cc1cc(C(F)F)cnc1C(=O)Nc1cnc(F)c([C@@]2(CF)N=C(N)O[C@@H]3C[C@@H]32)c1";"IC50";"'>'";"14800.0";"nM";"";"";"316009";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688747";"";"None";"411.77";"0";"2.72";"BDBM171691";"NC1=N[C@@](c2nc(NC(=O)c3ccc(Cl)cn3)ccc2F)(C(F)F)[C@H]2C[C@H]2O1";"IC50";"'='";"212500.0";"nM";"";"Outside typical range";"316095";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL1824140";"";"None";"417.52";"0";"2.81";"34";"CN1C(=O)C(c2cccc(-c3cncnc3)c2)(c2cnn(CCC(C)(C)C)c2)N=C1N";"IC50";"'='";"3800.0";"nM";"5.42";"";"";"UO_0000065";"12.98";"0.24";"2.61";"5.30";"0";"CHEMBL1825607";"Inhibition of cathepsin D by FRET assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1821667";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL1824340";"";"None";"406.47";"0";"2.77";"43";"CC(C)Cn1cc(C2(c3cccc(-c4cccnc4F)c3)N=C(N)N(C)C2=O)cn1";"IC50";"'='";"1470.0";"nM";"5.83";"";"";"UO_0000065";"14.35";"0.27";"3.06";"6.52";"0";"CHEMBL1825607";"Inhibition of cathepsin D by FRET assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1821667";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL2349471";"";"None";"308.39";"0";"2.66";"(R)-63";"CC1(C)Cc2ccc(-c3cncnc3)cc2[C@@]2(COC(N)=N2)C1";"IC50";"'='";"88464.0";"nM";"4.05";"";"";"UO_0000065";"13.14";"0.24";"1.39";"5.52";"0";"CHEMBL2352017";"Inhibition of human spleen cathepsin D using 5-FAM/QXL as peptide substrate after 1 hr by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"CHEMBL3559722";"Spleen";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346596";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL3321926";"";"None";"540.66";"1";"3.56";"25";"COc1ccc(CNC(=O)[C@@H](CC2CCCCC2)NC(=N)NC(=O)Cc2ccc(OC)c(OC)c2)cc1OC";"IC50";"'='";"120.0";"nM";"6.92";"";"";"UO_0000065";"12.80";"0.24";"3.36";"5.28";"0";"CHEMBL3371146";"Inhibition of human liver cathepsin D using MCA-labeled GKPILFFRLK(Dnp)-D-R-NH2 peptide by fluorescence-based assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351526";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL2425611";"";"None";"516.60";"1";"4.09";"11c";"CC(C)(C)c1cccc(CN[C@H]2C[S@+]([O-])C[C@@H](Cc3cc(F)c(N)c(OCC(F)(F)F)c3)[C@@H]2O)c1";"IC50";"'='";"1200.0";"nM";"5.92";"";"";"UO_0000065";"11.46";"0.23";"1.83";"6.54";"0";"CHEMBL2427050";"Inhibition of human cathepsin-D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2424550";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"None";"";"";""
"CHEMBL1615184";"";"None";"544.71";"1";"3.40";"23";"CCCN1C(=O)OC[C@@H]1Cc1cc(C[C@@H]2CS(=O)(=O)C[C@H](NCc3cccc(C(C)C)c3)[C@H]2O)ccc1O";"IC50";"'='";"6400.0";"nM";"5.19";"";"";"UO_0000065";"9.54";"0.19";"1.79";"4.47";"0";"CHEMBL1764636";"Inhibition of human cathepsin D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1759891";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL252495";"";"None";"526.68";"1";"4.22";"25";"CCNc1cc(C(=O)N[C@@H](Cc2ccccc2)[C@H](O)CN[C@@H]2CCc3ccccc32)cc(N2CCCC2=O)c1";"IC50";"'='";"10230.0";"nM";"4.99";"";"";"UO_0000065";"9.47";"0.17";"0.77";"5.33";"0";"CHEMBL945833";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140837";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";"";"";""
"CHEMBL404501";"";"None";"514.67";"1";"3.78";"23";"CCNc1cc(C(=O)N[C@@H](Cc2ccccc2)[C@H](O)CNCCc2ccccc2)cc(N2CCCC2=O)c1";"IC50";"'='";"1780.0";"nM";"5.75";"";"";"UO_0000065";"11.17";"0.21";"1.97";"6.14";"0";"CHEMBL945833";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140837";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";"";"";""
"CHEMBL252058";"";"None";"510.70";"1";"3.43";"9";"CCNc1cc(C(=O)N[C@@H](Cc2ccccc2)[C@H](O)CNC2CCSCC2)cc(N2CCCC2=O)c1";"IC50";"'='";"1550.0";"nM";"5.81";"";"";"UO_0000065";"11.38";"0.22";"2.38";"6.20";"0";"CHEMBL945833";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140837";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";"";"";""
"CHEMBL3914387";"";"None";"457.33";"0";"3.99";"BDBM214957";"[C-]#[N+]c1ccc(C(=O)Nc2cc(F)c(F)c([C@]3(CF)C[C@@H](C(F)(F)F)OC(N)=N3)c2)nc1";"IC50";"'='";"2200000.0";"nM";"";"Outside typical range";"377991";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3902460";"";"None";"480.37";"0";"4.35";"BDBM214968";"N#Cc1cnc2c(Nc3cc(F)c(F)c([C@]4(CF)C[C@@H](C(F)(F)F)OC(N)=N4)c3)nccc2c1";"IC50";"'>'";"400000.0";"nM";"";"Outside typical range";"378002";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3979325";"";"None";"496.41";"0";"4.20";"BDBM214964";"NC1=N[C@](CF)(c2cc(NC(=O)c3ccc(C#CC4CC4)cn3)cc(F)c2F)C[C@@H](C(F)(F)F)O1";"IC50";"'>'";"400000.0";"nM";"";"Outside typical range";"378003";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3955255";"";"None";"512.40";"1";"3.46";"BDBM215011";"C[C@@]1(c2cc(NC(=O)c3cnc(OCc4ncco4)cn3)cc(F)c2F)C[C@@H](C(F)(F)F)OC(N)=N1";"IC50";"'='";"1045000.0";"nM";"";"Outside typical range";"378058";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3683848";"";"None";"427.24";"0";"3.83";"BDBM171458";"NC1=N[C@](c2cc(NC(=O)c3ccc(Cl)cn3)ccc2Cl)(C(F)F)[C@@H]2C[C@@H]2O1";"IC50";"'='";"769500.0";"nM";"";"Outside typical range";"315867";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3683849";"";"None";"417.80";"0";"3.05";"BDBM171459";"N#Cc1ccc(C(=O)Nc2ccc(Cl)c([C@@]3(C(F)F)N=C(N)O[C@@H]4C[C@@H]43)c2)nc1";"IC50";"'='";"1301300.0";"nM";"";"Outside typical range";"315868";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3683870";"";"None";"392.79";"0";"3.02";"BDBM171484";"NC1=N[C@@](CF)(c2cc(NC(=O)c3ccc(Cl)cn3)ccc2F)[C@@H]2C[C@@H]2O1";"IC50";"'='";"1279100.0";"nM";"";"Outside typical range";"315893";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3683890";"";"None";"446.84";"0";"3.04";"BDBM171506";"C#CCOc1ccc(C(=O)Nc2cc(F)c(Cl)c([C@]3(CF)N=C(N)O[C@H]4C[C@H]43)c2)nc1";"IC50";"'='";"86900.0";"nM";"4.06";"";"315915";"UO_0000065";"9.09";"0.18";"1.02";"4.11";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3683899";"";"None";"416.31";"0";"3.20";"BDBM171516";"NC1=N[C@@](c2cc(NC(=O)c3coc(C(F)F)n3)ccc2F)(C(F)F)[C@H]2C[C@H]2O1";"IC50";"'='";"238370.0";"nM";"";"Outside typical range";"315925";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3683916";"";"None";"490.47";"0";"3.10";"BDBM171536";"NC1=N[C@@](c2cc(NC(=O)c3cnc(OCc4cncs4)cn3)ccc2F)(C(F)F)[C@H]2C[C@H]2O1";"IC50";"'='";"444850.0";"nM";"";"Outside typical range";"315945";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688669";"";"None";"395.43";"0";"3.93";"BDBM171607";"NC1=N[C@@](c2cc(NC(=O)CC3CCCCC3)ccc2F)(C(F)F)[C@H]2C[C@H]2O1";"IC50";"'>'";"400000.0";"nM";"";"Outside typical range";"316016";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688788";"";"None";"468.36";"0";"4.12";"BDBM171735";"NC1=N[C@@](c2cc(Nc3nccc4nc(C(F)(F)F)cnc34)ccc2F)(C(F)F)[C@H]2C[C@H]2O1";"IC50";"'>'";"44400.0";"nM";"";"";"316139";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL1210349";"";"None";"675.68";"2";"5.22";"28";"C[C@H](NC[C@@H](O)[C@H](Cc1ccccc1)NC(=O)c1cccc(N(c2cc(Cl)cc(Cl)c2)S(C)(=O)=O)c1)C(=O)NC1CCCCC1";"IC50";"'='";"170.0";"nM";"6.77";"";"";"UO_0000065";"10.02";"0.21";"1.55";"5.30";"0";"CHEMBL1211667";"Inhibition of Cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1208699";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL271230";"";"None";"520.67";"1";"2.94";"1";"C[C@H](NC[C@@H](O)[C@H](Cc1ccccc1)NC(=O)c1cccc(N2CCCC2=O)c1)C(=O)NC1CCCCC1";"IC50";"'='";"26000.0";"nM";"4.58";"";"";"UO_0000065";"8.81";"0.16";"1.65";"4.14";"0";"CHEMBL1211667";"Inhibition of Cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1208699";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL1210359";"";"None";"649.86";"1";"4.35";"41";"CCNc1cc(C(=O)N[C@@H](Cc2ccccc2)[C@H](O)CN[C@@H](C)C(=O)NC2CCCCC2)cc(N(c2ccccc2)S(C)(=O)=O)c1";"IC50";"'='";"630.0";"nM";"6.20";"";"";"UO_0000065";"9.54";"0.18";"1.85";"4.43";"0";"CHEMBL1211667";"Inhibition of Cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1208699";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL2349608";"";"None";"342.42";"0";"2.35";"40, rac-40";"CN1C(=O)C2(CC(C)(C)Oc3ccc(-c4ccns4)cc32)N=C1N";"IC50";"'='";"2829.0";"nM";"5.55";"";"";"UO_0000065";"16.20";"0.32";"3.20";"6.87";"0";"CHEMBL2352017";"Inhibition of human spleen cathepsin D using 5-FAM/QXL as peptide substrate after 1 hr by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"CHEMBL3559722";"Spleen";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346596";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL2349502";"";"None";"336.40";"0";"2.29";"32, rac-32";"CN1C(=O)C2(CC(C)(C)Oc3ccc(-c4ccccn4)cc32)N=C1N";"IC50";"'='";"37940.0";"nM";"4.42";"";"";"UO_0000065";"13.14";"0.24";"2.13";"5.47";"0";"CHEMBL2352017";"Inhibition of human spleen cathepsin D using 5-FAM/QXL as peptide substrate after 1 hr by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"CHEMBL3559722";"Spleen";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346596";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL2349619";"";"None";"383.42";"0";"3.04";"19, rac-19";"COc1ccc(F)c(-c2ccc3c(c2)C2(CC(C)(C)O3)N=C(N)N(C)C2=O)c1";"IC50";"'='";"249.0";"nM";"6.60";"";"";"UO_0000065";"17.22";"0.32";"3.56";"8.56";"0";"CHEMBL2352017";"Inhibition of human spleen cathepsin D using 5-FAM/QXL as peptide substrate after 1 hr by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"CHEMBL3559722";"Spleen";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346596";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL2349612";"";"None";"369.85";"0";"3.55";"12, rac-12";"CN1C(=O)C2(CC(C)(C)Oc3ccc(-c4cccc(Cl)c4)cc32)N=C1N";"IC50";"'='";"735.0";"nM";"6.13";"";"";"UO_0000065";"16.58";"0.32";"2.58";"9.03";"0";"CHEMBL2352017";"Inhibition of human spleen cathepsin D using 5-FAM/QXL as peptide substrate after 1 hr by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"CHEMBL3559722";"Spleen";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346596";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL231542";"";"None";"545.72";"1";"4.76";"19b";"CCCN(CCC)C(=O)c1cc(C)cc(C(=O)N[C@@H](Cc2ccccc2)[C@H](O)CNCc2cccc(OC)c2)c1";"IC50";"'='";"450.0";"nM";"6.35";"";"";"UO_0000065";"11.63";"0.22";"1.59";"6.98";"0";"CHEMBL888969";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1144655";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"None";"";"";""
"CHEMBL2349474";"";"None";"376.49";"0";"3.48";"44, rac-44";"CN1C(=O)C2(CC(C)(C)Sc3ccc(-c4cccc(C#N)c4)cc32)N=C1N";"IC50";"'='";"603.0";"nM";"6.22";"";"";"UO_0000065";"16.52";"0.31";"2.74";"7.54";"0";"CHEMBL2352017";"Inhibition of human spleen cathepsin D using 5-FAM/QXL as peptide substrate after 1 hr by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"CHEMBL3559722";"Spleen";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346596";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL493807";"";"None";"511.09";"0";"1.97";"9f";"CCNc1cc(C(=O)N[C@@H](Cc2ccccc2)[C@H](O)CNC)cc(N2CCCCS2(=O)=O)c1.Cl";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL959767";"Inhibition of cathepsin D expressed in CHO cells after 1 hrs by spectrophotometer";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1150334";"1";"Scientific Literature";"J Med Chem";"2008";"CHEMBL3308072";"";"";""
"CHEMBL2425606";"";"None";"565.63";"1";"3.38";"17m";"COC[C@@H](Oc1cc(C[C@@H]2C[S@@+]([O-])C[C@H](NCc3cc(CC(C)(C)C)on3)[C@H]2O)cc(F)c1N)C(F)(F)F";"IC50";"'='";"3570.0";"nM";"5.45";"";"";"UO_0000065";"9.63";"0.20";"2.07";"4.33";"0";"CHEMBL2427050";"Inhibition of human cathepsin-D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2424550";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"None";"";"";""
"CHEMBL2425608";"";"None";"584.60";"2";"5.02";"11a";"CC(C)(C)c1cccc(CN[C@H]2C[S@+]([O-])C[C@@H](Cc3cc(F)c(N)c(OC(C(F)(F)F)C(F)(F)F)c3)[C@@H]2O)c1";"IC50";"'='";"870.0";"nM";"6.06";"";"";"UO_0000065";"10.37";"0.21";"1.04";"6.69";"0";"CHEMBL2427050";"Inhibition of human cathepsin-D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2424550";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"None";"";"";""
"CHEMBL2347208";"";"None";"421.35";"0";"3.23";"89";"C[C@@]1(c2cc(NC(=O)c3ccc(C#N)cn3)ccc2F)C[C@@H](C(F)(F)F)OC(N)=N1";"IC50";"'>'";"200000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2353192";"Inhibition of human Cathepsin D using WTSVLMAAPC-MR121 as substrate";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346595";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL1092787";"";"None";"378.38";"0";"3.06";"rac-4g";"CN1C(=O)C(c2ccncc2)(c2cccc(-c3cc(F)ccc3F)c2)N=C1N";"IC50";"'='";"9400.0";"nM";"5.03";"";"";"UO_0000065";"13.29";"0.25";"1.97";"7.02";"0";"CHEMBL1115170";"Inhibition of cathepsin D by FRET assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156304";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL2349470";"";"None";"335.41";"0";"2.10";"(R)-50";"CN1C(=O)[C@]2(CC(C)(C)Cc3ccc(-c4cncnc4)cc32)N=C1N";"IC50";"'='";"5166.0";"nM";"5.29";"";"";"UO_0000065";"15.76";"0.29";"3.19";"6.26";"0";"CHEMBL2352017";"Inhibition of human spleen cathepsin D using 5-FAM/QXL as peptide substrate after 1 hr by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"CHEMBL3559722";"Spleen";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346596";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL3952111";"";"None";"518.51";"1";"3.16";"BDBM220797";"COc1cnc(C(=O)Nc2ccc3c(c2)C2(CCOC(N)=N2)c2cc(C4=CCOCC4)nc(F)c2O3)cn1";"IC50";"'='";"400000.0";"nM";"";"Outside typical range";"386483";"UO_0000065";"";"";"";"";"0";"CHEMBL3888270";"Fluorescence Resonance Energy Transfer (FRET) Assay: Recombinant CathepsinD was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The CathepsinD enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for CathepsinD) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886633";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL221543";"BETA-SITOSTENONE";"None";"412.70";"1";"8.23";"6";"CC[C@H](CC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)C";"IC50";"'='";"9400.0";"nM";"5.03";"";"";"UO_0000065";"12.18";"0.23";"-3.20";"29.45";"0";"CHEMBL3072144";"Inhibition of cathepsin D (unknown origin) using hemoglobin as substrate after 30 min by spectrophotometric analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3045990";"1";"Scientific Literature";"Med Chem Res";"2013";"None";"";"";""
"CHEMBL3915849";"";"None";"412.32";"0";"3.72";"BDBM214908";"N#Cc1cccnc1Oc1ccc(F)c([C@]2(CF)C[C@@H](C(F)(F)F)OC(N)=N2)c1";"IC50";"'='";"1400000.0";"nM";"";"Outside typical range";"377906";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3902829";"";"None";"477.37";"0";"3.66";"BDBM214884";"Cc1cc(OC(F)F)cnc1C(=O)Nc1ccc(F)c([C@]2(C)C[C@@H](C(F)(F)F)OC(N)=N2)n1";"IC50";"'='";"492000.0";"nM";"";"Outside typical range";"377930";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3985831";"";"None";"404.31";"0";"3.93";"BDBM214813";"NC1=N[C@](CF)(c2cc(Nc3ncccc3F)ccc2F)C[C@@H](C(F)(F)F)O1";"IC50";"'='";"879000.0";"nM";"";"Outside typical range";"377945";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3969182";"";"None";"416.35";"0";"3.80";"BDBM214814";"COc1cccnc1Nc1ccc(F)c([C@]2(CF)C[C@@H](C(F)(F)F)OC(N)=N2)c1";"IC50";"'='";"1080000.0";"nM";"";"Outside typical range";"377946";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL260673";"METHYL URSOLATE";"None";"470.74";"1";"7.18";"7";"COC(=O)[C@]12CC[C@@H](C)[C@H](C)[C@H]1C1=CC[C@@H]3[C@@]4(C)CC[C@H](O)C(C)(C)[C@@H]4CC[C@@]3(C)[C@]1(C)CC2";"IC50";"'='";"4.45";"ug.mL-1";"";"";"";"UO_0000274";"";"";"";"";"0";"CHEMBL3072144";"Inhibition of cathepsin D (unknown origin) using hemoglobin as substrate after 30 min by spectrophotometric analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3045990";"1";"Scientific Literature";"Med Chem Res";"2013";"None";"";"";""
"CHEMBL3977981";"";"None";"445.80";"0";"3.71";"BDBM214860";"Cc1cc(Cl)cnc1C(=O)Nc1cnc(F)c([C@]2(C)C[C@@H](C(F)(F)F)OC(N)=N2)c1";"IC50";"'>'";"400000.0";"nM";"";"Outside typical range";"377858";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3961045";"";"None";"462.38";"0";"4.40";"BDBM214987";"C[C@@]1(c2cc(Nc3nccc4cc(C#N)cnc34)cc(F)c2F)C[C@@H](C(F)(F)F)OC(N)=N1";"IC50";"'>'";"400000.0";"nM";"";"Outside typical range";"378016";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL1210363";"";"None";"694.78";"2";"5.42";"45";"CS(=O)(=O)N(c1ccccc1)c1cc(C(=O)N[C@@H](Cc2ccccc2)[C@H](O)CNCc2cccc(C(F)(F)F)c2)cc(N2CCCC2=O)c1";"IC50";"'='";"350.0";"nM";"6.46";"";"";"UO_0000065";"9.29";"0.18";"1.04";"5.42";"0";"CHEMBL1211667";"Inhibition of Cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1208699";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL253060";"";"None";"526.68";"1";"4.22";"24";"CCNc1cc(C(=O)N[C@@H](Cc2ccccc2)[C@H](O)CN[C@H]2CCc3ccccc32)cc(N2CCCC2=O)c1";"IC50";"'='";"5250.0";"nM";"5.28";"";"";"UO_0000065";"10.02";"0.18";"1.06";"5.63";"0";"CHEMBL945833";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140837";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";"";"";""
"CHEMBL252861";"";"None";"486.62";"0";"4.06";"22";"CCNc1cc(C(=O)N[C@@H](Cc2ccccc2)[C@H](O)CNc2ccccc2)cc(N2CCCC2=O)c1";"IC50";"'='";"4680.0";"nM";"5.33";"";"";"UO_0000065";"10.95";"0.20";"1.27";"5.69";"0";"CHEMBL945833";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140837";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";"";"";""
"CHEMBL254069";"";"None";"576.76";"1";"4.03";"13";"CCNc1cc(C(=O)N[C@@H](Cc2ccccc2)[C@H](O)CN[C@H]2CCc3ccccc32)cc(N2CCCCS2(=O)=O)c1";"IC50";"'='";"3090.0";"nM";"5.51";"";"";"UO_0000065";"9.55";"0.18";"1.48";"4.97";"0";"CHEMBL945838";"Inhibition of Cathepsin D expressed in CHO cells by FRET assay";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140838";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"CHEMBL3308072";"";"";""
"CHEMBL403207";"";"None";"596.69";"2";"5.49";"19";"CCNc1cc(C(=O)N[C@@H](Cc2ccccc2)[C@H](O)CNC(C)(C)c2cccc(C(F)(F)F)c2)cc(N2CCCC2=O)c1";"IC50";"'='";"930.0";"nM";"6.03";"";"";"UO_0000065";"10.11";"0.19";"0.54";"6.44";"0";"CHEMBL945833";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140837";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";"";"";""
"CHEMBL3948443";"";"None";"517.52";"1";"3.76";"BDBM220812";"COc1ccc(C(=O)Nc2ccc3c(c2)[C@@]2(CCOC(N)=N2)c2cc(C4=CCOCC4)nc(F)c2O3)nc1";"IC50";"'='";"184000.0";"nM";"";"Outside typical range";"386498";"UO_0000065";"";"";"";"";"0";"CHEMBL3888270";"Fluorescence Resonance Energy Transfer (FRET) Assay: Recombinant CathepsinD was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The CathepsinD enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for CathepsinD) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886633";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL256063";"";"None";"434.58";"0";"3.43";"35";"C[C@@H](O)CN/C(N)=N\C(=O)Cn1c(-c2ccccc2)ccc1C12CC3CC(CC(C3)C1)C2";"IC50";"'='";"12500.0";"nM";"4.90";"";"";"UO_0000065";"11.28";"0.21";"1.47";"5.29";"0";"CHEMBL930552";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1142260";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";"";"";""
"CHEMBL1824134";"";"None";"361.41";"0";"1.39";"28";"CCn1cc(C2(c3cccc(-c4cncnc4)c3)N=C(N)N(C)C2=O)cn1";"IC50";"'='";"75800.0";"nM";"4.12";"";"";"UO_0000065";"11.40";"0.21";"2.73";"4.03";"0";"CHEMBL1825607";"Inhibition of cathepsin D by FRET assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1821667";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL1824135";"";"None";"379.40";"0";"1.53";"29";"CCn1cc(C2(c3ccc(F)c(-c4cncnc4)c3)N=C(N)N(C)C2=O)cn1";"IC50";"'='";"28500.0";"nM";"4.54";"";"";"UO_0000065";"11.98";"0.22";"3.02";"4.44";"0";"CHEMBL1825607";"Inhibition of cathepsin D by FRET assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1821667";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL3980634";"";"None";"446.35";"0";"3.75";"BDBM215031";"Cc1cc(NC(=O)c2ccc(F)cn2)cc([C@]2(CF)C[C@@H](C(F)(F)F)OC(N)=N2)c1F";"IC50";"'='";"832900.0";"nM";"";"Outside typical range";"378047";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3968489";"";"None";"513.35";"1";"3.83";"BDBM214993";"C[C@@]1(c2cc(NC(=O)c3cnc(OCC(F)(F)F)cn3)cc(F)c2F)C[C@@H](C(F)(F)F)OC(N)=N1";"IC50";"'>'";"400000.0";"nM";"";"Outside typical range";"378069";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3930009";"";"None";"487.76";"0";"4.34";"BDBM215003";"C[C@@]1(c2cc(NC(=O)c3nn(C(F)F)cc3Cl)cc(F)c2F)C[C@@H](C(F)(F)F)OC(N)=N1";"IC50";"'='";"627600.0";"nM";"";"Outside typical range";"378070";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3912456";"";"None";"445.34";"0";"3.63";"BDBM214907";"COC(=O)c1ccnc(Oc2ccc(F)c([C@]3(CF)C[C@@H](C(F)(F)F)OC(N)=N3)c2)c1";"IC50";"'>'";"400000.0";"nM";"";"Outside typical range";"377904";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3986014";"";"None";"455.31";"0";"4.86";"BDBM214911";"NC1=N[C@](CF)(c2cc(Oc3cccc(C(F)(F)F)n3)ccc2F)C[C@@H](C(F)(F)F)O1";"IC50";"'='";"1820000.0";"nM";"";"Outside typical range";"377911";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3923394";"";"None";"448.41";"0";"2.77";"BDBM214955";"[C-]#[N+]c1cnc(C(=O)Nc2cc([C@]3(C)C[C@@H](C(F)(F)F)OC(N)=N3)c(=O)n(C)c2)c(C)c1";"IC50";"'>'";"400000.0";"nM";"";"Outside typical range";"377927";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3924137";"";"None";"439.34";"0";"3.77";"BDBM214919";"NC1=N[C@](CF)(c2cc(-c3cncc(-c4nnco4)c3)ccc2F)C[C@@H](C(F)(F)F)O1";"IC50";"'='";"454000.0";"nM";"";"Outside typical range";"377943";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3905256";"";"None";"442.80";"1";"5.25";"BDBM214830";"C[C@@]1(c2cc(Nc3nc4cc(Cl)ccc4o3)ccc2F)C[C@@H](C(F)(F)F)OC(N)=N1";"IC50";"'='";"162000.0";"nM";"";"Outside typical range";"377944";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3966080";"";"None";"527.37";"1";"3.95";"BDBM214838";"Cc1nc(OCC(F)(F)F)cnc1C(=O)Nc1ccc(F)c([C@]2(CF)C[C@@H](C(F)(F)F)OC(N)=N2)c1";"IC50";"'>'";"400000.0";"nM";"";"Outside typical range";"377959";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3962299";"";"None";"377.31";"0";"2.55";"BDBM214989";"NC1=N[C@](CF)(c2cc(C(=O)NC3CC3)ccc2F)C[C@@H](C(F)(F)F)O1";"IC50";"'='";"3490000.0";"nM";"";"Outside typical range";"377972";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3968711";"";"None";"488.75";"0";"3.55";"BDBM214937";"NC1=N[C@](CF)(c2nc(NC(=O)c3nn(C(F)F)cc3Cl)ccc2F)C[C@@H](C(F)(F)F)O1";"IC50";"'='";"1170000.0";"nM";"";"Outside typical range";"377982";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3903133";"";"None";"439.34";"0";"4.04";"BDBM214970";"[C-]#[N+]c1ccc(C(=O)Nc2cc(F)c(F)c([C@]3(C)C[C@@H](C(F)(F)F)OC(N)=N3)c2)nc1";"IC50";"'='";"1790000.0";"nM";"";"Outside typical range";"378014";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3911484";"";"None";"467.40";"0";"4.54";"BDBM214986";"COc1cnc2c(Nc3cc(F)c(F)c([C@]4(C)C[C@@H](C(F)(F)F)OC(N)=N4)c3)nccc2c1";"IC50";"'>'";"400000.0";"nM";"";"Outside typical range";"378019";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3683893";"";"None";"407.35";"0";"1.91";"BDBM171510";"COc1cnc(C(=O)Nc2cc(F)c(F)c([C@]3(CF)N=C(N)O[C@H]4C[C@H]43)c2)cn1";"IC50";"'='";"1336800.0";"nM";"";"Outside typical range";"315919";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688620";"";"None";"488.39";"0";"3.92";"BDBM171555";"Cc1cc(OCC(F)(F)F)cnc1C(=O)Nc1ccc(F)c([C@@]2(C(F)F)N=C(N)O[C@@H]3C[C@@H]32)c1";"IC50";"'='";"770000.0";"nM";"";"Outside typical range";"315964";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688639";"";"None";"410.78";"0";"3.48";"BDBM171574";"NC1=N[C@](c2cccc(NC(=O)c3ccc(Cl)cn3)c2)(C(F)(F)F)[C@@H]2C[C@@H]2O1";"IC50";"'='";"489480.0";"nM";"";"Outside typical range";"315983";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688687";"";"None";"445.40";"0";"2.96";"BDBM171625";"C[C@H](C#N)Oc1ccc(C(=O)Nc2ccc(F)c([C@@]3(C(F)F)N=C(N)O[C@@H]4C[C@@H]43)c2)nc1";"IC50";"'='";"668250.0";"nM";"";"Outside typical range";"316034";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688692";"";"None";"392.79";"0";"3.18";"BDBM171630";"NC1=N[C@](c2cccc(NC(=O)c3ccc(Cl)cn3)c2)(C(F)F)[C@@H]2C[C@@H]2O1";"IC50";"'>'";"400000.0";"nM";"";"Outside typical range";"316039";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL399656";"";"None";"568.74";"1";"2.76";"15";"CCNc1cc(C(=O)N[C@@H](Cc2ccccc2)[C@H](O)CNCc2cnn(CC)c2)cc(N2CCCCS2(=O)=O)c1";"IC50";"'='";"56230.0";"nM";"4.25";"";"";"UO_0000065";"7.47";"0.15";"1.49";"3.31";"0";"CHEMBL945838";"Inhibition of Cathepsin D expressed in CHO cells by FRET assay";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140838";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"CHEMBL3308072";"";"";""
"CHEMBL401474";"";"None";"632.75";"1";"4.95";"9";"CC(C)Nc1cc(C(=O)N[C@@H](Cc2ccccc2)[C@H](O)CNCc2cccc(C(F)(F)F)c2)cc(N2CCCCS2(=O)=O)c1";"IC50";"'='";"25120.0";"nM";"4.60";"";"";"UO_0000065";"7.27";"0.14";"-0.35";"4.15";"0";"CHEMBL945838";"Inhibition of Cathepsin D expressed in CHO cells by FRET assay";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140838";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"CHEMBL3308072";"";"";""
"CHEMBL3898408";"";"None";"462.84";"0";"3.78";"BDBM214870";"CC(C)n1cc(Cl)c(C(=O)Nc2cnc(F)c([C@]3(C)C[C@@H](C(F)(F)F)OC(N)=N3)c2)n1";"IC50";"'>'";"400000.0";"nM";"";"Outside typical range";"377989";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL402122";"";"None";"478.64";"0";"3.48";"8";"CCNc1cc(C(=O)N[C@@H](Cc2ccccc2)[C@H](O)CNC2CCCC2)cc(N2CCCC2=O)c1";"IC50";"'='";"10960.0";"nM";"4.96";"";"";"UO_0000065";"10.36";"0.19";"1.48";"5.29";"0";"CHEMBL945833";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140837";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";"";"";""
"CHEMBL2334376";"";"None";"559.75";"2";"5.18";"(S,R)-4b";"CCCN(CCC)C(=O)c1cccc(C(=O)N[C@@H](Cc2ccccc2)[C@H](O)CNC(C)(C)c2cccc(OC)c2)c1";"IC50";"'='";"1150.0";"nM";"5.94";"";"";"UO_0000065";"10.61";"0.20";"0.76";"6.53";"0";"CHEMBL4331648";"Inhibition of human cathepsin D using DABCYL-Glu-Arg-Nle-Phe-Leu-Ser-Phe-Pro-EDANS as substrate preincubated for 30 mins followed by substrate addition and measured every min for 8 to 15 mins by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4330085";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";"";"";""
"CHEMBL2407344";"";"None";"490.69";"1";"5.18";"13";"CCc1ccc2c(c1)[C@@H](NC[C@@H](O)[C@@H]1Cc3cccc(c3)CCCCCCC(=O)N1)CC1(CCC1)O2";"IC50";"'='";"370.0";"nM";"6.43";"";"";"UO_0000065";"13.11";"0.24";"1.25";"9.11";"0";"CHEMBL2411009";"Inhibition of Cathepsin D (unknown origin) by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2406987";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"None";"";"";""
"CHEMBL2407340";"";"None";"660.65";"2";"5.83";"16";"C=CCc1cccc(C[C@H](NC(=O)c2cc(Br)c(=O)n(CC=C)c2)[C@H](O)CN[C@H]2CC3(CCC3)Oc3ccc(CC)cc32)c1";"IC50";"'<'";"2.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2411009";"Inhibition of Cathepsin D (unknown origin) by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2406987";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"None";"";"";""
"CHEMBL2407342";"";"None";"650.86";"2";"5.66";"18";"C=CCc1cccc(C[C@H](NC(=O)c2cc(N3CCCC3)c(=O)n(CC=C)c2)[C@H](O)CN[C@H]2CC3(CCC3)Oc3ccc(CC)cc32)c1";"IC50";"'='";"29.0";"nM";"7.54";"";"";"UO_0000065";"11.58";"0.21";"1.88";"7.87";"0";"CHEMBL2411009";"Inhibition of Cathepsin D (unknown origin) by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2406987";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"None";"";"";""
"CHEMBL402330";"";"None";"376.50";"0";"3.42";"4";"NC(N)=NC(=O)Cn1c(-c2ccccc2)ccc1C12CC3CC(CC(C3)C1)C2";"IC50";"'='";"25000.0";"nM";"4.60";"";"";"UO_0000065";"12.22";"0.22";"1.18";"5.33";"0";"CHEMBL930552";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1142260";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";"";"";""
"CHEMBL401832";"";"None";"450.58";"0";"2.41";"37";"N/C(=N/C(=O)Cn1c(-c2ccccc2)ccc1C12CC3CC(CC(C3)C1)C2)NCC(O)CO";"IC50";"'='";"73500.0";"nM";"4.13";"";"";"UO_0000065";"9.17";"0.17";"1.72";"3.66";"0";"CHEMBL930552";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1142260";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";"";"";""
"CHEMBL403819";"";"None";"434.58";"0";"3.44";"31";"N/C(=N/C(=O)Cn1c(-c2ccccc2)ccc1C12CC3CC(CC(C3)C1)C2)NCCCO";"IC50";"'='";"19900.0";"nM";"4.70";"";"";"UO_0000065";"10.82";"0.20";"1.26";"5.07";"0";"CHEMBL930552";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1142260";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";"";"";""
"CHEMBL3394039";"";"None";"430.44";"0";"3.78";"10";"NC1=N[C@@]2(CO1)c1cc(-c3cccnc3F)ccc1Oc1cnc(C3=CCOCC3)cc12";"IC50";"'='";"640.0";"nM";"6.19";"";"";"UO_0000065";"14.39";"0.26";"2.41";"6.74";"0";"CHEMBL3395116";"Inhibition of cathepsin D (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3393054";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";""
"CHEMBL3394042";"";"None";"432.46";"0";"3.87";"13";"NC1=N[C@@]2(CO1)c1cc(-c3cccnc3F)ccc1Oc1cnc(C3CCOCC3)cc12";"IC50";"'='";"3390.0";"nM";"5.47";"";"";"UO_0000065";"12.65";"0.23";"1.60";"5.96";"0";"CHEMBL3395116";"Inhibition of cathepsin D (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3393054";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";""
"CHEMBL3394053";"";"None";"425.42";"0";"4.04";"24";"NC1=N[C@@]2(CO1)c1cc(-c3cccnc3F)ccc1Oc1cnc(-c3ccccn3)cc12";"IC50";"'='";"4100.0";"nM";"5.39";"";"";"UO_0000065";"12.66";"0.23";"1.35";"5.64";"0";"CHEMBL3395116";"Inhibition of cathepsin D (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3393054";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";""
"CHEMBL124380";"";"None";"658.88";"2";"5.71";"19i";"CCCN(CCC)C(=O)c1cc(C(=O)N[C@@H](Cc2ccccc2)[C@H](O)CNCc2cccc(OC)c2)cc(C(=O)N(CCC)CCC)c1";"IC50";"'='";"3600.0";"nM";"5.44";"";"";"UO_0000065";"8.26";"0.15";"-0.27";"4.89";"0";"CHEMBL888969";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1144655";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"None";"";"";""
"CHEMBL396010";"";"None";"532.64";"1";"2.43";"19h";"CCCNC(=O)c1cc(C(N)=O)cc(C(=O)N[C@@H](Cc2ccccc2)[C@H](O)CNCc2cccc(OC)c2)c1";"IC50";"'>'";"20000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL888969";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1144655";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"None";"";"";""
"CHEMBL566548";"";"None";"483.47";"0";"4.85";"45";"CC1(C)CN2C(N)=NC(c3ccc(OC(F)(F)F)cc3)(c3cccc(-c4cccnc4F)c3)C2=N1";"IC50";"'='";"33000.0";"nM";"4.48";"";"";"UO_0000065";"9.27";"0.17";"-0.37";"5.89";"0";"CHEMBL1061266";"Inhibition of human cathepsin D by FRET";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1155232";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL584521";"";"None";"452.44";"0";"3.72";"35";"NC1=NC(c2ccc(OC(F)(F)F)cc2)(c2cccc(-c3cncnc3)c2)C2=NCCCN12";"IC50";"'='";"78700.0";"nM";"4.10";"";"";"UO_0000065";"9.07";"0.17";"0.38";"4.61";"0";"CHEMBL1061266";"Inhibition of human cathepsin D by FRET";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1155232";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL490305";"";"None";"453.67";"0";"3.44";"3d";"CCCCNC(=O)[C@H](C)C[C@H](O)[C@@H]1C[C@H](C)CCCCCCCCC(=O)N[C@@H](C)C(=O)N1";"IC50";"'='";"1700.0";"nM";"5.77";"";"";"UO_0000065";"12.72";"0.25";"2.33";"5.37";"1";"CHEMBL963292";"Inhibition of human cathepsin D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1153267";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL2425600";"";"None";"578.64";"1";"4.24";"17g";"COC[C@@H](Oc1cc(C[C@@H]2C[S@@+]([O-])C[C@H](NCc3cc(C(C)(C)C)ccc3F)[C@H]2O)cc(F)c1N)C(F)(F)F";"IC50";"'='";"290.0";"nM";"6.54";"";"";"UO_0000065";"11.30";"0.23";"2.30";"6.55";"0";"CHEMBL2427050";"Inhibition of human cathepsin-D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2424550";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"None";"";"";""
"CHEMBL3764405";"";"None";"397.48";"0";"4.57";"rac-3b";"Nc1nc2cc(-c3ccccc3)ccc2c(=O)n1C[C@@H]1CC[C@H](c2ccccc2)O1";"IC50";"'='";"13800.0";"nM";"4.86";"";"";"UO_0000065";"12.23";"0.22";"0.29";"6.93";"0";"CHEMBL3767017";"Inhibition of CatD (unknown origin) preincubated for 30 mins followed by DABCYL-Glu-Arg-Nle-Phe-Leu-Ser-Phe-Pro-EDANS substrate addition by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3763050";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";""
"CHEMBL3683843";"";"None";"472.83";"0";"3.93";"BDBM171453";"Cc1cc(OC(F)F)cnc1C(=O)Nc1cc(Cl)c(F)c([C@@]2(CF)N=C(N)O[C@@H]3C[C@@H]32)c1";"IC50";"'='";"164500.0";"nM";"";"Outside typical range";"315862";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3683853";"";"None";"427.24";"0";"3.83";"BDBM171463";"NC1=N[C@@](c2cc(NC(=O)c3ccc(Cl)cn3)ccc2Cl)(C(F)F)[C@H]2C[C@H]2O1";"IC50";"'='";"1281200.0";"nM";"";"Outside typical range";"315872";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3683858";"";"None";"423.81";"0";"2.58";"BDBM171470";"COc1cnc(C(=O)Nc2ccc(Cl)c([C@@]3(C(F)F)N=C(N)O[C@@H]4C[C@@H]43)c2)nc1";"IC50";"'='";"374140.0";"nM";"";"Outside typical range";"315879";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3683887";"";"None";"417.80";"0";"2.90";"BDBM171502";"N#Cc1ccc(C(=O)Nc2cc(F)c(Cl)c([C@]3(CF)N=C(N)O[C@H]4C[C@H]43)c2)nc1";"IC50";"'='";"490740.0";"nM";"";"Outside typical range";"315911";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3683910";"";"None";"431.78";"0";"3.22";"BDBM171530";"NC1=N[C@](CF)(c2cc(NC(=O)c3nn(C(F)F)cc3Cl)ccc2F)[C@H]2C[C@H]2O1";"IC50";"'='";"949930.0";"nM";"";"Outside typical range";"315939";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688613";"";"None";"415.82";"0";"3.99";"BDBM171547";"NC1=N[C@@](c2cc(NC(=O)c3csc(Cl)c3)ccc2F)(C(F)F)[C@H]2C[C@H]2O1";"IC50";"'='";"580110.0";"nM";"";"Outside typical range";"315956";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688648";"";"None";"428.77";"0";"3.62";"BDBM171584";"NC1=N[C@](c2cc(NC(=O)c3ccc(Cl)cn3)ccc2F)(C(F)(F)F)[C@@H]2C[C@@H]2O1";"IC50";"'>'";"400000.0";"nM";"";"Outside typical range";"315993";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688656";"";"None";"417.80";"0";"2.90";"BDBM171594";"N#Cc1cnc(C(=O)Nc2ccc(F)c([C@@]3(CF)N=C(N)O[C@@H]4C[C@@H]43)c2)c(Cl)c1";"IC50";"'='";"1013900.0";"nM";"";"Outside typical range";"316003";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688659";"";"None";"393.78";"0";"2.42";"BDBM171597";"NC1=N[C@](CF)(c2cc(NC(=O)c3ccc(Cl)cn3)cnc2F)[C@H]2C[C@H]2O1";"IC50";"'='";"389590.0";"nM";"";"Outside typical range";"316006";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL253641";"";"None";"636.71";"1";"4.70";"23";"CCNc1cc(C(=O)N[C@@H](Cc2ccccc2)[C@H](O)CNCc2cccc(C(F)(F)F)c2)c(F)c(N2CCCCS2(=O)=O)c1";"IC50";"'='";"2653.0";"nM";"5.58";"";"";"UO_0000065";"8.76";"0.17";"0.88";"5.03";"0";"CHEMBL945838";"Inhibition of Cathepsin D expressed in CHO cells by FRET assay";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140838";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"CHEMBL3308072";"";"";""
"CHEMBL252057";"";"None";"492.66";"0";"3.87";"6";"CCNc1cc(C(=O)N[C@@H](Cc2ccccc2)[C@H](O)CNC2CCCCC2)cc(N2CCCC2=O)c1";"IC50";"'='";"780.0";"nM";"6.11";"";"";"UO_0000065";"12.40";"0.23";"2.24";"6.52";"0";"CHEMBL945833";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140837";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";"";"";""
"CHEMBL492175";"";"None";"392.20";"0";"4.69";"1";"CC(=O)c1c(Nc2ccc(Cl)cc2)[nH]c2c(Cl)cc([N+](=O)[O-])cc2c1=O";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1021961";"Inhibition of human liver cathepsin D after 30 mins by fluorometric end-point assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138527";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL404020";"";"None";"486.69";"1";"5.36";"45";"N/C(=N/C(=O)Cn1c(-c2ccccc2)ccc1C12CC3CC(CC(C3)C1)C2)NCCc1ccsc1";"IC50";"'='";"599.0";"nM";"6.22";"";"";"UO_0000065";"12.79";"0.24";"0.86";"8.59";"0";"CHEMBL930552";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1142260";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";"";"";""
"CHEMBL4564735";"";"None";"448.43";"0";"3.92";"1";"NC1=N[C@@]2(CO1)c1cc(-c3cccnc3F)ccc1Oc1c2cc(C2=CCCOC2)nc1F";"IC50";"'='";"93.0";"nM";"7.03";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4343401";"Inhibition of recombinant CatD (unknown origin) expressed in CHO cells using FRET peptide substrate preincubated for 1 hr followed by substrate addition and measured after 1 hr by FRET assay";"A";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4342420";"1";"Scientific Literature";"J Med Chem";"2020";"CHEMBL3308072";"";"";""
"CHEMBL3344161";"";"None";"731.81";"2";"1.78";"34";"CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)OCc1ccccc1)[C@@H](O)CC(=O)NC1CCCCC1.O=C(O)C(F)(F)F";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL3370435";"Inhibition of human cathepsin D assessed as cleavage of wtKAHRP fluorogenic substrate";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3352063";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL2396989";"LY-2886721";"1.0";"390.42";"0";"2.52";"2; LY2886721";"NC1=N[C@@]2(c3cc(NC(=O)c4ccc(F)cn4)ccc3F)COC[C@H]2CS1";"IC50";"'>'";"300000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4614137";"Inhibition of human cathepsin D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4613225";"1";"Scientific Literature";"Bioorg Med Chem";"2020";"None";"";"";""
"CHEMBL4636286";"";"None";"374.51";"0";"1.27";"31";"CCCCNC(=O)[C@@H]1C[C@H]1[C@]12CN(c3ncccn3)C[C@H]1CSC(N)=N2";"IC50";"'='";"57000.0";"nM";"4.24";"";"";"UO_0000065";"11.33";"0.22";"2.97";"4.40";"0";"CHEMBL4614137";"Inhibition of human cathepsin D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4613225";"1";"Scientific Literature";"Bioorg Med Chem";"2020";"None";"";"";""
"CHEMBL2425617";"";"None";"562.67";"1";"4.10";"17b";"[2H]C([2H])(N[C@H]1C[S@+]([O-])C[C@@H](Cc2cc(F)c(N)c(O[C@H](COC)C(F)(F)F)c2)[C@@H]1O)c1cccc(C(C)(C)C)c1";"IC50";"'='";"1200.0";"nM";"5.92";"";"";"UO_0000065";"10.56";"0.21";"1.82";"5.93";"0";"CHEMBL2427050";"Inhibition of human cathepsin-D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2424550";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"None";"";"";""
"CHEMBL296588";"PEPSTATIN";"2.0";"685.90";"2";"1.47";"Pepstatin A";"CC(C)CC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)[C@@H](O)CC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)[C@@H](O)CC(=O)O)C(C)C)C(C)C";"IC50";"'='";"0.693";"nM";"9.16";"";"";"UO_0000065";"13.35";"0.26";"7.69";"4.10";"0";"CHEMBL2185513";"Inhibition of cathepsin D by fluorescence assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2176894";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL2048047";"";"None";"600.60";"1";"4.68";"1";"CC(C)(C)c1cccc(CN[C@H]2CS(=O)(=O)C[C@@H](Cc3cc(F)c(N)c(OC(C(F)(F)F)C(F)(F)F)c3)[C@@H]2O)c1";"IC50";"'='";"450.0";"nM";"6.35";"";"";"UO_0000065";"10.57";"0.22";"1.67";"6.24";"1";"CHEMBL2427050";"Inhibition of human cathepsin-D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2424550";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"None";"";"";""
"CHEMBL3904256";"";"None";"384.84";"0";"4.37";"BDBM202627";"CC1(c2cccc(Nc3cc(F)cc4cc(Cl)cnc34)c2)COCC(N)=N1";"IC50";"'='";"2600.0";"nM";"5.58";"";"359420";"UO_0000065";"14.51";"0.28";"1.22";"7.70";"0";"CHEMBL3887877";"Fluorescent Substrate Kinetic Assay: A substrate peptide is labeled at the N-terminus with tryptophan and at the C-terminus with the fluorophore MR121 (for cathepsin D the 10 amino acid peptide WTSVLMAAPC-MR121 was used; for cathepsin E, MR121-CKLVFFAEDW was used). The fluorescent substrate cathepsin D and cathepsin E kinetic assays were performed at room temperature in 384-well microtiter plates (black with clear flat bottom, non binding surface plates from Corning) in a final volume of 51 ul. The test compounds were serially diluted in DMSO (15 concentrations, 1/3 dilution steps) and 1 ul of diluted compounds were mixed for 10 min with 40 ul of cathepsin D (from human liver, Calbiochem) diluted in assay buffer (100 mM sodium acetate, 0.05% BSA, pH 5.5; final concentration: 200 nM) or with 40 ul of recombinant human cathepsin E (R&D Systems) diluted in assay buffer (100 mM sodium acetate, 0.05% BSA, pH 4.5; final concentration: 0.01 nM). After addition of 10 ul of the cathepsin D substrate WTSVLMAAPC-MR121 diluted in cathepsin D assay buffer (final concentration: 300 nM) or 10 ul of the cathepsin E substrate MR121-CKLVFFAEDW diluted in cathepsin E assay buffer (final concentration: 300 nM), the plates were strongly shaken for 2 minutes. The enzymatic reaction was followed in a plate: vision reader (Perkin Elmer) (excitation wavelength: 630 nm; emission: 695 nm) for at least 30 minutes in a kinetic measurement detecting an increase of MR121 fluorescence during the reaction time.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886483";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3950477";"";"None";"533.59";"1";"4.48";"BDBM220848";"COc1ccc(C(=O)Nc2ccc3c(c2)C2(CCSC(N)=N2)c2cc(C4=CCCOC4)nc(F)c2O3)nc1";"IC50";"'='";"569000.0";"nM";"";"Outside typical range";"386534";"UO_0000065";"";"";"";"";"0";"CHEMBL3888270";"Fluorescence Resonance Energy Transfer (FRET) Assay: Recombinant CathepsinD was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The CathepsinD enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for CathepsinD) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886633";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3894188";"";"None";"547.55";"1";"4.27";"BDBM220851";"COc1cnc(C(=O)Nc2ccc3c(c2)C2(CCSC(N)=N2)c2cc(-c4ccnc(F)c4)nc(F)c2O3)cn1";"IC50";"'='";"400000.0";"nM";"";"Outside typical range";"386537";"UO_0000065";"";"";"";"";"0";"CHEMBL3888270";"Fluorescence Resonance Energy Transfer (FRET) Assay: Recombinant CathepsinD was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The CathepsinD enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for CathepsinD) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886633";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3986646";"";"None";"478.81";"0";"3.97";"BDBM214849";"COc1cnc(C(=O)Nc2ccc(F)c([C@]3(CF)C[C@@H](C(F)(F)F)OC(N)=N3)c2)c(Cl)c1";"IC50";"'>'";"400000.0";"nM";"";"Outside typical range";"377868";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3953251";"";"None";"454.82";"0";"4.44";"BDBM214875";"C[C@@]1(c2cc(Nc3nccc4cc(Cl)cnc34)cnc2F)C[C@@H](C(F)(F)F)OC(N)=N1";"IC50";"'>'";"400000.0";"nM";"";"Outside typical range";"377879";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3960749";"";"None";"473.30";"1";"5.00";"BDBM214910";"NC1=N[C@](CF)(c2cc(Oc3nccc(C(F)(F)F)c3F)ccc2F)C[C@@H](C(F)(F)F)O1";"IC50";"'>'";"400000.0";"nM";"";"Outside typical range";"377909";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL487887";"URSONIC ACID";"None";"454.70";"1";"7.30";"8";"C[C@H]1[C@H](C)CC[C@]2(C(=O)O)CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CCC(=O)C(C)(C)[C@@H]5CC[C@]43C)[C@H]12";"IC50";"'='";"6.41";"ug.mL-1";"";"";"";"UO_0000274";"";"";"";"";"0";"CHEMBL3072144";"Inhibition of cathepsin D (unknown origin) using hemoglobin as substrate after 30 min by spectrophotometric analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3045990";"1";"Scientific Literature";"Med Chem Res";"2013";"None";"";"";""
"CHEMBL1210340";"";"None";"611.69";"2";"5.29";"19";"CS(=O)(=O)N(c1ccccc1)c1cccc(C(=O)N[C@@H](Cc2ccccc2)[C@H](O)CNCc2cccc(C(F)(F)F)c2)c1";"IC50";"'='";"450.0";"nM";"6.35";"";"";"UO_0000065";"10.38";"0.20";"1.06";"6.43";"0";"CHEMBL1211667";"Inhibition of Cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1208699";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL1210335";"";"None";"606.79";"1";"3.76";"10";"C[C@H](NC[C@@H](O)[C@H](Cc1ccccc1)NC(=O)c1cccc(NS(=O)(=O)Cc2ccccc2)c1)C(=O)NC1CCCCC1";"IC50";"'='";"30000.0";"nM";"4.52";"";"";"UO_0000065";"7.45";"0.14";"0.76";"3.31";"0";"CHEMBL1211667";"Inhibition of Cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1208699";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL4205912";"";"None";"388.44";"0";"3.67";"4; LY-2886721";"NC1=N[C@@]2(c3cc(NC(=O)c4ccc(F)cn4)ccc3F)CCC[C@H]2CS1";"IC50";"'>'";"3000000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4183173";"Inhibition of Cathepsin D (unknown origin)";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4177751";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL3261067";"";"None";"449.41";"0";"3.58";"6; NB-360";"Cc1cc(C#N)cnc1C(=O)Nc1ccc(F)c([C@]2(C)CO[C@@](C)(C(F)(F)F)C(N)=N2)c1";"IC50";"'>'";"250000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4183173";"Inhibition of Cathepsin D (unknown origin)";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4177751";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL296588";"PEPSTATIN";"2.0";"685.90";"2";"1.47";"1";"CC(C)CC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)[C@@H](O)CC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)[C@@H](O)CC(=O)O)C(C)C)C(C)C";"IC50";"'<'";"1.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3371144";"Inhibition of cathepsin D (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351526";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3683807";"";"None";"449.77";"0";"3.36";"BDBM171413";"NC1=N[C@@](CF)(c2cc(NC(=O)c3nn(C(F)F)cc3Cl)cc(F)c2F)[C@@H]2C[C@@H]2O1";"IC50";"'='";"967700.0";"nM";"";"Outside typical range";"315822";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3683822";"";"None";"421.38";"0";"2.38";"BDBM171429";"COc1cnc(C(=O)Nc2ccc(F)c([C@@]3(C(F)F)N=C(N)O[C@@H]4C[C@@H]43)c2)c(C)n1";"IC50";"'='";"99750.0";"nM";"4.00";"";"315838";"UO_0000065";"9.50";"0.18";"1.62";"3.58";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3683818";"";"None";"421.38";"0";"2.38";"BDBM171424";"COc1cnc(C(=O)Nc2ccc(F)c([C@]3(C(F)F)N=C(N)O[C@H]4C[C@H]43)c2)c(C)n1";"IC50";"'='";"191000.0";"nM";"";"Outside typical range";"315839";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3683819";"";"None";"401.35";"0";"2.54";"BDBM171425";"N#Cc1ccc(C(=O)Nc2ccc(F)c([C@]3(C(F)F)N=C(N)O[C@H]4C[C@H]43)c2)nc1";"IC50";"'>'";"400000.0";"nM";"";"Outside typical range";"315840";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3683832";"";"None";"410.78";"0";"3.32";"BDBM171442";"NC1=N[C@@](c2cc(NC(=O)c3ccc(Cl)cn3)ccc2F)(C(F)F)[C@H]2C[C@H]2O1";"IC50";"'='";"684310.0";"nM";"";"Outside typical range";"315851";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3683884";"";"None";"449.82";"0";"3.50";"BDBM171499";"Cc1cc(NC(=O)c2ncc(C#N)cc2Cl)cc([C@@]2(C(F)F)N=C(N)O[C@@H]3C[C@@H]32)c1F";"IC50";"'='";"558460.0";"nM";"";"Outside typical range";"315908";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3683896";"";"None";"435.41";"0";"2.85";"BDBM171513";"CC(C)Oc1cnc(C(=O)Nc2ccc(F)c([C@@]3(C(F)F)N=C(N)O[C@@H]4C[C@@H]43)c2)cn1";"IC50";"'='";"706050.0";"nM";"";"Outside typical range";"315922";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3683901";"";"None";"423.81";"0";"2.43";"BDBM171518";"COc1cnc(C(=O)Nc2cc(F)c(Cl)c([C@]3(CF)N=C(N)O[C@H]4C[C@H]43)c2)cn1";"IC50";"'='";"646570.0";"nM";"";"Outside typical range";"315930";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3683902";"";"None";"472.83";"0";"3.93";"BDBM171519";"Cc1cc(OC(F)F)cnc1C(=O)Nc1cc(F)c(Cl)c([C@]2(CF)N=C(N)O[C@H]3C[C@H]32)c1";"IC50";"'='";"395990.0";"nM";"";"Outside typical range";"315932";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688708";"";"None";"413.84";"0";"3.07";"BDBM171649";"Cc1cc(C#N)cnc1C(=O)Nc1ccc(Cl)c([C@@]2(CF)N=C(N)O[C@@H]3C[C@@H]32)c1";"IC50";"'='";"1579900.0";"nM";"";"Outside typical range";"316057";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688719";"";"None";"406.82";"0";"3.49";"BDBM171661";"Cc1ccc(NC(=O)c2ccc(Cl)cn2)cc1[C@@]1(C(F)F)N=C(N)O[C@@H]2C[C@@H]21";"IC50";"'='";"464360.0";"nM";"";"Outside typical range";"316069";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688730";"";"None";"424.35";"0";"2.81";"BDBM171672";"COc1cnc(C(=O)Nc2ccc(F)c([C@@]3(C(F)F)N=C(N)O[C@@H]4C[C@@H]43)c2)c(F)c1";"IC50";"'='";"1036800.0";"nM";"";"Outside typical range";"316080";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688735";"";"None";"442.34";"0";"3.27";"BDBM171678";"NC1=N[C@@](c2cc(NC(=O)c3ccc(OC(F)F)cn3)ccc2F)(C(F)F)[C@H]2C[C@H]2O1";"IC50";"'='";"441810.0";"nM";"";"Outside typical range";"316086";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3683917";"";"None";"474.40";"0";"2.63";"BDBM171537";"NC1=N[C@@](c2cc(NC(=O)c3cnc(OCc4cnco4)cn3)ccc2F)(C(F)F)[C@H]2C[C@H]2O1";"IC50";"'='";"845840.0";"nM";"";"Outside typical range";"315946";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688612";"";"None";"424.35";"0";"2.97";"BDBM171546";"NC1=N[C@@](c2cc(NC(=O)c3ccc(OCF)cn3)ccc2F)(C(F)F)[C@H]2C[C@H]2O1";"IC50";"'>'";"1650.0";"nM";"";"";"315955";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688663";"";"None";"438.23";"0";"2.53";"BDBM171601";"NC1=N[C@](CF)(c2cc(NC(=O)c3ccc(Br)cn3)cnc2F)[C@H]2C[C@H]2O1";"IC50";"'='";"1806900.0";"nM";"";"Outside typical range";"316010";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688670";"";"None";"383.37";"0";"2.38";"BDBM171608";"NC1=N[C@@](c2cc(NC(=O)C3CCOCC3)ccc2F)(C(F)F)[C@H]2C[C@H]2O1";"IC50";"'='";"1909500.0";"nM";"";"Outside typical range";"316017";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL584267";"";"None";"415.47";"0";"3.57";"36";"COc1ccc(C2(c3cccc(-c4cccnc4F)c3)N=C(N)N3CCCN=C32)cc1";"IC50";"'='";"16500.0";"nM";"4.78";"";"";"UO_0000065";"11.51";"0.21";"1.21";"6.28";"0";"CHEMBL1061266";"Inhibition of human cathepsin D by FRET";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1155232";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL576258";"";"None";"469.44";"0";"4.46";"(R)-37";"NC1=N[C@](c2ccc(OC(F)(F)F)cc2)(c2cccc(-c3cccnc3F)c2)C2=NCCCN12";"IC50";"'='";"6900.0";"nM";"5.16";"";"";"UO_0000065";"10.99";"0.21";"0.70";"6.78";"0";"CHEMBL1061266";"Inhibition of human cathepsin D by FRET";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1155232";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL402348";"";"None";"584.64";"1";"4.64";"27";"CCNc1cc(C(=O)N[C@@H](Cc2ccccc2)[C@H](O)CNCc2cccc(OC(F)(F)F)c2)cc(N2CCCC2=O)c1";"IC50";"'='";"3550.0";"nM";"5.45";"";"";"UO_0000065";"9.32";"0.18";"0.81";"5.29";"0";"CHEMBL945833";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140837";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";"";"";""
"CHEMBL2349485";"";"None";"413.91";"0";"3.57";"55, rac-55";"COCCN1C(=O)C2(CC(C)(C)Oc3ccc(-c4cccc(Cl)c4)cc32)N=C1N";"IC50";"'='";"329.0";"nM";"6.48";"";"";"UO_0000065";"15.66";"0.31";"2.91";"8.40";"0";"CHEMBL2352017";"Inhibition of human spleen cathepsin D using 5-FAM/QXL as peptide substrate after 1 hr by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"CHEMBL3559722";"Spleen";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346596";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL3414701";"";"None";"316.35";"0";"2.60";"36";"NC1=N[C@@]2(c3ccc(F)cc3F)CO[C@@H](CF)C[C@H]2CS1";"IC50";"'>'";"81000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3420009";"Inhibition of CatD (unknown origin) by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3414451";"1";"Scientific Literature";"J Med Chem";"2015";"None";"";"";""
"CHEMBL2349504";"";"None";"370.84";"0";"2.95";"34, rac-34";"CN1C(=O)C2(CC(C)(C)Oc3ccc(-c4cncc(Cl)c4)cc32)N=C1N";"IC50";"'='";"1606.0";"nM";"5.79";"";"";"UO_0000065";"15.62";"0.30";"2.84";"7.17";"0";"CHEMBL2352017";"Inhibition of human spleen cathepsin D using 5-FAM/QXL as peptide substrate after 1 hr by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"CHEMBL3559722";"Spleen";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346596";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL3127078";"";"None";"369.40";"0";"2.61";"84";"C[C@H]1OCC[C@H]2Oc3ccc(-c4cccnc4F)cc3[C@@]3(COC(N)=N3)[C@H]12";"IC50";"'='";"57000.0";"nM";"4.24";"";"";"UO_0000065";"11.49";"0.21";"1.63";"5.38";"0";"CHEMBL3131975";"Inhibition of human liver cathepsin D measured for 1 hr by FRET assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124885";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL2349469";"";"None";"352.41";"0";"2.84";"(R)-46";"CN1C(=O)[C@]2(CC(C)(C)Cc3ccc(-c4cccnc4F)cc32)N=C1N";"IC50";"'='";"990.0";"nM";"6.00";"";"";"UO_0000065";"17.04";"0.32";"3.16";"8.39";"0";"CHEMBL2352017";"Inhibition of human spleen cathepsin D using 5-FAM/QXL as peptide substrate after 1 hr by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"CHEMBL3559722";"Spleen";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346596";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL2349486";"";"None";"495.02";"0";"4.18";"56, rac-56";"CC(=O)N1CCC(CN2C(=O)C3(CC(C)(C)Oc4ccc(-c5cccc(Cl)c5)cc43)N=C2N)CC1";"IC50";"'='";"21.0";"nM";"7.68";"";"";"UO_0000065";"15.51";"0.30";"3.50";"8.70";"0";"CHEMBL2352017";"Inhibition of human spleen cathepsin D using 5-FAM/QXL as peptide substrate after 1 hr by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"CHEMBL3559722";"Spleen";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346596";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL2349482";"";"None";"371.39";"0";"2.65";"52, rac-52";"CN1C(=O)C2(CC(C)(C)C(F)(F)c3ccc(-c4cncnc4)cc32)N=C1N";"IC50";"'='";"3983.0";"nM";"5.40";"";"";"UO_0000065";"14.54";"0.27";"2.75";"6.39";"0";"CHEMBL2352017";"Inhibition of human spleen cathepsin D using 5-FAM/QXL as peptide substrate after 1 hr by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"CHEMBL3559722";"Spleen";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346596";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL2177322";"";"None";"372.42";"0";"4.36";"9c";"COc1ccc2c(c1)C1(COC(N)=N1)c1cc(-c3cccc(C)c3)ccc1O2";"IC50";"'='";"26900.0";"nM";"4.57";"";"";"UO_0000065";"12.27";"0.22";"0.21";"6.92";"0";"CHEMBL2183109";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2177044";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL3354688";"";"None";"416.48";"0";"4.26";"1";"CC(C)(C)COc1ccc2c(c1)[C@]1(COC(N)=N1)c1cc(-c3cncnc3)ccc1O2";"IC50";"'='";"1100.0";"nM";"5.96";"";"";"UO_0000065";"14.31";"0.26";"1.70";"6.49";"0";"CHEMBL3371640";"Inhibition of cathepsin D (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3352228";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL3127096";"";"None";"338.37";"0";"1.48";"74";"NC1=N[C@@]2(CO1)c1cc(-c3cncnc3)ccc1O[C@@H]1CCOC[C@H]12";"IC50";"'>'";"200000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3131974";"Inhibition of human spleen cathepsin D measured for 1 hr by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"CHEMBL3559722";"Spleen";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124885";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL3127101";"";"None";"366.21";"0";"1.23";"55";"CN1C(=O)[C@]2(N=C1N)c1cc(Br)ccc1O[C@H]1CCOC[C@@H]12";"IC50";"'='";"24000.0";"nM";"4.62";"";"";"UO_0000065";"12.62";"0.29";"3.39";"5.99";"0";"CHEMBL3131975";"Inhibition of human liver cathepsin D measured for 1 hr by FRET assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124885";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL3127106";"";"None";"382.39";"0";"1.67";"62";"CN1C(=O)[C@]2(N=C1N)c1cc(-c3cccnc3F)ccc1O[C@H]1CCOC[C@@H]12";"IC50";"'='";"840.0";"nM";"6.08";"";"";"UO_0000065";"15.89";"0.30";"4.41";"6.75";"0";"CHEMBL3131975";"Inhibition of human liver cathepsin D measured for 1 hr by FRET assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124885";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL3127070";"";"None";"365.43";"0";"2.91";"Figure 3, R1C2";"COc1cccc(-c2ccc3c(c2)[C@@]2(CC(C)(C)O3)N=C(N)N(C)C2=O)c1";"IC50";"'='";"300.0";"nM";"6.52";"";"";"UO_0000065";"17.85";"0.33";"3.61";"8.45";"0";"CHEMBL3131975";"Inhibition of human liver cathepsin D measured for 1 hr by FRET assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124885";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL2181016";"";"None";"979.19";"3";"0.35";"3";"COC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)N(C)C(=O)[C@@H](C)NC(=O)[C@H](CC(C)C)NC(=O)C[C@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(N)=O)N(C)C(=O)[C@@H](NC(=O)[C@H](C)O)C(C)C";"IC50";"'='";"3480.0";"nM";"5.46";"";"";"UO_0000065";"5.57";"0.11";"5.11";"1.90";"0";"CHEMBL2185513";"Inhibition of cathepsin D by fluorescence assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2176894";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL3968912";"";"None";"512.40";"1";"3.27";"BDBM214845";"NC1=N[C@](CF)(c2cc(NC(=O)c3cnc(OCc4ncco4)cn3)ccc2F)C[C@@H](C(F)(F)F)O1";"IC50";"'>'";"400000.0";"nM";"";"Outside typical range";"377970";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3957666";"";"None";"466.77";"0";"4.25";"BDBM214935";"NC1=NC(c2cc(NC(=O)c3ccc(Cl)cn3)ccc2F)(C(F)F)C[C@@H](C(F)(F)F)O1";"IC50";"'>'";"400000.0";"nM";"";"Outside typical range";"377981";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3931128";"";"None";"448.78";"0";"4.15";"BDBM214971";"C[C@@]1(c2cc(NC(=O)c3ccc(Cl)cn3)cc(F)c2F)C[C@@H](C(F)(F)F)OC(N)=N1";"IC50";"'='";"1350000.0";"nM";"";"Outside typical range";"378005";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3904149";"";"None";"483.40";"0";"3.02";"BDBM215026";"C#CCOc1cnc(C(=O)Nc2cc(C)c(F)c([C@]3(CF)C[C@@H](C(F)(F)F)OC(N)=N3)c2)cn1";"IC50";"'='";"188500.0";"nM";"";"Outside typical range";"378042";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3971569";"";"None";"472.41";"0";"3.93";"BDBM215034";"COc1cnc(C(=O)Nc2cc(C)c(F)c([C@]3(CF)C[C@@H](C(F)(F)F)OC(N)=N3)c2)c(C)c1";"IC50";"'='";"780500.0";"nM";"";"Outside typical range";"378051";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3972899";"";"None";"458.39";"0";"3.81";"BDBM215009";"COc1cnc(C(=O)Nc2cc(F)c(F)c([C@]3(C)C[C@@H](C(F)(F)F)OC(N)=N3)c2)c(C)c1";"IC50";"'='";"1138000.0";"nM";"";"Outside typical range";"378052";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL2030994";"";"None";"501.62";"1";"4.20";"40";"CC(=O)N[C@@H](Cc1cccc(F)c1)[C@H](O)CN[C@H]1C[C@]2(C[C@@H](F)C2)Oc2ncc(CC(C)(C)C)cc21";"IC50";"'='";"12.0";"nM";"7.92";"";"";"UO_0000065";"15.79";"0.30";"3.72";"9.49";"0";"CHEMBL2033077";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2029322";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL3683792";"";"None";"410.78";"0";"3.16";"BDBM171397";"NC1=N[C@@](CF)(c2cc(NC(=O)c3ccc(Cl)cn3)cc(F)c2F)[C@@H]2C[C@@H]2O1";"IC50";"'='";"339220.0";"nM";"";"Outside typical range";"315806";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688676";"";"None";"406.36";"0";"1.97";"BDBM171614";"Cn1cc(C(=O)Nc2ccc(F)c([C@@]3(C(F)F)N=C(N)O[C@@H]4C[C@@H]43)c2)ccc1=O";"IC50";"'='";"1229800.0";"nM";"";"Outside typical range";"316023";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3764837";"";"None";"397.48";"0";"4.57";"rac-3c";"Nc1nc2cc(-c3ccccc3)ccc2c(=O)n1C[C@@H]1CC[C@@H](c2ccccc2)O1";"IC50";"'='";"9000.0";"nM";"5.05";"";"";"UO_0000065";"12.69";"0.23";"0.48";"7.19";"0";"CHEMBL3767017";"Inhibition of CatD (unknown origin) preincubated for 30 mins followed by DABCYL-Glu-Arg-Nle-Phe-Leu-Ser-Phe-Pro-EDANS substrate addition by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3763050";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";""
"CHEMBL2059100";"";"None";"413.54";"1";"5.46";"11";"OC(CSc1ccc2ccccc2c1)C(O)Cn1c2ccccc2c2ccccc21";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL2061980";"Inhibition of cathepsin D by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2057073";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL2408756";"";"None";"496.55";"0";"4.46";"51";"CC(=O)N[C@@H](Cc1cc(F)cc(F)c1)[C@H](O)CN[C@H]1CC(C)(C)Oc2ccc(CC(C)(F)F)cc21";"IC50";"'='";"16.0";"nM";"7.80";"";"";"UO_0000065";"15.70";"0.30";"3.34";"11.04";"0";"CHEMBL2410948";"Inhibition of cathepsin-D (unknown origin) using C-terminal biotinylated peptide substrate treated 30 mins before addition of peptide substrate measured after 110 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2406984";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"None";"";"";""
"CHEMBL2408758";"";"None";"502.48";"1";"4.16";"53";"CC(=O)N[C@@H](Cc1cc(F)cc(F)c1)[C@H](O)CN[C@H]1CC(C)(C)Oc2ccc(OC(F)(F)F)cc21";"IC50";"'='";"59.0";"nM";"7.23";"";"";"UO_0000065";"14.39";"0.28";"3.07";"9.06";"0";"CHEMBL2410948";"Inhibition of cathepsin-D (unknown origin) using C-terminal biotinylated peptide substrate treated 30 mins before addition of peptide substrate measured after 110 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2406984";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"None";"";"";""
"CHEMBL2408751";"";"None";"516.67";"2";"5.63";"46";"CCC[C@@]1(C)C[C@H](NC[C@@H](O)[C@H](Cc2cc(F)cc(F)c2)NC(C)=O)c2cc(CC(C)(C)C)ccc2O1";"IC50";"'='";"1.0";"nM";"9.00";"";"";"UO_0000065";"17.42";"0.33";"3.37";"12.75";"0";"CHEMBL2410948";"Inhibition of cathepsin-D (unknown origin) using C-terminal biotinylated peptide substrate treated 30 mins before addition of peptide substrate measured after 110 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2406984";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"None";"";"";""
"CHEMBL3321939";"";"None";"607.52";"1";"4.45";"38";"COc1cc(CNC(=O)[C@@H](CC2CCCCC2)NC(=N)NC(=O)Cc2cc(OC)c(OC)cc2Br)ccc1F";"IC50";"'='";"8.6";"nM";"8.07";"";"";"UO_0000065";"13.28";"0.28";"3.62";"6.62";"0";"CHEMBL3371146";"Inhibition of human liver cathepsin D using MCA-labeled GKPILFFRLK(Dnp)-D-R-NH2 peptide by fluorescence-based assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351526";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3321936";"";"None";"526.57";"1";"1.94";"35";"COc1ccc(CC(=O)NC(=N)N[C@H](CC(C)C)C(=O)NCc2cccc(-c3nnn[nH]3)c2F)cc1OC";"IC50";"'='";"280.0";"nM";"6.55";"";"";"UO_0000065";"12.44";"0.24";"4.61";"3.92";"0";"CHEMBL3371146";"Inhibition of human liver cathepsin D using MCA-labeled GKPILFFRLK(Dnp)-D-R-NH2 peptide by fluorescence-based assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351526";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3321933";"";"None";"548.65";"1";"2.72";"32";"COc1ccc(CC(=O)NC(=N)N[C@H](CC2CCCCC2)C(=O)NCc2ccc(-c3nnn[nH]3)cc2)cc1OC";"IC50";"'='";"44.0";"nM";"7.36";"";"";"UO_0000065";"13.41";"0.25";"4.64";"4.41";"0";"CHEMBL3371146";"Inhibition of human liver cathepsin D using MCA-labeled GKPILFFRLK(Dnp)-D-R-NH2 peptide by fluorescence-based assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351526";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL4560579";"";"None";"473.51";"0";"2.70";"20; AM-6494";"C#CCOc1cnc(C(=O)Nc2cc(F)c(F)c([C@@]3(C)N=C(N)S[C@@]4(COC)C[C@H]43)c2)cn1";"IC50";"'='";"137000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4343401";"Inhibition of recombinant CatD (unknown origin) expressed in CHO cells using FRET peptide substrate preincubated for 1 hr followed by substrate addition and measured after 1 hr by FRET assay";"A";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4342420";"1";"Scientific Literature";"J Med Chem";"2020";"CHEMBL3308072";"";"";""
"CHEMBL2349503";"";"None";"336.40";"0";"2.29";"33, rac-33";"CN1C(=O)C2(CC(C)(C)Oc3ccc(-c4ccncc4)cc32)N=C1N";"IC50";"'='";"49700.0";"nM";"4.30";"";"";"UO_0000065";"12.79";"0.24";"2.01";"5.33";"0";"CHEMBL2352017";"Inhibition of human spleen cathepsin D using 5-FAM/QXL as peptide substrate after 1 hr by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"CHEMBL3559722";"Spleen";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346596";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL2349499";"";"None";"331.42";"0";"2.26";"29, rac-29";"CC(C)COc1ccc2c(c1)C1(CC(C)(C)O2)N=C(N)N(C)C1=O";"IC50";"'='";"16820.0";"nM";"4.77";"";"";"UO_0000065";"14.41";"0.27";"2.51";"6.19";"0";"CHEMBL2352017";"Inhibition of human spleen cathepsin D using 5-FAM/QXL as peptide substrate after 1 hr by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"CHEMBL3559722";"Spleen";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346596";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL43185";"PIPERINE";"2.0";"285.34";"0";"3.00";"3";"O=C(/C=C/C=C/c1ccc2c(c1)OCO2)N1CCCCC1";"IC50";"'='";"42300.0";"nM";"4.37";"";"";"UO_0000065";"15.33";"0.28";"1.37";"11.28";"0";"CHEMBL3072144";"Inhibition of cathepsin D (unknown origin) using hemoglobin as substrate after 30 min by spectrophotometric analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3045990";"1";"Scientific Literature";"Med Chem Res";"2013";"None";"";"";""
"CHEMBL2177330";"";"None";"410.83";"0";"4.85";"9k";"COc1ccc2c(c1)C1(COC(N)=N1)c1cc(-c3ccc(Cl)cc3F)ccc1O2";"IC50";"'='";"28500.0";"nM";"4.54";"";"";"UO_0000065";"11.06";"0.21";"-0.30";"6.88";"0";"CHEMBL2183109";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2177044";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL2047914";"";"None";"459.65";"0";"3.88";"52";"CCCOc1cccc(C[C@@H]2CS(=O)(=O)C[C@H](NCc3cccc(C(C)(C)C)c3)[C@H]2O)c1";"IC50";"'='";"290.0";"nM";"6.54";"";"";"UO_0000065";"14.22";"0.28";"2.66";"8.64";"0";"CHEMBL2049562";"Inhibition of human recombinant CatD using Mca-GKPILFFRLK(DNP)-dR-NH2 as substrate after 1 hr by fluorescence analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2046351";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL1077236";"";"None";"547.78";"2";"5.20";"24";"CC(C)c1cccc(CNC[C@H](O)[C@H](Cc2ccccc2)NC(=O)[C@@H]2CCC[C@H](C(C)(C)N3CCCC3=O)C2)c1";"IC50";"'='";"560.0";"nM";"6.25";"";"";"UO_0000065";"11.41";"0.21";"1.05";"7.65";"0";"CHEMBL1107841";"Inhibition of Cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1155410";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL4541926";"";"None";"476.69";"1";"5.40";"66";"CCCCCCc1ccc(S(=O)(=O)C2C3CCC(N3)C2NCc2ccc3ccccc3c2)cc1";"IC50";"'='";"2030.0";"nM";"5.69";"";"";"UO_0000065";"11.94";"0.23";"0.29";"9.78";"0";"CHEMBL4357658";"Inhibition of human cathepsin D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4354841";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";""
"CHEMBL2059453";"";"None";"337.49";"0";"4.59";"E5T7";"Cc1ccccc1SCC(O)Cn1c2c(c3ccccc31)CCC2";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL2061980";"Inhibition of cathepsin D by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2057073";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL2058867";"";"None";"367.52";"1";"7.13";"2";"c1ccc2cc(SCCCn3c4ccccc4c4ccccc43)ccc2c1";"IC50";"'>'";"300000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2061980";"Inhibition of cathepsin D by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2057073";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL1824137";"";"None";"393.43";"0";"2.09";"31";"CC(C)n1cc(C2(c3ccc(F)c(-c4cncnc4)c3)N=C(N)N(C)C2=O)cn1";"IC50";"'='";"28300.0";"nM";"4.55";"";"";"UO_0000065";"11.56";"0.21";"2.46";"4.45";"0";"CHEMBL1825607";"Inhibition of cathepsin D by FRET assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1821667";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL2047904";"";"None";"462.63";"0";"3.37";"46a";"CCc1cc(C[C@@H]2CS(=O)(=O)C[C@H](NCc3cccc(C(C)(C)C)c3)[C@H]2O)cc(F)c1N";"IC50";"'='";"2000.0";"nM";"5.70";"";"";"UO_0000065";"12.32";"0.24";"2.33";"6.17";"0";"CHEMBL2049562";"Inhibition of human recombinant CatD using Mca-GKPILFFRLK(DNP)-dR-NH2 as substrate after 1 hr by fluorescence analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2046351";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL3809662";"";"None";"488.93";"0";"4.49";"2";"NC1=NC2(CO1)c1cc(NC(=O)c3ccc(Cl)cn3)ccc1Oc1ccc(C3=CCCOC3)cc12";"IC50";"'='";"470000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3811221";"Inhibition of Cathepsin D (unknown origin) by fluorescence assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3808306";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";""
"CHEMBL490305";"";"None";"453.67";"0";"3.44";"2b";"CCCCNC(=O)[C@H](C)C[C@H](O)[C@@H]1C[C@H](C)CCCCCCCCC(=O)N[C@@H](C)C(=O)N1";"IC50";"'='";"1700.0";"nM";"5.77";"";"";"UO_0000065";"12.72";"0.25";"2.33";"5.37";"0";"CHEMBL1030363";"Inhibition of human cathepsin D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1151821";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL2181010";"";"None";"1010.22";"None";"None";"12";"COC(=O)[C@@H]1CCCN1C(=O)[C@@H](Cc1ccccc1)N(C)C(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)C[C@H](O)[C@H](Cc1ccccc1)NC(=O)c1cc(NS(C)(=O)=O)cc(C(=O)N[C@H](C)c2ccccc2)c1";"IC50";"'='";"11.3";"nM";"7.95";"";"";"UO_0000065";"7.87";"None";"None";"None";"0";"CHEMBL2185513";"Inhibition of cathepsin D by fluorescence assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2176894";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL3930806";"";"None";"701.90";"1";"4.65";"BDBM232286";"CC(C)CC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)[C@@H](N)CC(=O)N[C@H](COc1ccc(F)cc1F)C(C)C)C(C)C";"IC50";"'='";"39.0";"nM";"7.41";"";"405060";"UO_0000065";"10.56";"0.20";"2.76";"4.89";"0";"CHEMBL3888498";"In-Vitro Fluorescence Assay: In order to identify modulators of cathepsin D activity, a continuous enzymatic test was carried out with a synthetic peptide which carries a fluorescent group (MCA=(7-methoxycoumarin-4-yl)acetyl) which is quenched by energy transfer from a Dpn (2,4 dinitrophenyl) group on the same molecule, in Greiner 384-well nb microtitre plates. Cleavage of the peptidic substrate by cathepsin D causes an increase in the fluorescence intensity. In order to determine the efficacy of substances, the time-dependent increase in the fluorescence intensity in the presence of the substance was compared with the time-dependent increase in fluorescence in the absence of substances. The reference substance used was pepstatin A (Sigma-Aldrich). The substrate used was MCAGKPILFFRLK(Dnp)d-R-NH2 (Enzo Life Sciences, Lorrach). The enzyme employed was cathepsin D isolated from the human liver (Sigma-Aldrich) in a final concentration of 1.4 nM. The test was carried out in 100 mM sodium acetate buffer, 1.25% (v/v) of DMSO, 0.25% (w/v) of Chaps, pH 5.5. 2 ul of each substance solution with serially diluted substance concentration were added to in each case 4 ul of cathepsin D solution and incubated at room temperature for 10 min. The reaction was started by addition of 2 ul of substrate solution (final concentration 5 uM). After carrying out a starting-point fluorescence measurement (excitation wavelength 340 nm/emission wavelength 450 nm) using an Envision multilabel reader (Perkin Elmer), the reaction was incubated at room temperature for 60 min. The amount of peptide fragment cleaved off during the reaction time was subsequently measured by determination of the increase in the fluorescence intensity at 450 nm (excitation wavelength 340 nm).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886733";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3942544";"";"None";"478.37";"0";"4.55";"BDBM215029";"Cc1cc(NC(=O)c2ccc(C(F)F)cn2)cc([C@]2(CF)C[C@@H](C(F)(F)F)OC(N)=N2)c1F";"IC50";"'='";"991700.0";"nM";"";"Outside typical range";"378045";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL554281";"";"None";"508.64";"1";"1.91";"11";"C#CCNC[C@@H](O)[C@H](Cc1ccccc1)NC(=O)c1cc2c3c(cn(CC)c3c1)CCS(=O)(=O)N2C";"IC50";"'='";"34590.0";"nM";"4.46";"";"";"UO_0000065";"8.77";"0.17";"2.55";"4.30";"0";"CHEMBL725829";"Inhibition of cathepsin-D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1158411";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL3924457";"";"None";"464.84";"0";"3.48";"BDBM220773";"N#Cc1ccc(C(=O)Nc2ccc3c(c2)C2(CCOC(N)=N2)c2cc(Cl)nc(F)c2O3)nc1";"IC50";"'>'";"400000.0";"nM";"";"Outside typical range";"386456";"UO_0000065";"";"";"";"";"0";"CHEMBL3888270";"Fluorescence Resonance Energy Transfer (FRET) Assay: Recombinant CathepsinD was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The CathepsinD enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for CathepsinD) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886633";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3966377";"";"None";"518.51";"1";"3.16";"BDBM220784";"COc1cnc(C(=O)Nc2ccc3c(c2)C2(CCOC(N)=N2)c2cc(C4=CCCOC4)nc(F)c2O3)cn1";"IC50";"'>'";"400000.0";"nM";"";"Outside typical range";"386467";"UO_0000065";"";"";"";"";"0";"CHEMBL3888270";"Fluorescence Resonance Energy Transfer (FRET) Assay: Recombinant CathepsinD was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The CathepsinD enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for CathepsinD) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886633";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL2380822";"";"None";"521.09";"2";"5.48";"9";"CCCc1scc(-c2cn[nH]c2)c1CC(NC1=NC(C)(C)Cc2cc(Cl)ccc21)c1nccc(=O)[nH]1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2384470";"Inhibition of cathepsin-D (unknown origin) after 110 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2380283";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"None";"";"";""
"CHEMBL566968";"";"None";"443.48";"0";"3.34";"39";"NC1=NC(c2cccc(-c3cccnc3F)c2)(c2ccc3c(c2)OCCO3)C2=NCCCN12";"IC50";"'='";"9600.0";"nM";"5.02";"";"";"UO_0000065";"11.31";"0.21";"1.68";"5.88";"0";"CHEMBL1061266";"Inhibition of human cathepsin D by FRET";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1155232";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL568506";"";"None";"410.52";"0";"3.96";"29";"COc1ccc(Cc2cccc(C3(c4ccccc4)N=C(N)N4CCCN=C43)c2)cc1";"IC50";"'='";"24900.0";"nM";"4.60";"";"";"UO_0000065";"11.21";"0.20";"0.64";"7.28";"0";"CHEMBL1061266";"Inhibition of human cathepsin D by FRET";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1155232";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL3974715";"";"None";"732.96";"2";"3.11";"BDBM232243";"CC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)OC(C)(C)C)C(=O)N[C@@H](Cc1ccccc1)[C@@H](N)CC(=O)N[C@H](C(=O)N[C@H](C(=O)OC)C(C)C)[C@@H](C)CC";"IC50";"'='";"40.0";"nM";"7.40";"";"405020";"UO_0000065";"10.09";"0.19";"4.29";"3.57";"0";"CHEMBL3888498";"In-Vitro Fluorescence Assay: In order to identify modulators of cathepsin D activity, a continuous enzymatic test was carried out with a synthetic peptide which carries a fluorescent group (MCA=(7-methoxycoumarin-4-yl)acetyl) which is quenched by energy transfer from a Dpn (2,4 dinitrophenyl) group on the same molecule, in Greiner 384-well nb microtitre plates. Cleavage of the peptidic substrate by cathepsin D causes an increase in the fluorescence intensity. In order to determine the efficacy of substances, the time-dependent increase in the fluorescence intensity in the presence of the substance was compared with the time-dependent increase in fluorescence in the absence of substances. The reference substance used was pepstatin A (Sigma-Aldrich). The substrate used was MCAGKPILFFRLK(Dnp)d-R-NH2 (Enzo Life Sciences, Lorrach). The enzyme employed was cathepsin D isolated from the human liver (Sigma-Aldrich) in a final concentration of 1.4 nM. The test was carried out in 100 mM sodium acetate buffer, 1.25% (v/v) of DMSO, 0.25% (w/v) of Chaps, pH 5.5. 2 ul of each substance solution with serially diluted substance concentration were added to in each case 4 ul of cathepsin D solution and incubated at room temperature for 10 min. The reaction was started by addition of 2 ul of substrate solution (final concentration 5 uM). After carrying out a starting-point fluorescence measurement (excitation wavelength 340 nm/emission wavelength 450 nm) using an Envision multilabel reader (Perkin Elmer), the reaction was incubated at room temperature for 60 min. The amount of peptide fragment cleaved off during the reaction time was subsequently measured by determination of the increase in the fluorescence intensity at 450 nm (excitation wavelength 340 nm).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886733";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3923269";"";"None";"728.98";"2";"2.89";"BDBM232254";"CCOC(=O)C1(NC(=O)[C@@H](NC(=O)C[C@H](N)[C@H](Cc2ccccc2)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)CC(C)C)C(C)C)[C@@H](C)CC)CC1";"IC50";"'='";"110.0";"nM";"6.96";"";"405031";"UO_0000065";"9.55";"0.18";"4.07";"3.52";"0";"CHEMBL3888498";"In-Vitro Fluorescence Assay: In order to identify modulators of cathepsin D activity, a continuous enzymatic test was carried out with a synthetic peptide which carries a fluorescent group (MCA=(7-methoxycoumarin-4-yl)acetyl) which is quenched by energy transfer from a Dpn (2,4 dinitrophenyl) group on the same molecule, in Greiner 384-well nb microtitre plates. Cleavage of the peptidic substrate by cathepsin D causes an increase in the fluorescence intensity. In order to determine the efficacy of substances, the time-dependent increase in the fluorescence intensity in the presence of the substance was compared with the time-dependent increase in fluorescence in the absence of substances. The reference substance used was pepstatin A (Sigma-Aldrich). The substrate used was MCAGKPILFFRLK(Dnp)d-R-NH2 (Enzo Life Sciences, Lorrach). The enzyme employed was cathepsin D isolated from the human liver (Sigma-Aldrich) in a final concentration of 1.4 nM. The test was carried out in 100 mM sodium acetate buffer, 1.25% (v/v) of DMSO, 0.25% (w/v) of Chaps, pH 5.5. 2 ul of each substance solution with serially diluted substance concentration were added to in each case 4 ul of cathepsin D solution and incubated at room temperature for 10 min. The reaction was started by addition of 2 ul of substrate solution (final concentration 5 uM). After carrying out a starting-point fluorescence measurement (excitation wavelength 340 nm/emission wavelength 450 nm) using an Envision multilabel reader (Perkin Elmer), the reaction was incubated at room temperature for 60 min. The amount of peptide fragment cleaved off during the reaction time was subsequently measured by determination of the increase in the fluorescence intensity at 450 nm (excitation wavelength 340 nm).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886733";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3301601";"VERUBECESTAT";"3.0";"409.42";"0";"1.42";"2; MK-8931";"CN1C(N)=N[C@](C)(c2cc(NC(=O)c3ccc(F)cn3)ccc2F)CS1(=O)=O";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4183174";"Inhibition of human Cathepsin D using Mca-Gly-Lys-Pro-Ile-Leu-Phe-PheArg-Leu-Lys(Dnp)-D-Arg-NH2 as substrate after 45 mins";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4177751";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL2048038";"";"None";"492.66";"0";"3.60";"60a";"CCCOc1cc(C[C@@H]2CS(=O)(=O)C[C@H](NCc3cccc(C(C)(C)C)c3)[C@H]2O)cc(F)c1N";"IC50";"'='";"2220.0";"nM";"5.65";"";"";"UO_0000065";"11.48";"0.23";"2.05";"5.56";"0";"CHEMBL2049562";"Inhibition of human recombinant CatD using Mca-GKPILFFRLK(DNP)-dR-NH2 as substrate after 1 hr by fluorescence analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2046351";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL2048053";"";"None";"576.65";"1";"3.77";"60p";"COC[C@@H](Oc1cc(C[C@@H]2CS(=O)(=O)C[C@H](NCc3cccc(C(C)(C)C)c3)[C@H]2O)cc(F)c1N)C(F)(F)F";"IC50";"'='";"250.0";"nM";"6.60";"";"";"UO_0000065";"11.45";"0.23";"2.83";"5.95";"0";"CHEMBL2049562";"Inhibition of human recombinant CatD using Mca-GKPILFFRLK(DNP)-dR-NH2 as substrate after 1 hr by fluorescence analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2046351";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL2177337";"";"None";"393.83";"0";"4.10";"9r";"COc1ccc2c(c1)C1(COC(N)=N1)c1cc(-c3ccnc(Cl)c3)ccc1O2";"IC50";"'='";"44200.0";"nM";"4.36";"";"";"UO_0000065";"11.06";"0.21";"0.25";"5.51";"0";"CHEMBL2183109";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2177044";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL402120";"";"None";"515.68";"1";"2.22";"1";"C[C@H](NC[C@@H](O)[C@H](Cc1ccccc1)NC(=O)c1cccc(S(C)(=O)=O)c1)C(=O)NC1CCCCC1";"IC50";"'='";"7700.0";"nM";"5.11";"";"";"UO_0000065";"9.92";"0.19";"2.89";"4.10";"0";"CHEMBL945833";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140837";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";"";"";""
"CHEMBL251862";"";"None";"563.74";"1";"3.37";"2";"CCNc1cc(C(=O)N[C@@H](Cc2ccccc2)[C@H](O)CN[C@@H](C)C(=O)NC2CCCCC2)cc(N2CCCC2=O)c1";"IC50";"'='";"2695.0";"nM";"5.57";"";"";"UO_0000065";"9.88";"0.19";"2.20";"4.54";"1";"CHEMBL945833";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140837";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";"";"";""
"CHEMBL429668";"";"None";"530.67";"1";"3.75";"20";"CCNc1cc(C(=O)N[C@@H](Cc2ccccc2)[C@H](O)CNCc2ccccc2OC)cc(N2CCCC2=O)c1";"IC50";"'='";"9770.0";"nM";"5.01";"";"";"UO_0000065";"9.44";"0.18";"1.26";"4.87";"0";"CHEMBL945833";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140837";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";"";"";""
"CHEMBL211499";"";"None";"574.81";"1";"2.21";"27";"CCCCNC(=O)[C@H](C)C[C@H](O)[C@@H]1CSC/C=C\CSC[C@H](NC(=O)OC(C)(C)C)C(=O)N[C@@H](C)C(=O)N1";"IC50";"'='";"460.0";"nM";"6.34";"";"";"UO_0000065";"11.02";"0.23";"4.13";"4.34";"0";"CHEMBL866007";"Inhibition of Cathepsin D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1137429";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";"";""
"CHEMBL264321";"";"None";"617.73";"2";"5.08";"8";"CCCc1cc(C(=O)N[C@@H](Cc2ccccc2)[C@H](O)CNCc2cccc(C(F)(F)F)c2)cc(N2CCCCS2(=O)=O)c1";"IC50";"'='";"4790.0";"nM";"5.32";"";"";"UO_0000065";"8.61";"0.17";"0.24";"5.39";"0";"CHEMBL945838";"Inhibition of Cathepsin D expressed in CHO cells by FRET assay";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140838";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"CHEMBL3308072";"";"";""
"CHEMBL558459";"HYDRAZOBENZENE";"None";"184.24";"0";"3.13";"74";"c1ccc(NNc2ccccc2)cc1";"IC50";"'='";"1000.0";"nM";"6.00";"";"";"UO_0000065";"32.57";"0.59";"2.87";"24.94";"0";"CHEMBL4355299";"Inhibition of human liver cathepsin D using DABCYL-Glu-Arg-Nle-Phe-Leu-Ser-Phe-Pro-EDANS as substrate by FRET assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4354799";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";""
"CHEMBL3127093";"";"None";"355.37";"0";"2.23";"71";"NC1=N[C@@]2(CO1)c1cc(-c3cccnc3F)ccc1O[C@H]1CCOC[C@@H]12";"IC50";"'='";"15000.0";"nM";"4.82";"";"";"UO_0000065";"13.57";"0.25";"2.59";"6.11";"0";"CHEMBL3131974";"Inhibition of human spleen cathepsin D measured for 1 hr by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"CHEMBL3559722";"Spleen";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124885";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL3127105";"";"None";"415.85";"0";"2.93";"60";"CN1C(=O)[C@]2(N=C1N)c1cc(-c3cc(F)cc(Cl)c3)ccc1O[C@H]1CCOC[C@@H]12";"IC50";"'='";"2300.0";"nM";"5.64";"";"";"UO_0000065";"13.56";"0.27";"2.71";"7.31";"0";"CHEMBL3131974";"Inhibition of human spleen cathepsin D measured for 1 hr by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"CHEMBL3559722";"Spleen";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124885";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL3127097";"";"None";"387.89";"0";"3.46";"75";"NC1=N[C@@]2(CS1)c1cc(-c3cncc(Cl)c3)ccc1O[C@@H]1CCOC[C@H]12";"IC50";"'='";"57000.0";"nM";"4.24";"";"";"UO_0000065";"10.94";"0.22";"0.78";"6.09";"0";"CHEMBL3131975";"Inhibition of human liver cathepsin D measured for 1 hr by FRET assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124885";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL3127076";"";"None";"352.39";"0";"1.87";"82";"C[C@]12CCOC[C@@H]1[C@]1(COC(N)=N1)c1cc(-c3cncnc3)ccc1O2";"IC50";"'>'";"200000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3131975";"Inhibition of human liver cathepsin D measured for 1 hr by FRET assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124885";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL597233";"";"None";"266.30";"0";"1.11";"3";"CN1C(=O)C(c2ccccc2)(c2ccncc2)N=C1N";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1115170";"Inhibition of cathepsin D by FRET assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156304";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL4644249";"";"None";"309.44";"0";"0.84";"18";"C[C@@H]1C[C@H]1CNC(=O)[C@@H]1C[C@H]1[C@]12COC[C@H]1CSC(N)=N2";"IC50";"'>'";"300000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4614137";"Inhibition of human cathepsin D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4613225";"1";"Scientific Literature";"Bioorg Med Chem";"2020";"None";"";"";""
"CHEMBL3927361";"";"None";"631.86";"1";"2.85";"BDBM232245";"CC[C@H](C)[C@H](NC(=O)C[C@H](N)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)CC(C)C)C(=O)N[C@H](C(=O)OC)C(C)C";"IC50";"'='";"5500.0";"nM";"5.26";"";"405022";"UO_0000065";"8.32";"0.16";"2.41";"3.12";"0";"CHEMBL3888498";"In-Vitro Fluorescence Assay: In order to identify modulators of cathepsin D activity, a continuous enzymatic test was carried out with a synthetic peptide which carries a fluorescent group (MCA=(7-methoxycoumarin-4-yl)acetyl) which is quenched by energy transfer from a Dpn (2,4 dinitrophenyl) group on the same molecule, in Greiner 384-well nb microtitre plates. Cleavage of the peptidic substrate by cathepsin D causes an increase in the fluorescence intensity. In order to determine the efficacy of substances, the time-dependent increase in the fluorescence intensity in the presence of the substance was compared with the time-dependent increase in fluorescence in the absence of substances. The reference substance used was pepstatin A (Sigma-Aldrich). The substrate used was MCAGKPILFFRLK(Dnp)d-R-NH2 (Enzo Life Sciences, Lorrach). The enzyme employed was cathepsin D isolated from the human liver (Sigma-Aldrich) in a final concentration of 1.4 nM. The test was carried out in 100 mM sodium acetate buffer, 1.25% (v/v) of DMSO, 0.25% (w/v) of Chaps, pH 5.5. 2 ul of each substance solution with serially diluted substance concentration were added to in each case 4 ul of cathepsin D solution and incubated at room temperature for 10 min. The reaction was started by addition of 2 ul of substrate solution (final concentration 5 uM). After carrying out a starting-point fluorescence measurement (excitation wavelength 340 nm/emission wavelength 450 nm) using an Envision multilabel reader (Perkin Elmer), the reaction was incubated at room temperature for 60 min. The amount of peptide fragment cleaved off during the reaction time was subsequently measured by determination of the increase in the fluorescence intensity at 450 nm (excitation wavelength 340 nm).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886733";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL2177314";"";"None";"363.39";"0";"3.48";"5";"COc1ccc(C2(c3cccc(-c4ccc(F)nc4)c3)COC(N)=N2)cc1";"IC50";"'='";"47700.0";"nM";"4.32";"";"";"UO_0000065";"11.89";"0.22";"0.84";"6.20";"0";"CHEMBL2183109";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2177044";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL2177342";"";"None";"388.43";"0";"3.63";"10a";"CCCOc1ccc2c(c1)[C@]1(COC(N)=N1)c1cc(-c3cncnc3)ccc1O2";"IC50";"'='";"9120.0";"nM";"5.04";"";"";"UO_0000065";"12.98";"0.24";"1.41";"5.49";"0";"CHEMBL2183109";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2177044";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL3127088";"";"None";"394.43";"0";"1.54";"66";"COc1cncc(-c2ccc3c(c2)[C@]2(N=C(N)N(C)C2=O)[C@H]2COCC[C@@H]2O3)c1";"IC50";"'='";"5400.0";"nM";"5.27";"";"";"UO_0000065";"13.35";"0.25";"3.73";"5.31";"0";"CHEMBL3131975";"Inhibition of human liver cathepsin D measured for 1 hr by FRET assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124885";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL2177320";"";"None";"358.40";"0";"4.06";"9a";"COc1ccc2c(c1)C1(COC(N)=N1)c1cc(-c3ccccc3)ccc1O2";"IC50";"'>'";"40000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2183109";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2177044";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL2047893";"";"None";"476.66";"0";"3.76";"15";"CCCc1cc(C[C@@H]2CS(=O)(=O)C[C@H](NCc3cccc(C(C)(C)C)c3)[C@H]2O)cc(F)c1N";"IC50";"'='";"1390.0";"nM";"5.86";"";"";"UO_0000065";"12.29";"0.24";"2.10";"6.34";"0";"CHEMBL2049562";"Inhibition of human recombinant CatD using Mca-GKPILFFRLK(DNP)-dR-NH2 as substrate after 1 hr by fluorescence analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2046351";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL2047895";"";"None";"441.60";"0";"2.97";"22";"CC(C)(C)c1cccc(CN[C@H]2CS(=O)(=O)C[C@@H](Cc3ccc4[nH]ncc4c3)[C@@H]2O)c1";"IC50";"'='";"3750.0";"nM";"5.43";"";"";"UO_0000065";"12.29";"0.24";"2.46";"5.71";"0";"CHEMBL2049562";"Inhibition of human recombinant CatD using Mca-GKPILFFRLK(DNP)-dR-NH2 as substrate after 1 hr by fluorescence analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2046351";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL2047896";"";"None";"483.68";"0";"3.92";"24";"CCCc1n[nH]c2ccc(C[C@@H]3CS(=O)(=O)C[C@H](NCc4cccc(C(C)(C)C)c4)[C@H]3O)cc12";"IC50";"'='";"1630.0";"nM";"5.79";"";"";"UO_0000065";"11.97";"0.23";"1.87";"6.09";"0";"CHEMBL2049562";"Inhibition of human recombinant CatD using Mca-GKPILFFRLK(DNP)-dR-NH2 as substrate after 1 hr by fluorescence analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2046351";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL3414709";"";"None";"312.39";"0";"3.04";"39";"CC[C@H]1C[C@H]2CSC(N)=N[C@@]2(c2ccc(F)cc2F)CO1";"IC50";"'='";"63000.0";"nM";"4.20";"";"";"UO_0000065";"13.45";"0.27";"1.16";"8.82";"0";"CHEMBL3420009";"Inhibition of CatD (unknown origin) by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3414451";"1";"Scientific Literature";"J Med Chem";"2015";"None";"";"";""
"CHEMBL3414704";"";"None";"286.35";"0";"2.50";"14b";"COC[C@@H]1CSC(N)=N[C@]1(C)c1ccc(F)cc1F";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3420009";"Inhibition of CatD (unknown origin) by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3414451";"1";"Scientific Literature";"J Med Chem";"2015";"None";"";"";""
"CHEMBL3978732";"";"None";"516.58";"1";"3.74";"BDBM220839";"COc1cnc(C(=O)Nc2ccc3c(c2)C2(CCSC(N)=N2)c2cc(C4=CCOCC4)ncc2O3)cn1";"IC50";"'='";"400000.0";"nM";"";"Outside typical range";"386525";"UO_0000065";"";"";"";"";"0";"CHEMBL3888270";"Fluorescence Resonance Energy Transfer (FRET) Assay: Recombinant CathepsinD was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The CathepsinD enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for CathepsinD) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886633";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3965633";"";"None";"546.56";"1";"4.88";"BDBM220850";"COc1ccc(C(=O)Nc2ccc3c(c2)C2(CCSC(N)=N2)c2cc(-c4cncc(F)c4)nc(F)c2O3)nc1";"IC50";"'='";"120100.0";"nM";"";"Outside typical range";"386536";"UO_0000065";"";"";"";"";"0";"CHEMBL3888270";"Fluorescence Resonance Energy Transfer (FRET) Assay: Recombinant CathepsinD was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The CathepsinD enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for CathepsinD) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886633";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3893104";"";"None";"555.99";"2";"5.27";"BDBM220856";"NC1=NC2(CCS1)c1cc(NC(=O)c3ncc(Cl)cc3F)ccc1Oc1c2cc(C2=CCOCC2)nc1F";"IC50";"'='";"311000.0";"nM";"";"Outside typical range";"386542";"UO_0000065";"";"";"";"";"0";"CHEMBL3888270";"Fluorescence Resonance Energy Transfer (FRET) Assay: Recombinant CathepsinD was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The CathepsinD enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for CathepsinD) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886633";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL1210331";"";"None";"570.73";"1";"4.50";"6";"CC(=O)N(c1ccccc1)c1cccc(C(=O)N[C@@H](Cc2ccccc2)[C@H](O)CN[C@@H](C)C(=O)NC2CCCCC2)c1";"IC50";"'='";"6200.0";"nM";"5.21";"";"";"UO_0000065";"9.12";"0.17";"0.71";"4.70";"0";"CHEMBL1211667";"Inhibition of Cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1208699";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL104966";"";"None";"749.95";"3";"5.03";"22";"CC(C)[C@H](NC(=O)[C@H](NCc1ccccc1)[C@H](O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)OCc1ccccc1)C(C)(C)C)C(=O)NCc1ccccc1";"IC50";"'='";"60.0";"nM";"7.22";"";"";"UO_0000065";"9.63";"0.18";"2.19";"4.57";"0";"CHEMBL657353";"Selectivity for their inhibitory potency against human cathepsin D.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1127464";"1";"Scientific Literature";"J Med Chem";"1994";"None";"";"";""
"CHEMBL1092476";"";"None";"360.39";"0";"2.92";"4e";"CN1C(=O)C(c2ccncc2)(c2cccc(-c3cccc(F)c3)c2)N=C1N";"IC50";"'='";"20800.0";"nM";"4.68";"";"";"UO_0000065";"12.99";"0.24";"1.76";"6.54";"0";"CHEMBL1115170";"Inhibition of cathepsin D by FRET assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156304";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL2069617";"";"None";"554.09";"1";"4.65";"7";"CC(C)C[C@H](NC(=O)OCc1ccccc1)C(=O)N[C@@H](C)C(=O)NCCCNc1ccnc2cc(Cl)ccc12";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL2072160";"Inhibition of human cathepsin D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2069175";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL3414711";"";"None";"340.44";"0";"3.67";"40";"CC(C)C[C@H]1C[C@H]2CSC(N)=N[C@@]2(c2ccc(F)cc2F)CO1";"IC50";"'='";"25100.0";"nM";"4.60";"";"";"UO_0000065";"13.51";"0.27";"0.93";"9.66";"0";"CHEMBL3420009";"Inhibition of CatD (unknown origin) by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3414451";"1";"Scientific Literature";"J Med Chem";"2015";"None";"";"";""
"CHEMBL600326";"";"None";"543.71";"2";"5.05";"20";"Cc1cc2cc(n1)OCCCCOc1cccc(c1)C[C@@H]([C@H](O)CNC1(c3cccc(C(C)C)c3)CC1)NC2=O";"IC50";"'='";"11.0";"nM";"7.96";"";"";"UO_0000065";"14.64";"0.27";"2.91";"8.58";"0";"CHEMBL1050390";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1153192";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL595066";"";"None";"571.76";"2";"5.52";"3, NB-216";"COCc1cc2cc(c1)C(=O)N[C@H]([C@H](O)CNC1(c3cccc(C(C)C)c3)CC1)Cc1cccc(c1)OCCCCN2";"IC50";"'='";"1.0";"nM";"9.00";"";"";"UO_0000065";"15.74";"0.29";"3.48";"9.80";"0";"CHEMBL1050390";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1153192";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL3127075";"";"None";"369.40";"0";"2.62";"81";"C[C@]12CCOC[C@@H]1[C@]1(COC(N)=N1)c1cc(-c3cccnc3F)ccc1O2";"IC50";"'='";"42000.0";"nM";"4.38";"";"";"UO_0000065";"11.85";"0.22";"1.76";"5.54";"0";"CHEMBL3131975";"Inhibition of human liver cathepsin D measured for 1 hr by FRET assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124885";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL3127100";"";"None";"402.85";"0";"3.87";"78";"C[C@]12CCOC[C@@H]1[C@]1(COC(N)=N1)c1cc(-c3cc(F)cc(Cl)c3)ccc1O2";"IC50";"'='";"7500.0";"nM";"5.12";"";"";"UO_0000065";"12.72";"0.25";"1.25";"7.76";"0";"CHEMBL3131975";"Inhibition of human liver cathepsin D measured for 1 hr by FRET assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124885";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL67701";"";"None";"447.54";"0";"4.69";"8f";"O=C1NC(=S)S/C1=C\c1ccc(COc2ccc(C(=O)c3ccccc3)c(O)c2)cc1";"IC50";"'='";"7200.0";"nM";"5.14";"";"";"UO_0000065";"11.49";"0.23";"0.45";"6.80";"0";"CHEMBL658685";"In vitro inhibition of cathepsin D.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1129769";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1996";"None";"";"";""
"CHEMBL3916243";"ATABECESTAT";"2.0";"367.41";"0";"3.14";"1; NJ-54861911";"C[C@@]1(c2cc(NC(=O)c3ccc(C#N)cn3)ccc2F)C=CSC(N)=N1";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4811874";"Inhibition of CatD (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4811232";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"";""
"CHEMBL1208803";"";"None";"416.51";"0";"3.82";"7";"CC(=O)N[C@@H](Cc1cc(F)cc(F)c1)[C@H](O)CNC1(c2ccccc2)CCCCC1";"IC50";"";"";"";"";"";"Not Active";"";"";"";"";"";"0";"CHEMBL1260849";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1255191";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL1271346";"";"None";"399.40";"0";"2.32";"67";"COCC#Cc1cccc([C@@]2(c3ccc(OC(F)F)cc3)N=C(N)N(C)C2=O)c1";"IC50";"'='";"6200.0";"nM";"5.21";"";"";"UO_0000065";"13.04";"0.25";"2.89";"6.75";"0";"CHEMBL1273977";"Inhibition of cathepsin D by FRET assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1268920";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL1270631";"";"None";"419.38";"0";"3.09";"97";"Cc1cc([C@]2(c3ccc(F)c(C#CCF)c3)N=C(N)N(C)C2=O)ccc1OC(F)F";"IC50";"'='";"2200.0";"nM";"5.66";"";"";"UO_0000065";"13.49";"0.26";"2.57";"8.33";"0";"CHEMBL1273977";"Inhibition of cathepsin D by FRET assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1268920";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL1210351";"";"None";"612.67";"1";"4.69";"30";"CS(=O)(=O)N(c1cccc(C(=O)N[C@@H](Cc2ccccc2)[C@H](O)CNCc2cccc(C(F)(F)F)c2)c1)c1ccccn1";"IC50";"'='";"1020.0";"nM";"5.99";"";"";"UO_0000065";"9.78";"0.19";"1.30";"5.37";"0";"CHEMBL1211667";"Inhibition of Cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1208699";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL1210344";"";"None";"631.80";"1";"3.78";"23";"C[C@H](NC[C@@H](O)[C@H](Cc1ccccc1)NC(=O)c1cccc(N(c2cccc(C#N)c2)S(C)(=O)=O)c1)C(=O)NC1CCCCC1";"IC50";"'='";"600.0";"nM";"6.22";"";"";"UO_0000065";"9.85";"0.19";"2.44";"4.10";"0";"CHEMBL1211667";"Inhibition of Cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1208699";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL1210361";"";"None";"653.77";"2";"6.42";"43";"CC(C)c1cc(C(=O)N[C@@H](Cc2ccccc2)[C@H](O)CNCc2cccc(C(F)(F)F)c2)cc(N(c2ccccc2)S(C)(=O)=O)c1";"IC50";"'='";"520.0";"nM";"6.28";"";"";"UO_0000065";"9.61";"0.19";"-0.14";"6.36";"0";"CHEMBL1211667";"Inhibition of Cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1208699";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL2177341";"";"None";"360.37";"0";"2.85";"9v";"COc1ccc2c(c1)[C@@]1(COC(N)=N1)c1cc(-c3cncnc3)ccc1O2";"IC50";"'>'";"40000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2183109";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2177044";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL447220";"";"None";"592.66";"2";"5.37";"18a";"CCc1c[nH]c2c(N3CCCC3=O)cc(C(=O)N[C@@H](Cc3ccccc3)[C@H](O)CNCc3cccc(C(F)(F)F)c3)cc12";"IC50";"'='";"4070.0";"nM";"5.39";"";"";"UO_0000065";"9.10";"0.17";"0.02";"5.53";"0";"CHEMBL1036847";"Inhibition of cathepsin-D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1137769";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL565297";"";"None";"473.61";"0";"3.54";"18, mixture of epimers";"CC(=O)N[C@@H](Cc1cc(F)cc(F)c1)[C@H](O)CNC1(c2cccc(C(C)(C)C)c2)CCCNC1";"IC50";"'='";"2327.0";"nM";"5.63";"";"";"UO_0000065";"11.89";"0.23";"2.09";"7.68";"0";"CHEMBL1045212";"Inhibition of cathepsin D assessed as reduction in polarization after 110 mins by oregon green based fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156090";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL584121";"";"None";"515.65";"1";"3.80";"21, mixture of epimers";"CC(=O)N[C@@H](Cc1cc(F)cc(F)c1)[C@H](O)CNC1(c2cccc(C(C)(C)C)c2)CCCN(C(C)=O)C1";"IC50";"'='";"410.0";"nM";"6.39";"";"";"UO_0000065";"12.39";"0.24";"2.59";"7.82";"0";"CHEMBL1045212";"Inhibition of cathepsin D assessed as reduction in polarization after 110 mins by oregon green based fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156090";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL569390";"";"None";"488.62";"0";"4.09";"32";"CC(=O)N[C@@H](Cc1cc(F)cc(F)c1)[C@H](O)CN[C@]1(c2cccc(C(C)(C)C)c2)CC[C@H](O)CC1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1045212";"Inhibition of cathepsin D assessed as reduction in polarization after 110 mins by oregon green based fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156090";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL584731";"";"None";"487.64";"0";"3.93";"37";"CC(=O)N[C@@H](Cc1cc(F)cc(F)c1)[C@H](O)CN[C@@]1(c2cccc(C(C)(C)C)c2)CC[C@H](C)NC1";"IC50";"'='";"80.0";"nM";"7.10";"";"";"UO_0000065";"14.55";"0.28";"3.17";"9.67";"0";"CHEMBL1045212";"Inhibition of cathepsin D assessed as reduction in polarization after 110 mins by oregon green based fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156090";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL2181017";"";"None";"979.19";"3";"0.35";"4";"COC(=O)[C@@H]1CCCN1C(=O)[C@@H](Cc1ccccc1)N(C)C(=O)[C@@H](C)NC(=O)[C@H](CC(C)C)NC(=O)C[C@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(N)=O)N(C)C(=O)[C@@H](NC(=O)[C@H](C)O)C(C)C";"IC50";"'='";"7590.0";"nM";"5.12";"";"";"UO_0000065";"5.23";"0.10";"4.77";"1.78";"0";"CHEMBL2185513";"Inhibition of cathepsin D by fluorescence assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2176894";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL4215837";"";"None";"428.49";"0";"2.67";"68";"C[C@H]1C[C@H]2CSC(N)=N[C@@]2(c2nc(NC(=O)c3ccn(C(F)F)n3)cs2)CO1";"IC50";"'>'";"300000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4183115";"Inhibition of Cathepsin D (unknown origin) by fluorescence polarization assay";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4177751";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL3972449";"";"None";"469.54";"0";"3.38";"65";"Cc1cc(OC(F)F)cnc1C(=O)Nc1csc([C@]23CO[C@@H](C)C[C@H]2CSC(N)=N3)n1";"IC50";"'>'";"70300.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4183115";"Inhibition of Cathepsin D (unknown origin) by fluorescence polarization assay";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4177751";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL3952064";"";"None";"455.51";"0";"3.07";"64";"C[C@H]1C[C@H]2CSC(N)=N[C@@]2(c2nc(NC(=O)c3ccc(OC(F)F)cn3)cs2)CO1";"IC50";"'>'";"95300.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4183115";"Inhibition of Cathepsin D (unknown origin) by fluorescence polarization assay";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4177751";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL3983988";"";"None";"421.52";"0";"2.92";"59";"Cc1cc(F)cnc1C(=O)Nc1csc([C@]23CO[C@@H](C)C[C@H]2CSC(N)=N3)n1";"IC50";"'='";"34800.0";"nM";"4.46";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4183115";"Inhibition of Cathepsin D (unknown origin) by fluorescence polarization assay";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4177751";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL539436";"";"None";"590.75";"1";"3.48";"22";"CCc1cn2c3c(cc(C(=O)N[C@@H](Cc4ccccc4)[C@H](O)CNCc4cccc(OC)c4)cc13)N(C)S(=O)(=O)CC2";"IC50";"'='";"2950.0";"nM";"5.53";"";"";"UO_0000065";"9.36";"0.18";"2.05";"4.90";"0";"CHEMBL1035560";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1158445";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL2349483";"";"None";"383.88";"0";"3.94";"53, rac-53";"CCN1C(=O)C2(CC(C)(C)Oc3ccc(-c4cccc(Cl)c4)cc32)N=C1N";"IC50";"'='";"1224.0";"nM";"5.91";"";"";"UO_0000065";"15.40";"0.30";"1.97";"8.70";"0";"CHEMBL2352017";"Inhibition of human spleen cathepsin D using 5-FAM/QXL as peptide substrate after 1 hr by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"CHEMBL3559722";"Spleen";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346596";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL2349477";"";"None";"386.91";"0";"3.66";"47, rac-47";"CN1C(=O)C2(CC(C)(C)Sc3ccc(-c4cncc(Cl)c4)cc32)N=C1N";"IC50";"'='";"404.0";"nM";"6.39";"";"";"UO_0000065";"16.52";"0.34";"2.73";"8.93";"0";"CHEMBL2352017";"Inhibition of human spleen cathepsin D using 5-FAM/QXL as peptide substrate after 1 hr by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"CHEMBL3559722";"Spleen";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346596";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL2349472";"";"None";"403.91";"0";"4.40";"42, rac-42";"CN1C(=O)C2(CC(C)(C)Sc3ccc(-c4cc(F)cc(Cl)c4)cc32)N=C1N";"IC50";"'='";"477.0";"nM";"6.32";"";"";"UO_0000065";"15.65";"0.32";"1.92";"10.77";"0";"CHEMBL2352017";"Inhibition of human spleen cathepsin D using 5-FAM/QXL as peptide substrate after 1 hr by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"CHEMBL3559722";"Spleen";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346596";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL2349501";"";"None";"336.40";"0";"2.29";"31, rac-31";"CN1C(=O)C2(CC(C)(C)Oc3ccc(-c4cccnc4)cc32)N=C1N";"IC50";"'='";"8611.0";"nM";"5.07";"";"";"UO_0000065";"15.06";"0.28";"2.77";"6.27";"0";"CHEMBL2352017";"Inhibition of human spleen cathepsin D using 5-FAM/QXL as peptide substrate after 1 hr by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"CHEMBL3559722";"Spleen";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346596";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL2349495";"";"None";"381.50";"0";"3.62";"25, rac-25";"CSc1cccc(-c2ccc3c(c2)C2(CC(C)(C)O3)N=C(N)N(C)C2=O)c1";"IC50";"'='";"447.0";"nM";"6.35";"";"";"UO_0000065";"16.64";"0.32";"2.73";"9.35";"0";"CHEMBL2352017";"Inhibition of human spleen cathepsin D using 5-FAM/QXL as peptide substrate after 1 hr by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"CHEMBL3559722";"Spleen";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346596";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL2349494";"";"None";"403.40";"0";"3.92";"24, rac-24";"CN1C(=O)C2(CC(C)(C)Oc3ccc(-c4cccc(C(F)(F)F)c4)cc32)N=C1N";"IC50";"'='";"798.0";"nM";"6.10";"";"";"UO_0000065";"15.12";"0.29";"2.18";"8.98";"0";"CHEMBL2352017";"Inhibition of human spleen cathepsin D using 5-FAM/QXL as peptide substrate after 1 hr by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"CHEMBL3559722";"Spleen";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346596";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL2349465";"";"None";"325.39";"0";"3.40";"62, rac-62";"CC1(C)Cc2ccc(-c3cccnc3F)cc2C2(COC(N)=N2)C1";"IC50";"'='";"29540.0";"nM";"4.53";"";"";"UO_0000065";"13.92";"0.26";"1.13";"7.49";"0";"CHEMBL2352017";"Inhibition of human spleen cathepsin D using 5-FAM/QXL as peptide substrate after 1 hr by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"CHEMBL3559722";"Spleen";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346596";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL2349479";"";"None";"353.45";"0";"2.40";"49, rac-49";"CN1C(=O)C2(CC(C)(C)Sc3ccc(-c4cncnc4)cc32)N=C1N";"IC50";"'='";"3072.0";"nM";"5.51";"";"";"UO_0000065";"15.60";"0.30";"3.11";"6.53";"0";"CHEMBL2352017";"Inhibition of human spleen cathepsin D using 5-FAM/QXL as peptide substrate after 1 hr by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"CHEMBL3559722";"Spleen";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346596";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL2349609";"";"None";"382.42";"0";"2.38";"41, rac-41";"Cc1ccc(C(=O)Nc2ccc3c(c2)C2(CC(C)(C)O3)N=C(N)N(C)C2=O)o1";"IC50";"'='";"180420.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2352017";"Inhibition of human spleen cathepsin D using 5-FAM/QXL as peptide substrate after 1 hr by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"CHEMBL3559722";"Spleen";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346596";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL2349500";"";"None";"342.44";"0";"2.22";"30, rac-30";"CN1C(=O)C2(CC(C)(C)Oc3ccc(N4CCCCC4)cc32)N=C1N";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL2352017";"Inhibition of human spleen cathepsin D using 5-FAM/QXL as peptide substrate after 1 hr by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"CHEMBL3559722";"Spleen";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346596";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL2349497";"";"None";"353.40";"0";"3.04";"27, rac-27";"CN1C(=O)C2(CC(C)(C)Oc3ccc(-c4cccc(F)c4)cc32)N=C1N";"IC50";"'='";"2292.0";"nM";"5.64";"";"";"UO_0000065";"15.96";"0.30";"2.60";"8.30";"0";"CHEMBL2352017";"Inhibition of human spleen cathepsin D using 5-FAM/QXL as peptide substrate after 1 hr by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"CHEMBL3559722";"Spleen";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346596";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL2029366";"";"None";"497.66";"0";"4.50";"32";"CC(=O)N[C@@H](Cc1ccc(F)cc1)[C@H](O)CN[C@H]1C[C@]2(CC[C@H]2C)Oc2ncc(CC(C)(C)C)cc21";"IC50";"'='";"46.0";"nM";"7.34";"";"";"UO_0000065";"14.74";"0.28";"2.84";"8.79";"0";"CHEMBL2033077";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2029322";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL1257649";"";"None";"551.52";"2";"5.88";"10";"CC(=O)N[C@@H](Cc1cc(F)cc(F)c1)[C@H](O)CNC1(c2cc(Br)cc(C(C)(C)C)c2)CCCCC1";"IC50";"'='";"42.0";"nM";"7.38";"";"";"UO_0000065";"13.38";"0.29";"1.50";"12.02";"0";"CHEMBL1260849";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1255191";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL1258001";"";"None";"565.73";"1";"4.49";"15";"CC(=O)N[C@@H](Cc1cc(F)cc(F)c1)[C@H](O)CNC1(c2cc(NS(C)(=O)=O)cc(C(C)(C)C)c2)CCCCC1";"IC50";"'='";"12.0";"nM";"7.92";"";"";"UO_0000065";"14.00";"0.28";"3.43";"7.37";"0";"CHEMBL1260849";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1255191";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL3394041";"";"None";"430.44";"0";"3.78";"12";"NC1=N[C@@]2(CO1)c1cc(-c3cccnc3F)ccc1Oc1cnc(C3=CCCOC3)cc12";"IC50";"'='";"1080.0";"nM";"5.97";"";"";"UO_0000065";"13.86";"0.25";"2.19";"6.50";"0";"CHEMBL3395116";"Inhibition of cathepsin D (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3393054";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";""
"CHEMBL584694";"";"None";"353.47";"0";"2.89";"30";"COc1ccc(C2(C34CC5CC(CC(C5)C3)C4)N=C(N)N(C)C2=O)cc1";"IC50";"'='";"15320.0";"nM";"4.82";"";"";"UO_0000065";"13.62";"0.25";"1.92";"7.09";"0";"CHEMBL1044551";"Inhibition of human cathepsin D by FRET based peptide cleavage assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156789";"1";"Scientific Literature";"J Med Chem";"2010";"None";"";"";""
"CHEMBL367404";"";"None";"450.59";"1";"6.42";"39";"CCOc1ccc2nc(Sc3ccc(NC(=O)c4cc(C)cc(C)c4O)cc3)sc2c1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL657347";"Inhibitory activity against human liver Cathepsin D using Cathepsin D assay.";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1132101";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1999";"None";"";"";""
"CHEMBL3400435";"";"None";"519.69";"1";"4.49";"23a";"COCCCOc1cc(C(=O)N(C[C@@H]2CNC[C@H]2NCc2ccc3ccccc3c2)C(C)C)ccc1OC";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3404892";"Inhibition of human cathepsin D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3400139";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";""
"CHEMBL1210350";"";"None";"611.64";"1";"4.97";"29";"O=C(N[C@@H](Cc1ccccc1)[C@H](O)CNCc1cccc(C(F)(F)F)c1)c1cccc(N2c3ccccc3OS2(=O)=O)c1";"IC50";"'='";"1860.0";"nM";"5.73";"";"";"UO_0000065";"9.37";"0.18";"0.76";"5.31";"0";"CHEMBL1211667";"Inhibition of Cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1208699";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL1210348";"";"None";"631.80";"1";"3.78";"27";"C[C@H](NC[C@@H](O)[C@H](Cc1ccccc1)NC(=O)c1cccc(N(c2ccc(C#N)cc2)S(C)(=O)=O)c1)C(=O)NC1CCCCC1";"IC50";"'='";"5145.0";"nM";"5.29";"";"";"UO_0000065";"8.37";"0.16";"1.51";"3.49";"0";"CHEMBL1211667";"Inhibition of Cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1208699";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL2408764";"";"None";"444.57";"0";"4.24";"5";"CC(=O)N[C@@H](Cc1cc(F)cc(F)c1)[C@H](O)CN[C@H]1CCCc2ccc(CC(C)C)cc21";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL2410948";"Inhibition of cathepsin-D (unknown origin) using C-terminal biotinylated peptide substrate treated 30 mins before addition of peptide substrate measured after 110 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2406984";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"None";"";"";""
"CHEMBL2408761";"";"None";"478.58";"0";"4.63";"8";"CC(=O)N[C@@H](Cc1cc(F)cc(F)c1)[C@H](O)CN[C@H]1CCCc2ccc(Cc3ccccc3)cc21";"IC50";"'='";"251.0";"nM";"6.60";"";"";"UO_0000065";"13.79";"0.26";"1.97";"10.76";"0";"CHEMBL2410948";"Inhibition of cathepsin-D (unknown origin) using C-terminal biotinylated peptide substrate treated 30 mins before addition of peptide substrate measured after 110 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2406984";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"None";"";"";""
"CHEMBL2408763";"";"None";"444.57";"0";"4.38";"4";"CCCCc1ccc2c(c1)[C@@H](NC[C@@H](O)[C@H](Cc1cc(F)cc(F)c1)NC(C)=O)CCC2";"IC50";"'='";"77.0";"nM";"7.11";"";"";"UO_0000065";"16.00";"0.30";"2.73";"11.59";"0";"CHEMBL2410948";"Inhibition of cathepsin-D (unknown origin) using C-terminal biotinylated peptide substrate treated 30 mins before addition of peptide substrate measured after 110 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2406984";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"None";"";"";""
"CHEMBL2408736";"";"None";"473.61";"0";"4.13";"14";"CC(=O)N[C@@H](Cc1cc(F)cc(F)c1)[C@H](O)CN[C@H]1CCN(C)c2ccc(CC(C)(C)C)cc21";"IC50";"'='";"68.0";"nM";"7.17";"";"";"UO_0000065";"15.13";"0.29";"3.04";"11.10";"0";"CHEMBL2410948";"Inhibition of cathepsin-D (unknown origin) using C-terminal biotinylated peptide substrate treated 30 mins before addition of peptide substrate measured after 110 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2406984";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"None";"";"";""
"CHEMBL2408760";"";"None";"458.59";"0";"4.63";"7";"CC(=O)N[C@@H](Cc1cc(F)cc(F)c1)[C@H](O)CN[C@H]1CCCc2ccc(CC(C)(C)C)cc21";"IC50";"'='";"8.0";"nM";"8.10";"";"";"UO_0000065";"17.66";"0.34";"3.47";"13.20";"0";"CHEMBL2410948";"Inhibition of cathepsin-D (unknown origin) using C-terminal biotinylated peptide substrate treated 30 mins before addition of peptide substrate measured after 110 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2406984";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"None";"";"";""
"CHEMBL567026";"";"None";"551.70";"1";"2.91";"42";"CC(=O)N[C@@H](Cc1cc(F)cc(F)c1)[C@H](O)CN[C@@]1(c2cccc(C(C)(C)C)c2)CC[C@H](S(C)(=O)=O)NC1";"IC50";"'='";"2300.0";"nM";"5.64";"";"";"UO_0000065";"10.22";"0.20";"2.73";"5.24";"0";"CHEMBL1045212";"Inhibition of cathepsin D assessed as reduction in polarization after 110 mins by oregon green based fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156090";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL3923927";"";"None";"492.40";"0";"4.86";"BDBM215024";"Cc1cc(C(F)F)cnc1C(=O)Nc1cc(C)c(F)c([C@]2(CF)C[C@@H](C(F)(F)F)OC(N)=N2)c1";"IC50";"'>'";"400000.0";"nM";"";"Outside typical range";"378040";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3973889";"";"None";"492.83";"0";"4.29";"BDBM215006";"COCc1cc(Cl)cnc1C(=O)Nc1cc(F)c(F)c([C@]2(C)C[C@@H](C(F)(F)F)OC(N)=N2)c1";"IC50";"'='";"1712000.0";"nM";"";"Outside typical range";"378073";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3892657";"";"None";"469.83";"0";"4.19";"BDBM215018";"Cc1cc(C#N)cnc1C(=O)Nc1cc(Cl)c(F)c([C@]2(C)C[C@@H](C(F)(F)F)OC(N)=N2)c1";"IC50";"'='";"416000.0";"nM";"";"Outside typical range";"378078";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3955707";"";"None";"461.80";"0";"3.41";"BDBM215046";"COc1cnc(C(=O)Nc2cc(F)c(Cl)c([C@]3(C)C[C@@H](C(F)(F)F)OC(N)=N3)c2)cn1";"IC50";"'='";"194000.0";"nM";"";"Outside typical range";"378085";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL1257891";"";"None";"488.62";"0";"4.83";"13";"CC(=O)N[C@@H](Cc1cc(F)cc(F)c1)[C@H](O)CNC1(c2cc(O)cc(C(C)(C)C)c2)CCCCC1";"IC50";"'='";"90.0";"nM";"7.05";"";"";"UO_0000065";"14.42";"0.27";"2.22";"8.64";"0";"CHEMBL1260849";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1255191";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL1258234";"";"None";"464.62";"1";"5.01";"24";"CC(=O)N[C@@H](Cc1cc(F)cc(F)c1)[C@H](O)CNC1(c2ccc(C(C)C)s2)CCCCC1";"IC50";"'='";"411.0";"nM";"6.39";"";"";"UO_0000065";"13.74";"0.27";"1.38";"10.41";"0";"CHEMBL1260849";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1255191";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL1258352";"";"None";"464.62";"1";"5.01";"25";"CC(=O)N[C@@H](Cc1cc(F)cc(F)c1)[C@H](O)CNC1(c2csc(C(C)C)c2)CCCCC1";"IC50";"'='";"42.0";"nM";"7.38";"";"";"UO_0000065";"15.88";"0.31";"2.37";"12.02";"0";"CHEMBL1260849";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1255191";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL1258466";"";"None";"478.65";"1";"5.18";"27";"CC(=O)N[C@@H](Cc1cc(F)cc(F)c1)[C@H](O)CNC1(c2cc(C(C)(C)C)cs2)CCCCC1";"IC50";"'='";"32.0";"nM";"7.50";"";"";"UO_0000065";"15.66";"0.31";"2.31";"12.21";"0";"CHEMBL1260849";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1255191";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL1258686";"";"None";"463.57";"0";"4.11";"32";"CC(=O)N[C@@H](Cc1cc(F)cc(F)c1)[C@H](O)CNC1(c2cc(C(C)(C)C)no2)CCCCC1";"IC50";"'='";"263.0";"nM";"6.58";"";"";"UO_0000065";"14.19";"0.27";"2.47";"7.53";"0";"CHEMBL1260849";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1255191";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL1258803";"";"None";"463.57";"0";"4.11";"40";"CC(=O)N[C@@H](Cc1cc(F)cc(F)c1)[C@H](O)CNC1(c2nc(C(C)(C)C)co2)CCCCC1";"IC50";"'='";"12170.0";"nM";"4.92";"";"";"UO_0000065";"10.60";"0.20";"0.80";"5.62";"0";"CHEMBL1260849";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1255191";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL1258003";"";"None";"434.53";"0";"2.89";"68";"CC(=O)N[C@@H](Cc1cc(F)cc(F)c1)[C@H](O)CNC1(c2ccn(CC(C)(C)C)n2)CC1";"IC50";"'='";"3080.0";"nM";"5.51";"";"";"UO_0000065";"12.68";"0.24";"2.62";"6.96";"0";"CHEMBL1260849";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1255191";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL1213687";"";"None";"1066.40";"None";"None";"1";"CCCCNC(=O)C[C@H](O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)c1ccc(Oc2ccc(C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCCCC(C)Nc3cc(OC)cc4cccnc34)cc2)cc1)[C@@H](C)CC";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL2072160";"Inhibition of human cathepsin D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2069175";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL1941005";"";"None";"358.36";"0";"3.89";"2";"O=C(Cn1c(-c2ccccn2)nc2ccccc21)c1cccc([N+](=O)[O-])c1";"IC50";"'='";"21200.0";"nM";"4.67";"";"";"UO_0000065";"13.04";"0.24";"0.78";"5.14";"0";"CHEMBL1942416";"Inhibition of human cathepsin D using DABCYL-Glu-Arg-Nle-Phe-Leu-Ser-Phe-Pro-EDANS as substrate by FRET analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1938395";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL1941008";"";"None";"358.36";"0";"3.89";"5";"O=C(Cn1c(-c2ccccn2)nc2ccccc21)c1ccccc1[N+](=O)[O-]";"IC50";"'='";"39200.0";"nM";"4.41";"";"";"UO_0000065";"12.30";"0.22";"0.52";"4.85";"0";"CHEMBL1942416";"Inhibition of human cathepsin D using DABCYL-Glu-Arg-Nle-Phe-Leu-Ser-Phe-Pro-EDANS as substrate by FRET analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1938395";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL3930808";"";"None";"510.67";"1";"4.17";"BDBM214885";"C[C@@]1(c2nc(NC(=O)c3ncc(Br)cc3Cl)ccc2F)C[C@@H](C(F)(F)F)OC(N)=N1";"IC50";"'='";"636000.0";"nM";"";"Outside typical range";"377931";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL397715";"";"None";"590.72";"1";"3.25";"19k";"CCCN(CCC)C(=O)c1cc(C(N)=O)cc(C(=O)N[C@@H](Cc2ccc(O)cc2)[C@H](O)CNCc2cccc(OC)c2)c1";"IC50";"'>'";"20000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL888969";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1144655";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"None";"";"";""
"CHEMBL230314";"";"None";"514.63";"1";"3.20";"19g";"CCCNC(=O)c1cc(C#N)cc(C(=O)N[C@@H](Cc2ccccc2)[C@H](O)CNCc2cccc(OC)c2)c1";"IC50";"'>'";"20000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL888969";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1144655";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"None";"";"";""
"CHEMBL2349484";"";"None";"437.85";"0";"4.48";"54, rac-54";"CC1(C)CC2(N=C(N)N(CC(F)(F)F)C2=O)c2cc(-c3cccc(Cl)c3)ccc2O1";"IC50";"'='";"420.0";"nM";"6.38";"";"";"UO_0000065";"14.56";"0.29";"1.90";"9.39";"0";"CHEMBL2352017";"Inhibition of human spleen cathepsin D using 5-FAM/QXL as peptide substrate after 1 hr by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"CHEMBL3559722";"Spleen";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346596";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL443509";"";"None";"598.67";"1";"4.76";"8";"CCNc1cc(C(=O)N[C@@H](Cc2ccccc2)[C@H](O)CNCc2cccc(C(F)(F)F)c2)cc(N2CCCC2=O)c1OC";"IC50";"'='";"3720.0";"nM";"5.43";"";"";"UO_0000065";"9.07";"0.17";"0.67";"5.27";"0";"CHEMBL1036847";"Inhibition of cathepsin-D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1137769";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL2047890";"";"None";"495.48";"0";"3.44";"14c";"CC(C)(C)c1cccc(CN[C@H]2CS(=O)(=O)C[C@@H](Cc3ccc(N)c(Br)c3)[C@@H]2O)c1";"IC50";"'='";"720.0";"nM";"6.14";"";"";"UO_0000065";"12.40";"0.28";"2.70";"6.65";"0";"CHEMBL2049562";"Inhibition of human recombinant CatD using Mca-GKPILFFRLK(DNP)-dR-NH2 as substrate after 1 hr by fluorescence analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2046351";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL558488";"";"None";"557.82";"2";"5.86";"14, NB-533";"CC(C)c1ccc2c(c1)[C@@H](NC[C@@H](O)[C@@H]1C[C@H](C)CCCCCCCCC(=O)N(C)[C@@H](C)C(=O)N1)CC(C)(C)O2";"IC50";"'='";"1.0";"nM";"9.00";"";"";"UO_0000065";"16.13";"0.31";"3.14";"9.90";"0";"CHEMBL1030363";"Inhibition of human cathepsin D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1151821";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL564010";"";"None";"487.73";"0";"4.75";"3, NB-544";"CC(C)c1cccc(CNC[C@@H](O)[C@@H]2C[C@H](C)CCCCCCCCC(=O)N(C)[C@@H](C)C(=O)N2)c1";"IC50";"'='";"1400.0";"nM";"5.85";"";"";"UO_0000065";"12.00";"0.23";"1.10";"7.17";"0";"CHEMBL1030363";"Inhibition of human cathepsin D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1151821";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL429357";"";"None";"516.26";"2";"8.02";"30";"O=C(Nc1cc(Cl)c(Sc2nc3ccccc3s2)c(Cl)c1)c1cc(Cl)cc(Cl)c1O";"IC50";"'='";"1300.0";"nM";"5.89";"";"";"UO_0000065";"11.40";"0.27";"-2.13";"9.46";"0";"CHEMBL657347";"Inhibitory activity against human liver Cathepsin D using Cathepsin D assay.";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1132101";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1999";"None";"";"";""
"CHEMBL2408737";"";"None";"460.57";"0";"4.07";"15";"CC(=O)N[C@@H](Cc1cc(F)cc(F)c1)[C@H](O)CN[C@H]1CCOc2ccc(CC(C)(C)C)cc21";"IC50";"'='";"12.0";"nM";"7.92";"";"";"UO_0000065";"17.20";"0.33";"3.85";"11.22";"0";"CHEMBL2410948";"Inhibition of cathepsin-D (unknown origin) using C-terminal biotinylated peptide substrate treated 30 mins before addition of peptide substrate measured after 110 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2406984";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"None";"";"";""
"CHEMBL68163";"";"None";"469.58";"0";"4.83";"17b";"CCCc1c(OCc2ccc(/C=C3\SC(=S)NC3=O)cc2)ccc(C(C)=O)c1OC(C)=O";"IC50";"'='";"2980.0";"nM";"5.53";"";"";"UO_0000065";"11.77";"0.24";"0.70";"6.76";"0";"CHEMBL658685";"In vitro inhibition of cathepsin D.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1129769";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1996";"None";"";"";""
"CHEMBL326831";"";"None";"894.93";"3";"7.58";"1";"CC1=C(CCC(=O)O)c2cc3[nH]c(cc4[nH]c(cc5nc(cc1n2)C(C)=C5C(COC(=O)C1=CC1)OC(=O)C1=CC1)c(C)c4C(COC(=O)C1=CC1)OC(=O)C1=CC1)c(C)c3CCC(=O)O";"IC50";"'='";"10000.0";"nM";"5.00";"";"";"UO_0000065";"5.59";"0.10";"-2.58";"2.11";"0";"CHEMBL661017";"Inhibitory concentration against cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1126254";"1";"Scientific Literature";"J Med Chem";"1992";"None";"";"";""
"CHEMBL69128";"";"None";"385.51";"0";"4.41";"29a";"CCCc1c(O)cccc1OCc1ccc(/C=C2\SC(=S)NC2=O)cc1";"IC50";"'='";"2940.0";"nM";"5.53";"";"";"UO_0000065";"14.35";"0.29";"1.12";"9.45";"0";"CHEMBL658685";"In vitro inhibition of cathepsin D.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1129769";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1996";"None";"";"";""
"CHEMBL1824350";"";"None";"391.50";"0";"3.11";"53";"CCc1cc(C2(c3cccc(-c4cncnc4)c3)N=C(N)N(C)C2=O)c(C)s1";"IC50";"'='";"11800.0";"nM";"4.93";"";"";"UO_0000065";"12.59";"0.24";"1.82";"5.83";"0";"CHEMBL1825607";"Inhibition of cathepsin D by FRET assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1821667";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL1824355";"";"None";"366.42";"0";"2.98";"58";"CN1C(=O)C(c2ccsc2)(c2cccc(-c3cccnc3F)c2)N=C1N";"IC50";"'='";"8000.0";"nM";"5.10";"";"";"UO_0000065";"13.91";"0.27";"2.12";"7.12";"0";"CHEMBL1825607";"Inhibition of cathepsin D by FRET assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1821667";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL1824357";"";"None";"384.41";"0";"3.12";"60";"CN1C(=O)C(c2ccsc2)(c2ccc(F)c(-c3cccnc3F)c2)N=C1N";"IC50";"'='";"2200.0";"nM";"5.66";"";"";"UO_0000065";"14.72";"0.29";"2.54";"7.90";"0";"CHEMBL1825607";"Inhibition of cathepsin D by FRET assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1821667";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL1824358";"";"None";"378.46";"0";"2.85";"61";"COc1cncc(-c2cccc(C3(c4ccsc4)N=C(N)N(C)C3=O)c2)c1";"IC50";"'='";"18600.0";"nM";"4.73";"";"";"UO_0000065";"12.50";"0.24";"1.88";"5.85";"0";"CHEMBL1825607";"Inhibition of cathepsin D by FRET assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1821667";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL113085";"";"None";"775.94";"2";"2.87";"23";"CC(C)[C@H](NC(=O)OCc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)[C@@H](O)[C@H]1NCc2ccc(cc2)OCCOCCOCCNC(=O)[C@H](C(C)C)NC1=O";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL662648";"The compound was tested for inhibition of Human Cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1129607";"1";"Scientific Literature";"J Med Chem";"1996";"None";"";"";""
"CHEMBL83361";"";"None";"456.98";"1";"6.46";"34";"CCOc1ccc2nc(Sc3ccc(NC(=O)c4cccc(Cl)c4O)cc3)sc2c1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL657347";"Inhibitory activity against human liver Cathepsin D using Cathepsin D assay.";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1132101";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1999";"None";"";"";""
"CHEMBL3127087";"";"None";"398.85";"0";"2.18";"65";"CN1C(=O)[C@]2(N=C1N)c1cc(-c3cncc(Cl)c3)ccc1O[C@H]1CCOC[C@@H]12";"IC50";"'='";"3200.0";"nM";"5.50";"";"";"UO_0000065";"13.78";"0.27";"3.31";"6.10";"0";"CHEMBL3131975";"Inhibition of human liver cathepsin D measured for 1 hr by FRET assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124885";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL3127103";"";"None";"429.42";"0";"2.73";"57";"CN1C(=O)[C@]2(N=C1N)c1cc(-c3cccc(OC(F)F)c3)ccc1O[C@H]1CCOC[C@@H]12";"IC50";"'='";"780.0";"nM";"6.11";"";"";"UO_0000065";"14.22";"0.27";"3.38";"7.07";"0";"CHEMBL3131975";"Inhibition of human liver cathepsin D measured for 1 hr by FRET assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124885";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL583546";"";"None";"566.72";"1";"2.41";"48";"CC(=O)N[C@@H](Cc1cc(F)cc(F)c1)[C@H](O)CN[C@@]1(c2cccc(C(C)(C)C)c2)CC[C@H](NS(C)(=O)=O)NC1";"IC50";"'='";"7200.0";"nM";"5.14";"";"";"UO_0000065";"9.07";"0.18";"2.73";"4.30";"0";"CHEMBL1045212";"Inhibition of cathepsin D assessed as reduction in polarization after 110 mins by oregon green based fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156090";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL495087";"";"None";"491.61";"1";"5.08";"16";"CC(=O)Nc1ccc(CN2CCC3(CC2)C(NC2CCCCC2)=NC(=O)N3c2cccc(F)c2)cc1";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1032302";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140155";"1";"Scientific Literature";"J Med Chem";"2008";"None";"";"";""
"CHEMBL3422245";"";"None";"397.42";"0";"3.63";"13";"Cc1cc([C@H]2C[C@H]3[C@@H](CF)SC(N)=N[C@@]3(c3ccc(F)cc3F)CO2)on1";"IC50";"'='";"8000.0";"nM";"5.10";"";"";"UO_0000065";"12.82";"0.26";"1.47";"6.92";"0";"CHEMBL3423725";"Inhibition of CatD (unknown origin) assessed as fluorescence polarization by cell free assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3421534";"1";"Scientific Literature";"J Med Chem";"2015";"None";"";"";""
"CHEMBL1088215";"";"None";"502.72";"1";"1.58";"1";"CCCCNC(=O)[C@H](C)C[C@H](O)[C@H](CC(C)C)NC(=O)[C@H](CCSC)NC(=O)[C@H](C)NC(C)=O";"IC50";"'='";"35.0";"nM";"7.46";"";"";"UO_0000065";"14.83";"0.30";"5.88";"5.46";"0";"CHEMBL1107841";"Inhibition of Cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1155410";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL1084154";"";"None";"521.75";"1";"4.71";"26";"CC(=O)NC(C)(C)[C@H]1CCC[C@@H](C(=O)N[C@@H](Cc2ccccc2)[C@@H](O)CNCc2cccc(C(C)C)c2)C1";"IC50";"'='";"7900.0";"nM";"5.10";"";"";"UO_0000065";"9.78";"0.18";"0.39";"5.64";"0";"CHEMBL1107841";"Inhibition of Cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1155410";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL453841";"";"None";"582.67";"2";"5.06";"7";"CCNc1cc(C(=O)N[C@@H](Cc2ccccc2)[C@H](O)CNCc2cccc(C(F)(F)F)c2)cc(N2CCCC2=O)c1C";"IC50";"'='";"4270.0";"nM";"5.37";"";"";"UO_0000065";"9.22";"0.17";"0.31";"5.73";"0";"CHEMBL1036847";"Inhibition of cathepsin-D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1137769";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL1210338";"";"None";"591.77";"1";"3.79";"13";"C[C@H](NC[C@@H](O)[C@H](Cc1ccccc1)NC(=O)c1cccc(S(=O)(=O)Cc2ccccc2)c1)C(=O)NC1CCCCC1";"IC50";"'='";"6600.0";"nM";"5.18";"";"";"UO_0000065";"8.75";"0.17";"1.39";"4.16";"0";"CHEMBL1211667";"Inhibition of Cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1208699";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL1210337";"";"None";"591.77";"1";"3.79";"12";"C[C@H](NC[C@@H](O)[C@H](Cc1ccccc1)NC(=O)c1cccc(CS(=O)(=O)c2ccccc2)c1)C(=O)NC1CCCCC1";"IC50";"'='";"12000.0";"nM";"4.92";"";"";"UO_0000065";"8.32";"0.16";"1.13";"3.95";"0";"CHEMBL1211667";"Inhibition of Cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1208699";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL3394045";"";"None";"432.46";"0";"4.22";"16";"NC1=N[C@@]2(CO1)c1cc(-c3cccnc3F)ccc1Oc1cnc([C@H]3CCCCO3)cc12";"IC50";"'='";"1040.0";"nM";"5.98";"";"";"UO_0000065";"13.83";"0.26";"1.76";"6.51";"0";"CHEMBL3395116";"Inhibition of cathepsin D (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3393054";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";""
"CHEMBL3394055";"";"None";"425.42";"0";"4.04";"26";"NC1=N[C@@]2(CO1)c1cc(-c3cccnc3F)ccc1Oc1cnc(-c3ccncc3)cc12";"IC50";"'='";"3190.0";"nM";"5.50";"";"";"UO_0000065";"12.92";"0.23";"1.46";"5.75";"0";"CHEMBL3395116";"Inhibition of cathepsin D (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3393054";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";""
"CHEMBL170804";"";"None";"378.49";"1";"5.79";"11";"O=c1cc(-c2ccccc2)oc(O)c1C(CC1CC1)SCc1ccccc1";"IC50";"'>'";"40000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL657343";"Ability to inhibit the human Native cathepsin D aspartic protease enzyme";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1128706";"1";"Scientific Literature";"J Med Chem";"1995";"None";"";"";""
"CHEMBL2349488";"";"None";"357.91";"0";"4.63";"58, rac-58";"CC1(C)Cc2ccc(-c3cncc(Cl)c3)cc2C2(CSC(N)=N2)C1";"IC50";"'='";"8096.0";"nM";"5.09";"";"";"UO_0000065";"14.23";"0.29";"0.46";"9.93";"0";"CHEMBL2352017";"Inhibition of human spleen cathepsin D using 5-FAM/QXL as peptide substrate after 1 hr by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"CHEMBL3559722";"Spleen";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346596";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL68971";"";"None";"469.58";"0";"4.83";"15";"CCCc1c(COc2ccc(/C=C3\SC(=S)NC3=O)cc2)ccc(C(C)=O)c1OC(C)=O";"IC50";"'='";"33000.0";"nM";"4.48";"";"";"UO_0000065";"9.54";"0.19";"-0.35";"5.49";"0";"CHEMBL658684";"Compound was evaluated for the inhibition of cathepsin D at concentration of 4.15 ug/mL";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1129769";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1996";"None";"";"";""
"CHEMBL2151151";"";"None";"465.64";"0";"4.11";"page no 4490, R47C2, 5-2";"CC(=O)N[C@@H](Cc1ccccc1)[C@H](O)CN[C@H]1CC2(CCC2)Oc2ncc(CC(C)(C)C)cc21";"IC50";"'='";"4.5";"nM";"8.35";"";"";"UO_0000065";"17.93";"0.34";"4.24";"10.00";"0";"CHEMBL2411009";"Inhibition of Cathepsin D (unknown origin) by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2406987";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"None";"";"";""
"CHEMBL210176";"";"None";"514.76";"1";"1.29";"69";"CCCCNC(=O)[C@H](C)C[C@H](O)[C@@H]1CSC/C=C/CS[C@@H]2CNCC[C@@H]2C(=O)N[C@@H](C)C(=O)N1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL866007";"Inhibition of Cathepsin D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1137429";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";"";""
"CHEMBL1169538";"";"None";"638.81";"1";"2.87";"8a";"CN1CC[C@H]([C@H](O)[C@H](CC2CCCCC2)NC(=O)[C@H](Cc2c[nH]cn2)NC(=O)[C@H](Cc2ccccc2)NC(=O)OC(C)(C)C)C1=O";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL657351";"Inhibitory concentration against cathepsin D";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1125921";"1";"Scientific Literature";"J Med Chem";"1991";"None";"";"";""
"CHEMBL170504";"";"None";"666.86";"1";"3.65";"34";"CN1C(=O)[C@H]([C@H](O)[C@H](CC2CCCCC2)NC(=O)[C@H](Cc2c[nH]cn2)NC(=O)[C@H](Cc2ccccc2)NC(=O)OC(C)(C)C)CC1(C)C";"IC50";"'='";"150.0";"nM";"6.82";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL657351";"Inhibitory concentration against cathepsin D";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1125921";"1";"Scientific Literature";"J Med Chem";"1991";"None";"";"";""
"CHEMBL3745922";"";"None";"412.49";"0";"4.15";"8a";"Cc1ccc2[nH]c(N[C@H]3CNC[C@@H]3OC(=O)c3ccc(-c4ccccc4)cc3)nc2c1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3749955";"Inhibition of cathepsin D (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3745702";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";"";""
"CHEMBL1210342";"";"None";"631.80";"1";"3.78";"21";"C[C@H](NC[C@@H](O)[C@H](Cc1ccccc1)NC(=O)c1cccc(N(c2ccccc2C#N)S(C)(=O)=O)c1)C(=O)NC1CCCCC1";"IC50";"'='";"1090.0";"nM";"5.96";"";"";"UO_0000065";"9.44";"0.18";"2.18";"3.93";"0";"CHEMBL1211667";"Inhibition of Cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1208699";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL2069614";"";"None";"951.22";"3";"6.64";"4";"CCCCNC(=O)C[C@H](O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)c1ccc(Oc2ccc(C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)NCCCNc3ccnc4ccccc34)cc2)cc1)[C@@H](C)CC";"IC50";"'='";"300.0";"nM";"6.52";"";"";"UO_0000065";"6.86";"0.13";"-0.12";"2.85";"0";"CHEMBL2072160";"Inhibition of human cathepsin D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2069175";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL401473";"";"None";"618.72";"1";"4.56";"9";"CCNc1cc(C(=O)N[C@@H](Cc2ccccc2)[C@H](O)CNCc2cccc(C(F)(F)F)c2)cc(N2CCCCS2(=O)=O)c1";"IC50";"'='";"3570.0";"nM";"5.45";"";"";"UO_0000065";"8.80";"0.17";"0.89";"4.92";"0";"CHEMBL1036847";"Inhibition of cathepsin-D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1137769";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL501958";"";"None";"604.67";"2";"5.43";"22";"CCc1ccnc2c(N3CCCC3=O)cc(C(=O)N[C@@H](Cc3ccccc3)[C@H](O)CNCc3cccc(C(F)(F)F)c3)cc12";"IC50";"'='";"14390.0";"nM";"4.84";"";"";"UO_0000065";"8.01";"0.15";"-0.59";"5.12";"0";"CHEMBL1036847";"Inhibition of cathepsin-D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1137769";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL2047898";"";"None";"504.64";"1";"4.38";"32a";"CC(C)(C)c1cccc(CN[C@H]2CS(=O)(=O)C[C@@H](Cc3ccc4[nH]cc(CC(F)F)c4c3)[C@@H]2O)c1";"IC50";"'='";"1220.0";"nM";"5.91";"";"";"UO_0000065";"11.72";"0.23";"1.53";"7.20";"0";"CHEMBL2049562";"Inhibition of human recombinant CatD using Mca-GKPILFFRLK(DNP)-dR-NH2 as substrate after 1 hr by fluorescence analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2046351";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL3127083";"";"None";"447.41";"0";"2.87";"90";"CN1C(=O)[C@]2(N=C1N)c1cc(-c3cccc(OC(F)F)c3)c(F)cc1O[C@H]1CCOC[C@@H]12";"IC50";"'='";"600.0";"nM";"6.22";"";"";"UO_0000065";"13.91";"0.27";"3.35";"7.20";"0";"CHEMBL3131975";"Inhibition of human liver cathepsin D measured for 1 hr by FRET assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124885";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL3127074";"";"None";"369.40";"0";"2.62";"80";"C[C@]12CCOC[C@@H]1[C@]1(COC(N)=N1)c1cc(-c3cncc(F)c3)ccc1O2";"IC50";"'='";"160000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3131975";"Inhibition of human liver cathepsin D measured for 1 hr by FRET assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124885";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL3127086";"";"None";"382.39";"0";"1.67";"64";"CN1C(=O)[C@]2(N=C1N)c1cc(-c3cncc(F)c3)ccc1O[C@H]1CCOC[C@@H]12";"IC50";"'='";"6200.0";"nM";"5.21";"";"";"UO_0000065";"13.62";"0.25";"3.54";"5.78";"0";"CHEMBL3131975";"Inhibition of human liver cathepsin D measured for 1 hr by FRET assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124885";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL2181011";"";"None";"1024.25";"None";"None";"13";"COC(=O)[C@@H]1CCCN1C(=O)[C@@H](Cc1ccccc1)N(C)C(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)C[C@H](O)[C@H](Cc1ccccc1)NC(=O)c1cc(C(=O)N[C@H](C)c2ccccc2)cc(N(C)S(C)(=O)=O)c1";"IC50";"'='";"5.84";"nM";"8.23";"";"";"UO_0000065";"8.04";"None";"None";"None";"0";"CHEMBL2185513";"Inhibition of cathepsin D by fluorescence assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2176894";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL3765358";"";"None";"465.60";"1";"5.91";"rac-4g";"Nc1nc2cc(-c3ccc(CCC4CC4)cc3)ccc2c(=O)n1C[C@@H]1CC[C@H](c2ccccc2)O1";"IC50";"'='";"3200.0";"nM";"5.50";"";"";"UO_0000065";"11.80";"0.21";"-0.42";"7.83";"0";"CHEMBL3767017";"Inhibition of CatD (unknown origin) preincubated for 30 mins followed by DABCYL-Glu-Arg-Nle-Phe-Leu-Ser-Phe-Pro-EDANS substrate addition by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3763050";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";""
"CHEMBL210240";"";"None";"514.76";"1";"1.44";"52";"CCCCNC(=O)[C@H](C)C[C@H](O)[C@@H]1CSC/C=C/CS[C@H]2CCCN[C@H]2C(=O)N[C@@H](C)C(=O)N1";"IC50";"'='";"10.0";"nM";"8.00";"";"";"UO_0000065";"15.54";"0.32";"6.56";"6.69";"0";"CHEMBL866007";"Inhibition of Cathepsin D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1137429";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";"";""
"CHEMBL272714";"";"None";"578.75";"1";"3.73";"21";"CCCOc1cc(C(=O)N[C@@H](Cc2ccccc2)[C@H](O)CN[C@@H](C)C(=O)NC2CCCCC2)cc(N2CCCC2=O)c1";"IC50";"'='";"47080.0";"nM";"4.33";"";"";"UO_0000065";"7.48";"0.14";"0.60";"3.61";"0";"CHEMBL931965";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1143153";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";"";"";""
"CHEMBL258277";"";"None";"550.70";"1";"2.95";"16";"COc1cc(C(=O)N[C@@H](Cc2ccccc2)[C@H](O)CN[C@@H](C)C(=O)NC2CCCCC2)cc(N2CCCC2=O)c1";"IC50";"'='";"30015.0";"nM";"4.52";"";"";"UO_0000065";"8.21";"0.15";"1.57";"3.77";"0";"CHEMBL931965";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1143153";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";"";"";""
"CHEMBL402305";"";"None";"571.78";"1";"3.78";"14";"CCCCCS(=O)(=O)c1cccc(C(=O)N[C@@H](Cc2ccccc2)[C@H](O)CN[C@@H](C)C(=O)NC2CCCCC2)c1";"IC50";"'='";"600.0";"nM";"6.22";"";"";"UO_0000065";"10.88";"0.21";"2.44";"4.99";"0";"CHEMBL931965";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1143153";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";"";"";""
"CHEMBL251862";"";"None";"563.74";"1";"3.37";"22";"CCNc1cc(C(=O)N[C@@H](Cc2ccccc2)[C@H](O)CN[C@@H](C)C(=O)NC2CCCCC2)cc(N2CCCC2=O)c1";"IC50";"'='";"2695.0";"nM";"5.57";"";"";"UO_0000065";"9.88";"0.19";"2.20";"4.54";"0";"CHEMBL931965";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1143153";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";"";"";""
"CHEMBL256823";"";"None";"484.65";"0";"4.34";"38";"N/C(=N/C(=O)Cn1c(-c2ccccc2)ccc1C12CC3CC(CC(C3)C1)C2)NCCCn1ccnc1";"IC50";"'>'";"25000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL930552";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1142260";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";"";"";""
"CHEMBL64958";"";"None";"820.00";"2";"4.92";"50";"COc1ccc(CN[C@@H](C(=O)N[C@H](C(=O)NCc2nc3ccccc3[nH]2)C(C)C)[C@H](O)[C@H](Cc2ccccc2)NC(=O)[C@@H](NC(=O)OCc2ccccc2)C(C)(C)C)cc1";"IC50";"'='";"1000.0";"nM";"6.00";"";"";"UO_0000065";"7.32";"0.14";"1.08";"3.06";"0";"CHEMBL657353";"Selectivity for their inhibitory potency against human cathepsin D.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1127464";"1";"Scientific Literature";"J Med Chem";"1994";"None";"";"";""
"CHEMBL609988";"";"None";"537.66";"1";"3.72";"57, mixture of epimers";"CC(=O)N[C@@H](Cc1cc(F)cc(F)c1)[C@H](O)CNC1(c2cccc(C(C)(C)C)c2)CCc2nc(N)ncc2C1";"IC50";"'='";"210.0";"nM";"6.68";"";"";"UO_0000065";"12.42";"0.23";"2.96";"5.90";"0";"CHEMBL1045212";"Inhibition of cathepsin D assessed as reduction in polarization after 110 mins by oregon green based fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156090";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL3973477";"";"None";"517.52";"1";"3.76";"BDBM220818";"COc1ccc(C(=O)Nc2ccc3c(c2)C2(CCOC(N)=N2)c2cc(C4=CCCOC4)nc(F)c2O3)nc1";"IC50";"'='";"312700.0";"nM";"";"Outside typical range";"386504";"UO_0000065";"";"";"";"";"0";"CHEMBL3888270";"Fluorescence Resonance Energy Transfer (FRET) Assay: Recombinant CathepsinD was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The CathepsinD enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for CathepsinD) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886633";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3938375";"";"None";"467.48";"0";"3.38";"BDBM220845";"COc1cnc(C(=O)Nc2ccc3c(c2)C2(CCSC(N)=N2)c2cc(O)cc(F)c2O3)cn1";"IC50";"'='";"400000.0";"nM";"";"Outside typical range";"386531";"UO_0000065";"";"";"";"";"0";"CHEMBL3888270";"Fluorescence Resonance Energy Transfer (FRET) Assay: Recombinant CathepsinD was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The CathepsinD enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for CathepsinD) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886633";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3925462";"";"None";"501.84";"1";"4.52";"BDBM214805";"Cc1c(C(=O)Nc2ccc(F)c([C@]3(CF)C[C@@H](C(F)(F)F)OC(N)=N3)c2)nc2ccc(Cl)cn12";"IC50";"'>'";"400000.0";"nM";"";"Outside typical range";"377854";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3976045";"";"None";"444.82";"0";"4.32";"BDBM214831";"Cc1cc(Cl)cnc1C(=O)Nc1ccc(F)c([C@]2(C)C[C@@H](C(F)(F)F)OC(N)=N2)c1";"IC50";"'='";"202000.0";"nM";"";"Outside typical range";"377860";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3901695";"";"None";"430.79";"0";"3.82";"BDBM214948";"NC1=N[C@](CF)(c2cccc(NC(=O)c3ccc(Cl)cn3)c2)C[C@@H](C(F)(F)F)O1";"IC50";"'='";"2370000.0";"nM";"";"Outside typical range";"377920";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3928092";"";"None";"443.81";"0";"2.57";"BDBM214953";"Cn1cc(NC(=O)c2ccc(Cl)cn2)cc([C@]2(C)C[C@@H](C(F)(F)F)OC(N)=N2)c1=O";"IC50";"'>'";"400000.0";"nM";"";"Outside typical range";"377926";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3912808";"";"None";"450.39";"0";"3.37";"BDBM214828";"C#CCOc1ccc(C(=O)Nc2ccc(F)c([C@]3(C)C[C@@H](C(F)(F)F)OC(N)=N3)c2)nc1";"IC50";"'='";"666000.0";"nM";"";"Outside typical range";"377933";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3952357";"";"None";"440.35";"0";"4.41";"BDBM214915";"NC1=N[C@](CF)(c2cc(-c3ncc4cc(F)ccc4n3)ccc2F)C[C@@H](C(F)(F)F)O1";"IC50";"'='";"758000.0";"nM";"";"Outside typical range";"377939";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3944240";"";"None";"442.80";"1";"5.25";"BDBM214829";"C[C@@]1(c2cc(Nc3nc4ccc(Cl)cc4o3)ccc2F)C[C@@H](C(F)(F)F)OC(N)=N1";"IC50";"'='";"210000.0";"nM";"";"Outside typical range";"377942";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3986682";"";"None";"387.31";"0";"3.84";"BDBM214902";"NC1=N[C@](CF)(c2cc(Oc3ccccn3)ccc2F)C[C@@H](C(F)(F)F)O1";"IC50";"'>'";"400000.0";"nM";"";"Outside typical range";"377951";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3924932";"";"None";"498.79";"0";"4.89";"BDBM214840";"NC1=N[C@](CF)(c2cc(NC(=O)c3ncc(C(F)F)cc3Cl)ccc2F)C[C@@H](C(F)(F)F)O1";"IC50";"'>'";"400000.0";"nM";"";"Outside typical range";"377961";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL2177321";"";"None";"372.42";"0";"4.36";"9b";"COc1ccc2c(c1)C1(COC(N)=N1)c1cc(-c3ccccc3C)ccc1O2";"IC50";"'='";"30900.0";"nM";"4.51";"";"";"UO_0000065";"12.11";"0.22";"0.15";"6.83";"0";"CHEMBL2183109";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2177044";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL2177333";"";"None";"406.41";"0";"4.20";"9n";"COc1ccc(F)c(-c2ccc3c(c2)C2(COC(N)=N2)c2cc(OC)ccc2O3)c1";"IC50";"'='";"13700.0";"nM";"4.86";"";"";"UO_0000065";"11.97";"0.22";"0.66";"6.46";"0";"CHEMBL2183109";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2177044";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL398418";"";"None";"569.62";"1";"4.72";"1";"CCOc1cc(C(=O)N[C@@H](Cc2ccccc2)[C@H](O)CNCc2cccc(C(F)(F)F)c2)cc(N2CCCC2=O)c1";"IC50";"'='";"34325.0";"nM";"4.46";"";"";"UO_0000065";"7.84";"0.15";"-0.26";"4.91";"0";"CHEMBL945838";"Inhibition of Cathepsin D expressed in CHO cells by FRET assay";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140838";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"CHEMBL3308072";"";"";""
"CHEMBL3908016";"";"None";"485.87";"0";"4.96";"BDBM220810";"COc1cc(F)c2c(c1)C1(CCOC(N)=N1)c1cc(NC(=O)c3ccc(Cl)cc3F)ccc1O2";"IC50";"'='";"400000.0";"nM";"";"Outside typical range";"386496";"UO_0000065";"";"";"";"";"0";"CHEMBL3888270";"Fluorescence Resonance Energy Transfer (FRET) Assay: Recombinant CathepsinD was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The CathepsinD enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for CathepsinD) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886633";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3688674";"";"None";"463.89";"0";"4.73";"BDBM171612";"NC1=N[C@@](c2cc(NC(=O)C3(c4ccc(Cl)cc4)CCC3)ccc2F)(C(F)F)[C@H]2C[C@H]2O1";"IC50";"'='";"323700.0";"nM";"";"Outside typical range";"316021";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL1076908";"";"None";"759.87";"1";"2.88";"30";"CNC(=O)c1cc(C(=O)N[C@@H](COCc2cc(F)cc(F)c2)[C@@H](O)C[C@@H](C)C(=O)N[C@H](C(=O)NCc2ccccc2)C(C)C)cc(N(C)S(C)(=O)=O)c1";"IC50";"'>'";"5000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1106032";"Inhibition of human liver cathepsin D after 20 mins by homogeneous time resolved fluorescence assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1154862";"1";"Scientific Literature";"Eur J Med Chem";"2010";"None";"";"";""
"CHEMBL2069612";"";"None";"801.43";"3";"7.26";"2";"CCCCNC(=O)C[C@H](O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)c1ccc(Oc2ccc(C(=O)NCCCNc3ccnc4cc(Cl)ccc34)cc2)cc1)[C@@H](C)CC";"IC50";"'='";"220.0";"nM";"6.66";"";"";"UO_0000065";"8.31";"0.16";"-0.60";"3.90";"0";"CHEMBL2072160";"Inhibition of human cathepsin D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2069175";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL357253";"";"None";"680.86";"2";"0.40";"33";"CC(C)(C)S(=O)(=O)CC(Cc1ccccc1)C(=O)NC(Cc1c[nH]cn1)C(=O)N[C@@H](CC1CCCCC1)[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO";"IC50";"'>'";"1000000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL661016";"Concentration required for 50% inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1126155";"1";"Scientific Literature";"J Med Chem";"1992";"None";"";"";""
"CHEMBL1076907";"";"None";"822.03";"2";"4.60";"29";"CSCC[C@H](NC(=O)[C@@H](NC(=O)OC(C)(C)C)C(C)C)C(=O)N[C@@H](COCc1cc(F)cc(F)c1)[C@@H](O)C[C@@H](C)C(=O)N[C@H](C(=O)NCc1ccccc1)C(C)C";"IC50";"'='";"0.63";"nM";"9.20";"";"";"UO_0000065";"11.19";"0.22";"4.60";"5.00";"0";"CHEMBL1106032";"Inhibition of human liver cathepsin D after 20 mins by homogeneous time resolved fluorescence assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1154862";"1";"Scientific Literature";"Eur J Med Chem";"2010";"None";"";"";""
"CHEMBL404166";"";"None";"487.67";"1";"5.02";"42";"Cc1csc(CN/C(N)=N\C(=O)Cn2c(-c3ccccc3)ccc2C23CC4CC(CC(C4)C2)C3)n1";"IC50";"'='";"144.0";"nM";"6.84";"";"";"UO_0000065";"14.03";"0.27";"1.82";"8.02";"0";"CHEMBL930552";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1142260";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";"";"";""
"CHEMBL403429";"";"None";"568.64";"1";"4.76";"16";"CCNc1cc(C(=O)N[C@@H](Cc2ccccc2)[C@H](O)CNCc2cccc(C(F)(F)F)c2)cc(N2CCCC2=O)c1";"IC50";"'='";"5750.0";"nM";"5.24";"";"";"UO_0000065";"9.22";"0.17";"0.48";"5.59";"0";"CHEMBL945833";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140837";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";"";"";""
"CHEMBL402120";"";"None";"515.68";"1";"2.22";"7";"C[C@H](NC[C@@H](O)[C@H](Cc1ccccc1)NC(=O)c1cccc(S(C)(=O)=O)c1)C(=O)NC1CCCCC1";"IC50";"'='";"7700.0";"nM";"5.11";"";"";"UO_0000065";"9.92";"0.19";"2.89";"4.10";"1";"CHEMBL931965";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1143153";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";"";"";""
"CHEMBL1760734";"";"None";"459.65";"0";"3.84";"14d";"CCCOCc1cccc(C[C@@H]2CS(=O)(=O)C[C@H](NCc3cccc(C(C)C)c3)[C@H]2O)c1";"IC50";"'='";"900.0";"nM";"6.05";"";"";"UO_0000065";"13.15";"0.26";"2.21";"7.99";"0";"CHEMBL1764636";"Inhibition of human cathepsin D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1759891";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL1760858";"";"None";"431.60";"0";"3.18";"20e";"CCc1cc(C[C@@H]2CS(=O)(=O)C[C@H](NCc3cccc(C(C)C)c3)[C@H]2O)ccc1O";"IC50";"'='";"2400.0";"nM";"5.62";"";"";"UO_0000065";"13.02";"0.26";"2.44";"6.49";"0";"CHEMBL1764636";"Inhibition of human cathepsin D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1759891";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL1760859";"";"None";"482.44";"0";"3.38";"20f";"CC(C)c1cccc(CN[C@H]2CS(=O)(=O)C[C@@H](Cc3ccc(O)c(Br)c3)[C@@H]2O)c1";"IC50";"'='";"1200.0";"nM";"5.92";"";"";"UO_0000065";"12.27";"0.28";"2.54";"6.83";"0";"CHEMBL1764636";"Inhibition of human cathepsin D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1759891";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL399749";"";"None";"524.68";"1";"3.52";"15";"COc1cccc(CNC[C@@H](O)[C@H](Cc2ccccc2)NC(=O)CCCCS(=O)(=O)c2ccccc2)c1";"IC50";"'='";"11202.0";"nM";"4.95";"";"";"UO_0000065";"9.44";"0.18";"1.43";"4.73";"0";"CHEMBL942098";"Inhibition of human recombinant cathepsin D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140593";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"None";"";"";""
"CHEMBL69980";"";"None";"489.62";"1";"5.64";"24";"CCCc1c(COc2ccc(/C=C3\SC(=S)NC3=O)cc2)ccc(C(=O)c2ccccc2)c1O";"IC50";"'='";"210.0";"nM";"6.68";"";"";"UO_0000065";"13.64";"0.27";"1.04";"8.83";"1";"CHEMBL657349";"Inhibitory concentration against Human cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133572";"1";"Scientific Literature";"J Med Chem";"2000";"None";"";"";""
"CHEMBL582817";"";"None";"570.75";"2";"5.04";"52";"CC(=O)N[C@@H](Cc1cc(F)cc(F)c1)[C@H](O)CN[C@@]1(c2cccc(C(C)(C)C)c2)CC[C@H](Nc2cccs2)NC1";"IC50";"'='";"3100.0";"nM";"5.51";"";"";"UO_0000065";"9.65";"0.19";"0.47";"6.45";"0";"CHEMBL1045212";"Inhibition of cathepsin D assessed as reduction in polarization after 110 mins by oregon green based fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156090";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL253237";"";"None";"486.96";"1";"5.48";"3.b.10";"CC(=O)c1ccc(Oc2ccc(-c3ccc(-c4ccccc4Cl)n3CC(=O)NC(=N)N)cc2)cc1";"IC50";"'='";"18900.0";"nM";"4.72";"";"";"UO_0000065";"9.70";"0.18";"-0.76";"4.29";"0";"CHEMBL944849";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140831";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";"";"";""
"CHEMBL2031138";"";"None";"497.66";"0";"4.50";"31";"CC(=O)N[C@@H](Cc1ccc(F)cc1)[C@H](O)CN[C@H]1C[C@@]2(CC[C@H]2C)Oc2ncc(CC(C)(C)C)cc21";"IC50";"'='";"20500.0";"nM";"4.69";"";"";"UO_0000065";"9.42";"0.18";"0.19";"5.62";"0";"CHEMBL2033077";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2029322";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL2048055";"";"None";"454.36";"0";"1.56";"62a";"Nc1c(F)cc(C[C@@H]2CS(=O)(=O)C[C@H](N)[C@H]2O)cc1OC(C(F)(F)F)C(F)(F)F";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2049562";"Inhibition of human recombinant CatD using Mca-GKPILFFRLK(DNP)-dR-NH2 as substrate after 1 hr by fluorescence analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2046351";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL2048058";"";"None";"602.57";"1";"3.61";"62d";"CC(C)(O)c1cccc(CN[C@H]2CS(=O)(=O)C[C@@H](Cc3cc(F)c(N)c(OC(C(F)(F)F)C(F)(F)F)c3)[C@@H]2O)c1";"IC50";"'='";"1320.0";"nM";"5.88";"";"";"UO_0000065";"9.76";"0.20";"2.27";"4.82";"0";"CHEMBL2049562";"Inhibition of human recombinant CatD using Mca-GKPILFFRLK(DNP)-dR-NH2 as substrate after 1 hr by fluorescence analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2046351";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL403820";"";"None";"560.70";"1";"3.75";"29";"CCNc1cc(C(=O)N[C@@H](Cc2ccccc2)[C@H](O)CNCc2cc(OC)cc(OC)c2)cc(N2CCCC2=O)c1";"IC50";"'='";"5890.0";"nM";"5.23";"";"";"UO_0000065";"9.33";"0.17";"1.48";"4.66";"0";"CHEMBL945833";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140837";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";"";"";""
"CHEMBL252860";"";"None";"500.64";"1";"3.74";"18";"CCNc1cc(C(=O)N[C@@H](Cc2ccccc2)[C@H](O)CNCc2ccccc2)cc(N2CCCC2=O)c1";"IC50";"'='";"19050.0";"nM";"4.72";"";"";"UO_0000065";"9.43";"0.17";"0.98";"5.04";"0";"CHEMBL945833";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140837";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";"";"";""
"CHEMBL253866";"";"None";"587.64";"2";"6.13";"4";"CCOc1cc(C(=O)N[C@@H](Cc2ccccc2)[C@H](O)CNCc2cccc(C(F)(F)F)c2)cc(-c2ccccc2C#N)c1";"IC50";"'='";"2020.0";"nM";"5.70";"";"";"UO_0000065";"9.69";"0.18";"-0.44";"6.03";"0";"CHEMBL945838";"Inhibition of Cathepsin D expressed in CHO cells by FRET assay";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140838";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"CHEMBL3308072";"";"";""
"CHEMBL448945";"";"None";"606.75";"1";"3.48";"8b";"CCc1cn2c3c(cc(C(=O)N[C@@H](Cc4ccccc4)[C@H](O)CNCc4ccccc4)cc13)N(C)S(=O)(=O)CC2.O=CO";"IC50";"'='";"17180.0";"nM";"4.76";"";"";"UO_0000065";"8.50";"0.16";"1.28";"4.60";"0";"CHEMBL959767";"Inhibition of cathepsin D expressed in CHO cells after 1 hrs by spectrophotometer";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1150334";"1";"Scientific Literature";"J Med Chem";"2008";"CHEMBL3308072";"";"";""
"CHEMBL1258917";"";"None";"462.59";"0";"3.77";"44";"CC(=O)N[C@@H](Cc1cc(F)cc(F)c1)[C@H](O)CNC1(c2cnn(C(C)(C)C)c2)CCCCC1";"IC50";"'='";"140.0";"nM";"6.85";"";"";"UO_0000065";"14.82";"0.28";"3.08";"8.66";"0";"CHEMBL1260849";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1255191";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL1257303";"";"None";"430.54";"0";"3.95";"54";"CC(=O)N[C@@H](Cc1cc(F)cc(F)c1)[C@H](O)CNC1(c2cccc(C(C)(C)C)c2)CC1";"IC50";"'='";"290.0";"nM";"6.54";"";"";"UO_0000065";"15.18";"0.29";"2.59";"10.65";"0";"CHEMBL1260849";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1255191";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL1257533";"";"None";"461.55";"0";"2.87";"58";"CC(=O)N[C@@H](Cc1cc(F)cc(F)c1)[C@H](O)CNC1(c2cc(CC(C)(C)C)c[n+]([O-])c2)CC1";"IC50";"'='";"1050.0";"nM";"5.98";"";"";"UO_0000065";"12.95";"0.25";"3.11";"6.77";"0";"CHEMBL1260849";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1255191";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL3688678";"";"None";"470.45";"0";"3.46";"BDBM171616";"NC1=N[C@@](c2cc(NC(=O)c3ccc(OCC#CC4CC4)cn3)ccc2F)(C(F)F)[C@H]2C[C@H]2O1";"IC50";"'='";"77500.0";"nM";"4.11";"";"316025";"UO_0000065";"8.74";"0.17";"0.65";"4.16";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688723";"";"None";"421.38";"0";"2.38";"BDBM171665";"COc1cnc(C(=O)Nc2cc(C)c(F)c([C@@]3(C(F)F)N=C(N)O[C@@H]4C[C@@H]43)c2)cn1";"IC50";"'='";"465440.0";"nM";"";"Outside typical range";"316073";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688746";"";"None";"371.37";"0";"1.83";"BDBM171690";"COc1cnc(C(=O)Nc2ccc(F)c([C@]3(C)N=C(N)O[C@H]4C[C@H]43)c2)cn1";"IC50";"'>'";"400000.0";"nM";"";"Outside typical range";"316093";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688761";"";"None";"393.42";"0";"3.47";"BDBM171707";"COc1cnc2c(Nc3ccc(F)c([C@@]4(C)N=C(N)O[C@H]5C[C@H]54)c3)nccc2c1";"IC50";"'>'";"400000.0";"nM";"";"Outside typical range";"316111";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688786";"";"None";"440.84";"0";"3.94";"BDBM171733";"N#Cc1cnc2c(Nc3ccc(Cl)c([C@@]4(CF)N=C(N)O[C@@H]5C[C@@H]54)c3)ncc(F)c2c1";"IC50";"'>'";"44400.0";"nM";"";"";"316137";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL2047912";"";"None";"546.63";"1";"3.28";"48";"CC(C)(C)c1cccc(CN[C@H]2CS(=O)(=O)C[C@@H](Cc3cc(F)c(N)c(C[C@H](O)C(F)(F)F)c3)[C@@H]2O)c1";"IC50";"'='";"1050.0";"nM";"5.98";"";"";"UO_0000065";"10.94";"0.22";"2.70";"5.31";"0";"CHEMBL2049562";"Inhibition of human recombinant CatD using Mca-GKPILFFRLK(DNP)-dR-NH2 as substrate after 1 hr by fluorescence analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2046351";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL2048041";"";"None";"506.64";"1";"2.59";"60d";"CC(C)(C)c1cccc(CN[C@H]2CS(=O)(=O)C[C@@H](Cc3cc(F)c(N)c(OC4COC4)c3)[C@@H]2O)c1";"IC50";"'='";"1150.0";"nM";"5.94";"";"";"UO_0000065";"11.72";"0.23";"3.35";"5.36";"0";"CHEMBL2049562";"Inhibition of human recombinant CatD using Mca-GKPILFFRLK(DNP)-dR-NH2 as substrate after 1 hr by fluorescence analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2046351";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL2048052";"";"None";"590.68";"1";"4.16";"60o";"CCOC[C@H](Oc1cc(C[C@@H]2CS(=O)(=O)C[C@H](NCc3cccc(C(C)(C)C)c3)[C@H]2O)cc(F)c1N)C(F)(F)F";"IC50";"'='";"1230.0";"nM";"5.91";"";"";"UO_0000065";"10.01";"0.20";"1.75";"5.33";"0";"CHEMBL2049562";"Inhibition of human recombinant CatD using Mca-GKPILFFRLK(DNP)-dR-NH2 as substrate after 1 hr by fluorescence analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2046351";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL2047889";"";"None";"513.47";"1";"3.57";"14b";"CC(C)(C)c1cccc(CN[C@H]2CS(=O)(=O)C[C@@H](Cc3cc(F)c(N)c(Br)c3)[C@@H]2O)c1";"IC50";"'='";"340.0";"nM";"6.47";"";"";"UO_0000065";"12.60";"0.28";"2.90";"7.00";"0";"CHEMBL2049562";"Inhibition of human recombinant CatD using Mca-GKPILFFRLK(DNP)-dR-NH2 as substrate after 1 hr by fluorescence analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2046351";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL76";"CHLOROQUINE";"4.0";"319.88";"0";"4.81";"CQ";"CCN(CC)CCCC(C)Nc1ccnc2cc(Cl)ccc12";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL2072160";"Inhibition of human cathepsin D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2069175";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL2177338";"";"None";"359.39";"0";"3.45";"9s";"COc1ccc2c(c1)C1(COC(N)=N1)c1cc(-c3ccncc3)ccc1O2";"IC50";"'>'";"40000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2183109";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2177044";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL2177323";"";"None";"372.42";"0";"4.36";"9d";"COc1ccc2c(c1)C1(COC(N)=N1)c1cc(-c3ccc(C)cc3)ccc1O2";"IC50";"'>'";"40000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2183109";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2177044";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL2177312";"";"None";"345.40";"0";"3.35";"3";"COc1ccc(C2(c3cccc(-c4cccnc4)c3)COC(N)=N2)cc1";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2183109";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2177044";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL213300";"";"None";"514.76";"1";"1.29";"63";"CCCCNC(=O)[C@H](C)C[C@H](O)[C@@H]1CSC/C=C/CS[C@H]2CNCC[C@H]2C(=O)N[C@@H](C)C(=O)N1";"IC50";"'='";"9000.0";"nM";"5.05";"";"";"UO_0000065";"9.80";"0.20";"3.76";"4.22";"0";"CHEMBL866007";"Inhibition of Cathepsin D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1137429";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";"";""
"CHEMBL570762";"";"None";"541.61";"1";"4.47";"39";"CC(=O)N[C@@H](Cc1cc(F)cc(F)c1)[C@H](O)CN[C@@]1(c2cccc(C(C)(C)C)c2)CC[C@H](C(F)(F)F)NC1";"IC50";"'='";"28.0";"nM";"7.55";"";"";"UO_0000065";"13.95";"0.27";"3.08";"10.29";"0";"CHEMBL1045212";"Inhibition of cathepsin D assessed as reduction in polarization after 110 mins by oregon green based fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156090";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL566603";"";"None";"502.61";"1";"3.33";"43";"CC(=O)N[C@@H](Cc1cc(F)cc(F)c1)[C@H](O)CN[C@@]1(c2cccc(C(C)(C)C)c2)CC/C(=N/O)NC1";"IC50";"'='";"430.0";"nM";"6.37";"";"";"UO_0000065";"12.67";"0.24";"3.04";"6.01";"0";"CHEMBL1045212";"Inhibition of cathepsin D assessed as reduction in polarization after 110 mins by oregon green based fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156090";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL2152353";"";"None";"695.25";"1";"2.93";"5, DS-8108b";"CC[C@H](C[C@H](O)[C@@H](N)CN1CC(=O)N(c2ccccc2Cl)CC1(C)C)C(=O)NC1C2CC3CC1CC(O)(C3)C2.O.O=C(O)/C=C/C(=O)O";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2155359";"Inhibition of human cathepsin D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2150897";"1";"Scientific Literature";"ACS Med Chem Lett";"2012";"None";"";"";""
"CHEMBL401141";"";"None";"518.72";"1";"3.65";"23";"CCCC(CCC)S(=O)(=O)CCC(=O)N[C@@H](Cc1ccccc1)[C@H](O)CNCc1cccc(OC)c1";"IC50";"'='";"9669.0";"nM";"5.01";"";"";"UO_0000065";"9.67";"0.19";"1.36";"4.79";"0";"CHEMBL942098";"Inhibition of human recombinant cathepsin D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140593";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"None";"";"";""
"CHEMBL3127092";"";"None";"371.82";"0";"2.74";"70";"NC1=N[C@@]2(CO1)c1cc(-c3cncc(Cl)c3)ccc1O[C@@H]1CCOC[C@H]12";"IC50";"'='";"120000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3131975";"Inhibition of human liver cathepsin D measured for 1 hr by FRET assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124885";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL3124962";"";"None";"385.46";"0";"3.33";"85";"C[C@H]1OCC[C@H]2Oc3ccc(-c4cccnc4F)cc3[C@@]3(CSC(N)=N3)[C@H]12";"IC50";"'='";"47000.0";"nM";"4.33";"";"";"UO_0000065";"11.23";"0.22";"1.00";"6.21";"0";"CHEMBL3131975";"Inhibition of human liver cathepsin D measured for 1 hr by FRET assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124885";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL3127085";"";"None";"382.40";"0";"1.67";"63";"CN1C(=O)[C@@]2(N=C1N)c1cc(-c3cccnc3F)ccc1O[C@@H]1CCOC[C@H]12";"IC50";"'='";"14000.0";"nM";"4.85";"";"";"UO_0000065";"12.69";"0.24";"3.18";"5.39";"0";"CHEMBL3131975";"Inhibition of human liver cathepsin D measured for 1 hr by FRET assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124885";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL3127089";"";"None";"389.42";"0";"1.40";"67";"CN1C(=O)[C@]2(N=C1N)c1cc(-c3cncc(C#N)c3)ccc1O[C@H]1CCOC[C@@H]12";"IC50";"'='";"6300.0";"nM";"5.20";"";"";"UO_0000065";"13.35";"0.24";"3.80";"4.57";"0";"CHEMBL3131975";"Inhibition of human liver cathepsin D measured for 1 hr by FRET assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124885";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL3127084";"";"None";"400.38";"0";"1.81";"91";"CN1C(=O)[C@]2(N=C1N)c1cc(-c3cccnc3F)c(F)cc1O[C@H]1CCOC[C@@H]12";"IC50";"'='";"940.0";"nM";"6.03";"";"";"UO_0000065";"15.05";"0.28";"4.22";"6.69";"0";"CHEMBL3131975";"Inhibition of human liver cathepsin D measured for 1 hr by FRET assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124885";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL2047888";"";"None";"434.58";"0";"2.81";"14a";"CC(C)(C)c1cccc(CN[C@H]2CS(=O)(=O)C[C@@H](Cc3ccc(N)c(F)c3)[C@@H]2O)c1";"IC50";"'='";"2520.0";"nM";"5.60";"";"";"UO_0000065";"12.88";"0.25";"2.79";"6.06";"0";"CHEMBL2049562";"Inhibition of human recombinant CatD using Mca-GKPILFFRLK(DNP)-dR-NH2 as substrate after 1 hr by fluorescence analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2046351";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL566633";"";"None";"445.38";"0";"3.21";"62";"CN1C(=O)C(c2ccc(OC(F)(F)F)cc2)(c2cc(F)cc(-c3cncnc3)c2)N=C1N";"IC50";"'='";"8550.0";"nM";"5.07";"";"";"UO_0000065";"11.38";"0.22";"1.86";"5.41";"0";"CHEMBL1044551";"Inhibition of human cathepsin D by FRET based peptide cleavage assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156789";"1";"Scientific Literature";"J Med Chem";"2010";"None";"";"";""
"CHEMBL566198";"";"None";"367.49";"0";"3.28";"31";"CCOc1ccc(C2(C34CC5CC(CC(C5)C3)C4)N=C(N)N(C)C2=O)cc1";"IC50";"'='";"11530.0";"nM";"4.94";"";"";"UO_0000065";"13.44";"0.25";"1.66";"7.27";"0";"CHEMBL1044551";"Inhibition of human cathepsin D by FRET based peptide cleavage assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156789";"1";"Scientific Literature";"J Med Chem";"2010";"None";"";"";""
"CHEMBL565996";"";"None";"406.87";"0";"3.44";"46";"COc1ccc(C2(c3cccc(-c4cccnc4)c3)N=C(N)N(C)C2=O)cc1Cl";"IC50";"'='";"6280.0";"nM";"5.20";"";"";"UO_0000065";"12.79";"0.24";"1.76";"6.44";"0";"CHEMBL1044551";"Inhibition of human cathepsin D by FRET based peptide cleavage assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156789";"1";"Scientific Literature";"J Med Chem";"2010";"None";"";"";""
"CHEMBL572290";"";"None";"498.62";"0";"3.43";"41";"CC(=O)N[C@@H](Cc1cc(F)cc(F)c1)[C@H](O)CN[C@@]1(c2cccc(C(C)(C)C)c2)CC[C@H](C#N)NC1";"IC50";"'='";"640.0";"nM";"6.19";"";"";"UO_0000065";"12.42";"0.23";"2.76";"6.37";"0";"CHEMBL1045212";"Inhibition of cathepsin D assessed as reduction in polarization after 110 mins by oregon green based fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156090";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL571433";"";"None";"565.71";"1";"4.37";"51";"CC(=O)N[C@@H](Cc1cc(F)cc(F)c1)[C@H](O)CN[C@@]1(c2cccc(C(C)(C)C)c2)CC[C@H](Nc2ccccn2)NC1";"IC50";"'='";"4400.0";"nM";"5.36";"";"";"UO_0000065";"9.47";"0.18";"0.99";"5.45";"0";"CHEMBL1045212";"Inhibition of cathepsin D assessed as reduction in polarization after 110 mins by oregon green based fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156090";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL3127072";"";"None";"387.39";"0";"2.75";"93";"C[C@]12CCOC[C@@H]1[C@]1(COC(N)=N1)c1cc(-c3cccnc3F)c(F)cc1O2";"IC50";"'='";"3700.0";"nM";"5.43";"";"";"UO_0000065";"14.02";"0.26";"2.68";"6.88";"0";"CHEMBL3131975";"Inhibition of human liver cathepsin D measured for 1 hr by FRET assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124885";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL3127081";"";"None";"379.42";"0";"1.31";"88";"CN1C(=O)[C@]2(N=C1N)c1cc(-c3cncnc3)ccc1O[C@H]1CCOC[C@@]12C";"IC50";"'='";"2600.0";"nM";"5.58";"";"";"UO_0000065";"14.72";"0.27";"4.28";"5.43";"0";"CHEMBL3131975";"Inhibition of human liver cathepsin D measured for 1 hr by FRET assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124885";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL3127079";"";"None";"402.45";"0";"2.39";"86";"CN1C(=O)[C@]2(N=C1N)c1cc(-c3cccc(C#N)c3)ccc1O[C@H]1CCOC[C@@]12C";"IC50";"'='";"1700.0";"nM";"5.77";"";"";"UO_0000065";"14.34";"0.26";"3.38";"5.72";"0";"CHEMBL3131975";"Inhibition of human liver cathepsin D measured for 1 hr by FRET assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124885";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL3127106";"";"None";"382.39";"0";"1.67";"62";"CN1C(=O)[C@]2(N=C1N)c1cc(-c3cccnc3F)ccc1O[C@H]1CCOC[C@@H]12";"IC50";"'='";"1100.0";"nM";"5.96";"";"";"UO_0000065";"15.58";"0.29";"4.29";"6.62";"0";"CHEMBL3131975";"Inhibition of human liver cathepsin D measured for 1 hr by FRET assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124885";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL3422243";"";"None";"378.45";"0";"3.12";"11";"C[C@H]1SC(N)=N[C@@]2(c3ccc(F)cc3F)CO[C@@H](c3cnn(C)c3)C[C@@H]12";"IC50";"'='";"19300.0";"nM";"4.71";"";"";"UO_0000065";"12.46";"0.25";"1.59";"7.21";"0";"CHEMBL3423725";"Inhibition of CatD (unknown origin) assessed as fluorescence polarization by cell free assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3421534";"1";"Scientific Literature";"J Med Chem";"2015";"None";"";"";""
"CHEMBL3422246";"";"None";"396.44";"0";"3.07";"14";"Cn1cc([C@H]2C[C@H]3[C@@H](CF)SC(N)=N[C@@]3(c3ccc(F)cc3F)CO2)cn1";"IC50";"'='";"6600.0";"nM";"5.18";"";"";"UO_0000065";"13.07";"0.26";"2.11";"7.92";"0";"CHEMBL3423725";"Inhibition of CatD (unknown origin) assessed as fluorescence polarization by cell free assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3421534";"1";"Scientific Literature";"J Med Chem";"2015";"None";"";"";""
"CHEMBL1088572";"";"None";"387.24";"0";"3.17";"4, CHM-1-P-Na";"O=P([O-])(O)OC1C=C(c2ccccc2F)Nc2cc3c(cc21)OCO3.[Na+]";"IC50";"'='";"9790.0";"nM";"5.01";"";"";"UO_0000065";"13.71";"0.27";"1.84";"5.15";"0";"CHEMBL1113388";"Inhibition of human cathepsin D by enzyme assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1154907";"1";"Scientific Literature";"J Med Chem";"2010";"None";"";"";""
"CHEMBL1076902";"";"None";"850.00";"2";"5.01";"28";"CC(C)[C@H](NC(=O)[C@H](C)C[C@H](O)[C@H](COCc1cc(F)cc(F)c1)NC(=O)c1cc(C(=O)N[C@H](C)c2ccccc2)cc(N(C)S(C)(=O)=O)c1)C(=O)NCc1ccccc1";"IC50";"'='";"210.0";"nM";"6.68";"";"";"UO_0000065";"7.86";"0.15";"1.67";"3.64";"0";"CHEMBL1106032";"Inhibition of human liver cathepsin D after 20 mins by homogeneous time resolved fluorescence assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1154862";"1";"Scientific Literature";"Eur J Med Chem";"2010";"None";"";"";""
"CHEMBL1271246";"";"None";"395.41";"0";"3.08";"65";"CN1C(=O)[C@@](c2ccc(OC(F)F)cc2)(c2cccc(C#CC3CC3)c2)N=C1N";"IC50";"'='";"3750.0";"nM";"5.43";"";"";"UO_0000065";"13.72";"0.26";"2.35";"7.99";"0";"CHEMBL1273977";"Inhibition of cathepsin D by FRET assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1268920";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL501338";"";"None";"592.66";"2";"5.30";"17";"CCn1ccc2c(N3CCCC3=O)cc(C(=O)N[C@@H](Cc3ccccc3)[C@H](O)CNCc3cccc(C(F)(F)F)c3)cc21";"IC50";"'='";"13490.0";"nM";"4.87";"";"";"UO_0000065";"8.22";"0.15";"-0.43";"5.62";"0";"CHEMBL1036847";"Inhibition of cathepsin-D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1137769";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL2030996";"";"None";"483.63";"0";"4.25";"1";"CC(=O)N[C@@H](Cc1cccc(F)c1)[C@H](O)CN[C@H]1CC2(CCC2)Oc2ncc(CC(C)(C)C)cc21";"IC50";"'='";"4.0";"nM";"8.40";"";"";"UO_0000065";"17.36";"0.33";"4.15";"10.06";"0";"CHEMBL2033077";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2029322";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL589369";"";"None";"517.67";"1";"4.56";"11";"Cc1cc2cc(n1)OCCCCOc1cccc(c1)C[C@@H]([C@H](O)CNCc1cccc(C(C)C)c1)NC2=O";"IC50";"'='";"156.0";"nM";"6.81";"";"";"UO_0000065";"13.15";"0.24";"2.25";"7.34";"0";"CHEMBL1050390";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1153192";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL68201";"";"None";"490.61";"1";"5.04";"20a";"CCCc1c(OCc2ccc(/C=C3\SC(=S)NC3=O)cc2)ccc(C(=O)c2cccnc2)c1O";"IC50";"'='";"1460.0";"nM";"5.84";"";"";"UO_0000065";"11.89";"0.23";"0.80";"6.59";"0";"CHEMBL658685";"In vitro inhibition of cathepsin D.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1129769";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1996";"None";"";"";""
"CHEMBL1270029";"";"None";"425.38";"0";"3.20";"73";"CN1C(=O)[C@@](c2ccc(OC(F)F)cc2)(c2ccc(F)c(OCCCF)c2)N=C1N";"IC50";"'='";"2980.0";"nM";"5.53";"";"";"UO_0000065";"12.99";"0.25";"2.33";"7.16";"0";"CHEMBL1273977";"Inhibition of cathepsin D by FRET assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1268920";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL4225481";"";"None";"379.42";"0";"2.45";"2b";"Nc1nc2cc(-c3ccccc3)cc(CC(=O)O)c2c(=O)n1CC1CCCO1";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4223547";"Inhibition of human cathepsin D using DABCYL-Glu-Arg-Nle-Phe-Leu-Ser-Phe-Pro-EDANS as substrate preincubated for 30 mins followed by substrate addition measured every 1 min within 8 to 15 mins by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4219216";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";"";""
"CHEMBL447120";"";"None";"593.65";"2";"5.63";"21";"CCc1coc2c(N3CCCC3=O)cc(C(=O)N[C@@H](Cc3ccccc3)[C@H](O)CNCc3cccc(C(F)(F)F)c3)cc12";"IC50";"'='";"15140.0";"nM";"4.82";"";"";"UO_0000065";"8.12";"0.15";"-0.81";"5.08";"0";"CHEMBL1036847";"Inhibition of cathepsin-D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1137769";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL1257530";"";"None";"486.65";"1";"5.41";"8";"CC(=O)N[C@@H](Cc1cc(F)cc(F)c1)[C@H](O)CNC1(c2cccc(CC(C)(C)C)c2)CCCCC1";"IC50";"'='";"125.0";"nM";"6.90";"";"";"UO_0000065";"14.18";"0.27";"1.49";"11.25";"0";"CHEMBL1260849";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1255191";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL1258918";"";"None";"476.61";"0";"4.06";"48";"CC(=O)N[C@@H](Cc1cc(F)cc(F)c1)[C@H](O)CNC1(c2cnn(CC(C)(C)C)c2)CCCCC1";"IC50";"'='";"29.0";"nM";"7.54";"";"";"UO_0000065";"15.82";"0.30";"3.48";"9.52";"0";"CHEMBL1260849";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1255191";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL114167";"";"None";"547.70";"1";"4.27";"25";"CCCCNC(=O)C[C@H](O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)COc1ccc2ccccc2c1)c1ccccc1";"IC50";"'='";"110.0";"nM";"6.96";"";"";"UO_0000065";"12.71";"0.24";"2.69";"5.96";"0";"CHEMBL657349";"Inhibitory concentration against Human cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133572";"1";"Scientific Literature";"J Med Chem";"2000";"None";"";"";""
"CHEMBL2333941";"LY-2811376";"1.0";"320.37";"0";"3.09";"1; LY2811376";"C[C@@]1(c2cc(-c3cncnc3)c(F)cc2F)CCSC(N)=N1";"IC50";"'='";"15700.0";"nM";"4.80";"";"";"UO_0000065";"15.00";"0.30";"1.71";"7.49";"1";"CHEMBL4614137";"Inhibition of human cathepsin D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4613225";"1";"Scientific Literature";"Bioorg Med Chem";"2020";"None";"";"";""
"CHEMBL4636311";"";"None";"283.40";"0";"0.60";"16";"CCCNC(=O)[C@@H]1C[C@H]1[C@]12COC[C@H]1CSC(N)=N2";"IC50";"'>'";"300000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4614137";"Inhibition of human cathepsin D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4613225";"1";"Scientific Literature";"Bioorg Med Chem";"2020";"None";"";"";""
"CHEMBL230807";"";"None";"602.78";"1";"4.15";"19m";"CCCN(CCC)C(=O)c1cc(C(=O)N[C@@H](Cc2ccccc2)[C@H](O)CNCc2cccc(OC)c2)cc(C(=O)N(C)C)c1";"IC50";"'='";"3800.0";"nM";"5.42";"";"";"UO_0000065";"8.99";"0.17";"1.27";"4.87";"0";"CHEMBL888969";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1144655";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"None";"";"";""
"CHEMBL554146";"";"None";"615.67";"1";"4.44";"18";"CCc1cn2c3c(cc(C(=O)N[C@@H](Cc4ccccc4)[C@H](O)CNCc4cccc(C(F)(F)F)c4)cc13)OS(=O)(=O)CC2";"IC50";"'='";"2160.0";"nM";"5.67";"";"";"UO_0000065";"9.20";"0.18";"1.23";"5.17";"0";"CHEMBL725829";"Inhibition of cathepsin-D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1158411";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL1210364";"";"None";"703.81";"2";"5.09";"46";"CCS(=O)(=O)c1cc(C(=O)N[C@@H](Cc2ccccc2)[C@H](O)CNCc2cccc(C(F)(F)F)c2)cc(N(c2ccccc2)S(C)(=O)=O)c1";"IC50";"'='";"550.0";"nM";"6.26";"";"";"UO_0000065";"8.89";"0.18";"1.17";"4.71";"0";"CHEMBL1211667";"Inhibition of Cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1208699";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL541757";"";"None";"596.84";"1";"4.88";"24";"CCc1cn2c3c(cc(C(=O)N[C@@H](Cc4ccccc4)[C@H](O)CNC(C)(C)CCCC(C)C)cc13)N(C)S(=O)(=O)CC2";"IC50";"'='";"1000.0";"nM";"6.00";"";"";"UO_0000065";"10.05";"0.20";"1.12";"5.79";"0";"CHEMBL1035560";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1158445";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL523193";"";"None";"510.66";"1";"2.44";"18";"CCc1cn2c3c(cc(C(=O)N[C@@H](Cc4ccccc4)[C@H](O)CNC4CC4)cc13)N(C)S(=O)(=O)CC2";"IC50";"'='";"7930.0";"nM";"5.10";"";"";"UO_0000065";"9.99";"0.19";"2.66";"4.92";"1";"CHEMBL1035560";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1158445";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL4573241";"";"None";"453.67";"0";"3.44";"7";"CC(C)C[C@@H]1NC(=O)CCCCCCCCCCCNC(=O)[C@H](C(C)C)NC(=O)C[C@@H]1O";"IC50";"'='";"22.0";"nM";"7.66";"";"";"UO_0000065";"16.88";"0.33";"4.22";"7.12";"0";"CHEMBL4325791";"Inhibition of human placenta CatD using Abz-Lys-Pro-Ala-Glu-Phe-Nph-Ala-Leu as substrate preincubated for 10 mins followed by substrate addition and measured by FRET assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4321885";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";""
"CHEMBL4536689";"";"None";"593.81";"2";"5.22";"21";"CC(C)[C@@H]1NC(=O)C[C@H](O)[C@H](Cc2ccc(OCc3ccccc3)cc2)NC(=O)CCCCCCCCCCCNC1=O";"IC50";"'='";"55.0";"nM";"7.26";"";"";"UO_0000065";"12.23";"0.23";"2.04";"6.22";"0";"CHEMBL4325791";"Inhibition of human placenta CatD using Abz-Lys-Pro-Ala-Glu-Phe-Nph-Ala-Leu as substrate preincubated for 10 mins followed by substrate addition and measured by FRET assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4321885";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";""
"CHEMBL4455874";"";"None";"558.76";"1";"3.29";"29";"CC(=O)NCCCC[C@@H]1NC(=O)C[C@H](O)[C@H](Cc2ccccc2)NC(=O)CCCCCCCCCCCNC1=O";"IC50";"'='";"16.0";"nM";"7.80";"";"";"UO_0000065";"13.95";"0.27";"4.51";"5.71";"0";"CHEMBL4325791";"Inhibition of human placenta CatD using Abz-Lys-Pro-Ala-Glu-Phe-Nph-Ala-Leu as substrate preincubated for 10 mins followed by substrate addition and measured by FRET assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4321885";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";""
"CHEMBL4562486";"";"None";"502.70";"1";"3.43";"34";"CC(C)[C@@H]1NC(=O)NC[C@H](O)[C@H](Cc2ccccc2)NC(=O)CCCCCCCCCCCNC1=O";"IC50";"'='";"21.0";"nM";"7.68";"";"";"UO_0000065";"15.27";"0.29";"4.25";"6.42";"0";"CHEMBL4325791";"Inhibition of human placenta CatD using Abz-Lys-Pro-Ala-Glu-Phe-Nph-Ala-Leu as substrate preincubated for 10 mins followed by substrate addition and measured by FRET assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4321885";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";""
"CHEMBL553699";"";"None";"618.72";"1";"4.34";"11";"CCNc1cc(C(=O)N[C@@H](Cc2ccccc2)[C@H](O)CNCc2cccc(C(F)(F)F)c2)cc2c1CCCS(=O)(=O)N2C";"IC50";"'='";"1210.0";"nM";"5.92";"";"";"UO_0000065";"9.56";"0.19";"1.58";"5.34";"0";"CHEMBL1035560";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1158445";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL554349";"";"None";"628.72";"1";"4.49";"9";"CCc1cn2c3c(cc(C(=O)N[C@@H](Cc4ccccc4)[C@H](O)CNCc4cccc(C(F)(F)F)c4)cc13)N(C)S(=O)(=O)CC2";"IC50";"'='";"1259.0";"nM";"5.90";"";"";"UO_0000065";"9.38";"0.18";"1.41";"5.69";"0";"CHEMBL1035560";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1158445";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL583136";"";"None";"516.67";"1";"4.73";"35";"CC(=O)N[C@@H](Cc1cc(F)cc(F)c1)[C@H](O)CN[C@]1(c2cccc(C(C)(C)C)c2)CC[C@@H](CCO)CC1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1045212";"Inhibition of cathepsin D assessed as reduction in polarization after 110 mins by oregon green based fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156090";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL68214";"";"None";"385.47";"0";"3.66";"3c";"CC(=O)c1ccc(COc2ccc(/C=C3\SC(=S)NC3=O)cc2)cc1O";"IC50";"'='";"14100.0";"nM";"4.85";"";"";"UO_0000065";"12.58";"0.25";"1.19";"6.41";"0";"CHEMBL658685";"In vitro inhibition of cathepsin D.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1129769";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1996";"None";"";"";""
"CHEMBL3344153";"";"None";"642.68";"2";"-2.08";"12";"CC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)[C@@H](O)CC(=O)NCCCC(N)=O.O=C(O)C(F)(F)F";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3370435";"Inhibition of human cathepsin D assessed as cleavage of wtKAHRP fluorogenic substrate";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3352063";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL1210347";"";"None";"641.23";"1";"4.57";"26";"C[C@H](NC[C@@H](O)[C@H](Cc1ccccc1)NC(=O)c1cccc(N(c2ccc(Cl)cc2)S(C)(=O)=O)c1)C(=O)NC1CCCCC1";"IC50";"'='";"350.0";"nM";"6.46";"";"";"UO_0000065";"10.07";"0.20";"1.89";"5.05";"0";"CHEMBL1211667";"Inhibition of Cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1208699";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL1210345";"";"None";"636.82";"1";"3.92";"24";"COc1ccc(N(c2cccc(C(=O)N[C@@H](Cc3ccccc3)[C@H](O)CN[C@@H](C)C(=O)NC3CCCCC3)c2)S(C)(=O)=O)cc1";"IC50";"'='";"350.0";"nM";"6.46";"";"";"UO_0000065";"10.14";"0.20";"2.54";"4.71";"0";"CHEMBL1211667";"Inhibition of Cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1208699";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL1210333";"";"None";"620.82";"1";"3.78";"8";"C[C@H](NC[C@@H](O)[C@H](Cc1ccccc1)NC(=O)c1cccc(N(Cc2ccccc2)S(C)(=O)=O)c1)C(=O)NC1CCCCC1";"IC50";"'='";"600.0";"nM";"6.22";"";"";"UO_0000065";"10.02";"0.19";"2.44";"4.87";"0";"CHEMBL1211667";"Inhibition of Cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1208699";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL1941007";"";"None";"347.81";"0";"4.63";"4";"O=C(Cn1c(-c2ccccn2)nc2ccccc21)c1ccc(Cl)cc1";"IC50";"'='";"31900.0";"nM";"4.50";"";"";"UO_0000065";"12.93";"0.25";"-0.13";"9.41";"0";"CHEMBL1942416";"Inhibition of human cathepsin D using DABCYL-Glu-Arg-Nle-Phe-Leu-Ser-Phe-Pro-EDANS as substrate by FRET analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1938395";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL565378";"";"None";"411.47";"0";"2.97";"50";"COc1ccc(C2(c3ccc(C#N)c(-c4cccnc4)c3)N=C(N)N(C)C2=O)cc1C";"IC50";"'='";"2190.0";"nM";"5.66";"";"";"UO_0000065";"13.75";"0.25";"2.69";"5.41";"0";"CHEMBL1044551";"Inhibition of human cathepsin D by FRET based peptide cleavage assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156789";"1";"Scientific Literature";"J Med Chem";"2010";"None";"";"";""
"CHEMBL2059611";"";"None";"387.55";"1";"6.02";"E8T15";"CCc1ccccc1SCC(O)Cn1c(-c2ccccc2)cc2ccccc21";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL2061980";"Inhibition of cathepsin D by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2057073";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL2058871";"";"None";"382.53";"1";"6.07";"6";"NC(CSc1ccc2ccccc2c1)Cn1c2ccccc2c2ccccc21";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL2061980";"Inhibition of cathepsin D by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2057073";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL2058872";"";"None";"425.60";"1";"5.66";"7";"NCCNC(CSc1ccc2ccccc2c1)Cn1c2ccccc2c2ccccc21";"IC50";"'>'";"300000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2061980";"Inhibition of cathepsin D by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2057073";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL2059101";"";"None";"390.49";"1";"5.96";"12";"OC(Cn1c2ccccc2c2ccccc21)Cn1c2ccccc2c2ccccc21";"IC50";"'>'";"300000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2061980";"Inhibition of cathepsin D by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2057073";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL2059104";"";"None";"420.51";"1";"5.32";"15";"OC(Cn1c2ccccc2c2ccccc21)C(O)Cn1c2ccccc2c2ccccc21";"IC50";"'>'";"300000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2061980";"Inhibition of cathepsin D by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2057073";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL585286";"";"None";"395.55";"0";"4.06";"32";"CCCCOc1ccc(C2(C34CC5CC(CC(C5)C3)C4)N=C(N)N(C)C2=O)cc1";"IC50";"'='";"8400.0";"nM";"5.08";"";"";"UO_0000065";"12.83";"0.24";"1.02";"7.47";"0";"CHEMBL1044551";"Inhibition of human cathepsin D by FRET based peptide cleavage assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156789";"1";"Scientific Literature";"J Med Chem";"2010";"None";"";"";""
"CHEMBL584917";"";"None";"400.44";"0";"2.55";"53";"CN1C(=O)C(c2cccc(-c3cccnc3)c2)(c2ccc3c(c2)OCCO3)N=C1N";"IC50";"'='";"10900.0";"nM";"4.96";"";"";"UO_0000065";"12.39";"0.23";"2.41";"5.51";"0";"CHEMBL1044551";"Inhibition of human cathepsin D by FRET based peptide cleavage assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156789";"1";"Scientific Literature";"J Med Chem";"2010";"None";"";"";""
"CHEMBL567485";"";"None";"383.49";"0";"2.90";"36";"COc1ccc(C2(C34CC5CC(CC(C5)C3)C4)N=C(N)N(C)C2=O)cc1OC";"IC50";"'='";"36600.0";"nM";"4.44";"";"";"UO_0000065";"11.57";"0.22";"1.54";"5.75";"0";"CHEMBL1044551";"Inhibition of human cathepsin D by FRET based peptide cleavage assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156789";"1";"Scientific Literature";"J Med Chem";"2010";"None";"";"";""
"CHEMBL571320";"";"None";"367.49";"0";"3.20";"(S)-34";"COc1ccc([C@]2(C34CC5CC(CC(C5)C3)C4)N=C(N)N(C)C2=O)cc1C";"IC50";"'='";"9210.0";"nM";"5.04";"";"";"UO_0000065";"13.70";"0.25";"1.84";"7.41";"0";"CHEMBL1044551";"Inhibition of human cathepsin D by FRET based peptide cleavage assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156789";"1";"Scientific Literature";"J Med Chem";"2010";"None";"";"";""
"CHEMBL2059103";"";"None";"404.51";"1";"6.35";"14";"OC(CCn1c2ccccc2c2ccccc21)Cn1c2ccccc2c2ccccc21";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL2061980";"Inhibition of cathepsin D by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2057073";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL3344159";"";"None";"622.81";"1";"4.15";"75";"CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCc1ccccc1)NC(=O)OCc1ccccc1)[C@@H](O)CC(=O)NC1CCCCC1";"IC50";"'='";"43.0";"nM";"7.37";"";"";"UO_0000065";"11.83";"0.22";"3.22";"5.05";"0";"CHEMBL3370435";"Inhibition of human cathepsin D assessed as cleavage of wtKAHRP fluorogenic substrate";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3352063";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL1824143";"";"None";"443.56";"0";"3.34";"37";"CN1C(=O)C(c2cccc(-c3cncnc3)c2)(c2cnn(CCC3CCCCC3)c2)N=C1N";"IC50";"'='";"4400.0";"nM";"5.36";"";"";"UO_0000065";"12.08";"0.22";"2.02";"5.24";"0";"CHEMBL1825607";"Inhibition of cathepsin D by FRET assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1821667";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL272765";"";"None";"486.69";"1";"5.36";"43";"N/C(=N/C(=O)Cn1c(-c2ccccc2)ccc1C12CC3CC(CC(C3)C1)C2)NCCc1cccs1";"IC50";"'='";"476.0";"nM";"6.32";"";"";"UO_0000065";"12.99";"0.25";"0.96";"8.73";"0";"CHEMBL930552";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1142260";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";"";"";""
"CHEMBL168640";"PPL-100";"1.0";"624.80";"1";"4.12";"PL-100";"COC(=O)N[C@H](C(=O)NCCCC[C@@H](CO)N(CC(C)C)S(=O)(=O)c1ccc(N)cc1)C(c1ccccc1)c1ccccc1";"IC50";"'>'";"50000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL996242";"Inhibition of human cathepsin D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1137017";"1";"Scientific Literature";"Antimicrob Agents Chemother";"2007";"None";"";"";""
"CHEMBL379824";"";"None";"544.69";"1";"1.00";"16";"CCCCNC(=O)[C@H](C)C[C@H](O)[C@@H]1COCCCCOC[C@H](NC(=O)OC(C)(C)C)C(=O)N[C@@H](C)C(=O)N1";"IC50";"'='";"1110.0";"nM";"5.96";"";"";"UO_0000065";"10.93";"0.21";"4.95";"3.62";"0";"CHEMBL866007";"Inhibition of Cathepsin D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1137429";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";"";""
"CHEMBL567430";"";"None";"471.41";"0";"4.00";"46";"NC1=NC(c2ccc(OC(F)(F)F)cc2)(c2cccc(-c3cccnc3F)c2)C2=NOCCN12";"IC50";"'='";"2400.0";"nM";"5.62";"";"";"UO_0000065";"11.92";"0.23";"1.62";"6.59";"0";"CHEMBL1061266";"Inhibition of human cathepsin D by FRET";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1155232";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL565914";"";"None";"483.47";"0";"4.85";"43";"NC1=NC(c2ccc(OC(F)(F)F)cc2)(c2cccc(-c3cccnc3F)c2)C2=NCCCCN12";"IC50";"'='";"10800.0";"nM";"4.97";"";"";"UO_0000065";"10.27";"0.19";"0.12";"6.53";"0";"CHEMBL1061266";"Inhibition of human cathepsin D by FRET";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1155232";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL559954";"";"None";"555.70";"1";"2.64";"19";"CCc1cn2c3c(cc(C(=O)N[C@@H](Cc4ccccc4)[C@H](O)CNCC4CCOCC4)cc13)OS(=O)(=O)CC2";"IC50";"'='";"130.0";"nM";"6.89";"";"";"UO_0000065";"12.39";"0.24";"4.25";"5.79";"0";"CHEMBL725829";"Inhibition of cathepsin-D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1158411";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL254273";"";"None";"532.71";"1";"2.96";"20";"CCNc1cc(C(=O)N[C@@H](C(C)C)[C@H](O)CNCc2cccc(OC)c2)cc(N2CCCCS2(=O)=O)c1";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL945838";"Inhibition of Cathepsin D expressed in CHO cells by FRET assay";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140838";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"CHEMBL3308072";"";"";""
"CHEMBL403427";"";"None";"598.79";"2";"5.41";"26";"CCNc1cc(C(=O)N[C@@H](Cc2ccccc2)[C@H](O)CNC2(c3cccc(OC)c3)CCCCC2)cc(N2CCCC2=O)c1";"IC50";"'='";"380.0";"nM";"6.42";"";"";"UO_0000065";"10.72";"0.20";"1.01";"6.24";"0";"CHEMBL945833";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140837";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";"";"";""
"CHEMBL69365";"";"None";"399.54";"0";"4.72";"29b";"CCCc1c(OC)cccc1OCc1ccc(/C=C2\SC(=S)NC2=O)cc1";"IC50";"'='";"2760.0";"nM";"5.56";"";"";"UO_0000065";"13.91";"0.28";"0.84";"11.69";"0";"CHEMBL658685";"In vitro inhibition of cathepsin D.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1129769";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1996";"None";"";"";""
"CHEMBL3237776";"";"None";"166.18";"0";"0.30";"33-2";"COc1ccccc1C(=O)NN";"IC50";"'='";"1000.0";"nM";"6.00";"";"";"UO_0000065";"36.11";"0.68";"5.70";"9.32";"0";"CHEMBL4355299";"Inhibition of human liver cathepsin D using DABCYL-Glu-Arg-Nle-Phe-Leu-Ser-Phe-Pro-EDANS as substrate by FRET assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4354799";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";""
"CHEMBL121769";"";"None";"181.15";"0";"0.20";"33-3";"NNC(=O)c1ccccc1[N+](=O)[O-]";"IC50";"'='";"1000.0";"nM";"6.00";"";"";"UO_0000065";"33.12";"0.63";"5.80";"6.11";"0";"CHEMBL4355299";"Inhibition of human liver cathepsin D using DABCYL-Glu-Arg-Nle-Phe-Leu-Ser-Phe-Pro-EDANS as substrate by FRET assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4354799";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";""
"CHEMBL1257303";"";"None";"430.54";"0";"3.95";"10";"CC(=O)N[C@@H](Cc1cc(F)cc(F)c1)[C@H](O)CNC1(c2cccc(C(C)(C)C)c2)CC1";"IC50";"'='";"220.0";"nM";"6.66";"";"";"UO_0000065";"15.46";"0.29";"2.71";"10.85";"0";"CHEMBL1274834";"Inhibition of cathepsin-D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1268878";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL1269949";"";"None";"432.56";"0";"4.20";"9";"CC(=O)N[C@@H](Cc1cc(F)cc(F)c1)[C@H](O)CNC(C)(C)c1cccc(C(C)(C)C)c1";"IC50";"'='";"610.0";"nM";"6.21";"";"";"UO_0000065";"14.37";"0.27";"2.01";"10.13";"0";"CHEMBL1274834";"Inhibition of cathepsin-D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1268878";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL567893";"GRASSYSTATIN A";"None";"1174.44";"None";"None";"1";"COC(=O)[C@@H]1CCCN1C(=O)[C@@H](Cc1ccccc1)N(C)C(=O)[C@H](C)NC(=O)[C@@H](NC(=O)C[C@H](O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](OC(=O)[C@@H](OC(=O)[C@H](C(C)C)N(C)C)C(C)C)C(C)C)[C@@H](C)O";"IC50";"'='";"5000.0";"nM";"5.30";"";"";"UO_0000065";"4.51";"None";"None";"None";"0";"CHEMBL1043707";"Inhibition of cathepsin D in human MCF7 cells treated for 1 hr measured after washout and trypsin treatment by fluorescence assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"MCF7";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156023";"1";"Scientific Literature";"J Med Chem";"2009";"CHEMBL3308403";"";"";""
"CHEMBL4226087";"";"None";"433.60";"1";"5.73";"4c";"CCCCCCCCc1ccc(-c2ccc3c(=O)n(CC4CCCO4)c(N)nc3c2)cc1";"IC50";"'='";"2700.0";"nM";"5.57";"";"";"UO_0000065";"12.84";"0.24";"-0.16";"7.94";"0";"CHEMBL4223547";"Inhibition of human cathepsin D using DABCYL-Glu-Arg-Nle-Phe-Leu-Ser-Phe-Pro-EDANS as substrate preincubated for 30 mins followed by substrate addition measured every 1 min within 8 to 15 mins by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4219216";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";"";""
"CHEMBL4227924";"";"None";"398.47";"0";"3.89";"2d";"Nc1nc2cc(-c3ccccc3)cc(-c3cccnc3)c2c(=O)n1CC1CCCO1";"IC50";"'='";"71000.0";"nM";"4.15";"";"";"UO_0000065";"10.41";"0.19";"0.26";"5.00";"0";"CHEMBL4223547";"Inhibition of human cathepsin D using DABCYL-Glu-Arg-Nle-Phe-Leu-Ser-Phe-Pro-EDANS as substrate preincubated for 30 mins followed by substrate addition measured every 1 min within 8 to 15 mins by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4219216";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";"";""
"CHEMBL500555";"";"None";"593.65";"1";"4.69";"16";"CCn1cnc2c(N3CCCC3=O)cc(C(=O)N[C@@H](Cc3ccccc3)[C@H](O)CNCc3cccc(C(F)(F)F)c3)cc21";"IC50";"'='";"53700.0";"nM";"4.27";"";"";"UO_0000065";"7.19";"0.14";"-0.42";"4.29";"0";"CHEMBL1036847";"Inhibition of cathepsin-D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1137769";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL1076909";"";"None";"700.81";"1";"3.83";"31";"C[C@H](C[C@H](O)[C@H](COCc1cc(F)cc(F)c1)NC(=O)c1cc(C(=O)N[C@H](C)c2ccccc2)cc(N(C)S(C)(=O)=O)c1)C(=O)NC1CC1";"IC50";"'>'";"5000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1106032";"Inhibition of human liver cathepsin D after 20 mins by homogeneous time resolved fluorescence assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1154862";"1";"Scientific Literature";"Eur J Med Chem";"2010";"None";"";"";""
"CHEMBL571419";"";"None";"503.63";"1";"3.51";"40";"CO[C@H]1CC[C@@](NC[C@@H](O)[C@H](Cc2cc(F)cc(F)c2)NC(C)=O)(c2cccc(C(C)(C)C)c2)CN1";"IC50";"'='";"130.0";"nM";"6.89";"";"";"UO_0000065";"13.67";"0.26";"3.38";"8.33";"0";"CHEMBL1045212";"Inhibition of cathepsin D assessed as reduction in polarization after 110 mins by oregon green based fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156090";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL377142";"";"None";"501.54";"2";"5.12";"17";"COc1ccc(NC(=O)COc2ccc3ccccc3c2C(=O)c2cc(OC)c(OC)c(OC)c2)cc1";"IC50";"'>'";"1000000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL869858";"Inhibition of human cathepsin D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149516";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"None";"";"";""
"CHEMBL1270363";"";"None";"466.52";"0";"3.85";"17";"CC(=O)N[C@@H](Cc1cc(F)cc(F)c1)[C@H](O)CNC1(c2cccc(C(C)(CF)CF)c2)CC1";"IC50";"'='";"500.0";"nM";"6.30";"";"";"UO_0000065";"13.51";"0.26";"2.45";"10.27";"0";"CHEMBL1274834";"Inhibition of cathepsin-D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1268878";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL1210356";"";"None";"625.71";"2";"5.60";"35";"Cc1ccc(N(c2ccccc2)S(C)(=O)=O)cc1C(=O)N[C@@H](Cc1ccccc1)[C@H](O)CNCc1cccc(C(F)(F)F)c1";"IC50";"'='";"980.0";"nM";"6.01";"";"";"UO_0000065";"9.60";"0.19";"0.41";"6.09";"0";"CHEMBL1211667";"Inhibition of Cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1208699";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL210022";"";"None";"496.72";"0";"1.73";"84";"CCCCNC(=O)[C@H](C)C[C@H](O)[C@@H]1CSC/C=C/CC[C@H]2CCCN[C@H]2C(=O)N[C@@H](C)C(=O)N1";"IC50";"'='";"6900.0";"nM";"5.16";"";"";"UO_0000065";"10.39";"0.21";"3.43";"4.32";"0";"CHEMBL866007";"Inhibition of Cathepsin D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1137429";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";"";""
"CHEMBL211107";"";"None";"604.88";"1";"3.21";"25";"CCCCNC(=O)[C@H](C)C[C@H](O)[C@@H]1CSCCCCCCSC[C@H](NC(=O)OC(C)(C)C)C(=O)N[C@@H](C)C(=O)N1";"IC50";"'='";"25.0";"nM";"7.60";"";"";"UO_0000065";"12.57";"0.26";"4.39";"5.21";"0";"CHEMBL866007";"Inhibition of Cathepsin D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1137429";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";"";""
"CHEMBL1941009";"";"None";"358.36";"0";"3.89";"6";"O=C(Cn1c(-c2ccccn2)nc2ccccc21)c1ccc([N+](=O)[O-])cc1";"IC50";"'='";"17800.0";"nM";"4.75";"";"";"UO_0000065";"13.25";"0.24";"0.86";"5.22";"0";"CHEMBL1942416";"Inhibition of human cathepsin D using DABCYL-Glu-Arg-Nle-Phe-Leu-Ser-Phe-Pro-EDANS as substrate by FRET analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1938395";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL556660";"";"None";"526.70";"1";"3.07";"10";"CCc1cn2c3c(cc(C(=O)N[C@@H](Cc4ccccc4)[C@H](O)CN[C@H](C)CC)cc13)N(C)S(=O)(=O)CC2";"IC50";"'='";"5430.0";"nM";"5.26";"";"";"UO_0000065";"10.00";"0.19";"2.20";"5.08";"0";"CHEMBL725829";"Inhibition of cathepsin-D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1158411";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL2059601";"";"None";"383.52";"1";"6.10";"E7T18";"OC(CSc1ccc2ccccc2c1)Cn1c2ccccc2c2ccccc21";"IC50";"'>'";"300000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2061980";"Inhibition of cathepsin D by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2057073";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL2059605";"";"None";"375.49";"1";"5.17";"E8T9";"Oc1ccc(SCC(O)Cn2c(-c3ccccc3)cc3ccccc32)cc1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL2061980";"Inhibition of cathepsin D by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2057073";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL1824139";"";"None";"403.49";"0";"2.42";"33";"CC(C)CCn1cc(C2(c3cccc(-c4cncnc4)c3)N=C(N)N(C)C2=O)cn1";"IC50";"'='";"7400.0";"nM";"5.13";"";"";"UO_0000065";"12.72";"0.23";"2.71";"5.02";"0";"CHEMBL1825607";"Inhibition of cathepsin D by FRET assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1821667";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL3394057";"";"None";"443.41";"0";"4.18";"28";"NC1=N[C@@]2(CO1)c1cc(-c3cccnc3F)ccc1Oc1cnc(-c3ccnc(F)c3)cc12";"IC50";"'='";"660.0";"nM";"6.18";"";"";"UO_0000065";"13.94";"0.26";"2.00";"6.47";"0";"CHEMBL3395116";"Inhibition of cathepsin D (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3393054";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";""
"CHEMBL85305";"";"None";"527.48";"2";"6.66";"6";"CCOc1ccc2nc(Sc3ccc(NS(=O)(=O)c4cc(Cl)cc(Cl)c4O)cc3)sc2c1";"IC50";"'='";"1500.0";"nM";"5.82";"";"";"UO_0000065";"11.04";"0.25";"-0.84";"6.58";"0";"CHEMBL657347";"Inhibitory activity against human liver Cathepsin D using Cathepsin D assay.";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1132101";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1999";"None";"";"";""
"CHEMBL2030998";"";"None";"501.62";"1";"4.39";"3";"CC(=O)N[C@@H](Cc1cc(F)cc(F)c1)[C@H](O)CN[C@H]1CC2(CCC2)Oc2ncc(CC(C)(C)C)cc21";"IC50";"'='";"2.0";"nM";"8.70";"";"";"UO_0000065";"17.34";"0.33";"4.31";"10.42";"0";"CHEMBL2033077";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2029322";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL3321919";"";"None";"372.38";"0";"2.00";"11";"COc1cc(CC(=O)NC(=N)NCc2ccccc2)c([N+](=O)[O-])cc1OC";"IC50";"'='";"10000.0";"nM";"5.00";"";"";"UO_0000065";"13.43";"0.25";"3.00";"3.95";"0";"CHEMBL3371146";"Inhibition of human liver cathepsin D using MCA-labeled GKPILFFRLK(Dnp)-D-R-NH2 peptide by fluorescence-based assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351526";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL4226994";"";"None";"459.38";"0";"3.10";"21";"CC(F)(F)[C@H]1OC(N)=N[C@](C)(c2cc(NC(=O)c3cnc(OCF)cn3)ccc2F)[C@H]1F";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4224430";"Inhibition of Cathepsin D (unknown origin)";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4219264";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4226007";"";"None";"441.39";"0";"2.80";"24";"C[C@@H](F)[C@H]1OC(N)=N[C@](C)(c2cc(NC(=O)c3cnc(OCF)cn3)ccc2F)[C@H]1F";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4224430";"Inhibition of Cathepsin D (unknown origin)";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4219264";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL3693244";"";"None";"371.36";"0";"1.78";"BDBM171803";"COC[C@H](C)NC(=O)c1ccc(F)c([C@@]2(C(F)F)N=C(N)O[C@@H]3C[C@@H]32)c1";"IC50";"'='";"1522300.0";"nM";"";"Outside typical range";"316199";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3693248";"";"None";"363.34";"0";"2.63";"BDBM171808";"N=C1NC(CF)(c2cc(-c3cncc(F)c3)c(CO)cc2F)C2CC2O1";"IC50";"'='";"612810.0";"nM";"";"Outside typical range";"316204";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3693253";"";"None";"389.36";"0";"1.93";"BDBM171813";"COc1cnc(C(=O)Nc2cccc([C@@]3(C(F)F)N=C(N)O[C@@H]4C[C@@H]43)c2)cn1";"IC50";"'='";"792770.0";"nM";"";"Outside typical range";"316209";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3693254";"";"None";"406.37";"0";"2.10";"BDBM171814";"CNc1cnc(C(=O)Nc2ccc(F)c([C@@]3(C(F)F)N=C(N)O[C@@H]4C[C@@H]43)c2)nc1";"IC50";"'='";"489920.0";"nM";"";"Outside typical range";"316210";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688791";"";"None";"447.39";"0";"3.85";"BDBM171738";"COc1cnc2c(Nc3ccc(F)c([C@@]4(C(F)F)N=C(N)O[C@@H]5C[C@@H]54)c3)ncc(F)c2c1";"IC50";"'='";"169000.0";"nM";"";"Outside typical range";"316219";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL2059592";"";"None";"355.48";"0";"4.81";"E6T3";"OC(CSc1ccccc1F)Cn1c2c(c3ccccc31)CCCC2";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL2061980";"Inhibition of cathepsin D by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2057073";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL1269841";"";"None";"488.58";"0";"3.17";"7";"CC(=O)N[C@@H](Cc1cc(F)cc(F)c1)[C@H](O)CNC1(c2cccc(C3CCOC3)c2)CCOCC1";"IC50";"'='";"150.0";"nM";"6.82";"";"";"UO_0000065";"13.97";"0.27";"3.65";"8.55";"0";"CHEMBL1274834";"Inhibition of cathepsin-D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1268878";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL353944";"";"None";"708.94";"1";"4.82";"35";"CCCCN1C(=O)[C@H]([C@H](O)[C@H](CC2CCCCC2)NC(=O)[C@H](Cc2c[nH]cn2)NC(=O)[C@H](Cc2ccccc2)NC(=O)OC(C)(C)C)CC1(C)C";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL657351";"Inhibitory concentration against cathepsin D";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1125921";"1";"Scientific Literature";"J Med Chem";"1991";"None";"";"";""
"CHEMBL584926";"";"None";"422.44";"0";"3.37";"55";"COc1ccc(C2(c3ccc(F)c(-c4cccnc4F)c3)N=C(N)N(C)C2=O)cc1C";"IC50";"'='";"2410.0";"nM";"5.62";"";"";"UO_0000065";"13.30";"0.25";"2.25";"6.95";"0";"CHEMBL1044551";"Inhibition of human cathepsin D by FRET based peptide cleavage assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156789";"1";"Scientific Literature";"J Med Chem";"2010";"None";"";"";""
"CHEMBL1824362";"";"None";"422.49";"0";"3.57";"(R)-63";"CCC(=O)c1cc([C@@]2(c3cccc(-c4cccnc4F)c3)N=C(N)N(C)C2=O)cs1";"IC50";"'='";"78400.0";"nM";"4.11";"";"";"UO_0000065";"9.72";"0.19";"0.54";"4.63";"0";"CHEMBL1825607";"Inhibition of cathepsin D by FRET assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1821667";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL4163078";"";"None";"1134.43";"None";"None";"3";"CC[C@H](C)[C@H](NC(=O)C[C@H](O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)N(C)C(=O)[C@H](CC(C)C)NC(=O)[C@H](C)OC(=O)[C@H](Cc1ccccc1)N(C)C)C(=O)N[C@@H](C)C(=O)N(C)[C@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)OC";"IC50";"'='";"10000.0";"nM";"5.00";"";"";"UO_0000065";"4.41";"None";"None";"None";"0";"CHEMBL4141005";"Inhibition of cathepsin D in human MDA-MB-231 cells using Mca-Gly-Lys-Pro-Ile-Leu-PhePhe-Arg-Leu-Lys-(Dnp)-D-Arg-NH2 as substrate pretreated for 4 hrs followed by compound washout and subsequent substrate addition measured at 30 secs interval for 30 mins by fluorescence assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"MDA-MB-231";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4138143";"1";"Scientific Literature";"J Nat Prod";"2017";"None";"";"";""
"CHEMBL3932378";"";"None";"815.07";"2";"4.34";"BDBM232270";"COC(=O)[C@@H](NC(=O)[C@H](Cc1cccc2ccccc12)NC(=O)C[C@H](N)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)CC(C)C)C(C)C)C(C)C";"IC50";"'='";"3.7";"nM";"8.43";"";"405044";"UO_0000065";"10.34";"0.20";"4.09";"4.26";"0";"CHEMBL3888498";"In-Vitro Fluorescence Assay: In order to identify modulators of cathepsin D activity, a continuous enzymatic test was carried out with a synthetic peptide which carries a fluorescent group (MCA=(7-methoxycoumarin-4-yl)acetyl) which is quenched by energy transfer from a Dpn (2,4 dinitrophenyl) group on the same molecule, in Greiner 384-well nb microtitre plates. Cleavage of the peptidic substrate by cathepsin D causes an increase in the fluorescence intensity. In order to determine the efficacy of substances, the time-dependent increase in the fluorescence intensity in the presence of the substance was compared with the time-dependent increase in fluorescence in the absence of substances. The reference substance used was pepstatin A (Sigma-Aldrich). The substrate used was MCAGKPILFFRLK(Dnp)d-R-NH2 (Enzo Life Sciences, Lorrach). The enzyme employed was cathepsin D isolated from the human liver (Sigma-Aldrich) in a final concentration of 1.4 nM. The test was carried out in 100 mM sodium acetate buffer, 1.25% (v/v) of DMSO, 0.25% (w/v) of Chaps, pH 5.5. 2 ul of each substance solution with serially diluted substance concentration were added to in each case 4 ul of cathepsin D solution and incubated at room temperature for 10 min. The reaction was started by addition of 2 ul of substrate solution (final concentration 5 uM). After carrying out a starting-point fluorescence measurement (excitation wavelength 340 nm/emission wavelength 450 nm) using an Envision multilabel reader (Perkin Elmer), the reaction was incubated at room temperature for 60 min. The amount of peptide fragment cleaved off during the reaction time was subsequently measured by determination of the increase in the fluorescence intensity at 450 nm (excitation wavelength 340 nm).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886733";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3930138";"";"None";"706.97";"2";"4.00";"BDBM232271";"CC[C@H](C)[C@H](NC(=O)C[C@H](N)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)CC(C)C)C(C)C)C(=O)NCc1ccccc1";"IC50";"'='";"180.0";"nM";"6.75";"";"405045";"UO_0000065";"9.54";"0.18";"2.74";"3.93";"0";"CHEMBL3888498";"In-Vitro Fluorescence Assay: In order to identify modulators of cathepsin D activity, a continuous enzymatic test was carried out with a synthetic peptide which carries a fluorescent group (MCA=(7-methoxycoumarin-4-yl)acetyl) which is quenched by energy transfer from a Dpn (2,4 dinitrophenyl) group on the same molecule, in Greiner 384-well nb microtitre plates. Cleavage of the peptidic substrate by cathepsin D causes an increase in the fluorescence intensity. In order to determine the efficacy of substances, the time-dependent increase in the fluorescence intensity in the presence of the substance was compared with the time-dependent increase in fluorescence in the absence of substances. The reference substance used was pepstatin A (Sigma-Aldrich). The substrate used was MCAGKPILFFRLK(Dnp)d-R-NH2 (Enzo Life Sciences, Lorrach). The enzyme employed was cathepsin D isolated from the human liver (Sigma-Aldrich) in a final concentration of 1.4 nM. The test was carried out in 100 mM sodium acetate buffer, 1.25% (v/v) of DMSO, 0.25% (w/v) of Chaps, pH 5.5. 2 ul of each substance solution with serially diluted substance concentration were added to in each case 4 ul of cathepsin D solution and incubated at room temperature for 10 min. The reaction was started by addition of 2 ul of substrate solution (final concentration 5 uM). After carrying out a starting-point fluorescence measurement (excitation wavelength 340 nm/emission wavelength 450 nm) using an Envision multilabel reader (Perkin Elmer), the reaction was incubated at room temperature for 60 min. The amount of peptide fragment cleaved off during the reaction time was subsequently measured by determination of the increase in the fluorescence intensity at 450 nm (excitation wavelength 340 nm).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886733";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3939138";"";"None";"649.76";"1";"3.38";"BDBM232277";"CC(C)CCNC(=O)[C@H](C)NC(=O)C[C@H](N)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)Cc1cccc(OC(F)(F)F)c1)C(C)C";"IC50";"'='";"190.0";"nM";"6.72";"";"405051";"UO_0000065";"10.34";"0.20";"3.34";"4.43";"0";"CHEMBL3888498";"In-Vitro Fluorescence Assay: In order to identify modulators of cathepsin D activity, a continuous enzymatic test was carried out with a synthetic peptide which carries a fluorescent group (MCA=(7-methoxycoumarin-4-yl)acetyl) which is quenched by energy transfer from a Dpn (2,4 dinitrophenyl) group on the same molecule, in Greiner 384-well nb microtitre plates. Cleavage of the peptidic substrate by cathepsin D causes an increase in the fluorescence intensity. In order to determine the efficacy of substances, the time-dependent increase in the fluorescence intensity in the presence of the substance was compared with the time-dependent increase in fluorescence in the absence of substances. The reference substance used was pepstatin A (Sigma-Aldrich). The substrate used was MCAGKPILFFRLK(Dnp)d-R-NH2 (Enzo Life Sciences, Lorrach). The enzyme employed was cathepsin D isolated from the human liver (Sigma-Aldrich) in a final concentration of 1.4 nM. The test was carried out in 100 mM sodium acetate buffer, 1.25% (v/v) of DMSO, 0.25% (w/v) of Chaps, pH 5.5. 2 ul of each substance solution with serially diluted substance concentration were added to in each case 4 ul of cathepsin D solution and incubated at room temperature for 10 min. The reaction was started by addition of 2 ul of substrate solution (final concentration 5 uM). After carrying out a starting-point fluorescence measurement (excitation wavelength 340 nm/emission wavelength 450 nm) using an Envision multilabel reader (Perkin Elmer), the reaction was incubated at room temperature for 60 min. The amount of peptide fragment cleaved off during the reaction time was subsequently measured by determination of the increase in the fluorescence intensity at 450 nm (excitation wavelength 340 nm).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886733";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3945996";"";"None";"465.23";"0";"4.66";"BDBM215015";"C[C@@]1(c2cc(NC(=O)c3ccc(Cl)cn3)cc(Cl)c2F)C[C@@H](C(F)(F)F)OC(N)=N1";"IC50";"'='";"385600.0";"nM";"";"Outside typical range";"378075";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3958521";"";"None";"463.37";"0";"3.80";"BDBM214877";"C[C@@]1(c2cc(Nc3ncc(F)c4cc(C#N)cnc34)cnc2F)C[C@@H](C(F)(F)F)OC(N)=N1";"IC50";"'>'";"400000.0";"nM";"";"Outside typical range";"377874";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3911117";"";"None";"455.80";"0";"3.84";"BDBM214873";"C[C@@]1(c2cc(Nc3ncnc4cc(Cl)cnc34)cnc2F)C[C@@H](C(F)(F)F)OC(N)=N1";"IC50";"'>'";"400000.0";"nM";"";"Outside typical range";"377880";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3964122";"";"None";"467.40";"0";"3.86";"BDBM214806";"Cc1c(C(=O)Nc2ccc(F)c([C@]3(CF)C[C@@H](C(F)(F)F)OC(N)=N3)c2)nc2ccccn12";"IC50";"'>'";"400000.0";"nM";"";"Outside typical range";"377887";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3683821";"";"None";"435.79";"0";"3.19";"BDBM171428";"N#Cc1cnc(C(=O)Nc2ccc(F)c([C@]3(C(F)F)N=C(N)O[C@H]4C[C@H]43)c2)c(Cl)c1";"IC50";"'='";"1099300.0";"nM";"";"Outside typical range";"315837";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688700";"";"None";"453.70";"0";"3.65";"BDBM171640";"NC1=N[C@](CF)(c2cc(NC(=O)c3ccc(Br)cn3)ccc2Cl)[C@H]2C[C@H]2O1";"IC50";"'='";"537750.0";"nM";"";"Outside typical range";"316048";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688740";"";"None";"447.83";"0";"2.43";"BDBM171684";"C#CCOc1cnc(C(=O)Nc2cc(F)c(Cl)c([C@]3(CF)N=C(N)O[C@H]4C[C@H]43)c2)cn1";"IC50";"'='";"370020.0";"nM";"";"Outside typical range";"316092";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688787";"";"None";"430.39";"0";"3.11";"BDBM171734";"COc1cnc2c(Nc3ccc(F)c([C@@]4(C(F)F)N=C(N)O[C@@H]5C[C@@H]54)c3)ncnc2c1";"IC50";"'='";"596240.0";"nM";"";"Outside typical range";"316138";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL1941006";"";"None";"345.36";"0";"3.39";"3";"O=C(Cn1c(-c2ccccn2)nc2ccccc21)c1ccc(O)c(O)c1";"IC50";"'='";"28500.0";"nM";"4.54";"";"";"UO_0000065";"13.16";"0.24";"1.16";"5.15";"0";"CHEMBL1942416";"Inhibition of human cathepsin D using DABCYL-Glu-Arg-Nle-Phe-Leu-Ser-Phe-Pro-EDANS as substrate by FRET analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1938395";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL3264797";"";"None";"662.90";"2";"5.11";"2SR";"CCCN(CCC)C(=O)c1cc(C(=O)N[C@@H](Cc2ccccc2)[C@H](O)CNC(C)(C)c2ccccc2)cc(N2CCCCS2(=O)=O)c1";"IC50";"'='";"120.0";"nM";"6.92";"";"";"UO_0000065";"10.44";"0.20";"1.81";"5.81";"0";"CHEMBL3271470";"Inhibition of human cathepsin-D using DABCYL-Glu-Arg-Nle-Phe-Leu-Ser-Phe-Pro-EDANS as substrate preincubated for 30 mins by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3259525";"1";"Scientific Literature";"ACS Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3688628";"";"None";"413.38";"0";"1.78";"BDBM171563";"C#CCOc1cnc(C(=O)Nc2ccc(F)c([C@@]3(CF)N=C(N)O[C@@H]4C[C@@H]43)c2)cn1";"IC50";"'='";"260500.0";"nM";"";"Outside typical range";"315972";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3359763";"";"None";"442.45";"0";"3.36";"42, AMG-8718";"CC1(C#Cc2cnc3c(c2)[C@]2(COC(N)=N2)c2cc(-c4cccnc4F)ccc2O3)COC1";"IC50";"'='";"2300.0";"nM";"5.64";"";"";"UO_0000065";"12.74";"0.23";"2.28";"6.14";"0";"CHEMBL3371640";"Inhibition of cathepsin D (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3352228";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL404256";"";"None";"458.65";"1";"5.39";"40";"N/C(=N/C(=O)Cn1c(-c2ccccc2)ccc1C12CC3CC(CC(C3)C1)C2)NC1CCCCC1";"IC50";"'='";"54200.0";"nM";"4.27";"";"";"UO_0000065";"9.30";"0.17";"-1.12";"5.89";"0";"CHEMBL930552";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1142260";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";"";"";""
"CHEMBL4173516";"";"None";"959.20";"3";"0.54";"1";"CC[C@H](C)[C@H](NC(=O)C[C@H](O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)N(C)C(=O)[C@H](CC(C)C)NC(=O)[C@H](C)O)C(=O)N[C@@H](C)C(=O)N(C)[C@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)OC";"IC50";"'='";"2000.0";"nM";"5.70";"";"";"UO_0000065";"5.94";"0.11";"5.16";"1.98";"0";"CHEMBL4141000";"Inhibition of human liver cathepsin D using Mca-Gly-Lys-Pro-Ile-Leu-PhePhe-Arg-Leu-Lys-(Dnp)-D-Arg-NH2 as substrate pretreated for 15 mins followed by substrate addition measured at 5 mins interval for 120 mins by fluorescence assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4138143";"1";"Scientific Literature";"J Nat Prod";"2017";"None";"";"";""
"CHEMBL253867";"";"None";"619.71";"1";"4.53";"6";"CCOc1cc(C(=O)N[C@@H](Cc2ccccc2)[C@H](O)CNCc2cccc(C(F)(F)F)c2)cc(N2CCCCS2(=O)=O)c1";"IC50";"'='";"5890.0";"nM";"5.23";"";"";"UO_0000065";"8.44";"0.17";"0.70";"4.84";"0";"CHEMBL945838";"Inhibition of Cathepsin D expressed in CHO cells by FRET assay";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140838";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"CHEMBL3308072";"";"";""
"CHEMBL521771";"";"None";"406.23";"0";"5.00";"5";"CC(=O)c1c(Nc2ccc(C)cc2Cl)[nH]c2c([N+](=O)[O-])cc(Cl)cc2c1=O";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1021961";"Inhibition of human liver cathepsin D after 30 mins by fluorometric end-point assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138527";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL3688733";"";"None";"429.40";"0";"3.16";"BDBM171675";"Cc1cc(C#N)cnc1C(=O)Nc1cc(F)c(C)c([C@@]2(C(F)F)N=C(N)O[C@@H]3C[C@@H]32)c1";"IC50";"'='";"421050.0";"nM";"";"Outside typical range";"316083";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688733";"";"None";"429.40";"0";"3.16";"BDBM171675";"Cc1cc(C#N)cnc1C(=O)Nc1cc(F)c(C)c([C@@]2(C(F)F)N=C(N)O[C@@H]3C[C@@H]32)c1";"IC50";"'='";"1771500.0";"nM";"";"Outside typical range";"316084";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL565995";"";"None";"400.48";"0";"3.40";"49";"COc1ccc(C2(c3ccc(C)c(-c4cccnc4)c3)N=C(N)N(C)C2=O)cc1C";"IC50";"'='";"2470.0";"nM";"5.61";"";"";"UO_0000065";"14.00";"0.26";"2.21";"6.94";"0";"CHEMBL1044551";"Inhibition of human cathepsin D by FRET based peptide cleavage assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156789";"1";"Scientific Literature";"J Med Chem";"2010";"None";"";"";""
"CHEMBL3693239";"";"None";"374.80";"0";"2.89";"BDBM171798";"NC1=NC(CF)(c2cccc(NC(=O)c3ccc(Cl)cn3)c2)C2CC2O1";"IC50";"'='";"591980.0";"nM";"";"Outside typical range";"316194";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL1089204";"";"None";"519.09";"2";"6.86";"52";"CCCCCOc1ccc(-c2ccc(-c3ccccc3Cl)n2Cc2ccc(NCCCO)c(N)n2)cc1";"IC50";"'='";"470.0";"nM";"6.33";"";"";"UO_0000065";"12.19";"0.23";"-0.53";"7.42";"0";"CHEMBL1108758";"Inhibition of cathepsin D by FRET assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156953";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL2058874";"";"None";"397.54";"1";"6.49";"9";"OC(CCn1c2ccccc2c2ccccc21)CSc1ccc2ccccc2c1";"IC50";"'>'";"300000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2061980";"Inhibition of cathepsin D by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2057073";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL2425602";"";"None";"562.63";"1";"3.03";"17i";"COC[C@@H](Oc1cc(C[C@@H]2C[S@@+]([O-])C[C@H](NCc3cccc(C(C)(C)O)c3)[C@H]2O)cc(F)c1N)C(F)(F)F";"IC50";"'='";"7900.0";"nM";"5.10";"";"";"UO_0000065";"9.07";"0.18";"2.07";"4.25";"0";"CHEMBL2427050";"Inhibition of human cathepsin-D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2424550";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"None";"";"";""
"CHEMBL523193";"";"None";"510.66";"1";"2.44";"16";"CCc1cn2c3c(cc(C(=O)N[C@@H](Cc4ccccc4)[C@H](O)CNC4CC4)cc13)N(C)S(=O)(=O)CC2";"IC50";"'='";"7930.0";"nM";"5.10";"";"";"UO_0000065";"9.99";"0.19";"2.66";"4.92";"0";"CHEMBL725829";"Inhibition of cathepsin-D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1158411";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL559355";"";"None";"554.71";"1";"2.45";"5";"CCn1cc2c3c(cc(C(=O)N[C@@H](Cc4ccccc4)[C@H](O)CNC4CCOCC4)cc31)N(C)S(=O)(=O)CC2";"IC50";"'='";"2110.0";"nM";"5.68";"";"";"UO_0000065";"10.23";"0.20";"3.23";"5.03";"0";"CHEMBL725829";"Inhibition of cathepsin-D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1158411";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL446972";"";"None";"674.74";"1";"4.49";"8a";"CCc1cn2c3c(cc(C(=O)N[C@@H](Cc4ccccc4)[C@H](O)CNCc4cccc(C(F)(F)F)c4)cc13)N(C)S(=O)(=O)CC2.O=CO";"IC50";"'='";"1260.0";"nM";"5.90";"";"";"UO_0000065";"9.38";"0.18";"1.41";"5.69";"0";"CHEMBL959767";"Inhibition of cathepsin D expressed in CHO cells after 1 hrs by spectrophotometer";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1150334";"1";"Scientific Literature";"J Med Chem";"2008";"CHEMBL3308072";"";"";""
"CHEMBL302534";"";"None";"427.55";"0";"4.62";"3a";"CCCc1c(COc2ccc(/C=C3\SC(=S)NC3=O)cc2)ccc(C(C)=O)c1O";"IC50";"'='";"640.0";"nM";"6.19";"";"";"UO_0000065";"14.49";"0.29";"1.57";"8.19";"0";"CHEMBL658685";"In vitro inhibition of cathepsin D.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1129769";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1996";"None";"";"";""
"CHEMBL595267";"";"None";"573.73";"1";"4.88";"21";"COCc1cc2cc(n1)OCCCCOc1cccc(c1)C[C@@H]([C@H](O)CNC1(c3cccc(C(C)C)c3)CC1)NC2=O";"IC50";"'='";"3.0";"nM";"8.52";"";"";"UO_0000065";"14.86";"0.28";"3.64";"8.36";"0";"CHEMBL1050390";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1153192";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL1097361";"";"None";"544.80";"1";"2.61";"3";"CCCCNC(=O)[C@H](C)C[C@H](O)[C@H](CC(C)C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(C)C)NC(C)=O";"IC50";"'='";"9.0";"nM";"8.05";"";"";"UO_0000065";"14.77";"0.30";"5.44";"5.89";"0";"CHEMBL1107841";"Inhibition of Cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1155410";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL1084153";"";"None";"527.75";"1";"4.27";"11";"CCCCNC(=O)[C@H](C)C[C@H](O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCC[C@H](C2(NC(C)=O)CCCC2)C1";"IC50";"'='";"170.0";"nM";"6.77";"";"";"UO_0000065";"12.83";"0.24";"2.50";"6.30";"0";"CHEMBL1107841";"Inhibition of Cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1155410";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL3394040";"";"None";"458.49";"0";"4.56";"11";"CC1(C)C=C(c2cc3c(cn2)Oc2ccc(-c4cccnc4F)cc2[C@@]32COC(N)=N2)CCO1";"IC50";"'='";"710.0";"nM";"6.15";"";"";"UO_0000065";"13.41";"0.25";"1.59";"6.69";"0";"CHEMBL3395116";"Inhibition of cathepsin D (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3393054";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";""
"CHEMBL565337";"";"None";"546.66";"1";"3.10";"49";"CC(=O)N[C@@H](Cc1cc(F)cc(F)c1)[C@H](O)CN[C@@]1(c2cccc(C(C)(C)C)c2)CC[C@H](N(O)C(C)=O)NC1";"IC50";"'='";"2300.0";"nM";"5.64";"";"";"UO_0000065";"10.31";"0.20";"2.54";"4.95";"0";"CHEMBL1045212";"Inhibition of cathepsin D assessed as reduction in polarization after 110 mins by oregon green based fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156090";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL3688696";"";"None";"409.25";"0";"3.54";"BDBM171636";"NC1=N[C@](CF)(c2cc(NC(=O)c3ccc(Cl)cn3)ccc2Cl)[C@H]2C[C@H]2O1";"IC50";"'='";"646370.0";"nM";"";"Outside typical range";"316044";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3321940";"";"None";"627.54";"1";"3.48";"39";"COc1cc(Br)c(CC(=O)NC(=N)N[C@H](CC2CCCCC2)C(=O)NCc2cccc(-c3nnn[nH]3)c2)cc1OC";"IC50";"'='";"140.0";"nM";"6.85";"";"";"UO_0000065";"10.92";"0.23";"3.37";"4.10";"0";"CHEMBL3371146";"Inhibition of human liver cathepsin D using MCA-labeled GKPILFFRLK(Dnp)-D-R-NH2 peptide by fluorescence-based assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351526";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3321927";"";"None";"500.60";"1";"2.64";"26";"COc1ccc(CNC(=O)[C@@H](CC(C)C)NC(=N)NC(=O)Cc2ccc(OC)c(OC)c2)cc1OC";"IC50";"'='";"67.0";"nM";"7.17";"";"";"UO_0000065";"14.33";"0.27";"4.53";"5.48";"0";"CHEMBL3371146";"Inhibition of human liver cathepsin D using MCA-labeled GKPILFFRLK(Dnp)-D-R-NH2 peptide by fluorescence-based assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351526";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL4086633";"";"None";"353.36";"0";"3.28";"6k";"C[C@@]1(c2cc(CNCC(F)(F)F)c(F)cc2F)CCSC(N)=N1";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4042703";"Inhibition of Cathepsin D (unknown origin) by cell free assay";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4041533";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";"";""
"CHEMBL3344158";"";"None";"745.84";"2";"2.17";"20";"CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCNC(=N)N)NC(=O)OCc1ccccc1)[C@@H](O)CC(=O)NC1CCCCC1.O=C(O)C(F)(F)F";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL3370435";"Inhibition of human cathepsin D assessed as cleavage of wtKAHRP fluorogenic substrate";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3352063";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL3688626";"";"None";"388.37";"0";"2.38";"BDBM171561";"COc1ccc(C(=O)Nc2ccc(F)c([C@@]3(CF)N=C(N)O[C@@H]4C[C@@H]43)c2)nc1";"IC50";"'='";"759190.0";"nM";"";"Outside typical range";"315970";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688798";"";"None";"401.43";"0";"4.24";"BDBM171745";"NC1=N[C@@](c2cc(NC[C@@H]3C[C@H]3c3ccccc3)ccc2F)(C(F)F)[C@H]2C[C@H]2O1";"IC50";"'='";"102350.0";"nM";"";"Outside typical range";"316145";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3321937";"";"None";"508.58";"1";"1.80";"36";"COc1ccc(CC(=O)NC(=N)N[C@H](CC(C)C)C(=O)NCc2ccc(-c3nnn[nH]3)cc2)cc1OC";"IC50";"'='";"510.0";"nM";"6.29";"";"";"UO_0000065";"12.37";"0.23";"4.49";"3.77";"0";"CHEMBL3371146";"Inhibition of human liver cathepsin D using MCA-labeled GKPILFFRLK(Dnp)-D-R-NH2 peptide by fluorescence-based assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351526";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3321918";"";"None";"331.80";"0";"2.73";"10";"COc1ccc(Cl)c(CC(=O)NC(=N)NCc2ccccc2)c1";"IC50";"'='";"6100.0";"nM";"5.21";"";"";"UO_0000065";"15.72";"0.31";"2.48";"7.03";"0";"CHEMBL3371146";"Inhibition of human liver cathepsin D using MCA-labeled GKPILFFRLK(Dnp)-D-R-NH2 peptide by fluorescence-based assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351526";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL2181014";"";"None";"610.75";"1";"1.76";"16";"COC(=O)[C@@H](Cc1ccccc1)N(C)C(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)C[C@H](O)[C@H](Cc1ccccc1)NC(C)=O";"IC50";"'='";"412.0";"nM";"6.38";"";"";"UO_0000065";"10.45";"0.20";"4.63";"4.14";"0";"CHEMBL2185513";"Inhibition of cathepsin D by fluorescence assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2176894";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL2181013";"";"None";"836.00";"2";"0.50";"15";"COC(=O)[C@@H]1CCCN1C(=O)[C@@H](Cc1ccccc1)N(C)C(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)C[C@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(N)=O)NC(C)=O";"IC50";"'='";"7.81";"nM";"8.11";"";"";"UO_0000065";"9.70";"0.18";"7.61";"3.29";"0";"CHEMBL2185513";"Inhibition of cathepsin D by fluorescence assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2176894";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL68595";"";"None";"489.62";"1";"5.64";"8d";"CCCc1c(OCc2ccc(/C=C3\SC(=S)NC3=O)cc2)ccc(C(=O)c2ccccc2)c1O";"IC50";"'='";"1300.0";"nM";"5.89";"";"";"UO_0000065";"12.02";"0.24";"0.25";"7.78";"0";"CHEMBL658683";"Compound was evaluated for the inhibition of cathepsin D at an enzyme level of 50 ng/mL";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1129769";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1996";"None";"";"";""
"CHEMBL2408754";"";"None";"502.60";"1";"3.84";"49";"CC(=O)N[C@@H](Cc1cc(F)cc(F)c1)[C@H](O)CN[C@H]1CC2(COC2)Oc2ccc(CC(C)(C)C)cc21";"IC50";"'='";"22506.0";"nM";"4.65";"";"";"UO_0000065";"9.25";"0.18";"0.81";"5.82";"0";"CHEMBL2410948";"Inhibition of cathepsin-D (unknown origin) using C-terminal biotinylated peptide substrate treated 30 mins before addition of peptide substrate measured after 110 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2406984";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"None";"";"";""
"CHEMBL590830";"";"None";"394.48";"0";"3.40";"20b";"Cc1ccoc1C(=O)Nc1cccc(C2(C3CCCCC3)N=C(N)N(C)C2=O)c1";"IC50";"'='";"17100.0";"nM";"4.77";"";"";"UO_0000065";"12.08";"0.22";"1.37";"4.72";"0";"CHEMBL1042917";"Inhibition of human cathepsin D by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1153180";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL2059606";"";"None";"375.49";"1";"5.17";"E8T10";"Oc1ccccc1SCC(O)Cn1c(-c2ccccc2)cc2ccccc21";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL2061980";"Inhibition of cathepsin D by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2057073";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL2059613";"";"None";"409.55";"1";"6.61";"E8T18";"OC(CSc1ccc2ccccc2c1)Cn1c(-c2ccccc2)cc2ccccc21";"IC50";"'>'";"300000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2061980";"Inhibition of cathepsin D by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2057073";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL567893";"GRASSYSTATIN A";"None";"1174.44";"None";"None";"Grassystatin A";"COC(=O)[C@@H]1CCCN1C(=O)[C@@H](Cc1ccccc1)N(C)C(=O)[C@H](C)NC(=O)[C@@H](NC(=O)C[C@H](O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](OC(=O)[C@@H](OC(=O)[C@H](C(C)C)N(C)C)C(C)C)C(C)C)[C@@H](C)O";"IC50";"'='";"40.0";"nM";"7.40";"";"";"UO_0000065";"6.30";"None";"None";"None";"1";"CHEMBL2185513";"Inhibition of cathepsin D by fluorescence assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2176894";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL431978";"";"None";"431.30";"1";"6.24";"19";"O=C(Nc1ccc(Sc2nc3ccccc3o2)cc1)c1cc(Cl)cc(Cl)c1O";"IC50";"'='";"3200.0";"nM";"5.50";"";"";"UO_0000065";"12.74";"0.27";"-0.75";"7.29";"0";"CHEMBL657347";"Inhibitory activity against human liver Cathepsin D using Cathepsin D assay.";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1132101";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1999";"None";"";"";""
"CHEMBL333564";"";"None";"646.89";"1";"3.06";"13, (CP-108671)";"CNC1CCN(C(=O)C[C@@H](Cc2ccccc2)C(=O)N[C@@H](CSC)C(=O)N[C@@H](CC2CCCCC2)[C@@H](O)C(=O)OC(C)C)CC1";"IC50";"'='";"550.0";"nM";"6.26";"";"";"UO_0000065";"9.68";"0.19";"3.20";"4.57";"0";"CHEMBL657352";"Inhibitory concentration against human cathepsin D.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133572";"1";"Scientific Literature";"J Med Chem";"2000";"None";"";"";""
"CHEMBL3688808";"";"None";"481.32";"0";"4.67";"BDBM171756";"NC1=N[C@@](c2cc(N[C@H]3CCCc4cc(Br)cnc43)ccc2F)(C(F)F)[C@H]2C[C@H]2O1";"IC50";"'='";"263000.0";"nM";"";"Outside typical range";"316156";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL2048057";"";"None";"601.58";"1";"4.08";"62c";"CC(C)(C)c1ccnc(CN[C@H]2CS(=O)(=O)C[C@@H](Cc3cc(F)c(N)c(OC(C(F)(F)F)C(F)(F)F)c3)[C@@H]2O)c1";"IC50";"'='";"3070.0";"nM";"5.51";"";"";"UO_0000065";"9.16";"0.19";"1.43";"4.81";"0";"CHEMBL2049562";"Inhibition of human recombinant CatD using Mca-GKPILFFRLK(DNP)-dR-NH2 as substrate after 1 hr by fluorescence analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2046351";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL3127091";"";"None";"371.82";"0";"2.74";"69";"NC1=N[C@@]2(CO1)c1cc(-c3cncc(Cl)c3)ccc1O[C@H]1CCOC[C@@H]12";"IC50";"'='";"12000.0";"nM";"4.92";"";"";"UO_0000065";"13.23";"0.26";"2.18";"6.23";"0";"CHEMBL3131975";"Inhibition of human liver cathepsin D measured for 1 hr by FRET assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124885";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL3912456";"";"None";"445.34";"0";"3.63";"BDBM214907";"COC(=O)c1ccnc(Oc2ccc(F)c([C@]3(CF)C[C@@H](C(F)(F)F)OC(N)=N3)c2)c1";"IC50";"'='";"1170000.0";"nM";"";"Outside typical range";"377899";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3905535";"";"None";"426.37";"0";"3.17";"BDBM214950";"COc1ccc(C(=O)Nc2cccc([C@]3(CF)C[C@@H](C(F)(F)F)OC(N)=N3)c2)nc1";"IC50";"'='";"3520000.0";"nM";"";"Outside typical range";"377922";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3966600";"";"None";"468.39";"0";"3.75";"BDBM214812";"COc1cnc2c(Nc3ccc(F)c([C@]4(CF)C[C@@H](C(F)(F)F)OC(N)=N4)c3)ncnc2c1";"IC50";"'>'";"400000.0";"nM";"";"Outside typical range";"377929";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3939821";"";"None";"428.35";"0";"2.15";"BDBM214869";"COc1cnc(C(=O)Nc2cnc(F)c([C@]3(C)C[C@@H](C(F)(F)F)OC(N)=N3)c2)cn1";"IC50";"'='";"397000.0";"nM";"";"Outside typical range";"377984";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3927382";"";"None";"495.36";"0";"3.69";"BDBM214864";"C[C@@]1(c2cc(NC(=O)c3ccc(OCC(F)(F)F)cn3)cnc2F)C[C@@H](C(F)(F)F)OC(N)=N1";"IC50";"'='";"150000.0";"nM";"";"Outside typical range";"377987";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3683795";"";"None";"445.40";"0";"2.31";"BDBM171401";"CC#CCOc1cnc(C(=O)Nc2cc(F)c(F)c([C@@]3(CF)N=C(N)O[C@@H]4C[C@@H]43)c2)cn1";"IC50";"'='";"255770.0";"nM";"";"Outside typical range";"315810";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3683796";"";"None";"445.40";"0";"2.31";"BDBM171402";"CC#CCOc1cnc(C(=O)Nc2cc(F)c(F)c([C@]3(CF)N=C(N)O[C@H]4C[C@H]43)c2)cn1";"IC50";"'='";"526500.0";"nM";"";"Outside typical range";"315811";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL1824136";"";"None";"433.37";"0";"2.07";"30";"CN1C(=O)C(c2ccc(F)c(-c3cncnc3)c2)(c2cnn(CC(F)(F)F)c2)N=C1N";"IC50";"'='";"38600.0";"nM";"4.41";"";"";"UO_0000065";"10.18";"0.19";"2.34";"4.31";"0";"CHEMBL1825607";"Inhibition of cathepsin D by FRET assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1821667";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL1824138";"";"None";"389.46";"0";"2.03";"32";"CC(C)Cn1cc(C2(c3cccc(-c4cncnc4)c3)N=C(N)N(C)C2=O)cn1";"IC50";"'='";"11300.0";"nM";"4.95";"";"";"UO_0000065";"12.70";"0.23";"2.92";"4.84";"0";"CHEMBL1825607";"Inhibition of cathepsin D by FRET assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1821667";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL3683861";"";"None";"428.77";"0";"3.46";"BDBM171473";"NC1=N[C@@](c2cc(NC(=O)c3ccc(Cl)cn3)cc(F)c2F)(C(F)F)[C@H]2C[C@H]2O1";"IC50";"'='";"213000.0";"nM";"";"Outside typical range";"315882";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3683863";"";"None";"419.34";"0";"2.68";"BDBM171475";"N#Cc1ccc(C(=O)Nc2cc(F)c(F)c([C@]3(C(F)F)N=C(N)O[C@H]4C[C@H]43)c2)nc1";"IC50";"'>'";"400000.0";"nM";"";"Outside typical range";"315884";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3639827";"";"None";"467.76";"0";"3.66";"BDBM171476";"NC1=N[C@](c2cc(NC(=O)c3nn(C(F)F)cc3Cl)cc(F)c2F)(C(F)F)[C@@H]2C[C@@H]2O1";"IC50";"'='";"1482500.0";"nM";"";"Outside typical range";"315885";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3683865";"";"None";"425.34";"0";"2.21";"BDBM171478";"COc1cnc(C(=O)Nc2cc(F)c(F)c([C@@]3(C(F)F)N=C(N)O[C@@H]4C[C@@H]43)c2)cn1";"IC50";"'='";"4184000.0";"nM";"";"Outside typical range";"315887";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3683864";"";"None";"449.36";"0";"2.21";"BDBM171477";"C#CCOc1cnc(C(=O)Nc2cc(F)c(F)c([C@@]3(C(F)F)N=C(N)O[C@@H]4C[C@@H]43)c2)cn1";"IC50";"'='";"42450.0";"nM";"4.37";"";"315890";"UO_0000065";"9.73";"0.19";"2.16";"3.91";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3683868";"";"None";"473.22";"0";"3.57";"BDBM171482";"NC1=N[C@@](c2cc(NC(=O)c3ccc(Br)cn3)cc(F)c2F)(C(F)F)[C@H]2C[C@H]2O1";"IC50";"'='";"81884.0";"nM";"4.09";"";"315891";"UO_0000065";"8.64";"0.19";"0.52";"4.56";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3683905";"";"None";"472.83";"0";"3.93";"BDBM171524";"Cc1cc(OC(F)F)cnc1C(=O)Nc1cc(F)c(Cl)c([C@@]2(CF)N=C(N)O[C@@H]3C[C@@H]32)c1";"IC50";"'='";"230500.0";"nM";"";"Outside typical range";"315933";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688619";"";"None";"458.36";"0";"3.99";"BDBM171554";"Cc1cc(C(F)(F)F)cnc1C(=O)Nc1ccc(F)c([C@@]2(C(F)F)N=C(N)O[C@@H]3C[C@@H]32)c1";"IC50";"'='";"159000.0";"nM";"";"Outside typical range";"315963";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688660";"";"None";"430.39";"0";"2.68";"BDBM171598";"C#CCOc1ccc(C(=O)Nc2ccc(F)c([C@@]3(C(F)F)N=C(N)O[C@@H]4C[C@@H]43)c2)nc1";"IC50";"'='";"587650.0";"nM";"";"Outside typical range";"316007";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688675";"";"None";"357.33";"0";"1.99";"BDBM171613";"COCCC(=O)Nc1ccc(F)c([C@@]2(C(F)F)N=C(N)O[C@@H]3C[C@@H]32)c1";"IC50";"'='";"486400.0";"nM";"";"Outside typical range";"316022";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688722";"";"None";"416.36";"0";"2.24";"BDBM171664";"Cc1cc(NC(=O)c2ncc(C#N)cn2)cc([C@@]2(C(F)F)N=C(N)O[C@@H]3C[C@@H]32)c1F";"IC50";"'>'";"400000.0";"nM";"";"Outside typical range";"316072";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3938934";"";"None";"421.35";"0";"3.90";"BDBM214992";"[C-]#[N+]c1ccc(C(=O)Nc2ccc(F)c([C@]3(C)C[C@@H](C(F)(F)F)OC(N)=N3)c2)nc1";"IC50";"'>'";"400000.0";"nM";"";"Outside typical range";"377867";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3683815";"";"None";"410.78";"0";"3.32";"BDBM171421";"NC1=N[C@](c2cc(NC(=O)c3ccc(Cl)cn3)ccc2F)(C(F)F)[C@@H]2C[C@@H]2O1";"IC50";"'>'";"400000.0";"nM";"";"Outside typical range";"315835";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3683845";"";"None";"437.83";"0";"2.74";"BDBM171455";"COc1cnc(C(=O)Nc2cc(Cl)c(F)c([C@@]3(CF)N=C(N)O[C@@H]4C[C@@H]43)c2)c(C)n1";"IC50";"'='";"574200.0";"nM";"";"Outside typical range";"315864";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3683850";"";"None";"417.80";"0";"3.05";"BDBM171460";"N#Cc1ccc(C(=O)Nc2ccc(Cl)c([C@]3(C(F)F)N=C(N)O[C@H]4C[C@H]43)c2)nc1";"IC50";"'='";"1922000.0";"nM";"";"Outside typical range";"315869";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3683849";"";"None";"417.80";"0";"3.05";"BDBM171459";"N#Cc1ccc(C(=O)Nc2ccc(Cl)c([C@@]3(C(F)F)N=C(N)O[C@@H]4C[C@@H]43)c2)nc1";"IC50";"'='";"1160800.0";"nM";"";"Outside typical range";"315873";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688756";"";"None";"402.34";"0";"2.61";"BDBM171700";"[C-]#[N+]c1ccc(C(=O)Nc2ccc(F)c([C@@]3(C(F)F)N=C(N)O[C@@H]4C[C@@H]43)n2)nc1";"IC50";"'='";"1511900.0";"nM";"";"Outside typical range";"316105";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688757";"";"None";"438.84";"0";"3.41";"BDBM171702";"NC1=N[C@@](c2cc(NC3(c4ccc(Cl)cn4)COC3)ccc2F)(C(F)F)[C@H]2C[C@H]2O1";"IC50";"'='";"163000.0";"nM";"";"Outside typical range";"316106";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688780";"";"None";"474.90";"0";"4.25";"BDBM171727";"CC(C)Oc1cnc2c(Nc3cc(Cl)c(F)c([C@@]4(CF)N=C(N)O[C@@H]5C[C@@H]54)c3)nccc2n1";"IC50";"'='";"322620.0";"nM";"";"Outside typical range";"316131";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688782";"";"None";"432.29";"0";"4.58";"BDBM171729";"NC1=N[C@](CF)(c2cc(Nc3nccc4cc(Cl)cnc34)ccc2Cl)[C@H]2C[C@H]2O1";"IC50";"'='";"251180.0";"nM";"";"Outside typical range";"316133";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688802";"";"None";"351.37";"0";"3.40";"BDBM171749";"C=C1CC(CNc2ccc(F)c([C@@]3(C(F)F)N=C(N)O[C@@H]4C[C@@H]43)c2)C1";"IC50";"'='";"78850.0";"nM";"4.10";"";"316149";"UO_0000065";"11.68";"0.22";"0.70";"6.88";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3693242";"";"None";"407.78";"0";"4.48";"BDBM171801";"NC1=N[C@@](c2cc(-c3nc4ccc(Cl)cc4o3)ccc2F)(C(F)F)[C@H]2C[C@H]2O1";"IC50";"'='";"195650.0";"nM";"";"Outside typical range";"316197";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL2047906";"";"None";"547.74";"1";"3.29";"46c";"CCc1cc(C[C@@H]2CS(=O)(=O)C[C@H](NCc3cccc(C(C)(C)C)c3)[C@H]2O)cc(F)c1NC(=O)CN(C)C";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2049562";"Inhibition of human recombinant CatD using Mca-GKPILFFRLK(DNP)-dR-NH2 as substrate after 1 hr by fluorescence analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2046351";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL2047909";"";"None";"500.64";"1";"4.07";"45b";"CC(C)(C)c1cccc(CN[C@H]2CS(=O)(=O)C[C@@H](Cc3cc(F)c(N)c(-c4ccco4)c3)[C@@H]2O)c1";"IC50";"'='";"360.0";"nM";"6.44";"";"";"UO_0000065";"12.87";"0.25";"2.37";"6.10";"0";"CHEMBL2049562";"Inhibition of human recombinant CatD using Mca-GKPILFFRLK(DNP)-dR-NH2 as substrate after 1 hr by fluorescence analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2046351";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL2047910";"";"None";"500.64";"1";"4.07";"45c";"CC(C)(C)c1cccc(CN[C@H]2CS(=O)(=O)C[C@@H](Cc3cc(F)c(N)c(-c4ccoc4)c3)[C@@H]2O)c1";"IC50";"'='";"510.0";"nM";"6.29";"";"";"UO_0000065";"12.57";"0.25";"2.22";"5.96";"0";"CHEMBL2049562";"Inhibition of human recombinant CatD using Mca-GKPILFFRLK(DNP)-dR-NH2 as substrate after 1 hr by fluorescence analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2046351";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL2047911";"";"None";"530.63";"1";"4.31";"47";"CC(C)(C)c1cccc(CN[C@H]2CS(=O)(=O)C[C@@H](Cc3cc(F)c(N)c(CCC(F)(F)F)c3)[C@@H]2O)c1";"IC50";"'='";"980.0";"nM";"6.01";"";"";"UO_0000065";"11.32";"0.23";"1.70";"6.50";"0";"CHEMBL2049562";"Inhibition of human recombinant CatD using Mca-GKPILFFRLK(DNP)-dR-NH2 as substrate after 1 hr by fluorescence analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2046351";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL2047913";"";"None";"560.65";"1";"3.93";"49";"CO[C@@H](Cc1cc(C[C@@H]2CS(=O)(=O)C[C@H](NCc3cccc(C(C)(C)C)c3)[C@H]2O)cc(F)c1N)C(F)(F)F";"IC50";"'='";"1140.0";"nM";"5.94";"";"";"UO_0000065";"10.60";"0.21";"2.01";"5.85";"0";"CHEMBL2049562";"Inhibition of human recombinant CatD using Mca-GKPILFFRLK(DNP)-dR-NH2 as substrate after 1 hr by fluorescence analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2046351";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL3683808";"";"None";"410.78";"0";"3.16";"BDBM171414";"NC1=N[C@](CF)(c2cc(NC(=O)c3ccc(Cl)cn3)cc(F)c2F)[C@H]2C[C@H]2O1";"IC50";"'='";"229080.0";"nM";"";"Outside typical range";"315917";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688673";"";"None";"449.86";"0";"4.34";"BDBM171611";"NC1=N[C@@](c2cc(NC(=O)C3(c4ccc(Cl)cc4)CC3)ccc2F)(C(F)F)[C@H]2C[C@H]2O1";"IC50";"'='";"447240.0";"nM";"";"Outside typical range";"316020";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688811";"";"None";"421.81";"1";"5.16";"BDBM171759";"NC1=N[C@@](c2cc(Nc3coc4cc(Cl)ccc34)ccc2F)(C(F)F)[C@H]2C[C@H]2O1";"IC50";"'='";"153000.0";"nM";"";"Outside typical range";"316159";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3693223";"";"None";"463.46";"0";"4.47";"BDBM171781";"NC1=N[C@@](c2cc(Nc3nccc4cc(C#CC5CC5)cnc34)ccc2F)(C(F)F)[C@H]2C[C@H]2O1";"IC50";"'='";"8908400.0";"nM";"";"Outside typical range";"316178";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3693224";"";"None";"441.41";"0";"2.82";"BDBM171782";"NC1=N[C@@](c2cc(NC(=O)c3cnc(C#CC4CC4)cn3)ccc2F)(C(F)F)[C@H]2C[C@H]2O1";"IC50";"'='";"169850.0";"nM";"";"Outside typical range";"316179";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3683812";"";"None";"458.36";"0";"3.84";"BDBM171418";"Cc1cc(C(F)(F)F)cnc1C(=O)Nc1cc(F)c(F)c([C@]2(CF)N=C(N)O[C@H]3C[C@H]32)c1";"IC50";"'='";"1630100.0";"nM";"";"Outside typical range";"315827";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688681";"";"None";"369.34";"0";"1.99";"BDBM171619";"NC1=N[C@@](c2cc(NC(=O)[C@@H]3CCOC3)ccc2F)(C(F)F)[C@H]2C[C@H]2O1";"IC50";"'='";"188000.0";"nM";"";"Outside typical range";"316028";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688731";"";"None";"424.35";"0";"2.81";"BDBM171673";"COc1cc(F)cnc1C(=O)Nc1ccc(F)c([C@@]2(C(F)F)N=C(N)O[C@@H]3C[C@@H]32)c1";"IC50";"'>'";"400000.0";"nM";"";"Outside typical range";"316081";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688748";"";"None";"372.36";"0";"1.22";"BDBM171692";"COc1cnc(C(=O)Nc2ccc(F)c([C@@]3(C)N=C(N)O[C@@H]4C[C@@H]43)n2)cn1";"IC50";"'='";"521420.0";"nM";"";"Outside typical range";"316096";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688771";"";"None";"416.82";"0";"3.46";"BDBM171717";"NC1=N[C@](CF)(c2cc(Nc3ncnc4cc(Cl)cnc34)ccc2F)[C@H]2C[C@H]2O1";"IC50";"'='";"105750.0";"nM";"";"Outside typical range";"316121";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3683791";"";"None";"424.81";"0";"3.63";"BDBM171396";"Cc1cc(NC(=O)c2ccc(Cl)cn2)cc([C@@]2(C(F)F)N=C(N)O[C@@H]3C[C@@H]32)c1F";"IC50";"'='";"469070.0";"nM";"";"Outside typical range";"315805";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3683892";"";"None";"407.35";"0";"1.91";"BDBM171509";"COc1cnc(C(=O)Nc2cc(F)c(F)c([C@@]3(CF)N=C(N)O[C@@H]4C[C@@H]43)c2)cn1";"IC50";"'='";"529160.0";"nM";"";"Outside typical range";"315918";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3683895";"";"None";"422.82";"0";"3.03";"BDBM171512";"COc1c(F)cc(NC(=O)c2ccc(Cl)cn2)cc1[C@]1(CF)N=C(N)O[C@H]2C[C@H]21";"IC50";"'='";"768310.0";"nM";"";"Outside typical range";"315921";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688699";"";"None";"405.82";"0";"2.29";"BDBM171639";"COc1cnc(C(=O)Nc2ccc(Cl)c([C@]3(CF)N=C(N)O[C@H]4C[C@H]43)c2)cn1";"IC50";"'='";"1973000.0";"nM";"";"Outside typical range";"316047";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688717";"";"None";"390.37";"0";"2.98";"BDBM171659";"Cc1cccnc1C(=O)Nc1ccc(F)c([C@@]2(C(F)F)N=C(N)O[C@@H]3C[C@@H]32)c1";"IC50";"'='";"1661300.0";"nM";"";"Outside typical range";"316067";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688816";"";"None";"445.40";"0";"2.68";"BDBM171765";"COCc1cc(C#N)cnc1C(=O)Nc1ccc(F)c([C@@]2(C(F)F)N=C(N)O[C@@H]3C[C@@H]32)c1";"IC50";"'='";"1353200.0";"nM";"";"Outside typical range";"316165";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3953730";"";"None";"486.37";"0";"3.45";"BDBM214965";"C#CCOc1ccc(C(=O)Nc2cc(F)c(F)c([C@]3(CF)C[C@@H](C(F)(F)F)OC(N)=N3)c2)nc1";"IC50";"'>'";"400000.0";"nM";"";"Outside typical range";"377999";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3916872";"";"None";"473.79";"0";"4.02";"BDBM214974";"C[C@@]1(c2cc(NC(=O)c3ncc(C#N)cc3Cl)cc(F)c2F)C[C@@H](C(F)(F)F)OC(N)=N1";"IC50";"'='";"113000.0";"nM";"";"Outside typical range";"378008";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3915749";"";"None";"452.38";"0";"2.81";"BDBM214930";"CNC(=O)c1ccnc(C#Cc2ccc(F)c([C@]3(CF)C[C@@H](C(F)(F)F)OC(N)=N3)c2)c1";"IC50";"'>'";"400000.0";"nM";"";"Outside typical range";"378030";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3901216";"";"None";"463.34";"0";"2.85";"BDBM214959";"COc1cnc(C(=O)Nc2cc(F)c(F)c([C@]3(CF)C[C@@H](C(F)(F)F)OC(N)=N3)c2)cn1";"IC50";"'='";"3360000.0";"nM";"";"Outside typical range";"377993";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3935512";"";"None";"452.37";"0";"2.16";"BDBM214872";"C#CCOc1cnc(C(=O)Nc2cnc(F)c([C@]3(C)C[C@@H](C(F)(F)F)OC(N)=N3)c2)cn1";"IC50";"'='";"1690000.0";"nM";"";"Outside typical range";"378024";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3925243";"";"None";"452.38";"0";"2.81";"BDBM214927";"CNC(=O)c1ccc(C#Cc2ccc(F)c([C@]3(CF)C[C@@H](C(F)(F)F)OC(N)=N3)c2)nc1";"IC50";"'>'";"400000.0";"nM";"";"Outside typical range";"378027";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3940040";"";"None";"468.38";"0";"3.51";"BDBM214999";"C#CCOc1ccc(C(=O)Nc2cc(F)c(F)c([C@]3(C)C[C@@H](C(F)(F)F)OC(N)=N3)c2)nc1";"IC50";"'='";"1189000.0";"nM";"";"Outside typical range";"378065";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3973815";"";"None";"484.94";"0";"4.94";"BDBM220777";"COc1cc(F)c2c(c1)C1(CCSC(N)=N1)c1cc(NC(=O)c3ccc(Cl)cn3)ccc1O2";"IC50";"'='";"350200.0";"nM";"";"Outside typical range";"386460";"UO_0000065";"";"";"";"";"0";"CHEMBL3888270";"Fluorescence Resonance Energy Transfer (FRET) Assay: Recombinant CathepsinD was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The CathepsinD enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for CathepsinD) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886633";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3949245";"";"None";"535.90";"1";"4.20";"BDBM220803";"NC1=NC2(CCO1)c1cc(NC(=O)c3cnc(Cl)cn3)ccc1Oc1c2cc(-c2cncc(F)c2)nc1F";"IC50";"'='";"400000.0";"nM";"";"Outside typical range";"386489";"UO_0000065";"";"";"";"";"0";"CHEMBL3888270";"Fluorescence Resonance Energy Transfer (FRET) Assay: Recombinant CathepsinD was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The CathepsinD enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for CathepsinD) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886633";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3921606";"";"None";"461.91";"0";"4.34";"BDBM220815";"NC1=NC2(CCO1)c1cc(NC(=O)c3ccc(Cl)cn3)ccc1Oc1cnc(C3CC3)cc12";"IC50";"'='";"400000.0";"nM";"";"Outside typical range";"386501";"UO_0000065";"";"";"";"";"0";"CHEMBL3888270";"Fluorescence Resonance Energy Transfer (FRET) Assay: Recombinant CathepsinD was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The CathepsinD enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for CathepsinD) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886633";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3693257";"";"None";"371.37";"0";"1.83";"BDBM171817";"COc1cnc(C(=O)Nc2ccc(F)c([C@@]3(C)N=C(N)O[C@H]4C[C@H]43)c2)cn1";"IC50";"'>'";"400000.0";"nM";"";"Outside typical range";"315801";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL69209";"";"None";"413.52";"0";"4.23";"3d";"CCc1c(COc2ccc(/C=C3\SC(=S)NC3=O)cc2)ccc(C(C)=O)c1O";"IC50";"'='";"17600.0";"nM";"4.75";"";"";"UO_0000065";"11.50";"0.23";"0.52";"6.29";"0";"CHEMBL658685";"In vitro inhibition of cathepsin D.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1129769";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1996";"None";"";"";""
"CHEMBL1257302";"";"None";"474.60";"0";"3.91";"3";"CC(=O)N[C@@H](Cc1cc(F)cc(F)c1)[C@H](O)CNC1(c2cc(C(C)(C)C)ncn2)CCCCC1";"IC50";"'='";"250.0";"nM";"6.60";"";"";"UO_0000065";"13.91";"0.27";"2.69";"7.58";"0";"CHEMBL1274834";"Inhibition of cathepsin-D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1268878";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL1824337";"";"None";"396.40";"0";"2.08";"40";"CN1C(=O)C(c2cccc(-c3cccnc3F)c2)(c2cnn(CCF)c2)N=C1N";"IC50";"'='";"13120.0";"nM";"4.88";"";"";"UO_0000065";"12.32";"0.23";"2.80";"5.46";"0";"CHEMBL1825607";"Inhibition of cathepsin D by FRET assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1821667";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL1824343";"";"None";"434.52";"0";"3.55";"46";"CCC(CC)Cn1cc(C2(c3cccc(-c4cccnc4F)c3)N=C(N)N(C)C2=O)cn1";"IC50";"'='";"1420.0";"nM";"5.85";"";"";"UO_0000065";"13.46";"0.25";"2.30";"6.54";"0";"CHEMBL1825607";"Inhibition of cathepsin D by FRET assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1821667";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL566969";"";"None";"465.44";"0";"3.89";"40";"NC1=NC(c2cccc(-c3cccnc3F)c2)(c2ccc3c(c2)OC(F)(F)O3)C2=NCCCN12";"IC50";"'='";"95300.0";"nM";"4.02";"";"";"UO_0000065";"8.64";"0.16";"0.13";"4.71";"0";"CHEMBL1061266";"Inhibition of human cathepsin D by FRET";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1155232";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL584288";"";"None";"469.44";"0";"4.46";"37";"NC1=NC(c2ccc(OC(F)(F)F)cc2)(c2cccc(-c3cccnc3F)c2)C2=NCCCN12";"IC50";"'='";"18100.0";"nM";"4.74";"";"";"UO_0000065";"10.10";"0.19";"0.28";"6.23";"0";"CHEMBL1061266";"Inhibition of human cathepsin D by FRET";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1155232";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL583213";"";"None";"346.48";"0";"3.66";"27";"CC(C)(C)c1cccc(C2(c3ccccc3)N=C(N)N3CCCN=C32)c1";"IC50";"'='";"150100.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1061266";"Inhibition of human cathepsin D by FRET";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1155232";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL2408752";"";"None";"516.67";"2";"5.63";"47";"CCC[C@]1(C)C[C@H](NC[C@@H](O)[C@H](Cc2cc(F)cc(F)c2)NC(C)=O)c2cc(CC(C)(C)C)ccc2O1";"IC50";"'='";"2.0";"nM";"8.70";"";"";"UO_0000065";"16.84";"0.32";"3.07";"12.32";"0";"CHEMBL2410948";"Inhibition of cathepsin-D (unknown origin) using C-terminal biotinylated peptide substrate treated 30 mins before addition of peptide substrate measured after 110 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2406984";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"None";"";"";""
"CHEMBL2408740";"";"None";"480.58";"0";"2.76";"18";"CC(=O)N[C@@H](Cc1cc(F)cc(F)c1)[C@H](O)CN[C@H]1CS(=O)(=O)Cc2ccc(C(C)C)cc21";"IC50";"'='";"940.0";"nM";"6.03";"";"";"UO_0000065";"12.54";"0.25";"3.27";"6.31";"0";"CHEMBL2410948";"Inhibition of cathepsin-D (unknown origin) using C-terminal biotinylated peptide substrate treated 30 mins before addition of peptide substrate measured after 110 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2406984";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"None";"";"";""
"CHEMBL354360";"";"None";"758.96";"1";"4.45";"30";"CN1C(=O)[C@H]([C@H](O)[C@H](CC2CCCCC2)NC(=O)[C@H](Cc2c[nH]cn2)NC(=O)[C@H](Cc2ccccc2)NC(=O)OC(C)(C)C)C[C@H]1COCc1ccccc1";"IC50";"'='";"115.0";"nM";"6.94";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL657351";"Inhibitory concentration against cathepsin D";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1125921";"1";"Scientific Literature";"J Med Chem";"1991";"None";"";"";""
"CHEMBL1271036";"";"None";"397.43";"0";"3.47";"60";"CCCC#Cc1cccc([C@@]2(c3ccc(OC(F)F)cc3)N=C(N)N(C)C2=O)c1";"IC50";"'='";"4200.0";"nM";"5.38";"";"";"UO_0000065";"13.53";"0.25";"1.91";"7.92";"0";"CHEMBL1273977";"Inhibition of cathepsin D by FRET assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1268920";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL1270530";"";"None";"443.37";"0";"3.41";"89";"Cc1cc([C@]2(c3ccc(F)c(OCC(F)F)c3)N=C(N)N(C)C2=O)ccc1OC(F)F";"IC50";"'='";"3400.0";"nM";"5.47";"";"";"UO_0000065";"12.33";"0.24";"2.06";"7.09";"0";"CHEMBL1273977";"Inhibition of cathepsin D by FRET assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1268920";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL1257650";"";"None";"598.52";"2";"5.72";"6";"CC(=O)N[C@@H](Cc1cc(F)cc(F)c1)[C@H](O)CNC1(c2cc(I)cc(C(C)(C)C)c2)CCCCC1";"IC50";"'='";"55.0";"nM";"7.26";"";"";"UO_0000065";"12.13";"0.28";"1.54";"11.83";"0";"CHEMBL1260849";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1255191";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL1257773";"";"None";"502.65";"2";"5.13";"12";"COc1cc(C(C)(C)C)cc(C2(NC[C@@H](O)[C@H](Cc3cc(F)cc(F)c3)NC(C)=O)CCCCC2)c1";"IC50";"'='";"47.0";"nM";"7.33";"";"";"UO_0000065";"14.58";"0.28";"2.20";"10.38";"0";"CHEMBL1260849";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1255191";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL1271142";"";"None";"429.44";"0";"3.81";"63";"CN1C(=O)[C@@](c2ccc(OC(F)F)cc2)(c2cccc(C#CCCCCF)c2)N=C1N";"IC50";"'='";"3500.0";"nM";"5.46";"";"";"UO_0000065";"12.70";"0.24";"1.65";"8.03";"0";"CHEMBL1273977";"Inhibition of cathepsin D by FRET assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1268920";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL566007";"";"None";"299.76";"0";"2.37";"28";"CN1C(=O)C(c2ccccc2)(c2ccc(Cl)cc2)N=C1N";"IC50";"'='";"38180.0";"nM";"4.42";"";"";"UO_0000065";"14.74";"0.29";"2.05";"7.53";"0";"CHEMBL1044551";"Inhibition of human cathepsin D by FRET based peptide cleavage assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156789";"1";"Scientific Literature";"J Med Chem";"2010";"None";"";"";""
"CHEMBL567688";"";"None";"405.43";"0";"2.63";"60";"COc1ccc(C2(c3ccc(F)c(-c4cncnc4)c3)N=C(N)N(C)C2=O)cc1C";"IC50";"'='";"6700.0";"nM";"5.17";"";"";"UO_0000065";"12.76";"0.24";"2.54";"5.52";"0";"CHEMBL1044551";"Inhibition of human cathepsin D by FRET based peptide cleavage assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156789";"1";"Scientific Literature";"J Med Chem";"2010";"None";"";"";""
"CHEMBL566406";"";"None";"416.48";"0";"3.19";"39";"CCOc1cc(C2(c3cccc(-c4cccnc4)c3)N=C(N)N(C)C2=O)ccc1OC";"IC50";"'='";"10300.0";"nM";"4.99";"";"";"UO_0000065";"11.97";"0.22";"1.80";"5.54";"0";"CHEMBL1044551";"Inhibition of human cathepsin D by FRET based peptide cleavage assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156789";"1";"Scientific Literature";"J Med Chem";"2010";"None";"";"";""
"CHEMBL566200";"";"None";"386.46";"0";"3.10";"37";"COc1ccc(C2(c3cccc(-c4cccnc4)c3)N=C(N)N(C)C2=O)cc1C";"IC50";"'='";"12500.0";"nM";"4.90";"";"";"UO_0000065";"12.69";"0.23";"1.80";"6.07";"1";"CHEMBL1044551";"Inhibition of human cathepsin D by FRET based peptide cleavage assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156789";"1";"Scientific Literature";"J Med Chem";"2010";"None";"";"";""
"CHEMBL578410";"";"None";"299.76";"0";"2.37";"26";"CN1C(=O)C(c2ccccc2)(c2cccc(Cl)c2)N=C1N";"IC50";"'='";"69180.0";"nM";"4.16";"";"";"UO_0000065";"13.88";"0.27";"1.79";"7.09";"0";"CHEMBL1044551";"Inhibition of human cathepsin D by FRET based peptide cleavage assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156789";"1";"Scientific Literature";"J Med Chem";"2010";"None";"";"";""
"CHEMBL314649";"";"None";"716.47";"2";"9.19";"42";"CCOc1ccc2nc(Sc3ccc(NC(=O)c4cc(Cl)cc(Cl)c4OS(=O)(=O)c4cc(Cl)cc(Cl)c4O)cc3)sc2c1";"IC50";"'='";"490.0";"nM";"6.31";"";"";"UO_0000065";"8.81";"0.20";"-2.88";"5.50";"0";"CHEMBL657347";"Inhibitory activity against human liver Cathepsin D using Cathepsin D assay.";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1132101";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1999";"None";"";"";""
"CHEMBL1210434";"";"None";"679.81";"2";"6.95";"50";"CS(=O)(=O)N(c1ccccc1)c1cc(C(=O)N[C@@H](Cc2ccccc2)[C@H](O)CNCc2cccc(C(F)(F)F)c2)cc(C2CCCC2)c1";"IC50";"'='";"430.0";"nM";"6.37";"";"";"UO_0000065";"9.37";"0.18";"-0.58";"6.45";"0";"CHEMBL1211667";"Inhibition of Cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1208699";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL3321916";"";"None";"432.43";"0";"2.01";"8";"COc1ccc(CNC(=N)NC(=O)Cc2cc(OC)c(OC)cc2[N+](=O)[O-])cc1OC";"IC50";"'='";"2700.0";"nM";"5.57";"";"";"UO_0000065";"12.88";"0.25";"3.56";"3.84";"0";"CHEMBL3371146";"Inhibition of human liver cathepsin D using MCA-labeled GKPILFFRLK(Dnp)-D-R-NH2 peptide by fluorescence-based assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351526";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL2059330";"";"None";"345.90";"1";"5.01";"E3T5";"CCc1cccc2ccn(CC(O)CSc3ccccc3Cl)c12";"IC50";"'>'";"300000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2061980";"Inhibition of cathepsin D by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2057073";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL2059596";"";"None";"351.45";"1";"5.09";"E7T3";"OC(CSc1ccccc1F)Cn1c2ccccc2c2ccccc21";"IC50";"'>'";"300000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2061980";"Inhibition of cathepsin D by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2057073";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL2059597";"";"None";"348.47";"0";"4.53";"E7T11";"Nc1cccc(SCC(O)Cn2c3ccccc3c3ccccc32)c1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL2061980";"Inhibition of cathepsin D by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2057073";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL66793";"";"None";"443.55";"0";"4.20";"8b";"CCCc1c(OCc2ccc(/C=C3\SC(=S)NC3=O)cc2)ccc(C(=O)OC)c1O";"IC50";"'='";"9740.0";"nM";"5.01";"";"";"UO_0000065";"11.30";"0.23";"0.81";"5.91";"0";"CHEMBL658685";"In vitro inhibition of cathepsin D.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1129769";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1996";"None";"";"";""
"CHEMBL493984";"";"None";"530.65";"0";"1.90";"8f";"CCc1cn2c3c(cc(C(=O)N[C@@H](Cc4ccccc4)[C@H](O)CNC)cc13)N(C)S(=O)(=O)CC2.O=CO";"IC50";"'='";"58880.0";"nM";"4.23";"";"";"UO_0000065";"8.73";"0.17";"2.33";"4.08";"0";"CHEMBL959767";"Inhibition of cathepsin D expressed in CHO cells after 1 hrs by spectrophotometer";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1150334";"1";"Scientific Literature";"J Med Chem";"2008";"CHEMBL3308072";"";"";""
"CHEMBL2059594";"";"None";"367.51";"0";"4.68";"E6T12";"COc1ccc(SCC(O)Cn2c3c(c4ccccc42)CCCC3)cc1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL2061980";"Inhibition of cathepsin D by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2057073";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL2058875";"";"None";"397.54";"1";"6.49";"10";"OC(CCSc1ccc2ccccc2c1)Cn1c2ccccc2c2ccccc21";"IC50";"'>'";"300000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2061980";"Inhibition of cathepsin D by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2057073";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL1210346";"";"None";"674.79";"1";"4.93";"25";"C[C@H](NC[C@@H](O)[C@H](Cc1ccccc1)NC(=O)c1cccc(N(c2ccc(C(F)(F)F)cc2)S(C)(=O)=O)c1)C(=O)NC1CCCCC1";"IC50";"'='";"580.0";"nM";"6.24";"";"";"UO_0000065";"9.24";"0.18";"1.31";"4.88";"0";"CHEMBL1211667";"Inhibition of Cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1208699";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL2031142";"";"None";"515.65";"1";"4.64";"36";"CC(=O)N[C@@H](Cc1ccc(F)c(F)c1)[C@H](O)CN[C@H]1C[C@]2(C[C@@H](C)C2)Oc2ncc(CC(C)(C)C)cc21";"IC50";"'='";"4.0";"nM";"8.40";"";"";"UO_0000065";"16.29";"0.31";"3.76";"10.06";"0";"CHEMBL2033077";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2029322";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL1941013";"";"None";"389.46";"1";"5.65";"10";"O=C(Cn1c(-c2ccccn2)nc2ccccc21)c1ccc(-c2ccccc2)cc1";"IC50";"'='";"2000.0";"nM";"5.70";"";"";"UO_0000065";"14.63";"0.26";"0.05";"11.93";"0";"CHEMBL1942416";"Inhibition of human cathepsin D using DABCYL-Glu-Arg-Nle-Phe-Leu-Ser-Phe-Pro-EDANS as substrate by FRET analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1938395";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL553387";"";"None";"582.77";"1";"3.23";"36";"CCc1cn2c3c(cc(C(=O)N[C@@H](Cc4ccccc4)[C@H](O)CNC4CCOCC4)cc13)N(C(C)C)S(=O)(=O)CC2";"IC50";"'='";"2960.0";"nM";"5.53";"";"";"UO_0000065";"9.49";"0.18";"2.30";"4.90";"0";"CHEMBL1035560";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1158445";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL314638";"";"None";"714.50";"2";"9.39";"14";"CCOc1ccc2nc(Sc3ccc(NC(=O)c4cc(Cl)cc(Cl)c4CS(=O)(=O)c4cc(Cl)cc(Cl)c4O)cc3)sc2c1";"IC50";"'='";"600.0";"nM";"6.22";"";"";"UO_0000065";"8.71";"0.20";"-3.17";"5.89";"0";"CHEMBL657347";"Inhibitory activity against human liver Cathepsin D using Cathepsin D assay.";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1132101";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1999";"None";"";"";""
"CHEMBL2322896";"";"None";"413.39";"1";"5.56";"6a, (3S,4S)-6a";"Cl.Clc1ccc(N(C[C@@H]2CNC[C@H]2Cc2ccccc2)c2ccccc2)cc1";"IC50";"'='";"11000.0";"nM";"4.96";"";"";"UO_0000065";"13.16";"0.25";"-0.60";"32.47";"0";"CHEMBL2330925";"Inhibition of human recombinant cathepsin-D expressed in baculovirus-infected insect sf9 cells using Ac- E-D(EDANS)-KPILFFRLG-K(Dabcyl)-E-Amid as substrate incubated for 1 hr prior to substrate addition measured after 1 hr by FRET-based enzymatic assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2321868";"1";"Scientific Literature";"J Med Chem";"2013";"CHEMBL3308860";"";"";""
"CHEMBL1257893";"";"None";"451.58";"0";"3.70";"64";"CC(=O)N[C@@H](Cc1cc(F)cc(F)c1)[C@H](O)CNC1(c2nc(CC(C)(C)C)cs2)CC1";"IC50";"'='";"3110.0";"nM";"5.51";"";"";"UO_0000065";"12.20";"0.24";"1.81";"7.42";"0";"CHEMBL1260849";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1255191";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL2177332";"";"None";"406.41";"0";"4.20";"9m";"COc1ccc2c(c1)C1(COC(N)=N1)c1cc(-c3cccc(OC)c3F)ccc1O2";"IC50";"'='";"37300.0";"nM";"4.43";"";"";"UO_0000065";"10.90";"0.20";"0.23";"5.88";"0";"CHEMBL2183109";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2177044";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL2177328";"";"None";"442.39";"0";"4.96";"9i";"COc1ccc2c(c1)C1(COC(N)=N1)c1cc(-c3cccc(OC(F)(F)F)c3)ccc1O2";"IC50";"'='";"20100.0";"nM";"4.70";"";"";"UO_0000065";"10.62";"0.20";"-0.26";"6.24";"0";"CHEMBL2183109";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2177044";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL2177311";"";"None";"378.86";"0";"4.60";"2";"COc1ccc(C2(c3cccc(-c4cccc(Cl)c4)c3)COC(N)=N2)cc1";"IC50";"'='";"12700.0";"nM";"4.90";"";"";"UO_0000065";"12.92";"0.25";"0.30";"8.61";"0";"CHEMBL2183109";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2177044";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL1098669";"";"None";"621.74";"2";"0.73";"7";"CC(C)C[C@H](NC(=O)[C@H](CC#N)NC(=O)C[C@H](O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)c1ccccn1)C(C)C)C(N)=O";"IC50";"'='";"50.0";"nM";"7.30";"";"";"UO_0000065";"11.74";"0.22";"6.57";"3.37";"0";"CHEMBL1114767";"Inhibition of human cathepsin D after 30 mins by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1157812";"1";"Scientific Literature";"J Med Chem";"2010";"None";"";"";""
"CHEMBL1092227";"";"None";"408.51";"0";"4.76";"36";"C=CCNC(=O)c1ccc(-c2ccc(-c3ccccc3)n2Cc2cccc(N)n2)cc1";"IC50";"'='";"43600.0";"nM";"4.36";"";"";"UO_0000065";"10.67";"0.19";"-0.40";"5.98";"0";"CHEMBL1108758";"Inhibition of cathepsin D by FRET assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156953";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL2181019";"";"None";"957.18";"2";"1.50";"6";"CC(C)C[C@H](NC(=O)C[C@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(N)=O)N(C)C(=O)[C@@H](NC(=O)[C@H](C)O)C(C)C)C(=O)N[C@@H](C)C(=O)N(C)[C@H](Cc1ccccc1)C(=O)NCc1ccccc1";"IC50";"'='";"20.9";"nM";"7.68";"";"";"UO_0000065";"8.02";"0.15";"6.18";"2.85";"0";"CHEMBL2185513";"Inhibition of cathepsin D by fluorescence assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2176894";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL251862";"";"None";"563.74";"1";"3.37";"40";"CCNc1cc(C(=O)N[C@@H](Cc2ccccc2)[C@H](O)CN[C@@H](C)C(=O)NC2CCCCC2)cc(N2CCCC2=O)c1";"IC50";"'='";"2695.0";"nM";"5.57";"";"";"UO_0000065";"9.88";"0.19";"2.20";"4.54";"1";"CHEMBL1211667";"Inhibition of Cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1208699";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL1163020";"";"None";"536.67";"1";"4.44";"58, mixture of epimers";"CC(=O)N[C@@H](Cc1cc(F)cc(F)c1)[C@H](O)CNC1(c2cccc(C(C)(C)C)c2)CCc2nc(C)ncc2C1";"IC50";"'='";"910.0";"nM";"6.04";"";"";"UO_0000065";"11.26";"0.21";"1.60";"6.93";"0";"CHEMBL1045212";"Inhibition of cathepsin D assessed as reduction in polarization after 110 mins by oregon green based fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156090";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL401473";"";"None";"618.72";"1";"4.56";"8";"CCNc1cc(C(=O)N[C@@H](Cc2ccccc2)[C@H](O)CNCc2cccc(C(F)(F)F)c2)cc(N2CCCCS2(=O)=O)c1";"IC50";"'='";"6760.0";"nM";"5.17";"";"";"UO_0000065";"8.36";"0.16";"0.61";"4.67";"0";"CHEMBL1035560";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1158445";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL1257418";"";"None";"431.53";"0";"3.34";"56";"CC(=O)N[C@@H](Cc1cc(F)cc(F)c1)[C@H](O)CNC1(c2cc(C(C)(C)C)ccn2)CC1";"IC50";"'='";"850.0";"nM";"6.07";"";"";"UO_0000065";"14.07";"0.27";"2.73";"8.18";"0";"CHEMBL1260849";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1255191";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL584695";"";"None";"422.44";"0";"3.37";"(R)-55";"COc1ccc([C@]2(c3ccc(F)c(-c4cccnc4F)c3)N=C(N)N(C)C2=O)cc1C";"IC50";"'='";"2710.0";"nM";"5.57";"";"";"UO_0000065";"13.18";"0.25";"2.20";"6.89";"0";"CHEMBL1044551";"Inhibition of human cathepsin D by FRET based peptide cleavage assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156789";"1";"Scientific Literature";"J Med Chem";"2010";"None";"";"";""
"CHEMBL85111";"";"None";"472.38";"1";"6.58";"29";"N#Cc1cc(NC(=O)c2cc(Cl)cc(Cl)c2O)ccc1Sc1nc2ccccc2s1";"IC50";"'='";"1600.0";"nM";"5.80";"";"";"UO_0000065";"12.27";"0.26";"-0.78";"6.74";"0";"CHEMBL657347";"Inhibitory activity against human liver Cathepsin D using Cathepsin D assay.";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1132101";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1999";"None";"";"";""
"CHEMBL84616";"";"None";"618.14";"2";"7.63";"45";"CCOc1ccc2nc(Sc3ccc(NC(=O)c4cc(Cl)ccc4NC(=O)c4ccccc4CC(=O)O)cc3)sc2c1";"IC50";"'='";"2700.0";"nM";"5.57";"";"";"UO_0000065";"9.01";"0.18";"-2.06";"4.73";"0";"CHEMBL657347";"Inhibitory activity against human liver Cathepsin D using Cathepsin D assay.";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1132101";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1999";"None";"";"";""
"CHEMBL85842";"";"None";"456.98";"1";"6.46";"36";"CCOc1ccc2nc(Sc3ccc(NC(=O)c4cc(Cl)ccc4O)cc3)sc2c1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL657347";"Inhibitory activity against human liver Cathepsin D using Cathepsin D assay.";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1132101";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1999";"None";"";"";""
"CHEMBL421524";"";"None";"491.42";"1";"7.11";"5";"CCOc1ccc2sc(Sc3ccc(NC(=O)c4cc(Cl)cc(Cl)c4O)cc3)nc2c1";"IC50";"'='";"1800.0";"nM";"5.75";"";"";"UO_0000065";"11.69";"0.25";"-1.37";"8.04";"0";"CHEMBL657347";"Inhibitory activity against human liver Cathepsin D using Cathepsin D assay.";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1132101";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1999";"None";"";"";""
"CHEMBL3394051";"";"None";"435.43";"0";"3.53";"22";"NC1=N[C@@]2(CO1)c1cc(-c3cccnc3F)ccc1Oc1cnc(N3CC[C@@H](F)C3)cc12";"IC50";"'='";"680.0";"nM";"6.17";"";"";"UO_0000065";"14.16";"0.26";"2.64";"7.18";"0";"CHEMBL3395116";"Inhibition of cathepsin D (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3393054";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";""
"CHEMBL81996";"";"None";"415.23";"1";"5.88";"18";"O=C(Nc1ccc(Oc2nc3ccccc3o2)cc1)c1cc(Cl)cc(Cl)c1O";"IC50";"'='";"7200.0";"nM";"5.14";"";"";"UO_0000065";"12.39";"0.25";"-0.74";"6.08";"0";"CHEMBL657347";"Inhibitory activity against human liver Cathepsin D using Cathepsin D assay.";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1132101";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1999";"None";"";"";""
"CHEMBL3321922";"";"None";"342.40";"0";"1.67";"14";"COc1ccc(CC(=O)NC(=N)NCc2ccc(N)cc2)cc1OC";"IC50";"'='";"29000.0";"nM";"4.54";"";"";"UO_0000065";"13.25";"0.25";"2.87";"4.15";"0";"CHEMBL3371146";"Inhibition of human liver cathepsin D using MCA-labeled GKPILFFRLK(Dnp)-D-R-NH2 peptide by fluorescence-based assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351526";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3321920";"";"None";"400.44";"0";"2.78";"12";"COc1cc(CCCC(=O)NC(=N)NCc2ccccc2)c([N+](=O)[O-])cc1OC";"IC50";"'='";"18000.0";"nM";"4.75";"";"";"UO_0000065";"11.85";"0.22";"1.96";"3.75";"0";"CHEMBL3371146";"Inhibition of human liver cathepsin D using MCA-labeled GKPILFFRLK(Dnp)-D-R-NH2 peptide by fluorescence-based assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351526";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL81927";"";"None";"889.63";"2";"8.03";"2";"COc1cc(Br)c(C(=O)N[C@@H](Cc2cccc(Oc3ccccc3)c2)[C@@H](O)CN(CCc2ccc(Cl)cc2Cl)C(=O)CCN2C(=O)c3ccccc3C2=O)cc1OC";"IC50";"'='";"85.0";"nM";"7.07";"";"";"UO_0000065";"7.95";"0.17";"-0.96";"5.25";"0";"CHEMBL3371144";"Inhibition of cathepsin D (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351526";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3344272";"";"None";"801.93";"2";"1.52";"1";"CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NS(=O)(=O)Cc1ccccc1)C(C)C)[C@@H](O)CC(=O)NCCc1ccccc1.O=C(O)C(F)(F)F";"IC50";"'='";"32000.0";"nM";"4.50";"";"";"UO_0000065";"6.53";"0.13";"2.97";"2.08";"0";"CHEMBL3370435";"Inhibition of human cathepsin D assessed as cleavage of wtKAHRP fluorogenic substrate";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3352063";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL585120";"";"None";"367.49";"0";"3.20";"(R)-34";"COc1ccc([C@@]2(C34CC5CC(CC(C5)C3)C4)N=C(N)N(C)C2=O)cc1C";"IC50";"'='";"13140.0";"nM";"4.88";"";"";"UO_0000065";"13.28";"0.25";"1.68";"7.19";"0";"CHEMBL1044551";"Inhibition of human cathepsin D by FRET based peptide cleavage assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156789";"1";"Scientific Literature";"J Med Chem";"2010";"None";"";"";""
"CHEMBL571860";"";"None";"472.62";"1";"5.12";"1";"CC(=O)N[C@@H](Cc1cc(F)cc(F)c1)[C@H](O)CNC1(c2cccc(C(C)(C)C)c2)CCCCC1";"IC50";"'='";"25.0";"nM";"7.60";"";"";"UO_0000065";"16.08";"0.31";"2.48";"12.39";"1";"CHEMBL1274834";"Inhibition of cathepsin-D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1268878";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL1210334";"";"None";"592.76";"1";"3.62";"9";"C[C@H](NC[C@@H](O)[C@H](Cc1ccccc1)NC(=O)c1cccc(NS(=O)(=O)c2ccccc2)c1)C(=O)NC1CCCCC1";"IC50";"'='";"12000.0";"nM";"4.92";"";"";"UO_0000065";"8.30";"0.16";"1.30";"3.60";"0";"CHEMBL1211667";"Inhibition of Cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1208699";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL104326";"";"None";"834.03";"2";"4.44";"51";"COc1ccc(CN[C@@H](C(=O)N[C@H](C(=O)NCc2nc3ccccc3[nH]2)C(C)C)[C@H](O)[C@H](Cc2ccccc2)NC(=O)[C@@H](NC(=O)CCc2ccc(O)cc2)C(C)(C)C)cc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL657353";"Selectivity for their inhibitory potency against human cathepsin D.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1127464";"1";"Scientific Literature";"J Med Chem";"1994";"None";"";"";""
"CHEMBL321943";"";"None";"834.03";"2";"4.57";"52";"COc1ccc(CN[C@@H](C(=O)N[C@H](C(=O)NCc2nc3ccccc3[nH]2)C(C)C)[C@H](O)[C@H](Cc2ccccc2)NC(=O)[C@@H](NC(=O)C(C)Oc2ccccc2)C(C)(C)C)cc1";"IC50";"'='";"2000.0";"nM";"5.70";"";"";"UO_0000065";"6.83";"0.13";"1.13";"2.91";"0";"CHEMBL657353";"Selectivity for their inhibitory potency against human cathepsin D.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1127464";"1";"Scientific Literature";"J Med Chem";"1994";"None";"";"";""
"CHEMBL560612";"";"None";"554.71";"1";"2.45";"13";"CCc1cn2c3c(cc(C(=O)N[C@@H](Cc4ccccc4)[C@H](O)CNC4CCOCC4)cc13)N(C)S(=O)(=O)CC2";"IC50";"'='";"6610.0";"nM";"5.18";"";"";"UO_0000065";"9.34";"0.18";"2.73";"4.59";"0";"CHEMBL1035560";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1158445";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL1788375";"";"None";"693.59";"1";"4.69";"39";"Br.CS(=O)(=O)N(c1cccc(C(=O)N[C@@H](Cc2ccccc2)[C@H](O)CNCc2cccc(C(F)(F)F)c2)c1)c1ccccn1";"IC50";"'='";"5890.0";"nM";"5.23";"";"";"UO_0000065";"8.54";"0.17";"0.54";"4.69";"0";"CHEMBL1211667";"Inhibition of Cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1208699";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL3321924";"";"None";"557.61";"1";"1.91";"23";"COc1ccc(CC(=O)NC(=N)N[C@@H](Cc2ccccc2)C(=O)NCCN2C(=O)c3ccccc3C2=O)cc1OC";"IC50";"'='";"8300.0";"nM";"5.08";"";"";"UO_0000065";"9.11";"0.17";"3.17";"3.39";"0";"CHEMBL3371146";"Inhibition of human liver cathepsin D using MCA-labeled GKPILFFRLK(Dnp)-D-R-NH2 peptide by fluorescence-based assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351526";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL566011";"";"None";"404.45";"0";"3.24";"54";"COc1ccc(C2(c3cccc(-c4cccnc4F)c3)N=C(N)N(C)C2=O)cc1C";"IC50";"'='";"2580.0";"nM";"5.59";"";"";"UO_0000065";"13.82";"0.25";"2.35";"6.92";"0";"CHEMBL1044551";"Inhibition of human cathepsin D by FRET based peptide cleavage assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156789";"1";"Scientific Literature";"J Med Chem";"2010";"None";"";"";""
"CHEMBL263810";"";"None";"461.40";"1";"7.02";"26";"Cc1cc(NC(=O)c2cc(Cl)cc(Cl)c2O)ccc1Sc1nc2ccccc2s1";"IC50";"'='";"2000.0";"nM";"5.70";"";"";"UO_0000065";"12.35";"0.27";"-1.32";"9.16";"0";"CHEMBL657347";"Inhibitory activity against human liver Cathepsin D using Cathepsin D assay.";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1132101";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1999";"None";"";"";""
"CHEMBL3344165";"";"None";"773.89";"2";"2.81";"47";"CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)OCc1ccccc1)C(=O)N[C@@H](CC(C)C)[C@@H](O)CC(=O)NC1CCCCC1.O=C(O)C(F)(F)F";"IC50";"'='";"447.0";"nM";"6.35";"";"";"UO_0000065";"9.62";"0.18";"3.54";"3.06";"0";"CHEMBL3370435";"Inhibition of human cathepsin D assessed as cleavage of wtKAHRP fluorogenic substrate";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3352063";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL83114";"";"None";"715.49";"2";"9.22";"13";"CCOc1ccc2nc(Sc3ccc(NC(=O)c4cc(Cl)cc(Cl)c4NS(=O)(=O)c4cc(Cl)cc(Cl)c4O)cc3)sc2c1";"IC50";"'='";"250.0";"nM";"6.60";"";"";"UO_0000065";"9.23";"0.21";"-2.62";"5.61";"0";"CHEMBL657347";"Inhibitory activity against human liver Cathepsin D using Cathepsin D assay.";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1132101";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1999";"None";"";"";""
"CHEMBL189901";"";"None";"616.71";"2";"-1.81";"2";"CC(C)C[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CCC(=O)O)C(C)C)[C@@H](O)C[C@@H](C)C(=O)N[C@@H](C)C(=O)O";"IC50";"'='";"98.0";"nM";"7.01";"";"";"UO_0000065";"11.36";"0.22";"8.82";"2.50";"0";"CHEMBL828480";"Inhibitory concentration against human Cathepsin D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1145163";"1";"Scientific Literature";"J Med Chem";"2005";"None";"";"";""
"CHEMBL190058";"";"None";"570.84";"1";"3.00";"50";"CCCCNC(=O)[C@@H]1CCC[C@H]1[C@H](O)[C@H](CC(C)C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(C)C)NC(C)=O";"IC50";"'='";"60.0";"nM";"7.22";"";"";"UO_0000065";"12.65";"0.25";"4.22";"5.29";"0";"CHEMBL828480";"Inhibitory concentration against human Cathepsin D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1145163";"1";"Scientific Literature";"J Med Chem";"2005";"None";"";"";""
"CHEMBL561838";"";"None";"470.60";"0";"1.86";"27";"CCc1cn2c3c(cc(C(=O)N[C@@H](Cc4ccccc4)[C@H](O)CNC)cc13)N(C)S(=O)(=O)C2";"IC50";"'='";"6610.0";"nM";"5.18";"";"";"UO_0000065";"11.01";"0.21";"3.32";"5.00";"0";"CHEMBL1035560";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1158445";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL191129";"";"None";"683.96";"2";"2.32";"45";"CCCCNC(=O)[C@@H](NC(=O)[C@@H]1CC(=O)C[C@H]1[C@H](O)[C@H](CC(C)C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(C)C)NC(C)=O)C(C)C";"IC50";"'='";"56.0";"nM";"7.25";"";"";"UO_0000065";"10.60";"0.21";"4.93";"3.97";"0";"CHEMBL828480";"Inhibitory concentration against human Cathepsin D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1145163";"1";"Scientific Literature";"J Med Chem";"2005";"None";"";"";""
"CHEMBL439671";"";"None";"684.99";"2";"1.90";"53";"CCCCNC(=O)[C@@H](NC(=O)[C@@H]1CN(C)C[C@H]1[C@H](O)[C@H](CC(C)C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(C)C)NC(C)=O)C(C)C";"IC50";"'='";"1230.0";"nM";"5.91";"";"";"UO_0000065";"8.63";"0.17";"4.01";"3.50";"0";"CHEMBL828480";"Inhibitory concentration against human Cathepsin D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1145163";"1";"Scientific Literature";"J Med Chem";"2005";"None";"";"";""
"CHEMBL553938";"";"None";"576.72";"1";"4.17";"32";"CCc1cn2c3c(cc(C(=O)N[C@@H](Cc4ccccc4)[C@H](O)CNc4ccc(OC)cc4)cc13)NS(=O)(=O)CCC2";"IC50";"'='";"1570.0";"nM";"5.80";"";"";"UO_0000065";"10.06";"0.19";"1.63";"4.77";"0";"CHEMBL1035560";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1158445";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL213373";"";"None";"507.63";"2";"5.95";"15";"CCCCCCCCNC(=O)COc1ccc2ccccc2c1C(=O)c1cc(OC)c(OC)c(OC)c1";"IC50";"'='";"8900.0";"nM";"5.05";"";"";"UO_0000065";"9.95";"0.19";"-0.90";"6.08";"0";"CHEMBL869858";"Inhibition of human cathepsin D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149516";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"None";"";"";""
"CHEMBL213136";"";"None";"422.43";"0";"4.12";"13";"COc1cc(C(=O)c2c(OC/C=C/C(=O)O)ccc3ccccc23)cc(OC)c1OC";"IC50";"'>'";"1000000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL869858";"Inhibition of human cathepsin D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149516";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"None";"";"";""
"CHEMBL521636";"";"None";"413.86";"1";"5.33";"2";"CC(=O)c1c(Nc2ccc(C(C)(C)C)cc2)[nH]c2c(Cl)cc([N+](=O)[O-])cc2c1=O";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1021961";"Inhibition of human liver cathepsin D after 30 mins by fluorometric end-point assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138527";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL491348";"";"None";"426.64";"1";"5.34";"6";"CC(=O)c1c(Nc2ccc(Cl)cc2Cl)[nH]c2c([N+](=O)[O-])cc(Cl)cc2c1=O";"IC50";"'='";"42.0";"nM";"7.38";"";"";"UO_0000065";"17.29";"0.37";"2.04";"7.02";"0";"CHEMBL1021961";"Inhibition of human liver cathepsin D after 30 mins by fluorometric end-point assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138527";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL471915";"";"None";"416.09";"1";"6.09";"11";"CC(=O)c1c(Nc2ccc(Cl)cc2Cl)[nH]c2c(Cl)ccc(Cl)c2c1=O";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1021961";"Inhibition of human liver cathepsin D after 30 mins by fluorometric end-point assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138527";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL523822";"";"None";"484.58";"1";"5.96";"17";"CC(=O)c1c(Nc2ccc(Br)cc2Br)[nH]c2c(Cl)ccc(C)c2c1=O";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1021961";"Inhibition of human liver cathepsin D after 30 mins by fluorometric end-point assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138527";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL1760731";"";"None";"387.55";"0";"2.92";"14a";"CC(C)c1cccc(CN[C@H]2CS(=O)(=O)C[C@@H](Cc3ccccc3)[C@@H]2O)c1";"IC50";"'='";"1900.0";"nM";"5.72";"";"";"UO_0000065";"14.76";"0.29";"2.80";"8.62";"0";"CHEMBL1764636";"Inhibition of human cathepsin D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1759891";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL1760732";"";"None";"466.44";"0";"3.68";"14b";"CC(C)c1cccc(CN[C@H]2CS(=O)(=O)C[C@@H](Cc3cccc(Br)c3)[C@@H]2O)c1";"IC50";"'='";"2300.0";"nM";"5.64";"";"";"UO_0000065";"12.09";"0.28";"1.96";"8.49";"0";"CHEMBL1764636";"Inhibition of human cathepsin D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1759891";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL1760733";"";"None";"445.63";"0";"3.71";"14c";"CCCOc1cccc(C[C@@H]2CS(=O)(=O)C[C@H](NCc3cccc(C(C)C)c3)[C@H]2O)c1";"IC50";"'='";"2000.0";"nM";"5.70";"";"";"UO_0000065";"12.79";"0.25";"1.99";"7.54";"0";"CHEMBL1764636";"Inhibition of human cathepsin D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1759891";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL378329";"";"None";"497.55";"1";"5.67";"21";"COc1cc(C(=O)c2c(OC/C=C/C(=O)Nc3ccccc3)ccc3ccccc23)cc(OC)c1OC";"IC50";"'>'";"1000000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL869858";"Inhibition of human cathepsin D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149516";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"None";"";"";""
"CHEMBL214974";"";"None";"477.56";"0";"4.95";"19";"CCCCNC(=O)/C=C/COc1ccc2ccccc2c1C(=O)c1cc(OC)c(OC)c(OC)c1";"IC50";"'='";"140.0";"nM";"6.85";"";"";"UO_0000065";"14.35";"0.27";"1.90";"8.25";"0";"CHEMBL869858";"Inhibition of human cathepsin D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149516";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"None";"";"";""
"CHEMBL273264";"NAFAMOSTAT";"3.0";"347.38";"0";"2.65";"69 (FUT-175)";"N=C(N)Nc1ccc(C(=O)Oc2ccc3cc(C(=N)N)ccc3c2)cc1";"IC50";"'>'";"1000000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL657350";"Inhibitory concentration against cathepsin";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133572";"1";"Scientific Literature";"J Med Chem";"2000";"None";"";"";""
"CHEMBL2408748";"";"None";"476.52";"0";"3.00";"37, epimeric mixture";"CC(=O)N[C@@H](Cc1cc(F)cc(F)c1)[C@H](O)CN[C@H]1CCOc2ccc(OC3CCCO3)cc21";"IC50";"'='";"286.0";"nM";"6.54";"";"";"UO_0000065";"13.73";"0.26";"3.54";"7.35";"0";"CHEMBL2410948";"Inhibition of cathepsin-D (unknown origin) using C-terminal biotinylated peptide substrate treated 30 mins before addition of peptide substrate measured after 110 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2406984";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"None";"";"";""
"CHEMBL3344152";"";"None";"628.65";"2";"-2.47";"11";"CC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)[C@@H](O)CC(=O)N[C@@H](C)C(N)=O.O=C(O)C(F)(F)F";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3370435";"Inhibition of human cathepsin D assessed as cleavage of wtKAHRP fluorogenic substrate";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3352063";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL3344166";"";"None";"773.89";"2";"2.81";"48";"CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)OCc1ccccc1)C(=O)N[C@@H](CC(C)C)[C@@H](O)CC(=O)NC1CCCCC1.O=C(O)C(F)(F)F";"IC50";"'='";"5100.0";"nM";"5.29";"";"";"UO_0000065";"8.02";"0.15";"2.48";"2.55";"0";"CHEMBL3370435";"Inhibition of human cathepsin D assessed as cleavage of wtKAHRP fluorogenic substrate";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3352063";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL378225";"";"None";"578.74";"1";"3.03";"page no 6665, R22C2";"C[C@@H](NC(=O)c1cc(C(=O)N[C@@H](Cc2ccccc2)[C@H](O)CNC2CC2)cc(N(C)S(C)(=O)=O)c1)c1ccccc1";"IC50";"'='";"7620.0";"nM";"5.12";"";"";"UO_0000065";"8.84";"0.17";"2.09";"4.00";"0";"CHEMBL2445100";"Inhibition of human cathepsin D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2440003";"1";"Scientific Literature";"Bioorg Med Chem";"2013";"None";"";"";""
"CHEMBL170320";"";"None";"358.50";"1";"5.78";"19";"CC(C)CC(SC1CCCC1)c1c(O)cc(-c2ccccc2)oc1=O";"IC50";"'>'";"40000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL657343";"Ability to inhibit the human Native cathepsin D aspartic protease enzyme";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1128706";"1";"Scientific Literature";"J Med Chem";"1995";"None";"";"";""
"CHEMBL272766";"";"None";"472.59";"0";"3.95";"41";"Cc1nnc(CN/C(N)=N\C(=O)Cn2c(-c3ccccc3)ccc2C23CC4CC(CC(C4)C2)C3)o1";"IC50";"'='";"3010.0";"nM";"5.52";"";"";"UO_0000065";"11.68";"0.22";"1.57";"4.96";"0";"CHEMBL930552";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1142260";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";"";"";""
"CHEMBL567893";"GRASSYSTATIN A";"None";"1174.44";"None";"None";"1";"COC(=O)[C@@H]1CCCN1C(=O)[C@@H](Cc1ccccc1)N(C)C(=O)[C@H](C)NC(=O)[C@@H](NC(=O)C[C@H](O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](OC(=O)[C@@H](OC(=O)[C@H](C(C)C)N(C)C)C(C)C)C(C)C)[C@@H](C)O";"IC50";"'='";"26.5";"nM";"7.58";"";"";"UO_0000065";"6.45";"None";"None";"None";"0";"CHEMBL1043695";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156023";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL1257772";"";"None";"486.65";"1";"5.43";"11";"CC(=O)N[C@@H](Cc1cc(F)cc(F)c1)[C@H](O)CNC1(c2cc(C)cc(C(C)(C)C)c2)CCCCC1";"IC50";"'='";"67.0";"nM";"7.17";"";"";"UO_0000065";"14.74";"0.28";"1.74";"11.69";"0";"CHEMBL1260849";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1255191";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL1258575";"";"None";"446.56";"0";"3.86";"28";"C#Cc1csc(C2(NC[C@@H](O)[C@H](Cc3cc(F)cc(F)c3)NC(C)=O)CCCCC2)c1";"IC50";"'='";"276.0";"nM";"6.56";"";"";"UO_0000065";"14.69";"0.29";"2.70";"10.69";"0";"CHEMBL1260849";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1255191";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL1257894";"";"None";"451.58";"0";"3.70";"65";"CC(=O)N[C@@H](Cc1cc(F)cc(F)c1)[C@H](O)CNC1(c2csc(CC(C)(C)C)n2)CC1";"IC50";"'='";"1950.0";"nM";"5.71";"";"";"UO_0000065";"12.64";"0.25";"2.01";"7.69";"0";"CHEMBL1260849";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1255191";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL2425599";"";"None";"574.68";"1";"4.66";"17e";"COC[C@@H](Oc1cc(C[C@@H]2C[S@@+]([O-])C[C@H](N[C@H](C)c3cccc(C(C)(C)C)c3)[C@H]2O)cc(F)c1N)C(F)(F)F";"IC50";"'='";"750.0";"nM";"6.12";"";"";"UO_0000065";"10.66";"0.21";"1.46";"6.14";"0";"CHEMBL2427050";"Inhibition of human cathepsin-D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2424550";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"None";"";"";""
"CHEMBL2425612";"";"None";"560.65";"1";"4.10";"11d";"COC[C@@H](Oc1cc(C[C@@H]2C[S@@+]([O-])C[C@H](NCc3cccc(C(C)(C)C)c3)[C@H]2O)cc(F)c1N)C(F)(F)F";"IC50";"'='";"820.0";"nM";"6.09";"";"";"UO_0000065";"10.86";"0.22";"1.99";"6.10";"0";"CHEMBL2427050";"Inhibition of human cathepsin-D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2424550";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"None";"";"";""
"CHEMBL2031143";"";"None";"515.65";"1";"4.64";"37";"CC(=O)N[C@@H](Cc1ccc(F)c(F)c1)[C@H](O)CN[C@H]1C[C@]2(C[C@H](C)C2)Oc2ncc(CC(C)(C)C)cc21";"IC50";"'='";"17.0";"nM";"7.77";"";"";"UO_0000065";"15.07";"0.29";"3.13";"9.31";"0";"CHEMBL2033077";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2029322";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL2408762";"";"None";"416.51";"0";"3.60";"3";"CCc1ccc2c(c1)[C@@H](NC[C@@H](O)[C@H](Cc1cc(F)cc(F)c1)NC(C)=O)CCC2";"IC50";"'='";"126.0";"nM";"6.90";"";"";"UO_0000065";"16.57";"0.31";"3.30";"11.24";"0";"CHEMBL2410948";"Inhibition of cathepsin-D (unknown origin) using C-terminal biotinylated peptide substrate treated 30 mins before addition of peptide substrate measured after 110 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2406984";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"None";"";"";""
"CHEMBL2408742";"";"None";"464.53";"0";"3.78";"30";"CC(=O)N[C@@H](Cc1cc(F)cc(F)c1)[C@H](O)CN[C@H]1CCOc2ccc(CC(C)(C)F)cc21";"IC50";"'='";"80.0";"nM";"7.10";"";"";"UO_0000065";"15.28";"0.29";"3.32";"10.05";"0";"CHEMBL2410948";"Inhibition of cathepsin-D (unknown origin) using C-terminal biotinylated peptide substrate treated 30 mins before addition of peptide substrate measured after 110 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2406984";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"None";"";"";""
"CHEMBL2408765";"";"None";"444.57";"0";"4.34";"6";"CC(=O)N[C@@H](Cc1cc(F)cc(F)c1)[C@H](O)CN[C@H]1CCCc2ccc(C(C)(C)C)cc21";"IC50";"'='";"74.0";"nM";"7.13";"";"";"UO_0000065";"16.04";"0.30";"2.79";"11.62";"0";"CHEMBL2410948";"Inhibition of cathepsin-D (unknown origin) using C-terminal biotinylated peptide substrate treated 30 mins before addition of peptide substrate measured after 110 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2406984";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"None";"";"";""
"CHEMBL2408755";"";"None";"486.60";"0";"4.61";"50, epimeric mixture";"CC(=O)N[C@@H](Cc1cc(F)cc(F)c1)[C@H](O)CN[C@H]1CC2(CC2)Oc2ccc(CC(C)(C)C)cc21";"IC50";"'='";"6.0";"nM";"8.22";"";"";"UO_0000065";"16.90";"0.32";"3.61";"11.65";"0";"CHEMBL2410948";"Inhibition of cathepsin-D (unknown origin) using C-terminal biotinylated peptide substrate treated 30 mins before addition of peptide substrate measured after 110 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2406984";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"None";"";"";""
"CHEMBL572313";"";"None";"484.55";"0";"2.85";"9, mixture of epimers";"CC(=O)N[C@@H](Cc1cc(F)cc(F)c1)[C@H](O)CNC1(c2cccc(-n3cccn3)c2)CCCOC1";"IC50";"'='";"170.0";"nM";"6.77";"";"";"UO_0000065";"13.97";"0.26";"3.92";"7.66";"0";"CHEMBL1045212";"Inhibition of cathepsin D assessed as reduction in polarization after 110 mins by oregon green based fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156090";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL584936";"";"None";"516.63";"1";"3.33";"14";"CC(=O)N[C@@H](Cc1cc(F)cc(F)c1)[C@H](O)CNC1(c2cccc(C(C)(C)C)c2)CCN(C(N)=O)CC1";"IC50";"'='";"4300.0";"nM";"5.37";"";"";"UO_0000065";"10.39";"0.20";"2.04";"4.98";"0";"CHEMBL1045212";"Inhibition of cathepsin D assessed as reduction in polarization after 110 mins by oregon green based fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156090";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL570165";"";"None";"607.74";"2";"5.59";"20, mixture of epimers";"CC(=O)N[C@@H](Cc1cc(F)cc(F)c1)[C@H](O)CNC1(c2cccc(C(C)(C)C)c2)CCCN(C(=O)OCc2ccccc2)C1";"IC50";"'='";"3.3";"nM";"8.48";"";"";"UO_0000065";"13.96";"0.26";"2.89";"9.33";"0";"CHEMBL1045212";"Inhibition of cathepsin D assessed as reduction in polarization after 110 mins by oregon green based fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156090";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL570745";"";"None";"488.62";"0";"4.09";"33";"CC(=O)N[C@@H](Cc1cc(F)cc(F)c1)[C@H](O)CN[C@]1(c2cccc(C(C)(C)C)c2)CC[C@@H](O)CC1";"IC50";"'='";"1400.0";"nM";"5.85";"";"";"UO_0000065";"11.98";"0.23";"1.76";"7.17";"0";"CHEMBL1045212";"Inhibition of cathepsin D assessed as reduction in polarization after 110 mins by oregon green based fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156090";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL569608";"";"None";"519.70";"1";"4.23";"38";"CS[C@H]1CC[C@@](NC[C@@H](O)[C@H](Cc2cc(F)cc(F)c2)NC(C)=O)(c2cccc(C(C)(C)C)c2)CN1";"IC50";"'='";"84.0";"nM";"7.08";"";"";"UO_0000065";"13.62";"0.27";"2.85";"9.64";"0";"CHEMBL1045212";"Inhibition of cathepsin D assessed as reduction in polarization after 110 mins by oregon green based fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156090";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL533064";"";"None";"524.69";"1";"2.83";"39";"CCc1cn2c3c(cc(C(=O)N[C@@H](Cc4ccccc4)[C@H](O)CNC4CC4)cc13)N(CC)S(=O)(=O)CC2";"IC50";"'='";"12300.0";"nM";"4.91";"";"";"UO_0000065";"9.36";"0.18";"2.08";"4.74";"0";"CHEMBL1035560";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1158445";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL561961";"";"None";"552.74";"1";"3.61";"26";"CCc1cn2c3c(cc(C(=O)N[C@@H](Cc4ccccc4)[C@H](O)CNC4CCCCC4)cc13)N(C)S(=O)(=O)CC2";"IC50";"'='";"660.0";"nM";"6.18";"";"";"UO_0000065";"11.18";"0.22";"2.57";"5.96";"0";"CHEMBL1035560";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1158445";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL3707011";"";"None";"645.75";"1";"3.62";"10";"CCN1CCN2CCS(=O)(=O)N(C)c3cc(C(=O)N[C@@H](Cc4ccccc4)[C@H](O)CNCc4cccc(C(F)(F)F)c4)cc1c32";"IC50";"'='";"2240.0";"nM";"5.65";"";"";"UO_0000065";"8.75";"0.17";"2.03";"5.37";"0";"CHEMBL1035560";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1158445";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL567259";"";"None";"456.42";"0";"3.69";"57";"COc1ncccc1-c1cccc(C2(c3ccc(OC(F)(F)F)cc3)N=C(N)N(C)C2=O)c1";"IC50";"'='";"2050.0";"nM";"5.69";"";"";"UO_0000065";"12.46";"0.24";"2.00";"6.32";"0";"CHEMBL1044551";"Inhibition of human cathepsin D by FRET based peptide cleavage assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156789";"1";"Scientific Literature";"J Med Chem";"2010";"None";"";"";""
"CHEMBL461606";"";"None";"487.75";"0";"3.49";"1";"CCCCNC(=O)[C@H](C)C[C@H](O)[C@H](CC(C)C)NC(=O)[C@H](CCSC)NC(=O)CCC(C)C";"IC50";"'='";"370.0";"nM";"6.43";"";"";"UO_0000065";"13.19";"0.27";"2.94";"5.98";"1";"CHEMBL1030363";"Inhibition of human cathepsin D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1151821";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL562554";"";"None";"484.62";"0";"1.90";"28";"CCc1cn2c3c(cc(C(=O)N[C@@H](Cc4ccccc4)[C@H](O)CNC)cc13)N(C)S(=O)(=O)CC2";"IC50";"'='";"58880.0";"nM";"4.23";"";"";"UO_0000065";"8.73";"0.17";"2.33";"4.08";"0";"CHEMBL1035560";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1158445";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL1270834";"";"None";"429.44";"0";"3.92";"101";"CCCC#Cc1cc([C@@]2(c3ccc(OC(F)F)c(C)c3)N=C(N)N(C)C2=O)ccc1F";"IC50";"'='";"2120.0";"nM";"5.67";"";"";"UO_0000065";"13.21";"0.25";"1.75";"8.35";"0";"CHEMBL1273977";"Inhibition of cathepsin D by FRET assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1268920";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL2059626";"";"None";"366.48";"0";"4.52";"E10T9";"Oc1ccc(SCC(O)COc2ccc(Cc3ccccc3)cc2)cc1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL2061980";"Inhibition of cathepsin D by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2057073";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL2058870";"";"None";"381.50";"1";"6.31";"5";"O=C(CSc1ccc2ccccc2c1)Cn1c2ccccc2c2ccccc21";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL2061980";"Inhibition of cathepsin D by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2057073";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL3414705";"";"None";"270.30";"0";"1.87";"24a";"NC1=N[C@@]2(c3ccc(F)cc3F)COC[C@H]2CS1";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3420009";"Inhibition of CatD (unknown origin) by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3414451";"1";"Scientific Literature";"J Med Chem";"2015";"None";"";"";""
"CHEMBL192836";"";"None";"641.92";"2";"2.50";"46";"CCCCNC(=O)[C@H](C)NC(=O)[C@@H]1CCC[C@H]1[C@H](O)[C@H](CC(C)C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(C)C)NC(C)=O";"IC50";"'<'";"10.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL828480";"Inhibitory concentration against human Cathepsin D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1145163";"1";"Scientific Literature";"J Med Chem";"2005";"None";"";"";""
"CHEMBL3321934";"";"None";"566.64";"1";"2.86";"33";"COc1ccc(CC(=O)NC(=N)N[C@H](CC2CCCCC2)C(=O)NCc2ccc(-c3nnn[nH]3)c(F)c2)cc1OC";"IC50";"'='";"81.0";"nM";"7.09";"";"";"UO_0000065";"12.52";"0.24";"4.23";"4.25";"0";"CHEMBL3371146";"Inhibition of human liver cathepsin D using MCA-labeled GKPILFFRLK(Dnp)-D-R-NH2 peptide by fluorescence-based assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351526";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL561217";"";"None";"510.66";"1";"2.80";"33";"CCc1cn2c3c(cc(C(=O)N[C@@H](Cc4ccccc4)[C@H](O)CNC4CC4)cc13)NS(=O)(=O)CCC2";"IC50";"'='";"2900.0";"nM";"5.54";"";"";"UO_0000065";"10.84";"0.21";"2.74";"4.92";"0";"CHEMBL1035560";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1158445";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL2408743";"";"None";"468.49";"0";"3.68";"31";"CC(=O)N[C@@H](Cc1cc(F)cc(F)c1)[C@H](O)CN[C@H]1CCOc2ccc(CC(C)(F)F)cc21";"IC50";"'='";"144.0";"nM";"6.84";"";"";"UO_0000065";"14.60";"0.28";"3.16";"9.69";"0";"CHEMBL2410948";"Inhibition of cathepsin-D (unknown origin) using C-terminal biotinylated peptide substrate treated 30 mins before addition of peptide substrate measured after 110 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2406984";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"None";"";"";""
"CHEMBL2425603";"";"None";"562.63";"1";"3.59";"17j";"COC[C@@H](Oc1cc(C[C@@H]2C[S@@+]([O-])C[C@H](NCc3cccc(OC(C)C)c3)[C@H]2O)cc(F)c1N)C(F)(F)F";"IC50";"'='";"780.0";"nM";"6.11";"";"";"UO_0000065";"10.86";"0.22";"2.52";"5.60";"0";"CHEMBL2427050";"Inhibition of human cathepsin-D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2424550";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"None";"";"";""
"CHEMBL2425614";"";"None";"434.58";"0";"2.85";"20";"CC(C)(C)c1cccc(CN[C@H]2C[S@+]([O-])C[C@@H](Cc3cc(O)c(N)c(F)c3)[C@@H]2O)c1";"IC50";"'='";"1780.0";"nM";"5.75";"";"";"UO_0000065";"13.23";"0.26";"2.90";"5.66";"0";"CHEMBL2427050";"Inhibition of human cathepsin-D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2424550";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"None";"";"";""
"CHEMBL3344155";"";"None";"612.21";"2";"2.26";"17";"CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCN)NC(=O)OCc1ccccc1)[C@@H](O)CC(=O)NC1CCCCC1.Cl";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3370435";"Inhibition of human cathepsin D assessed as cleavage of wtKAHRP fluorogenic substrate";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3352063";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL3344263";"";"None";"753.82";"2";"1.69";"53";"CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)OCc1ccccc1)[C@@H](O)CC(=O)NCCc1ccccc1.O=C(O)C(F)(F)F";"IC50";"'='";"29000.0";"nM";"4.54";"";"";"UO_0000065";"7.09";"0.13";"2.85";"2.18";"0";"CHEMBL3370435";"Inhibition of human cathepsin D assessed as cleavage of wtKAHRP fluorogenic substrate";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3352063";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL3344270";"";"None";"759.85";"2";"0.74";"72";"CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NS(=O)(=O)c1ccccc1)[C@@H](O)CC(=O)NCCc1ccccc1.O=C(O)C(F)(F)F";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3370435";"Inhibition of human cathepsin D assessed as cleavage of wtKAHRP fluorogenic substrate";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3352063";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL83993";"";"None";"490.44";"1";"6.99";"8";"CCOc1ccc2nc(Sc3ccc(NC(=O)c4cc(Cl)cc(Cl)c4N)cc3)sc2c1";"IC50";"'='";"5500.0";"nM";"5.26";"";"";"UO_0000065";"10.72";"0.23";"-1.73";"6.81";"0";"CHEMBL657347";"Inhibitory activity against human liver Cathepsin D using Cathepsin D assay.";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1132101";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1999";"None";"";"";""
"CHEMBL569445";"GRASSYSTATIN C";"None";"987.25";"3";"1.18";"3";"CC[C@H](C)[C@H](NC(=O)C[C@H](O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)N(C)C(=O)[C@H](CC(C)C)NC(=O)[C@H](O)[C@@H](C)CC)C(=O)NCC(=O)N(C)[C@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)OC";"IC50";"'='";"1620.0";"nM";"5.79";"";"";"UO_0000065";"5.87";"0.11";"4.61";"2.02";"0";"CHEMBL1043695";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156023";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL1270934";"";"None";"369.37";"0";"2.69";"58";"CC#Cc1cccc([C@@]2(c3ccc(OC(F)F)cc3)N=C(N)N(C)C2=O)c1";"IC50";"'='";"4120.0";"nM";"5.38";"";"";"UO_0000065";"14.58";"0.27";"2.70";"7.93";"0";"CHEMBL1273977";"Inhibition of cathepsin D by FRET assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1268920";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL3394048";"";"None";"467.45";"0";"4.21";"19";"NC1=N[C@@]2(CO1)c1cc(-c3cccnc3F)ccc1Oc1cnc(N3CCC(F)(F)CC3)cc12";"IC50";"'='";"140.0";"nM";"6.85";"";"";"UO_0000065";"14.66";"0.28";"2.64";"7.98";"0";"CHEMBL3395116";"Inhibition of cathepsin D (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3393054";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";""
"CHEMBL3394049";"";"None";"453.42";"0";"3.82";"20";"NC1=N[C@@]2(CO1)c1cc(-c3cccnc3F)ccc1Oc1cnc(N3CCC(F)(F)C3)cc12";"IC50";"'='";"440.0";"nM";"6.36";"";"";"UO_0000065";"14.02";"0.26";"2.54";"7.40";"0";"CHEMBL3395116";"Inhibition of cathepsin D (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3393054";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";""
"CHEMBL570519";"";"None";"516.63";"1";"3.33";"22, mixture of epimers";"CC(=O)N[C@@H](Cc1cc(F)cc(F)c1)[C@H](O)CNC1(c2cccc(C(C)(C)C)c2)CCCN(C(N)=O)C1";"IC50";"'='";"90.0";"nM";"7.05";"";"";"UO_0000065";"13.64";"0.26";"3.72";"6.54";"0";"CHEMBL1045212";"Inhibition of cathepsin D assessed as reduction in polarization after 110 mins by oregon green based fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156090";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL1272322";"";"None";"409.49";"0";"4.30";"A18, JJCA-140";"COc1ccc2cc(-c3cn(C[C@@H]4Cc5c([nH]c6ccccc56)CN4)nn3)ccc2c1";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1273321";"Inhibition of human recombinant Cathepsin D by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1268999";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL569609";"";"None";"502.65";"1";"4.34";"34";"CC(=O)N[C@@H](Cc1cc(F)cc(F)c1)[C@H](O)CN[C@]1(c2cccc(C(C)(C)C)c2)CC[C@@H](CO)CC1";"IC50";"'='";"330.0";"nM";"6.48";"";"";"UO_0000065";"12.89";"0.25";"2.14";"7.94";"0";"CHEMBL1045212";"Inhibition of cathepsin D assessed as reduction in polarization after 110 mins by oregon green based fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156090";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL583034";"";"None";"504.62";"2";"2.84";"44";"CC(=O)N[C@@H](Cc1cc(F)cc(F)c1)[C@H](O)CN[C@@]1(c2cccc(C(C)(C)C)c2)CC[C@H](NO)NC1";"IC50";"'='";"3900.0";"nM";"5.41";"";"";"UO_0000065";"10.72";"0.21";"2.57";"5.12";"0";"CHEMBL1045212";"Inhibition of cathepsin D assessed as reduction in polarization after 110 mins by oregon green based fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156090";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL403429";"";"None";"568.64";"1";"4.76";"6";"CCNc1cc(C(=O)N[C@@H](Cc2ccccc2)[C@H](O)CNCc2cccc(C(F)(F)F)c2)cc(N2CCCC2=O)c1";"IC50";"'='";"6580.0";"nM";"5.18";"";"";"UO_0000065";"9.11";"0.17";"0.42";"5.53";"0";"CHEMBL1036847";"Inhibition of cathepsin-D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1137769";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL212787";"";"None";"396.40";"0";"3.56";"12";"COc1cc(C(=O)c2c(OCC(=O)O)ccc3ccccc23)cc(OC)c1OC";"IC50";"'='";"60.0";"nM";"7.22";"";"";"UO_0000065";"18.22";"0.34";"3.66";"7.91";"0";"CHEMBL869858";"Inhibition of human cathepsin D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149516";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"None";"";"";""
"CHEMBL571860";"";"None";"472.62";"1";"5.12";"1";"CC(=O)N[C@@H](Cc1cc(F)cc(F)c1)[C@H](O)CNC1(c2cccc(C(C)(C)C)c2)CCCCC1";"IC50";"'='";"24.0";"nM";"7.62";"";"";"UO_0000065";"16.12";"0.31";"2.50";"12.42";"0";"CHEMBL1260849";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1255191";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL1258120";"";"None";"551.52";"2";"5.88";"17";"CC(=O)N[C@@H](Cc1cc(F)cc(F)c1)[C@H](O)CNC1(c2ccc(Br)c(C(C)(C)C)c2)CCCCC1";"IC50";"'='";"1500.0";"nM";"5.82";"";"";"UO_0000065";"10.56";"0.23";"-0.06";"9.49";"0";"CHEMBL1260849";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1255191";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL1258353";"";"None";"464.62";"1";"5.01";"26";"CC(=O)N[C@@H](Cc1cc(F)cc(F)c1)[C@H](O)CNC1(c2cc(C(C)C)cs2)CCCCC1";"IC50";"'='";"40.0";"nM";"7.40";"";"";"UO_0000065";"15.92";"0.32";"2.39";"12.06";"0";"CHEMBL1260849";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1255191";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL1258687";"";"None";"477.60";"0";"4.40";"33";"CC(=O)N[C@@H](Cc1cc(F)cc(F)c1)[C@H](O)CNC1(c2cc(CC(C)(C)C)no2)CCCCC1";"IC50";"'='";"14.0";"nM";"7.85";"";"";"UO_0000065";"16.44";"0.32";"3.45";"8.99";"0";"CHEMBL1260849";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1255191";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL1258802";"";"None";"463.57";"0";"4.11";"49";"CC(=O)N[C@@H](Cc1cc(F)cc(F)c1)[C@H](O)CNC1(c2ncc(C(C)(C)C)o2)CCCCC1";"IC50";"'='";"310.0";"nM";"6.51";"";"";"UO_0000065";"14.04";"0.27";"2.40";"7.45";"0";"CHEMBL1260849";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1255191";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL4581955";"";"None";"554.74";"2";"7.09";"64";"c1ccc2cc(COC3C4CCC(N4)C3Oc3ccc(OCCSc4nc5ccccc5s4)cc3)ccc2c1";"IC50";"'='";"15000.0";"nM";"4.82";"";"";"UO_0000065";"8.70";"0.17";"-2.27";"9.17";"0";"CHEMBL4357658";"Inhibition of human cathepsin D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4354841";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";""
"CHEMBL599965";"";"None";"271.36";"0";"2.25";"2b";"CN1C(=O)C(c2ccccc2)(C2CCCCC2)N=C1N";"IC50";"'='";"24000.0";"nM";"4.62";"";"";"UO_0000065";"17.02";"0.32";"2.37";"7.87";"0";"CHEMBL1042917";"Inhibition of human cathepsin D by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1153180";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL2058873";"";"None";"451.64";"1";"6.01";"8";"c1ccc2cc(SCC(Cn3c4ccccc4c4ccccc43)N3CCNCC3)ccc2c1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL2061980";"Inhibition of cathepsin D by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2057073";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL2059102";"";"None";"376.55";"1";"6.24";"13";"OC(CSc1ccc2ccccc2c1)CSc1ccc2ccccc2c1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL2061980";"Inhibition of cathepsin D by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2057073";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL523193";"";"None";"510.66";"1";"2.44";"8e";"CCc1cn2c3c(cc(C(=O)N[C@@H](Cc4ccccc4)[C@H](O)CNC4CC4)cc13)N(C)S(=O)(=O)CC2";"IC50";"'='";"7933.0";"nM";"5.10";"";"";"UO_0000065";"9.99";"0.19";"2.66";"4.92";"0";"CHEMBL959767";"Inhibition of cathepsin D expressed in CHO cells after 1 hrs by spectrophotometer";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1150334";"1";"Scientific Literature";"J Med Chem";"2008";"CHEMBL3308072";"";"";""
"CHEMBL504197";"";"None";"598.77";"1";"3.61";"8c";"CCc1cn2c3c(cc(C(=O)N[C@@H](Cc4ccccc4)[C@H](O)CNC4CCCCC4)cc13)N(C)S(=O)(=O)CC2.O=CO";"IC50";"'='";"1000.0";"nM";"6.00";"";"";"UO_0000065";"10.86";"0.21";"2.39";"5.79";"0";"CHEMBL959767";"Inhibition of cathepsin D expressed in CHO cells after 1 hrs by spectrophotometer";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1150334";"1";"Scientific Literature";"J Med Chem";"2008";"CHEMBL3308072";"";"";""
"CHEMBL567477";"";"None";"422.44";"0";"3.37";"(S)-55";"COc1ccc([C@@]2(c3ccc(F)c(-c4cccnc4F)c3)N=C(N)N(C)C2=O)cc1C";"IC50";"'='";"820.0";"nM";"6.09";"";"";"UO_0000065";"14.41";"0.27";"2.72";"7.53";"0";"CHEMBL1044551";"Inhibition of human cathepsin D by FRET based peptide cleavage assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156789";"1";"Scientific Literature";"J Med Chem";"2010";"None";"";"";""
"CHEMBL1760855";"";"None";"447.60";"0";"2.16";"20b";"CC(C)c1cccc(CN[C@H]2CS(=O)(=O)C[C@@H](Cc3ccc(O)c(CCO)c3)[C@@H]2O)c1";"IC50";"'='";"1700.0";"nM";"5.77";"";"";"UO_0000065";"12.89";"0.25";"3.61";"5.40";"0";"CHEMBL1764636";"Inhibition of human cathepsin D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1759891";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL2177313";"";"None";"346.39";"0";"2.74";"4";"COc1ccc(C2(c3cccc(-c4cncnc4)c3)COC(N)=N2)cc1";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2183109";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2177044";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL490495";"";"None";"439.64";"0";"3.19";"3e";"CCCCNC(=O)[C@H](C)C[C@H](O)[C@@H]1CCCCCCCCCCC(=O)N[C@@H](C)C(=O)N1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL963292";"Inhibition of human cathepsin D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1153267";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL3344164";"";"None";"759.87";"2";"2.42";"46";"CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)OCc1ccccc1)C(C)C)[C@@H](O)CC(=O)NC1CCCCC1.O=C(O)C(F)(F)F";"IC50";"'='";"713.0";"nM";"6.15";"";"";"UO_0000065";"9.52";"0.18";"3.73";"2.96";"0";"CHEMBL3370435";"Inhibition of human cathepsin D assessed as cleavage of wtKAHRP fluorogenic substrate";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3352063";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL3344266";"";"None";"788.27";"2";"2.34";"56";"CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)OCc1ccccc1)[C@@H](O)CC(=O)NCCc1ccc(Cl)cc1.O=C(O)C(F)(F)F";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3370435";"Inhibition of human cathepsin D assessed as cleavage of wtKAHRP fluorogenic substrate";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3352063";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL3344261";"";"None";"807.91";"2";"3.00";"49";"CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)OCc1ccccc1)[C@@H](O)CC(=O)NC1CCCCC1.O=C(O)C(F)(F)F";"IC50";"'='";"4800.0";"nM";"5.32";"";"";"UO_0000065";"7.67";"0.15";"2.32";"2.56";"0";"CHEMBL3370435";"Inhibition of human cathepsin D assessed as cleavage of wtKAHRP fluorogenic substrate";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3352063";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL3344271";"";"None";"773.88";"2";"0.88";"73";"CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NS(=O)(=O)Cc1ccccc1)[C@@H](O)CC(=O)NCCc1ccccc1.O=C(O)C(F)(F)F";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3370435";"Inhibition of human cathepsin D assessed as cleavage of wtKAHRP fluorogenic substrate";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3352063";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL3764518";"";"None";"507.68";"2";"7.08";"rac-4f";"Nc1nc2cc(-c3ccc(CCC4CCCCC4)cc3)ccc2c(=O)n1C[C@@H]1CC[C@H](c2ccccc2)O1";"IC50";"'='";"100000.0";"nM";"4.00";"";"";"UO_0000065";"7.88";"0.14";"-3.08";"5.70";"0";"CHEMBL3767017";"Inhibition of CatD (unknown origin) preincubated for 30 mins followed by DABCYL-Glu-Arg-Nle-Phe-Leu-Ser-Phe-Pro-EDANS substrate addition by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3763050";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";""
"CHEMBL4761356";"";"None";"647.67";"1";"2.16";"4c";"CNS(=O)(=O)c1ccc(C)c(NC(=O)[C@@H](CC(C)C)NC(=N)NC(=O)Cc2ccc(OC)c(OC)c2)c1.O=C(O)C(F)(F)F";"IC50";"'='";"258.0";"nM";"6.59";"";"";"UO_0000065";"12.35";"0.24";"4.43";"4.15";"0";"CHEMBL4706202";"Inhibition of human liver Cathepsin D preincubated for 10 mins followed by substrate addition and further incubated for 2 hrs in dark by fluorimetric analysis";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699662";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"TIME = 2.167 hr";"INHIBITOR";""
"CHEMBL3127069";"";"None";"380.42";"0";"2.08";"94";"CN1C(=O)[C@]2(N=C1N)c1cc(-c3cccnc3F)ccc1C[C@H]1CCOC[C@@H]12";"IC50";"'='";"810.0";"nM";"6.09";"";"";"UO_0000065";"16.01";"0.30";"4.01";"7.54";"0";"CHEMBL3131975";"Inhibition of human liver cathepsin D measured for 1 hr by FRET assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124885";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL455207";"";"None";"467.70";"0";"3.83";"3f";"CCCCNC(=O)[C@H](C)C[C@H](O)[C@@H]1C[C@H](C)CCCCCCCCCC(=O)N[C@@H](C)C(=O)N1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL963292";"Inhibition of human cathepsin D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1153267";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL401067";"";"None";"604.67";"2";"6.47";"3";"CCOc1cc(C(=O)N[C@@H](Cc2ccccc2)[C@H](O)CNCc2cccc(C(F)(F)F)c2)cc(-c2ccccc2C(C)=O)c1";"IC50";"'='";"2940.0";"nM";"5.53";"";"";"UO_0000065";"9.15";"0.17";"-0.94";"6.31";"0";"CHEMBL945838";"Inhibition of Cathepsin D expressed in CHO cells by FRET assay";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140838";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"CHEMBL3308072";"";"";""
"CHEMBL571432";"";"None";"546.66";"1";"3.22";"46";"COC(=O)N[C@H]1CC[C@@](NC[C@@H](O)[C@H](Cc2cc(F)cc(F)c2)NC(C)=O)(c2cccc(C(C)(C)C)c2)CN1";"IC50";"'='";"2000.0";"nM";"5.70";"";"";"UO_0000065";"10.43";"0.20";"2.48";"5.10";"0";"CHEMBL1045212";"Inhibition of cathepsin D assessed as reduction in polarization after 110 mins by oregon green based fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156090";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL565550";"";"None";"565.71";"1";"4.37";"53";"CC(=O)N[C@@H](Cc1cc(F)cc(F)c1)[C@H](O)CN[C@@]1(c2cccc(C(C)(C)C)c2)CC[C@H](Nc2cccnc2)NC1";"IC50";"'='";"9800.0";"nM";"5.01";"";"";"UO_0000065";"8.85";"0.17";"0.64";"5.09";"0";"CHEMBL1045212";"Inhibition of cathepsin D assessed as reduction in polarization after 110 mins by oregon green based fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156090";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL1222240";"";"None";"362.91";"0";"4.31";"14i";"CC[C@@H](CC(=O)NCC1CCCCC1)n1c(N)nc2cc(Cl)ccc21";"IC50";"'='";"42000.0";"nM";"4.38";"";"";"UO_0000065";"12.06";"0.24";"0.07";"6.00";"0";"CHEMBL1227792";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1221253";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL68595";"";"None";"489.62";"1";"5.64";"2";"CCCc1c(OCc2ccc(/C=C3\SC(=S)NC3=O)cc2)ccc(C(=O)c2ccccc2)c1O";"IC50";"'='";"340.0";"nM";"6.47";"";"";"UO_0000065";"13.21";"0.26";"0.83";"8.55";"1";"CHEMBL657347";"Inhibitory activity against human liver Cathepsin D using Cathepsin D assay.";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1132101";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1999";"None";"";"";""
"CHEMBL556747";"";"None";"576.72";"1";"3.44";"21";"CCc1cn2c3c(cc(C(=O)N[C@@H](Cc4ccccc4)[C@H](O)CNCc4cccc(OC)c4)cc13)N(C)S(=O)(=O)C2";"IC50";"'='";"1000.0";"nM";"6.00";"";"";"UO_0000065";"10.40";"0.20";"2.56";"5.31";"0";"CHEMBL1035560";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1158445";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL1269840";"";"None";"484.55";"0";"2.85";"6";"CC(=O)N[C@@H](Cc1cc(F)cc(F)c1)[C@H](O)CNC1(c2cccc(-n3cccn3)c2)CCOCC1";"IC50";"'='";"160.0";"nM";"6.80";"";"";"UO_0000065";"14.03";"0.27";"3.95";"7.69";"0";"CHEMBL1274834";"Inhibition of cathepsin-D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1268878";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL1209106";"";"None";"486.60";"0";"4.33";"5";"CC(=O)N[C@@H](Cc1cc(F)cc(F)c1)[C@H](O)CNC1(c2cccc(C3CCOC3)c2)CCCCC1";"IC50";"'='";"140.0";"nM";"6.85";"";"";"UO_0000065";"14.09";"0.27";"2.52";"9.71";"0";"CHEMBL1274834";"Inhibition of cathepsin-D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1268878";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL69180";"";"None";"534.62";"1";"4.74";"27";"CCCc1c(OCc2ccc(/C=C3\SC(=S)NC3=O)cc2)ccc(C(=O)c2cncc(C(=O)O)c2)c1O";"IC50";"'='";"690.0";"nM";"6.16";"";"";"UO_0000065";"11.52";"0.23";"1.42";"4.90";"0";"CHEMBL658685";"In vitro inhibition of cathepsin D.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1129769";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1996";"None";"";"";""
"CHEMBL2407341";"";"None";"658.84";"2";"6.13";"17";"C=CCc1cccc(C[C@H](NC(=O)c2cc(-c3ccccn3)c(=O)n(CC=C)c2)[C@H](O)CN[C@H]2CC3(CCC3)Oc3ccc(CC)cc32)c1";"IC50";"'='";"78.0";"nM";"7.11";"";"";"UO_0000065";"10.79";"0.20";"0.98";"6.74";"0";"CHEMBL2411009";"Inhibition of Cathepsin D (unknown origin) by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2406987";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"None";"";"";""
"CHEMBL2407495";"";"None";"502.70";"2";"5.37";"8";"C=CCCC(=O)N[C@@H](Cc1cccc(CC=C)c1)[C@H](O)CN[C@H]1CC2(CCC2)Oc2ccc(CC)cc21";"IC50";"'='";"29.0";"nM";"7.54";"";"";"UO_0000065";"14.99";"0.28";"2.17";"10.68";"0";"CHEMBL2411009";"Inhibition of Cathepsin D (unknown origin) by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2406987";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"None";"";"";""
"CHEMBL191344";"";"None";"669.97";"2";"3.14";"47";"CCCCNC(=O)[C@@H](NC(=O)[C@@H]1CCC[C@H]1[C@H](O)[C@H](CC(C)C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(C)C)NC(C)=O)C(C)C";"IC50";"'<'";"10.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL828480";"Inhibitory concentration against human Cathepsin D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1145163";"1";"Scientific Literature";"J Med Chem";"2005";"None";"";"";""
"CHEMBL1760853";"";"None";"507.70";"1";"4.52";"14f";"Cc1cccc(Cc2cc(C[C@@H]3CS(=O)(=O)C[C@H](NCc4cccc(C(C)C)c4)[C@H]3O)ccc2O)c1";"IC50";"'='";"7100.0";"nM";"5.15";"";"";"UO_0000065";"10.14";"0.20";"0.63";"5.94";"0";"CHEMBL1764636";"Inhibition of human cathepsin D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1759891";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL1760852";"";"None";"496.47";"0";"3.69";"11";"COc1ccc(C[C@@H]2CS(=O)(=O)C[C@H](NCc3cccc(C(C)C)c3)[C@H]2O)cc1Br";"IC50";"'='";"2400.0";"nM";"5.62";"";"";"UO_0000065";"11.32";"0.26";"1.93";"7.43";"0";"CHEMBL1764636";"Inhibition of human cathepsin D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1759891";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL320800";"";"None";"731.89";"2";"2.85";"3";"CC(C)[C@H](NC(=O)OCc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)[C@@H](O)[C@H]1NCc2ccc(cc2)OCCOCCNC(=O)[C@H](C(C)C)NC1=O";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL662648";"The compound was tested for inhibition of Human Cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1129607";"1";"Scientific Literature";"J Med Chem";"1996";"None";"";"";""
"CHEMBL309479";"";"None";"448.36";"1";"6.11";"28";"O=C(Nc1ccc(Sc2nc3ccccc3s2)nc1)c1cc(Cl)cc(Cl)c1O";"IC50";"'='";"2500.0";"nM";"5.60";"";"";"UO_0000065";"12.49";"0.27";"-0.51";"7.46";"0";"CHEMBL657347";"Inhibitory activity against human liver Cathepsin D using Cathepsin D assay.";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1132101";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1999";"None";"";"";""
"CHEMBL115048";"";"None";"511.71";"1";"4.11";"20";"CCCCNC(=O)C[C@H](O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)Cc1ccc2ccccc2c1)C(C)CC";"IC50";"'='";"320.0";"nM";"6.50";"";"";"UO_0000065";"12.69";"0.24";"2.38";"6.04";"0";"CHEMBL657349";"Inhibitory concentration against Human cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133572";"1";"Scientific Literature";"J Med Chem";"2000";"None";"";"";""
"CHEMBL4747598";"";"None";"689.73";"1";"3.55";"4a";"COc1ccc(CC(=O)NC(=N)N[C@H](CC2CCCCC2)C(=O)Nc2cc(S(=O)(=O)N(C)C)ccc2C)cc1F.O=C(O)C(F)(F)F";"IC50";"'='";"44.0";"nM";"7.36";"";"";"UO_0000065";"12.78";"0.25";"3.81";"5.23";"0";"CHEMBL4706202";"Inhibition of human liver Cathepsin D preincubated for 10 mins followed by substrate addition and further incubated for 2 hrs in dark by fluorimetric analysis";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699662";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"TIME = 2.167 hr";"INHIBITOR";""
"CHEMBL4743108";"";"None";"666.72";"1";"3.28";"5a";"Cc1ccc(S(=O)(=O)N(C)C)cc1NC(=O)[C@@H](CC1CCCCC1)NC(=N)NC(=O)Cc1cccc(C#N)c1.O=C(O)C(F)(F)F";"IC50";"'='";"51.0";"nM";"7.29";"";"";"UO_0000065";"13.19";"0.26";"4.01";"4.70";"0";"CHEMBL4706202";"Inhibition of human liver Cathepsin D preincubated for 10 mins followed by substrate addition and further incubated for 2 hrs in dark by fluorimetric analysis";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699662";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"TIME = 2.167 hr";"INHIBITOR";""
"CHEMBL4787350";"";"None";"709.71";"1";"4.42";"6a";"Cc1ccc(S(=O)(=O)N(C)C)cc1NC(=O)[C@@H](CC1CCCCC1)NC(=N)NC(=O)Cc1ccccc1C(F)(F)F.O=C(O)C(F)(F)F";"IC50";"'='";"53.0";"nM";"7.28";"";"";"UO_0000065";"12.21";"0.24";"2.86";"5.53";"0";"CHEMBL4706202";"Inhibition of human liver Cathepsin D preincubated for 10 mins followed by substrate addition and further incubated for 2 hrs in dark by fluorimetric analysis";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699662";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"TIME = 2.167 hr";"INHIBITOR";""
"CHEMBL4755601";"";"None";"709.71";"1";"4.42";"7a";"Cc1ccc(S(=O)(=O)N(C)C)cc1NC(=O)[C@@H](CC1CCCCC1)NC(=N)NC(=O)Cc1cccc(C(F)(F)F)c1.O=C(O)C(F)(F)F";"IC50";"'='";"69.0";"nM";"7.16";"";"";"UO_0000065";"12.02";"0.24";"2.74";"5.45";"0";"CHEMBL4706202";"Inhibition of human liver Cathepsin D preincubated for 10 mins followed by substrate addition and further incubated for 2 hrs in dark by fluorimetric analysis";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699662";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"TIME = 2.167 hr";"INHIBITOR";""
"CHEMBL4751573";"";"None";"685.72";"1";"3.25";"10a";"Cc1ccc(S(=O)(=O)N(C)C)cc1NC(=O)[C@@H](CC1CCCCC1)NC(=N)NC(=O)c1ccc2c(c1)OCCO2.O=C(O)C(F)(F)F";"IC50";"'='";"7323.0";"nM";"5.13";"";"";"UO_0000065";"8.98";"0.18";"1.89";"3.43";"0";"CHEMBL4706202";"Inhibition of human liver Cathepsin D preincubated for 10 mins followed by substrate addition and further incubated for 2 hrs in dark by fluorimetric analysis";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699662";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"TIME = 2.167 hr";"INHIBITOR";""
"CHEMBL4757469";"";"None";"681.78";"1";"4.28";"13a";"Cc1ccc(S(=O)(=O)N(C)C)cc1NC(=O)[C@@H](CC1CCCCC1)NC(=N)NC(=O)C1CCCc2ccccc21.O=C(O)C(F)(F)F";"IC50";"'='";"95.0";"nM";"7.02";"";"";"UO_0000065";"12.37";"0.24";"2.74";"5.34";"0";"CHEMBL4706202";"Inhibition of human liver Cathepsin D preincubated for 10 mins followed by substrate addition and further incubated for 2 hrs in dark by fluorimetric analysis";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699662";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"TIME = 2.167 hr";"INHIBITOR";""
"CHEMBL4778460";"";"None";"633.65";"1";"1.77";"3c";"CNS(=O)(=O)c1ccc(C)c(NC(=O)[C@H](NC(=N)NC(=O)Cc2ccc(OC)c(OC)c2)C(C)C)c1.O=C(O)C(F)(F)F";"IC50";"'='";"124.0";"nM";"6.91";"";"";"UO_0000065";"13.29";"0.26";"5.14";"4.35";"0";"CHEMBL4706202";"Inhibition of human liver Cathepsin D preincubated for 10 mins followed by substrate addition and further incubated for 2 hrs in dark by fluorimetric analysis";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699662";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"TIME = 2.167 hr";"INHIBITOR";""
"CHEMBL4763902";"";"None";"667.66";"1";"2.09";"1e";"COc1ccc(CC(=O)NC(=N)N[C@H](Cc2ccccc2)C(=O)Nc2cc(S(N)(=O)=O)ccc2C)cc1OC.O=C(O)C(F)(F)F";"IC50";"'='";"61.0";"nM";"7.21";"";"";"UO_0000065";"13.03";"0.25";"5.12";"4.18";"0";"CHEMBL4706202";"Inhibition of human liver Cathepsin D preincubated for 10 mins followed by substrate addition and further incubated for 2 hrs in dark by fluorimetric analysis";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699662";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"TIME = 2.167 hr";"INHIBITOR";""
"CHEMBL83114";"";"None";"715.49";"2";"9.22";"6";"CCOc1ccc2nc(Sc3ccc(NC(=O)c4cc(Cl)cc(Cl)c4NS(=O)(=O)c4cc(Cl)cc(Cl)c4O)cc3)sc2c1";"IC50";"'='";"250.0";"nM";"6.60";"";"";"UO_0000065";"9.23";"0.21";"-2.62";"5.61";"1";"CHEMBL4706201";"Inhibition of human liver Cathepsin D using N-succinyl-R-P-F-L-L-V-Y-7-amido-4-methylcoumarin peptide as substrate preincubated for 10 mins followed by substrate addition and further incubated for 45 mins by Cyto-fluor fluorescence analysis";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699662";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"TIME = 0.9167 hr";"INHIBITOR";""
"CHEMBL4792649";"";"None";"692.16";"1";"3.73";"3d";"CNS(=O)(=O)c1ccc(C)c(NC(=O)[C@@H](CC2CCCCC2)NC(=N)NC(=O)Cc2cc(Cl)cc(OC)c2)c1.O=C(O)C(F)(F)F";"IC50";"'='";"10.0";"nM";"8.00";"";"";"UO_0000065";"13.84";"0.28";"4.27";"5.35";"0";"CHEMBL4706202";"Inhibition of human liver Cathepsin D preincubated for 10 mins followed by substrate addition and further incubated for 2 hrs in dark by fluorimetric analysis";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699662";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"TIME = 2.167 hr";"INHIBITOR";""
"CHEMBL4786011";"";"None";"655.65";"1";"2.13";"8e";"COc1ccc(CC(=O)NC(=N)N[C@@H](C(=O)Nc2cc(S(N)(=O)=O)ccc2C)C2=CCC=CC2)cc1OC.O=C(O)C(F)(F)F";"IC50";"'='";"83.0";"nM";"7.08";"";"";"UO_0000065";"13.07";"0.25";"4.95";"4.10";"0";"CHEMBL4706202";"Inhibition of human liver Cathepsin D preincubated for 10 mins followed by substrate addition and further incubated for 2 hrs in dark by fluorimetric analysis";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699662";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"TIME = 2.167 hr";"INHIBITOR";""
"CHEMBL4777316";"";"None";"633.65";"1";"1.90";"12e";"COc1ccc(CC(=O)NC(=N)N[C@H](CC(C)C)C(=O)Nc2cc(S(N)(=O)=O)ccc2C)cc1OC.O=C(O)C(F)(F)F";"IC50";"'='";"84.0";"nM";"7.08";"";"";"UO_0000065";"13.62";"0.27";"5.18";"4.10";"0";"CHEMBL4706202";"Inhibition of human liver Cathepsin D preincubated for 10 mins followed by substrate addition and further incubated for 2 hrs in dark by fluorimetric analysis";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699662";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"TIME = 2.167 hr";"INHIBITOR";""
"CHEMBL323465";"";"None";"752.40";"2";"5.94";"PS-172564";"CCCCNC(=O)C[C@H](O)[C@H](Cc1ccccc1)NC(=O)CC1CN(Cc2ccc(-c3ccccc3)cc2)CCN1C(=O)CC(CN)c1ccc(Cl)cc1";"IC50";"'~'";"45000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL657344";"Compound was tested for inhibitory activity against cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1130672";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1998";"None";"";"";""
"CHEMBL1824353";"";"None";"405.48";"0";"2.83";"56";"CCC(=O)c1cc(C2(c3cccc(-c4cncnc4)c3)N=C(N)N(C)C2=O)cs1";"IC50";"'='";"13050.0";"nM";"4.88";"";"";"UO_0000065";"12.05";"0.23";"2.05";"4.81";"0";"CHEMBL1825607";"Inhibition of cathepsin D by FRET assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1821667";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL400654";"";"None";"580.65";"2";"5.73";"2";"CCOc1cc(C(=O)N[C@@H](Cc2ccccc2)[C@H](O)CNCc2cccc(C(F)(F)F)c2)cc(C2=C(C)CCC2=O)c1";"IC50";"'='";"1750.0";"nM";"5.76";"";"";"UO_0000065";"9.91";"0.19";"0.03";"6.57";"0";"CHEMBL945838";"Inhibition of Cathepsin D expressed in CHO cells by FRET assay";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140838";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"CHEMBL3308072";"";"";""
"CHEMBL501068";"";"None";"646.89";"1";"4.94";"9d";"CC(=O)O.CCNc1cc(C(=O)N[C@@H](Cc2ccccc2)[C@H](O)CNC(C)(C)CCCC(C)C)cc(N2CCCCS2(=O)=O)c1";"IC50";"'='";"2340.0";"nM";"5.63";"";"";"UO_0000065";"9.60";"0.19";"0.69";"5.08";"0";"CHEMBL959767";"Inhibition of cathepsin D expressed in CHO cells after 1 hrs by spectrophotometer";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1150334";"1";"Scientific Literature";"J Med Chem";"2008";"CHEMBL3308072";"";"";""
"CHEMBL510865";"";"None";"596.75";"1";"3.54";"9b";"CCNc1cc(C(=O)N[C@@H](Cc2ccccc2)[C@H](O)CNCc2ccccc2)cc(N2CCCCS2(=O)=O)c1.O=CO";"IC50";"'='";"26300.0";"nM";"4.58";"";"";"UO_0000065";"8.32";"0.16";"1.04";"4.13";"0";"CHEMBL959767";"Inhibition of cathepsin D expressed in CHO cells after 1 hrs by spectrophotometer";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1150334";"1";"Scientific Literature";"J Med Chem";"2008";"CHEMBL3308072";"";"";""
"CHEMBL534410";"";"None";"498.65";"0";"2.29";"14";"CCNC[C@@H](O)[C@H](Cc1ccccc1)NC(=O)c1cc2c3c(c1)c(CC)cn3CCS(=O)(=O)N2C";"IC50";"'='";"36310.0";"nM";"4.44";"";"";"UO_0000065";"8.90";"0.17";"2.15";"4.28";"0";"CHEMBL725829";"Inhibition of cathepsin-D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1158411";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL5074449";"";"None";"510.82";"1";"4.65";"64i";"C[C@@]1(c2cc(NC(=O)c3ncc(OC(F)F)cc3Cl)ccc2F)CO[C@@](C)(C(F)(F)F)C(N)=N1";"IC50";"'>'";"250000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5055931";"Inhibition of human cathepsin D using Mca-GKPILFFRLK(DNP)D-R-NH2 as a substrate";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5055623";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"";""
"CHEMBL4744222";"";"None";"621.59";"1";"0.50";"21e";"COC[C@@H](NC(=N)NC(=O)Cc1ccc(OC)c(OC)c1)C(=O)Nc1cc(S(N)(=O)=O)ccc1C.O=C(O)C(F)(F)F";"IC50";"'='";"243.0";"nM";"6.61";"";"";"UO_0000065";"13.03";"0.26";"6.11";"3.64";"0";"CHEMBL4706202";"Inhibition of human liver Cathepsin D preincubated for 10 mins followed by substrate addition and further incubated for 2 hrs in dark by fluorimetric analysis";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699662";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"TIME = 2.167 hr";"INHIBITOR";""
"CHEMBL191100";"";"None";"713.00";"2";"1.82";"55";"CCCCNC(=O)[C@@H](NC(=O)[C@@H]1C(=O)N(CC)C[C@H]1[C@H](O)[C@H](CC(C)C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(C)C)NC(C)=O)C(C)C";"IC50";"'='";"130.0";"nM";"6.89";"";"";"UO_0000065";"9.66";"0.19";"5.07";"3.70";"0";"CHEMBL828480";"Inhibitory concentration against human Cathepsin D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1145163";"1";"Scientific Literature";"J Med Chem";"2005";"None";"";"";""
"CHEMBL4795048";"";"None";"691.77";"1";"4.56";"12a";"Cc1ccc(S(=O)(=O)N(C)C)cc1NC(=O)[C@@H](CC1CCCCC1)NC(=N)NC(=O)Cc1ccc2ccccc2c1.O=C(O)C(F)(F)F";"IC50";"'='";"102.0";"nM";"6.99";"";"";"UO_0000065";"12.10";"0.23";"2.43";"5.32";"0";"CHEMBL4706202";"Inhibition of human liver Cathepsin D preincubated for 10 mins followed by substrate addition and further incubated for 2 hrs in dark by fluorimetric analysis";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699662";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"TIME = 2.167 hr";"INHIBITOR";""
"CHEMBL4791638";"";"None";"659.68";"1";"2.43";"7e";"COc1ccc(CC(=O)NC(=N)N[C@@H](C(=O)Nc2cc(S(N)(=O)=O)ccc2C)C2CCCCC2)cc1OC.O=C(O)C(F)(F)F";"IC50";"'='";"9.0";"nM";"8.05";"";"";"UO_0000065";"14.75";"0.29";"5.62";"4.66";"0";"CHEMBL4706202";"Inhibition of human liver Cathepsin D preincubated for 10 mins followed by substrate addition and further incubated for 2 hrs in dark by fluorimetric analysis";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699662";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"TIME = 2.167 hr";"INHIBITOR";""
"CHEMBL1270431";"";"None";"345.35";"0";"2.63";"83";"Cc1cc([C@]2(c3ccccc3)N=C(N)N(C)C2=O)ccc1OC(F)F";"IC50";"'='";"22500.0";"nM";"4.65";"";"";"UO_0000065";"13.46";"0.25";"2.02";"6.84";"0";"CHEMBL1273977";"Inhibition of cathepsin D by FRET assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1268920";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL3109544";"";"None";"395.46";"0";"2.49";"BDBM234520";"COc1ccc(C2(c3ccc(OC)cc3)NC(=N)N(C3CCOCC3)C2=O)cc1";"IC50";"'>'";"10000.0";"nM";"";"";"408846";"UO_0000065";"";"";"";"";"0";"CHEMBL3887168";"Fluorescence Resonance Energy Transfer (FRET) Assay : The recombinant human BACE1, Cathepsin D, and Cathepsin E enzymes were purchased from R&D Systems (catalog numbers are 931-AS, 1014AS and 1294AS, respectively). The enzymatic inhibition activity assays were determined using the fluorescence resonance energy transfer (FRET) assay. The assays were performed in a 384-well plate format. The recombinant human BACE-1 enzyme (R&D Systems, catalog#931-AS) was diluted to 20 ng/L in assay buffer (100 mM sodium acetate pH 4.0), 10 point 1:3 serial dilutions of compound in DMSO were preincubated with the enzyme for 15 min at room temperature. The concentration of Cathepsin D was 20 ng/L, and 1 ng/L of Cathepsin E was used. CatD and CatE were activated by incubation in assay buffer (0.1 M NaOAc, 0.2 M NaCl, pH 3.5) at room temperature for 30 min. Subsequently, the rhBACE-1 substrate (R&D Systems, catalog# ES004), the Cathepsin D and Cathepsin E substrate (R&D Systems, Catalog # ES001) were added accordingly to final concentration";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886201";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL291784";"";"None";"265.32";"0";"1.72";"2";"CN1C(=O)C(c2ccccc2)(c2ccccc2)N=C1N";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1071582";"Inhibition of human cathepsin D by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1159096";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL565790";"";"None";"440.55";"0";"4.45";"44";"COc1ccc(C2(c3cccc(-c4cccnc4)c3)N=C(N)N(C)C2=O)cc1C1CCCC1";"IC50";"'='";"1870.0";"nM";"5.73";"";"";"UO_0000065";"13.00";"0.24";"1.28";"7.09";"0";"CHEMBL1044551";"Inhibition of human cathepsin D by FRET based peptide cleavage assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156789";"1";"Scientific Literature";"J Med Chem";"2010";"None";"";"";""
"CHEMBL568115";"";"None";"445.38";"0";"3.21";"(R)-61";"CN1C(=O)[C@@](c2ccc(OC(F)(F)F)cc2)(c2ccc(F)c(-c3cncnc3)c2)N=C1N";"IC50";"'='";"2330.0";"nM";"5.63";"";"";"UO_0000065";"12.65";"0.24";"2.42";"6.01";"0";"CHEMBL1044551";"Inhibition of human cathepsin D by FRET based peptide cleavage assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156789";"1";"Scientific Literature";"J Med Chem";"2010";"None";"";"";""
"CHEMBL585506";"";"None";"445.38";"0";"3.21";"61";"CN1C(=O)C(c2ccc(OC(F)(F)F)cc2)(c2ccc(F)c(-c3cncnc3)c2)N=C1N";"IC50";"'='";"4180.0";"nM";"5.38";"";"";"UO_0000065";"12.08";"0.23";"2.17";"5.74";"0";"CHEMBL1044551";"Inhibition of human cathepsin D by FRET based peptide cleavage assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156789";"1";"Scientific Literature";"J Med Chem";"2010";"None";"";"";""
"CHEMBL4788257";"";"None";"675.70";"1";"3.21";"1d";"CNS(=O)(=O)c1ccc(C)c(NC(=O)[C@@H](CC2CCCCC2)NC(=N)NC(=O)Cc2ccc(F)c(OC)c2)c1.O=C(O)C(F)(F)F";"IC50";"'='";"729.0";"nM";"6.14";"";"";"UO_0000065";"10.93";"0.21";"2.93";"4.11";"0";"CHEMBL4706202";"Inhibition of human liver Cathepsin D preincubated for 10 mins followed by substrate addition and further incubated for 2 hrs in dark by fluorimetric analysis";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699662";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"TIME = 2.167 hr";"INHIBITOR";""
"CHEMBL4745166";"";"None";"635.62";"1";"0.89";"23e";"COCC[C@@H](NC(=N)NC(=O)Cc1ccc(OC)c(OC)c1)C(=O)Nc1cc(S(N)(=O)=O)ccc1C.O=C(O)C(F)(F)F";"IC50";"'='";"529.0";"nM";"6.28";"";"";"UO_0000065";"12.03";"0.24";"5.39";"3.45";"0";"CHEMBL4706202";"Inhibition of human liver Cathepsin D preincubated for 10 mins followed by substrate addition and further incubated for 2 hrs in dark by fluorimetric analysis";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699662";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"TIME = 2.167 hr";"INHIBITOR";""
"CHEMBL213830";"";"None";"546.80";"1";"1.82";"31";"CCCCNC(=O)[C@H](C)C[C@H](O)[C@@H]1CSCCCCCCSC[C@H](NC(C)=O)C(=O)N[C@@H](C)C(=O)N1";"IC50";"'='";"1250.0";"nM";"5.90";"";"";"UO_0000065";"10.80";"0.22";"4.08";"4.32";"0";"CHEMBL866007";"Inhibition of Cathepsin D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1137429";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";"";""
"CHEMBL2048060";"";"None";"614.58";"1";"4.15";"62f";"CC1(C)OCc2ccc(CN[C@H]3CS(=O)(=O)C[C@@H](Cc4cc(F)c(N)c(OC(C(F)(F)F)C(F)(F)F)c4)[C@@H]3O)cc21";"IC50";"'='";"1510.0";"nM";"5.82";"";"";"UO_0000065";"9.47";"0.19";"1.67";"5.25";"0";"CHEMBL2049562";"Inhibition of human recombinant CatD using Mca-GKPILFFRLK(DNP)-dR-NH2 as substrate after 1 hr by fluorescence analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2046351";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL3344151";"";"None";"571.68";"2";"-3.22";"74";"CC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)[C@@H](O)CC(=O)N[C@@H](CCC(N)=O)C(N)=O";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3370435";"Inhibition of human cathepsin D assessed as cleavage of wtKAHRP fluorogenic substrate";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3352063";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL3344160";"";"None";"717.79";"2";"1.39";"33";"CC(C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)OCc1ccccc1)[C@@H](O)CC(=O)NC1CCCCC1.O=C(O)C(F)(F)F";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL3370435";"Inhibition of human cathepsin D assessed as cleavage of wtKAHRP fluorogenic substrate";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3352063";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL4469961";"";"None";"477.60";"1";"7.15";"63";"CCCCCc1ccc(N(C[C@@H]2CCC(=O)C(F)(F)C2)C(=O)Cc2ccc3ccccc3c2)cc1";"IC50";"'='";"87000.0";"nM";"4.06";"";"";"UO_0000065";"8.50";"0.16";"-3.09";"10.86";"0";"CHEMBL4357658";"Inhibition of human cathepsin D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4354841";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";""
"CHEMBL4556003";"";"None";"559.82";"2";"5.77";"67";"CCCCCc1ccc(S(=O)(=O)C2C3NC(CC3CNC3CCCC3)C2NCc2ccc3ccccc3c2)cc1";"IC50";"'='";"1997.0";"nM";"5.70";"";"";"UO_0000065";"10.18";"0.19";"-0.07";"8.12";"0";"CHEMBL4357658";"Inhibition of human cathepsin D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4354841";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";""
"CHEMBL4162480";"";"None";"674.84";"1";"1.84";"3";"CC[C@H](C)[C@H](NC(=O)[C@H](OC(=O)[C@@H](O)C(C)C)[C@@H](C)CC)C(=O)NCC(=O)N(C)[C@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)OC";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4150649";"Inhibition of human cathepsin D using GKPILFFRLK(DNP)-D-RNH2) labeled MCA as substrate preincubated for 10 mins followed by substrate addition measured after 1 to 2 hrs by fluorometric method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4145636";"1";"Scientific Literature";"J Nat Prod";"2018";"None";"";"";""
"CHEMBL3344267";"";"None";"802.29";"2";"2.69";"57";"CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)OCc1ccccc1)[C@@H](O)CC(=O)N(C)CCc1ccc(Cl)cc1.O=C(O)C(F)(F)F";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3370435";"Inhibition of human cathepsin D assessed as cleavage of wtKAHRP fluorogenic substrate";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3352063";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL3967984";"";"None";"423.95";"0";"3.13";"61";"C[C@H]1C[C@H]2CSC(N)=N[C@@]2(c2nc(NC(=O)c3ccc(Cl)cn3)cs2)CO1";"IC50";"'>'";"97000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4183115";"Inhibition of Cathepsin D (unknown origin) by fluorescence polarization assay";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4177751";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL3344157";"";"None";"731.81";"2";"1.78";"19";"CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)OCc1ccccc1)[C@@H](O)CC(=O)NC1CCCCC1.O=C(O)C(F)(F)F";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3370435";"Inhibition of human cathepsin D assessed as cleavage of wtKAHRP fluorogenic substrate";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3352063";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL2333941";"LY-2811376";"1.0";"320.37";"0";"3.09";"1; LY-2811376";"C[C@@]1(c2cc(-c3cncnc3)c(F)cc2F)CCSC(N)=N1";"IC50";"'='";"15700.0";"nM";"4.80";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4183173";"Inhibition of Cathepsin D (unknown origin)";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4177751";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4217620";"";"None";"412.54";"0";"4.24";"5; AZD3293";"CC#Cc1cncc(-c2ccc3c(c2)[C@@]2(N=C(C)C(N)=N2)[C@]2(CC[C@@H](OC)CC2)C3)c1";"IC50";"'='";"16100.0";"nM";"4.79";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4183173";"Inhibition of Cathepsin D (unknown origin)";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4177751";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL85929";"";"None";"477.39";"1";"6.72";"23";"COc1ccc2nc(Sc3ccc(NC(=O)c4cc(Cl)cc(Cl)c4O)cc3)sc2c1";"IC50";"'='";"2000.0";"nM";"5.70";"";"";"UO_0000065";"11.94";"0.26";"-1.02";"7.98";"0";"CHEMBL657347";"Inhibitory activity against human liver Cathepsin D using Cathepsin D assay.";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1132101";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1999";"None";"";"";""
"CHEMBL81927";"";"None";"889.63";"2";"8.03";"1";"COc1cc(Br)c(C(=O)N[C@@H](Cc2cccc(Oc3ccccc3)c2)[C@@H](O)CN(CCc2ccc(Cl)cc2Cl)C(=O)CCN2C(=O)c3ccccc3C2=O)cc1OC";"IC50";"'='";"0.7";"nM";"9.15";"";"";"UO_0000065";"10.29";"0.22";"1.12";"6.80";"0";"CHEMBL657347";"Inhibitory activity against human liver Cathepsin D using Cathepsin D assay.";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1132101";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1999";"None";"";"";""
"CHEMBL296588";"PEPSTATIN";"2.0";"685.90";"2";"1.47";"6";"CC(C)CC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)[C@@H](O)CC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)[C@@H](O)CC(=O)O)C(C)C)C(C)C";"IC50";"'='";"0.35";"nM";"9.46";"";"";"UO_0000065";"13.79";"0.27";"7.99";"4.24";"0";"CHEMBL3816585";"Inhibition of human liver cathepsin D using Mca-Gly-Lys-Pro-Ile-Leu-Phe-Phe-Arg-Leu-Lys-(Dnp)-D-Arg-NH2 as substrate preincubated for 15 mins followed by substrate addition measured every 5 mins for 120 mins by fluorescence analysis";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3813591";"1";"Scientific Literature";"Bioorg Med Chem";"2016";"None";"";"";""
"CHEMBL3670375";"";"None";"513.80";"1";"4.46";"15; CNP520";"C[C@@]1(c2nc(NC(=O)c3ncc(C(F)(F)F)cc3Cl)ccc2F)CO[C@@](C)(C(F)(F)F)C(N)=N1";"IC50";"'='";"205000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5054673";"Inhibition of human Cathepsin D using Mca-GKPILFFRLK(DNP)D-R-NH2 as a substrate";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5053529";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL3261067";"";"None";"449.41";"0";"3.58";"8; NB-360";"Cc1cc(C#N)cnc1C(=O)Nc1ccc(F)c([C@]2(C)CO[C@@](C)(C(F)(F)F)C(N)=N2)c1";"IC50";"'>'";"250000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"1";"CHEMBL5054673";"Inhibition of human Cathepsin D using Mca-GKPILFFRLK(DNP)D-R-NH2 as a substrate";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5053529";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"";""
"CHEMBL5080033";"";"None";"501.44";"1";"1.79";"20";"COCCOc1cnc(C(=O)Nc2ccc(F)c([C@]3(C)CO[C@@](C)(C(F)(F)F)C(N)=N3)n2)c(N)n1";"IC50";"'='";"95100.0";"nM";"4.02";"";"";"UO_0000065";"8.02";"0.16";"2.23";"2.52";"0";"CHEMBL5054673";"Inhibition of human Cathepsin D using Mca-GKPILFFRLK(DNP)D-R-NH2 as a substrate";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5053529";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL1824345";"";"None";"418.48";"0";"3.23";"48";"CN1C(=O)C(c2cccc(-c3cccnc3F)c2)(c2cnn(C3CCCC3)c2)N=C1N";"IC50";"'='";"1790.0";"nM";"5.75";"";"";"UO_0000065";"13.73";"0.25";"2.52";"6.43";"0";"CHEMBL1825607";"Inhibition of cathepsin D by FRET assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1821667";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL254068";"";"None";"550.73";"1";"3.54";"12";"CCNc1cc(C(=O)N[C@@H](Cc2ccccc2)[C@H](O)CNCc2ccccc2)cc(N2CCCCS2(=O)=O)c1";"IC50";"'='";"26300.0";"nM";"4.58";"";"";"UO_0000065";"8.32";"0.16";"1.04";"4.13";"0";"CHEMBL945838";"Inhibition of Cathepsin D expressed in CHO cells by FRET assay";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140838";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"CHEMBL3308072";"";"";""
"CHEMBL3701715";"";"None";"396.90";"0";"1.94";"17";"Cl.N#Cc1ccc([C@]23CN(c4ncc(F)cn4)C[C@H]2CSC(N)=N3)s1";"IC50";"'='";"14000.0";"nM";"4.85";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5034187";"Inhibition of human Cathepsin D by FRET assay";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5033995";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL252961";"";"None";"519.71";"1";"2.72";"27";"CCCN(CCC)S(=O)(=O)CCC(=O)N[C@@H](Cc1ccccc1)[C@H](O)CNCc1cccc(OC)c1";"IC50";"'='";"4900.0";"nM";"5.31";"";"";"UO_0000065";"10.22";"0.20";"2.59";"4.92";"0";"CHEMBL942098";"Inhibition of human recombinant cathepsin D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140593";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"None";"";"";""
"CHEMBL437961";"";"None";"496.63";"0";"2.74";"17";"COc1cccc(CNC[C@@H](O)[C@H](Cc2ccccc2)NC(=O)CCS(=O)(=O)c2ccccc2)c1";"IC50";"'='";"6042.0";"nM";"5.22";"";"";"UO_0000065";"10.51";"0.20";"2.48";"4.98";"0";"CHEMBL942098";"Inhibition of human recombinant cathepsin D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140593";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"None";"";"";""
"CHEMBL3980894";"";"None";"459.38";"0";"3.02";"BDBM214833";"COc1cnc(C(=O)Nc2ccc(F)c([C@]3(CF)C[C@@H](C(F)(F)F)OC(N)=N3)c2)c(C)n1";"IC50";"'>'";"400000.0";"nM";"";"Outside typical range";"377862";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3903880";"";"None";"422.34";"0";"2.62";"BDBM214861";"C[C@@]1(c2cc(NC(=O)c3ccc(C#N)cn3)cnc2F)C[C@@H](C(F)(F)F)OC(N)=N1";"IC50";"'>'";"400000.0";"nM";"";"Outside typical range";"377866";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL5184529";"";"None";"3052.58";"None";"None";"3";"CC(C)C[C@H](NC(=O)C[C@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(N)=O)N(C)C(=O)[C@@H](NC(=O)OCc1ccccc1)C(C)C)C(=O)N[C@@H](C)C(=O)N(C)[C@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)NCCOCCOCCn1cc(CNC(=O)[C@H](CCCCNC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)CCN2c3ccccc3C(C)(C)[C@]23C=Cc2cc([N+](=O)[O-])ccc2O3)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)C(CCC(N)=O)NC(=O)[C@H](CO)NC(=O)CCN2c3ccccc3C(C)(C)[C@]23CCc2cc([N+](=O)[O-])ccc2O3)nn1";"IC50";"'='";"22.0";"nM";"7.66";"";"";"UO_0000065";"2.51";"None";"None";"None";"0";"CHEMBL5158466";"Inhibition of recombinant human liver Cathepsin D using Mca-Gly-Lys-Pro-Ile-Leu-Phe-Phe-Arg-Leu-Lys-(Dnp)-D-Arg-NH2 as substrate incubated for 120 mins by fluorescence assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5154724";"1";"Scientific Literature";"Bioorg Med Chem";"2022";"None";"TIME = 2.0 hr";"INHIBITOR";""
"CHEMBL4203347";"";"None";"268.41";"0";"2.43";"45";"C[C@H]1C[C@H]2CSC(N)=N[C@@]2(c2ccsc2)CO1";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4183115";"Inhibition of Cathepsin D (unknown origin) by fluorescence polarization assay";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4177751";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL3109548";"";"None";"494.59";"0";"3.71";"BDBM234527";"COc1ccc(C2(c3ccc(OC)cc3)NC(=N)N(C3CCN(C(=O)OC(C)(C)C)CC3)C2=O)cc1";"IC50";"'='";"520.0";"nM";"6.28";"";"408847";"UO_0000065";"12.71";"0.24";"2.57";"6.03";"0";"CHEMBL3887168";"Fluorescence Resonance Energy Transfer (FRET) Assay : The recombinant human BACE1, Cathepsin D, and Cathepsin E enzymes were purchased from R&D Systems (catalog numbers are 931-AS, 1014AS and 1294AS, respectively). The enzymatic inhibition activity assays were determined using the fluorescence resonance energy transfer (FRET) assay. The assays were performed in a 384-well plate format. The recombinant human BACE-1 enzyme (R&D Systems, catalog#931-AS) was diluted to 20 ng/L in assay buffer (100 mM sodium acetate pH 4.0), 10 point 1:3 serial dilutions of compound in DMSO were preincubated with the enzyme for 15 min at room temperature. The concentration of Cathepsin D was 20 ng/L, and 1 ng/L of Cathepsin E was used. CatD and CatE were activated by incubation in assay buffer (0.1 M NaOAc, 0.2 M NaCl, pH 3.5) at room temperature for 30 min. Subsequently, the rhBACE-1 substrate (R&D Systems, catalog# ES004), the Cathepsin D and Cathepsin E substrate (R&D Systems, Catalog # ES001) were added accordingly to final concentration";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886201";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL1824142";"";"None";"401.47";"0";"2.49";"36";"CN1C(=O)C(c2cccc(-c3cncnc3)c2)(c2cnn(C3CCCC3)c2)N=C1N";"IC50";"'='";"17300.0";"nM";"4.76";"";"";"UO_0000065";"11.86";"0.22";"2.27";"4.66";"0";"CHEMBL1825607";"Inhibition of cathepsin D by FRET assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1821667";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL291784";"";"None";"265.32";"0";"1.72";"2";"CN1C(=O)C(c2ccccc2)(c2ccccc2)N=C1N";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"1";"CHEMBL1825607";"Inhibition of cathepsin D by FRET assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1821667";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL3973933";"";"None";"530.49";"1";"4.16";"BDBM220829";"COc1cnc(C(=O)Nc2ccc3c(c2)C2(CCOC(N)=N2)c2cc(-c4ccnc(F)c4)cc(F)c2O3)cn1";"IC50";"'='";"400000.0";"nM";"";"Outside typical range";"386515";"UO_0000065";"";"";"";"";"0";"CHEMBL3888270";"Fluorescence Resonance Energy Transfer (FRET) Assay: Recombinant CathepsinD was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The CathepsinD enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for CathepsinD) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886633";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3971440";"";"None";"524.49";"1";"4.63";"BDBM220844";"N#Cc1ccc(C(=O)Nc2ccc3c(c2)C2(CCOC(N)=N2)c2cc(-c4ccnc(F)c4)cc(F)c2O3)nc1";"IC50";"'='";"400000.0";"nM";"";"Outside typical range";"386530";"UO_0000065";"";"";"";"";"0";"CHEMBL3888270";"Fluorescence Resonance Energy Transfer (FRET) Assay: Recombinant CathepsinD was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The CathepsinD enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for CathepsinD) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886633";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3979965";"";"None";"465.22";"0";"4.56";"BDBM214816";"NC1=N[C@](CF)(c2cc(Nc3ccnc(Br)c3)ccc2F)C[C@@H](C(F)(F)F)O1";"IC50";"'='";"469000.0";"nM";"";"Outside typical range";"377948";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3904438";"";"None";"501.39";"1";"3.24";"BDBM214961";"CC#CCOc1cnc(C(=O)Nc2cc(F)c(F)c([C@]3(CF)C[C@@H](C(F)(F)F)OC(N)=N3)c2)cn1";"IC50";"'>'";"400000.0";"nM";"";"Outside typical range";"377996";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3898955";"";"None";"511.22";"1";"4.21";"BDBM214963";"NC1=N[C@](CF)(c2cc(NC(=O)c3ccc(Br)cn3)cc(F)c2F)C[C@@H](C(F)(F)F)O1";"IC50";"'>'";"400000.0";"nM";"";"Outside typical range";"377998";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL1076906";"";"None";"835.97";"1";"4.87";"35-(S)";"CC(C)[C@H](NC(=O)[C@@H](C)C[C@H](O)[C@H](COc1cc(F)cc(F)c1)NC(=O)c1cc(C(=O)N[C@H](C)c2ccccc2)cc(N(C)S(C)(=O)=O)c1)C(=O)NCc1ccccc1";"IC50";"'='";"120.0";"nM";"6.92";"";"";"UO_0000065";"8.28";"0.16";"2.05";"3.78";"0";"CHEMBL1106032";"Inhibition of human liver cathepsin D after 20 mins by homogeneous time resolved fluorescence assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1154862";"1";"Scientific Literature";"Eur J Med Chem";"2010";"None";"";"";""
"CHEMBL1076910";"";"None";"867.99";"2";"5.15";"32";"CC(C)[C@H](NC(=O)[C@H](C)C[C@H](O)[C@H](COCc1cc(F)cc(F)c1)NC(=O)c1cc(C(=O)N[C@H](C)c2ccccc2)cc(N(C)S(C)(=O)=O)c1)C(=O)NCc1ccc(F)cc1";"IC50";"'>'";"5000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1106032";"Inhibition of human liver cathepsin D after 20 mins by homogeneous time resolved fluorescence assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1154862";"1";"Scientific Literature";"Eur J Med Chem";"2010";"None";"";"";""
"CHEMBL3109550";"";"None";"409.49";"0";"2.74";"BDBM234541";"COc1ccc(C2(c3ccc(OC)cc3)NC(=N)N(CC3CCOCC3)C2=O)cc1";"IC50";"'='";"934.0";"nM";"6.03";"";"408848";"UO_0000065";"14.72";"0.27";"3.29";"7.19";"0";"CHEMBL3887168";"Fluorescence Resonance Energy Transfer (FRET) Assay : The recombinant human BACE1, Cathepsin D, and Cathepsin E enzymes were purchased from R&D Systems (catalog numbers are 931-AS, 1014AS and 1294AS, respectively). The enzymatic inhibition activity assays were determined using the fluorescence resonance energy transfer (FRET) assay. The assays were performed in a 384-well plate format. The recombinant human BACE-1 enzyme (R&D Systems, catalog#931-AS) was diluted to 20 ng/L in assay buffer (100 mM sodium acetate pH 4.0), 10 point 1:3 serial dilutions of compound in DMSO were preincubated with the enzyme for 15 min at room temperature. The concentration of Cathepsin D was 20 ng/L, and 1 ng/L of Cathepsin E was used. CatD and CatE were activated by incubation in assay buffer (0.1 M NaOAc, 0.2 M NaCl, pH 3.5) at room temperature for 30 min. Subsequently, the rhBACE-1 substrate (R&D Systems, catalog# ES004), the Cathepsin D and Cathepsin E substrate (R&D Systems, Catalog # ES001) were added accordingly to final concentration";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886201";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3905422";"";"None";"481.78";"0";"4.34";"BDBM215019";"C[C@@]1(c2cc(NC(=O)c3cnc(C(F)F)cn3)cc(Cl)c2F)C[C@@H](C(F)(F)F)OC(N)=N1";"IC50";"'='";"604000.0";"nM";"";"Outside typical range";"378079";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3897373";"";"None";"470.85";"0";"3.01";"BDBM220774";"COc1cnc(C(=O)Nc2ccc3c(c2)C2(CCOC(N)=N2)c2cc(Cl)nc(F)c2O3)cn1";"IC50";"'='";"334900.0";"nM";"";"Outside typical range";"386457";"UO_0000065";"";"";"";"";"0";"CHEMBL3888270";"Fluorescence Resonance Energy Transfer (FRET) Assay: Recombinant CathepsinD was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The CathepsinD enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for CathepsinD) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886633";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL566200";"";"None";"386.46";"0";"3.10";"3b";"COc1ccc(C2(c3cccc(-c4cccnc4)c3)N=C(N)N(C)C2=O)cc1C";"IC50";"'='";"12500.0";"nM";"4.90";"";"";"UO_0000065";"12.69";"0.23";"1.80";"6.07";"0";"CHEMBL1071582";"Inhibition of human cathepsin D by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1159096";"1";"Scientific Literature";"Bioorg Med Chem";"2010";"None";"";"";""
"CHEMBL3683877";"";"None";"454.84";"0";"3.80";"BDBM171492";"Cc1cc(OC(F)F)cnc1C(=O)Nc1ccc(Cl)c([C@@]2(CF)N=C(N)O[C@@H]3C[C@@H]32)c1";"IC50";"'='";"1203800.0";"nM";"";"Outside typical range";"315901";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3683880";"";"None";"428.77";"0";"3.46";"BDBM171495";"NC1=N[C@@](c2cc(NC(=O)c3ncc(Cl)cc3F)ccc2F)(C(F)F)[C@H]2C[C@H]2O1";"IC50";"'='";"1275400.0";"nM";"";"Outside typical range";"315904";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3683891";"";"None";"438.89";"0";"3.75";"BDBM171507";"CSc1c(F)cc(NC(=O)c2ccc(Cl)cn2)cc1[C@@]1(CF)N=C(N)O[C@@H]2C[C@@H]21";"IC50";"'='";"654540.0";"nM";"";"Outside typical range";"315916";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3683901";"";"None";"423.81";"0";"2.43";"BDBM171518";"COc1cnc(C(=O)Nc2cc(F)c(Cl)c([C@]3(CF)N=C(N)O[C@H]4C[C@H]43)c2)cn1";"IC50";"'='";"403830.0";"nM";"";"Outside typical range";"315927";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688636";"";"None";"412.40";"0";"2.38";"BDBM171571";"C#CCOc1ccc(C(=O)Nc2ccc(F)c([C@@]3(CF)N=C(N)O[C@@H]4C[C@@H]43)c2)nc1";"IC50";"'='";"820880.0";"nM";"";"Outside typical range";"315980";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688646";"";"None";"461.86";"0";"2.98";"BDBM171581";"CC#CCOc1cnc(C(=O)Nc2ccc(Cl)c([C@@]3(C(F)F)N=C(N)O[C@@H]4C[C@@H]43)c2)cn1";"IC50";"'='";"1932300.0";"nM";"";"Outside typical range";"315990";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688657";"";"None";"422.82";"0";"3.03";"BDBM171595";"COc1cnc(C(=O)Nc2ccc(F)c([C@@]3(CF)N=C(N)O[C@@H]4C[C@@H]43)c2)c(Cl)c1";"IC50";"'='";"956160.0";"nM";"";"Outside typical range";"316004";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688718";"";"None";"403.39";"0";"2.24";"BDBM171660";"COc1cnc(C(=O)Nc2ccc(C)c([C@@]3(C(F)F)N=C(N)O[C@@H]4C[C@@H]43)c2)cn1";"IC50";"'='";"684340.0";"nM";"";"Outside typical range";"316068";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688732";"";"None";"442.80";"0";"3.79";"BDBM171674";"NC1=N[C@@](c2cc(NC(=O)c3ncc(Cl)cc3CF)ccc2F)(C(F)F)[C@H]2C[C@H]2O1";"IC50";"'='";"186000.0";"nM";"";"Outside typical range";"316082";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3693245";"";"None";"371.36";"0";"3.45";"BDBM171804";"CC#Cc1cncc(-c2ccc(F)c([C@@]3(C(F)F)N=C(N)O[C@@H]4C[C@@H]43)c2)c1";"IC50";"'='";"72850.0";"nM";"4.14";"";"316200";"UO_0000065";"11.14";"0.21";"0.69";"6.84";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3926305";"";"None";"547.55";"1";"4.27";"BDBM220849";"COc1cnc(C(=O)Nc2ccc3c(c2)C2(CCSC(N)=N2)c2cc(-c4cncc(F)c4)nc(F)c2O3)cn1";"IC50";"'='";"223500.0";"nM";"";"Outside typical range";"386535";"UO_0000065";"";"";"";"";"0";"CHEMBL3888270";"Fluorescence Resonance Energy Transfer (FRET) Assay: Recombinant CathepsinD was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The CathepsinD enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for CathepsinD) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886633";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3908654";"";"None";"534.52";"2";"5.01";"BDBM220855";"NC1=NC2(CCS1)c1cc(NC(=O)c3ccc(F)cn3)ccc1Oc1c2cc(-c2ccnc(F)c2)nc1F";"IC50";"'='";"400000.0";"nM";"";"Outside typical range";"386541";"UO_0000065";"";"";"";"";"0";"CHEMBL3888270";"Fluorescence Resonance Energy Transfer (FRET) Assay: Recombinant CathepsinD was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The CathepsinD enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for CathepsinD) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886633";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3683798";"";"None";"401.35";"0";"2.38";"BDBM171404";"N#Cc1ccc(C(=O)Nc2cc(F)c(F)c([C@]3(CF)N=C(N)O[C@H]4C[C@H]43)c2)nc1";"IC50";"'='";"2618400.0";"nM";"";"Outside typical range";"315813";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3683808";"";"None";"410.78";"0";"3.16";"BDBM171414";"NC1=N[C@](CF)(c2cc(NC(=O)c3ccc(Cl)cn3)cc(F)c2F)[C@H]2C[C@H]2O1";"IC50";"'='";"154000.0";"nM";"";"Outside typical range";"315823";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3683817";"";"None";"422.46";"0";"3.13";"BDBM171423";"CC#CCOc1cnc(C(=O)Nc2ccc(F)c([C@]3(C)N=C(N)O[C@H]4C[C@H]43)c2)c(C)c1";"IC50";"'='";"332730.0";"nM";"";"Outside typical range";"315832";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3683826";"";"None";"440.81";"0";"3.33";"BDBM171436";"COc1cnc(C(=O)Nc2ccc(F)c([C@@]3(C(F)F)N=C(N)O[C@@H]4C[C@@H]43)c2)c(Cl)c1";"IC50";"'='";"378870.0";"nM";"";"Outside typical range";"315845";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688769";"";"None";"415.83";"0";"4.06";"BDBM171715";"NC1=N[C@](CF)(c2cc(Nc3nccc4cc(Cl)cnc34)ccc2F)[C@H]2C[C@H]2O1";"IC50";"'='";"282000.0";"nM";"";"Outside typical range";"316119";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688779";"";"None";"446.85";"0";"3.47";"BDBM171726";"COc1cnc2c(Nc3cc(Cl)c(F)c([C@@]4(CF)N=C(N)O[C@@H]5C[C@@H]54)c3)nccc2n1";"IC50";"'='";"725380.0";"nM";"";"Outside typical range";"316130";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688812";"";"None";"443.87";"0";"2.90";"BDBM171760";"COCc1cc(C#N)cnc1C(=O)Nc1ccc(Cl)c([C@@]2(CF)N=C(N)O[C@@H]3C[C@@H]32)c1";"IC50";"'='";"1815700.0";"nM";"";"Outside typical range";"316160";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688820";"";"None";"431.37";"0";"2.03";"BDBM171770";"N#Cc1cnc(C(=O)Nc2ccc(F)c([C@@]3(C(F)F)N=C(N)O[C@@H]4C[C@@H]43)c2)c(CO)c1";"IC50";"'='";"197500.0";"nM";"";"Outside typical range";"316169";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688823";"";"None";"445.40";"0";"2.86";"BDBM171773";"COc1cc(C#N)cnc1C(=O)Nc1cc(C)c(F)c([C@@]2(C(F)F)N=C(N)O[C@@H]3C[C@@H]32)c1";"IC50";"'='";"1090000.0";"nM";"";"Outside typical range";"316172";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688827";"";"None";"427.43";"0";"3.78";"BDBM171778";"N#Cc1cnc2c(c1)CCC[C@H]2Nc1ccc(F)c([C@@]2(C(F)F)N=C(N)O[C@@H]3C[C@@H]32)c1";"IC50";"'='";"468840.0";"nM";"";"Outside typical range";"316175";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3693228";"";"None";"491.47";"0";"2.87";"BDBM171787";"NC1=N[C@@](c2cc(NC(=O)c3cnc(OCC4CCOCC4)cn3)ccc2F)(C(F)F)[C@H]2C[C@H]2O1";"IC50";"'='";"640340.0";"nM";"";"Outside typical range";"316183";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3693233";"";"None";"421.38";"0";"2.46";"BDBM171792";"CCOc1cnc(C(=O)Nc2ccc(F)c([C@@]3(C(F)F)N=C(N)O[C@@H]4C[C@@H]43)c2)cn1";"IC50";"'='";"1465100.0";"nM";"";"Outside typical range";"316188";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688651";"";"None";"447.83";"0";"2.59";"BDBM171587";"C#CCOc1cnc(C(=O)Nc2ccc(Cl)c([C@@]3(C(F)F)N=C(N)O[C@@H]4C[C@@H]43)c2)cn1";"IC50";"'='";"51050.0";"nM";"4.29";"";"315996";"UO_0000065";"9.58";"0.19";"1.70";"3.84";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688698";"";"None";"405.82";"0";"2.29";"BDBM171638";"COc1cnc(C(=O)Nc2ccc(Cl)c([C@@]3(CF)N=C(N)O[C@@H]4C[C@@H]43)c2)cn1";"IC50";"'='";"1733600.0";"nM";"";"Outside typical range";"316046";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688726";"";"None";"442.80";"0";"3.77";"BDBM171668";"Cc1cc(NC(=O)c2ncc(Cl)cc2F)cc([C@@]2(C(F)F)N=C(N)O[C@@H]3C[C@@H]32)c1F";"IC50";"'='";"810690.0";"nM";"";"Outside typical range";"316076";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688752";"";"None";"375.79";"0";"2.47";"BDBM171696";"C[C@]1(c2nc(NC(=O)c3ccc(Cl)cn3)ccc2F)N=C(N)O[C@@H]2C[C@@H]21";"IC50";"'='";"279000.0";"nM";"";"Outside typical range";"316100";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL2181022";"";"None";"1041.26";"None";"None";"9";"COC(=O)[C@@H]1CCCN1C(=O)[C@@H](Cc1ccccc1)N(C)C(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)C[C@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(N)=O)N(C)C(=O)[C@@H](NC(=O)OCc1ccccc1)C(C)C";"IC50";"'='";"0.0783";"nM";"10.11";"";"";"UO_0000065";"9.71";"None";"None";"None";"0";"CHEMBL2185513";"Inhibition of cathepsin D by fluorescence assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2176894";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL2048062";"";"None";"604.59";"1";"3.63";"62h";"CC(C)(C)Cn1cc(CN[C@H]2CS(=O)(=O)C[C@@H](Cc3cc(F)c(N)c(OC(C(F)(F)F)C(F)(F)F)c3)[C@@H]2O)cn1";"IC50";"'='";"2810.0";"nM";"5.55";"";"";"UO_0000065";"9.18";"0.19";"1.92";"4.65";"0";"CHEMBL2049562";"Inhibition of human recombinant CatD using Mca-GKPILFFRLK(DNP)-dR-NH2 as substrate after 1 hr by fluorescence analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2046351";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL3414700";"";"None";"334.34";"0";"2.89";"38";"NC1=N[C@@]2(c3ccc(F)cc3F)CO[C@@H](C(F)F)C[C@H]2CS1";"IC50";"'='";"83100.0";"nM";"4.08";"";"";"UO_0000065";"12.20";"0.25";"1.19";"8.57";"0";"CHEMBL3420009";"Inhibition of CatD (unknown origin) by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3414451";"1";"Scientific Literature";"J Med Chem";"2015";"None";"";"";""
"CHEMBL3414706";"";"None";"284.33";"0";"2.26";"24b";"NC1=N[C@@]2(c3ccc(F)cc3F)COCC[C@H]2CS1";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3420009";"Inhibition of CatD (unknown origin) by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3414451";"1";"Scientific Literature";"J Med Chem";"2015";"None";"";"";""
"CHEMBL3422244";"";"None";"397.42";"0";"3.63";"12";"Cc1coc([C@H]2C[C@H]3[C@@H](CF)SC(N)=N[C@@]3(c3ccc(F)cc3F)CO2)n1";"IC50";"'='";"19100.0";"nM";"4.72";"";"";"UO_0000065";"11.87";"0.24";"1.09";"6.41";"0";"CHEMBL3423725";"Inhibition of CatD (unknown origin) assessed as fluorescence polarization by cell free assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3421534";"1";"Scientific Literature";"J Med Chem";"2015";"None";"";"";""
"CHEMBL3422235";"";"None";"351.38";"0";"2.99";"2";"NC1=N[C@@]2(c3ccc(F)cc3F)CO[C@@H](c3ncco3)C[C@H]2CS1";"IC50";"'='";"74900.0";"nM";"4.13";"";"";"UO_0000065";"11.74";"0.23";"1.14";"5.60";"0";"CHEMBL3423725";"Inhibition of CatD (unknown origin) assessed as fluorescence polarization by cell free assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3421534";"1";"Scientific Literature";"J Med Chem";"2015";"None";"";"";""
"CHEMBL1077232";"";"None";"549.80";"2";"5.44";"28";"CCC(=O)N(C)C(C)(C)[C@H]1CCC[C@@H](C(=O)N[C@@H](Cc2ccccc2)[C@@H](O)CNCc2cccc(C(C)C)c2)C1";"IC50";"'='";"410.0";"nM";"6.39";"";"";"UO_0000065";"11.62";"0.22";"0.95";"7.82";"0";"CHEMBL1107841";"Inhibition of Cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1155410";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL1092504";"";"None";"515.74";"1";"3.98";"8";"CCCCNC(=O)[C@H](C)C[C@H](O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCC[C@H]([C@@H](NC(C)=O)C(C)C)C1";"IC50";"'='";"150.0";"nM";"6.82";"";"";"UO_0000065";"13.23";"0.25";"2.84";"6.35";"0";"CHEMBL1107841";"Inhibition of Cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1155410";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL1090027";"";"None";"361.38";"0";"2.31";"4m";"CN1C(=O)C(c2ccncc2)(c2cccc(-c3cccnc3F)c2)N=C1N";"IC50";"'='";"17400.0";"nM";"4.76";"";"";"UO_0000065";"13.17";"0.24";"2.45";"5.63";"0";"CHEMBL1115170";"Inhibition of cathepsin D by FRET assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156304";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL2408749";"";"None";"476.52";"0";"2.65";"38, epimeric mixture";"CC(=O)N[C@@H](Cc1cc(F)cc(F)c1)[C@H](O)CN[C@H]1CCOc2ccc(OC3CCOC3)cc21";"IC50";"'='";"255.0";"nM";"6.59";"";"";"UO_0000065";"13.84";"0.26";"3.94";"7.40";"0";"CHEMBL2410948";"Inhibition of cathepsin-D (unknown origin) using C-terminal biotinylated peptide substrate treated 30 mins before addition of peptide substrate measured after 110 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2406984";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"None";"";"";""
"CHEMBL3918407";"";"None";"637.82";"1";"2.99";"BDBM232247";"CC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)CC(C)C)C(=O)N[C@@H](Cc1ccccc1)[C@@H](N)CC(=O)NCCc1ccc2c(c1)OCO2";"IC50";"'='";"1800.0";"nM";"5.75";"";"405024";"UO_0000065";"9.01";"0.17";"2.75";"3.57";"0";"CHEMBL3888498";"In-Vitro Fluorescence Assay: In order to identify modulators of cathepsin D activity, a continuous enzymatic test was carried out with a synthetic peptide which carries a fluorescent group (MCA=(7-methoxycoumarin-4-yl)acetyl) which is quenched by energy transfer from a Dpn (2,4 dinitrophenyl) group on the same molecule, in Greiner 384-well nb microtitre plates. Cleavage of the peptidic substrate by cathepsin D causes an increase in the fluorescence intensity. In order to determine the efficacy of substances, the time-dependent increase in the fluorescence intensity in the presence of the substance was compared with the time-dependent increase in fluorescence in the absence of substances. The reference substance used was pepstatin A (Sigma-Aldrich). The substrate used was MCAGKPILFFRLK(Dnp)d-R-NH2 (Enzo Life Sciences, Lorrach). The enzyme employed was cathepsin D isolated from the human liver (Sigma-Aldrich) in a final concentration of 1.4 nM. The test was carried out in 100 mM sodium acetate buffer, 1.25% (v/v) of DMSO, 0.25% (w/v) of Chaps, pH 5.5. 2 ul of each substance solution with serially diluted substance concentration were added to in each case 4 ul of cathepsin D solution and incubated at room temperature for 10 min. The reaction was started by addition of 2 ul of substrate solution (final concentration 5 uM). After carrying out a starting-point fluorescence measurement (excitation wavelength 340 nm/emission wavelength 450 nm) using an Envision multilabel reader (Perkin Elmer), the reaction was incubated at room temperature for 60 min. The amount of peptide fragment cleaved off during the reaction time was subsequently measured by determination of the increase in the fluorescence intensity at 450 nm (excitation wavelength 340 nm).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886733";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3924316";"";"None";"745.02";"2";"3.38";"BDBM232255";"CC[C@H](C)[C@H](NC(=O)C[C@H](N)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)CC(C)C)C(C)C)C(=O)N[C@H](C(=O)OC)[C@@H](C)CC";"IC50";"'='";"47.0";"nM";"7.33";"";"405032";"UO_0000065";"9.84";"0.19";"3.95";"3.70";"0";"CHEMBL3888498";"In-Vitro Fluorescence Assay: In order to identify modulators of cathepsin D activity, a continuous enzymatic test was carried out with a synthetic peptide which carries a fluorescent group (MCA=(7-methoxycoumarin-4-yl)acetyl) which is quenched by energy transfer from a Dpn (2,4 dinitrophenyl) group on the same molecule, in Greiner 384-well nb microtitre plates. Cleavage of the peptidic substrate by cathepsin D causes an increase in the fluorescence intensity. In order to determine the efficacy of substances, the time-dependent increase in the fluorescence intensity in the presence of the substance was compared with the time-dependent increase in fluorescence in the absence of substances. The reference substance used was pepstatin A (Sigma-Aldrich). The substrate used was MCAGKPILFFRLK(Dnp)d-R-NH2 (Enzo Life Sciences, Lorrach). The enzyme employed was cathepsin D isolated from the human liver (Sigma-Aldrich) in a final concentration of 1.4 nM. The test was carried out in 100 mM sodium acetate buffer, 1.25% (v/v) of DMSO, 0.25% (w/v) of Chaps, pH 5.5. 2 ul of each substance solution with serially diluted substance concentration were added to in each case 4 ul of cathepsin D solution and incubated at room temperature for 10 min. The reaction was started by addition of 2 ul of substrate solution (final concentration 5 uM). After carrying out a starting-point fluorescence measurement (excitation wavelength 340 nm/emission wavelength 450 nm) using an Envision multilabel reader (Perkin Elmer), the reaction was incubated at room temperature for 60 min. The amount of peptide fragment cleaved off during the reaction time was subsequently measured by determination of the increase in the fluorescence intensity at 450 nm (excitation wavelength 340 nm).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886733";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3670375";"";"None";"513.80";"1";"4.46";"15; CNP520";"C[C@@]1(c2nc(NC(=O)c3ncc(C(F)(F)F)cc3Cl)ccc2F)CO[C@@](C)(C(F)(F)F)C(N)=N1";"IC50";"'='";"205000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5054750";"Inhibition of human cathepsin D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5053529";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL1824342";"";"None";"434.52";"0";"3.55";"45";"CN1C(=O)C(c2cccc(-c3cccnc3F)c2)(c2cnn(CCC(C)(C)C)c2)N=C1N";"IC50";"'='";"360.0";"nM";"6.44";"";"";"UO_0000065";"14.83";"0.28";"2.89";"7.21";"0";"CHEMBL1825607";"Inhibition of cathepsin D by FRET assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1821667";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL69019";"";"None";"427.55";"0";"4.62";"8a";"CCCc1c(OCc2ccc(/C=C3\SC(=S)NC3=O)cc2)ccc(C(C)=O)c1O";"IC50";"'='";"2560.0";"nM";"5.59";"";"";"UO_0000065";"13.08";"0.26";"0.97";"7.39";"0";"CHEMBL658685";"In vitro inhibition of cathepsin D.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1129769";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1996";"None";"";"";""
"CHEMBL3688655";"";"None";"417.80";"0";"2.90";"BDBM171593";"N#Cc1cnc(C(=O)Nc2ccc(F)c([C@]3(CF)N=C(N)O[C@H]4C[C@H]43)c2)c(Cl)c1";"IC50";"'='";"2256300.0";"nM";"";"Outside typical range";"316002";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL113560";"";"None";"745.92";"2";"3.24";"32";"CC(C)[C@@H]1NC(=O)[C@@H]([C@H](O)[C@H](Cc2ccccc2)NC(=O)[C@@H](NC(=O)OCc2ccccc2)C(C)(C)C)NCc2ccc(cc2)OCCOCCNC1=O";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL662648";"The compound was tested for inhibition of Human Cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1129607";"1";"Scientific Literature";"J Med Chem";"1996";"None";"";"";""
"CHEMBL405692";"";"None";"668.84";"2";"2.23";"33";"CN1C(=O)[C@H]([C@H](O)[C@H](CC2CCCCC2)NC(=O)[C@H](Cc2c[nH]cn2)NC(=O)[C@H](Cc2ccccc2)NC(=O)OC(C)(C)C)C[C@H]1CO";"IC50";"'~'";"5000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL657351";"Inhibitory concentration against cathepsin D";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1125921";"1";"Scientific Literature";"J Med Chem";"1991";"None";"";"";""
"CHEMBL104783";"";"None";"765.95";"2";"4.65";"16";"COc1ccc(CN[C@@H](C(=O)N[C@H](C(=O)NCc2ccccc2)C(C)C)[C@H](O)[C@H](Cc2ccccc2)NC(=O)[C@@H](NC(=O)OCc2ccccc2)C(C)C)cc1";"IC50";"'='";"110.0";"nM";"6.96";"";"";"UO_0000065";"9.08";"0.17";"2.31";"4.16";"0";"CHEMBL657353";"Selectivity for their inhibitory potency against human cathepsin D.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1127464";"1";"Scientific Literature";"J Med Chem";"1994";"None";"";"";""
"CHEMBL212492";"";"None";"527.57";"2";"5.68";"22";"COc1ccc(NC(=O)/C=C/COc2ccc3ccccc3c2C(=O)c2cc(OC)c(OC)c(OC)c2)cc1";"IC50";"'='";"4710.0";"nM";"5.33";"";"";"UO_0000065";"10.10";"0.19";"-0.35";"5.77";"0";"CHEMBL869858";"Inhibition of human cathepsin D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1149516";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"None";"";"";""
"CHEMBL3422237";"";"None";"365.41";"0";"3.30";"4";"Cc1cc([C@H]2C[C@H]3CSC(N)=N[C@@]3(c3ccc(F)cc3F)CO2)on1";"IC50";"'='";"9400.0";"nM";"5.03";"";"";"UO_0000065";"13.76";"0.27";"1.73";"6.83";"0";"CHEMBL3423725";"Inhibition of CatD (unknown origin) assessed as fluorescence polarization by cell free assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3421534";"1";"Scientific Literature";"J Med Chem";"2015";"None";"";"";""
"CHEMBL1941011";"";"None";"349.34";"0";"4.26";"8";"O=C(Cn1c(-c2ccccn2)nc2ccccc21)c1ccc(F)cc1F";"IC50";"'='";"44500.0";"nM";"4.35";"";"";"UO_0000065";"12.46";"0.23";"0.09";"9.11";"0";"CHEMBL1942416";"Inhibition of human cathepsin D using DABCYL-Glu-Arg-Nle-Phe-Leu-Ser-Phe-Pro-EDANS as substrate by FRET analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1938395";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL3109522";"";"None";"410.52";"0";"4.69";"BDBM234503";"N=C1NC(c2ccccc2)(c2cccc(-c3cccnc3)c2)C(=O)N1C1CCCCC1";"IC50";"'>'";"10000.0";"nM";"";"";"312499";"UO_0000065";"";"";"";"";"0";"CHEMBL3887168";"Fluorescence Resonance Energy Transfer (FRET) Assay : The recombinant human BACE1, Cathepsin D, and Cathepsin E enzymes were purchased from R&D Systems (catalog numbers are 931-AS, 1014AS and 1294AS, respectively). The enzymatic inhibition activity assays were determined using the fluorescence resonance energy transfer (FRET) assay. The assays were performed in a 384-well plate format. The recombinant human BACE-1 enzyme (R&D Systems, catalog#931-AS) was diluted to 20 ng/L in assay buffer (100 mM sodium acetate pH 4.0), 10 point 1:3 serial dilutions of compound in DMSO were preincubated with the enzyme for 15 min at room temperature. The concentration of Cathepsin D was 20 ng/L, and 1 ng/L of Cathepsin E was used. CatD and CatE were activated by incubation in assay buffer (0.1 M NaOAc, 0.2 M NaCl, pH 3.5) at room temperature for 30 min. Subsequently, the rhBACE-1 substrate (R&D Systems, catalog# ES004), the Cathepsin D and Cathepsin E substrate (R&D Systems, Catalog # ES001) were added accordingly to final concentration";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886201";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL253800";"";"None";"667.87";"1";"4.55";"32";"CCCC(CCC)S(=O)(=O)CC(NC(=O)OCc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)[C@H](O)CNCc1cccc(OC)c1";"IC50";"'='";"67.0";"nM";"7.17";"";"";"UO_0000065";"10.74";"0.21";"2.62";"5.01";"0";"CHEMBL942098";"Inhibition of human recombinant cathepsin D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140593";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"None";"";"";""
"CHEMBL4170992";"";"None";"945.17";"3";"0.15";"2";"CC[C@H](C)[C@H](NC(=O)C[C@H](O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)N(C)C(=O)[C@H](CC(C)C)NC(=O)[C@H](C)O)C(=O)NCC(=O)N(C)[C@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)OC";"IC50";"'='";"900.0";"nM";"6.05";"";"";"UO_0000065";"6.40";"0.12";"5.90";"2.11";"0";"CHEMBL4141000";"Inhibition of human liver cathepsin D using Mca-Gly-Lys-Pro-Ile-Leu-PhePhe-Arg-Leu-Lys-(Dnp)-D-Arg-NH2 as substrate pretreated for 15 mins followed by substrate addition measured at 5 mins interval for 120 mins by fluorescence assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4138143";"1";"Scientific Literature";"J Nat Prod";"2017";"None";"";"";""
"CHEMBL4163078";"";"None";"1134.43";"None";"None";"3";"CC[C@H](C)[C@H](NC(=O)C[C@H](O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)N(C)C(=O)[C@H](CC(C)C)NC(=O)[C@H](C)OC(=O)[C@H](Cc1ccccc1)N(C)C)C(=O)N[C@@H](C)C(=O)N(C)[C@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)OC";"IC50";"'='";"5.5";"nM";"8.26";"";"";"UO_0000065";"7.28";"None";"None";"None";"0";"CHEMBL4141003";"Inhibition of cathepsin D in human MDA-MB-231 cell lysates using Mca-Gly-Lys-Pro-Ile-Leu-PhePhe-Arg-Leu-Lys-(Dnp)-D-Arg-NH2 as substrate pretreated for 15 mins followed by substrate addition measured at 30 secs interval for 30 mins by fluorescence assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4138143";"1";"Scientific Literature";"J Nat Prod";"2017";"None";"";"";""
"CHEMBL4203860";"";"None";"418.54";"0";"3.09";"70";"COc1cccc(NC(=O)c2cnc([C@]34CO[C@@H](C)C[C@H]3CSC(N)=N4)s2)c1";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4183115";"Inhibition of Cathepsin D (unknown origin) by fluorescence polarization assay";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4177751";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL402576";"";"None";"474.65";"0";"4.36";"39";"N/C(=N/C(=O)Cn1c(-c2ccccc2)ccc1C12CC3CC(CC(C3)C1)C2)N[C@H]1CC[C@H](O)CC1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL930552";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1142260";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";"";"";""
"CHEMBL2047915";"";"None";"474.67";"0";"3.46";"41a";"CCCOc1cc(C[C@@H]2CS(=O)(=O)C[C@H](NCc3cccc(C(C)(C)C)c3)[C@H]2O)ccc1N";"IC50";"'='";"5200.0";"nM";"5.28";"";"";"UO_0000065";"11.13";"0.22";"1.82";"5.20";"0";"CHEMBL2049562";"Inhibition of human recombinant CatD using Mca-GKPILFFRLK(DNP)-dR-NH2 as substrate after 1 hr by fluorescence analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2046351";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL2048048";"";"None";"508.66";"1";"2.84";"60k";"COCCOc1cc(C[C@@H]2CS(=O)(=O)C[C@H](NCc3cccc(C(C)(C)C)c3)[C@H]2O)cc(F)c1N";"IC50";"'='";"3980.0";"nM";"5.40";"";"";"UO_0000065";"10.62";"0.21";"2.56";"4.87";"0";"CHEMBL2049562";"Inhibition of human recombinant CatD using Mca-GKPILFFRLK(DNP)-dR-NH2 as substrate after 1 hr by fluorescence analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2046351";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL3653401";"";"None";"489.27";"0";"4.16";"38b";"C[C@@]1(c2cc(NC(=O)c3ccc(Br)cn3)ccc2F)CO[C@@](C)(C(F)(F)F)C(N)=N1";"IC50";"'>'";"250000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5055931";"Inhibition of human cathepsin D using Mca-GKPILFFRLK(DNP)D-R-NH2 as a substrate";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5055623";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"";""
"CHEMBL3653403";"";"None";"436.37";"0";"2.66";"rac-64b";"C[C@@]1(c2cc(NC(=O)c3ncc(C#N)cn3)ccc2F)CO[C@@](C)(C(F)(F)F)C(N)=N1";"IC50";"'>'";"250000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5055931";"Inhibition of human cathepsin D using Mca-GKPILFFRLK(DNP)D-R-NH2 as a substrate";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5055623";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"";""
"CHEMBL5077684";"";"None";"450.40";"0";"2.97";"64d";"Cc1nc(C#N)cnc1C(=O)Nc1ccc(F)c([C@]2(C)CO[C@@](C)(C(F)(F)F)C(N)=N2)c1";"IC50";"'>'";"250000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5055931";"Inhibition of human cathepsin D using Mca-GKPILFFRLK(DNP)D-R-NH2 as a substrate";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5055623";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"";""
"CHEMBL2069616";"";"None";"673.85";"2";"6.18";"6";"CCCCNC(=O)C[C@H](O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)c1ccc(Oc2ccc(C(=O)OCc3ccccc3)cc2)cc1)[C@@H](C)CC";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL2072160";"Inhibition of human cathepsin D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2069175";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL2048049";"";"None";"492.66";"0";"3.60";"60l";"CC(C)Oc1cc(C[C@@H]2CS(=O)(=O)C[C@H](NCc3cccc(C(C)(C)C)c3)[C@H]2O)cc(F)c1N";"IC50";"'='";"2220.0";"nM";"5.65";"";"";"UO_0000065";"11.48";"0.23";"2.05";"5.56";"0";"CHEMBL2049562";"Inhibition of human recombinant CatD using Mca-GKPILFFRLK(DNP)-dR-NH2 as substrate after 1 hr by fluorescence analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2046351";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL2047900";"";"None";"468.66";"0";"4.13";"32c";"CCc1c[nH]c2ccc(C[C@@H]3CS(=O)(=O)C[C@H](NCc4cccc(C(C)(C)C)c4)[C@H]3O)cc12";"IC50";"'='";"2480.0";"nM";"5.61";"";"";"UO_0000065";"11.96";"0.23";"1.48";"6.82";"0";"CHEMBL2049562";"Inhibition of human recombinant CatD using Mca-GKPILFFRLK(DNP)-dR-NH2 as substrate after 1 hr by fluorescence analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2046351";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL2047902";"";"None";"500.68";"1";"4.08";"39b";"CC(C)(C)c1cccc(CN[C@H]2CS(=O)(=O)C[C@@H](Cc3cc(F)c4c(c3)C3(CCC3)CN4)[C@@H]2O)c1";"IC50";"'='";"1720.0";"nM";"5.76";"";"";"UO_0000065";"11.51";"0.22";"1.68";"7.35";"0";"CHEMBL2049562";"Inhibition of human recombinant CatD using Mca-GKPILFFRLK(DNP)-dR-NH2 as substrate after 1 hr by fluorescence analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2046351";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL4460278";"";"None";"408.86";"0";"3.93";"6";"C[C@]1(c2cc(NC(=O)c3ccc(Cl)cn3)cc(F)c2F)N=C(N)S[C@H]2C[C@H]21";"IC50";"'>='";"750000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4343401";"Inhibition of recombinant CatD (unknown origin) expressed in CHO cells using FRET peptide substrate preincubated for 1 hr followed by substrate addition and measured after 1 hr by FRET assay";"A";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4342420";"1";"Scientific Literature";"J Med Chem";"2020";"CHEMBL3308072";"";"";""
"CHEMBL4471141";"";"None";"433.87";"0";"3.82";"14";"C[C@]1(c2cc(NC(=O)c3ccc(Cl)cn3)cc(F)c2F)N=C(N)S[C@@]2(C#N)C[C@H]21";"IC50";"'='";"400000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4343401";"Inhibition of recombinant CatD (unknown origin) expressed in CHO cells using FRET peptide substrate preincubated for 1 hr followed by substrate addition and measured after 1 hr by FRET assay";"A";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4342420";"1";"Scientific Literature";"J Med Chem";"2020";"CHEMBL3308072";"";"";""
"CHEMBL1098671";"";"None";"597.72";"1";"1.79";"9";"C#CCNC(=O)[C@H](Cc1ccccc1)NC(=O)C[C@H](O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)c1ccccn1)C(C)C";"IC50";"'='";"50.0";"nM";"7.30";"";"";"UO_0000065";"12.21";"0.23";"5.51";"4.88";"0";"CHEMBL1114767";"Inhibition of human cathepsin D after 30 mins by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1157812";"1";"Scientific Literature";"J Med Chem";"2010";"None";"";"";""
"CHEMBL2069615";"";"None";"672.87";"2";"5.75";"5";"CCCCNC(=O)C[C@H](O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)c1ccc(Oc2ccc(C(=O)NCc3ccccc3)cc2)cc1)[C@@H](C)CC";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL2072160";"Inhibition of human cathepsin D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2069175";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL2048037";"";"None";"514.61";"1";"3.61";"41b";"CC(C)(C)c1cccc(CN[C@H]2CS(=O)(=O)C[C@@H](Cc3ccc(N)c(OCC(F)(F)F)c3)[C@@H]2O)c1";"IC50";"'='";"4370.0";"nM";"5.36";"";"";"UO_0000065";"10.41";"0.21";"1.75";"5.27";"0";"CHEMBL2049562";"Inhibition of human recombinant CatD using Mca-GKPILFFRLK(DNP)-dR-NH2 as substrate after 1 hr by fluorescence analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2046351";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL2048042";"";"None";"450.58";"0";"2.52";"60e";"CC(C)(C)c1cccc(CN[C@H]2CS(=O)(=O)C[C@@H](Cc3cc(O)c(N)c(F)c3)[C@@H]2O)c1";"IC50";"'='";"540.0";"nM";"6.27";"";"";"UO_0000065";"13.91";"0.28";"3.75";"5.56";"0";"CHEMBL2049562";"Inhibition of human recombinant CatD using Mca-GKPILFFRLK(DNP)-dR-NH2 as substrate after 1 hr by fluorescence analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2046351";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL2048051";"";"None";"590.68";"1";"4.16";"60n";"CCOC[C@@H](Oc1cc(C[C@@H]2CS(=O)(=O)C[C@H](NCc3cccc(C(C)(C)C)c3)[C@H]2O)cc(F)c1N)C(F)(F)F";"IC50";"'='";"230.0";"nM";"6.64";"";"";"UO_0000065";"11.24";"0.23";"2.48";"5.99";"0";"CHEMBL2049562";"Inhibition of human recombinant CatD using Mca-GKPILFFRLK(DNP)-dR-NH2 as substrate after 1 hr by fluorescence analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2046351";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL3344163";"";"None";"771.88";"2";"2.70";"36";"C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)OCc1ccccc1)C(=O)N[C@@H](CC1CCCCC1)[C@@H](O)CC(=O)NC1CCCCC1.O=C(O)C(F)(F)F";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL3370435";"Inhibition of human cathepsin D assessed as cleavage of wtKAHRP fluorogenic substrate";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3352063";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL3763261";"";"None";"453.59";"1";"5.91";"rac-4a";"CCCCc1ccc(-c2ccc3c(=O)n(C[C@@H]4CC[C@H](c5ccccc5)O4)c(N)nc3c2)cc1";"IC50";"'='";"2200.0";"nM";"5.66";"";"";"UO_0000065";"12.47";"0.23";"-0.25";"8.07";"0";"CHEMBL3767017";"Inhibition of CatD (unknown origin) preincubated for 30 mins followed by DABCYL-Glu-Arg-Nle-Phe-Leu-Ser-Phe-Pro-EDANS substrate addition by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3763050";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";""
"CHEMBL3667410";"";"None";"485.50";"0";"2.93";"20";"NC1=N[C@@]2(c3cc(NC(=O)c4ccc(F)cn4)ccc3F)CN(c3ncc(F)cn3)C[C@H]2CS1";"IC50";"'='";"80000.0";"nM";"4.10";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5034187";"Inhibition of human Cathepsin D by FRET assay";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5033995";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL4073296";"";"None";"355.45";"0";"2.85";"6e";"CO[C@@H]1CCN(Cc2cc([C@]3(C)CCSC(N)=N3)c(F)cc2F)C1";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4042703";"Inhibition of Cathepsin D (unknown origin) by cell free assay";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4041533";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";"";""
"CHEMBL4088234";"";"None";"393.43";"0";"4.20";"12";"C[C@@H]1C[C@@](C)(c2cc(CNC3(C(F)(F)F)CC3)c(F)cc2F)N=C(N)S1";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4042703";"Inhibition of Cathepsin D (unknown origin) by cell free assay";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4041533";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";"";""
"CHEMBL400530";"";"None";"563.72";"1";"4.28";"2b";"CCCN(c1cc2cc(c1)C(=O)N[C@@H](c1ccccc1)CCc1cccc(c1)C[C@@](C)(N)C(=O)OC2)S(C)(=O)=O";"IC50";"'='";"97000.0";"nM";"4.01";"";"";"UO_0000065";"7.12";"0.14";"-0.27";"3.38";"0";"CHEMBL886447";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1139967";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"None";"";"";""
"CHEMBL1454208";"";"None";"250.66";"0";"3.13";"3";"O=C(Nc1ccc(Cl)nc1)c1ccc(F)cc1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL3811221";"Inhibition of Cathepsin D (unknown origin) by fluorescence assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3808306";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";""
"CHEMBL3808672";"";"None";"389.54";"1";"5.28";"5";"Cc1ccccc1-c1ccc2nc(N)c(CCC(=O)NCCC(C)(C)C)cc2c1";"IC50";"'='";"510.0";"nM";"6.29";"";"";"UO_0000065";"16.15";"0.30";"1.01";"9.25";"0";"CHEMBL3811221";"Inhibition of Cathepsin D (unknown origin) by fluorescence assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3808306";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";""
"CHEMBL252458";"";"None";"536.76";"2";"5.14";"12";"CCNc1cc(C(=O)N[C@@H](Cc2ccccc2)[C@H](O)CNC(C)(C)CCCC(C)C)cc(N2CCCC2=O)c1";"IC50";"'='";"2510.0";"nM";"5.60";"";"";"UO_0000065";"10.43";"0.20";"0.46";"5.98";"0";"CHEMBL945833";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140837";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";"";"";""
"CHEMBL252262";"";"None";"506.69";"1";"4.12";"10";"CCNc1cc(C(=O)N[C@@H](Cc2ccccc2)[C@H](O)CNCC2CCCCC2)cc(N2CCCC2=O)c1";"IC50";"'='";"12020.0";"nM";"4.92";"";"";"UO_0000065";"9.71";"0.18";"0.80";"5.25";"0";"CHEMBL945833";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140837";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";"";"";""
"CHEMBL255192";"";"None";"589.78";"1";"3.54";"25";"C[C@H](NC[C@@H](O)[C@H](Cc1ccccc1)NC(=O)c1cc(N2CCCC2)cc(N2CCCC2=O)c1)C(=O)NC1CCCCC1";"IC50";"'='";"9277.0";"nM";"5.03";"";"";"UO_0000065";"8.53";"0.16";"1.49";"4.41";"0";"CHEMBL931965";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1143153";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";"";"";""
"CHEMBL271231";"";"None";"494.64";"0";"2.77";"13";"CC(=O)Nc1ccc(C(=O)N[C@@H](Cc2ccccc2)[C@H](O)CN[C@@H](C)C(=O)NC2CCCCC2)cc1";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL931965";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1143153";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";"";"";""
"CHEMBL83926";"";"None";"531.36";"2";"7.61";"3";"O=C(Nc1ccc(Sc2nc3ccc(OC(F)(F)F)cc3s2)cc1)c1cc(Cl)cc(Cl)c1O";"IC50";"'='";"1700.0";"nM";"5.77";"";"";"UO_0000065";"10.86";"0.24";"-1.84";"8.07";"0";"CHEMBL657347";"Inhibitory activity against human liver Cathepsin D using Cathepsin D assay.";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1132101";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1999";"None";"";"";""
"CHEMBL311721";"";"None";"422.53";"1";"5.80";"38";"CCOc1ccc2nc(Sc3ccc(NC(=O)c4ccccc4O)cc3)sc2c1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL657347";"Inhibitory activity against human liver Cathepsin D using Cathepsin D assay.";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1132101";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1999";"None";"";"";""
"CHEMBL587764";"";"None";"692.92";"2";"5.11";"1SR";"CCCN(CCC)C(=O)c1cc(C(=O)N[C@@H](Cc2ccccc2)[C@H](O)CNC(C)(C)c2cccc(OC)c2)cc(N2CCCCS2(=O)=O)c1";"IC50";"'='";"43.0";"nM";"7.37";"";"";"UO_0000065";"10.63";"0.21";"2.26";"5.74";"0";"CHEMBL3271470";"Inhibition of human cathepsin-D using DABCYL-Glu-Arg-Nle-Phe-Leu-Ser-Phe-Pro-EDANS as substrate preincubated for 30 mins by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3259525";"1";"Scientific Literature";"ACS Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3264798";"";"None";"662.90";"2";"5.11";"2SS";"CCCN(CCC)C(=O)c1cc(C(=O)N[C@@H](Cc2ccccc2)[C@@H](O)CNC(C)(C)c2ccccc2)cc(N2CCCCS2(=O)=O)c1";"IC50";"'='";"5800.0";"nM";"5.24";"";"";"UO_0000065";"7.90";"0.15";"0.13";"4.40";"0";"CHEMBL3271470";"Inhibition of human cathepsin-D using DABCYL-Glu-Arg-Nle-Phe-Leu-Ser-Phe-Pro-EDANS as substrate preincubated for 30 mins by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3259525";"1";"Scientific Literature";"ACS Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3264801";"";"None";"612.86";"2";"6.17";"5";"CCCN(CCC)C(=O)c1cc(C(=O)N[C@@H](Cc2ccccc2)[C@H](O)CNC(C)(C)c2ccccc2)cc(N2CCCCC2)c1";"IC50";"'='";"51.0";"nM";"7.29";"";"";"UO_0000065";"11.90";"0.22";"1.12";"8.59";"0";"CHEMBL3271470";"Inhibition of human cathepsin-D using DABCYL-Glu-Arg-Nle-Phe-Leu-Ser-Phe-Pro-EDANS as substrate preincubated for 30 mins by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3259525";"1";"Scientific Literature";"ACS Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3259870";"";"None";"600.80";"2";"5.05";"13";"CCCNC(=O)c1cc(C(=O)N[C@@H](Cc2ccccc2)[C@H](O)CNC(C)(C)c2cccc(OC)c2)cc(N2CCCCC2)c1";"IC50";"'='";"110.0";"nM";"6.96";"";"";"UO_0000065";"11.58";"0.22";"1.91";"6.76";"0";"CHEMBL3271470";"Inhibition of human cathepsin-D using DABCYL-Glu-Arg-Nle-Phe-Leu-Ser-Phe-Pro-EDANS as substrate preincubated for 30 mins by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3259525";"1";"Scientific Literature";"ACS Med Chem Lett";"2014";"None";"";"";""
"CHEMBL4470897";"";"None";"460.51";"0";"2.87";"90";"C#CCOc1cnc(/C(F)=C/c2ccc(F)c([C@]3(C)CS(=O)(=O)C(C)(C)C(N)=N3)c2)cn1";"IC50";"'='";"35800.0";"nM";"4.45";"";"";"UO_0000065";"9.65";"0.19";"1.58";"4.13";"0";"CHEMBL4342626";"Inhibition of recombinant Cathepsin D (unknown origin) expressed in CHO cells preincubated for 1 hr followed by substrate addition and measured after 1 hr by FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4342403";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"CHEMBL3308072";"";"";""
"CHEMBL4569563";"";"None";"556.58";"1";"4.94";"16";"CC(C)[C@@H]1NC(=O)C[C@H](O)[C@H](Cc2ccc(Cl)c(Cl)c2)NC(=O)CCCCCCCCCCCNC1=O";"IC50";"'='";"4.2";"nM";"8.38";"";"";"UO_0000065";"15.05";"0.31";"3.44";"7.79";"0";"CHEMBL4325791";"Inhibition of human placenta CatD using Abz-Lys-Pro-Ala-Glu-Phe-Nph-Ala-Leu as substrate preincubated for 10 mins followed by substrate addition and measured by FRET assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4321885";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";""
"CHEMBL4522728";"";"None";"443.65";"0";"2.32";"23";"CC(C)[C@@H]1NC(=O)C[C@H](O)[C@H](CS)NC(=O)CCCCCCCCCCCNC1=O";"IC50";"'='";"340.0";"nM";"6.47";"";"";"UO_0000065";"14.58";"0.29";"4.15";"6.02";"0";"CHEMBL4325791";"Inhibition of human placenta CatD using Abz-Lys-Pro-Ala-Glu-Phe-Nph-Ala-Leu as substrate preincubated for 10 mins followed by substrate addition and measured by FRET assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4321885";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";""
"CHEMBL4475533";"";"None";"465.91";"0";"3.05";"12";"CNC(=O)[C@]12C[C@H]1[C@@](C)(c1cc(NC(=O)c3ccc(Cl)cn3)cc(F)c1F)N=C(N)S2";"IC50";"'='";"795000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4343401";"Inhibition of recombinant CatD (unknown origin) expressed in CHO cells using FRET peptide substrate preincubated for 1 hr followed by substrate addition and measured after 1 hr by FRET assay";"A";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4342420";"1";"Scientific Literature";"J Med Chem";"2020";"CHEMBL3308072";"";"";""
"CHEMBL4562169";"";"None";"330.43";"0";"0.90";"5";"CC(C)CC(=O)N[C@@H](CC(C)C)[C@@H](O)CC(=O)N[C@@H](C)C(=O)O";"IC50";"'>'";"200000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4325791";"Inhibition of human placenta CatD using Abz-Lys-Pro-Ala-Glu-Phe-Nph-Ala-Leu as substrate preincubated for 10 mins followed by substrate addition and measured by FRET assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4321885";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";""
"CHEMBL2047897";"";"None";"440.61";"0";"3.57";"27";"CC(C)(C)c1cccc(CN[C@H]2CS(=O)(=O)C[C@@H](Cc3ccc4[nH]ccc4c3)[C@@H]2O)c1";"IC50";"'='";"5530.0";"nM";"5.26";"";"";"UO_0000065";"11.93";"0.23";"1.69";"6.40";"0";"CHEMBL2049562";"Inhibition of human recombinant CatD using Mca-GKPILFFRLK(DNP)-dR-NH2 as substrate after 1 hr by fluorescence analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2046351";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL2349463";"";"None";"382.89";"0";"3.75";"60, rac-60";"CN1C(=O)CC2(CC(C)(C)Cc3ccc(-c4cncc(Cl)c4)cc32)N=C1N";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL2352017";"Inhibition of human spleen cathepsin D using 5-FAM/QXL as peptide substrate after 1 hr by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"CHEMBL3559722";"Spleen";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346596";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL2349489";"";"None";"371.94";"1";"5.02";"59, rac-59";"CC1(C)Cc2ccc(-c3cncc(Cl)c3)cc2C2(CCSC(N)=N2)C1";"IC50";"'='";"44161.0";"nM";"4.36";"";"";"UO_0000065";"11.71";"0.24";"-0.67";"8.49";"0";"CHEMBL2352017";"Inhibition of human spleen cathepsin D using 5-FAM/QXL as peptide substrate after 1 hr by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"CHEMBL3559722";"Spleen";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346596";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL2349487";"";"None";"341.84";"0";"3.91";"57, rac-57";"CC1(C)Cc2ccc(-c3cncc(Cl)c3)cc2C2(COC(N)=N2)C1";"IC50";"'='";"11844.0";"nM";"4.93";"";"";"UO_0000065";"14.41";"0.28";"1.02";"8.14";"0";"CHEMBL2352017";"Inhibition of human spleen cathepsin D using 5-FAM/QXL as peptide substrate after 1 hr by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"CHEMBL3559722";"Spleen";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346596";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL2349475";"";"None";"358.45";"0";"3.18";"45, rac-45";"CN1C(=O)C2(CC(C)(C)Cc3ccc(-c4cccc(C#N)c4)cc32)N=C1N";"IC50";"'='";"1894.0";"nM";"5.72";"";"";"UO_0000065";"15.96";"0.29";"2.54";"6.94";"0";"CHEMBL2352017";"Inhibition of human spleen cathepsin D using 5-FAM/QXL as peptide substrate after 1 hr by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"CHEMBL3559722";"Spleen";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346596";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL2349490";"";"None";"387.84";"0";"3.69";"20, rac-20";"CN1C(=O)C2(CC(C)(C)Oc3ccc(-c4cc(F)cc(Cl)c4)cc32)N=C1N";"IC50";"'='";"1030.0";"nM";"5.99";"";"";"UO_0000065";"15.44";"0.30";"2.30";"8.82";"0";"CHEMBL2352017";"Inhibition of human spleen cathepsin D using 5-FAM/QXL as peptide substrate after 1 hr by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"CHEMBL3559722";"Spleen";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346596";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL2349618";"";"None";"383.42";"0";"3.04";"18, rac-18";"COc1cc(F)cc(-c2ccc3c(c2)C2(CC(C)(C)O3)N=C(N)N(C)C2=O)c1";"IC50";"'='";"683.0";"nM";"6.17";"";"";"UO_0000065";"16.08";"0.30";"3.13";"7.99";"0";"CHEMBL2352017";"Inhibition of human spleen cathepsin D using 5-FAM/QXL as peptide substrate after 1 hr by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"CHEMBL3559722";"Spleen";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346596";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL2349617";"";"None";"404.30";"0";"4.20";"17, rac-17";"CN1C(=O)C2(CC(C)(C)Oc3ccc(-c4cc(Cl)cc(Cl)c4)cc32)N=C1N";"IC50";"'='";"185.0";"nM";"6.73";"";"";"UO_0000065";"16.65";"0.34";"2.53";"9.91";"0";"CHEMBL2352017";"Inhibition of human spleen cathepsin D using 5-FAM/QXL as peptide substrate after 1 hr by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"CHEMBL3559722";"Spleen";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346596";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL2047894";"";"None";"417.58";"0";"2.07";"18";"CC(C)(C)c1cccc(CN[C@H]2CS(=O)(=O)C[C@@H](Cc3ccc(N)nc3)[C@@H]2O)c1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2049562";"Inhibition of human recombinant CatD using Mca-GKPILFFRLK(DNP)-dR-NH2 as substrate after 1 hr by fluorescence analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2046351";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";""
"CHEMBL4439389";"";"None";"602.78";"1";"3.63";"(S,R)-3j";"COc1cccc(C(C)(C)NC[C@@H](O)[C@H](Cc2ccccc2)NC(=O)c2cc(C(=O)NCCO)cc(N3CCCCC3)c2)c1";"IC50";"'='";"1420.0";"nM";"5.85";"";"";"UO_0000065";"9.70";"0.18";"2.22";"4.75";"0";"CHEMBL4331648";"Inhibition of human cathepsin D using DABCYL-Glu-Arg-Nle-Phe-Leu-Ser-Phe-Pro-EDANS as substrate preincubated for 30 mins followed by substrate addition and measured every min for 8 to 15 mins by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4330085";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";"";"";""
"CHEMBL4464784";"";"None";"545.72";"1";"4.70";"(S,R)-5a";"COc1cccc(C(C)(C)NC[C@@H](O)[C@H](Cc2ccccc2)NC(=O)c2cccc(C(=O)NCC(C)(C)C)c2)c1";"IC50";"'='";"3800.0";"nM";"5.42";"";"";"UO_0000065";"9.93";"0.19";"0.72";"5.44";"0";"CHEMBL4331648";"Inhibition of human cathepsin D using DABCYL-Glu-Arg-Nle-Phe-Leu-Ser-Phe-Pro-EDANS as substrate preincubated for 30 mins followed by substrate addition and measured every min for 8 to 15 mins by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4330085";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";"";"";""
"CHEMBL4762370";"";"None";"431.39";"0";"3.70";"3";"CC(C)CN(C[C@H](O)[C@@H](N)c1ccccc1)S(=O)(=O)c1ccc(Cl)c(Cl)c1";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4667898";"Inhibition of human cathepsin D (1 to 412 residues) expressed in baculovirus infected insect cells using R-C(PT14)-KPILFFRLGWR-OH as substrate preincubated for 1 hr followed by substrate addition and measured after 1 hr by fluorescence based assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665664";"1";"Scientific Literature";"ACS Med Chem Lett";"2019";"None";"TIME = 2.0 hr";"";""
"CHEMBL4280656";"";"None";"402.84";"0";"3.86";"9";"CC#Cc1cncc(-c2ccc3c(c2)[C@@]2(COC(N)=N2)c2cc(Cl)ncc2O3)c1";"IC50";"'='";"72000.0";"nM";"4.14";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4262564";"Inhibition of recombinant human CatD using fluorophore/quencher-tagged peptide as substrate pretreated for 60 mins followed by substrate addition and measured after 60 mins by FRET assay";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261519";"1";"Scientific Literature";"Medchemcomm";"2017";"None";"";"";""
"CHEMBL296588";"PEPSTATIN";"2.0";"685.90";"2";"1.47";"4";"CC(C)CC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)[C@@H](O)CC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)[C@@H](O)CC(=O)O)C(C)C)C(C)C";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"10.21";"0.20";"5.53";"3.14";"0";"CHEMBL4141005";"Inhibition of cathepsin D in human MDA-MB-231 cells using Mca-Gly-Lys-Pro-Ile-Leu-PhePhe-Arg-Leu-Lys-(Dnp)-D-Arg-NH2 as substrate pretreated for 4 hrs followed by compound washout and subsequent substrate addition measured at 30 secs interval for 30 mins by fluorescence assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"MDA-MB-231";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4138143";"1";"Scientific Literature";"J Nat Prod";"2017";"None";"";"";""
"CHEMBL567893";"GRASSYSTATIN A";"None";"1174.44";"None";"None";"Grassystatin A";"COC(=O)[C@@H]1CCCN1C(=O)[C@@H](Cc1ccccc1)N(C)C(=O)[C@H](C)NC(=O)[C@@H](NC(=O)C[C@H](O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](OC(=O)[C@@H](OC(=O)[C@H](C(C)C)N(C)C)C(C)C)C(C)C)[C@@H](C)O";"IC50";"'='";"26.0";"nM";"7.58";"";"";"UO_0000065";"6.46";"None";"None";"None";"1";"CHEMBL4141000";"Inhibition of human liver cathepsin D using Mca-Gly-Lys-Pro-Ile-Leu-PhePhe-Arg-Leu-Lys-(Dnp)-D-Arg-NH2 as substrate pretreated for 15 mins followed by substrate addition measured at 5 mins interval for 120 mins by fluorescence assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4138143";"1";"Scientific Literature";"J Nat Prod";"2017";"None";"";"";""
"CHEMBL4173516";"";"None";"959.20";"3";"0.54";"1";"CC[C@H](C)[C@H](NC(=O)C[C@H](O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)N(C)C(=O)[C@H](CC(C)C)NC(=O)[C@H](C)O)C(=O)N[C@@H](C)C(=O)N(C)[C@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)OC";"IC50";"'='";"5500.0";"nM";"5.26";"";"";"UO_0000065";"5.48";"0.11";"4.72";"1.83";"0";"CHEMBL4141003";"Inhibition of cathepsin D in human MDA-MB-231 cell lysates using Mca-Gly-Lys-Pro-Ile-Leu-PhePhe-Arg-Leu-Lys-(Dnp)-D-Arg-NH2 as substrate pretreated for 15 mins followed by substrate addition measured at 30 secs interval for 30 mins by fluorescence assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4138143";"1";"Scientific Literature";"J Nat Prod";"2017";"None";"";"";""
"CHEMBL4287483";"";"None";"463.47";"0";"4.41";"15";"CC#Cc1cncc(-c2ccc3c(c2)[C@@]2(COC(N)=N2)c2cc(-c4ccnc(F)c4)ncc2O3)c1";"IC50";"'='";"4500.0";"nM";"5.35";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4262564";"Inhibition of recombinant human CatD using fluorophore/quencher-tagged peptide as substrate pretreated for 60 mins followed by substrate addition and measured after 60 mins by FRET assay";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261519";"1";"Scientific Literature";"Medchemcomm";"2017";"None";"";"";""
"CHEMBL4225394";"";"None";"439.56";"1";"5.00";"4b";"Nc1nc2cc(-c3ccc(CCCc4ccccc4)cc3)ccc2c(=O)n1CC1CCCO1";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4223547";"Inhibition of human cathepsin D using DABCYL-Glu-Arg-Nle-Phe-Leu-Ser-Phe-Pro-EDANS as substrate preincubated for 30 mins followed by substrate addition measured every 1 min within 8 to 15 mins by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4219216";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";"";""
"CHEMBL3264799";"";"None";"642.89";"2";"6.17";"3";"CCCN(CCC)C(=O)c1cc(C(=O)N[C@@H](Cc2ccccc2)[C@H](O)CNC(C)(C)c2cccc(OC)c2)cc(N2CCCCC2)c1";"IC50";"'='";"42.0";"nM";"7.38";"";"";"UO_0000065";"11.47";"0.21";"1.21";"7.84";"0";"CHEMBL3271470";"Inhibition of human cathepsin-D using DABCYL-Glu-Arg-Nle-Phe-Leu-Ser-Phe-Pro-EDANS as substrate preincubated for 30 mins by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3259525";"1";"Scientific Literature";"ACS Med Chem Lett";"2014";"None";"";"";""
"CHEMBL4228633";"";"None";"412.49";"0";"4.07";"2e";"Nc1cccc(-c2cc(-c3ccccc3)cc3nc(N)n(CC4CCCO4)c(=O)c23)c1";"IC50";"'='";"93000.0";"nM";"4.03";"";"";"UO_0000065";"9.77";"0.18";"-0.04";"4.19";"0";"CHEMBL4223547";"Inhibition of human cathepsin D using DABCYL-Glu-Arg-Nle-Phe-Leu-Ser-Phe-Pro-EDANS as substrate preincubated for 30 mins followed by substrate addition measured every 1 min within 8 to 15 mins by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4219216";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";"";""
"CHEMBL4287410";"";"None";"437.84";"0";"3.09";"32";"COc1cc2c(cn1)Oc1ccc(NC(=O)c3ccc(Cl)cn3)cc1[C@@]21COC(N)=N1";"IC50";"'='";"1200000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4262564";"Inhibition of recombinant human CatD using fluorophore/quencher-tagged peptide as substrate pretreated for 60 mins followed by substrate addition and measured after 60 mins by FRET assay";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261519";"1";"Scientific Literature";"Medchemcomm";"2017";"None";"";"";""
"CHEMBL4159706";"";"None";"965.16";"3";"0.26";"Tasiamide F";"CC[C@H](C)[C@H](NC(=O)C[C@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(N)=O)N(C)C(=O)[C@@H](NC(=O)[C@H](C)O)[C@@H](C)CC)C(=O)NCC(=O)N(C)[C@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)O";"IC50";"'='";"57.0";"nM";"7.24";"";"";"UO_0000065";"7.51";"0.14";"6.98";"2.43";"0";"CHEMBL4141000";"Inhibition of human liver cathepsin D using Mca-Gly-Lys-Pro-Ile-Leu-PhePhe-Arg-Leu-Lys-(Dnp)-D-Arg-NH2 as substrate pretreated for 15 mins followed by substrate addition measured at 5 mins interval for 120 mins by fluorescence assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4138143";"1";"Scientific Literature";"J Nat Prod";"2017";"None";"";"";""
"CHEMBL4163078";"";"None";"1134.43";"None";"None";"3";"CC[C@H](C)[C@H](NC(=O)C[C@H](O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)N(C)C(=O)[C@H](CC(C)C)NC(=O)[C@H](C)OC(=O)[C@H](Cc1ccccc1)N(C)C)C(=O)N[C@@H](C)C(=O)N(C)[C@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)OC";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"6.17";"None";"None";"None";"0";"CHEMBL4140999";"Inhibition of secreted cathepsin D in human MDA-MB-231 cells using Mca-Gly-Lys-Pro-Ile-Leu-PhePhe-Arg-Leu-Lys-(Dnp)-D-Arg-NH2 as substrate pretreated for 3 days under pH 6.6 conditioned media followed by substrate addition measured at 5 mins interval for 2 hrs by fluorescence assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"MDA-MB-231";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4138143";"1";"Scientific Literature";"J Nat Prod";"2017";"None";"";"";""
"CHEMBL258355";"";"None";"420.56";"0";"3.05";"32";"N/C(=N/C(=O)Cn1c(-c2ccccc2)ccc1C12CC3CC(CC(C3)C1)C2)NCCO";"IC50";"'='";"24700.0";"nM";"4.61";"";"";"UO_0000065";"10.96";"0.20";"1.56";"4.97";"0";"CHEMBL930552";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1142260";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";"";"";""
"CHEMBL252656";"";"None";"530.67";"1";"3.75";"17";"CCNc1cc(C(=O)N[C@@H](Cc2ccccc2)[C@H](O)CNCc2cccc(OC)c2)cc(N2CCCC2=O)c1";"IC50";"'='";"5010.0";"nM";"5.30";"";"";"UO_0000065";"9.99";"0.19";"1.55";"5.15";"0";"CHEMBL945833";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140837";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";"";"";""
"CHEMBL3683801";"";"None";"406.36";"0";"2.52";"BDBM171407";"COc1ccc(C(=O)Nc2cc(F)c(F)c([C@@]3(CF)N=C(N)O[C@@H]4C[C@@H]43)c2)nc1";"IC50";"'='";"238440.0";"nM";"";"Outside typical range";"315816";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3693258";"";"None";"371.37";"0";"1.83";"BDBM171819";"COc1cnc(C(=O)Nc2ccc(F)c([C@@]3(C)N=C(N)O[C@@H]4C[C@@H]43)c2)cn1";"IC50";"'>'";"400000.0";"nM";"";"Outside typical range";"316094";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688750";"";"None";"366.36";"0";"1.69";"BDBM171694";"C[C@]1(c2nc(NC(=O)c3ccc(C#N)cn3)ccc2F)N=C(N)O[C@@H]2C[C@@H]21";"IC50";"'='";"182000.0";"nM";"";"Outside typical range";"316098";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688756";"";"None";"402.34";"0";"2.61";"BDBM171700";"[C-]#[N+]c1ccc(C(=O)Nc2ccc(F)c([C@@]3(C(F)F)N=C(N)O[C@@H]4C[C@@H]43)n2)nc1";"IC50";"'='";"139000.0";"nM";"";"Outside typical range";"316104";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688758";"";"None";"375.79";"0";"2.47";"BDBM171703";"C[C@@]1(c2cc(NC(=O)c3ccc(Cl)cn3)cnc2F)N=C(N)O[C@H]2C[C@H]21";"IC50";"'='";"815580.0";"nM";"";"Outside typical range";"316107";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688759";"";"None";"375.79";"0";"2.47";"BDBM171704";"C[C@]1(c2cc(NC(=O)c3ccc(Cl)cn3)cnc2F)N=C(N)O[C@@H]2C[C@@H]21";"IC50";"'='";"401920.0";"nM";"";"Outside typical range";"316108";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688760";"";"None";"372.36";"0";"1.22";"BDBM171706";"COc1cnc(C(=O)Nc2cnc(F)c([C@]3(C)N=C(N)O[C@H]4C[C@H]43)c2)cn1";"IC50";"'>'";"400000.0";"nM";"";"Outside typical range";"316110";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688764";"";"None";"393.42";"0";"3.47";"BDBM171710";"COc1cnc2c(Nc3ccc(F)c([C@@]4(C)N=C(N)O[C@@H]5C[C@@H]54)c3)nccc2c1";"IC50";"'>'";"400000.0";"nM";"";"Outside typical range";"316114";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688774";"";"None";"458.83";"0";"4.23";"BDBM171720";"N#Cc1cnc2c(Nc3ccc(Cl)c([C@@]4(C(F)F)N=C(N)O[C@@H]5C[C@@H]54)c3)ncc(F)c2c1";"IC50";"'>'";"14800.0";"nM";"";"";"316124";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3965566";"";"None";"497.85";"1";"6.16";"BDBM215043";"NC1=N[C@](CF)(c2cc(Oc3cc(-c4ccccc4)cc(Cl)n3)ccc2F)C[C@@H](C(F)(F)F)O1";"IC50";"'>'";"133000.0";"nM";"";"Outside typical range";"378035";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL4457661";"";"None";"471.69";"0";"4.67";"36";"CC(C)[C@@H]1NC(=O)CC[C@H](Cc2ccccc2)NC(=O)CCCCCCCCCCCNC1=O";"IC50";"'='";"2000.0";"nM";"5.70";"";"";"UO_0000065";"12.08";"0.23";"1.03";"6.53";"0";"CHEMBL4325791";"Inhibition of human placenta CatD using Abz-Lys-Pro-Ala-Glu-Phe-Nph-Ala-Leu as substrate preincubated for 10 mins followed by substrate addition and measured by FRET assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4321885";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";""
"CHEMBL252547";"";"None";"510.66";"1";"3.13";"16";"COc1cccc(CNC[C@@H](O)[C@H](Cc2ccccc2)NC(=O)CCCS(=O)(=O)c2ccccc2)c1";"IC50";"'>'";"20000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL942098";"Inhibition of human recombinant cathepsin D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140593";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2007";"None";"";"";""
"CHEMBL428587";"";"None";"508.71";"1";"4.36";"13";"CCNc1cc(C(=O)N[C@@H](Cc2ccccc2)[C@H](O)CNCCCCC(C)C)cc(N2CCCC2=O)c1";"IC50";"'='";"970.0";"nM";"6.01";"";"";"UO_0000065";"11.82";"0.22";"1.65";"6.42";"0";"CHEMBL945833";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140837";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";"";"";""
"CHEMBL3653401";"";"None";"489.27";"0";"4.16";"38b";"C[C@@]1(c2cc(NC(=O)c3ccc(Br)cn3)ccc2F)CO[C@@](C)(C(F)(F)F)C(N)=N1";"IC50";"'>'";"250000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5055931";"Inhibition of human cathepsin D using Mca-GKPILFFRLK(DNP)D-R-NH2 as a substrate";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5055623";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"";""
"CHEMBL4276834";"";"None";"450.50";"0";"4.01";"14";"CC#Cc1cncc(-c2ccc3c(c2)[C@@]2(COC(N)=N2)c2cc(C4=CCCOC4)ncc2O3)c1";"IC50";"'='";"2700.0";"nM";"5.57";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4262564";"Inhibition of recombinant human CatD using fluorophore/quencher-tagged peptide as substrate pretreated for 60 mins followed by substrate addition and measured after 60 mins by FRET assay";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261519";"1";"Scientific Literature";"Medchemcomm";"2017";"None";"";"";""
"CHEMBL3916240";"";"None";"486.49";"0";"3.83";"14";"CC(C)CN(C(=O)c1cnc(C(C)(C)C)nc1NCc1ccco1)[C@H]1CCCNC1.Cl.Cl";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3859583";"Inhibition of cathepsin D (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3856272";"1";"Scientific Literature";"Bioorg Med Chem";"2016";"None";"";"";""
"CHEMBL4464845";"";"None";"464.95";"0";"3.36";"72";"Cc1cc(Cl)cnc1C(=O)Nc1ccc(F)c([C@@]2(C)N=C(N)[C@]3(C)CC[C@H]2S3(=O)=O)c1";"IC50";"'='";"1740000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4342626";"Inhibition of recombinant Cathepsin D (unknown origin) expressed in CHO cells preincubated for 1 hr followed by substrate addition and measured after 1 hr by FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4342403";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"CHEMBL3308072";"";"";""
"CHEMBL3935940";"";"None";"487.36";"0";"2.85";"BDBM214960";"C#CCOc1cnc(C(=O)Nc2cc(F)c(F)c([C@]3(CF)C[C@@H](C(F)(F)F)OC(N)=N3)c2)cn1";"IC50";"'>'";"400000.0";"nM";"";"Outside typical range";"377995";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3940730";"";"None";"461.34";"0";"4.05";"BDBM214928";"NC1=N[C@](CF)(c2cc(C#Cc3ccc(OC(F)F)cn3)ccc2F)C[C@@H](C(F)(F)F)O1";"IC50";"'='";"605000.0";"nM";"";"Outside typical range";"378028";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3688772";"";"None";"429.40";"0";"3.71";"BDBM171718";"COc1cnc2c(Nc3ccc(F)c([C@@]4(C(F)F)N=C(N)O[C@@H]5C[C@@H]54)c3)nccc2c1";"IC50";"'='";"738320.0";"nM";"";"Outside typical range";"316122";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3109551";"";"None";"393.49";"0";"3.65";"BDBM234501";"COc1cccc(C2(c3cccc(OC)c3)NC(=N)N(C3CCCCC3)C2=O)c1";"IC50";"'='";"1100.0";"nM";"5.96";"";"408849";"UO_0000065";"15.14";"0.28";"2.31";"7.98";"0";"CHEMBL3887168";"Fluorescence Resonance Energy Transfer (FRET) Assay : The recombinant human BACE1, Cathepsin D, and Cathepsin E enzymes were purchased from R&D Systems (catalog numbers are 931-AS, 1014AS and 1294AS, respectively). The enzymatic inhibition activity assays were determined using the fluorescence resonance energy transfer (FRET) assay. The assays were performed in a 384-well plate format. The recombinant human BACE-1 enzyme (R&D Systems, catalog#931-AS) was diluted to 20 ng/L in assay buffer (100 mM sodium acetate pH 4.0), 10 point 1:3 serial dilutions of compound in DMSO were preincubated with the enzyme for 15 min at room temperature. The concentration of Cathepsin D was 20 ng/L, and 1 ng/L of Cathepsin E was used. CatD and CatE were activated by incubation in assay buffer (0.1 M NaOAc, 0.2 M NaCl, pH 3.5) at room temperature for 30 min. Subsequently, the rhBACE-1 substrate (R&D Systems, catalog# ES004), the Cathepsin D and Cathepsin E substrate (R&D Systems, Catalog # ES001) were added accordingly to final concentration";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886201";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3109520";"";"None";"440.55";"0";"4.70";"BDBM234517";"COc1ccc(C2(c3cccc(-c4cccnc4)c3)NC(=N)N(C3CCCCC3)C2=O)cc1";"IC50";"'='";"14900.0";"nM";"4.83";"";"408850";"UO_0000065";"10.96";"0.20";"0.13";"6.16";"0";"CHEMBL3887168";"Fluorescence Resonance Energy Transfer (FRET) Assay : The recombinant human BACE1, Cathepsin D, and Cathepsin E enzymes were purchased from R&D Systems (catalog numbers are 931-AS, 1014AS and 1294AS, respectively). The enzymatic inhibition activity assays were determined using the fluorescence resonance energy transfer (FRET) assay. The assays were performed in a 384-well plate format. The recombinant human BACE-1 enzyme (R&D Systems, catalog#931-AS) was diluted to 20 ng/L in assay buffer (100 mM sodium acetate pH 4.0), 10 point 1:3 serial dilutions of compound in DMSO were preincubated with the enzyme for 15 min at room temperature. The concentration of Cathepsin D was 20 ng/L, and 1 ng/L of Cathepsin E was used. CatD and CatE were activated by incubation in assay buffer (0.1 M NaOAc, 0.2 M NaCl, pH 3.5) at room temperature for 30 min. Subsequently, the rhBACE-1 substrate (R&D Systems, catalog# ES004), the Cathepsin D and Cathepsin E substrate (R&D Systems, Catalog # ES001) were added accordingly to final concentration";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886201";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3688801";"";"None";"435.78";"0";"3.88";"BDBM171748";"NC1=N[C@@](c2cc(NCc3nn(C(F)F)cc3Cl)ccc2F)(C(F)F)[C@H]2C[C@H]2O1";"IC50";"'='";"115500.0";"nM";"";"Outside typical range";"316148";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688807";"";"None";"467.29";"0";"4.28";"BDBM171754";"NC1=N[C@@](c2cc(N[C@H]3CCc4cc(Br)cnc43)ccc2F)(C(F)F)[C@H]2C[C@H]2O1";"IC50";"'='";"83300.0";"nM";"4.08";"";"316155";"UO_0000065";"8.73";"0.19";"-0.20";"5.62";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3966650";"";"None";"450.47";"0";"4.46";"BDBM220795";"CCOc1cccnc1Nc1ccc2c(c1)C1(CCOC(N)=N1)c1cc(OC)cc(F)c1O2";"IC50";"'='";"400000.0";"nM";"";"Outside typical range";"386478";"UO_0000065";"";"";"";"";"0";"CHEMBL3888270";"Fluorescence Resonance Energy Transfer (FRET) Assay: Recombinant CathepsinD was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The CathepsinD enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for CathepsinD) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886633";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL4644249";"";"None";"309.44";"0";"0.84";"3";"C[C@@H]1C[C@H]1CNC(=O)[C@@H]1C[C@H]1[C@]12COC[C@H]1CSC(N)=N2";"IC50";"'>'";"300000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"1";"CHEMBL5034187";"Inhibition of human Cathepsin D by FRET assay";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5033995";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"";""
"CHEMBL2333941";"LY-2811376";"1.0";"320.37";"0";"3.09";"LY2811376; 1";"C[C@@]1(c2cc(-c3cncnc3)c(F)cc2F)CCSC(N)=N1";"IC50";"'='";"15000.0";"nM";"4.82";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5034187";"Inhibition of human Cathepsin D by FRET assay";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5033995";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL2030997";"";"None";"483.63";"0";"4.25";"2";"CC(=O)N[C@@H](Cc1ccc(F)cc1)[C@H](O)CN[C@H]1CC2(CCC2)Oc2ncc(CC(C)(C)C)cc21";"IC50";"'='";"3.0";"nM";"8.52";"";"";"UO_0000065";"17.62";"0.33";"4.27";"10.21";"0";"CHEMBL2033077";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2029322";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL2031147";"";"None";"499.63";"0";"3.22";"43";"CC(=O)N[C@@H](Cc1ccc(F)cc1)[C@H](O)CN[C@H]1C[C@]2(C[C@@H](O)C2)Oc2ncc(CC(C)(C)C)cc21";"IC50";"'='";"1650.0";"nM";"5.78";"";"";"UO_0000065";"11.57";"0.22";"2.56";"5.58";"0";"CHEMBL2033077";"Inhibition of cathepsin D";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2029322";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL3670365";"";"None";"470.81";"0";"3.32";"11";"C[C@@]1(c2nc(NC(=O)c3ncc(C#N)cc3Cl)ccc2F)CO[C@@](C)(C(F)(F)F)C(N)=N1";"IC50";"'='";"205000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5054673";"Inhibition of human Cathepsin D using Mca-GKPILFFRLK(DNP)D-R-NH2 as a substrate";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5053529";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL3808967";"";"None";"590.74";"2";"6.67";"7";"CC(C)(C)CCNC(=O)CCc1cc2cc(-c3ccccc3C#CC3CC(NC(=O)c4ccc(F)cc4)C3)ccc2nc1N";"IC50";"'='";"197.0";"nM";"6.71";"";"";"UO_0000065";"11.35";"0.21";"0.04";"6.91";"0";"CHEMBL3811221";"Inhibition of Cathepsin D (unknown origin) by fluorescence assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3808306";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";""
"CHEMBL3809897";"";"None";"613.74";"2";"7.16";"8";"CC(C)(C)CCNC(=O)CCc1cc2cc(-c3ccccc3C#Cc3ccc(NC(=O)c4ccc(F)cc4)cn3)ccc2nc1N";"IC50";"'='";"58.0";"nM";"7.24";"";"";"UO_0000065";"11.79";"0.21";"0.08";"6.58";"0";"CHEMBL3811221";"Inhibition of Cathepsin D (unknown origin) by fluorescence assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3808306";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";""
"CHEMBL3746637";"";"None";"516.57";"2";"5.63";"7c";"CC(C)(C)OC(=O)N1C[C@H](Nc2nc3cc(F)ccc3[nH]2)[C@@H](OC(=O)c2ccc(-c3ccccc3)cc2)C1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3749955";"Inhibition of cathepsin D (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3745702";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";"";""
"CHEMBL3747556";"";"None";"516.60";"2";"5.70";"8c";"Cc1ccc2[nH]c(N[C@H]3CN(C(=O)c4ccccc4)C[C@@H]3OC(=O)c3ccc(-c4ccccc4)cc3)nc2c1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3749955";"Inhibition of cathepsin D (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3745702";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";"";""
"CHEMBL1824348";"";"None";"363.45";"0";"2.54";"51";"Cc1sccc1C1(c2cccc(-c3cncnc3)c2)N=C(N)N(C)C1=O";"IC50";"'='";"38650.0";"nM";"4.41";"";"";"UO_0000065";"12.14";"0.23";"1.87";"5.22";"0";"CHEMBL1825607";"Inhibition of cathepsin D by FRET assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1821667";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL1824338";"";"None";"432.38";"0";"2.68";"(S)-41";"CN1C(=O)[C@](c2cccc(-c3cccnc3F)c2)(c2cnn(CC(F)(F)F)c2)N=C1N";"IC50";"'='";"4790.0";"nM";"5.32";"";"";"UO_0000065";"12.30";"0.23";"2.64";"5.95";"0";"CHEMBL1825607";"Inhibition of cathepsin D by FRET assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1821667";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL1824361";"";"None";"422.49";"0";"3.57";"(S)-63";"CCC(=O)c1cc([C@]2(c3cccc(-c4cccnc4F)c3)N=C(N)N(C)C2=O)cs1";"IC50";"'='";"2500.0";"nM";"5.60";"";"";"UO_0000065";"13.26";"0.26";"2.03";"6.32";"0";"CHEMBL1825607";"Inhibition of cathepsin D by FRET assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1821667";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL3683900";"";"None";"430.39";"0";"3.02";"BDBM171517";"NC1=N[C@@](c2cc(NC(=O)c3coc(C#CC4CC4)n3)ccc2F)(C(F)F)[C@H]2C[C@H]2O1";"IC50";"'='";"302500.0";"nM";"";"Outside typical range";"315926";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3683911";"";"None";"490.47";"0";"3.10";"BDBM171531";"NC1=N[C@@](c2cc(NC(=O)c3cnc(OCc4nccs4)cn3)ccc2F)(C(F)F)[C@H]2C[C@H]2O1";"IC50";"'='";"383220.0";"nM";"";"Outside typical range";"315940";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3683914";"";"None";"398.32";"0";"2.73";"BDBM171534";"NC1=N[C@@](c2cc(NC(=O)c3coc(CF)n3)ccc2F)(C(F)F)[C@H]2C[C@H]2O1";"IC50";"'='";"56750.0";"nM";"4.25";"";"315943";"UO_0000065";"10.66";"0.21";"1.52";"4.13";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL4515147";"";"None";"628.86";"2";"5.69";"(S,R)-3h";"COc1cccc(C(C)(C)NC[C@@H](O)[C@H](Cc2ccccc2)NC(=O)c2cc(C(=O)NCC(C)(C)C)cc(N3CCCCC3)c2)c1";"IC50";"'='";"400.0";"nM";"6.40";"";"";"UO_0000065";"10.17";"0.19";"0.71";"6.22";"0";"CHEMBL4331648";"Inhibition of human cathepsin D using DABCYL-Glu-Arg-Nle-Phe-Leu-Ser-Phe-Pro-EDANS as substrate preincubated for 30 mins followed by substrate addition and measured every min for 8 to 15 mins by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4330085";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";"";"";""
"CHEMBL296588";"PEPSTATIN";"2.0";"685.90";"2";"1.47";"Pepstatin A";"CC(C)CC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)[C@@H](O)CC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)[C@@H](O)CC(=O)O)C(C)C)C(C)C";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"12.10";"0.24";"6.83";"3.72";"0";"CHEMBL1043702";"Inhibition of cathepsin D in human MCF7 cells by fluorescence assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"MCF7";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156023";"1";"Scientific Literature";"J Med Chem";"2009";"CHEMBL3308403";"";"";""
"CHEMBL567687";"";"None";"430.51";"0";"3.57";"42";"COc1ccc(C2(c3cccc(-c4cccnc4)c3)N=C(N)N(C)C2=O)cc1OC(C)C";"IC50";"'='";"12200.0";"nM";"4.91";"";"";"UO_0000065";"11.41";"0.21";"1.34";"5.46";"0";"CHEMBL1044551";"Inhibition of human cathepsin D by FRET based peptide cleavage assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156789";"1";"Scientific Literature";"J Med Chem";"2010";"None";"";"";""
"CHEMBL585952";"";"None";"323.44";"0";"2.89";"29";"CN1C(=O)C(c2ccccc2)(C23CC4CC(CC(C4)C2)C3)N=C1N";"IC50";"'='";"27280.0";"nM";"4.56";"";"";"UO_0000065";"14.11";"0.26";"1.67";"7.78";"0";"CHEMBL1044551";"Inhibition of human cathepsin D by FRET based peptide cleavage assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156789";"1";"Scientific Literature";"J Med Chem";"2010";"None";"";"";""
"CHEMBL566415";"";"None";"386.41";"0";"2.51";"52";"CN1C(=O)C(c2cccc(-c3cccnc3)c2)(c2ccc3c(c2)OCO3)N=C1N";"IC50";"'='";"21440.0";"nM";"4.67";"";"";"UO_0000065";"12.08";"0.22";"2.16";"5.19";"0";"CHEMBL1044551";"Inhibition of human cathepsin D by FRET based peptide cleavage assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156789";"1";"Scientific Literature";"J Med Chem";"2010";"None";"";"";""
"CHEMBL3960890";"";"None";"496.44";"0";"4.20";"BDBM214995";"CC#CCOc1cnc(C(=O)Nc2cc(F)c(F)c([C@]3(C)C[C@@H](C(F)(F)F)OC(N)=N3)c2)c(C)c1";"IC50";"'='";"286000.0";"nM";"";"Outside typical range";"378061";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3924515";"";"None";"482.41";"0";"3.90";"BDBM214996";"CC#CCOc1ccc(C(=O)Nc2cc(F)c(F)c([C@]3(C)C[C@@H](C(F)(F)F)OC(N)=N3)c2)nc1";"IC50";"'='";"783800.0";"nM";"";"Outside typical range";"378062";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3956483";"";"None";"498.79";"1";"5.08";"BDBM215005";"C[C@@]1(c2cc(NC(=O)c3ncc(C(F)F)cc3Cl)cc(F)c2F)C[C@@H](C(F)(F)F)OC(N)=N1";"IC50";"'>'";"400000.0";"nM";"";"Outside typical range";"378072";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3966981";"";"None";"461.80";"0";"3.41";"BDBM215016";"COc1cnc(C(=O)Nc2cc(Cl)c(F)c([C@]3(C)C[C@@H](C(F)(F)F)OC(N)=N3)c2)cn1";"IC50";"'='";"393600.0";"nM";"";"Outside typical range";"378076";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3683872";"";"None";"489.38";"0";"3.31";"BDBM171486";"Cc1nc(OCC(F)(F)F)cnc1C(=O)Nc1ccc(F)c([C@@]2(C(F)F)N=C(N)O[C@@H]3C[C@@H]32)c1";"IC50";"'='";"351420.0";"nM";"";"Outside typical range";"315895";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3683882";"";"None";"420.39";"0";"2.98";"BDBM171497";"COc1cnc(C(=O)Nc2ccc(F)c([C@@]3(C(F)F)N=C(N)O[C@@H]4C[C@@H]43)c2)c(C)c1";"IC50";"'='";"342490.0";"nM";"";"Outside typical range";"315906";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3683921";"";"None";"412.34";"0";"3.29";"BDBM171541";"C[C@H](F)c1nc(C(=O)Nc2ccc(F)c([C@@]3(C(F)F)N=C(N)O[C@@H]4C[C@@H]43)c2)co1";"IC50";"'='";"1344400.0";"nM";"";"Outside typical range";"315950";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688609";"";"None";"415.82";"0";"3.99";"BDBM171543";"NC1=N[C@@](c2cc(NC(=O)c3cc(Cl)cs3)ccc2F)(C(F)F)[C@H]2C[C@H]2O1";"IC50";"'='";"762010.0";"nM";"";"Outside typical range";"315952";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688627";"";"None";"397.39";"0";"2.55";"BDBM171562";"Cc1cc(C#N)cnc1C(=O)Nc1ccc(F)c([C@@]2(CF)N=C(N)O[C@@H]3C[C@@H]32)c1";"IC50";"'='";"703110.0";"nM";"";"Outside typical range";"315971";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688668";"";"None";"343.31";"0";"1.60";"BDBM171606";"COCC(=O)Nc1ccc(F)c([C@@]2(C(F)F)N=C(N)O[C@@H]3C[C@@H]32)c1";"IC50";"'='";"48150.0";"nM";"4.32";"";"316015";"UO_0000065";"12.58";"0.25";"2.72";"5.02";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688682";"";"None";"385.39";"0";"2.77";"BDBM171620";"CC(C)(C)OCC(=O)Nc1ccc(F)c([C@@]2(C(F)F)N=C(N)O[C@@H]3C[C@@H]32)c1";"IC50";"'='";"2563500.0";"nM";"";"Outside typical range";"316029";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL1824339";"";"None";"410.43";"0";"2.83";"42";"CC(C)n1cc(C2(c3ccc(F)c(-c4cccnc4F)c3)N=C(N)N(C)C2=O)cn1";"IC50";"'='";"4850.0";"nM";"5.31";"";"";"UO_0000065";"12.95";"0.24";"2.48";"5.94";"0";"CHEMBL1825607";"Inhibition of cathepsin D by FRET assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1821667";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL3414708";"";"None";"328.38";"0";"2.27";"43";"COC[C@H]1C[C@H]2CSC(N)=N[C@@]2(c2ccc(F)cc2F)CO1";"IC50";"'>'";"91400.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3420009";"Inhibition of CatD (unknown origin) by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3414451";"1";"Scientific Literature";"J Med Chem";"2015";"None";"";"";""
"CHEMBL4580856";"";"None";"457.61";"0";"1.68";"3";"CC(C)CC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)[C@@H](O)CC(=O)O)C(C)C)C(C)C";"IC50";"'='";"500.0";"nM";"6.30";"";"";"UO_0000065";"13.77";"0.27";"4.62";"4.35";"0";"CHEMBL4325791";"Inhibition of human placenta CatD using Abz-Lys-Pro-Ala-Glu-Phe-Nph-Ala-Leu as substrate preincubated for 10 mins followed by substrate addition and measured by FRET assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4321885";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";""
"CHEMBL4174823";"";"None";"973.22";"3";"0.79";"Grassystatin C";"CC[C@H](C)[C@H](NC(=O)C[C@H](O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)N(C)C(=O)[C@H](CC(C)C)NC(=O)[C@H](O)[C@@H](C)CC)C(=O)NCC(=O)N(C)[C@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)OC";"IC50";"'='";"1600.0";"nM";"5.80";"";"";"UO_0000065";"5.96";"0.11";"5.01";"2.02";"0";"CHEMBL4141000";"Inhibition of human liver cathepsin D using Mca-Gly-Lys-Pro-Ile-Leu-PhePhe-Arg-Leu-Lys-(Dnp)-D-Arg-NH2 as substrate pretreated for 15 mins followed by substrate addition measured at 5 mins interval for 120 mins by fluorescence assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4138143";"1";"Scientific Literature";"J Nat Prod";"2017";"None";"";"";""
"CHEMBL3586131";"";"None";"402.35";"0";"2.44";"7.HCl";"Cl.NC1=N[C@]23CC[C@H](NC(=O)c4cccc(Cl)c4)C[C@@H]2[C@@H](COC3)S1";"IC50";"'>'";"300000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3588066";"Inhibition of human cathepsin D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3585284";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL3586138";"";"None";"325.87";"0";"2.02";"5.HCl";"Cl.NC1=NC2CCC(NC(=O)c3ccccc3)CC2CS1";"IC50";"'='";"797000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3588066";"Inhibition of human cathepsin D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3585284";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL4084653";"";"None";"343.44";"0";"2.76";"6h";"COC[C@@H](C)NCc1cc([C@]2(C)CCSC(N)=N2)c(F)cc1F";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4042703";"Inhibition of Cathepsin D (unknown origin) by cell free assay";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4041533";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";"";""
"CHEMBL4092406";"";"None";"329.42";"0";"2.37";"6f";"COCCNCc1cc([C@]2(C)CCSC(N)=N2)c(F)cc1F";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4042703";"Inhibition of Cathepsin D (unknown origin) by cell free assay";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4041533";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";"";""
"CHEMBL1824356";"";"None";"366.42";"0";"2.98";"59";"CN1C(=O)C(c2ccsc2)(c2ccc(F)c(-c3cccnc3)c2)N=C1N";"IC50";"'='";"12800.0";"nM";"4.89";"";"";"UO_0000065";"13.35";"0.26";"1.91";"6.84";"0";"CHEMBL1825607";"Inhibition of cathepsin D by FRET assay";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1821667";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL4212046";"";"None";"419.53";"0";"2.48";"71";"COc1cccc(NC(=O)c2cnc([C@]34CO[C@@H](C)C[C@H]3CSC(N)=N4)s2)n1";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4183115";"Inhibition of Cathepsin D (unknown origin) by fluorescence polarization assay";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4177751";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4277255";"";"None";"382.78";"0";"3.63";"6";"NC1=N[C@@]2(CO1)c1cc(-c3cccc(F)n3)ccc1Oc1cnc(Cl)cc12";"IC50";"'='";"15000.0";"nM";"4.82";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4262564";"Inhibition of recombinant human CatD using fluorophore/quencher-tagged peptide as substrate pretreated for 60 mins followed by substrate addition and measured after 60 mins by FRET assay";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261519";"1";"Scientific Literature";"Medchemcomm";"2017";"None";"";"";""
"CHEMBL4288556";"";"None";"382.78";"0";"3.63";"7";"NC1=N[C@@]2(CO1)c1cc(-c3cncc(F)c3)ccc1Oc1cnc(Cl)cc12";"IC50";"'='";"130000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4262564";"Inhibition of recombinant human CatD using fluorophore/quencher-tagged peptide as substrate pretreated for 60 mins followed by substrate addition and measured after 60 mins by FRET assay";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261519";"1";"Scientific Literature";"Medchemcomm";"2017";"None";"";"";""
"CHEMBL1233569";"";"None";"592.78";"2";"6.83";"50";"CCCCCc1ccc(C(=O)N(Cc2ccc(-c3ccc(CC(=O)OC)cc3)cc2)C2CCN(Cc3ncc[nH]3)CC2)cc1";"IC50";"'='";"20362.0";"nM";"4.69";"";"";"UO_0000065";"7.91";"0.15";"-2.14";"5.97";"0";"CHEMBL4357658";"Inhibition of human cathepsin D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4354841";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";""
"CHEMBL1233097";"";"None";"346.39";"0";"4.41";"61";"N=C(N)c1ccc(NC(=O)Nc2ccc(Oc3ccccc3)cc2)cc1";"IC50";"'>'";"1300000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4357658";"Inhibition of human cathepsin D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4354841";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";""
"CHEMBL3911798";"";"None";"445.35";"0";"2.71";"BDBM214801";"COc1cnc(C(=O)Nc2ccc(F)c([C@]3(CF)C[C@@H](C(F)(F)F)OC(N)=N3)c2)cn1";"IC50";"'>'";"400000.0";"nM";"";"Outside typical range";"377848";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3925020";"";"None";"463.37";"0";"3.80";"BDBM214888";"C[C@@]1(c2nc(Nc3ncc(F)c4cc(C#N)cnc34)ccc2F)C[C@@H](C(F)(F)F)OC(N)=N1";"IC50";"'='";"229000.0";"nM";"";"Outside typical range";"377889";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3952503";"";"None";"500.65";"2";"5.26";"BDBM214899";"NC1=N[C@](CF)(c2cc(Oc3cc(Br)cc(Cl)n3)ccc2F)C[C@@H](C(F)(F)F)O1";"IC50";"'>'";"400000.0";"nM";"";"Outside typical range";"377912";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3955892";"";"None";"455.31";"0";"4.86";"BDBM214900";"NC1=N[C@](CF)(c2cc(Oc3cc(C(F)(F)F)ccn3)ccc2F)C[C@@H](C(F)(F)F)O1";"IC50";"'>'";"400000.0";"nM";"";"Outside typical range";"377913";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3932837";"";"None";"445.35";"0";"2.71";"BDBM214946";"COc1ccc(C(=O)Nc2cnc(F)c([C@]3(CF)C[C@@H](C(F)(F)F)OC(N)=N3)c2)nc1";"IC50";"'='";"5520000.0";"nM";"";"Outside typical range";"377919";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3909033";"";"None";"453.83";"0";"4.86";"BDBM214951";"NC1=N[C@](CF)(c2cccc(Nc3nccc4cc(Cl)cnc34)c2)C[C@@H](C(F)(F)F)O1";"IC50";"'='";"733000.0";"nM";"";"Outside typical range";"377923";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3900111";"";"None";"443.81";"0";"3.27";"BDBM214952";"COc1ncc(NC(=O)c2ccc(Cl)cn2)cc1[C@]1(C)C[C@@H](C(F)(F)F)OC(N)=N1";"IC50";"'='";"1420000.0";"nM";"";"Outside typical range";"377924";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3900583";"";"None";"487.76";"0";"4.15";"BDBM214836";"NC1=N[C@](CF)(c2cc(NC(=O)c3nn(C(F)F)cc3Cl)ccc2F)C[C@@H](C(F)(F)F)O1";"IC50";"'='";"2380000.0";"nM";"";"Outside typical range";"377956";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3944783";"";"None";"469.37";"0";"3.37";"BDBM214975";"COc1cc(C#N)cnc1C(=O)Nc1cc(F)c(F)c([C@]2(C)C[C@@H](C(F)(F)F)OC(N)=N2)c1";"IC50";"'>'";"400000.0";"nM";"";"Outside typical range";"378009";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3939374";"";"None";"451.38";"0";"2.76";"BDBM214844";"C#CCOc1cnc(C(=O)Nc2ccc(F)c([C@]3(C)C[C@@H](C(F)(F)F)OC(N)=N3)c2)cn1";"IC50";"'='";"2570000.0";"nM";"";"Outside typical range";"378025";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3928397";"";"None";"467.40";"0";"3.79";"BDBM215027";"Cc1cc(C#N)cnc1C(=O)Nc1cc(C)c(F)c([C@]2(CF)C[C@@H](C(F)(F)F)OC(N)=N2)c1";"IC50";"'>'";"400000.0";"nM";"";"Outside typical range";"378043";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3913544";"";"None";"444.36";"0";"3.50";"BDBM215008";"COc1ccc(C(=O)Nc2cc(F)c(F)c([C@]3(C)C[C@@H](C(F)(F)F)OC(N)=N3)c2)nc1";"IC50";"'='";"761600.0";"nM";"";"Outside typical range";"378048";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3944430";"";"None";"464.34";"0";"4.43";"BDBM215007";"C[C@@]1(c2cc(NC(=O)c3ccc(C(F)F)cn3)cc(F)c2F)C[C@@H](C(F)(F)F)OC(N)=N1";"IC50";"'='";"997300.0";"nM";"";"Outside typical range";"378074";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3919193";"";"None";"511.22";"1";"4.39";"BDBM215049";"C[C@@]1(c2cc(NC(=O)c3ncc(Br)cc3F)cc(F)c2F)C[C@@H](C(F)(F)F)OC(N)=N1";"IC50";"'='";"928000.0";"nM";"";"Outside typical range";"378088";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3957556";"";"None";"478.81";"0";"4.16";"BDBM215002";"COc1cc(Cl)cnc1C(=O)Nc1cc(F)c(F)c([C@]2(C)C[C@@H](C(F)(F)F)OC(N)=N2)c1";"IC50";"'>'";"400000.0";"nM";"";"Outside typical range";"378068";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3975793";"";"None";"478.42";"0";"4.07";"BDBM214852";"NC1=N[C@](CF)(c2cc(NC(=O)c3ccc(C#CC4CC4)cn3)ccc2F)C[C@@H](C(F)(F)F)O1";"IC50";"'='";"2990000.0";"nM";"";"Outside typical range";"377957";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3889832";"";"None";"721.00";"2";"4.04";"BDBM232266";"CC[C@H](C)[C@H](NC(=O)C[C@H](N)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)CC(C)C)C(C)C)C(=O)NCCc1ccccc1";"IC50";"'='";"240.0";"nM";"6.62";"";"405041";"UO_0000065";"9.18";"0.17";"2.58";"3.86";"0";"CHEMBL3888498";"In-Vitro Fluorescence Assay: In order to identify modulators of cathepsin D activity, a continuous enzymatic test was carried out with a synthetic peptide which carries a fluorescent group (MCA=(7-methoxycoumarin-4-yl)acetyl) which is quenched by energy transfer from a Dpn (2,4 dinitrophenyl) group on the same molecule, in Greiner 384-well nb microtitre plates. Cleavage of the peptidic substrate by cathepsin D causes an increase in the fluorescence intensity. In order to determine the efficacy of substances, the time-dependent increase in the fluorescence intensity in the presence of the substance was compared with the time-dependent increase in fluorescence in the absence of substances. The reference substance used was pepstatin A (Sigma-Aldrich). The substrate used was MCAGKPILFFRLK(Dnp)d-R-NH2 (Enzo Life Sciences, Lorrach). The enzyme employed was cathepsin D isolated from the human liver (Sigma-Aldrich) in a final concentration of 1.4 nM. The test was carried out in 100 mM sodium acetate buffer, 1.25% (v/v) of DMSO, 0.25% (w/v) of Chaps, pH 5.5. 2 ul of each substance solution with serially diluted substance concentration were added to in each case 4 ul of cathepsin D solution and incubated at room temperature for 10 min. The reaction was started by addition of 2 ul of substrate solution (final concentration 5 uM). After carrying out a starting-point fluorescence measurement (excitation wavelength 340 nm/emission wavelength 450 nm) using an Envision multilabel reader (Perkin Elmer), the reaction was incubated at room temperature for 60 min. The amount of peptide fragment cleaved off during the reaction time was subsequently measured by determination of the increase in the fluorescence intensity at 450 nm (excitation wavelength 340 nm).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886733";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3974563";"";"None";"721.86";"2";"3.77";"BDBM232283";"CC[C@H](C)[C@H](NC(=O)Cc1cccc(OC(F)(F)F)c1)C(=O)N[C@@H](Cc1ccccc1)[C@@H](N)CC(=O)N[C@H](C(=O)N[C@H](CO)C(C)C)[C@@H](C)CC";"IC50";"'='";"480.0";"nM";"6.32";"";"405057";"UO_0000065";"8.75";"0.17";"2.55";"3.68";"0";"CHEMBL3888498";"In-Vitro Fluorescence Assay: In order to identify modulators of cathepsin D activity, a continuous enzymatic test was carried out with a synthetic peptide which carries a fluorescent group (MCA=(7-methoxycoumarin-4-yl)acetyl) which is quenched by energy transfer from a Dpn (2,4 dinitrophenyl) group on the same molecule, in Greiner 384-well nb microtitre plates. Cleavage of the peptidic substrate by cathepsin D causes an increase in the fluorescence intensity. In order to determine the efficacy of substances, the time-dependent increase in the fluorescence intensity in the presence of the substance was compared with the time-dependent increase in fluorescence in the absence of substances. The reference substance used was pepstatin A (Sigma-Aldrich). The substrate used was MCAGKPILFFRLK(Dnp)d-R-NH2 (Enzo Life Sciences, Lorrach). The enzyme employed was cathepsin D isolated from the human liver (Sigma-Aldrich) in a final concentration of 1.4 nM. The test was carried out in 100 mM sodium acetate buffer, 1.25% (v/v) of DMSO, 0.25% (w/v) of Chaps, pH 5.5. 2 ul of each substance solution with serially diluted substance concentration were added to in each case 4 ul of cathepsin D solution and incubated at room temperature for 10 min. The reaction was started by addition of 2 ul of substrate solution (final concentration 5 uM). After carrying out a starting-point fluorescence measurement (excitation wavelength 340 nm/emission wavelength 450 nm) using an Envision multilabel reader (Perkin Elmer), the reaction was incubated at room temperature for 60 min. The amount of peptide fragment cleaved off during the reaction time was subsequently measured by determination of the increase in the fluorescence intensity at 450 nm (excitation wavelength 340 nm).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886733";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL1941012";"";"None";"313.36";"0";"3.98";"9";"O=C(Cn1c(-c2ccccn2)nc2ccccc21)c1ccccc1";"IC50";"'='";"39200.0";"nM";"4.41";"";"";"UO_0000065";"14.06";"0.25";"0.43";"9.22";"0";"CHEMBL1942416";"Inhibition of human cathepsin D using DABCYL-Glu-Arg-Nle-Phe-Leu-Ser-Phe-Pro-EDANS as substrate by FRET analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1938395";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL1941014";"";"None";"343.39";"0";"3.99";"11";"COc1ccc(C(=O)Cn2c(-c3ccccn3)nc3ccccc32)cc1";"IC50";"'='";"14200.0";"nM";"4.85";"";"";"UO_0000065";"14.12";"0.25";"0.86";"8.50";"0";"CHEMBL1942416";"Inhibition of human cathepsin D using DABCYL-Glu-Arg-Nle-Phe-Leu-Ser-Phe-Pro-EDANS as substrate by FRET analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1938395";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL4520267";"";"None";"392.43";"0";"2.84";"9a";"O=C(CF)CNC(=O)[C@H](Cc1ccccc1)NC(=O)c1cccc2ccccc12";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4480320";"Inhibition of recombinant human cathepsin D (400 residues) expressed in CHO cells using 5-FAM/QXL 520 FRET peptide as substrate preincubated for 20 mins followed by substrate addition by fluorescence plate reader analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4477275";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3808988";"";"None";"404.56";"0";"4.92";"1";"Cc1cccnc1-c1ccc2nc(N)c(C[C@H](C)C(=O)NCCC(C)(C)C)cc2c1";"IC50";"'='";"820.0";"nM";"6.09";"";"";"UO_0000065";"15.04";"0.28";"1.17";"7.52";"0";"CHEMBL3811221";"Inhibition of Cathepsin D (unknown origin) by fluorescence assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3808306";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";""
"CHEMBL3890449";"";"None";"531.48";"1";"3.56";"BDBM220826";"COc1cnc(C(=O)Nc2ccc3c(c2)C2(CCOC(N)=N2)c2cc(-c4ccnc(F)c4)nc(F)c2O3)cn1";"IC50";"'='";"400000.0";"nM";"";"Outside typical range";"386512";"UO_0000065";"";"";"";"";"0";"CHEMBL3888270";"Fluorescence Resonance Energy Transfer (FRET) Assay: Recombinant CathepsinD was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The CathepsinD enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for CathepsinD) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886633";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL4561907";"";"None";"527.75";"1";"4.56";"27";"O=C1C[C@H](O)[C@H](Cc2ccccc2)NC(=O)CCCCCCCCCCCNC(=O)[C@H](C2CCCCC2)N1";"IC50";"'='";"8.2";"nM";"8.09";"";"";"UO_0000065";"15.32";"0.29";"3.53";"7.52";"0";"CHEMBL4325791";"Inhibition of human placenta CatD using Abz-Lys-Pro-Ala-Glu-Phe-Nph-Ala-Leu as substrate preincubated for 10 mins followed by substrate addition and measured by FRET assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4321885";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";""
"CHEMBL4474088";"";"None";"535.73";"1";"4.22";"28";"O=C1C[C@H](O)[C@H](Cc2ccccc2)NC(=O)CCCCCCCCCCCNC(=O)[C@H](Cc2ccccc2)N1";"IC50";"'='";"15.0";"nM";"7.82";"";"";"UO_0000065";"14.60";"0.27";"3.60";"7.28";"0";"CHEMBL4325791";"Inhibition of human placenta CatD using Abz-Lys-Pro-Ala-Glu-Phe-Nph-Ala-Leu as substrate preincubated for 10 mins followed by substrate addition and measured by FRET assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4321885";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";""
"CHEMBL4591056";"";"None";"579.78";"1";"4.59";"32";"C[C@@H](OCc1ccccc1)[C@@H]1NC(=O)C[C@H](O)[C@H](Cc2ccccc2)NC(=O)CCCCCCCCCCCNC1=O";"IC50";"'='";"560.0";"nM";"6.25";"";"";"UO_0000065";"10.78";"0.20";"1.66";"5.35";"0";"CHEMBL4325791";"Inhibition of human placenta CatD using Abz-Lys-Pro-Ala-Glu-Phe-Nph-Ala-Leu as substrate preincubated for 10 mins followed by substrate addition and measured by FRET assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4321885";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";""
"CHEMBL3673194";"";"None";"427.41";"0";"3.25";"16";"NC1=N[C@@]2(c3cc(CNCC(F)(F)F)c(F)cc3F)CO[C@@H](CF)C[C@H]2CS1";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4042703";"Inhibition of Cathepsin D (unknown origin) by cell free assay";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4041533";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";"";""
"CHEMBL3937937";"";"None";"735.85";"2";"3.86";"BDBM232279";"CC[C@H](C)[C@H](NC(=O)C[C@H](N)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)Cc1cccc(OC(F)(F)F)c1)[C@@H](C)CC)C(=O)N[C@H](C(=O)O)C(C)C";"IC50";"'='";"3.2";"nM";"8.49";"";"405053";"UO_0000065";"11.54";"0.22";"4.63";"4.50";"0";"CHEMBL3888498";"In-Vitro Fluorescence Assay: In order to identify modulators of cathepsin D activity, a continuous enzymatic test was carried out with a synthetic peptide which carries a fluorescent group (MCA=(7-methoxycoumarin-4-yl)acetyl) which is quenched by energy transfer from a Dpn (2,4 dinitrophenyl) group on the same molecule, in Greiner 384-well nb microtitre plates. Cleavage of the peptidic substrate by cathepsin D causes an increase in the fluorescence intensity. In order to determine the efficacy of substances, the time-dependent increase in the fluorescence intensity in the presence of the substance was compared with the time-dependent increase in fluorescence in the absence of substances. The reference substance used was pepstatin A (Sigma-Aldrich). The substrate used was MCAGKPILFFRLK(Dnp)d-R-NH2 (Enzo Life Sciences, Lorrach). The enzyme employed was cathepsin D isolated from the human liver (Sigma-Aldrich) in a final concentration of 1.4 nM. The test was carried out in 100 mM sodium acetate buffer, 1.25% (v/v) of DMSO, 0.25% (w/v) of Chaps, pH 5.5. 2 ul of each substance solution with serially diluted substance concentration were added to in each case 4 ul of cathepsin D solution and incubated at room temperature for 10 min. The reaction was started by addition of 2 ul of substrate solution (final concentration 5 uM). After carrying out a starting-point fluorescence measurement (excitation wavelength 340 nm/emission wavelength 450 nm) using an Envision multilabel reader (Perkin Elmer), the reaction was incubated at room temperature for 60 min. The amount of peptide fragment cleaved off during the reaction time was subsequently measured by determination of the increase in the fluorescence intensity at 450 nm (excitation wavelength 340 nm).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886733";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3813928";"";"None";"979.19";"3";"0.35";"1";"CC[C@H](C)[C@H](NC(=O)C[C@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(N)=O)N(C)C(=O)[C@@H](NC(=O)[C@H](C)O)[C@@H](C)CC)C(=O)NCC(=O)N(C)[C@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)OC";"IC50";"'='";"57.0";"nM";"7.24";"";"";"UO_0000065";"7.40";"0.14";"6.89";"2.52";"0";"CHEMBL3816585";"Inhibition of human liver cathepsin D using Mca-Gly-Lys-Pro-Ile-Leu-Phe-Phe-Arg-Leu-Lys-(Dnp)-D-Arg-NH2 as substrate preincubated for 15 mins followed by substrate addition measured every 5 mins for 120 mins by fluorescence analysis";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3813591";"1";"Scientific Literature";"Bioorg Med Chem";"2016";"None";"";"";""
"CHEMBL4448566";"";"None";"587.21";"2";"8.29";"65";"Clc1ccc2sc(SCCCc3ccc(OC4C5CCC(N5)C4OCc4ccc5ccccc5c4)cc3)nc2c1";"IC50";"'='";"7000.0";"nM";"5.16";"";"";"UO_0000065";"8.78";"0.18";"-3.14";"11.88";"0";"CHEMBL4357658";"Inhibition of human cathepsin D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4354841";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";""
"CHEMBL4554448";"";"None";"428.53";"0";"4.78";"68";"Nc1ccc(C(=O)CCC2CNCC=C(COC(=O)c3ccc4ccccc4c3)C2)cc1";"IC50";"'='";"262000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4357658";"Inhibition of human cathepsin D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4354841";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";""
"CHEMBL4225824";"";"None";"463.58";"0";"4.57";"70";"CCCCCc1ccc(-c2cc(CCC(=O)O)c3c(=O)n(CC4CCCO4)c(N)nc3c2)cc1";"IC50";"'='";"21000.0";"nM";"4.68";"";"";"UO_0000065";"10.09";"0.19";"0.11";"4.35";"1";"CHEMBL4357658";"Inhibition of human cathepsin D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4354841";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";""
"CHEMBL3422238";"";"None";"364.42";"0";"2.73";"5";"Cn1cc([C@H]2C[C@H]3CSC(N)=N[C@@]3(c3ccc(F)cc3F)CO2)cn1";"IC50";"'='";"13100.0";"nM";"4.88";"";"";"UO_0000065";"13.40";"0.27";"2.15";"7.46";"0";"CHEMBL3423725";"Inhibition of CatD (unknown origin) assessed as fluorescence polarization by cell free assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3421534";"1";"Scientific Literature";"J Med Chem";"2015";"None";"";"";""
"CHEMBL3971010";"";"None";"691.84";"1";"4.41";"BDBM232278";"CC[C@H](C)[C@H](NC(=O)C[C@H](N)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)Cc1cccc(OC(F)(F)F)c1)C(C)C)C(=O)NCCC(C)C";"IC50";"'='";"28.0";"nM";"7.55";"";"405052";"UO_0000065";"10.92";"0.21";"3.14";"4.98";"0";"CHEMBL3888498";"In-Vitro Fluorescence Assay: In order to identify modulators of cathepsin D activity, a continuous enzymatic test was carried out with a synthetic peptide which carries a fluorescent group (MCA=(7-methoxycoumarin-4-yl)acetyl) which is quenched by energy transfer from a Dpn (2,4 dinitrophenyl) group on the same molecule, in Greiner 384-well nb microtitre plates. Cleavage of the peptidic substrate by cathepsin D causes an increase in the fluorescence intensity. In order to determine the efficacy of substances, the time-dependent increase in the fluorescence intensity in the presence of the substance was compared with the time-dependent increase in fluorescence in the absence of substances. The reference substance used was pepstatin A (Sigma-Aldrich). The substrate used was MCAGKPILFFRLK(Dnp)d-R-NH2 (Enzo Life Sciences, Lorrach). The enzyme employed was cathepsin D isolated from the human liver (Sigma-Aldrich) in a final concentration of 1.4 nM. The test was carried out in 100 mM sodium acetate buffer, 1.25% (v/v) of DMSO, 0.25% (w/v) of Chaps, pH 5.5. 2 ul of each substance solution with serially diluted substance concentration were added to in each case 4 ul of cathepsin D solution and incubated at room temperature for 10 min. The reaction was started by addition of 2 ul of substrate solution (final concentration 5 uM). After carrying out a starting-point fluorescence measurement (excitation wavelength 340 nm/emission wavelength 450 nm) using an Envision multilabel reader (Perkin Elmer), the reaction was incubated at room temperature for 60 min. The amount of peptide fragment cleaved off during the reaction time was subsequently measured by determination of the increase in the fluorescence intensity at 450 nm (excitation wavelength 340 nm).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886733";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3908288";"";"None";"452.37";"0";"2.16";"BDBM214886";"C#CCOc1cnc(C(=O)Nc2ccc(F)c([C@]3(C)C[C@@H](C(F)(F)F)OC(N)=N3)n2)cn1";"IC50";"'='";"609000.0";"nM";"";"Outside typical range";"377932";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3941417";"";"None";"500.40";"1";"3.84";"BDBM214966";"CC#CCOc1ccc(C(=O)Nc2cc(F)c(F)c([C@]3(CF)C[C@@H](C(F)(F)F)OC(N)=N3)c2)nc1";"IC50";"'>'";"400000.0";"nM";"";"Outside typical range";"378000";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3894515";"";"None";"464.85";"0";"4.49";"BDBM214890";"NC1=N[C@](CF)(c2cc(NC(=S)c3ccc(Cl)cn3)ccc2F)C[C@@H](C(F)(F)F)O1";"IC50";"'='";"805000.0";"nM";"";"Outside typical range";"378023";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3921212";"";"None";"433.38";"0";"4.54";"BDBM214932";"NC1=N[C@](CF)(c2cc(C#Cc3ccc4[nH]ccc4c3)ccc2F)C[C@@H](C(F)(F)F)O1";"IC50";"'='";"381000.0";"nM";"";"Outside typical range";"378032";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3973710";"";"None";"416.35";"0";"3.99";"BDBM215039";"COc1cccnc1Nc1cc(F)c(F)c([C@]2(C)C[C@@H](C(F)(F)F)OC(N)=N2)c1";"IC50";"'='";"282000.0";"nM";"";"Outside typical range";"378039";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3979006";"";"None";"538.00";"2";"5.13";"BDBM220854";"NC1=NC2(CCS1)c1cc(NC(=O)c3ccc(Cl)cn3)ccc1Oc1c2cc(C2=CCOCC2)nc1F";"IC50";"'='";"133000.0";"nM";"";"Outside typical range";"386540";"UO_0000065";"";"";"";"";"0";"CHEMBL3888270";"Fluorescence Resonance Energy Transfer (FRET) Assay: Recombinant CathepsinD was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The CathepsinD enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for CathepsinD) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886633";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL4755936";"";"None";"619.62";"1";"1.65";"16e";"CCC[C@@H](NC(=N)NC(=O)Cc1ccc(OC)c(OC)c1)C(=O)Nc1cc(S(N)(=O)=O)ccc1C.O=C(O)C(F)(F)F";"IC50";"'='";"45.0";"nM";"7.35";"";"";"UO_0000065";"14.53";"0.29";"5.70";"4.25";"0";"CHEMBL4706202";"Inhibition of human liver Cathepsin D preincubated for 10 mins followed by substrate addition and further incubated for 2 hrs in dark by fluorimetric analysis";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699662";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"TIME = 2.167 hr";"INHIBITOR";""
"CHEMBL4575752";"";"None";"438.89";"0";"3.29";"7";"C[C@]1(c2cc(NC(=O)c3ccc(Cl)cn3)cc(F)c2F)N=C(N)S[C@@]2(CO)C[C@H]21";"IC50";"'='";"1245000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4343401";"Inhibition of recombinant CatD (unknown origin) expressed in CHO cells using FRET peptide substrate preincubated for 1 hr followed by substrate addition and measured after 1 hr by FRET assay";"A";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4342420";"1";"Scientific Literature";"J Med Chem";"2020";"CHEMBL3308072";"";"";""
"CHEMBL4468455";"";"None";"451.89";"0";"2.79";"11";"C[C@]1(c2cc(NC(=O)c3ccc(Cl)cn3)cc(F)c2F)N=C(N)S[C@@]2(C(N)=O)C[C@H]21";"IC50";"'='";"856000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4343401";"Inhibition of recombinant CatD (unknown origin) expressed in CHO cells using FRET peptide substrate preincubated for 1 hr followed by substrate addition and measured after 1 hr by FRET assay";"A";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4342420";"1";"Scientific Literature";"J Med Chem";"2020";"CHEMBL3308072";"";"";""
"CHEMBL4577527";"";"None";"479.46";"0";"3.32";"25";"C#CCOc1cnc(C(=O)Nc2cc(F)c(F)c([C@@]3(C)N=C(N)S[C@@]4(C(F)F)C[C@@H]34)c2)cn1";"IC50";"'='";"48000.0";"nM";"4.32";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4343401";"Inhibition of recombinant CatD (unknown origin) expressed in CHO cells using FRET peptide substrate preincubated for 1 hr followed by substrate addition and measured after 1 hr by FRET assay";"A";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4342420";"1";"Scientific Literature";"J Med Chem";"2020";"CHEMBL3308072";"";"";""
"CHEMBL3683805";"";"None";"431.37";"0";"2.55";"BDBM171411";"COc1cc(C#N)cnc1C(=O)Nc1ccc(F)c([C@@]2(C(F)F)N=C(N)O[C@@H]3C[C@@H]32)c1";"IC50";"'='";"3449400.0";"nM";"";"Outside typical range";"315820";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3683867";"";"None";"467.76";"0";"3.66";"BDBM171480";"NC1=N[C@@](c2cc(NC(=O)c3nn(C(F)F)cc3Cl)cc(F)c2F)(C(F)F)[C@H]2C[C@H]2O1";"IC50";"'='";"158500.0";"nM";"";"Outside typical range";"315889";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688658";"";"None";"393.78";"0";"2.42";"BDBM171596";"NC1=N[C@@](CF)(c2cc(NC(=O)c3ccc(Cl)cn3)cnc2F)[C@@H]2C[C@@H]2O1";"IC50";"'>'";"400000.0";"nM";"";"Outside typical range";"316005";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3683803";"";"None";"424.81";"0";"3.63";"BDBM171409";"Cc1cc(Cl)cnc1C(=O)Nc1ccc(F)c([C@@]2(C(F)F)N=C(N)O[C@@H]3C[C@@H]32)c1";"IC50";"'='";"595960.0";"nM";"";"Outside typical range";"315818";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3683811";"";"None";"458.36";"0";"3.84";"BDBM171417";"Cc1cc(C(F)(F)F)cnc1C(=O)Nc1cc(F)c(F)c([C@@]2(CF)N=C(N)O[C@@H]3C[C@@H]32)c1";"IC50";"'='";"113000.0";"nM";"";"Outside typical range";"315826";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688810";"";"None";"466.30";"0";"4.88";"BDBM171758";"NC1=N[C@@](c2cc(N[C@@H]3CCc4cc(Br)ccc43)ccc2F)(C(F)F)[C@H]2C[C@H]2O1";"IC50";"'='";"82550.0";"nM";"4.08";"";"316158";"UO_0000065";"8.76";"0.19";"-0.80";"6.85";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688813";"";"None";"429.84";"0";"2.25";"BDBM171761";"N#Cc1cnc(C(=O)Nc2ccc(Cl)c([C@@]3(CF)N=C(N)O[C@@H]4C[C@@H]43)c2)c(CO)c1";"IC50";"'='";"352100.0";"nM";"";"Outside typical range";"316161";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3909521";"";"None";"421.84";"0";"3.47";"BDBM220781";"NC1=NC2(CCO1)c1cc(NC(=O)c3ccc(Cl)cn3)ccc1Oc1ncccc12";"IC50";"'>'";"400000.0";"nM";"";"Outside typical range";"386464";"UO_0000065";"";"";"";"";"0";"CHEMBL3888270";"Fluorescence Resonance Energy Transfer (FRET) Assay: Recombinant CathepsinD was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The CathepsinD enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for CathepsinD) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886633";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3962806";"";"None";"517.74";"1";"4.97";"BDBM220782";"NC1=NC2(CCO1)c1cc(NC(=O)c3ccc(Cl)cc3F)ccc1Oc1ncc(Br)cc12";"IC50";"'>'";"400000.0";"nM";"";"Outside typical range";"386465";"UO_0000065";"";"";"";"";"0";"CHEMBL3888270";"Fluorescence Resonance Energy Transfer (FRET) Assay: Recombinant CathepsinD was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The CathepsinD enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for CathepsinD) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886633";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3895059";"";"None";"512.50";"1";"3.63";"BDBM220785";"N#Cc1ccc(C(=O)Nc2ccc3c(c2)C2(CCOC(N)=N2)c2cc(C4=CCCOC4)nc(F)c2O3)nc1";"IC50";"'='";"132000.0";"nM";"";"Outside typical range";"386468";"UO_0000065";"";"";"";"";"0";"CHEMBL3888270";"Fluorescence Resonance Energy Transfer (FRET) Assay: Recombinant CathepsinD was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The CathepsinD enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for CathepsinD) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886633";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3683790";"";"None";"466.51";"0";"2.88";"BDBM171395";"Cc1cc(OCC#CC(C)(C)O)cnc1C(=O)Nc1ccc(F)c(C2(C)N=C(N)O[C@H]3C[C@H]32)c1";"IC50";"'='";"462460.0";"nM";"";"Outside typical range";"315804";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3683830";"";"None";"455.23";"0";"3.43";"BDBM171440";"NC1=N[C@@](c2cc(NC(=O)c3ccc(Br)cn3)ccc2F)(C(F)F)[C@H]2C[C@H]2O1";"IC50";"'='";"282500.0";"nM";"";"Outside typical range";"315849";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3683851";"";"None";"431.37";"0";"2.07";"BDBM171461";"C#CCOc1cnc(C(=O)Nc2ccc(F)c([C@@]3(C(F)F)N=C(N)O[C@@H]4C[C@@H]43)c2)cn1";"IC50";"'='";"143000.0";"nM";"";"Outside typical range";"315870";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688633";"";"None";"408.41";"0";"3.52";"BDBM171568";"NC1=N[C@](CF)(c2cc(NC(=O)c3cc4ccccc4cn3)ccc2F)[C@H]2C[C@H]2O1";"IC50";"'='";"430210.0";"nM";"";"Outside typical range";"315977";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3639875";"";"None";"505.24";"1";"4.37";"BDBM171656";"NC1=N[C@@](c2cc(NC(=O)c3ncc(Br)cc3C(F)F)ccc2F)(C(F)F)[C@H]2C[C@H]2O1";"IC50";"'='";"251500.0";"nM";"";"Outside typical range";"316064";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688725";"";"None";"419.84";"0";"2.60";"BDBM171667";"COc1cnc(C(=O)Nc2ccc(Cl)c([C@@]3(CF)N=C(N)O[C@@H]4C[C@@H]43)c2)c(C)n1";"IC50";"'='";"714940.0";"nM";"";"Outside typical range";"316075";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3693222";"";"None";"440.43";"0";"3.43";"BDBM171780";"NC1=N[C@@](c2cc(NC(=O)c3ccc(C#CC4CC4)cn3)ccc2F)(C(F)F)[C@H]2C[C@H]2O1";"IC50";"'='";"398530.0";"nM";"";"Outside typical range";"316177";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3683915";"";"None";"490.47";"0";"3.10";"BDBM171535";"NC1=N[C@@](c2cc(NC(=O)c3cnc(OCc4cscn4)cn3)ccc2F)(C(F)F)[C@H]2C[C@H]2O1";"IC50";"'='";"581850.0";"nM";"";"Outside typical range";"315944";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688615";"";"None";"422.82";"0";"3.19";"BDBM171549";"NC1=N[C@](CF)(c2cc(NC(=O)c3ccc(OCF)cn3)ccc2Cl)[C@H]2C[C@H]2O1";"IC50";"'='";"882020.0";"nM";"";"Outside typical range";"315958";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688683";"";"None";"387.36";"0";"1.62";"BDBM171621";"COCCOCC(=O)Nc1ccc(F)c([C@@]2(C(F)F)N=C(N)O[C@@H]3C[C@@H]32)c1";"IC50";"'='";"666150.0";"nM";"";"Outside typical range";"316030";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3983343";"";"None";"388.30";"0";"3.24";"BDBM214892";"NC1=N[C@](CF)(c2cc(Oc3cnccn3)ccc2F)C[C@@H](C(F)(F)F)O1";"IC50";"'>'";"400000.0";"nM";"";"Outside typical range";"377900";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3940322";"";"None";"489.81";"1";"5.14";"BDBM214818";"NC1=N[C@](CF)(c2cc(Nc3ncc(F)c4cc(Cl)cnc34)ccc2F)C[C@@H](C(F)(F)F)O1";"IC50";"'>'";"133000.0";"nM";"";"Outside typical range";"377966";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3906761";"";"None";"480.37";"0";"4.54";"BDBM214984";"C[C@@]1(c2cc(Nc3ncc(F)c4cc(C#N)cnc34)cc(F)c2F)C[C@@H](C(F)(F)F)OC(N)=N1";"IC50";"'>'";"4940.0";"nM";"";"";"378017";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3414710";"";"None";"324.40";"0";"3.04";"34";"NC1=N[C@@]2(c3ccc(F)cc3F)CO[C@@H](C3CC3)C[C@H]2CS1";"IC50";"'='";"45000.0";"nM";"4.35";"";"";"UO_0000065";"13.40";"0.27";"1.31";"9.13";"0";"CHEMBL3420009";"Inhibition of CatD (unknown origin) by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3414451";"1";"Scientific Literature";"J Med Chem";"2015";"None";"";"";""
"CHEMBL3688625";"";"None";"389.36";"0";"1.77";"BDBM171560";"COc1cnc(C(=O)Nc2ccc(F)c([C@@]3(CF)N=C(N)O[C@@H]4C[C@@H]43)c2)cn1";"IC50";"'='";"1225600.0";"nM";"";"Outside typical range";"315969";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688677";"";"None";"406.36";"0";"1.97";"BDBM171615";"Cn1ccc(C(=O)Nc2ccc(F)c([C@@]3(C(F)F)N=C(N)O[C@@H]4C[C@@H]43)c2)cc1=O";"IC50";"'='";"1586300.0";"nM";"";"Outside typical range";"316024";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688691";"";"None";"392.79";"0";"3.18";"BDBM171629";"NC1=N[C@@](c2cccc(NC(=O)c3ccc(Cl)cn3)c2)(C(F)F)[C@H]2C[C@H]2O1";"IC50";"'='";"1060300.0";"nM";"";"Outside typical range";"316038";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688703";"";"None";"399.81";"0";"2.76";"BDBM171644";"N#Cc1ccc(C(=O)Nc2ccc(Cl)c([C@]3(CF)N=C(N)O[C@H]4C[C@H]43)c2)nc1";"IC50";"'='";"904390.0";"nM";"";"Outside typical range";"316052";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688705";"";"None";"429.84";"0";"2.29";"BDBM171646";"C#CCOc1cnc(C(=O)Nc2ccc(Cl)c([C@]3(CF)N=C(N)O[C@H]4C[C@H]43)c2)cn1";"IC50";"'='";"1473800.0";"nM";"";"Outside typical range";"316054";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688707";"";"None";"404.83";"0";"2.89";"BDBM171648";"COc1ccc(C(=O)Nc2ccc(Cl)c([C@@]3(CF)N=C(N)O[C@@H]4C[C@@H]43)c2)nc1";"IC50";"'='";"649740.0";"nM";"";"Outside typical range";"316056";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688727";"";"None";"438.84";"0";"3.94";"BDBM171669";"Cc1cc(Cl)cnc1C(=O)Nc1cc(C)c(F)c([C@@]2(C(F)F)N=C(N)O[C@@H]3C[C@@H]32)c1";"IC50";"'='";"334880.0";"nM";"";"Outside typical range";"316077";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688773";"";"None";"458.83";"0";"4.23";"BDBM171719";"N#Cc1cnc2c(Nc3ccc(Cl)c([C@]4(C(F)F)N=C(N)O[C@H]5C[C@H]54)c3)ncc(F)c2c1";"IC50";"'>'";"14800.0";"nM";"";"";"316125";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL4285211";"";"None";"443.41";"0";"4.18";"1";"NC1=N[C@@]2(CO1)c1cc(-c3cccc(F)n3)ccc1Oc1cnc(-c3ccnc(F)c3)cc12";"IC50";"'='";"660.0";"nM";"6.18";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4262564";"Inhibition of recombinant human CatD using fluorophore/quencher-tagged peptide as substrate pretreated for 60 mins followed by substrate addition and measured after 60 mins by FRET assay";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261519";"1";"Scientific Literature";"Medchemcomm";"2017";"None";"";"";""
"CHEMBL4284110";"";"None";"450.50";"0";"4.01";"13";"CC#Cc1cncc(-c2ccc3c(c2)[C@@]2(COC(N)=N2)c2cc(C4=CCOCC4)ncc2O3)c1";"IC50";"'='";"5900.0";"nM";"5.23";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4262564";"Inhibition of recombinant human CatD using fluorophore/quencher-tagged peptide as substrate pretreated for 60 mins followed by substrate addition and measured after 60 mins by FRET assay";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261519";"1";"Scientific Literature";"Medchemcomm";"2017";"None";"";"";""
"CHEMBL4282964";"";"None";"476.54";"0";"4.40";"16";"NC1=N[C@@]2(CO1)c1cc(-c3cncc(C#CC4CC4)c3)ccc1Oc1cnc(C3=CCOCC3)cc12";"IC50";"'='";"3600.0";"nM";"5.44";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4262564";"Inhibition of recombinant human CatD using fluorophore/quencher-tagged peptide as substrate pretreated for 60 mins followed by substrate addition and measured after 60 mins by FRET assay";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261519";"1";"Scientific Literature";"Medchemcomm";"2017";"None";"";"";""
"CHEMBL4294221";"";"None";"489.92";"0";"3.88";"30";"NC1=N[C@@]2(CO1)c1cc(NC(=O)c3ccc(Cl)cn3)ccc1Oc1cnc(C3=CCCOC3)cc12";"IC50";"'='";"480000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4262564";"Inhibition of recombinant human CatD using fluorophore/quencher-tagged peptide as substrate pretreated for 60 mins followed by substrate addition and measured after 60 mins by FRET assay";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261519";"1";"Scientific Literature";"Medchemcomm";"2017";"None";"";"";""
"CHEMBL3688817";"";"None";"407.38";"0";"2.68";"BDBM171767";"N#Cc1cnc2c(Nc3ccc(F)c([C@@]4(CF)N=C(N)O[C@@H]5C[C@@H]54)c3)ncnc2c1";"IC50";"'='";"147000.0";"nM";"";"Outside typical range";"316166";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3693227";"";"None";"471.44";"0";"2.85";"BDBM171786";"NC1=N[C@@](c2cc(NC(=O)c3cnc(OCC#CC4CC4)cn3)ccc2F)(C(F)F)[C@H]2C[C@H]2O1";"IC50";"'='";"359770.0";"nM";"";"Outside typical range";"316182";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3693230";"";"None";"433.39";"0";"2.63";"BDBM171789";"C=CCOc1cnc(C(=O)Nc2ccc(F)c([C@@]3(C(F)F)N=C(N)O[C@@H]4C[C@@H]43)c2)cn1";"IC50";"'='";"924060.0";"nM";"";"Outside typical range";"316185";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3693234";"";"None";"475.47";"0";"3.63";"BDBM171793";"NC1=N[C@@](c2cc(NC(=O)c3cnc(OCC4CCCC4)cn3)ccc2F)(C(F)F)[C@H]2C[C@H]2O1";"IC50";"'='";"890720.0";"nM";"";"Outside typical range";"316189";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3693249";"";"None";"360.34";"0";"2.58";"BDBM171809";"CC#Cc1cnn(-c2ccc(F)c([C@@]3(C(F)F)N=C(N)O[C@@H]4C[C@@H]43)c2)c1";"IC50";"'='";"385600.0";"nM";"";"Outside typical range";"316205";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3693259";"";"None";"417.37";"0";"3.61";"BDBM171820";"NC1=N[C@@](c2cc(-c3nnc(-c4ccc(F)cc4)[nH]3)ccc2F)(C(F)F)[C@H]2C[C@H]2O1";"IC50";"'='";"249590.0";"nM";"";"Outside typical range";"316211";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688741";"";"None";"441.27";"0";"4.01";"BDBM171685";"NC1=N[C@](CF)(c2cc(NC(=O)c3ncc(Cl)cc3CF)ccc2Cl)[C@H]2C[C@H]2O1";"IC50";"'='";"444190.0";"nM";"";"Outside typical range";"316212";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688743";"";"None";"423.28";"0";"3.85";"BDBM171687";"Cc1cc(Cl)cnc1C(=O)Nc1ccc(Cl)c([C@@]2(CF)N=C(N)O[C@@H]3C[C@@H]32)c1";"IC50";"'='";"517380.0";"nM";"";"Outside typical range";"316214";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688789";"";"None";"424.39";"0";"3.58";"BDBM171736";"N#Cc1cnc2c(Nc3ccc(F)c([C@@]4(C(F)F)N=C(N)O[C@@H]5C[C@@H]54)c3)nccc2c1";"IC50";"'='";"657710.0";"nM";"";"Outside typical range";"316217";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL5092328";"";"None";"530.50";"1";"3.30";"12; JNJ-67569762";"CCS(=O)(=O)[C@]1(C)CC[C@@](CF)(c2cc(NC(=O)c3cc4c(cn3)OC(F)(F)O4)ccc2F)N=C1N";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5029746";"Inhibition of human cathepsin D incubated for 3.5 hrs by fluorescence assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5029164";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 3.5 hr";"";""
"CHEMBL4209354";"";"None";"292.40";"0";"2.38";"43";"COc1ccccc1[C@]12CO[C@@H](C)C[C@H]1CSC(N)=N2";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4183115";"Inhibition of Cathepsin D (unknown origin) by fluorescence polarization assay";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4177751";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL3586137";"";"None";"344.84";"0";"1.55";"4.HCl";"Cl.NC1=NC2CCC(NC(=O)c3ccc(F)cn3)CC2CS1";"IC50";"'>'";"300000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3588066";"Inhibition of human cathepsin D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3585284";"1";"Scientific Literature";"Bioorg Med Chem";"2015";"None";"";"";""
"CHEMBL3763404";"";"None";"397.48";"0";"4.57";"2R,5S-3b";"Nc1nc2cc(-c3ccccc3)ccc2c(=O)n1C[C@H]1CC[C@@H](c2ccccc2)O1";"IC50";"'='";"4600.0";"nM";"5.34";"";"";"UO_0000065";"13.43";"0.24";"0.77";"7.61";"0";"CHEMBL3767017";"Inhibition of CatD (unknown origin) preincubated for 30 mins followed by DABCYL-Glu-Arg-Nle-Phe-Leu-Ser-Phe-Pro-EDANS substrate addition by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3763050";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";""
"CHEMBL3672916";"";"None";"425.87";"0";"2.14";"3";"CN1C(=N)N[C@](C)(c2cc(NC(=O)c3ccc(Cl)cn3)ccc2F)CS1(=O)=O";"IC50";"'>'";"1000000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4183174";"Inhibition of human Cathepsin D using Mca-Gly-Lys-Pro-Ile-Leu-Phe-PheArg-Leu-Lys(Dnp)-D-Arg-NH2 as substrate after 45 mins";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4177751";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4747539";"";"None";"715.79";"1";"3.81";"11a";"COc1ccc(CCC(=O)NC(=N)N[C@H](CC2CCCCC2)C(=O)Nc2cc(S(=O)(=O)N(C)C)ccc2C)cc1OC.O=C(O)C(F)(F)F";"IC50";"'='";"53.0";"nM";"7.28";"";"";"UO_0000065";"12.09";"0.24";"3.47";"4.85";"0";"CHEMBL4706202";"Inhibition of human liver Cathepsin D preincubated for 10 mins followed by substrate addition and further incubated for 2 hrs in dark by fluorimetric analysis";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699662";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"TIME = 2.167 hr";"INHIBITOR";""
"CHEMBL4225299";"";"None";"509.69";"2";"7.47";"5";"CCCCCCCCc1ccc(-c2ccc3c(=O)n(C[C@@H]4CC[C@H](c5ccccc5)O4)c(N)nc3c2)cc1";"IC50";"'='";"400.0";"nM";"6.40";"";"";"UO_0000065";"12.55";"0.23";"-1.07";"9.12";"0";"CHEMBL4223547";"Inhibition of human cathepsin D using DABCYL-Glu-Arg-Nle-Phe-Leu-Ser-Phe-Pro-EDANS as substrate preincubated for 30 mins followed by substrate addition measured every 1 min within 8 to 15 mins by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4219216";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";"";""
"CHEMBL4225298";"";"None";"429.56";"0";"4.08";"6c";"CCCCCCCCc1cc(CCC(=O)O)c2c(=O)n(CC3CCCO3)c(N)nc2c1";"IC50";"'='";"430.0";"nM";"6.37";"";"";"UO_0000065";"14.82";"0.28";"2.29";"5.93";"0";"CHEMBL4223547";"Inhibition of human cathepsin D using DABCYL-Glu-Arg-Nle-Phe-Leu-Ser-Phe-Pro-EDANS as substrate preincubated for 30 mins followed by substrate addition measured every 1 min within 8 to 15 mins by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4219216";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";"";""
"CHEMBL3683789";"";"None";"440.81";"0";"3.33";"BDBM171394";"COc1cc(Cl)cnc1C(=O)Nc1ccc(F)c([C@@]2(C(F)F)N=C(N)O[C@@H]3C[C@@H]32)c1";"IC50";"'='";"907850.0";"nM";"";"Outside typical range";"315803";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3683804";"";"None";"415.38";"0";"2.85";"BDBM171410";"Cc1cc(C#N)cnc1C(=O)Nc1ccc(F)c([C@@]2(C(F)F)N=C(N)O[C@@H]3C[C@@H]32)c1";"IC50";"'='";"376160.0";"nM";"";"Outside typical range";"315819";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3683809";"";"None";"415.38";"0";"2.69";"BDBM171415";"Cc1cc(C#N)cnc1C(=O)Nc1cc(F)c(F)c([C@@]2(CF)N=C(N)O[C@@H]3C[C@@H]32)c1";"IC50";"'='";"202000.0";"nM";"";"Outside typical range";"315824";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3683810";"";"None";"415.38";"0";"2.69";"BDBM171416";"Cc1cc(C#N)cnc1C(=O)Nc1cc(F)c(F)c([C@]2(CF)N=C(N)O[C@H]3C[C@H]32)c1";"IC50";"'='";"1746200.0";"nM";"";"Outside typical range";"315825";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3683903";"";"None";"429.35";"0";"2.94";"BDBM171520";"Cn1nc(C(F)F)cc1C(=O)Nc1ccc(F)c([C@@]2(C(F)F)N=C(N)O[C@@H]3C[C@@H]32)c1";"IC50";"'='";"514640.0";"nM";"";"Outside typical range";"315929";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688755";"";"None";"410.24";"0";"3.12";"BDBM171699";"C[C@@]1(c2nc(NC(=O)c3ncc(Cl)cc3Cl)ccc2F)N=C(N)O[C@H]2C[C@H]21";"IC50";"'='";"1611000.0";"nM";"";"Outside typical range";"316103";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688763";"";"None";"393.42";"0";"3.47";"BDBM171709";"COc1cnc2c(Nc3ccc(F)c([C@]4(C)N=C(N)O[C@H]5C[C@H]54)c3)nccc2c1";"IC50";"'>'";"400000.0";"nM";"";"Outside typical range";"316113";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688767";"";"None";"424.39";"0";"3.42";"BDBM171713";"N#Cc1cnc2c(Nc3ccc(F)c([C@@]4(CF)N=C(N)O[C@@H]5C[C@@H]54)c3)ncc(F)c2c1";"IC50";"'>'";"44400.0";"nM";"";"";"316117";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688766";"";"None";"433.82";"0";"4.20";"BDBM171712";"NC1=N[C@](CF)(c2cc(Nc3nccc4cc(Cl)cnc34)cc(F)c2F)[C@H]2C[C@H]2O1";"IC50";"'='";"50550.0";"nM";"4.30";"";"316116";"UO_0000065";"9.90";"0.20";"0.10";"5.03";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3693237";"";"None";"446.84";"0";"2.87";"BDBM171796";"NC1=N[C@@](c2cc(NS(=O)(=O)c3ccc(Cl)cn3)ccc2F)(C(F)F)[C@H]2C[C@H]2O1";"IC50";"'='";"223500.0";"nM";"";"Outside typical range";"316192";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3693235";"";"None";"440.81";"0";"2.81";"BDBM171794";"NC1=N[C@@](c2cc(NC(=O)c3ncc(Cl)cc3CO)ccc2F)(C(F)F)[C@H]2C[C@H]2O1";"IC50";"'='";"275500.0";"nM";"";"Outside typical range";"316190";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3693246";"";"None";"371.36";"0";"3.45";"BDBM171805";"CC#Cc1cncc(-c2ccc(F)c([C@]3(C(F)F)N=C(N)O[C@H]4C[C@H]43)c2)c1";"IC50";"'='";"1016500.0";"nM";"";"Outside typical range";"316201";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3693250";"";"None";"386.38";"0";"2.97";"BDBM171810";"NC1=N[C@@](c2cc(-n3cc(C#CC4CC4)cn3)ccc2F)(C(F)F)[C@H]2C[C@H]2O1";"IC50";"'='";"315500.0";"nM";"";"Outside typical range";"316206";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3683886";"";"None";"459.26";"0";"4.28";"BDBM171501";"Cc1cc(NC(=O)c2ncc(Cl)cc2Cl)cc([C@@]2(C(F)F)N=C(N)O[C@@H]3C[C@@H]32)c1F";"IC50";"'='";"493690.0";"nM";"";"Outside typical range";"315910";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688777";"";"None";"430.39";"0";"2.95";"BDBM171724";"COc1cnc2c(Nc3ccc(F)c([C@]4(CF)N=C(N)O[C@H]5C[C@H]54)c3F)nccc2n1";"IC50";"'='";"292000.0";"nM";"";"Outside typical range";"316128";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688783";"";"None";"428.86";"0";"3.33";"BDBM171730";"COc1cnc2c(Nc3ccc(Cl)c([C@@]4(CF)N=C(N)O[C@@H]5C[C@@H]54)c3)nccc2n1";"IC50";"'='";"843040.0";"nM";"";"Outside typical range";"316134";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3937992";"";"None";"517.47";"1";"4.90";"BDBM220838";"NC1=NC2(CCO1)c1cc(NC(=O)c3ccc(F)cn3)ccc1Oc1c(F)cc(-c3ccnc(F)c3)cc12";"IC50";"'='";"400000.0";"nM";"";"Outside typical range";"386524";"UO_0000065";"";"";"";"";"0";"CHEMBL3888270";"Fluorescence Resonance Energy Transfer (FRET) Assay: Recombinant CathepsinD was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The CathepsinD enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for CathepsinD) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886633";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3683856";"";"None";"490.85";"0";"3.14";"BDBM171468";"NC1=N[C@@](c2cc(NC(=O)c3cnc(OCc4cocn4)cn3)ccc2Cl)(C(F)F)[C@H]2C[C@H]2O1";"IC50";"'='";"591850.0";"nM";"";"Outside typical range";"315877";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688617";"";"None";"440.37";"0";"3.91";"BDBM171552";"Cc1cc(C(F)F)cnc1C(=O)Nc1ccc(F)c([C@@]2(C(F)F)N=C(N)O[C@@H]3C[C@@H]32)c1";"IC50";"'='";"767700.0";"nM";"";"Outside typical range";"315961";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688623";"";"None";"383.36";"0";"2.24";"BDBM171558";"N#Cc1ccc(C(=O)Nc2ccc(F)c([C@@]3(CF)N=C(N)O[C@@H]4C[C@@H]43)c2)nc1";"IC50";"'='";"590780.0";"nM";"";"Outside typical range";"315967";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3917225";"";"None";"503.95";"1";"4.27";"BDBM220789";"NC1=NC2(CCO1)c1cc(NC(=O)c3ccc(Cl)cn3)ccc1Oc1ncc(C3=CCCOC3)cc12";"IC50";"'>'";"1650.0";"nM";"";"";"386472";"UO_0000065";"";"";"";"";"0";"CHEMBL3888270";"Fluorescence Resonance Energy Transfer (FRET) Assay: Recombinant CathepsinD was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The CathepsinD enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for CathepsinD) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886633";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3970713";"";"None";"501.46";"2";"5.10";"BDBM214854";"NC1=N[C@](CF)(c2cc(Nc3nccc4cc(C#CC5CC5)cnc34)ccc2F)C[C@@H](C(F)(F)F)O1";"IC50";"'>'";"400000.0";"nM";"";"Outside typical range";"377968";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3908807";"";"None";"476.36";"0";"4.54";"BDBM214819";"NC1=N[C@](CF)(c2cc(Nc3nccc4cn(C(F)F)nc34)ccc2F)C[C@@H](C(F)(F)F)O1";"IC50";"'>'";"400000.0";"nM";"";"Outside typical range";"377969";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3930667";"";"None";"464.46";"0";"4.28";"BDBM214925";"C[C@@]1(c2cc(NC(=O)N3CC=C(C#CC4CC4)CC3)ccc2F)C[C@@H](C(F)(F)F)OC(N)=N1";"IC50";"'='";"810000.0";"nM";"";"Outside typical range";"377979";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3935479";"";"None";"526.38";"1";"4.74";"BDBM215001";"Cc1cc(OCC(F)(F)F)cnc1C(=O)Nc1cc(F)c(F)c([C@]2(C)C[C@@H](C(F)(F)F)OC(N)=N2)c1";"IC50";"'>'";"400000.0";"nM";"";"Outside typical range";"378067";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL4442495";"";"None";"674.88";"1";"4.65";"(S,R)-2d";"COCCN(CCOC)C(=O)c1cc(C(=O)N[C@@H](Cc2ccccc2)[C@H](O)CNC(C)(C)c2cccc(OC)c2)cc(N2CCCCC2)c1";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"10.37";"0.20";"2.35";"6.22";"0";"CHEMBL4331648";"Inhibition of human cathepsin D using DABCYL-Glu-Arg-Nle-Phe-Leu-Ser-Phe-Pro-EDANS as substrate preincubated for 30 mins followed by substrate addition and measured every min for 8 to 15 mins by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4330085";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";"";"";""
"CHEMBL4453065";"";"None";"646.83";"1";"3.34";"(S,R)-2c";"COc1cccc(C(C)(C)NC[C@@H](O)[C@H](Cc2ccccc2)NC(=O)c2cc(C(=O)N(CCO)CCO)cc(N3CCCCC3)c2)c1";"IC50";"'='";"270.0";"nM";"6.57";"";"";"UO_0000065";"10.16";"0.19";"3.23";"4.88";"0";"CHEMBL4331648";"Inhibition of human cathepsin D using DABCYL-Glu-Arg-Nle-Phe-Leu-Ser-Phe-Pro-EDANS as substrate preincubated for 30 mins followed by substrate addition and measured every min for 8 to 15 mins by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4330085";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";"";"";""
"CHEMBL4454828";"";"None";"670.94";"2";"6.67";"(S,R)-2f";"COc1cccc(C(C)(C)NC[C@@H](O)[C@H](Cc2ccccc2)NC(=O)c2cc(C(=O)N(CC(C)C)CC(C)C)cc(N3CCCCC3)c2)c1";"IC50";"'='";"1300.0";"nM";"5.89";"";"";"UO_0000065";"8.77";"0.16";"-0.78";"6.25";"0";"CHEMBL4331648";"Inhibition of human cathepsin D using DABCYL-Glu-Arg-Nle-Phe-Leu-Ser-Phe-Pro-EDANS as substrate preincubated for 30 mins followed by substrate addition and measured every min for 8 to 15 mins by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4330085";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";"";"";""
"CHEMBL4446738";"";"None";"573.78";"2";"5.49";"(S,R)-4a";"CCCN(CCC)C(=O)c1cc(C)cc(C(=O)N[C@@H](Cc2ccccc2)[C@H](O)CNC(C)(C)c2cccc(OC)c2)c1";"IC50";"'='";"210.0";"nM";"6.68";"";"";"UO_0000065";"11.64";"0.22";"1.19";"7.35";"0";"CHEMBL4331648";"Inhibition of human cathepsin D using DABCYL-Glu-Arg-Nle-Phe-Leu-Ser-Phe-Pro-EDANS as substrate preincubated for 30 mins followed by substrate addition and measured every min for 8 to 15 mins by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4330085";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";"";"";""
"CHEMBL4545195";"";"None";"594.20";"2";"5.84";"(S,R)-4d";"CCCN(CCC)C(=O)c1cc(Cl)cc(C(=O)N[C@@H](Cc2ccccc2)[C@H](O)CNC(C)(C)c2cccc(OC)c2)c1";"IC50";"'='";"96.0";"nM";"7.02";"";"";"UO_0000065";"11.81";"0.23";"1.18";"7.72";"0";"CHEMBL4331648";"Inhibition of human cathepsin D using DABCYL-Glu-Arg-Nle-Phe-Leu-Ser-Phe-Pro-EDANS as substrate preincubated for 30 mins followed by substrate addition and measured every min for 8 to 15 mins by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4330085";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";"";"";""
"CHEMBL4520253";"";"None";"571.64";"1";"4.60";"(S,R)-5b";"COc1cccc(C(C)(C)NC[C@@H](O)[C@H](Cc2ccccc2)NC(=O)c2cccc(C(=O)NCCC(F)(F)F)c2)c1";"IC50";"'='";"4900.0";"nM";"5.31";"";"";"UO_0000065";"9.29";"0.18";"0.71";"5.33";"0";"CHEMBL4331648";"Inhibition of human cathepsin D using DABCYL-Glu-Arg-Nle-Phe-Leu-Ser-Phe-Pro-EDANS as substrate preincubated for 30 mins followed by substrate addition and measured every min for 8 to 15 mins by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4330085";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";"";"";""
"CHEMBL3763900";"";"None";"543.71";"2";"7.52";"rac-4l";"Nc1nc2cc(-c3ccc(CCCCCc4ccccc4)cc3)ccc2c(=O)n1C[C@@H]1CC[C@H](c2ccccc2)O1";"IC50";"'='";"52000.0";"nM";"4.28";"";"";"UO_0000065";"7.88";"0.14";"-3.24";"6.11";"0";"CHEMBL3767017";"Inhibition of CatD (unknown origin) preincubated for 30 mins followed by DABCYL-Glu-Arg-Nle-Phe-Leu-Ser-Phe-Pro-EDANS substrate addition by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3763050";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";""
"CHEMBL3763442";"";"None";"501.63";"2";"6.35";"rac-4i";"Nc1nc2cc(-c3ccc(CCc4ccccc4)cc3)ccc2c(=O)n1C[C@@H]1CC[C@H](c2ccccc2)O1";"IC50";"'='";"220000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3767017";"Inhibition of CatD (unknown origin) preincubated for 30 mins followed by DABCYL-Glu-Arg-Nle-Phe-Leu-Ser-Phe-Pro-EDANS substrate addition by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3763050";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";""
"CHEMBL3765317";"";"None";"483.57";"0";"4.67";"rac-4d";"COC(=O)CCc1ccc(-c2ccc3c(=O)n(C[C@@H]4CC[C@H](c5ccccc5)O4)c(N)nc3c2)cc1";"IC50";"'='";"1400.0";"nM";"5.85";"";"";"UO_0000065";"12.11";"0.22";"1.18";"6.07";"0";"CHEMBL3767017";"Inhibition of CatD (unknown origin) preincubated for 30 mins followed by DABCYL-Glu-Arg-Nle-Phe-Leu-Ser-Phe-Pro-EDANS substrate addition by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3763050";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";""
"CHEMBL3965776";"";"None";"680.89";"2";"1.99";"BDBM232263";"CC[C@H](C)[C@H](NC(=O)C[C@H](N)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(=O)N[C@H](C(=O)OC)C(C)C";"IC50";"'='";"81.0";"nM";"7.09";"";"405038";"UO_0000065";"10.42";"0.20";"5.10";"3.64";"0";"CHEMBL3888498";"In-Vitro Fluorescence Assay: In order to identify modulators of cathepsin D activity, a continuous enzymatic test was carried out with a synthetic peptide which carries a fluorescent group (MCA=(7-methoxycoumarin-4-yl)acetyl) which is quenched by energy transfer from a Dpn (2,4 dinitrophenyl) group on the same molecule, in Greiner 384-well nb microtitre plates. Cleavage of the peptidic substrate by cathepsin D causes an increase in the fluorescence intensity. In order to determine the efficacy of substances, the time-dependent increase in the fluorescence intensity in the presence of the substance was compared with the time-dependent increase in fluorescence in the absence of substances. The reference substance used was pepstatin A (Sigma-Aldrich). The substrate used was MCAGKPILFFRLK(Dnp)d-R-NH2 (Enzo Life Sciences, Lorrach). The enzyme employed was cathepsin D isolated from the human liver (Sigma-Aldrich) in a final concentration of 1.4 nM. The test was carried out in 100 mM sodium acetate buffer, 1.25% (v/v) of DMSO, 0.25% (w/v) of Chaps, pH 5.5. 2 ul of each substance solution with serially diluted substance concentration were added to in each case 4 ul of cathepsin D solution and incubated at room temperature for 10 min. The reaction was started by addition of 2 ul of substrate solution (final concentration 5 uM). After carrying out a starting-point fluorescence measurement (excitation wavelength 340 nm/emission wavelength 450 nm) using an Envision multilabel reader (Perkin Elmer), the reaction was incubated at room temperature for 60 min. The amount of peptide fragment cleaved off during the reaction time was subsequently measured by determination of the increase in the fluorescence intensity at 450 nm (excitation wavelength 340 nm).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886733";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3917484";"";"None";"696.94";"2";"3.05";"BDBM232269";"CC[C@H](C)[C@H](NC(=O)C[C@H](N)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)CC(C)C)C(C)C)C(=O)Nc1ccn(C)n1";"IC50";"'='";"46.0";"nM";"7.34";"";"405043";"UO_0000065";"10.53";"0.20";"4.29";"3.88";"0";"CHEMBL3888498";"In-Vitro Fluorescence Assay: In order to identify modulators of cathepsin D activity, a continuous enzymatic test was carried out with a synthetic peptide which carries a fluorescent group (MCA=(7-methoxycoumarin-4-yl)acetyl) which is quenched by energy transfer from a Dpn (2,4 dinitrophenyl) group on the same molecule, in Greiner 384-well nb microtitre plates. Cleavage of the peptidic substrate by cathepsin D causes an increase in the fluorescence intensity. In order to determine the efficacy of substances, the time-dependent increase in the fluorescence intensity in the presence of the substance was compared with the time-dependent increase in fluorescence in the absence of substances. The reference substance used was pepstatin A (Sigma-Aldrich). The substrate used was MCAGKPILFFRLK(Dnp)d-R-NH2 (Enzo Life Sciences, Lorrach). The enzyme employed was cathepsin D isolated from the human liver (Sigma-Aldrich) in a final concentration of 1.4 nM. The test was carried out in 100 mM sodium acetate buffer, 1.25% (v/v) of DMSO, 0.25% (w/v) of Chaps, pH 5.5. 2 ul of each substance solution with serially diluted substance concentration were added to in each case 4 ul of cathepsin D solution and incubated at room temperature for 10 min. The reaction was started by addition of 2 ul of substrate solution (final concentration 5 uM). After carrying out a starting-point fluorescence measurement (excitation wavelength 340 nm/emission wavelength 450 nm) using an Envision multilabel reader (Perkin Elmer), the reaction was incubated at room temperature for 60 min. The amount of peptide fragment cleaved off during the reaction time was subsequently measured by determination of the increase in the fluorescence intensity at 450 nm (excitation wavelength 340 nm).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886733";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL4226891";"";"None";"517.59";"2";"5.93";"3a";"Nc1nc2cc(-c3ccccc3)cc(-c3ccc(C(=O)O)cc3)c2c(=O)n1C[C@@H]1CC[C@H](c2ccccc2)O1";"IC50";"'='";"20000.0";"nM";"4.70";"";"";"UO_0000065";"9.08";"0.16";"-1.23";"4.37";"0";"CHEMBL4223547";"Inhibition of human cathepsin D using DABCYL-Glu-Arg-Nle-Phe-Leu-Ser-Phe-Pro-EDANS as substrate preincubated for 30 mins followed by substrate addition measured every 1 min within 8 to 15 mins by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4219216";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";"";""
"CHEMBL3763523";"";"None";"515.66";"2";"6.74";"1c";"Nc1nc2cc(-c3ccc(CCCc4ccccc4)cc3)ccc2c(=O)n1C[C@@H]1CC[C@H](c2ccccc2)O1";"IC50";"'='";"6000.0";"nM";"5.22";"";"";"UO_0000065";"10.13";"0.18";"-1.52";"7.44";"1";"CHEMBL4223547";"Inhibition of human cathepsin D using DABCYL-Glu-Arg-Nle-Phe-Leu-Ser-Phe-Pro-EDANS as substrate preincubated for 30 mins followed by substrate addition measured every 1 min within 8 to 15 mins by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4219216";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";"";""
"CHEMBL4561558";"";"None";"586.78";"1";"4.61";"(S,R)-2b";"COc1cccc(C(C)(C)NC[C@@H](O)[C@H](Cc2ccccc2)NC(=O)c2cc(C(=O)N(C)C)cc(N3CCCCC3)c2)c1";"IC50";"'='";"500.0";"nM";"6.30";"";"";"UO_0000065";"10.74";"0.20";"1.69";"6.69";"0";"CHEMBL4331648";"Inhibition of human cathepsin D using DABCYL-Glu-Arg-Nle-Phe-Leu-Ser-Phe-Pro-EDANS as substrate preincubated for 30 mins followed by substrate addition and measured every min for 8 to 15 mins by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4330085";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";"";"";""
"CHEMBL4515257";"";"None";"644.86";"2";"5.07";"(S,R)-3a";"COc1cccc(C(C)(C)NC[C@@H](O)[C@H](Cc2ccccc2)NC(=O)c2cc(C(=O)NCC(C)(C)OC)cc(N3CCCCC3)c2)c1";"IC50";"'='";"2100.0";"nM";"5.68";"";"";"UO_0000065";"8.80";"0.16";"0.61";"5.06";"0";"CHEMBL4331648";"Inhibition of human cathepsin D using DABCYL-Glu-Arg-Nle-Phe-Leu-Ser-Phe-Pro-EDANS as substrate preincubated for 30 mins followed by substrate addition and measured every min for 8 to 15 mins by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4330085";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";"";"";""
"CHEMBL4533511";"";"None";"630.83";"1";"4.41";"(S,R)-3e";"COc1cccc(C(C)(C)NC[C@@H](O)[C@H](Cc2ccccc2)NC(=O)c2cc(C(=O)NCC(C)(C)O)cc(N3CCCCC3)c2)c1";"IC50";"'='";"1660.0";"nM";"5.78";"";"";"UO_0000065";"9.16";"0.17";"1.37";"4.69";"0";"CHEMBL4331648";"Inhibition of human cathepsin D using DABCYL-Glu-Arg-Nle-Phe-Leu-Ser-Phe-Pro-EDANS as substrate preincubated for 30 mins followed by substrate addition and measured every min for 8 to 15 mins by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4330085";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";"";"";""
"CHEMBL4640948";"";"None";"336.39";"0";"1.24";"4";"NC1=N[C@@]2([C@@H]3C[C@H]3C(=O)Nc3ccc(F)cn3)COC[C@H]2CS1";"IC50";"'>'";"300000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4614137";"Inhibition of human cathepsin D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4613225";"1";"Scientific Literature";"Bioorg Med Chem";"2020";"None";"";"";""
"CHEMBL4637426";"";"None";"401.58";"0";"2.80";"34";"C[C@@H]1C[C@H]1COC(C)(C)[C@@H]1C[C@H]1[C@]12CN(c3ncccn3)C[C@H]1CSC(N)=N2";"IC50";"'='";"160000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4614137";"Inhibition of human cathepsin D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4613225";"1";"Scientific Literature";"Bioorg Med Chem";"2020";"None";"";"";""
"CHEMBL4536592";"";"None";"654.90";"2";"6.22";"(S,R)-3m";"COc1cccc(C(C)(C)NC[C@@H](O)[C@H](Cc2ccccc2)NC(=O)c2cc(C(=O)NCC3CCCCC3)cc(N3CCCCC3)c2)c1";"IC50";"'='";"150.0";"nM";"6.82";"";"";"UO_0000065";"10.42";"0.19";"0.60";"6.63";"0";"CHEMBL4331648";"Inhibition of human cathepsin D using DABCYL-Glu-Arg-Nle-Phe-Leu-Ser-Phe-Pro-EDANS as substrate preincubated for 30 mins followed by substrate addition and measured every min for 8 to 15 mins by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4330085";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";"";"";""
"CHEMBL4539909";"";"None";"440.88";"0";"4.27";"9";"C[C@]1(c2cc(NC(=O)c3ccc(Cl)cn3)cc(F)c2F)N=C(N)S[C@@]2(CF)C[C@H]21";"IC50";"'='";"425000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4343401";"Inhibition of recombinant CatD (unknown origin) expressed in CHO cells using FRET peptide substrate preincubated for 1 hr followed by substrate addition and measured after 1 hr by FRET assay";"A";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4342420";"1";"Scientific Literature";"J Med Chem";"2020";"CHEMBL3308072";"";"";""
"CHEMBL3422241";"";"None";"379.43";"0";"3.68";"9";"Cc1coc([C@H]2C[C@H]3[C@@H](C)SC(N)=N[C@@]3(c3ccc(F)cc3F)CO2)n1";"IC50";"'='";"15700.0";"nM";"4.80";"";"";"UO_0000065";"12.66";"0.25";"1.12";"6.52";"0";"CHEMBL3423725";"Inhibition of CatD (unknown origin) assessed as fluorescence polarization by cell free assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3421534";"1";"Scientific Literature";"J Med Chem";"2015";"None";"";"";""
"CHEMBL3422242";"";"None";"379.43";"0";"3.68";"10";"Cc1cc([C@H]2C[C@H]3[C@@H](C)SC(N)=N[C@@]3(c3ccc(F)cc3F)CO2)on1";"IC50";"'='";"14200.0";"nM";"4.85";"";"";"UO_0000065";"12.78";"0.25";"1.17";"6.58";"0";"CHEMBL3423725";"Inhibition of CatD (unknown origin) assessed as fluorescence polarization by cell free assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3421534";"1";"Scientific Literature";"J Med Chem";"2015";"None";"";"";""
"CHEMBL296588";"PEPSTATIN";"2.0";"685.90";"2";"1.47";"1";"CC(C)CC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)[C@@H](O)CC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)[C@@H](O)CC(=O)O)C(C)C)C(C)C";"IC50";"'='";"0.49";"nM";"9.31";"";"";"UO_0000065";"13.57";"0.26";"7.84";"4.17";"0";"CHEMBL4325791";"Inhibition of human placenta CatD using Abz-Lys-Pro-Ala-Glu-Phe-Nph-Ala-Leu as substrate preincubated for 10 mins followed by substrate addition and measured by FRET assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4321885";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";""
"CHEMBL4452510";"";"None";"515.74";"1";"4.42";"12";"CC(C)[C@@H]1NC(=O)C[C@H](O)[C@H](Cc2ccccc2)NC(=O)CCCCCCCCCCCCCNC1=O";"IC50";"'='";"11.0";"nM";"7.96";"";"";"UO_0000065";"15.43";"0.29";"3.54";"7.40";"0";"CHEMBL4325791";"Inhibition of human placenta CatD using Abz-Lys-Pro-Ala-Glu-Phe-Nph-Ala-Leu as substrate preincubated for 10 mins followed by substrate addition and measured by FRET assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4321885";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";""
"CHEMBL4453458";"";"None";"529.77";"1";"4.81";"13";"CC(C)[C@@H]1NC(=O)C[C@H](O)[C@H](Cc2ccccc2)NC(=O)CCCCCCCCCCCCCCNC1=O";"IC50";"'='";"32.0";"nM";"7.50";"";"";"UO_0000065";"14.15";"0.27";"2.68";"6.97";"0";"CHEMBL4325791";"Inhibition of human placenta CatD using Abz-Lys-Pro-Ala-Glu-Phe-Nph-Ala-Leu as substrate preincubated for 10 mins followed by substrate addition and measured by FRET assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4321885";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";""
"CHEMBL4576166";"";"None";"537.75";"1";"4.79";"14";"CC(C)[C@@H]1NC(=O)C[C@H](O)[C@H](Cc2ccc3ccccc3c2)NC(=O)CCCCCCCCCCCNC1=O";"IC50";"'='";"0.6";"nM";"9.22";"";"";"UO_0000065";"17.15";"0.32";"4.43";"8.58";"0";"CHEMBL4325791";"Inhibition of human placenta CatD using Abz-Lys-Pro-Ala-Glu-Phe-Nph-Ala-Leu as substrate preincubated for 10 mins followed by substrate addition and measured by FRET assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4321885";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";""
"CHEMBL4583528";"";"None";"493.73";"0";"4.36";"18";"CC(C)[C@@H]1NC(=O)C[C@H](O)[C@H](CC2CCCCC2)NC(=O)CCCCCCCCCCCNC1=O";"IC50";"'='";"9.0";"nM";"8.05";"";"";"UO_0000065";"16.30";"0.31";"3.69";"7.48";"0";"CHEMBL4325791";"Inhibition of human placenta CatD using Abz-Lys-Pro-Ala-Glu-Phe-Nph-Ala-Leu as substrate preincubated for 10 mins followed by substrate addition and measured by FRET assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4321885";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";""
"CHEMBL4443156";"";"None";"526.72";"1";"4.12";"22";"CC(C)[C@@H]1NC(=O)C[C@H](O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)CCCCCCCCCCCNC1=O";"IC50";"'='";"190.0";"nM";"6.72";"";"";"UO_0000065";"12.76";"0.24";"2.60";"5.45";"0";"CHEMBL4325791";"Inhibition of human placenta CatD using Abz-Lys-Pro-Ala-Glu-Phe-Nph-Ala-Leu as substrate preincubated for 10 mins followed by substrate addition and measured by FRET assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4321885";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";""
"CHEMBL4558691";"";"None";"536.72";"1";"3.62";"25";"O=C1C[C@H](O)[C@H](Cc2ccccc2)NC(=O)CCCCCCCCCCCNC(=O)[C@H](Cc2cccnc2)N1";"IC50";"'='";"1.1";"nM";"8.96";"";"";"UO_0000065";"16.69";"0.31";"5.34";"7.44";"0";"CHEMBL4325791";"Inhibition of human placenta CatD using Abz-Lys-Pro-Ala-Glu-Phe-Nph-Ala-Leu as substrate preincubated for 10 mins followed by substrate addition and measured by FRET assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4321885";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";""
"CHEMBL4554001";"";"None";"521.70";"1";"4.35";"30";"O=C1C[C@H](O)[C@H](Cc2ccccc2)NC(=O)CCCCCCCCCCCNC(=O)[C@H](c2ccccc2)N1";"IC50";"'='";"27.0";"nM";"7.57";"";"";"UO_0000065";"14.51";"0.27";"3.22";"7.04";"0";"CHEMBL4325791";"Inhibition of human placenta CatD using Abz-Lys-Pro-Ala-Glu-Phe-Nph-Ala-Leu as substrate preincubated for 10 mins followed by substrate addition and measured by FRET assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4321885";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";""
"CHEMBL4580187";"";"None";"489.66";"0";"2.36";"31";"C[C@@H](O)[C@@H]1NC(=O)C[C@H](O)[C@H](Cc2ccccc2)NC(=O)CCCCCCCCCCCNC1=O";"IC50";"'='";"500.0";"nM";"6.30";"";"";"UO_0000065";"12.87";"0.25";"3.94";"4.93";"0";"CHEMBL4325791";"Inhibition of human placenta CatD using Abz-Lys-Pro-Ala-Glu-Phe-Nph-Ala-Leu as substrate preincubated for 10 mins followed by substrate addition and measured by FRET assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4321885";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";""
"CHEMBL5075177";"";"None";"454.42";"0";"3.71";"64g";"COc1cnc(C(=O)Nc2ccc(F)c([C@]3(C)CO[C@@](C)(C(F)(F)F)C(N)=N3)c2)c(C)c1";"IC50";"'>'";"250000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5055931";"Inhibition of human cathepsin D using Mca-GKPILFFRLK(DNP)D-R-NH2 as a substrate";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5055623";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"";""
"CHEMBL3957970";"";"None";"444.36";"0";"3.31";"BDBM214848";"COc1ccc(C(=O)Nc2ccc(F)c([C@]3(CF)C[C@@H](C(F)(F)F)OC(N)=N3)c2)nc1";"IC50";"'>'";"400000.0";"nM";"";"Outside typical range";"377877";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL2347208";"";"None";"421.35";"0";"3.23";"BDBM50432601";"C[C@@]1(c2cc(NC(=O)c3ccc(C#N)cn3)ccc2F)C[C@@H](C(F)(F)F)OC(N)=N1";"IC50";"'>'";"400000.0";"nM";"";"Outside typical range";"377878";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3934218";"";"None";"439.36";"1";"5.01";"BDBM214917";"NC1=N[C@](CF)(c2cc(-c3ccc4cc(F)ccc4n3)ccc2F)C[C@@H](C(F)(F)F)O1";"IC50";"'>'";"133000.0";"nM";"";"Outside typical range";"377940";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3974975";"";"None";"498.45";"0";"4.40";"BDBM214837";"Cc1cc(OCC2CC2)cnc1C(=O)Nc1ccc(F)c([C@]2(CF)C[C@@H](C(F)(F)F)OC(N)=N2)c1";"IC50";"'>'";"400000.0";"nM";"";"Outside typical range";"377958";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3321931";"";"None";"488.56";"0";"2.77";"30";"COc1cc(CNC(=O)[C@@H](CC(C)C)NC(=N)NC(=O)Cc2ccc(OC)c(OC)c2)ccc1F";"IC50";"'='";"24.0";"nM";"7.62";"";"";"UO_0000065";"15.60";"0.30";"4.85";"6.26";"0";"CHEMBL3371146";"Inhibition of human liver cathepsin D using MCA-labeled GKPILFFRLK(Dnp)-D-R-NH2 peptide by fluorescence-based assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351526";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3809870";"";"None";"617.77";"2";"7.54";"9";"CC(C)(C)CCNC(=O)CCc1cc2cc(-c3ccccc3CCc3ccc(NC(=O)c4ccc(F)cc4)cn3)ccc2nc1N";"IC50";"'='";"1900.0";"nM";"5.72";"";"";"UO_0000065";"9.26";"0.17";"-1.82";"5.20";"0";"CHEMBL3811221";"Inhibition of Cathepsin D (unknown origin) by fluorescence assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3808306";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";""
"CHEMBL3947150";"";"None";"535.60";"1";"4.12";"BDBM220843";"COc1ccc(C(=O)Nc2ccc3c(c2)C2(CCSC(N)=N2)c2cc(N4CCOCC4)cc(F)c2O3)nc1";"IC50";"'='";"326400.0";"nM";"";"Outside typical range";"386529";"UO_0000065";"";"";"";"";"0";"CHEMBL3888270";"Fluorescence Resonance Energy Transfer (FRET) Assay: Recombinant CathepsinD was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The CathepsinD enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for CathepsinD) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886633";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3264806";"";"None";"640.87";"2";"5.93";"11";"CCCN(CCC)C(=O)c1cc(C(=O)N[C@@H](Cc2ccccc2)[C@H](O)CNC2(c3cccc(OC)c3)CC2)cc(N2CCCCC2)c1";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"10.92";"0.20";"1.07";"7.44";"0";"CHEMBL3271470";"Inhibition of human cathepsin-D using DABCYL-Glu-Arg-Nle-Phe-Leu-Ser-Phe-Pro-EDANS as substrate preincubated for 30 mins by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3259525";"1";"Scientific Literature";"ACS Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3264807";"";"None";"614.83";"2";"5.44";"12";"CCCN(CCC)C(=O)c1cc(C(=O)N[C@@H](Cc2ccccc2)[C@H](O)CNCc2cccc(OC)c2)cc(N2CCCCC2)c1";"IC50";"'='";"200.0";"nM";"6.70";"";"";"UO_0000065";"10.90";"0.20";"1.26";"7.12";"0";"CHEMBL3271470";"Inhibition of human cathepsin-D using DABCYL-Glu-Arg-Nle-Phe-Leu-Ser-Phe-Pro-EDANS as substrate preincubated for 30 mins by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3259525";"1";"Scientific Literature";"ACS Med Chem Lett";"2014";"None";"";"";""
"CHEMBL4169189";"";"None";"832.05";"2";"2.12";"1";"CC[C@H](C)[C@H](NC(=O)C[C@H](O)[C@H](CC(C)C)NC(=O)[C@H](OC(=O)[C@@H](O)C(C)C)C(C)C)C(=O)N[C@@H](C)C(=O)N(C)[C@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)OC";"IC50";"'='";"380.0";"nM";"6.42";"";"";"UO_0000065";"7.72";"0.15";"4.30";"2.91";"0";"CHEMBL4150649";"Inhibition of human cathepsin D using GKPILFFRLK(DNP)-D-RNH2) labeled MCA as substrate preincubated for 10 mins followed by substrate addition measured after 1 to 2 hrs by fluorometric method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4145636";"1";"Scientific Literature";"J Nat Prod";"2018";"None";"";"";""
"CHEMBL296588";"PEPSTATIN";"2.0";"685.90";"2";"1.47";"pepstatin A";"CC(C)CC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)[C@@H](O)CC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)[C@@H](O)CC(=O)O)C(C)C)C(C)C";"IC50";"'='";"0.05";"nM";"10.30";"";"";"UO_0000065";"15.02";"0.29";"8.83";"4.61";"0";"CHEMBL4150649";"Inhibition of human cathepsin D using GKPILFFRLK(DNP)-D-RNH2) labeled MCA as substrate preincubated for 10 mins followed by substrate addition measured after 1 to 2 hrs by fluorometric method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4145636";"1";"Scientific Literature";"J Nat Prod";"2018";"None";"";"";""
"CHEMBL4457316";"";"None";"458.87";"0";"4.57";"10";"C[C@]1(c2cc(NC(=O)c3ccc(Cl)cn3)cc(F)c2F)N=C(N)S[C@@]2(C(F)F)C[C@@H]12";"IC50";"'='";"319000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4343401";"Inhibition of recombinant CatD (unknown origin) expressed in CHO cells using FRET peptide substrate preincubated for 1 hr followed by substrate addition and measured after 1 hr by FRET assay";"A";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4342420";"1";"Scientific Literature";"J Med Chem";"2020";"CHEMBL3308072";"";"";""
"CHEMBL4224896";"";"None";"455.51";"0";"4.19";"3b";"Nc1nc2cc(-c3ccccc3)cc(CC(=O)O)c2c(=O)n1C[C@@H]1CC[C@H](c2ccccc2)O1";"IC50";"'='";"11000.0";"nM";"4.96";"";"";"UO_0000065";"10.89";"0.20";"0.77";"4.62";"0";"CHEMBL4223547";"Inhibition of human cathepsin D using DABCYL-Glu-Arg-Nle-Phe-Leu-Ser-Phe-Pro-EDANS as substrate preincubated for 30 mins followed by substrate addition measured every 1 min within 8 to 15 mins by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4219216";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";"";""
"CHEMBL4228072";"";"None";"511.62";"2";"5.02";"6b";"Nc1nc2cc(-c3ccc(CCCc4ccccc4)cc3)cc(CCC(=O)O)c2c(=O)n1CC1CCCO1";"IC50";"'='";"13000.0";"nM";"4.89";"";"";"UO_0000065";"9.55";"0.18";"-0.13";"4.55";"0";"CHEMBL4223547";"Inhibition of human cathepsin D using DABCYL-Glu-Arg-Nle-Phe-Leu-Ser-Phe-Pro-EDANS as substrate preincubated for 30 mins followed by substrate addition measured every 1 min within 8 to 15 mins by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4219216";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";"";""
"CHEMBL4226144";"";"None";"559.67";"2";"6.37";"7b";"Nc1nc2cc(-c3ccc(CCCc4ccccc4)cc3-c3ccc(C(=O)O)cc3)ccc2c(=O)n1CC1CCCO1";"IC50";"'='";"25000.0";"nM";"4.60";"";"";"UO_0000065";"8.22";"0.15";"-1.77";"4.28";"0";"CHEMBL4223547";"Inhibition of human cathepsin D using DABCYL-Glu-Arg-Nle-Phe-Leu-Ser-Phe-Pro-EDANS as substrate preincubated for 30 mins followed by substrate addition measured every 1 min within 8 to 15 mins by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4219216";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";"";""
"CHEMBL4204163";"";"None";"456.50";"0";"2.47";"67";"C[C@H]1C[C@H]2CSC(N)=N[C@@]2(c2nc(NC(=O)c3cnc(OC(F)F)cn3)cs2)CO1";"IC50";"'>'";"300000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4183115";"Inhibition of Cathepsin D (unknown origin) by fluorescence polarization assay";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4177751";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL3979124";"";"None";"407.50";"0";"2.61";"58";"C[C@H]1C[C@H]2CSC(N)=N[C@@]2(c2nc(NC(=O)c3ccc(F)cn3)cs2)CO1";"IC50";"'>'";"43000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4183115";"Inhibition of Cathepsin D (unknown origin) by fluorescence polarization assay";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4177751";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4217023";"";"None";"418.54";"0";"3.09";"56";"COc1ccc(C(=O)Nc2csc([C@]34CO[C@@H](C)C[C@H]3CSC(N)=N4)n2)cc1";"IC50";"'>'";"97000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4183115";"Inhibition of Cathepsin D (unknown origin) by fluorescence polarization assay";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4177751";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4209994";"";"None";"330.38";"0";"3.39";"41";"C[C@H]1C[C@H]2CSC(N)=N[C@@]2(c2ccccc2C(F)(F)F)CO1";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4183115";"Inhibition of Cathepsin D (unknown origin) by fluorescence polarization assay";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4177751";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4551750";"";"None";"505.68";"1";"3.78";"17";"CC(C)[C@@H]1NC(=O)C[C@H](O)[C@H](Cc2ccc(F)cc2)NC(=O)CCCCCCCCCCCNC1=O";"IC50";"'='";"4.7";"nM";"8.33";"";"";"UO_0000065";"16.47";"0.32";"4.55";"7.74";"0";"CHEMBL4325791";"Inhibition of human placenta CatD using Abz-Lys-Pro-Ala-Glu-Phe-Nph-Ala-Leu as substrate preincubated for 10 mins followed by substrate addition and measured by FRET assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4321885";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";""
"CHEMBL4457424";"";"None";"487.64";"1";"1.19";"4";"CC(C)CC(=O)N[C@@H](CC(C)C)[C@@H](O)CC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)[C@@H](O)CC(=O)O";"IC50";"'='";"2500.0";"nM";"5.60";"";"";"UO_0000065";"11.49";"0.23";"4.41";"3.39";"0";"CHEMBL4325791";"Inhibition of human placenta CatD using Abz-Lys-Pro-Ala-Glu-Phe-Nph-Ala-Leu as substrate preincubated for 10 mins followed by substrate addition and measured by FRET assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4321885";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";""
"CHEMBL3966313";"";"None";"465.33";"0";"3.83";"BDBM215000";"C[C@@]1(c2cc(NC(=O)c3cnc(C(F)F)cn3)cc(F)c2F)C[C@@H](C(F)(F)F)OC(N)=N1";"IC50";"'='";"1271000.0";"nM";"";"Outside typical range";"378066";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3979143";"";"None";"485.83";"0";"3.41";"BDBM215020";"C#CCOc1cnc(C(=O)Nc2cc(Cl)c(F)c([C@]3(C)C[C@@H](C(F)(F)F)OC(N)=N3)c2)cn1";"IC50";"'='";"554000.0";"nM";"";"Outside typical range";"378080";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3959153";"";"None";"500.52";"1";"3.02";"BDBM220766";"COc1cnc(C(=O)Nc2ccc3c(c2)[C@@]2(CCOC(N)=N2)c2cc(C4=CCCOC4)ncc2O3)cn1";"IC50";"'='";"480000.0";"nM";"";"Outside typical range";"386479";"UO_0000065";"";"";"";"";"0";"CHEMBL3888270";"Fluorescence Resonance Energy Transfer (FRET) Assay: Recombinant CathepsinD was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The CathepsinD enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for CathepsinD) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886633";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL4440849";"";"None";"447.47";"0";"1.90";"89";"C#CCOc1cnc(/C(F)=C/c2ccc(F)c([C@]3(C)CS(=O)(=O)N(C)C(N)=N3)c2)cn1";"IC50";"'='";"35800.0";"nM";"4.45";"";"";"UO_0000065";"9.94";"0.20";"2.55";"4.01";"0";"CHEMBL4342626";"Inhibition of recombinant Cathepsin D (unknown origin) expressed in CHO cells preincubated for 1 hr followed by substrate addition and measured after 1 hr by FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4342403";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"CHEMBL3308072";"";"";""
"CHEMBL1821803";"";"None";"234.30";"0";"3.79";"4";"Cc1ccccc1-c1ccc2nc(N)ccc2c1";"IC50";"'='";"108000.0";"nM";"3.97";"";"";"UO_0000065";"16.93";"0.30";"0.18";"10.19";"0";"CHEMBL3811221";"Inhibition of Cathepsin D (unknown origin) by fluorescence assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3808306";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";""
"CHEMBL4751867";"";"None";"692.16";"1";"3.73";"2d";"CNS(=O)(=O)c1ccc(C)c(NC(=O)[C@@H](CC2CCCCC2)NC(=N)NC(=O)Cc2ccc(OC)c(Cl)c2)c1.O=C(O)C(F)(F)F";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"14.36";"0.29";"4.57";"5.55";"0";"CHEMBL4706202";"Inhibition of human liver Cathepsin D preincubated for 10 mins followed by substrate addition and further incubated for 2 hrs in dark by fluorimetric analysis";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699662";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"TIME = 2.167 hr";"INHIBITOR";""
"CHEMBL4740277";"";"None";"631.63";"1";"1.65";"10e";"COc1ccc(CC(=O)NC(=N)N[C@H](CC2CC2)C(=O)Nc2cc(S(N)(=O)=O)ccc2C)cc1OC.O=C(O)C(F)(F)F";"IC50";"'='";"95.0";"nM";"7.02";"";"";"UO_0000065";"13.57";"0.27";"5.37";"4.07";"0";"CHEMBL4706202";"Inhibition of human liver Cathepsin D preincubated for 10 mins followed by substrate addition and further incubated for 2 hrs in dark by fluorimetric analysis";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699662";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"TIME = 2.167 hr";"INHIBITOR";""
"CHEMBL3688621";"";"None";"390.37";"0";"2.98";"BDBM171556";"Cc1ccc(C(=O)Nc2ccc(F)c([C@@]3(C(F)F)N=C(N)O[C@@H]4C[C@@H]43)c2)nc1";"IC50";"'='";"1465300.0";"nM";"";"Outside typical range";"315965";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688632";"";"None";"422.38";"0";"3.62";"BDBM171567";"Cc1cc(C(F)F)cnc1C(=O)Nc1ccc(F)c([C@@]2(CF)N=C(N)O[C@@H]3C[C@@H]32)c1";"IC50";"'='";"515090.0";"nM";"";"Outside typical range";"315976";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688819";"";"None";"451.36";"0";"3.48";"BDBM171769";"N#Cc1cnc(C(=O)Nc2ccc(F)c([C@@]3(C(F)F)N=C(N)O[C@@H]4C[C@@H]43)c2)c(C(F)F)c1";"IC50";"'='";"476950.0";"nM";"";"Outside typical range";"316168";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3929911";"";"None";"516.78";"2";"5.17";"BDBM214994";"C[C@@]1(c2cc(NC(=O)c3ncc(C(F)(F)F)cc3Cl)cc(F)c2F)C[C@@H](C(F)(F)F)OC(N)=N1";"IC50";"'>'";"400000.0";"nM";"";"Outside typical range";"378060";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL4115023";"";"None";"445.35";"0";"2.71";"BDBM214824";"COc1cnc(C(=O)Nc2ccc(F)c([C@]3(CF)C[C@H](C(F)(F)F)OC(N)=N3)c2)cn1";"IC50";"'>'";"400000.0";"nM";"";"Outside typical range";"377849";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3929456";"";"None";"430.79";"0";"4.01";"BDBM214826";"C[C@@]1(c2cc(NC(=O)c3ccc(Cl)cn3)ccc2F)C[C@@H](C(F)(F)F)OC(N)=N1";"IC50";"'>'";"400000.0";"nM";"";"Outside typical range";"377864";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3929456";"";"None";"430.79";"0";"4.01";"BDBM214826";"C[C@@]1(c2cc(NC(=O)c3ccc(Cl)cn3)ccc2F)C[C@@H](C(F)(F)F)OC(N)=N1";"IC50";"'>'";"400000.0";"nM";"";"Outside typical range";"377865";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3683820";"";"None";"463.85";"0";"3.88";"BDBM171427";"Cc1c(C(=O)Nc2ccc(F)c([C@]3(C(F)F)N=C(N)O[C@H]4C[C@H]43)c2)nc2ccc(Cl)cn12";"IC50";"'='";"1780300.0";"nM";"";"Outside typical range";"315836";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3683827";"";"None";"445.23";"0";"3.97";"BDBM171437";"NC1=N[C@@](c2cc(NC(=O)c3ncc(Cl)cc3Cl)ccc2F)(C(F)F)[C@H]2C[C@H]2O1";"IC50";"'='";"477760.0";"nM";"";"Outside typical range";"315846";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3683839";"";"None";"404.83";"0";"2.70";"BDBM171449";"COC[C@@]1(c2cc(NC(=O)c3ccc(Cl)cn3)ccc2F)N=C(N)O[C@H]2C[C@H]21";"IC50";"'>'";"400000.0";"nM";"";"Outside typical range";"315858";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3683841";"";"None";"423.81";"0";"2.43";"BDBM171451";"COc1cnc(C(=O)Nc2cc(Cl)c(F)c([C@@]3(CF)N=C(N)O[C@@H]4C[C@@H]43)c2)cn1";"IC50";"'='";"373100.0";"nM";"";"Outside typical range";"315860";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688649";"";"None";"447.83";"0";"2.59";"BDBM171585";"C#CCOc1cnc(C(=O)Nc2ccc(Cl)c([C@]3(C(F)F)N=C(N)O[C@H]4C[C@H]43)c2)cn1";"IC50";"'='";"493180.0";"nM";"";"Outside typical range";"315997";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688652";"";"None";"431.83";"0";"3.36";"BDBM171589";"Cc1cc(C#N)cnc1C(=O)Nc1ccc(Cl)c([C@@]2(C(F)F)N=C(N)O[C@@H]3C[C@@H]32)c1";"IC50";"'='";"541280.0";"nM";"";"Outside typical range";"315998";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688672";"";"None";"369.34";"0";"2.14";"BDBM171610";"NC1=N[C@@](c2cc(NC(=O)[C@H]3CCCO3)ccc2F)(C(F)F)[C@H]2C[C@H]2O1";"IC50";"'='";"318540.0";"nM";"";"Outside typical range";"316019";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688697";"";"None";"409.25";"0";"3.54";"BDBM171637";"NC1=N[C@@](CF)(c2cc(NC(=O)c3ccc(Cl)cn3)ccc2Cl)[C@@H]2C[C@@H]2O1";"IC50";"'>'";"400000.0";"nM";"";"Outside typical range";"316045";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688711";"";"None";"410.78";"0";"3.32";"BDBM171652";"NC1=N[C@@](c2cc(NC(=O)c3cccc(Cl)n3)ccc2F)(C(F)F)[C@H]2C[C@H]2O1";"IC50";"'='";"724590.0";"nM";"";"Outside typical range";"316060";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3976447";"";"None";"517.52";"1";"3.76";"BDBM220842";"COc1cnc(C(=O)Nc2ccc3c(c2)C2(CCOC(N)=N2)c2cc(C4=CCCOC4)cc(F)c2O3)cn1";"IC50";"'='";"106500.0";"nM";"";"Outside typical range";"386528";"UO_0000065";"";"";"";"";"0";"CHEMBL3888270";"Fluorescence Resonance Energy Transfer (FRET) Assay: Recombinant CathepsinD was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The CathepsinD enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for CathepsinD) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886633";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3970753";"";"None";"546.56";"1";"4.88";"BDBM220852";"COc1ccc(C(=O)Nc2ccc3c(c2)C2(CCSC(N)=N2)c2cc(-c4ccnc(F)c4)nc(F)c2O3)nc1";"IC50";"'='";"162100.0";"nM";"";"Outside typical range";"386538";"UO_0000065";"";"";"";"";"0";"CHEMBL3888270";"Fluorescence Resonance Energy Transfer (FRET) Assay: Recombinant CathepsinD was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The CathepsinD enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for CathepsinD) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886633";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL588662";"";"None";"383.50";"0";"4.49";"BDBM234576";"CCC(CN1C(=N)NC(c2ccccc2)(c2ccccc2)C1=O)c1ccccc1";"IC50";"'='";"385.0";"nM";"6.42";"";"408844";"UO_0000065";"16.73";"0.30";"1.92";"11.42";"0";"CHEMBL3887168";"Fluorescence Resonance Energy Transfer (FRET) Assay : The recombinant human BACE1, Cathepsin D, and Cathepsin E enzymes were purchased from R&D Systems (catalog numbers are 931-AS, 1014AS and 1294AS, respectively). The enzymatic inhibition activity assays were determined using the fluorescence resonance energy transfer (FRET) assay. The assays were performed in a 384-well plate format. The recombinant human BACE-1 enzyme (R&D Systems, catalog#931-AS) was diluted to 20 ng/L in assay buffer (100 mM sodium acetate pH 4.0), 10 point 1:3 serial dilutions of compound in DMSO were preincubated with the enzyme for 15 min at room temperature. The concentration of Cathepsin D was 20 ng/L, and 1 ng/L of Cathepsin E was used. CatD and CatE were activated by incubation in assay buffer (0.1 M NaOAc, 0.2 M NaCl, pH 3.5) at room temperature for 30 min. Subsequently, the rhBACE-1 substrate (R&D Systems, catalog# ES004), the Cathepsin D and Cathepsin E substrate (R&D Systems, Catalog # ES001) were added accordingly to final concentration";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886201";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3109542";"";"None";"393.49";"0";"3.65";"BDBM234497";"COc1ccc(C2(c3ccc(OC)cc3)NC(=N)N(C3CCCCC3)C2=O)cc1";"IC50";"'>'";"10000.0";"nM";"";"";"408845";"UO_0000065";"";"";"";"";"0";"CHEMBL3887168";"Fluorescence Resonance Energy Transfer (FRET) Assay : The recombinant human BACE1, Cathepsin D, and Cathepsin E enzymes were purchased from R&D Systems (catalog numbers are 931-AS, 1014AS and 1294AS, respectively). The enzymatic inhibition activity assays were determined using the fluorescence resonance energy transfer (FRET) assay. The assays were performed in a 384-well plate format. The recombinant human BACE-1 enzyme (R&D Systems, catalog#931-AS) was diluted to 20 ng/L in assay buffer (100 mM sodium acetate pH 4.0), 10 point 1:3 serial dilutions of compound in DMSO were preincubated with the enzyme for 15 min at room temperature. The concentration of Cathepsin D was 20 ng/L, and 1 ng/L of Cathepsin E was used. CatD and CatE were activated by incubation in assay buffer (0.1 M NaOAc, 0.2 M NaCl, pH 3.5) at room temperature for 30 min. Subsequently, the rhBACE-1 substrate (R&D Systems, catalog# ES004), the Cathepsin D and Cathepsin E substrate (R&D Systems, Catalog # ES001) were added accordingly to final concentration";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886201";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL4450749";"";"None";"476.99";"0";"3.23";"71";"Cc1cc(Cl)cnc1C(=O)Nc1ccc2c(c1)[C@@]1(C)N=C(N)C(C)(C)S(=O)(=O)[C@@H]1CCO2";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4342626";"Inhibition of recombinant Cathepsin D (unknown origin) expressed in CHO cells preincubated for 1 hr followed by substrate addition and measured after 1 hr by FRET assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4342403";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2019";"CHEMBL3308072";"";"";""
"CHEMBL296588";"PEPSTATIN";"2.0";"685.90";"2";"1.47";"4";"CC(C)CC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)[C@@H](O)CC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)[C@@H](O)CC(=O)O)C(C)C)C(C)C";"IC50";"'='";"0.35";"nM";"9.46";"";"";"UO_0000065";"13.79";"0.27";"7.99";"4.24";"1";"CHEMBL4141000";"Inhibition of human liver cathepsin D using Mca-Gly-Lys-Pro-Ile-Leu-PhePhe-Arg-Leu-Lys-(Dnp)-D-Arg-NH2 as substrate pretreated for 15 mins followed by substrate addition measured at 5 mins interval for 120 mins by fluorescence assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4138143";"1";"Scientific Literature";"J Nat Prod";"2017";"None";"";"";""
"CHEMBL296588";"PEPSTATIN";"2.0";"685.90";"2";"1.47";"4";"CC(C)CC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)[C@@H](O)CC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)[C@@H](O)CC(=O)O)C(C)C)C(C)C";"IC50";"'='";"1000.0";"nM";"6.00";"";"";"UO_0000065";"8.75";"0.17";"4.53";"2.69";"0";"CHEMBL4141007";"Inhibition of cathepsin D in human MDA-MB-231 cells using Mca-Gly-Lys-Pro-Ile-Leu-PhePhe-Arg-Leu-Lys-(Dnp)-D-Arg-NH2 as substrate pretreated for 4 hrs followed by compound washout and subsequent 10 mins trypsinization prior to substrate addition measured at 30 secs interval for 30 mins by fluorescence assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"MDA-MB-231";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4138143";"1";"Scientific Literature";"J Nat Prod";"2017";"None";"";"";""
"CHEMBL296588";"PEPSTATIN";"2.0";"685.90";"2";"1.47";"4";"CC(C)CC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)[C@@H](O)CC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)[C@@H](O)CC(=O)O)C(C)C)C(C)C";"IC50";"'='";"0.1";"nM";"10.00";"";"";"UO_0000065";"14.58";"0.28";"8.53";"4.48";"0";"CHEMBL4140999";"Inhibition of secreted cathepsin D in human MDA-MB-231 cells using Mca-Gly-Lys-Pro-Ile-Leu-PhePhe-Arg-Leu-Lys-(Dnp)-D-Arg-NH2 as substrate pretreated for 3 days under pH 6.6 conditioned media followed by substrate addition measured at 5 mins interval for 2 hrs by fluorescence assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"MDA-MB-231";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4138143";"1";"Scientific Literature";"J Nat Prod";"2017";"None";"";"";""
"CHEMBL3683816";"";"None";"422.46";"0";"3.13";"BDBM171422";"CC#CCOc1cnc(C(=O)Nc2ccc(F)c([C@@]3(C)N=C(N)O[C@@H]4C[C@@H]43)c2)c(C)c1";"IC50";"'='";"302760.0";"nM";"";"Outside typical range";"315831";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3683834";"";"None";"406.36";"0";"2.52";"BDBM171444";"COc1ccc(C(=O)Nc2ccc(F)c([C@]3(CF)N=C(N)O[C@H]4C[C@H]43)c2F)nc1";"IC50";"'>'";"400000.0";"nM";"";"Outside typical range";"315853";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3683874";"";"None";"438.84";"0";"4.13";"BDBM171488";"Cc1cc(C(F)F)cnc1C(=O)Nc1ccc(Cl)c([C@@]2(CF)N=C(N)O[C@@H]3C[C@@H]32)c1";"IC50";"'='";"1074100.0";"nM";"";"Outside typical range";"315897";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688649";"";"None";"447.83";"0";"2.59";"BDBM171585";"C#CCOc1cnc(C(=O)Nc2ccc(Cl)c([C@]3(C(F)F)N=C(N)O[C@H]4C[C@H]43)c2)cn1";"IC50";"'='";"65800.0";"nM";"4.18";"";"315994";"UO_0000065";"9.34";"0.18";"1.59";"3.74";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688689";"";"None";"411.77";"0";"2.72";"BDBM171627";"NC1=N[C@@](c2cc(NC(=O)c3cnc(Cl)cn3)ccc2F)(C(F)F)[C@H]2C[C@H]2O1";"IC50";"'='";"444000.0";"nM";"";"Outside typical range";"316036";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688691";"";"None";"392.79";"0";"3.18";"BDBM171629";"NC1=N[C@@](c2cccc(NC(=O)c3ccc(Cl)cn3)c2)(C(F)F)[C@H]2C[C@H]2O1";"IC50";"'='";"397000.0";"nM";"";"Outside typical range";"316040";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL4286331";"";"None";"491.94";"0";"3.97";"29";"NC1=N[C@@]2(CO1)c1cc(NC(=O)c3ccc(Cl)cn3)ccc1Oc1cnc(C3CCOCC3)cc12";"IC50";"'='";"1000000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4262564";"Inhibition of recombinant human CatD using fluorophore/quencher-tagged peptide as substrate pretreated for 60 mins followed by substrate addition and measured after 60 mins by FRET assay";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261519";"1";"Scientific Literature";"Medchemcomm";"2017";"None";"";"";""
"CHEMBL4291981";"";"None";"442.26";"0";"3.73";"21";"NC1=N[C@@]2(CO1)c1cc(NC(=O)c3ccc(Cl)cn3)ccc1Oc1cnc(Cl)cc12";"IC50";"'='";"1100000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4262564";"Inhibition of recombinant human CatD using fluorophore/quencher-tagged peptide as substrate pretreated for 60 mins followed by substrate addition and measured after 60 mins by FRET assay";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261519";"1";"Scientific Literature";"Medchemcomm";"2017";"None";"";"";""
"CHEMBL4637913";"";"None";"269.37";"0";"0.21";"15";"CCNC(=O)[C@@H]1C[C@H]1[C@]12COC[C@H]1CSC(N)=N2";"IC50";"'>'";"300000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4614137";"Inhibition of human cathepsin D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4613225";"1";"Scientific Literature";"Bioorg Med Chem";"2020";"None";"";"";""
"CHEMBL4643727";"";"None";"386.52";"0";"1.12";"32";"C[C@@H]1C[C@H]1CNC(=O)[C@@H]1C[C@H]1[C@]12CN(c3ncccn3)C[C@H]1CSC(N)=N2";"IC50";"'='";"90000.0";"nM";"4.05";"";"";"UO_0000065";"10.47";"0.20";"2.93";"4.19";"0";"CHEMBL4614137";"Inhibition of human cathepsin D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4613225";"1";"Scientific Literature";"Bioorg Med Chem";"2020";"None";"";"";""
"CHEMBL4211913";"";"None";"414.52";"0";"2.34";"63";"C[C@H]1C[C@H]2CSC(N)=N[C@@]2(c2nc(NC(=O)c3ccc(C#N)cn3)cs2)CO1";"IC50";"'='";"197600.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4183115";"Inhibition of Cathepsin D (unknown origin) by fluorescence polarization assay";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4177751";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL2408738";"";"None";"460.57";"0";"3.82";"16";"CC(=O)N[C@@H](Cc1cc(F)cc(F)c1)[C@H](O)CN[C@H]1COCc2ccc(CC(C)(C)C)cc21";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL2410948";"Inhibition of cathepsin-D (unknown origin) using C-terminal biotinylated peptide substrate treated 30 mins before addition of peptide substrate measured after 110 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2406984";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"None";"";"";""
"CHEMBL2408741";"";"None";"508.63";"1";"3.22";"19";"CC(=O)N[C@@H](Cc1cc(F)cc(F)c1)[C@H](O)CN[C@H]1CS(=O)(=O)Cc2ccc(CC(C)(C)C)cc21";"IC50";"'='";"362.0";"nM";"6.44";"";"";"UO_0000065";"12.66";"0.25";"3.22";"6.74";"0";"CHEMBL2410948";"Inhibition of cathepsin-D (unknown origin) using C-terminal biotinylated peptide substrate treated 30 mins before addition of peptide substrate measured after 110 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2406984";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"None";"";"";""
"CHEMBL2408753";"";"None";"518.65";"1";"4.48";"48, distereomeric mixture";"COC[C@@]1(C)C[C@H](NC[C@@H](O)[C@H](Cc2cc(F)cc(F)c2)NC(C)=O)c2cc(CC(C)(C)C)ccc2O1";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"16.01";"0.31";"3.82";"10.40";"0";"CHEMBL2410948";"Inhibition of cathepsin-D (unknown origin) using C-terminal biotinylated peptide substrate treated 30 mins before addition of peptide substrate measured after 110 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2406984";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"None";"";"";""
"CHEMBL4161264";"";"None";"846.08";"2";"2.51";"2";"CC[C@H](C)[C@H](NC(=O)C[C@H](O)[C@H](CC(C)C)NC(=O)[C@H](OC(=O)[C@@H](O)C(C)C)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N(C)[C@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)OC";"IC50";"'='";"270.0";"nM";"6.57";"";"";"UO_0000065";"7.76";"0.15";"4.06";"2.97";"0";"CHEMBL4150649";"Inhibition of human cathepsin D using GKPILFFRLK(DNP)-D-RNH2) labeled MCA as substrate preincubated for 10 mins followed by substrate addition measured after 1 to 2 hrs by fluorometric method";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4145636";"1";"Scientific Literature";"J Nat Prod";"2018";"None";"";"";""
"CHEMBL3982332";"";"None";"736.74";"1";"3.80";"BDBM232264";"CC[C@H](C)[C@H](NC(=O)C[C@H](N)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)COc1ccc(Cl)cc1Cl)C(C)C)C(=O)N[C@H](C(=O)OC)C(C)C";"IC50";"'='";"27.0";"nM";"7.57";"";"405039";"UO_0000065";"10.27";"0.21";"3.77";"4.25";"0";"CHEMBL3888498";"In-Vitro Fluorescence Assay: In order to identify modulators of cathepsin D activity, a continuous enzymatic test was carried out with a synthetic peptide which carries a fluorescent group (MCA=(7-methoxycoumarin-4-yl)acetyl) which is quenched by energy transfer from a Dpn (2,4 dinitrophenyl) group on the same molecule, in Greiner 384-well nb microtitre plates. Cleavage of the peptidic substrate by cathepsin D causes an increase in the fluorescence intensity. In order to determine the efficacy of substances, the time-dependent increase in the fluorescence intensity in the presence of the substance was compared with the time-dependent increase in fluorescence in the absence of substances. The reference substance used was pepstatin A (Sigma-Aldrich). The substrate used was MCAGKPILFFRLK(Dnp)d-R-NH2 (Enzo Life Sciences, Lorrach). The enzyme employed was cathepsin D isolated from the human liver (Sigma-Aldrich) in a final concentration of 1.4 nM. The test was carried out in 100 mM sodium acetate buffer, 1.25% (v/v) of DMSO, 0.25% (w/v) of Chaps, pH 5.5. 2 ul of each substance solution with serially diluted substance concentration were added to in each case 4 ul of cathepsin D solution and incubated at room temperature for 10 min. The reaction was started by addition of 2 ul of substrate solution (final concentration 5 uM). After carrying out a starting-point fluorescence measurement (excitation wavelength 340 nm/emission wavelength 450 nm) using an Envision multilabel reader (Perkin Elmer), the reaction was incubated at room temperature for 60 min. The amount of peptide fragment cleaved off during the reaction time was subsequently measured by determination of the increase in the fluorescence intensity at 450 nm (excitation wavelength 340 nm).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886733";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3919301";"";"None";"670.94";"2";"3.21";"BDBM232272";"CC[C@H](C)[C@H](NC(=O)C[C@H](N)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)CC(C)C)C(C)C)C(=O)NCC1CC1";"IC50";"'='";"400.0";"nM";"6.40";"";"405046";"UO_0000065";"9.54";"0.18";"3.19";"3.73";"0";"CHEMBL3888498";"In-Vitro Fluorescence Assay: In order to identify modulators of cathepsin D activity, a continuous enzymatic test was carried out with a synthetic peptide which carries a fluorescent group (MCA=(7-methoxycoumarin-4-yl)acetyl) which is quenched by energy transfer from a Dpn (2,4 dinitrophenyl) group on the same molecule, in Greiner 384-well nb microtitre plates. Cleavage of the peptidic substrate by cathepsin D causes an increase in the fluorescence intensity. In order to determine the efficacy of substances, the time-dependent increase in the fluorescence intensity in the presence of the substance was compared with the time-dependent increase in fluorescence in the absence of substances. The reference substance used was pepstatin A (Sigma-Aldrich). The substrate used was MCAGKPILFFRLK(Dnp)d-R-NH2 (Enzo Life Sciences, Lorrach). The enzyme employed was cathepsin D isolated from the human liver (Sigma-Aldrich) in a final concentration of 1.4 nM. The test was carried out in 100 mM sodium acetate buffer, 1.25% (v/v) of DMSO, 0.25% (w/v) of Chaps, pH 5.5. 2 ul of each substance solution with serially diluted substance concentration were added to in each case 4 ul of cathepsin D solution and incubated at room temperature for 10 min. The reaction was started by addition of 2 ul of substrate solution (final concentration 5 uM). After carrying out a starting-point fluorescence measurement (excitation wavelength 340 nm/emission wavelength 450 nm) using an Envision multilabel reader (Perkin Elmer), the reaction was incubated at room temperature for 60 min. The amount of peptide fragment cleaved off during the reaction time was subsequently measured by determination of the increase in the fluorescence intensity at 450 nm (excitation wavelength 340 nm).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886733";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3946374";"";"None";"735.85";"1";"3.56";"BDBM232249";"CC[C@H](C)[C@H](NC(=O)C[C@H](N)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)Cc1cccc(OC(F)(F)F)c1)C(C)C)C(=O)N[C@H](C(=O)OC)C(C)C";"IC50";"'='";"18.0";"nM";"7.75";"";"405026";"UO_0000065";"10.52";"0.20";"4.18";"4.35";"0";"CHEMBL3888498";"In-Vitro Fluorescence Assay: In order to identify modulators of cathepsin D activity, a continuous enzymatic test was carried out with a synthetic peptide which carries a fluorescent group (MCA=(7-methoxycoumarin-4-yl)acetyl) which is quenched by energy transfer from a Dpn (2,4 dinitrophenyl) group on the same molecule, in Greiner 384-well nb microtitre plates. Cleavage of the peptidic substrate by cathepsin D causes an increase in the fluorescence intensity. In order to determine the efficacy of substances, the time-dependent increase in the fluorescence intensity in the presence of the substance was compared with the time-dependent increase in fluorescence in the absence of substances. The reference substance used was pepstatin A (Sigma-Aldrich). The substrate used was MCAGKPILFFRLK(Dnp)d-R-NH2 (Enzo Life Sciences, Lorrach). The enzyme employed was cathepsin D isolated from the human liver (Sigma-Aldrich) in a final concentration of 1.4 nM. The test was carried out in 100 mM sodium acetate buffer, 1.25% (v/v) of DMSO, 0.25% (w/v) of Chaps, pH 5.5. 2 ul of each substance solution with serially diluted substance concentration were added to in each case 4 ul of cathepsin D solution and incubated at room temperature for 10 min. The reaction was started by addition of 2 ul of substrate solution (final concentration 5 uM). After carrying out a starting-point fluorescence measurement (excitation wavelength 340 nm/emission wavelength 450 nm) using an Envision multilabel reader (Perkin Elmer), the reaction was incubated at room temperature for 60 min. The amount of peptide fragment cleaved off during the reaction time was subsequently measured by determination of the increase in the fluorescence intensity at 450 nm (excitation wavelength 340 nm).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886733";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3961449";"";"None";"730.99";"2";"2.99";"BDBM232252";"CC[C@H](C)[C@H](NC(=O)C[C@H](N)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)CC(C)C)C(C)C)C(=O)N[C@H](C(=O)OC)C(C)C";"IC50";"'='";"5.1";"nM";"8.29";"";"405029";"UO_0000065";"11.34";"0.22";"5.30";"4.19";"0";"CHEMBL3888498";"In-Vitro Fluorescence Assay: In order to identify modulators of cathepsin D activity, a continuous enzymatic test was carried out with a synthetic peptide which carries a fluorescent group (MCA=(7-methoxycoumarin-4-yl)acetyl) which is quenched by energy transfer from a Dpn (2,4 dinitrophenyl) group on the same molecule, in Greiner 384-well nb microtitre plates. Cleavage of the peptidic substrate by cathepsin D causes an increase in the fluorescence intensity. In order to determine the efficacy of substances, the time-dependent increase in the fluorescence intensity in the presence of the substance was compared with the time-dependent increase in fluorescence in the absence of substances. The reference substance used was pepstatin A (Sigma-Aldrich). The substrate used was MCAGKPILFFRLK(Dnp)d-R-NH2 (Enzo Life Sciences, Lorrach). The enzyme employed was cathepsin D isolated from the human liver (Sigma-Aldrich) in a final concentration of 1.4 nM. The test was carried out in 100 mM sodium acetate buffer, 1.25% (v/v) of DMSO, 0.25% (w/v) of Chaps, pH 5.5. 2 ul of each substance solution with serially diluted substance concentration were added to in each case 4 ul of cathepsin D solution and incubated at room temperature for 10 min. The reaction was started by addition of 2 ul of substrate solution (final concentration 5 uM). After carrying out a starting-point fluorescence measurement (excitation wavelength 340 nm/emission wavelength 450 nm) using an Envision multilabel reader (Perkin Elmer), the reaction was incubated at room temperature for 60 min. The amount of peptide fragment cleaved off during the reaction time was subsequently measured by determination of the increase in the fluorescence intensity at 450 nm (excitation wavelength 340 nm).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886733";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3890361";"";"None";"716.97";"2";"2.75";"BDBM232246";"CC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)CC(C)C)C(=O)N[C@@H](Cc1ccccc1)[C@@H](N)CC(=O)N[C@H](C(=O)N[C@H](C(=O)OC)C(C)C)[C@@H](C)CC";"IC50";"'='";"97.0";"nM";"7.01";"";"405023";"UO_0000065";"9.78";"0.19";"4.26";"3.55";"0";"CHEMBL3888498";"In-Vitro Fluorescence Assay: In order to identify modulators of cathepsin D activity, a continuous enzymatic test was carried out with a synthetic peptide which carries a fluorescent group (MCA=(7-methoxycoumarin-4-yl)acetyl) which is quenched by energy transfer from a Dpn (2,4 dinitrophenyl) group on the same molecule, in Greiner 384-well nb microtitre plates. Cleavage of the peptidic substrate by cathepsin D causes an increase in the fluorescence intensity. In order to determine the efficacy of substances, the time-dependent increase in the fluorescence intensity in the presence of the substance was compared with the time-dependent increase in fluorescence in the absence of substances. The reference substance used was pepstatin A (Sigma-Aldrich). The substrate used was MCAGKPILFFRLK(Dnp)d-R-NH2 (Enzo Life Sciences, Lorrach). The enzyme employed was cathepsin D isolated from the human liver (Sigma-Aldrich) in a final concentration of 1.4 nM. The test was carried out in 100 mM sodium acetate buffer, 1.25% (v/v) of DMSO, 0.25% (w/v) of Chaps, pH 5.5. 2 ul of each substance solution with serially diluted substance concentration were added to in each case 4 ul of cathepsin D solution and incubated at room temperature for 10 min. The reaction was started by addition of 2 ul of substrate solution (final concentration 5 uM). After carrying out a starting-point fluorescence measurement (excitation wavelength 340 nm/emission wavelength 450 nm) using an Envision multilabel reader (Perkin Elmer), the reaction was incubated at room temperature for 60 min. The amount of peptide fragment cleaved off during the reaction time was subsequently measured by determination of the increase in the fluorescence intensity at 450 nm (excitation wavelength 340 nm).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886733";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL4085715";"";"None";"311.40";"0";"2.88";"6p";"C[C@@]1(c2cc(CNC3CC3)c(F)cc2F)CCSC(N)=N1";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4042703";"Inhibition of Cathepsin D (unknown origin) by cell free assay";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4041533";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";"";""
"CHEMBL4064148";"";"None";"325.43";"0";"3.13";"6q";"C[C@@]1(c2cc(CNCC3CC3)c(F)cc2F)CCSC(N)=N1";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4042703";"Inhibition of Cathepsin D (unknown origin) by cell free assay";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4041533";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";"";""
"CHEMBL3683818";"";"None";"421.38";"0";"2.38";"BDBM171424";"COc1cnc(C(=O)Nc2ccc(F)c([C@]3(C(F)F)N=C(N)O[C@H]4C[C@H]43)c2)c(C)n1";"IC50";"'='";"821910.0";"nM";"";"Outside typical range";"315833";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3957032";"";"None";"531.47";"1";"4.23";"BDBM214827";"COc1cnc(C(=O)Nc2ccc(F)c([C@]3(C)C[C@@H](C(F)(F)F)OC(NC(=O)c4ccccc4)=N3)c2)cn1";"IC50";"'>'";"400000.0";"nM";"";"Outside typical range";"377855";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3966313";"";"None";"465.33";"0";"3.83";"BDBM215000";"C[C@@]1(c2cc(NC(=O)c3cnc(C(F)F)cn3)cc(F)c2F)C[C@@H](C(F)(F)F)OC(N)=N1";"IC50";"'>'";"400000.0";"nM";"";"Outside typical range";"377888";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3981436";"";"None";"483.22";"0";"4.61";"BDBM214857";"NC1=N[C@](CF)(c2cc(NC(=O)c3ncc(Cl)cc3Cl)ccc2F)C[C@@H](C(F)(F)F)O1";"IC50";"'='";"2390000.0";"nM";"";"Outside typical range";"377893";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3954714";"";"None";"466.20";"0";"4.61";"BDBM214893";"NC1=N[C@](CF)(c2cc(Oc3cc(Br)ccn3)ccc2F)C[C@@H](C(F)(F)F)O1";"IC50";"'='";"2140000.0";"nM";"";"Outside typical range";"377901";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3952065";"";"None";"439.74";"0";"4.64";"BDBM214896";"NC1=N[C@](CF)(c2cc(Oc3ncc(Cl)cc3F)ccc2F)C[C@@H](C(F)(F)F)O1";"IC50";"'>'";"400000.0";"nM";"";"Outside typical range";"377905";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3688828";"";"None";"413.40";"0";"3.39";"BDBM171779";"N#Cc1cnc2c(c1)CC[C@H]2Nc1ccc(F)c([C@@]2(C(F)F)N=C(N)O[C@@H]3C[C@@H]32)c1";"IC50";"'='";"131500.0";"nM";"";"Outside typical range";"316176";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3693238";"";"None";"464.80";"0";"4.78";"BDBM171797";"NC1=N[C@@](c2cc(N[C@H](c3ccc(Cl)cn3)C(F)(F)F)ccc2F)(C(F)F)[C@H]2C[C@H]2O1";"IC50";"'='";"68200.0";"nM";"4.17";"";"316193";"UO_0000065";"8.96";"0.18";"-0.61";"5.74";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3968517";"";"None";"508.90";"1";"3.40";"BDBM220775";"CC#CCOc1cnc(C(=O)Nc2ccc3c(c2)C2(CCOC(N)=N2)c2cc(Cl)nc(F)c2O3)cn1";"IC50";"'='";"151500.0";"nM";"";"Outside typical range";"386458";"UO_0000065";"";"";"";"";"0";"CHEMBL3888270";"Fluorescence Resonance Energy Transfer (FRET) Assay: Recombinant CathepsinD was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The CathepsinD enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for CathepsinD) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886633";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3976955";"";"None";"481.51";"0";"3.69";"BDBM220778";"COc1cc(F)c2c(c1)C1(CCSC(N)=N1)c1cc(NC(=O)c3cnc(OC)cn3)ccc1O2";"IC50";"'>'";"400000.0";"nM";"";"Outside typical range";"386461";"UO_0000065";"";"";"";"";"0";"CHEMBL3888270";"Fluorescence Resonance Energy Transfer (FRET) Assay: Recombinant CathepsinD was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The CathepsinD enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for CathepsinD) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886633";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3979722";"";"None";"468.87";"0";"4.22";"BDBM220780";"COc1cc(F)c2c(c1)C1(CCOC(N)=N1)c1cc(NC(=O)c3ccc(Cl)cn3)ccc1O2";"IC50";"'>'";"400000.0";"nM";"";"Outside typical range";"386463";"UO_0000065";"";"";"";"";"0";"CHEMBL3888270";"Fluorescence Resonance Energy Transfer (FRET) Assay: Recombinant CathepsinD was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The CathepsinD enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for CathepsinD) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886633";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3955334";"";"None";"779.04";"2";"3.58";"BDBM232253";"CC[C@H](C)[C@H](NC(=O)C[C@H](N)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)CC(C)C)C(=O)N[C@H](C(=O)OC)C(C)C";"IC50";"'='";"610.0";"nM";"6.21";"";"405030";"UO_0000065";"7.98";"0.15";"2.63";"3.14";"0";"CHEMBL3888498";"In-Vitro Fluorescence Assay: In order to identify modulators of cathepsin D activity, a continuous enzymatic test was carried out with a synthetic peptide which carries a fluorescent group (MCA=(7-methoxycoumarin-4-yl)acetyl) which is quenched by energy transfer from a Dpn (2,4 dinitrophenyl) group on the same molecule, in Greiner 384-well nb microtitre plates. Cleavage of the peptidic substrate by cathepsin D causes an increase in the fluorescence intensity. In order to determine the efficacy of substances, the time-dependent increase in the fluorescence intensity in the presence of the substance was compared with the time-dependent increase in fluorescence in the absence of substances. The reference substance used was pepstatin A (Sigma-Aldrich). The substrate used was MCAGKPILFFRLK(Dnp)d-R-NH2 (Enzo Life Sciences, Lorrach). The enzyme employed was cathepsin D isolated from the human liver (Sigma-Aldrich) in a final concentration of 1.4 nM. The test was carried out in 100 mM sodium acetate buffer, 1.25% (v/v) of DMSO, 0.25% (w/v) of Chaps, pH 5.5. 2 ul of each substance solution with serially diluted substance concentration were added to in each case 4 ul of cathepsin D solution and incubated at room temperature for 10 min. The reaction was started by addition of 2 ul of substrate solution (final concentration 5 uM). After carrying out a starting-point fluorescence measurement (excitation wavelength 340 nm/emission wavelength 450 nm) using an Envision multilabel reader (Perkin Elmer), the reaction was incubated at room temperature for 60 min. The amount of peptide fragment cleaved off during the reaction time was subsequently measured by determination of the increase in the fluorescence intensity at 450 nm (excitation wavelength 340 nm).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886733";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3944050";"";"None";"533.97";"1";"4.28";"BDBM220830";"COc1nc(C2=CCOCC2)cc2c1Oc1ccc(NC(=O)c3ccc(Cl)cn3)cc1C21CCOC(N)=N1";"IC50";"'='";"400000.0";"nM";"";"Outside typical range";"386516";"UO_0000065";"";"";"";"";"0";"CHEMBL3888270";"Fluorescence Resonance Energy Transfer (FRET) Assay: Recombinant CathepsinD was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The CathepsinD enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for CathepsinD) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886633";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3932872";"";"None";"533.59";"1";"4.48";"BDBM220847";"COc1cnc(C(=O)Nc2ccc3c(c2)C2(CCSC(N)=N2)c2cc(C4=CCOCC4)cc(F)c2O3)cn1";"IC50";"'='";"173600.0";"nM";"";"Outside typical range";"386533";"UO_0000065";"";"";"";"";"0";"CHEMBL3888270";"Fluorescence Resonance Energy Transfer (FRET) Assay: Recombinant CathepsinD was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The CathepsinD enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for CathepsinD) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886633";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL2408744";"";"None";"471.55";"0";"3.58";"32";"CC(=O)N[C@@H](Cc1cc(F)cc(F)c1)[C@H](O)CN[C@H]1CCOc2ccc(CC(C)(C)C#N)cc21";"IC50";"'='";"70.0";"nM";"7.16";"";"";"UO_0000065";"15.17";"0.29";"3.57";"7.58";"0";"CHEMBL2410948";"Inhibition of cathepsin-D (unknown origin) using C-terminal biotinylated peptide substrate treated 30 mins before addition of peptide substrate measured after 110 mins by fluorescence polarization assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2406984";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"None";"";"";""
"CHEMBL3127098";"";"None";"371.44";"0";"2.94";"76";"NC1=N[C@@]2(CS1)c1cc(-c3cccnc3F)ccc1O[C@@H]1CCOC[C@H]12";"IC50";"'='";"96000.0";"nM";"4.02";"";"";"UO_0000065";"10.82";"0.21";"1.08";"5.76";"0";"CHEMBL3131975";"Inhibition of human liver cathepsin D measured for 1 hr by FRET assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124885";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL3127104";"";"None";"388.43";"0";"2.00";"59";"CN1C(=O)[C@]2(N=C1N)c1cc(-c3cccc(C#N)c3)ccc1O[C@H]1CCOC[C@@H]12";"IC50";"'='";"2700.0";"nM";"5.57";"";"";"UO_0000065";"14.34";"0.26";"3.57";"5.52";"0";"CHEMBL3131975";"Inhibition of human liver cathepsin D measured for 1 hr by FRET assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124885";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL3127082";"";"None";"369.40";"0";"2.62";"89";"C[C@@]12COCC[C@H]1Oc1ccc(-c3cccnc3F)cc1[C@@]21COC(N)=N1";"IC50";"'>'";"200000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3131975";"Inhibition of human liver cathepsin D measured for 1 hr by FRET assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3124885";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL3895635";"";"None";"465.44";"0";"2.97";"BDBM220809";"COc1cc(F)c2c(c1)C1(CCOC(N)=N1)c1cc(NC(=O)c3cnc(OC)cn3)ccc1O2";"IC50";"'='";"400000.0";"nM";"";"Outside typical range";"386495";"UO_0000065";"";"";"";"";"0";"CHEMBL3888270";"Fluorescence Resonance Energy Transfer (FRET) Assay: Recombinant CathepsinD was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The CathepsinD enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for CathepsinD) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886633";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3986979";"";"None";"476.47";"0";"3.23";"BDBM220788";"COc1cnc(C(=O)Nc2ccc3c(c2)C2(CCOC(N)=N2)c2cc(C4CC4)nc(F)c2O3)cn1";"IC50";"'='";"269400.0";"nM";"";"Outside typical range";"386471";"UO_0000065";"";"";"";"";"0";"CHEMBL3888270";"Fluorescence Resonance Energy Transfer (FRET) Assay: Recombinant CathepsinD was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The CathepsinD enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for CathepsinD) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886633";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3902076";"";"None";"547.61";"1";"4.79";"BDBM220858";"COc1cnc(C(=O)Nc2ccc3c(c2)C2(CCSC(N)=N2)c2cc(C4=CCOCC4)nc(F)c2O3)c(C)c1";"IC50";"'='";"158800.0";"nM";"";"Outside typical range";"386544";"UO_0000065";"";"";"";"";"0";"CHEMBL3888270";"Fluorescence Resonance Energy Transfer (FRET) Assay: Recombinant CathepsinD was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The CathepsinD enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for CathepsinD) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886633";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3923890";"";"None";"454.36";"0";"2.88";"BDBM214944";"Cc1cc(C#N)cnc1C(=O)Nc1cnc(F)c([C@]2(CF)C[C@@H](C(F)(F)F)OC(N)=N2)c1";"IC50";"'>'";"400000.0";"nM";"";"Outside typical range";"377917";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3898875";"";"None";"434.38";"0";"2.46";"BDBM214954";"[C-]#[N+]c1ccc(C(=O)Nc2cc([C@]3(C)C[C@@H](C(F)(F)F)OC(N)=N3)c(=O)n(C)c2)nc1";"IC50";"'>'";"400000.0";"nM";"";"Outside typical range";"377925";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3964372";"";"None";"469.37";"0";"2.90";"BDBM214997";"C#CCOc1cnc(C(=O)Nc2cc(F)c(F)c([C@]3(C)C[C@@H](C(F)(F)F)OC(N)=N3)c2)cn1";"IC50";"'>'";"400000.0";"nM";"";"Outside typical range";"377971";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3951840";"";"None";"456.44";"0";"3.35";"BDBM214921";"C#CCOC1CCN(C(=O)Nc2ccc(F)c([C@]3(C)C[C@@H](C(F)(F)F)OC(N)=N3)c2)CC1";"IC50";"'>'";"400000.0";"nM";"";"Outside typical range";"377975";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3961630";"";"None";"400.38";"0";"3.50";"BDBM214924";"C[C@@]1(c2cc(NC(=O)N3CC=CCC3)ccc2F)C[C@@H](C(F)(F)F)OC(N)=N1";"IC50";"'>'";"400000.0";"nM";"";"Outside typical range";"377978";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3949134";"";"None";"449.77";"0";"3.35";"BDBM214938";"NC1=N[C@](CF)(c2nc(NC(=O)c3ccc(Cl)cn3)ccc2F)C[C@@H](C(F)(F)F)O1";"IC50";"'='";"717000.0";"nM";"";"Outside typical range";"377983";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3966149";"";"None";"415.32";"0";"2.89";"BDBM214863";"C[C@@]1(c2cc(NC(=O)c3ccc(F)cn3)cnc2F)C[C@@H](C(F)(F)F)OC(N)=N1";"IC50";"'>'";"400000.0";"nM";"";"Outside typical range";"377986";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3968748";"";"None";"534.57";"1";"3.88";"BDBM220798";"COc1cnc(C(=O)Nc2ccc3c(c2)C2(CCSC(N)=N2)c2cc(C4=CCCOC4)nc(F)c2O3)cn1";"IC50";"'='";"179300.0";"nM";"";"Outside typical range";"386484";"UO_0000065";"";"";"";"";"0";"CHEMBL3888270";"Fluorescence Resonance Energy Transfer (FRET) Assay: Recombinant CathepsinD was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The CathepsinD enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for CathepsinD) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886633";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL4555241";"";"None";"612.82";"2";"5.05";"(S,R)-3b";"COc1cccc(C(C)(C)NC[C@@H](O)[C@H](Cc2ccccc2)NC(=O)c2cc(C(=O)NCC3CC3)cc(N3CCCCC3)c2)c1";"IC50";"'='";"760.0";"nM";"6.12";"";"";"UO_0000065";"9.99";"0.19";"1.07";"5.94";"0";"CHEMBL4331648";"Inhibition of human cathepsin D using DABCYL-Glu-Arg-Nle-Phe-Leu-Ser-Phe-Pro-EDANS as substrate preincubated for 30 mins followed by substrate addition and measured every min for 8 to 15 mins by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4330085";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";"";"";""
"CHEMBL4569382";"";"None";"616.80";"1";"4.02";"(S,R)-3c";"COc1cccc(C(C)(C)NC[C@@H](O)[C@H](Cc2ccccc2)NC(=O)c2cc(C(=O)NCCCO)cc(N3CCCCC3)c2)c1";"IC50";"'='";"2250.0";"nM";"5.65";"";"";"UO_0000065";"9.16";"0.17";"1.63";"4.59";"0";"CHEMBL4331648";"Inhibition of human cathepsin D using DABCYL-Glu-Arg-Nle-Phe-Leu-Ser-Phe-Pro-EDANS as substrate preincubated for 30 mins followed by substrate addition and measured every min for 8 to 15 mins by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4330085";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";"";"";""
"CHEMBL4163078";"";"None";"1134.43";"None";"None";"3";"CC[C@H](C)[C@H](NC(=O)C[C@H](O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)N(C)C(=O)[C@H](CC(C)C)NC(=O)[C@H](C)OC(=O)[C@H](Cc1ccccc1)N(C)C)C(=O)N[C@@H](C)C(=O)N(C)[C@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)OC";"IC50";"'='";"10000.0";"nM";"5.00";"";"";"UO_0000065";"4.41";"None";"None";"None";"0";"CHEMBL4141007";"Inhibition of cathepsin D in human MDA-MB-231 cells using Mca-Gly-Lys-Pro-Ile-Leu-PhePhe-Arg-Leu-Lys-(Dnp)-D-Arg-NH2 as substrate pretreated for 4 hrs followed by compound washout and subsequent 10 mins trypsinization prior to substrate addition measured at 30 secs interval for 30 mins by fluorescence assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"MDA-MB-231";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4138143";"1";"Scientific Literature";"J Nat Prod";"2017";"None";"";"";""
"CHEMBL3906344";"";"None";"475.27";"0";"3.65";"BDBM220776";"NC1=NC2(CCO1)c1cc(NC(=O)c3cnc(Cl)cn3)ccc1Oc1c2cc(Cl)nc1F";"IC50";"'='";"323000.0";"nM";"";"Outside typical range";"386459";"UO_0000065";"";"";"";"";"0";"CHEMBL3888270";"Fluorescence Resonance Energy Transfer (FRET) Assay: Recombinant CathepsinD was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The CathepsinD enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for CathepsinD) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886633";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3905117";"";"None";"479.90";"0";"4.48";"BDBM220787";"NC1=NC2(CCO1)c1cc(NC(=O)c3ccc(Cl)cn3)ccc1Oc1c2cc(C2CC2)nc1F";"IC50";"'='";"360000.0";"nM";"";"Outside typical range";"386470";"UO_0000065";"";"";"";"";"0";"CHEMBL3888270";"Fluorescence Resonance Energy Transfer (FRET) Assay: Recombinant CathepsinD was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The CathepsinD enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for CathepsinD) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886633";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3974459";"";"None";"456.29";"0";"4.12";"BDBM220813";"NC1=NC2(CCO1)c1cc(NC(=O)c3ccc(Cl)cn3)ccc1Oc1cnc(Cl)cc12";"IC50";"'='";"400000.0";"nM";"";"Outside typical range";"386499";"UO_0000065";"";"";"";"";"0";"CHEMBL3888270";"Fluorescence Resonance Energy Transfer (FRET) Assay: Recombinant CathepsinD was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The CathepsinD enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for CathepsinD) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886633";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3908554";"";"None";"530.49";"1";"4.16";"BDBM220821";"COc1ccc(C(=O)Nc2ccc3c(c2)C2(CCOC(N)=N2)c2cc(-c4cncc(F)c4)nc(F)c2O3)nc1";"IC50";"'='";"256400.0";"nM";"";"Outside typical range";"386507";"UO_0000065";"";"";"";"";"0";"CHEMBL3888270";"Fluorescence Resonance Energy Transfer (FRET) Assay: Recombinant CathepsinD was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The CathepsinD enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for CathepsinD) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886633";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL4555649";"";"None";"493.60";"0";"0.18";"35";"CC(C)[C@@H]1NC(=O)C[C@H](O)[C@H](Cc2ccccc2)NC(=O)CCOCCOCCOCCNC1=O";"IC50";"'='";"850.0";"nM";"6.07";"";"";"UO_0000065";"12.30";"0.24";"5.89";"4.49";"0";"CHEMBL4325791";"Inhibition of human placenta CatD using Abz-Lys-Pro-Ala-Glu-Phe-Nph-Ala-Leu as substrate preincubated for 10 mins followed by substrate addition and measured by FRET assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4321885";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";""
"CHEMBL3688792";"";"None";"468.36";"0";"4.12";"BDBM171739";"NC1=N[C@@](c2cc(Nc3ncnc4cc(C(F)(F)F)cnc34)ccc2F)(C(F)F)[C@H]2C[C@H]2O1";"IC50";"'='";"79350.0";"nM";"4.10";"";"316220";"UO_0000065";"8.75";"0.17";"-0.02";"4.17";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3683799";"";"None";"455.23";"0";"3.27";"BDBM171405";"NC1=N[C@](CF)(c2cc(NC(=O)c3ccc(Br)cn3)cc(F)c2F)[C@H]2C[C@H]2O1";"IC50";"'='";"109250.0";"nM";"";"Outside typical range";"315814";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3683838";"";"None";"404.83";"0";"2.70";"BDBM171448";"COC[C@]1(c2cc(NC(=O)c3ccc(Cl)cn3)ccc2F)N=C(N)O[C@@H]2C[C@@H]21";"IC50";"'>'";"400000.0";"nM";"";"Outside typical range";"315857";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3683846";"";"None";"491.80";"0";"3.36";"BDBM171456";"NC1=N[C@](CF)(c2cc(NC(=O)c3cnc(OCC(F)(F)F)cn3)cc(Cl)c2F)[C@H]2C[C@H]2O1";"IC50";"'='";"913000.0";"nM";"";"Outside typical range";"315865";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3683852";"";"None";"445.40";"0";"2.46";"BDBM171462";"CC#CCOc1cnc(C(=O)Nc2ccc(F)c([C@@]3(C(F)F)N=C(N)O[C@@H]4C[C@@H]43)c2)cn1";"IC50";"'='";"467370.0";"nM";"";"Outside typical range";"315871";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688622";"";"None";"456.37";"0";"3.66";"BDBM171557";"CC(F)(F)Oc1ccc(C(=O)Nc2ccc(F)c([C@@]3(C(F)F)N=C(N)O[C@@H]4C[C@@H]43)c2)nc1";"IC50";"'='";"1073100.0";"nM";"";"Outside typical range";"315966";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688630";"";"None";"427.41";"0";"2.17";"BDBM171565";"CC#CCOc1cnc(C(=O)Nc2ccc(F)c([C@@]3(CF)N=C(N)O[C@@H]4C[C@@H]43)c2)cn1";"IC50";"'='";"958610.0";"nM";"";"Outside typical range";"315974";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688631";"";"None";"445.86";"0";"3.59";"BDBM171566";"Cc1c(C(=O)Nc2ccc(F)c([C@@]3(CF)N=C(N)O[C@@H]4C[C@@H]43)c2)nc2ccc(Cl)cn12";"IC50";"'='";"464930.0";"nM";"";"Outside typical range";"315975";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688635";"";"None";"384.35";"0";"1.64";"BDBM171570";"N#Cc1ccc(C(=O)Nc2cnc(F)c([C@@]3(CF)N=C(N)O[C@@H]4C[C@@H]43)c2)nc1";"IC50";"'='";"293500.0";"nM";"";"Outside typical range";"315979";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688814";"";"None";"444.42";"0";"2.60";"BDBM171763";"CN(C)c1cc(C#N)cnc1C(=O)Nc1ccc(F)c([C@@]2(C(F)F)N=C(N)O[C@@H]3C[C@@H]32)c1";"IC50";"'='";"732460.0";"nM";"";"Outside typical range";"316163";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3683800";"";"None";"455.23";"0";"3.27";"BDBM171406";"NC1=N[C@@](CF)(c2cc(NC(=O)c3ccc(Br)cn3)cc(F)c2F)[C@@H]2C[C@@H]2O1";"IC50";"'='";"516140.0";"nM";"";"Outside typical range";"315815";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3693243";"";"None";"371.36";"0";"1.78";"BDBM171802";"COC[C@H](C)NC(=O)c1ccc(F)c([C@]2(C(F)F)N=C(N)O[C@H]3C[C@H]32)c1";"IC50";"'>'";"400000.0";"nM";"";"Outside typical range";"316198";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3693252";"";"None";"422.79";"0";"3.23";"BDBM171812";"NC1=N[C@@](c2cc(N3Cc4cc(Cl)cnc4C3=O)ccc2F)(C(F)F)[C@H]2C[C@H]2O1";"IC50";"'='";"659310.0";"nM";"";"Outside typical range";"316208";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3683919";"";"None";"473.41";"0";"3.23";"BDBM171539";"NC1=N[C@@](c2cc(NC(=O)c3ccc(OCc4ncco4)cn3)ccc2F)(C(F)F)[C@H]2C[C@H]2O1";"IC50";"'='";"1011500.0";"nM";"";"Outside typical range";"315948";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688650";"";"None";"466.22";"0";"4.03";"BDBM171586";"NC1=N[C@](c2cc(NC(=O)c3nn(C(F)F)cc3Cl)ccc2Cl)(C(F)F)[C@@H]2C[C@@H]2O1";"IC50";"'='";"690710.0";"nM";"";"Outside typical range";"315995";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688650";"";"None";"466.22";"0";"4.03";"BDBM171586";"NC1=N[C@](c2cc(NC(=O)c3nn(C(F)F)cc3Cl)ccc2Cl)(C(F)F)[C@@H]2C[C@@H]2O1";"IC50";"'='";"1340300.0";"nM";"";"Outside typical range";"316000";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688805";"";"None";"410.83";"0";"4.24";"BDBM171752";"C[C@@H](Nc1ccc(F)c([C@@]2(C(F)F)N=C(N)O[C@@H]3C[C@@H]32)c1)c1ccc(Cl)cn1";"IC50";"'='";"77400.0";"nM";"4.11";"";"316152";"UO_0000065";"10.01";"0.20";"-0.13";"5.67";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688822";"";"None";"433.37";"0";"2.99";"BDBM171772";"Cc1cc(NC(=O)c2ncc(C#N)cc2F)cc([C@@]2(C(F)F)N=C(N)O[C@@H]3C[C@@H]32)c1F";"IC50";"'='";"690320.0";"nM";"";"Outside typical range";"316171";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3683825";"";"None";"463.85";"0";"3.88";"BDBM171435";"Cc1c(C(=O)Nc2ccc(F)c([C@@]3(C(F)F)N=C(N)O[C@@H]4C[C@@H]43)c2)nc2ccc(Cl)cn12";"IC50";"'='";"439580.0";"nM";"";"Outside typical range";"315844";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3683829";"";"None";"411.77";"0";"2.72";"BDBM171439";"NC1=N[C@](c2cc(NC(=O)c3ccc(Cl)cn3)cnc2F)(C(F)F)[C@@H]2C[C@@H]2O1";"IC50";"'='";"274500.0";"nM";"";"Outside typical range";"315848";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3683888";"";"None";"431.83";"0";"3.20";"BDBM171503";"Cc1cc(C#N)cnc1C(=O)Nc1cc(F)c(Cl)c([C@]2(CF)N=C(N)O[C@H]3C[C@H]32)c1";"IC50";"'='";"645650.0";"nM";"";"Outside typical range";"315914";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3683918";"";"None";"489.48";"0";"3.70";"BDBM171538";"NC1=N[C@@](c2cc(NC(=O)c3ccc(OCc4nccs4)cn3)ccc2F)(C(F)F)[C@H]2C[C@H]2O1";"IC50";"'='";"360350.0";"nM";"";"Outside typical range";"315947";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3639874";"";"None";"445.40";"0";"2.88";"BDBM171550";"Cc1cc(OCC#N)cnc1C(=O)Nc1ccc(F)c([C@@]2(C(F)F)N=C(N)O[C@@H]3C[C@@H]32)c1";"IC50";"'='";"1087400.0";"nM";"";"Outside typical range";"315959";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688679";"";"None";"381.28";"0";"2.91";"BDBM171617";"NC1=N[C@@](c2cc(NC(=O)CC(F)(F)F)ccc2F)(C(F)F)[C@H]2C[C@H]2O1";"IC50";"'='";"190000.0";"nM";"";"Outside typical range";"316026";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688684";"";"None";"405.38";"0";"3.04";"BDBM171622";"NC1=N[C@@](c2cc(NC(=O)COc3ccccc3)ccc2F)(C(F)F)[C@H]2C[C@H]2O1";"IC50";"'='";"331000.0";"nM";"";"Outside typical range";"316031";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688685";"";"None";"357.33";"0";"1.99";"BDBM171623";"CO[C@H](C)C(=O)Nc1ccc(F)c([C@@]2(C(F)F)N=C(N)O[C@@H]3C[C@@H]32)c1";"IC50";"'='";"376540.0";"nM";"";"Outside typical range";"316032";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688721";"";"None";"439.27";"0";"3.55";"BDBM171663";"COc1cc(Cl)cnc1C(=O)Nc1ccc(Cl)c([C@@]2(CF)N=C(N)O[C@@H]3C[C@@H]32)c1";"IC50";"'='";"834640.0";"nM";"";"Outside typical range";"316071";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688734";"";"None";"429.40";"0";"3.16";"BDBM171677";"Cc1cc(C#N)cnc1C(=O)Nc1cc(F)c(C)c([C@]2(C(F)F)N=C(N)O[C@H]3C[C@H]32)c1";"IC50";"'='";"293790.0";"nM";"";"Outside typical range";"316085";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3639876";"";"None";"419.34";"0";"2.68";"BDBM171762";"N#Cc1cnc(C(=O)Nc2ccc(F)c([C@@]3(C(F)F)N=C(N)O[C@@H]4C[C@@H]43)c2)c(F)c1";"IC50";"'='";"1272600.0";"nM";"";"Outside typical range";"316162";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3693231";"";"None";"447.42";"0";"2.85";"BDBM171790";"NC1=N[C@@](c2cc(NC(=O)c3cnc(OCC4CC4)cn3)ccc2F)(C(F)F)[C@H]2C[C@H]2O1";"IC50";"'='";"747300.0";"nM";"";"Outside typical range";"316186";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3693256";"";"None";"371.37";"0";"1.83";"BDBM171816";"COc1cnc(C(=O)Nc2ccc(F)c([C@]3(C)N=C(N)O[C@@H]4C[C@@H]43)c2)cn1";"IC50";"'='";"81300.0";"nM";"4.09";"";"315800";"UO_0000065";"11.01";"0.21";"2.26";"3.66";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3683802";"";"None";"454.84";"0";"3.47";"BDBM171408";"COCc1cc(Cl)cnc1C(=O)Nc1ccc(F)c([C@@]2(C(F)F)N=C(N)O[C@@H]3C[C@@H]32)c1";"IC50";"'='";"735560.0";"nM";"";"Outside typical range";"315817";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3683833";"";"None";"401.35";"0";"2.54";"BDBM171443";"N#Cc1ccc(C(=O)Nc2ccc(F)c([C@@]3(C(F)F)N=C(N)O[C@@H]4C[C@@H]43)c2)nc1";"IC50";"'='";"697750.0";"nM";"";"Outside typical range";"315852";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688712";"";"None";"410.78";"0";"3.32";"BDBM171653";"NC1=N[C@@](c2cc(NC(=O)c3cc(Cl)ccn3)ccc2F)(C(F)F)[C@H]2C[C@H]2O1";"IC50";"'='";"1625700.0";"nM";"";"Outside typical range";"316061";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688715";"";"None";"452.44";"0";"4.33";"BDBM171657";"NC1=N[C@@](c2cc(NC(=O)c3ccc(-c4ccccc4)cn3)ccc2F)(C(F)F)[C@H]2C[C@H]2O1";"IC50";"'='";"148000.0";"nM";"";"Outside typical range";"316065";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688758";"";"None";"375.79";"0";"2.47";"BDBM171703";"C[C@@]1(c2cc(NC(=O)c3ccc(Cl)cn3)cnc2F)N=C(N)O[C@H]2C[C@H]21";"IC50";"'>'";"400000.0";"nM";"";"Outside typical range";"316109";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688770";"";"None";"406.40";"0";"3.28";"BDBM171716";"N#Cc1cnc2c(Nc3ccc(F)c([C@@]4(CF)N=C(N)O[C@@H]5C[C@@H]54)c3)nccc2c1";"IC50";"'='";"204890.0";"nM";"";"Outside typical range";"316120";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688804";"";"None";"396.80";"0";"3.68";"BDBM171751";"NC1=N[C@@](c2cc(NCc3ccc(Cl)cn3)ccc2F)(C(F)F)[C@H]2C[C@H]2O1";"IC50";"'='";"177000.0";"nM";"";"Outside typical range";"316151";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688818";"";"None";"443.43";"0";"3.66";"BDBM171768";"CC(C)c1cc(C#N)cnc1C(=O)Nc1ccc(F)c([C@@]2(C(F)F)N=C(N)O[C@@H]3C[C@@H]32)c1";"IC50";"'='";"1066600.0";"nM";"";"Outside typical range";"316167";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3970199";"";"None";"461.91";"0";"4.34";"BDBM220807";"NC1=NC2(CCO1)c1cc(NC(=O)c3ccc(Cl)cn3)ccc1Oc1ncc(C3CC3)cc12";"IC50";"'='";"432500.0";"nM";"";"Outside typical range";"386493";"UO_0000065";"";"";"";"";"0";"CHEMBL3888270";"Fluorescence Resonance Energy Transfer (FRET) Assay: Recombinant CathepsinD was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The CathepsinD enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for CathepsinD) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886633";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3898979";"";"None";"501.97";"1";"4.86";"BDBM220816";"CC(C)(C)C#Cc1cc2c(cn1)Oc1ccc(NC(=O)c3ccc(Cl)cn3)cc1C21CCOC(N)=N1";"IC50";"'='";"400000.0";"nM";"";"Outside typical range";"386502";"UO_0000065";"";"";"";"";"0";"CHEMBL3888270";"Fluorescence Resonance Energy Transfer (FRET) Assay: Recombinant CathepsinD was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The CathepsinD enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for CathepsinD) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886633";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3950676";"";"None";"516.92";"1";"4.67";"BDBM220824";"NC1=NC2(CCO1)c1cc(NC(=O)c3ccc(Cl)cn3)ccc1Oc1ncc(-c3ccnc(F)c3)cc12";"IC50";"'='";"400800.0";"nM";"";"Outside typical range";"386510";"UO_0000065";"";"";"";"";"0";"CHEMBL3888270";"Fluorescence Resonance Energy Transfer (FRET) Assay: Recombinant CathepsinD was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The CathepsinD enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for CathepsinD) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886633";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3321941";"";"None";"587.48";"1";"2.56";"40";"COc1cc(Br)c(CC(=O)NC(=N)N[C@H](CC(C)C)C(=O)NCc2cccc(-c3nnn[nH]3)c2)cc1OC";"IC50";"'='";"240.0";"nM";"6.62";"";"";"UO_0000065";"11.27";"0.24";"4.06";"3.96";"0";"CHEMBL3371146";"Inhibition of human liver cathepsin D using MCA-labeled GKPILFFRLK(Dnp)-D-R-NH2 peptide by fluorescence-based assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351526";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3891797";"";"None";"512.54";"2";"5.64";"BDBM220794";"COc1cc(F)c2c(c1)C1(CCOC(N)=N1)c1cc(Nc3ncccc3OCc3ccccc3)ccc1O2";"IC50";"'='";"400000.0";"nM";"";"Outside typical range";"386477";"UO_0000065";"";"";"";"";"0";"CHEMBL3888270";"Fluorescence Resonance Energy Transfer (FRET) Assay: Recombinant CathepsinD was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The CathepsinD enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for CathepsinD) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886633";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3913972";"";"None";"518.46";"1";"4.29";"BDBM220823";"NC1=NC2(CCO1)c1cc(NC(=O)c3ccc(F)cn3)ccc1Oc1c2cc(-c2cncc(F)c2)nc1F";"IC50";"'='";"400000.0";"nM";"";"Outside typical range";"386509";"UO_0000065";"";"";"";"";"0";"CHEMBL3888270";"Fluorescence Resonance Energy Transfer (FRET) Assay: Recombinant CathepsinD was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The CathepsinD enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for CathepsinD) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886633";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3984506";"";"None";"516.58";"1";"3.74";"BDBM220840";"COc1cnc(C(=O)Nc2ccc3c(c2)C2(CCSC(N)=N2)c2cc(C4=CCCOC4)ncc2O3)cn1";"IC50";"'='";"294500.0";"nM";"";"Outside typical range";"386526";"UO_0000065";"";"";"";"";"0";"CHEMBL3888270";"Fluorescence Resonance Energy Transfer (FRET) Assay: Recombinant CathepsinD was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The CathepsinD enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for CathepsinD) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886633";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3937966";"";"None";"552.03";"2";"5.43";"BDBM220859";"Cc1cc(Cl)cnc1C(=O)Nc1ccc2c(c1)C1(CCSC(N)=N1)c1cc(C3=CCOCC3)nc(F)c1O2";"IC50";"'='";"133000.0";"nM";"";"Outside typical range";"386545";"UO_0000065";"";"";"";"";"0";"CHEMBL3888270";"Fluorescence Resonance Energy Transfer (FRET) Assay: Recombinant CathepsinD was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The CathepsinD enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for CathepsinD) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886633";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3688716";"";"None";"376.34";"0";"2.67";"BDBM171658";"NC1=N[C@@](c2cc(NC(=O)c3ccccn3)ccc2F)(C(F)F)[C@H]2C[C@H]2O1";"IC50";"'='";"689700.0";"nM";"";"Outside typical range";"316066";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688753";"";"None";"375.79";"0";"2.47";"BDBM171697";"C[C@@]1(c2nc(NC(=O)c3ccc(Cl)cn3)ccc2F)N=C(N)O[C@H]2C[C@H]21";"IC50";"'='";"1316300.0";"nM";"";"Outside typical range";"316101";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL4468607";"";"None";"473.66";"0";"3.25";"10";"CC(C)[C@@H]1NC(=O)C[C@H](O)[C@H](Cc2ccccc2)NC(=O)CCCCCCCCCCNC1=O";"IC50";"'='";"40.0";"nM";"7.40";"";"";"UO_0000065";"15.62";"0.30";"4.15";"6.88";"0";"CHEMBL4325791";"Inhibition of human placenta CatD using Abz-Lys-Pro-Ala-Glu-Phe-Nph-Ala-Leu as substrate preincubated for 10 mins followed by substrate addition and measured by FRET assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4321885";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";""
"CHEMBL3344264";"";"None";"765.83";"2";"1.61";"54";"CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)OCc1ccccc1)[C@@H](O)CC(=O)NC1Cc2ccccc2C1.O=C(O)C(F)(F)F";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3370435";"Inhibition of human cathepsin D assessed as cleavage of wtKAHRP fluorogenic substrate";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3352063";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL3344268";"";"None";"723.79";"2";"1.19";"70";"CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)c1ccccc1)[C@@H](O)CC(=O)NCCc1ccccc1.O=C(O)C(F)(F)F";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3370435";"Inhibition of human cathepsin D assessed as cleavage of wtKAHRP fluorogenic substrate";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3352063";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL3344269";"";"None";"767.85";"2";"1.10";"71";"CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)COCc1ccccc1)[C@@H](O)CC(=O)NCCc1ccccc1.O=C(O)C(F)(F)F";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3370435";"Inhibition of human cathepsin D assessed as cleavage of wtKAHRP fluorogenic substrate";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3352063";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL2402203";"";"None";"386.42";"0";"2.57";"1; Z-FA-FMK";"C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)OCc1ccccc1)C(=O)CF";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4480320";"Inhibition of recombinant human cathepsin D (400 residues) expressed in CHO cells using 5-FAM/QXL 520 FRET peptide as substrate preincubated for 20 mins followed by substrate addition by fluorescence plate reader analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4477275";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3949737";"";"None";"466.22";"0";"4.06";"BDBM214867";"C[C@@]1(c2cc(NC(=O)c3ncc(Cl)cc3Cl)cnc2F)C[C@@H](C(F)(F)F)OC(N)=N1";"IC50";"'>'";"400000.0";"nM";"";"Outside typical range";"377885";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3952727";"";"None";"478.87";"0";"4.80";"BDBM214889";"Cc1cc(Cl)cnc1C(=S)Nc1ccc(F)c([C@]2(CF)C[C@@H](C(F)(F)F)OC(N)=N2)c1";"IC50";"'>'";"400000.0";"nM";"";"Outside typical range";"377886";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3961673";"";"None";"431.78";"0";"3.40";"BDBM214882";"C[C@@]1(c2nc(NC(=O)c3ccc(Cl)cn3)ccc2F)C[C@@H](C(F)(F)F)OC(N)=N1";"IC50";"'>'";"400000.0";"nM";"";"Outside typical range";"377894";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3971100";"";"None";"444.36";"0";"3.20";"BDBM214897";"CNC(=O)c1ccnc(Oc2ccc(F)c([C@]3(CF)C[C@@H](C(F)(F)F)OC(N)=N3)c2)c1";"IC50";"'>'";"400000.0";"nM";"";"Outside typical range";"377908";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3984503";"";"None";"421.75";"0";"4.50";"BDBM214898";"NC1=N[C@](CF)(c2cc(Oc3ncccc3Cl)ccc2F)C[C@@H](C(F)(F)F)O1";"IC50";"'='";"1010000.0";"nM";"";"Outside typical range";"377910";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3942282";"";"None";"467.40";"0";"4.35";"BDBM214811";"COc1cnc2c(Nc3ccc(F)c([C@]4(CF)C[C@@H](C(F)(F)F)OC(N)=N4)c3)nccc2c1";"IC50";"'>'";"400000.0";"nM";"";"Outside typical range";"377928";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3936327";"";"None";"427.36";"0";"2.76";"BDBM214862";"COc1ccc(C(=O)Nc2cnc(F)c([C@]3(C)C[C@@H](C(F)(F)F)OC(N)=N3)c2)nc1";"IC50";"'>'";"400000.0";"nM";"";"Outside typical range";"377985";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3969602";"";"None";"470.76";"0";"3.60";"BDBM214871";"C[C@@]1(c2cc(NC(=O)c3nn(C(F)F)cc3Cl)cnc2F)C[C@@H](C(F)(F)F)OC(N)=N1";"IC50";"'='";"844000.0";"nM";"";"Outside typical range";"377990";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3972147";"";"None";"540.41";"1";"4.86";"BDBM215028";"Cc1cc(OCC(F)(F)F)cnc1C(=O)Nc1cc(C)c(F)c([C@]2(CF)C[C@@H](C(F)(F)F)OC(N)=N2)c1";"IC50";"'='";"263000.0";"nM";"";"Outside typical range";"378044";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3926258";"";"None";"455.80";"0";"3.88";"BDBM215047";"C[C@@]1(c2cc(NC(=O)c3ccc(C#N)cn3)cc(F)c2Cl)C[C@@H](C(F)(F)F)OC(N)=N1";"IC50";"'='";"131000.0";"nM";"";"Outside typical range";"378086";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL4542566";"";"None";"629.85";"1";"4.20";"(S,R)-3g";"COc1cccc(C(C)(C)NC[C@@H](O)[C@H](Cc2ccccc2)NC(=O)c2cc(C(=O)NCCN(C)C)cc(N3CCCCC3)c2)c1";"IC50";"'='";"4800.0";"nM";"5.32";"";"";"UO_0000065";"8.44";"0.16";"1.12";"5.01";"0";"CHEMBL4331648";"Inhibition of human cathepsin D using DABCYL-Glu-Arg-Nle-Phe-Leu-Ser-Phe-Pro-EDANS as substrate preincubated for 30 mins followed by substrate addition and measured every min for 8 to 15 mins by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4330085";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";"";"";""
"CHEMBL4522288";"";"None";"584.76";"2";"5.06";"(S,R)-4f";"CCCN(CCC)C(=O)c1cc(C#N)cc(C(=O)N[C@@H](Cc2ccccc2)[C@H](O)CNC(C)(C)c2cccc(OC)c2)c1";"IC50";"'='";"560.0";"nM";"6.25";"";"";"UO_0000065";"10.69";"0.20";"1.19";"5.45";"0";"CHEMBL4331648";"Inhibition of human cathepsin D using DABCYL-Glu-Arg-Nle-Phe-Leu-Ser-Phe-Pro-EDANS as substrate preincubated for 30 mins followed by substrate addition and measured every min for 8 to 15 mins by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4330085";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";"";"";""
"CHEMBL4289749";"";"None";"421.84";"0";"3.38";"27";"Cc1cc2c(cn1)Oc1ccc(NC(=O)c3ccc(Cl)cn3)cc1[C@@]21COC(N)=N1";"IC50";"'='";"640000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4262564";"Inhibition of recombinant human CatD using fluorophore/quencher-tagged peptide as substrate pretreated for 60 mins followed by substrate addition and measured after 60 mins by FRET assay";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4261519";"1";"Scientific Literature";"Medchemcomm";"2017";"None";"";"";""
"CHEMBL3693256";"";"None";"371.37";"0";"1.83";"BDBM171816";"COc1cnc(C(=O)Nc2ccc(F)c([C@]3(C)N=C(N)O[C@@H]4C[C@@H]43)c2)cn1";"IC50";"'='";"42800.0";"nM";"4.37";"";"315802";"UO_0000065";"11.76";"0.22";"2.54";"3.91";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3683871";"";"None";"411.77";"0";"2.72";"BDBM171485";"NC1=N[C@@](c2cc(NC(=O)c3ncc(Cl)cn3)ccc2F)(C(F)F)[C@H]2C[C@H]2O1";"IC50";"'='";"2992600.0";"nM";"";"Outside typical range";"315894";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3683875";"";"None";"424.81";"0";"3.63";"BDBM171490";"Cc1cc(NC(=O)c2ccc(Cl)cn2)cc([C@]2(C(F)F)N=C(N)O[C@H]3C[C@H]32)c1F";"IC50";"'='";"1232400.0";"nM";"";"Outside typical range";"315899";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3683883";"";"None";"429.40";"0";"3.16";"BDBM171498";"Cc1cc(C#N)cnc1C(=O)Nc1cc(C)c(F)c([C@@]2(C(F)F)N=C(N)O[C@@H]3C[C@@H]32)c1";"IC50";"'='";"725410.0";"nM";"";"Outside typical range";"315907";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3264802";"";"None";"613.85";"2";"5.56";"6";"CCCN(CCC)C(=O)c1cc(C(=O)N[C@@H](Cc2ccccc2)[C@H](O)CNC(C)(C)c2ccccn2)cc(N2CCCCC2)c1";"IC50";"'='";"350.0";"nM";"6.46";"";"";"UO_0000065";"10.52";"0.20";"0.90";"6.60";"0";"CHEMBL3271470";"Inhibition of human cathepsin-D using DABCYL-Glu-Arg-Nle-Phe-Leu-Ser-Phe-Pro-EDANS as substrate preincubated for 30 mins by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3259525";"1";"Scientific Literature";"ACS Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3683898";"";"None";"432.37";"0";"3.67";"BDBM171515";"NC1=N[C@@](c2cc(NC(=O)c3csc(C(F)F)n3)ccc2F)(C(F)F)[C@H]2C[C@H]2O1";"IC50";"'='";"1703300.0";"nM";"";"Outside typical range";"315924";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3683902";"";"None";"472.83";"0";"3.93";"BDBM171519";"Cc1cc(OC(F)F)cnc1C(=O)Nc1cc(F)c(Cl)c([C@]2(CF)N=C(N)O[C@H]3C[C@H]32)c1";"IC50";"'='";"555420.0";"nM";"";"Outside typical range";"315928";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688697";"";"None";"409.25";"0";"3.54";"BDBM171637";"NC1=N[C@@](CF)(c2cc(NC(=O)c3ccc(Cl)cn3)ccc2Cl)[C@@H]2C[C@@H]2O1";"IC50";"'='";"918190.0";"nM";"";"Outside typical range";"316050";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688710";"";"None";"443.87";"0";"2.68";"BDBM171651";"CC#CCOc1cnc(C(=O)Nc2ccc(Cl)c([C@@]3(CF)N=C(N)O[C@@H]4C[C@@H]43)c2)cn1";"IC50";"'='";"1834700.0";"nM";"";"Outside typical range";"316059";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688713";"";"None";"418.42";"0";"3.79";"BDBM171654";"CC(C)c1cccnc1C(=O)Nc1ccc(F)c([C@@]2(C(F)F)N=C(N)O[C@@H]3C[C@@H]32)c1";"IC50";"'='";"1255700.0";"nM";"";"Outside typical range";"316062";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688714";"";"None";"452.86";"0";"4.44";"BDBM171655";"CC(C)c1cc(Cl)cnc1C(=O)Nc1ccc(F)c([C@@]2(C(F)F)N=C(N)O[C@@H]3C[C@@H]32)c1";"IC50";"'='";"699950.0";"nM";"";"Outside typical range";"316063";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688629";"";"None";"406.82";"0";"3.33";"BDBM171564";"Cc1cc(Cl)cnc1C(=O)Nc1ccc(F)c([C@@]2(CF)N=C(N)O[C@@H]3C[C@@H]32)c1";"IC50";"'='";"348840.0";"nM";"";"Outside typical range";"315973";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688666";"";"None";"443.33";"0";"2.66";"BDBM171604";"NC1=N[C@@](c2cc(NC(=O)c3cnc(OC(F)F)cn3)ccc2F)(C(F)F)[C@H]2C[C@H]2O1";"IC50";"'='";"5917500.0";"nM";"";"Outside typical range";"316013";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL2407492";"";"None";"584.76";"1";"4.52";"23";"CC(C)(C)Cc1cnc2c(c1)[C@@H](NC[C@@H](O)[C@@H]1Cc3cccc(c3)CCCn3cc(ccc3=O)C(=O)N1)CC1(CCC1)O2";"IC50";"'='";"2.0";"nM";"8.70";"";"";"UO_0000065";"14.88";"0.28";"4.18";"8.25";"0";"CHEMBL2411009";"Inhibition of Cathepsin D (unknown origin) by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2406987";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"None";"";"";""
"CHEMBL3688640";"";"None";"472.83";"0";"4.09";"BDBM171575";"Cc1cc(OC(F)F)cnc1C(=O)Nc1ccc(Cl)c(C2(C(F)F)N=C(N)O[C@@H]3C[C@@H]32)c1";"IC50";"'='";"958310.0";"nM";"";"Outside typical range";"315984";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688645";"";"None";"471.69";"0";"3.94";"BDBM171580";"NC1=N[C@@](c2cc(NC(=O)c3ccc(Br)cn3)ccc2Cl)(C(F)F)[C@H]2C[C@H]2O1";"IC50";"'='";"459300.0";"nM";"";"Outside typical range";"315989";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688647";"";"None";"474.82";"0";"4.51";"BDBM171583";"Cc1cc(C(F)(F)F)cnc1C(=O)Nc1ccc(Cl)c([C@@]2(C(F)F)N=C(N)O[C@@H]3C[C@@H]32)c1";"IC50";"'='";"206030.0";"nM";"";"Outside typical range";"315992";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688797";"";"None";"435.88";"0";"4.82";"BDBM171744";"NC1=N[C@@](c2cc(NCC3(c4ccc(Cl)cc4)CC3)ccc2F)(C(F)F)[C@H]2C[C@H]2O1";"IC50";"'='";"63600.0";"nM";"4.20";"";"316144";"UO_0000065";"9.63";"0.19";"-0.62";"7.04";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688799";"";"None";"401.43";"0";"4.24";"BDBM171746";"NC1=N[C@@](c2cc(NC[C@H]3C[C@H]3c3ccccc3)ccc2F)(C(F)F)[C@H]2C[C@H]2O1";"IC50";"'='";"85450.0";"nM";"4.07";"";"316146";"UO_0000065";"10.13";"0.19";"-0.17";"6.82";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3318957";"";"None";"474.65";"0";"2.46";"31";"CCOC[C@@H](CC(C)C)NC(=O)[C@@H]1CNC[C@H](C(=O)N(c2ccc(C(C)C)cn2)C2CC2)[C@@H]1O";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3365830";"Inhibition of human recombinant procathepsin D expressed in SF9 cells using fluorescence-quenched Ac-E-D(EDANS)-KPILFFRLG-K(Dabcyl)-E-Amid substrate by fluorimetric assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3352242";"1";"Scientific Literature";"ACS Med Chem Lett";"2014";"CHEMBL3308860";"";"";""
"CHEMBL3949301";"";"None";"693.93";"2";"3.71";"BDBM232267";"CC[C@H](C)[C@H](NC(=O)C[C@H](N)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)CC(C)C)C(C)C)C(=O)Nc1cccnc1";"IC50";"'='";"520.0";"nM";"6.28";"";"405042";"UO_0000065";"9.06";"0.17";"2.57";"3.41";"0";"CHEMBL3888498";"In-Vitro Fluorescence Assay: In order to identify modulators of cathepsin D activity, a continuous enzymatic test was carried out with a synthetic peptide which carries a fluorescent group (MCA=(7-methoxycoumarin-4-yl)acetyl) which is quenched by energy transfer from a Dpn (2,4 dinitrophenyl) group on the same molecule, in Greiner 384-well nb microtitre plates. Cleavage of the peptidic substrate by cathepsin D causes an increase in the fluorescence intensity. In order to determine the efficacy of substances, the time-dependent increase in the fluorescence intensity in the presence of the substance was compared with the time-dependent increase in fluorescence in the absence of substances. The reference substance used was pepstatin A (Sigma-Aldrich). The substrate used was MCAGKPILFFRLK(Dnp)d-R-NH2 (Enzo Life Sciences, Lorrach). The enzyme employed was cathepsin D isolated from the human liver (Sigma-Aldrich) in a final concentration of 1.4 nM. The test was carried out in 100 mM sodium acetate buffer, 1.25% (v/v) of DMSO, 0.25% (w/v) of Chaps, pH 5.5. 2 ul of each substance solution with serially diluted substance concentration were added to in each case 4 ul of cathepsin D solution and incubated at room temperature for 10 min. The reaction was started by addition of 2 ul of substrate solution (final concentration 5 uM). After carrying out a starting-point fluorescence measurement (excitation wavelength 340 nm/emission wavelength 450 nm) using an Envision multilabel reader (Perkin Elmer), the reaction was incubated at room temperature for 60 min. The amount of peptide fragment cleaved off during the reaction time was subsequently measured by determination of the increase in the fluorescence intensity at 450 nm (excitation wavelength 340 nm).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886733";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3688821";"";"None";"429.84";"0";"2.77";"BDBM171771";"COc1cc(C#N)cnc1C(=O)Nc1ccc(Cl)c([C@@]2(CF)N=C(N)O[C@@H]3C[C@@H]32)c1";"IC50";"'>'";"400000.0";"nM";"";"Outside typical range";"316170";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3693240";"";"None";"470.89";"0";"2.43";"BDBM171799";"CS(=O)(=O)c1c(F)cc(NC(=O)c2ccc(Cl)cn2)cc1[C@@]1(CF)N=C(N)O[C@@H]2C[C@@H]21";"IC50";"'='";"831860.0";"nM";"";"Outside typical range";"316195";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3683828";"";"None";"407.35";"0";"2.07";"BDBM171438";"COc1cnc(C(=O)Nc2ccc(F)c([C@@]3(C(F)F)N=C(N)O[C@@H]4C[C@@H]43)c2)cn1";"IC50";"'='";"1112300.0";"nM";"";"Outside typical range";"315847";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3683854";"";"None";"422.82";"0";"3.19";"BDBM171466";"COc1ccc(C(=O)Nc2ccc(Cl)c([C@@]3(C(F)F)N=C(N)O[C@@H]4C[C@@H]43)c2)nc1";"IC50";"'='";"190500.0";"nM";"";"Outside typical range";"315875";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3683855";"";"None";"436.85";"0";"3.50";"BDBM171467";"COc1cnc(C(=O)Nc2ccc(Cl)c([C@@]3(C(F)F)N=C(N)O[C@@H]4C[C@@H]43)c2)c(C)c1";"IC50";"'='";"258460.0";"nM";"";"Outside typical range";"315876";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3683879";"";"None";"453.30";"0";"3.69";"BDBM171494";"COCc1cc(Cl)cnc1C(=O)Nc1ccc(Cl)c([C@@]2(CF)N=C(N)O[C@@H]3C[C@@H]32)c1";"IC50";"'='";"1001600.0";"nM";"";"Outside typical range";"315903";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3683913";"";"None";"474.40";"0";"2.63";"BDBM171533";"NC1=N[C@@](c2cc(NC(=O)c3cnc(OCc4ncco4)cn3)ccc2F)(C(F)F)[C@H]2C[C@H]2O1";"IC50";"'='";"767260.0";"nM";"";"Outside typical range";"315942";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688641";"";"None";"461.86";"0";"2.98";"BDBM171576";"CC#CCOc1cnc(C(=O)Nc2ccc(Cl)c([C@]3(C(F)F)N=C(N)O[C@H]4C[C@H]43)c2)cn1";"IC50";"'='";"569430.0";"nM";"";"Outside typical range";"315985";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688643";"";"None";"472.83";"0";"4.09";"BDBM171578";"Cc1cc(OC(F)F)cnc1C(=O)Nc1ccc(Cl)c([C@@]2(C(F)F)N=C(N)O[C@@H]3C[C@@H]32)c1";"IC50";"'='";"928320.0";"nM";"";"Outside typical range";"315987";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688641";"";"None";"461.86";"0";"2.98";"BDBM171576";"CC#CCOc1cnc(C(=O)Nc2ccc(Cl)c([C@]3(C(F)F)N=C(N)O[C@H]4C[C@H]43)c2)cn1";"IC50";"'='";"500140.0";"nM";"";"Outside typical range";"315991";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688688";"";"None";"339.32";"0";"2.37";"BDBM171626";"NC1=N[C@@](c2cc(NC(=O)C3CC3)ccc2F)(C(F)F)[C@H]2C[C@H]2O1";"IC50";"'='";"103950.0";"nM";"";"Outside typical range";"316035";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688701";"";"None";"453.70";"0";"3.65";"BDBM171641";"NC1=N[C@@](CF)(c2cc(NC(=O)c3ccc(Br)cn3)ccc2Cl)[C@@H]2C[C@@H]2O1";"IC50";"'='";"1129800.0";"nM";"";"Outside typical range";"316049";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3693225";"";"None";"481.45";"0";"4.61";"BDBM171783";"NC1=N[C@@](c2cc(Nc3ncc(F)c4cc(C#CC5CC5)cnc34)ccc2F)(C(F)F)[C@H]2C[C@H]2O1";"IC50";"'='";"346950.0";"nM";"";"Outside typical range";"316180";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3321932";"";"None";"548.65";"1";"2.72";"31";"COc1ccc(CC(=O)NC(=N)N[C@H](CC2CCCCC2)C(=O)NCc2cccc(-c3nnn[nH]3)c2)cc1OC";"IC50";"'='";"92.0";"nM";"7.04";"";"";"UO_0000065";"12.82";"0.24";"4.32";"4.21";"0";"CHEMBL3371146";"Inhibition of human liver cathepsin D using MCA-labeled GKPILFFRLK(Dnp)-D-R-NH2 peptide by fluorescence-based assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351526";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3321921";"";"None";"341.41";"0";"2.48";"13";"COc1ccc(CCC(=O)NC(=N)NCc2ccccc2)cc1OC";"IC50";"'='";"25000.0";"nM";"4.60";"";"";"UO_0000065";"13.48";"0.25";"2.12";"5.52";"0";"CHEMBL3371146";"Inhibition of human liver cathepsin D using MCA-labeled GKPILFFRLK(Dnp)-D-R-NH2 peptide by fluorescence-based assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351526";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3321935";"";"None";"508.58";"1";"1.80";"34";"COc1ccc(CC(=O)NC(=N)N[C@H](CC(C)C)C(=O)NCc2cccc(-c3nnn[nH]3)c2)cc1OC";"IC50";"'='";"370.0";"nM";"6.43";"";"";"UO_0000065";"12.65";"0.24";"4.63";"3.85";"0";"CHEMBL3371146";"Inhibition of human liver cathepsin D using MCA-labeled GKPILFFRLK(Dnp)-D-R-NH2 peptide by fluorescence-based assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351526";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL4475791";"";"None";"614.83";"2";"5.39";"(S,R)-2a";"CCN(CC)C(=O)c1cc(C(=O)N[C@@H](Cc2ccccc2)[C@H](O)CNC(C)(C)c2cccc(OC)c2)cc(N2CCCCC2)c1";"IC50";"'='";"250.0";"nM";"6.60";"";"";"UO_0000065";"10.74";"0.20";"1.21";"7.01";"0";"CHEMBL4331648";"Inhibition of human cathepsin D using DABCYL-Glu-Arg-Nle-Phe-Leu-Ser-Phe-Pro-EDANS as substrate preincubated for 30 mins followed by substrate addition and measured every min for 8 to 15 mins by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4330085";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";"";"";""
"CHEMBL3264805";"";"None";"643.87";"2";"5.57";"9";"CCCN(CCC)C(=O)c1cc(C(=O)N[C@@H](Cc2ccccc2)[C@H](O)CNC(C)(C)c2cncc(OC)c2)cc(N2CCCCC2)c1";"IC50";"'='";"68.0";"nM";"7.17";"";"";"UO_0000065";"11.13";"0.21";"1.60";"6.70";"0";"CHEMBL3271470";"Inhibition of human cathepsin-D using DABCYL-Glu-Arg-Nle-Phe-Leu-Ser-Phe-Pro-EDANS as substrate preincubated for 30 mins by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3259525";"1";"Scientific Literature";"ACS Med Chem Lett";"2014";"None";"";"";""
"CHEMBL581498";"";"None";"664.87";"1";"4.38";"10";"CCCN(CCC)C(=O)c1cc(C(=O)N[C@@H](Cc2ccccc2)[C@H](O)CNCc2cccc(OC)c2)cc(N2CCCCS2(=O)=O)c1";"IC50";"'='";"360.0";"nM";"6.44";"";"";"UO_0000065";"9.69";"0.19";"2.06";"5.02";"0";"CHEMBL3271470";"Inhibition of human cathepsin-D using DABCYL-Glu-Arg-Nle-Phe-Leu-Ser-Phe-Pro-EDANS as substrate preincubated for 30 mins by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3259525";"1";"Scientific Literature";"ACS Med Chem Lett";"2014";"None";"";"";""
"CHEMBL4778127";"";"None";"710.60";"1";"4.71";"2a";"Cc1ccc(S(=O)(=O)N(C)C)cc1NC(=O)[C@@H](CC1CCCCC1)NC(=N)NC(=O)Cc1ccc(Cl)c(Cl)c1.O=C(O)C(F)(F)F";"IC50";"'='";"70.0";"nM";"7.16";"";"";"UO_0000065";"11.99";"0.25";"2.44";"5.44";"0";"CHEMBL4706202";"Inhibition of human liver Cathepsin D preincubated for 10 mins followed by substrate addition and further incubated for 2 hrs in dark by fluorimetric analysis";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699662";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"TIME = 2.167 hr";"INHIBITOR";""
"CHEMBL4754691";"";"None";"687.74";"1";"3.08";"4b";"CNS(=O)(=O)c1ccc(C)c(NC(=O)[C@@H](CC2CCCCC2)NC(=N)NC(=O)Cc2ccc(OC)c(OC)c2)c1.O=C(O)C(F)(F)F";"IC50";"'='";"4.0";"nM";"8.40";"";"";"UO_0000065";"14.64";"0.29";"5.32";"5.29";"0";"CHEMBL4706202";"Inhibition of human liver Cathepsin D preincubated for 10 mins followed by substrate addition and further incubated for 2 hrs in dark by fluorimetric analysis";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699662";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"TIME = 2.167 hr";"INHIBITOR";""
"CHEMBL4783048";"";"None";"673.71";"1";"2.82";"10b";"COc1ccc(CC(=O)NC(=N)N[C@H](CC2CCCCC2)C(=O)Nc2cc(S(N)(=O)=O)ccc2C)cc1OC.O=C(O)C(F)(F)F";"IC50";"'='";"7.0";"nM";"8.15";"";"";"UO_0000065";"14.57";"0.29";"5.33";"4.72";"0";"CHEMBL4706202";"Inhibition of human liver Cathepsin D preincubated for 10 mins followed by substrate addition and further incubated for 2 hrs in dark by fluorimetric analysis";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699662";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"TIME = 2.167 hr";"INHIBITOR";""
"CHEMBL4781877";"";"None";"591.57";"0";"0.87";"18e";"COc1ccc(CC(=O)NC(=N)N[C@H](C)C(=O)Nc2cc(S(N)(=O)=O)ccc2C)cc1OC.O=C(O)C(F)(F)F";"IC50";"'='";"6553.0";"nM";"5.18";"";"";"UO_0000065";"10.85";"0.21";"4.31";"3.00";"0";"CHEMBL4706202";"Inhibition of human liver Cathepsin D preincubated for 10 mins followed by substrate addition and further incubated for 2 hrs in dark by fluorimetric analysis";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699662";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"TIME = 2.167 hr";"INHIBITOR";""
"CHEMBL121769";"";"None";"181.15";"0";"0.20";"75";"NNC(=O)c1ccccc1[N+](=O)[O-]";"IC50";"'='";"1300.0";"nM";"5.89";"";"";"UO_0000065";"32.49";"0.62";"5.69";"5.99";"0";"CHEMBL4357658";"Inhibition of human cathepsin D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4354841";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";""
"CHEMBL3683857";"";"None";"407.35";"0";"2.07";"BDBM171469";"COc1cnc(C(=O)Nc2ccc(F)c([C@@]3(C(F)F)N=C(N)O[C@@H]4C[C@@H]43)c2)nc1";"IC50";"'='";"762630.0";"nM";"";"Outside typical range";"315878";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3683859";"";"None";"393.78";"0";"2.42";"BDBM171471";"NC1=N[C@@](CF)(c2nc(NC(=O)c3ccc(Cl)cn3)ccc2F)[C@@H]2C[C@@H]2O1";"IC50";"'='";"1616000.0";"nM";"";"Outside typical range";"315880";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3683862";"";"None";"428.77";"0";"3.46";"BDBM171474";"NC1=N[C@](c2cc(NC(=O)c3ccc(Cl)cn3)cc(F)c2F)(C(F)F)[C@@H]2C[C@@H]2O1";"IC50";"'='";"471870.0";"nM";"";"Outside typical range";"315883";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3683791";"";"None";"424.81";"0";"3.63";"BDBM171396";"Cc1cc(NC(=O)c2ccc(Cl)cn2)cc([C@@]2(C(F)F)N=C(N)O[C@@H]3C[C@@H]32)c1F";"IC50";"'='";"257250.0";"nM";"";"Outside typical range";"315898";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3683881";"";"None";"406.36";"0";"2.68";"BDBM171496";"COc1ccc(C(=O)Nc2ccc(F)c([C@@]3(C(F)F)N=C(N)O[C@@H]4C[C@@H]43)c2)nc1";"IC50";"'='";"987710.0";"nM";"";"Outside typical range";"315905";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3683906";"";"None";"505.83";"1";"3.67";"BDBM171525";"Cc1nc(OCC(F)(F)F)cnc1C(=O)Nc1cc(F)c(Cl)c([C@]2(CF)N=C(N)O[C@H]3C[C@H]32)c1";"IC50";"'='";"2001400.0";"nM";"";"Outside typical range";"315935";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3683908";"";"None";"445.40";"0";"2.46";"BDBM171528";"C#C[C@H](C)Oc1cnc(C(=O)Nc2ccc(F)c([C@@]3(C(F)F)N=C(N)O[C@@H]4C[C@@H]43)c2)cn1";"IC50";"'='";"1063500.0";"nM";"";"Outside typical range";"315937";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3683909";"";"None";"449.77";"0";"3.52";"BDBM171529";"NC1=N[C@@](c2cc(NC(=O)c3nn(C(F)F)cc3Cl)ccc2F)(C(F)F)[C@H]2C[C@H]2O1";"IC50";"'='";"464440.0";"nM";"";"Outside typical range";"315938";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3683912";"";"None";"380.33";"0";"2.57";"BDBM171532";"Cc1nc(C(=O)Nc2ccc(F)c([C@@]3(C(F)F)N=C(N)O[C@@H]4C[C@@H]43)c2)co1";"IC50";"'='";"372960.0";"nM";"";"Outside typical range";"315941";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL4061602";"";"None";"367.39";"0";"3.67";"6n";"C[C@@H](NCc1cc([C@]2(C)CCSC(N)=N2)c(F)cc1F)C(F)(F)F";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4042703";"Inhibition of Cathepsin D (unknown origin) by cell free assay";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4041533";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";"";""
"CHEMBL4777223";"";"None";"472.54";"0";"0.89";"4; PF-00835231";"COc1cccc2[nH]c(C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C[C@@H]3CCNC3=O)C(=O)CO)cc12";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4703747";"Inhibition of human cathepsin D";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699574";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";""
"CHEMBL3683815";"";"None";"410.78";"0";"3.32";"BDBM171421";"NC1=N[C@](c2cc(NC(=O)c3ccc(Cl)cn3)ccc2F)(C(F)F)[C@@H]2C[C@@H]2O1";"IC50";"'='";"859980.0";"nM";"";"Outside typical range";"315830";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3683836";"";"None";"401.40";"0";"1.45";"BDBM171446";"COC[C@]1(c2cc(NC(=O)c3cnc(OC)cn3)ccc2F)N=C(N)O[C@@H]2C[C@@H]21";"IC50";"'>'";"400000.0";"nM";"";"Outside typical range";"315855";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3683847";"";"None";"431.83";"0";"3.20";"BDBM171457";"Cc1cc(C#N)cnc1C(=O)Nc1cc(Cl)c(F)c([C@@]2(CF)N=C(N)O[C@@H]3C[C@@H]32)c1";"IC50";"'='";"260000.0";"nM";"";"Outside typical range";"315866";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3683860";"";"None";"393.78";"0";"2.42";"BDBM171472";"NC1=N[C@](CF)(c2nc(NC(=O)c3ccc(Cl)cn3)ccc2F)[C@H]2C[C@H]2O1";"IC50";"'='";"216000.0";"nM";"";"Outside typical range";"315881";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3321938";"";"None";"526.57";"1";"1.94";"37";"COc1ccc(CC(=O)NC(=N)N[C@H](CC(C)C)C(=O)NCc2ccc(-c3nnn[nH]3)c(F)c2)cc1OC";"IC50";"'='";"690.0";"nM";"6.16";"";"";"UO_0000065";"11.70";"0.22";"4.22";"3.69";"0";"CHEMBL3371146";"Inhibition of human liver cathepsin D using MCA-labeled GKPILFFRLK(Dnp)-D-R-NH2 peptide by fluorescence-based assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351526";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL68595";"";"None";"489.62";"1";"5.64";"3";"CCCc1c(OCc2ccc(/C=C3\SC(=S)NC3=O)cc2)ccc(C(=O)c2ccccc2)c1O";"IC50";"'='";"210.0";"nM";"6.68";"";"";"UO_0000065";"13.64";"0.27";"1.04";"8.83";"0";"CHEMBL3371144";"Inhibition of cathepsin D (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351526";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3903132";"";"None";"521.55";"1";"4.61";"BDBM220853";"NC1=NC2(CCS1)c1cc(NC(=O)c3ccc(F)cn3)ccc1Oc1c2cc(C2=CCOCC2)nc1F";"IC50";"'='";"210700.0";"nM";"";"Outside typical range";"386539";"UO_0000065";"";"";"";"";"0";"CHEMBL3888270";"Fluorescence Resonance Energy Transfer (FRET) Assay: Recombinant CathepsinD was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The CathepsinD enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for CathepsinD) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886633";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3915529";"";"None";"498.45";"0";"4.59";"BDBM214998";"Cc1cc(OCC2CC2)cnc1C(=O)Nc1cc(F)c(F)c([C@]2(C)C[C@@H](C(F)(F)F)OC(N)=N2)c1";"IC50";"'='";"510800.0";"nM";"";"Outside typical range";"378064";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3683876";"";"None";"456.83";"0";"4.21";"BDBM171491";"Cc1cc(C(F)(F)F)cnc1C(=O)Nc1ccc(Cl)c([C@@]2(CF)N=C(N)O[C@@H]3C[C@@H]32)c1";"IC50";"'>'";"400000.0";"nM";"";"Outside typical range";"315900";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3683897";"";"None";"445.40";"0";"2.46";"BDBM171514";"C#C[C@@H](C)Oc1cnc(C(=O)Nc2ccc(F)c([C@@]3(C(F)F)N=C(N)O[C@@H]4C[C@@H]43)c2)cn1";"IC50";"'='";"848580.0";"nM";"";"Outside typical range";"315923";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688644";"";"None";"472.83";"0";"4.09";"BDBM171579";"Cc1cc(OC(F)F)cnc1C(=O)Nc1ccc(Cl)c([C@]2(C(F)F)N=C(N)O[C@H]3C[C@H]32)c1";"IC50";"'='";"1128000.0";"nM";"";"Outside typical range";"315988";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688653";"";"None";"466.22";"0";"4.03";"BDBM171590";"NC1=N[C@@](c2cc(NC(=O)c3nn(C(F)F)cc3Cl)ccc2Cl)(C(F)F)[C@H]2C[C@H]2O1";"IC50";"'='";"509920.0";"nM";"";"Outside typical range";"315999";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688654";"";"None";"423.81";"0";"2.58";"BDBM171592";"COc1cnc(C(=O)Nc2ccc(Cl)c([C@@]3(C(F)F)N=C(N)O[C@@H]4C[C@@H]43)c2)cn1";"IC50";"'='";"363000.0";"nM";"";"Outside typical range";"316001";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688728";"";"None";"420.39";"0";"2.98";"BDBM171670";"COc1ccc(C(=O)Nc2cc(C)c(F)c([C@@]3(C(F)F)N=C(N)O[C@@H]4C[C@@H]43)c2)nc1";"IC50";"'='";"354980.0";"nM";"";"Outside typical range";"316078";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3961455";"";"None";"463.41";"1";"5.51";"BDBM214903";"NC1=N[C@](CF)(c2cc(Oc3cc(-c4ccccc4)ccn3)ccc2F)C[C@@H](C(F)(F)F)O1";"IC50";"'='";"114000.0";"nM";"";"Outside typical range";"377914";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3971064";"";"None";"467.51";"None";"None";"BDBM214912";"C[Si](C)(C)C#Cc1ccc(-c2ccc(F)c([C@]3(CF)C[C@@H](C(F)(F)F)OC(N)=N3)c2)cn1";"IC50";"'>'";"400000.0";"nM";"";"Outside typical range";"377936";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3972722";"";"None";"411.33";"0";"3.67";"BDBM214823";"N#Cc1cc(Nc2ccc(F)c([C@]3(CF)C[C@@H](C(F)(F)F)OC(N)=N3)c2)ccn1";"IC50";"'='";"1760000.0";"nM";"";"Outside typical range";"377952";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3930384";"";"None";"494.37";"0";"4.21";"BDBM214842";"Cc1cc(OC(F)F)cnc1C(=O)Nc1ccc(F)c([C@]2(CF)C[C@@H](C(F)(F)F)OC(N)=N2)c1";"IC50";"'>'";"400000.0";"nM";"";"Outside typical range";"377963";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3908041";"";"None";"501.45";"1";"3.55";"BDBM220804";"NC1=NC2(CCO1)c1cc(NC(=O)c3cnc(F)cn3)ccc1Oc1c2cc(-c2cccnc2)nc1F";"IC50";"'='";"357900.0";"nM";"";"Outside typical range";"386490";"UO_0000065";"";"";"";"";"0";"CHEMBL3888270";"Fluorescence Resonance Energy Transfer (FRET) Assay: Recombinant CathepsinD was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The CathepsinD enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for CathepsinD) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886633";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3344154";"";"None";"639.72";"2";"-0.01";"13";"CC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)[C@@H](O)CC(=O)NC1CCCCC1.O=C(O)C(F)(F)F";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3370435";"Inhibition of human cathepsin D assessed as cleavage of wtKAHRP fluorogenic substrate";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3352063";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL3344156";"";"None";"626.24";"2";"2.65";"18";"CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)OCc1ccccc1)[C@@H](O)CC(=O)NC1CCCCC1.Cl";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3370435";"Inhibition of human cathepsin D assessed as cleavage of wtKAHRP fluorogenic substrate";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3352063";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL3344162";"";"None";"765.83";"2";"1.98";"35";"C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)OCc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)[C@@H](O)CC(=O)NC1CCCCC1.O=C(O)C(F)(F)F";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL3370435";"Inhibition of human cathepsin D assessed as cleavage of wtKAHRP fluorogenic substrate";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3352063";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";""
"CHEMBL4580614";"";"None";"540.79";"2";"8.25";"46";"CCCCCc1ccc(C(=O)N(Cc2ccc(-c3ccc(OC)cc3)cc2)C2CCN(CCC(C)C)CC2)cc1";"IC50";"'='";"4400.0";"nM";"5.36";"";"";"UO_0000065";"9.91";"0.18";"-2.89";"16.34";"0";"CHEMBL4357658";"Inhibition of human cathepsin D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4354841";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";""
"CHEMBL3951561";"";"None";"478.81";"0";"3.97";"BDBM214846";"COc1cc(Cl)cnc1C(=O)Nc1ccc(F)c([C@]2(CF)C[C@@H](C(F)(F)F)OC(N)=N2)c1";"IC50";"'>'";"400000.0";"nM";"";"Outside typical range";"377863";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3903960";"";"None";"480.37";"0";"4.35";"BDBM214809";"N#Cc1cnc2c(Nc3ccc(F)c([C@]4(CF)C[C@@H](C(F)(F)F)OC(N)=N4)c3)ncc(F)c2c1";"IC50";"'>'";"44000.0";"nM";"";"";"377869";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3892989";"";"None";"445.38";"0";"3.66";"BDBM214876";"C[C@@]1(c2cc(Nc3nccc4cc(C#N)cnc34)cnc2F)C[C@@H](C(F)(F)F)OC(N)=N1";"IC50";"'>'";"400000.0";"nM";"";"Outside typical range";"377883";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3945149";"";"None";"456.79";"0";"3.27";"BDBM214881";"C[C@@]1(c2nc(NC(=O)c3ncc(C#N)cc3Cl)ccc2F)C[C@@H](C(F)(F)F)OC(N)=N1";"IC50";"'>'";"400000.0";"nM";"";"Outside typical range";"377891";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3923494";"";"None";"432.32";"0";"3.44";"BDBM214856";"NC1=N[C@](CF)(c2cc(NC(=O)c3ccc(F)cn3)ccc2F)C[C@@H](C(F)(F)F)O1";"IC50";"'='";"4060000.0";"nM";"";"Outside typical range";"377892";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3926112";"";"None";"436.37";"0";"2.93";"BDBM214883";"Cc1cc(C#N)cnc1C(=O)Nc1ccc(F)c([C@]2(C)C[C@@H](C(F)(F)F)OC(N)=N2)n1";"IC50";"'='";"900000.0";"nM";"";"Outside typical range";"377895";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3956399";"";"None";"405.30";"0";"3.98";"BDBM214895";"NC1=N[C@](CF)(c2cc(Oc3ncccc3F)ccc2F)C[C@@H](C(F)(F)F)O1";"IC50";"'='";"2220000.0";"nM";"";"Outside typical range";"377903";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3950109";"";"None";"509.69";"1";"4.77";"BDBM215021";"C[C@@]1(c2cc(NC(=O)c3ccc(Br)cn3)cc(Cl)c2F)C[C@@H](C(F)(F)F)OC(N)=N1";"IC50";"'='";"739000.0";"nM";"";"Outside typical range";"378081";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3933312";"";"None";"475.83";"0";"3.72";"BDBM215023";"COc1cnc(C(=O)Nc2cc(Cl)c(F)c([C@]3(C)C[C@@H](C(F)(F)F)OC(N)=N3)c2)c(C)n1";"IC50";"'>'";"400000.0";"nM";"";"Outside typical range";"378082";"UO_0000065";"";"";"";"";"0";"CHEMBL3888177";"In Vitro Enzymatic Cathepsin D FRET Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p 379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886610";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3688729";"";"None";"434.42";"0";"3.29";"BDBM171671";"COc1cnc(C(=O)Nc2cc(C)c(F)c([C@@]3(C(F)F)N=C(N)O[C@@H]4C[C@@H]43)c2)c(C)c1";"IC50";"'='";"287990.0";"nM";"";"Outside typical range";"316079";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL4751432";"";"None";"705.78";"1";"2.47";"8d";"CNS(=O)(=O)c1ccc(C)c(NC(=O)[C@@H](CC2CCCCC2)NC(=N)NC(=O)Cc2ccc(S(C)(=O)=O)cc2)c1.O=C(O)C(F)(F)F";"IC50";"'='";"25.0";"nM";"7.60";"";"";"UO_0000065";"12.85";"0.26";"5.13";"4.36";"0";"CHEMBL4706202";"Inhibition of human liver Cathepsin D preincubated for 10 mins followed by substrate addition and further incubated for 2 hrs in dark by fluorimetric analysis";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699662";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"TIME = 2.167 hr";"INHIBITOR";""
"CHEMBL4781123";"";"None";"605.59";"0";"1.26";"17e";"CC[C@@H](NC(=N)NC(=O)Cc1ccc(OC)c(OC)c1)C(=O)Nc1cc(S(N)(=O)=O)ccc1C.O=C(O)C(F)(F)F";"IC50";"'='";"375.0";"nM";"6.43";"";"";"UO_0000065";"13.07";"0.26";"5.17";"3.72";"0";"CHEMBL4706202";"Inhibition of human liver Cathepsin D preincubated for 10 mins followed by substrate addition and further incubated for 2 hrs in dark by fluorimetric analysis";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699662";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"TIME = 2.167 hr";"INHIBITOR";""
"CHEMBL3670367";"";"None";"525.39";"1";"2.71";"18";"C[C@@]1(c2nc(NC(=O)c3ncc(OCC(F)(F)F)nc3N)ccc2F)CO[C@@](C)(C(F)(F)F)C(N)=N1";"IC50";"'='";"106000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5054673";"Inhibition of human Cathepsin D using Mca-GKPILFFRLK(DNP)D-R-NH2 as a substrate";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5053529";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL4227074";"";"None";"511.62";"2";"5.92";"7a";"CCCCCc1ccc(-c2cc(-c3ccc(C(=O)O)cc3)c3c(=O)n(CC4CCCO4)c(N)nc3c2)cc1";"IC50";"'='";"29000.0";"nM";"4.54";"";"";"UO_0000065";"8.87";"0.16";"-1.38";"4.22";"0";"CHEMBL4223547";"Inhibition of human cathepsin D using DABCYL-Glu-Arg-Nle-Phe-Leu-Ser-Phe-Pro-EDANS as substrate preincubated for 30 mins followed by substrate addition measured every 1 min within 8 to 15 mins by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4219216";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";"";""
"CHEMBL4750485";"";"None";"637.66";"1";"1.21";"20e";"COc1ccc(CC(=O)NC(=N)N[C@H](CSC)C(=O)Nc2cc(S(N)(=O)=O)ccc2C)cc1OC.O=C(O)C(F)(F)F";"IC50";"'='";"2532.0";"nM";"5.60";"";"";"UO_0000065";"10.69";"0.22";"4.39";"3.24";"0";"CHEMBL4706202";"Inhibition of human liver Cathepsin D preincubated for 10 mins followed by substrate addition and further incubated for 2 hrs in dark by fluorimetric analysis";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699662";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"TIME = 2.167 hr";"INHIBITOR";""
"CHEMBL3264808";"";"None";"612.81";"2";"5.15";"14";"COc1cccc(C(C)(C)NC[C@@H](O)[C@H](Cc2ccccc2)NC(=O)c2cc(C(=O)N3CCCC3)cc(N3CCCCC3)c2)c1";"IC50";"'='";"38.0";"nM";"7.42";"";"";"UO_0000065";"12.11";"0.23";"2.27";"7.88";"0";"CHEMBL3271470";"Inhibition of human cathepsin-D using DABCYL-Glu-Arg-Nle-Phe-Leu-Ser-Phe-Pro-EDANS as substrate preincubated for 30 mins by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3259525";"1";"Scientific Literature";"ACS Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3264810";"";"None";"641.90";"2";"7.23";"16";"CCCN(CCC)C(=O)c1cc(C(=O)N[C@@H](Cc2ccccc2)[C@H](O)CNC(C)(C)c2cccc(OC)c2)cc(C2CCCCC2)c1";"IC50";"'='";"19.0";"nM";"7.72";"";"";"UO_0000065";"12.03";"0.22";"0.49";"8.49";"0";"CHEMBL3271470";"Inhibition of human cathepsin-D using DABCYL-Glu-Arg-Nle-Phe-Leu-Ser-Phe-Pro-EDANS as substrate preincubated for 30 mins by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3259525";"1";"Scientific Literature";"ACS Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3264811";"";"None";"628.86";"2";"5.78";"17";"CCCN(CCC)C(=O)c1cc(C(=O)N[C@@H](Cc2ccccc2)[C@H](O)CNC(C)(C)c2cccc(OC)c2)cc(N2CCCC2)c1";"IC50";"'='";"32.0";"nM";"7.50";"";"";"UO_0000065";"11.92";"0.22";"1.71";"7.96";"0";"CHEMBL3271470";"Inhibition of human cathepsin-D using DABCYL-Glu-Arg-Nle-Phe-Leu-Ser-Phe-Pro-EDANS as substrate preincubated for 30 mins by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3259525";"1";"Scientific Literature";"ACS Med Chem Lett";"2014";"None";"";"";""
"CHEMBL2396989";"LY-2886721";"1.0";"390.42";"0";"2.52";"LY2886721; 2";"NC1=N[C@@]2(c3cc(NC(=O)c4ccc(F)cn4)ccc3F)COC[C@H]2CS1";"IC50";"'>'";"300000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"1";"CHEMBL5034187";"Inhibition of human Cathepsin D by FRET assay";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5033995";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"";""
"CHEMBL4873384";"";"None";"385.25";"0";"1.63";"(R)-18";"O=C1NC(=O)[C@@H](CCC(=O)N2CCN(c3cc(Cl)cc(Cl)c3)CC2)N1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4835182";"Inhibition of Cathepsin D (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4834410";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"";""
"CHEMBL2407491";"";"None";"598.79";"1";"4.91";"22";"CC(C)(C)Cc1cnc2c(c1)[C@@H](NC[C@@H](O)[C@@H]1Cc3cccc(c3)CCCCn3cc(ccc3=O)C(=O)N1)CC1(CCC1)O2";"IC50";"'<'";"2.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2411009";"Inhibition of Cathepsin D (unknown origin) by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2406987";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"None";"";"";""
"CHEMBL3941301";"";"None";"420.52";"0";"1.88";"66";"COc1cnc(C(=O)Nc2csc([C@]34CO[C@@H](C)C[C@H]3CSC(N)=N4)n2)cn1";"IC50";"'>'";"96700.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4183115";"Inhibition of Cathepsin D (unknown origin) by fluorescence polarization assay";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4177751";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4796144";"";"None";"685.65";"1";"2.23";"2e";"COc1ccc(CC(=O)NC(=N)N[C@H](Cc2ccccc2F)C(=O)Nc2cc(S(N)(=O)=O)ccc2C)cc1OC.O=C(O)C(F)(F)F";"IC50";"'='";"225.0";"nM";"6.65";"";"";"UO_0000065";"11.63";"0.23";"4.42";"3.85";"0";"CHEMBL4706202";"Inhibition of human liver Cathepsin D preincubated for 10 mins followed by substrate addition and further incubated for 2 hrs in dark by fluorimetric analysis";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699662";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"TIME = 2.167 hr";"INHIBITOR";""
"CHEMBL4746215";"";"None";"676.67";"1";"0.18";"6e";"COc1ccc(CC(=O)NC(=N)N[C@H](CN2CCOCC2)C(=O)Nc2cc(S(N)(=O)=O)ccc2C)cc1OC.O=C(O)C(F)(F)F";"IC50";"'='";"2593.0";"nM";"5.59";"";"";"UO_0000065";"9.93";"0.20";"5.41";"3.02";"0";"CHEMBL4706202";"Inhibition of human liver Cathepsin D preincubated for 10 mins followed by substrate addition and further incubated for 2 hrs in dark by fluorimetric analysis";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699662";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"TIME = 2.167 hr";"INHIBITOR";""
"CHEMBL4741742";"";"None";"633.65";"1";"1.90";"14e";"COc1ccc(CC(=O)NC(=N)N[C@@H](C(=O)Nc2cc(S(N)(=O)=O)ccc2C)C(C)(C)C)cc1OC.O=C(O)C(F)(F)F";"IC50";"'='";"212.0";"nM";"6.67";"";"";"UO_0000065";"12.84";"0.25";"4.77";"3.86";"0";"CHEMBL4706202";"Inhibition of human liver Cathepsin D preincubated for 10 mins followed by substrate addition and further incubated for 2 hrs in dark by fluorimetric analysis";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699662";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"TIME = 2.167 hr";"INHIBITOR";""
"CHEMBL4794632";"";"None";"633.65";"1";"2.04";"15e";"CCCC[C@@H](NC(=N)NC(=O)Cc1ccc(OC)c(OC)c1)C(=O)Nc1cc(S(N)(=O)=O)ccc1C.O=C(O)C(F)(F)F";"IC50";"'='";"8.0";"nM";"8.10";"";"";"UO_0000065";"15.58";"0.31";"6.06";"4.69";"0";"CHEMBL4706202";"Inhibition of human liver Cathepsin D preincubated for 10 mins followed by substrate addition and further incubated for 2 hrs in dark by fluorimetric analysis";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699662";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"TIME = 2.167 hr";"INHIBITOR";""
"CHEMBL4794580";"";"None";"765.83";"1";"2.90";"9b";"COc1ccc(CC(=O)NC(=N)N[C@H](CC2CCCCC2)C(=O)Nc2cc(N(S(C)(=O)=O)S(C)(=O)=O)ccc2C)cc1OC.O=C(O)C(F)(F)F";"IC50";"'='";"15.0";"nM";"7.82";"";"";"UO_0000065";"12.00";"0.24";"4.92";"4.25";"0";"CHEMBL4706202";"Inhibition of human liver Cathepsin D preincubated for 10 mins followed by substrate addition and further incubated for 2 hrs in dark by fluorimetric analysis";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699662";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"TIME = 2.167 hr";"INHIBITOR";""
"CHEMBL4518375";"";"None";"517.67";"1";"4.87";"71";"O=C(Cc1ccccc1)N(Cc1ccccc1)C1CNCC1N(Cc1ccccc1)C(=O)Cc1ccccc1";"IC50";"'='";"18300.0";"nM";"4.74";"";"";"UO_0000065";"9.15";"0.17";"-0.13";"9.00";"0";"CHEMBL4357658";"Inhibition of human cathepsin D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4354841";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";""
"CHEMBL558459";"HYDRAZOBENZENE";"None";"184.24";"0";"3.13";"74";"c1ccc(NNc2ccccc2)cc1";"IC50";"'='";"2400.0";"nM";"5.62";"";"";"UO_0000065";"30.50";"0.55";"2.49";"23.36";"0";"CHEMBL4357658";"Inhibition of human cathepsin D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4354841";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";""
"CHEMBL3763524";"";"None";"389.50";"0";"4.53";"rac-3f";"Nc1nc2cc(-c3ccccc3)ccc2c(=O)n1CC1CCC2(CCCCC2)O1";"IC50";"'='";"9000.0";"nM";"5.05";"";"";"UO_0000065";"12.95";"0.24";"0.52";"7.19";"0";"CHEMBL3767017";"Inhibition of CatD (unknown origin) preincubated for 30 mins followed by DABCYL-Glu-Arg-Nle-Phe-Leu-Ser-Phe-Pro-EDANS substrate addition by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3763050";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";""
"CHEMBL3264803";"";"None";"613.85";"2";"5.56";"7";"CCCN(CCC)C(=O)c1cc(C(=O)N[C@@H](Cc2ccccc2)[C@H](O)CNC(C)(C)c2cccnc2)cc(N2CCCCC2)c1";"IC50";"'='";"140.0";"nM";"6.85";"";"";"UO_0000065";"11.17";"0.21";"1.29";"7.01";"0";"CHEMBL3271470";"Inhibition of human cathepsin-D using DABCYL-Glu-Arg-Nle-Phe-Leu-Ser-Phe-Pro-EDANS as substrate preincubated for 30 mins by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3259525";"1";"Scientific Literature";"ACS Med Chem Lett";"2014";"None";"";"";""
"CHEMBL4788309";"";"None";"715.79";"1";"3.86";"3b";"COc1ccc(CC(=O)NC(=N)N[C@H](CC2CCCCC2)C(=O)Nc2cc(S(=O)(=O)NC(C)C)ccc2C)cc1OC.O=C(O)C(F)(F)F";"IC50";"'='";"59.0";"nM";"7.23";"";"";"UO_0000065";"12.01";"0.24";"3.37";"4.55";"0";"CHEMBL4706202";"Inhibition of human liver Cathepsin D preincubated for 10 mins followed by substrate addition and further incubated for 2 hrs in dark by fluorimetric analysis";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699662";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"TIME = 2.167 hr";"INHIBITOR";""
"CHEMBL4749657";"";"None";"713.78";"1";"3.61";"5b";"COc1ccc(CC(=O)NC(=N)N[C@H](CC2CCCCC2)C(=O)Nc2cc(S(=O)(=O)NC3CC3)ccc2C)cc1OC.O=C(O)C(F)(F)F";"IC50";"'='";"30.0";"nM";"7.52";"";"";"UO_0000065";"12.54";"0.24";"3.91";"4.74";"0";"CHEMBL4706202";"Inhibition of human liver Cathepsin D preincubated for 10 mins followed by substrate addition and further incubated for 2 hrs in dark by fluorimetric analysis";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699662";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"TIME = 2.167 hr";"INHIBITOR";""
"CHEMBL4791822";"";"None";"681.69";"1";"2.35";"5c";"CNS(=O)(=O)c1ccc(C)c(NC(=O)[C@@H](Cc2ccccc2)NC(=N)NC(=O)Cc2ccc(OC)c(OC)c2)c1.O=C(O)C(F)(F)F";"IC50";"'='";"204.0";"nM";"6.69";"";"";"UO_0000065";"11.79";"0.23";"4.34";"4.22";"0";"CHEMBL4706202";"Inhibition of human liver Cathepsin D preincubated for 10 mins followed by substrate addition and further incubated for 2 hrs in dark by fluorimetric analysis";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699662";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"TIME = 2.167 hr";"INHIBITOR";""
"CHEMBL4755364";"";"None";"730.13";"1";"4.74";"4d";"CNS(=O)(=O)c1ccc(C)c(NC(=O)[C@@H](CC2CCCCC2)NC(=N)NC(=O)Cc2cc(Cl)cc(C(F)(F)F)c2)c1.O=C(O)C(F)(F)F";"IC50";"'='";"18.0";"nM";"7.75";"";"";"UO_0000065";"12.57";"0.26";"3.00";"5.52";"0";"CHEMBL4706202";"Inhibition of human liver Cathepsin D preincubated for 10 mins followed by substrate addition and further incubated for 2 hrs in dark by fluorimetric analysis";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699662";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"TIME = 2.167 hr";"INHIBITOR";""
"CHEMBL4743799";"";"None";"673.69";"1";"2.15";"3e";"COc1ccc(CC(=O)NC(=N)N[C@H](Cc2cccs2)C(=O)Nc2cc(S(N)(=O)=O)ccc2C)cc1OC.O=C(O)C(F)(F)F";"IC50";"'='";"122.0";"nM";"6.91";"";"";"UO_0000065";"12.35";"0.25";"4.76";"4.00";"0";"CHEMBL4706202";"Inhibition of human liver Cathepsin D preincubated for 10 mins followed by substrate addition and further incubated for 2 hrs in dark by fluorimetric analysis";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699662";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"TIME = 2.167 hr";"INHIBITOR";""
"CHEMBL4743795";"";"None";"617.60";"1";"1.26";"11e";"COc1ccc(CC(=O)NC(=N)N[C@@H](C(=O)Nc2cc(S(N)(=O)=O)ccc2C)C2CC2)cc1OC.O=C(O)C(F)(F)F";"IC50";"'='";"106.0";"nM";"6.97";"";"";"UO_0000065";"13.85";"0.27";"5.71";"4.04";"0";"CHEMBL4706202";"Inhibition of human liver Cathepsin D preincubated for 10 mins followed by substrate addition and further incubated for 2 hrs in dark by fluorimetric analysis";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699662";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"TIME = 2.167 hr";"INHIBITOR";""
"CHEMBL4790435";"";"None";"619.62";"1";"1.51";"13e";"COc1ccc(CC(=O)NC(=N)N[C@@H](C(=O)Nc2cc(S(N)(=O)=O)ccc2C)C(C)C)cc1OC.O=C(O)C(F)(F)F";"IC50";"'='";"431.0";"nM";"6.37";"";"";"UO_0000065";"12.59";"0.25";"4.86";"3.69";"0";"CHEMBL4706202";"Inhibition of human liver Cathepsin D preincubated for 10 mins followed by substrate addition and further incubated for 2 hrs in dark by fluorimetric analysis";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699662";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"TIME = 2.167 hr";"INHIBITOR";""
"CHEMBL2407339";"";"None";"559.80";"2";"6.18";"11";"C=CCCCC(=O)N[C@@H](Cc1cccc(CC=C)c1)[C@H](O)CN[C@H]1CC2(CCC2)Oc2ncc(CC(C)(C)C)cc21";"IC50";"'='";"0.84";"nM";"9.08";"";"";"UO_0000065";"16.21";"0.30";"2.90";"10.87";"0";"CHEMBL2411009";"Inhibition of Cathepsin D (unknown origin) by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2406987";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"None";"";"";""
"CHEMBL2407494";"";"None";"610.68";"1";"4.60";"7";"O=C(N[C@@H](Cc1ccccc1)[C@H](O)CNCc1cccc(C(F)(F)F)c1)c1cc(N2CCCC2=O)c(=O)n(C2CCCC2)c1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2411009";"Inhibition of Cathepsin D (unknown origin) by FRET assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2406987";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"None";"";"";""
"CHEMBL5086270";"";"None";"490.40";"0";"4.31";"64h";"Cc1cc(OC(F)F)cnc1C(=O)Nc1ccc(F)c([C@]2(C)CO[C@@](C)(C(F)(F)F)C(N)=N2)c1";"IC50";"'>'";"250000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5055931";"Inhibition of human cathepsin D using Mca-GKPILFFRLK(DNP)D-R-NH2 as a substrate";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5055623";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"";""
"CHEMBL4760458";"";"None";"495.56";"0";"3.45";"15";"C[C@]1(c2cc(/C=C(\F)c3ccc(C#N)cn3)ccc2F)N=C(N)S[C@@]2(C(=O)N3CCOCC3)C[C@H]21";"IC50";"'='";"535000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4726141";"Inhibition of CatD (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4725250";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2020";"None";"";"INHIBITOR";""
"CHEMBL3912402";"";"None";"716.97";"2";"2.91";"BDBM232265";"CC[C@H](C)[C@H](NC(=O)C[C@H](N)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)CC(C)C)C(C)C)C(=O)N[C@H](C(=O)O)C(C)C";"IC50";"'='";"50.0";"nM";"7.30";"";"405040";"UO_0000065";"10.18";"0.20";"4.39";"3.50";"0";"CHEMBL3888498";"In-Vitro Fluorescence Assay: In order to identify modulators of cathepsin D activity, a continuous enzymatic test was carried out with a synthetic peptide which carries a fluorescent group (MCA=(7-methoxycoumarin-4-yl)acetyl) which is quenched by energy transfer from a Dpn (2,4 dinitrophenyl) group on the same molecule, in Greiner 384-well nb microtitre plates. Cleavage of the peptidic substrate by cathepsin D causes an increase in the fluorescence intensity. In order to determine the efficacy of substances, the time-dependent increase in the fluorescence intensity in the presence of the substance was compared with the time-dependent increase in fluorescence in the absence of substances. The reference substance used was pepstatin A (Sigma-Aldrich). The substrate used was MCAGKPILFFRLK(Dnp)d-R-NH2 (Enzo Life Sciences, Lorrach). The enzyme employed was cathepsin D isolated from the human liver (Sigma-Aldrich) in a final concentration of 1.4 nM. The test was carried out in 100 mM sodium acetate buffer, 1.25% (v/v) of DMSO, 0.25% (w/v) of Chaps, pH 5.5. 2 ul of each substance solution with serially diluted substance concentration were added to in each case 4 ul of cathepsin D solution and incubated at room temperature for 10 min. The reaction was started by addition of 2 ul of substrate solution (final concentration 5 uM). After carrying out a starting-point fluorescence measurement (excitation wavelength 340 nm/emission wavelength 450 nm) using an Envision multilabel reader (Perkin Elmer), the reaction was incubated at room temperature for 60 min. The amount of peptide fragment cleaved off during the reaction time was subsequently measured by determination of the increase in the fluorescence intensity at 450 nm (excitation wavelength 340 nm).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886733";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3979093";"";"None";"717.91";"1";"3.65";"BDBM232250";"CC[C@H](C)[C@H](NC(=O)C[C@H](N)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)COc1cccc2ccccc12)C(C)C)C(=O)N[C@H](C(=O)OC)C(C)C";"IC50";"'='";"200.0";"nM";"6.70";"";"405027";"UO_0000065";"9.33";"0.18";"3.05";"3.76";"0";"CHEMBL3888498";"In-Vitro Fluorescence Assay: In order to identify modulators of cathepsin D activity, a continuous enzymatic test was carried out with a synthetic peptide which carries a fluorescent group (MCA=(7-methoxycoumarin-4-yl)acetyl) which is quenched by energy transfer from a Dpn (2,4 dinitrophenyl) group on the same molecule, in Greiner 384-well nb microtitre plates. Cleavage of the peptidic substrate by cathepsin D causes an increase in the fluorescence intensity. In order to determine the efficacy of substances, the time-dependent increase in the fluorescence intensity in the presence of the substance was compared with the time-dependent increase in fluorescence in the absence of substances. The reference substance used was pepstatin A (Sigma-Aldrich). The substrate used was MCAGKPILFFRLK(Dnp)d-R-NH2 (Enzo Life Sciences, Lorrach). The enzyme employed was cathepsin D isolated from the human liver (Sigma-Aldrich) in a final concentration of 1.4 nM. The test was carried out in 100 mM sodium acetate buffer, 1.25% (v/v) of DMSO, 0.25% (w/v) of Chaps, pH 5.5. 2 ul of each substance solution with serially diluted substance concentration were added to in each case 4 ul of cathepsin D solution and incubated at room temperature for 10 min. The reaction was started by addition of 2 ul of substrate solution (final concentration 5 uM). After carrying out a starting-point fluorescence measurement (excitation wavelength 340 nm/emission wavelength 450 nm) using an Envision multilabel reader (Perkin Elmer), the reaction was incubated at room temperature for 60 min. The amount of peptide fragment cleaved off during the reaction time was subsequently measured by determination of the increase in the fluorescence intensity at 450 nm (excitation wavelength 340 nm).";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886733";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3688745";"";"None";"392.79";"0";"3.02";"BDBM171689";"NC1=N[C@](CF)(c2cc(NC(=O)c3ccc(F)cn3)ccc2Cl)[C@H]2C[C@H]2O1";"IC50";"'='";"1270500.0";"nM";"";"Outside typical range";"316216";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3693255";"";"None";"429.32";"0";"3.69";"BDBM171815";"NC1=N[C@@](c2cc(NC(=O)c3c(F)cc(F)cc3F)ccc2F)(C(F)F)[C@H]2C[C@H]2O1";"IC50";"'='";"959560.0";"nM";"";"Outside typical range";"316222";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688638";"";"None";"432.76";"0";"2.62";"BDBM171573";"NC1=N[C@](CF)(c2cc(NC(=O)c3nn(C(F)F)cc3Cl)cnc2F)[C@H]2C[C@H]2O1";"IC50";"'='";"370200.0";"nM";"";"Outside typical range";"315982";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688667";"";"None";"381.40";"0";"3.54";"BDBM171605";"NC1=N[C@@](c2cc(NC(=O)C3CCCCC3)ccc2F)(C(F)F)[C@H]2C[C@H]2O1";"IC50";"'>'";"400000.0";"nM";"";"Outside typical range";"316014";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688680";"";"None";"437.85";"0";"4.42";"BDBM171618";"C[C@H](C(=O)Nc1ccc(F)c([C@@]2(C(F)F)N=C(N)O[C@@H]3C[C@@H]32)c1)c1ccc(Cl)cc1";"IC50";"'='";"270500.0";"nM";"";"Outside typical range";"316027";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688690";"";"None";"399.37";"0";"3.01";"BDBM171628";"NC1=N[C@@](c2cc(NC(=O)C#Cc3ccccc3)ccc2F)(C(F)F)[C@H]2C[C@H]2O1";"IC50";"'='";"203500.0";"nM";"";"Outside typical range";"316037";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688709";"";"None";"439.27";"0";"3.55";"BDBM171650";"COc1cnc(C(=O)Nc2ccc(Cl)c([C@@]3(CF)N=C(N)O[C@@H]4C[C@@H]43)c2)c(Cl)c1";"IC50";"'='";"752050.0";"nM";"";"Outside typical range";"316058";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688724";"";"None";"435.41";"0";"2.69";"BDBM171666";"COc1cnc(C(=O)Nc2cc(C)c(F)c([C@@]3(C(F)F)N=C(N)O[C@@H]4C[C@@H]43)c2)c(C)n1";"IC50";"'='";"447110.0";"nM";"";"Outside typical range";"316074";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3683906";"";"None";"505.83";"1";"3.67";"BDBM171525";"Cc1nc(OCC(F)(F)F)cnc1C(=O)Nc1cc(F)c(Cl)c([C@]2(CF)N=C(N)O[C@H]3C[C@H]32)c1";"IC50";"'='";"1076700.0";"nM";"";"Outside typical range";"316090";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688778";"";"None";"430.39";"0";"2.95";"BDBM171725";"COc1cnc2c(Nc3ccc(F)c([C@@]4(CF)N=C(N)O[C@@H]5C[C@@H]54)c3F)nccc2n1";"IC50";"'='";"2745500.0";"nM";"";"Outside typical range";"316129";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688793";"";"None";"460.37";"0";"3.86";"BDBM171740";"N#Cc1cnc2c(Nc3cc(F)c(F)c([C@]4(C(F)F)N=C(N)O[C@H]5C[C@H]54)c3)ncc(F)c2c1";"IC50";"'='";"127610.0";"nM";"";"Outside typical range";"316140";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688803";"";"None";"393.33";"0";"3.77";"BDBM171750";"NC1=N[C@@](c2cc(NCC3(C(F)(F)F)CC3)ccc2F)(C(F)F)[C@H]2C[C@H]2O1";"IC50";"'='";"52900.0";"nM";"4.28";"";"316150";"UO_0000065";"10.87";"0.22";"0.51";"7.17";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688806";"";"None";"325.33";"0";"2.84";"BDBM171753";"NC1=N[C@@](c2cc(NCC3CC3)ccc2F)(C(F)F)[C@H]2C[C@H]2O1";"IC50";"'='";"188500.0";"nM";"";"Outside typical range";"316153";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3683806";"";"None";"449.77";"0";"3.36";"BDBM171412";"NC1=N[C@](CF)(c2cc(NC(=O)c3nn(C(F)F)cc3Cl)cc(F)c2F)[C@H]2C[C@H]2O1";"IC50";"'='";"173500.0";"nM";"";"Outside typical range";"315821";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3683821";"";"None";"435.79";"0";"3.19";"BDBM171428";"N#Cc1cnc(C(=O)Nc2ccc(F)c([C@]3(C(F)F)N=C(N)O[C@H]4C[C@H]43)c2)c(Cl)c1";"IC50";"'='";"1285900.0";"nM";"";"Outside typical range";"315842";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3683837";"";"None";"401.40";"0";"1.45";"BDBM171447";"COC[C@@]1(c2cc(NC(=O)c3cnc(OC)cn3)ccc2F)N=C(N)O[C@H]2C[C@H]21";"IC50";"'>'";"400000.0";"nM";"";"Outside typical range";"315856";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688665";"";"None";"456.37";"0";"3.58";"BDBM171603";"Cc1cc(OC(F)F)cnc1C(=O)Nc1ccc(F)c([C@@]2(C(F)F)N=C(N)O[C@@H]3C[C@@H]32)c1";"IC50";"'='";"326910.0";"nM";"";"Outside typical range";"316012";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688776";"";"None";"434.81";"0";"3.75";"BDBM171723";"NC1=N[C@@](c2cc(Nc3ncnc4cc(Cl)cnc34)ccc2F)(C(F)F)[C@H]2C[C@H]2O1";"IC50";"'='";"141050.0";"nM";"";"Outside typical range";"316127";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688781";"";"None";"402.38";"0";"3.04";"BDBM171728";"Cn1cc2ccnc(Nc3ccc(F)c([C@@]4(C(F)F)N=C(N)O[C@@H]5C[C@@H]54)c3)c2n1";"IC50";"'>'";"400000.0";"nM";"";"Outside typical range";"316132";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3688785";"";"None";"433.82";"0";"4.36";"BDBM171732";"NC1=N[C@@](c2cc(Nc3nccc4cc(Cl)cnc34)ccc2F)(C(F)F)[C@H]2C[C@H]2O1";"IC50";"'='";"399580.0";"nM";"";"Outside typical range";"316136";"UO_0000065";"";"";"";"";"0";"CHEMBL3706260";"Fluorescence Resonance Energy Transfer Assay: Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for Cat D) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site. The Cat D substrate peptide sequence is based on sequence #1 of Table 1 from Gulnik et al. FEBS Letters v413 p379-384 1997. Proteolytic cleavage of the FRET substrate releases quenching of fluorescence (Cat D excitation 500 nm and emission 580 nm).";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3639225";"37";"BindingDB Database";"";"2015";"CHEMBL3308072";"";"";""
"CHEMBL4793769";"";"None";"687.74";"1";"3.08";"11b";"CNS(=O)(=O)c1ccc(C)c(NC(=O)[C@H](CC2CCCCC2)NC(=N)NC(=O)Cc2ccc(OC)c(OC)c2)c1.O=C(O)C(F)(F)F";"IC50";"'='";"851.0";"nM";"6.07";"";"";"UO_0000065";"10.58";"0.21";"2.99";"3.82";"0";"CHEMBL4706202";"Inhibition of human liver Cathepsin D preincubated for 10 mins followed by substrate addition and further incubated for 2 hrs in dark by fluorimetric analysis";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699662";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"TIME = 2.167 hr";"INHIBITOR";""
"CHEMBL4753545";"";"None";"667.66";"1";"2.48";"2c";"CNS(=O)(=O)c1ccc(C)c(NC(=O)[C@H](NC(=N)NC(=O)Cc2ccc(OC)c(OC)c2)c2ccccc2)c1.O=C(O)C(F)(F)F";"IC50";"'='";"108.0";"nM";"6.97";"";"";"UO_0000065";"12.58";"0.24";"4.49";"4.39";"0";"CHEMBL4706202";"Inhibition of human liver Cathepsin D preincubated for 10 mins followed by substrate addition and further incubated for 2 hrs in dark by fluorimetric analysis";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699662";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"TIME = 2.167 hr";"INHIBITOR";""
"CHEMBL4747915";"";"None";"696.58";"1";"4.37";"5d";"CNS(=O)(=O)c1ccc(C)c(NC(=O)[C@@H](CC2CCCCC2)NC(=N)NC(=O)Cc2ccc(Cl)c(Cl)c2)c1.O=C(O)C(F)(F)F";"IC50";"'='";"36.0";"nM";"7.44";"";"";"UO_0000065";"12.78";"0.27";"3.07";"5.31";"0";"CHEMBL4706202";"Inhibition of human liver Cathepsin D preincubated for 10 mins followed by substrate addition and further incubated for 2 hrs in dark by fluorimetric analysis";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699662";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"TIME = 2.167 hr";"INHIBITOR";""
"CHEMBL3261069";"";"None";"450.40";"0";"2.97";"9";"Cc1cc(C#N)cnc1C(=O)Nc1ccc(F)c([C@]2(C)CO[C@@](C)(C(F)(F)F)C(N)=N2)n1";"IC50";"'='";"178000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5054673";"Inhibition of human Cathepsin D using Mca-GKPILFFRLK(DNP)D-R-NH2 as a substrate";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5053529";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL3808441";"";"None";"590.74";"2";"6.81";"6";"CC(C)(C)CCNC(=O)CCc1cc2cc(-c3ccccc3C#CCC3(NC(=O)c4ccc(F)cc4)CC3)ccc2nc1N";"IC50";"'='";"99.0";"nM";"7.00";"";"";"UO_0000065";"11.86";"0.22";"0.19";"7.21";"0";"CHEMBL3811221";"Inhibition of Cathepsin D (unknown origin) by fluorescence assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3808306";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";""
"CHEMBL3670371";"";"None";"511.81";"1";"4.05";"13";"C[C@@]1(c2nc(NC(=O)c3ncc(OC(F)F)cc3Cl)ccc2F)CO[C@@](C)(C(F)(F)F)C(N)=N1";"IC50";"'='";"236000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5054673";"Inhibition of human Cathepsin D using Mca-GKPILFFRLK(DNP)D-R-NH2 as a substrate";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5053529";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL3653399";"";"None";"471.28";"0";"4.02";"rac-(3R*,6R*)-38a";"C[C@@]1(c2cccc(NC(=O)c3ccc(Br)cn3)c2)CO[C@@](C)(C(F)(F)F)C(N)=N1";"IC50";"'='";"73000.0";"nM";"4.14";"";"";"UO_0000065";"8.78";"0.19";"0.12";"4.62";"0";"CHEMBL5055931";"Inhibition of human cathepsin D using Mca-GKPILFFRLK(DNP)D-R-NH2 as a substrate";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5055623";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL4473740";"";"None";"479.94";"0";"3.39";"13";"CN(C)C(=O)[C@]12C[C@H]1[C@@](C)(c1cc(NC(=O)c3ccc(Cl)cn3)cc(F)c1F)N=C(N)S2";"IC50";"'='";"796000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4343401";"Inhibition of recombinant CatD (unknown origin) expressed in CHO cells using FRET peptide substrate preincubated for 1 hr followed by substrate addition and measured after 1 hr by FRET assay";"A";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4342420";"1";"Scientific Literature";"J Med Chem";"2020";"CHEMBL3308072";"";"";""
"CHEMBL296588";"PEPSTATIN";"2.0";"685.90";"2";"1.47";"Pepstatin A";"CC(C)CC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)[C@@H](O)CC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)[C@@H](O)CC(=O)O)C(C)C)C(C)C";"IC50";"'='";"0.693";"nM";"9.16";"";"";"UO_0000065";"13.35";"0.26";"7.69";"4.10";"1";"CHEMBL5158466";"Inhibition of recombinant human liver Cathepsin D using Mca-Gly-Lys-Pro-Ile-Leu-Phe-Phe-Arg-Leu-Lys-(Dnp)-D-Arg-NH2 as substrate incubated for 120 mins by fluorescence assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5154724";"1";"Scientific Literature";"Bioorg Med Chem";"2022";"None";"TIME = 2.0 hr";"INHIBITOR";""
"CHEMBL5074068";"";"None";"420.41";"0";"1.58";"36";"COc1cnc(C(=O)Nc2ccc(F)c([C@]3(C)Cn4nc(C#N)cc4C(N)=N3)c2)cn1";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5041723";"Inhibition of Cathepsin D (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5038653";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";"";"";""
"CHEMBL5073160";"";"None";"469.83";"0";"3.92";"64e";"C[C@@]1(c2cc(NC(=O)c3ncc(C#N)cc3Cl)ccc2F)CO[C@@](C)(C(F)(F)F)C(N)=N1";"IC50";"'>'";"250000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5055931";"Inhibition of human cathepsin D using Mca-GKPILFFRLK(DNP)D-R-NH2 as a substrate";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5055623";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"";""
"CHEMBL3653341";"";"None";"389.25";"0";"2.70";"4";"C[C@@]1(c2cccc(NC(=O)c3ccc(Br)cn3)c2)COCC(N)=N1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5055931";"Inhibition of human cathepsin D using Mca-GKPILFFRLK(DNP)D-R-NH2 as a substrate";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5055623";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"";""
"CHEMBL3653404";"";"None";"490.26";"0";"3.55";"64a";"C[C@@]1(c2cc(NC(=O)c3ncc(Br)cn3)ccc2F)CO[C@@](C)(C(F)(F)F)C(N)=N1";"IC50";"'='";"180000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5055931";"Inhibition of human cathepsin D using Mca-GKPILFFRLK(DNP)D-R-NH2 as a substrate";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5055623";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL5090563";"";"None";"450.40";"0";"2.85";"64f";"C[C@@]1(c2cc(NC(=O)c3ncc(C#N)cc3N)ccc2F)CO[C@@](C)(C(F)(F)F)C(N)=N1";"IC50";"'='";"30000.0";"nM";"4.52";"";"";"UO_0000065";"10.04";"0.19";"1.67";"3.24";"0";"CHEMBL5055931";"Inhibition of human cathepsin D using Mca-GKPILFFRLK(DNP)D-R-NH2 as a substrate";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5055623";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL3947194";"";"None";"473.50";"0";"3.37";"62";"C[C@H]1C[C@H]2CSC(N)=N[C@@]2(c2nc(NC(=O)c3ccc(OC(F)(F)F)cn3)cs2)CO1";"IC50";"'='";"163600.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4183115";"Inhibition of Cathepsin D (unknown origin) by fluorescence polarization assay";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4177751";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL3922902";"";"None";"419.53";"0";"2.48";"57";"COc1ccc(C(=O)Nc2csc([C@]34CO[C@@H](C)C[C@H]3CSC(N)=N4)n2)nc1";"IC50";"'>'";"95000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4183115";"Inhibition of Cathepsin D (unknown origin) by fluorescence polarization assay";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4177751";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";"";""
"CHEMBL4802569";"";"None";"521.60";"1";"0.89";"Cath D";"CCOC[C@@H](NC(=N)NC(=O)Cc1ccc(OC)c(OC)c1)C(=O)Nc1cc(S(N)(=O)=O)ccc1C";"IC50";"'='";"45.0";"nM";"7.35";"";"";"UO_0000065";"14.09";"0.28";"6.46";"4.04";"0";"CHEMBL5158466";"Inhibition of recombinant human liver Cathepsin D using Mca-Gly-Lys-Pro-Ile-Leu-Phe-Phe-Arg-Leu-Lys-(Dnp)-D-Arg-NH2 as substrate incubated for 120 mins by fluorescence assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5154724";"1";"Scientific Literature";"Bioorg Med Chem";"2022";"None";"TIME = 2.0 hr";"INHIBITOR";""
"CHEMBL3976114";"";"None";"486.92";"0";"3.73";"BDBM220790";"COc1cnc(C(=O)Nc2ccc3c(c2)C2(CCSC(N)=N2)c2cc(Cl)nc(F)c2O3)cn1";"IC50";"'>'";"400000.0";"nM";"";"Outside typical range";"386474";"UO_0000065";"";"";"";"";"0";"CHEMBL3888270";"Fluorescence Resonance Energy Transfer (FRET) Assay: Recombinant CathepsinD was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The CathepsinD enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for CathepsinD) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886633";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3893463";"";"None";"483.53";"0";"3.93";"BDBM220767";"Cc1ccc(C(=O)Nc2ccc3c(c2)[C@@]2(CCOC(N)=N2)c2cc(C4=CCCOC4)ncc2O3)nc1";"IC50";"'='";"400000.0";"nM";"";"Outside typical range";"386480";"UO_0000065";"";"";"";"";"0";"CHEMBL3888270";"Fluorescence Resonance Energy Transfer (FRET) Assay: Recombinant CathepsinD was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The CathepsinD enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for CathepsinD) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886633";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3922952";"";"None";"534.91";"1";"4.81";"BDBM220825";"NC1=NC2(CCO1)c1cc(NC(=O)c3ccc(Cl)cn3)ccc1Oc1c2cc(-c2ccnc(F)c2)nc1F";"IC50";"'='";"400000.0";"nM";"";"Outside typical range";"386511";"UO_0000065";"";"";"";"";"0";"CHEMBL3888270";"Fluorescence Resonance Energy Transfer (FRET) Assay: Recombinant CathepsinD was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The CathepsinD enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for CathepsinD) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886633";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3904830";"";"None";"530.49";"1";"4.16";"BDBM220833";"COc1ccc(C(=O)Nc2ccc3c(c2)C2(CCOC(N)=N2)c2cc(-c4ccnc(F)c4)nc(F)c2O3)nc1";"IC50";"'='";"400000.0";"nM";"";"Outside typical range";"386519";"UO_0000065";"";"";"";"";"0";"CHEMBL3888270";"Fluorescence Resonance Energy Transfer (FRET) Assay: Recombinant CathepsinD was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The CathepsinD enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for CathepsinD) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886633";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3919324";"";"None";"519.53";"1";"3.85";"BDBM220837";"COc1cnc(C(=O)Nc2ccc3c(c2)C2(CCOC(N)=N2)c2cc(C4CCOCC4)cc(F)c2O3)cn1";"IC50";"'='";"378500.0";"nM";"";"Outside typical range";"386523";"UO_0000065";"";"";"";"";"0";"CHEMBL3888270";"Fluorescence Resonance Energy Transfer (FRET) Assay: Recombinant CathepsinD was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The CathepsinD enzyme (9 nM) is pre-incubated for one hour with inhibitors, typically in about 1 uL of DMSO according to a serial dilution, is added thereto. The assays are effectively started by the addition of different FRET substrates (20 nM for CathepsinD) and the combination is incubated for one hour. The FRET assay is terminated with by addition of Tris buffer, which raises the pH to neutrality, and the fluorescence is determined. The FRET substrate is a peptide with commercially available fluorophore and quencher, on opposite sides of the BACE cleavage site.";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886633";"37";"BindingDB Database";"";"2016";"CHEMBL3308072";"";"";""
"CHEMBL5190700";"";"None";"479.97";"0";"4.00";"UCB7362";"C[C@H]1C[C@@H](N2C(=N)N[C@](C)(c3cccc(NC(=O)c4cccc(C#N)c4)c3Cl)CC2=O)CCO1";"IC50";"'='";"3889.0";"nM";"5.41";"";"";"UO_0000065";"11.27";"0.22";"1.41";"4.57";"0";"CHEMBL5112378";"Inhibition of human cathepsin D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5108065";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";"INHIBITOR";""
"CHEMBL5091705";"";"None";"367.84";"0";"0.80";"16";"Cl.NC1=N[C@@]2(c3cnccn3)CN(c3ncc(F)cn3)C[C@H]2CS1";"IC50";"'='";"83000.0";"nM";"4.08";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5034187";"Inhibition of human Cathepsin D by FRET assay";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5033995";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL296588";"PEPSTATIN";"2.0";"685.90";"2";"1.47";"1";"CC(C)CC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)[C@@H](O)CC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)[C@@H](O)CC(=O)O)C(C)C)C(C)C";"IC50";"'<'";"1.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"1";"CHEMBL4706199";"Inhibition of Cathepsin D (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699662";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL68595";"";"None";"489.62";"1";"5.64";"4";"CCCc1c(OCc2ccc(/C=C3\SC(=S)NC3=O)cc2)ccc(C(=O)c2ccccc2)c1O";"IC50";"'='";"210.0";"nM";"6.68";"";"";"UO_0000065";"13.64";"0.27";"1.04";"8.83";"1";"CHEMBL4706199";"Inhibition of Cathepsin D (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699662";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL5093835";"";"None";"371.89";"0";"2.07";"15";"Cl.NC1=N[C@@]2(c3cccs3)CN(c3ncc(F)cn3)C[C@H]2CS1";"IC50";"'='";"19000.0";"nM";"4.72";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5034187";"Inhibition of human Cathepsin D by FRET assay";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5033995";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL3670368";"";"None";"451.38";"0";"2.25";"12";"C[C@@]1(c2nc(NC(=O)c3ncc(C#N)cc3N)ccc2F)CO[C@@](C)(C(F)(F)F)C(N)=N1";"IC50";"'='";"17500.0";"nM";"4.76";"";"";"UO_0000065";"10.54";"0.20";"2.51";"3.12";"0";"CHEMBL5054673";"Inhibition of human Cathepsin D using Mca-GKPILFFRLK(DNP)D-R-NH2 as a substrate";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5053529";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL3261067";"";"None";"449.41";"0";"3.58";"54";"Cc1cc(C#N)cnc1C(=O)Nc1ccc(F)c([C@]2(C)CO[C@@](C)(C(F)(F)F)C(N)=N2)c1";"IC50";"'>'";"250000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"1";"CHEMBL5055931";"Inhibition of human cathepsin D using Mca-GKPILFFRLK(DNP)D-R-NH2 as a substrate";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5055623";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"";""
"CHEMBL3670372";"";"None";"480.25";"0";"4.10";"14";"C[C@@]1(c2nc(NC(=O)c3ncc(Cl)cc3Cl)ccc2F)CO[C@@](C)(C(F)(F)F)C(N)=N1";"IC50";"'='";"217000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5054673";"Inhibition of human Cathepsin D using Mca-GKPILFFRLK(DNP)D-R-NH2 as a substrate";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5053529";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL5085959";"";"None";"479.26";"0";"4.70";"64j";"C[C@@]1(c2cc(NC(=O)c3ncc(Cl)cc3Cl)ccc2F)CO[C@@](C)(C(F)(F)F)C(N)=N1";"IC50";"'>'";"250000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5055931";"Inhibition of human cathepsin D using Mca-GKPILFFRLK(DNP)D-R-NH2 as a substrate";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5055623";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"";""
"CHEMBL5184180";"";"None";"3036.58";"None";"None";"2";"CC(C)C[C@H](NC(=O)C[C@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(N)=O)N(C)C(=O)[C@@H](NC(=O)OCc1ccccc1)C(C)C)C(=O)N[C@@H](C)C(=O)N(C)[C@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)NCCOCCOCCn1cc(CNC(=O)[C@H](CCCCNC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)CCN2c3ccccc3C(C)(C)[C@]23C=Cc2cc([N+](=O)[O-])ccc2O3)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)C(CCC(N)=O)NC(=O)[C@H](CO)NC(=O)CCN2c3ccccc3C(C)(C)[C@]23CCc2cc([N+](=O)[O-])ccc2O3)nn1";"IC50";"'='";"41.0";"nM";"7.39";"";"";"UO_0000065";"2.43";"None";"None";"None";"0";"CHEMBL5158466";"Inhibition of recombinant human liver Cathepsin D using Mca-Gly-Lys-Pro-Ile-Leu-Phe-Phe-Arg-Leu-Lys-(Dnp)-D-Arg-NH2 as substrate incubated for 120 mins by fluorescence assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5154724";"1";"Scientific Literature";"Bioorg Med Chem";"2022";"None";"TIME = 2.0 hr";"INHIBITOR";""
"CHEMBL3951810";"";"None";"538.93";"1";"4.92";"PF-03084014";"Cc1cn(-c2ccc3n(c2=O)CCN([C@@H](C)[C@@H]2CC[C@H](c4cc(F)c(Cl)cc4C(F)(F)F)O2)C3=O)cn1";"IC50";"'='";"20000.0";"nM";"4.70";"";"";"UO_0000065";"8.72";"0.17";"-0.22";"6.77";"0";"CHEMBL5128153";"Inhibition of Cathepsin D (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5126536";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"";"INHIBITOR";""
"CHEMBL4637426";"";"None";"401.58";"0";"2.80";"5";"C[C@@H]1C[C@H]1COC(C)(C)[C@@H]1C[C@H]1[C@]12CN(c3ncccn3)C[C@H]1CSC(N)=N2";"IC50";"'>'";"300000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5034187";"Inhibition of human Cathepsin D by FRET assay";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5033995";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"";""
"CHEMBL5088790";"";"None";"390.37";"0";"1.93";"6";"Cl.Cl.NC1=N[C@@]2(c3cccs3)CN(c3ncccn3)C[C@H]2CS1";"IC50";"'='";"40900.0";"nM";"4.39";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5034187";"Inhibition of human Cathepsin D by FRET assay";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5033995";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL3701713";"";"None";"372.88";"0";"1.47";"18";"Cl.NC1=N[C@@]2(c3ccns3)CN(c3ncc(F)cn3)C[C@H]2CS1";"IC50";"'='";"29000.0";"nM";"4.54";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5034187";"Inhibition of human Cathepsin D by FRET assay";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5033995";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL3667415";"";"None";"503.49";"1";"3.07";"21";"NC1=N[C@@]2(c3cc(NC(=O)c4ncc(F)cc4F)ccc3F)CN(c3ncc(F)cn3)C[C@H]2CS1";"IC50";"'='";"169000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5034187";"Inhibition of human Cathepsin D by FRET assay";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5033995";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL3261068";"";"None";"450.40";"0";"2.97";"10";"Cc1cc(C#N)cnc1C(=O)Nc1cc([C@]2(C)CO[C@@](C)(C(F)(F)F)C(N)=N2)c(F)cn1";"IC50";"'>'";"250000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5054673";"Inhibition of human Cathepsin D using Mca-GKPILFFRLK(DNP)D-R-NH2 as a substrate";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5053529";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"";""
"CHEMBL4530776";"";"None";"226.28";"0";"1.81";"33-4";"NNC(=O)C(c1ccccc1)c1ccccc1";"IC50";"'='";"1000.0";"nM";"6.00";"";"";"UO_0000065";"26.52";"0.48";"4.19";"10.89";"0";"CHEMBL4355299";"Inhibition of human liver cathepsin D using DABCYL-Glu-Arg-Nle-Phe-Leu-Ser-Phe-Pro-EDANS as substrate by FRET assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4354799";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";""
"CHEMBL3653393";"";"None";"407.24";"0";"2.84";"rac-20";"CC1(c2cc(NC(=O)c3ccc(Br)cn3)ccc2F)COCC(N)=N1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5055931";"Inhibition of human cathepsin D using Mca-GKPILFFRLK(DNP)D-R-NH2 as a substrate";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5055623";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"";""
"CHEMBL4745201";"";"None";"635.62";"1";"0.89";"24e";"CCOC[C@@H](NC(=N)NC(=O)Cc1ccc(OC)c(OC)c1)C(=O)Nc1cc(S(N)(=O)=O)ccc1C.O=C(O)C(F)(F)F";"IC50";"'='";"45.0";"nM";"7.35";"";"";"UO_0000065";"14.09";"0.28";"6.46";"4.04";"0";"CHEMBL4706202";"Inhibition of human liver Cathepsin D preincubated for 10 mins followed by substrate addition and further incubated for 2 hrs in dark by fluorimetric analysis";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699662";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"TIME = 2.167 hr";"INHIBITOR";""
"CHEMBL5188873";"";"None";"1099.34";"None";"None";"6";"CC(C)C[C@H](NC(=O)C[C@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(N)=O)N(C)C(=O)[C@@H](NC(=O)OCc1ccccc1)C(C)C)C(=O)N[C@@H](C)C(=O)N(C)[C@H](Cc1ccc(OC(C)(C)C)cc1)C(=O)N1CCC[C@H]1C(=O)O";"IC50";"'='";"19.0";"nM";"7.72";"";"";"UO_0000065";"7.02";"None";"None";"None";"0";"CHEMBL5158466";"Inhibition of recombinant human liver Cathepsin D using Mca-Gly-Lys-Pro-Ile-Leu-Phe-Phe-Arg-Leu-Lys-(Dnp)-D-Arg-NH2 as substrate incubated for 120 mins by fluorescence assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5154724";"1";"Scientific Literature";"Bioorg Med Chem";"2022";"None";"TIME = 2.0 hr";"INHIBITOR";""
"CHEMBL5204856";"";"None";"440.93";"0";"3.74";"5";"C[C@@]1(c2cccc(NC(=O)c3ccccc3)c2Cl)CC(=O)N(C2CCOCC2)C(=N)N1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5112378";"Inhibition of human cathepsin D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5108065";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";"";""
"CHEMBL3653405";"";"None";"435.38";"0";"3.27";"64c";"C[C@@]1(c2cc(NC(=O)c3ccc(C#N)cn3)ccc2F)CO[C@@](C)(C(F)(F)F)C(N)=N1";"IC50";"'>'";"250000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5055931";"Inhibition of human cathepsin D using Mca-GKPILFFRLK(DNP)D-R-NH2 as a substrate";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5055623";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"";""
"CHEMBL3670385";"";"None";"495.36";"0";"2.79";"17";"C[C@@]1(c2nc(NC(=O)c3ncc(C(F)(F)F)nc3N)ccc2F)CO[C@@](C)(C(F)(F)F)C(N)=N1";"IC50";"'='";"54000.0";"nM";"4.27";"";"";"UO_0000065";"8.62";"0.17";"1.48";"3.02";"0";"CHEMBL5054673";"Inhibition of human Cathepsin D using Mca-GKPILFFRLK(DNP)D-R-NH2 as a substrate";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5053529";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL5070669";"";"None";"494.37";"0";"3.39";"16";"C[C@@]1(c2nc(NC(=O)c3ncc(C(F)(F)F)cc3N)ccc2F)CO[C@@](C)(C(F)(F)F)C(N)=N1";"IC50";"'='";"20600.0";"nM";"4.69";"";"";"UO_0000065";"9.48";"0.19";"1.30";"3.65";"0";"CHEMBL5054673";"Inhibition of human Cathepsin D using Mca-GKPILFFRLK(DNP)D-R-NH2 as a substrate";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5053529";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL4798170";"";"None";"743.80";"1";"3.19";"7b";"COc1ccc(CC(=O)NC(=N)N[C@H](CC2CCCCC2)C(=O)Nc2cc(S(=O)(=O)N3CCOCC3)ccc2C)cc1OC.O=C(O)C(F)(F)F";"IC50";"'='";"12.0";"nM";"7.92";"";"";"UO_0000065";"12.58";"0.25";"4.73";"4.98";"0";"CHEMBL4706202";"Inhibition of human liver Cathepsin D preincubated for 10 mins followed by substrate addition and further incubated for 2 hrs in dark by fluorimetric analysis";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699662";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"TIME = 2.167 hr";"INHIBITOR";""
"CHEMBL5184970";"";"None";"1113.36";"None";"None";"5";"COC(=O)[C@@H]1CCCN1C(=O)[C@@H](Cc1ccc(OC(C)(C)C)cc1)N(C)C(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)C[C@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(N)=O)N(C)C(=O)[C@@H](NC(=O)OCc1ccccc1)C(C)C";"IC50";"'='";"18.0";"nM";"7.75";"";"";"UO_0000065";"6.96";"None";"None";"None";"0";"CHEMBL5158466";"Inhibition of recombinant human liver Cathepsin D using Mca-Gly-Lys-Pro-Ile-Leu-Phe-Phe-Arg-Leu-Lys-(Dnp)-D-Arg-NH2 as substrate incubated for 120 mins by fluorescence assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5154724";"1";"Scientific Literature";"Bioorg Med Chem";"2022";"None";"TIME = 2.0 hr";"INHIBITOR";""
"CHEMBL4643727";"";"None";"386.52";"0";"1.12";"4";"C[C@@H]1C[C@H]1CNC(=O)[C@@H]1C[C@H]1[C@]12CN(c3ncccn3)C[C@H]1CSC(N)=N2";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5034187";"Inhibition of human Cathepsin D by FRET assay";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5033995";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"";""
"CHEMBL5208335";"";"None";"453.97";"0";"4.51";"2";"C[C@@]1(c2cccc(Nc3ccc(C4CC4)nc3)c2Cl)CC(=O)N(C2CCOCC2)C(=N)N1";"IC50";"'='";"1193.0";"nM";"5.92";"";"";"UO_0000065";"13.05";"0.25";"1.41";"6.56";"0";"CHEMBL5112378";"Inhibition of human cathepsin D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5108065";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";"INHIBITOR";""
"CHEMBL5191783";"";"None";"468.00";"0";"4.90";"3";"C[C@H]1C[C@@H](N2C(=N)N[C@](C)(c3cccc(Nc4ccc(C5CC5)nc4)c3Cl)CC2=O)CCO1";"IC50";"'='";"64.0";"nM";"7.19";"";"";"UO_0000065";"15.37";"0.30";"2.29";"7.96";"0";"CHEMBL5112378";"Inhibition of human cathepsin D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5108065";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";"INHIBITOR";""
"CHEMBL5204196";"";"None";"468.99";"0";"4.29";"4";"C[C@H]1C[C@@H](N2C(=N)N[C@](C)(c3cccc(Nc4cnc(C5CC5)nc4)c3Cl)CC2=O)CCO1";"IC50";"'='";"215.0";"nM";"6.67";"";"";"UO_0000065";"14.22";"0.28";"2.38";"6.46";"0";"CHEMBL5112378";"Inhibition of human cathepsin D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5108065";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";"INHIBITOR";""
"CHEMBL5172999";"";"None";"412.92";"0";"4.23";"1";"C[C@@]1(c2cccc(Nc3ccccc3)c2Cl)CC(=O)N(C2CCOCC2)C(=N)N1";"IC50";"'='";"58.0";"nM";"7.24";"";"";"UO_0000065";"17.53";"0.34";"3.01";"9.34";"0";"CHEMBL5112378";"Inhibition of human cathepsin D";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5108065";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";"INHIBITOR";""
"CHEMBL2181022";"";"None";"1041.26";"None";"None";"TB-9";"COC(=O)[C@@H]1CCCN1C(=O)[C@@H](Cc1ccccc1)N(C)C(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)C[C@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(N)=O)N(C)C(=O)[C@@H](NC(=O)OCc1ccccc1)C(C)C";"IC50";"'='";"0.0783";"nM";"10.11";"";"";"UO_0000065";"9.71";"None";"None";"None";"1";"CHEMBL5158466";"Inhibition of recombinant human liver Cathepsin D using Mca-Gly-Lys-Pro-Ile-Leu-Phe-Phe-Arg-Leu-Lys-(Dnp)-D-Arg-NH2 as substrate incubated for 120 mins by fluorescence assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5154724";"1";"Scientific Literature";"Bioorg Med Chem";"2022";"None";"TIME = 2.0 hr";"INHIBITOR";""
"CHEMBL5179569";"";"None";"1027.23";"None";"None";"4";"CC(C)C[C@H](NC(=O)C[C@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(N)=O)N(C)C(=O)[C@@H](NC(=O)OCc1ccccc1)C(C)C)C(=O)N[C@@H](C)C(=O)N(C)[C@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)O";"IC50";"'='";"4.89";"nM";"8.31";"";"";"UO_0000065";"8.09";"None";"None";"None";"0";"CHEMBL5158466";"Inhibition of recombinant human liver Cathepsin D using Mca-Gly-Lys-Pro-Ile-Leu-Phe-Phe-Arg-Leu-Lys-(Dnp)-D-Arg-NH2 as substrate incubated for 120 mins by fluorescence assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5154724";"1";"Scientific Literature";"Bioorg Med Chem";"2022";"None";"TIME = 2.0 hr";"INHIBITOR";""
"CHEMBL4128145";"";"None";"471.28";"0";"4.02";"rac-(3R*,6S*)-38e";"C[C@]1(C(F)(F)F)OC[C@@](C)(c2cccc(NC(=O)c3ccc(Br)cn3)c2)N=C1N";"IC50";"'='";"139000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5055931";"Inhibition of human cathepsin D using Mca-GKPILFFRLK(DNP)D-R-NH2 as a substrate";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5055623";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL4452566";"";"None";"498.52";"0";"2.20";"LY3202626; 22";"COc1cnc(C(=O)Nc2ccc(F)c([C@]34CN(c5ncc(F)cn5)C[C@H]3CSC(N)=N4)c2)cn1";"IC50";"'='";"65000.0";"nM";"4.19";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5034187";"Inhibition of human Cathepsin D by FRET assay";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5033995";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL2181015";"";"None";"979.19";"3";"0.35";"Tasiamide B";"COC(=O)[C@@H]1CCCN1C(=O)[C@@H](Cc1ccccc1)N(C)C(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)C[C@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(N)=O)N(C)C(=O)[C@@H](NC(=O)[C@H](C)O)C(C)C";"IC50";"'='";"182.0";"nM";"6.74";"";"";"UO_0000065";"6.88";"0.13";"6.39";"2.35";"1";"CHEMBL5158466";"Inhibition of recombinant human liver Cathepsin D using Mca-Gly-Lys-Pro-Ile-Leu-Phe-Phe-Arg-Leu-Lys-(Dnp)-D-Arg-NH2 as substrate incubated for 120 mins by fluorescence assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5154724";"1";"Scientific Literature";"Bioorg Med Chem";"2022";"None";"TIME = 2.0 hr";"INHIBITOR";""
"CHEMBL5089745";"";"None";"489.41";"0";"2.12";"19";"C[C@@]1(c2nc(NC(=O)c3ncc(OCCF)nc3N)ccc2F)CO[C@@](C)(C(F)(F)F)C(N)=N1";"IC50";"'='";"41900.0";"nM";"4.38";"";"";"UO_0000065";"8.95";"0.18";"2.26";"2.91";"0";"CHEMBL5054673";"Inhibition of human Cathepsin D using Mca-GKPILFFRLK(DNP)D-R-NH2 as a substrate";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5053529";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"INHIBITOR";""
"CHEMBL5183847";"ENSITRELVIR";"3.0";"531.89";"1";"1.75";"3; S-217622";"Cn1cnc(Cn2c(=O)[nH]/c(=N\c3cc4cn(C)nc4cc3Cl)n(Cc3cc(F)c(F)cc3F)c2=O)n1";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5163373";"Inhibition of human liver cathepsin D using MOCAc-Gly-Lys-Pro-Ile-Leu-Phe-Phe-Arg-Leu-Lys(Dnp)-D-Arg-NH2 as substrate preincubated for 15 mins followed by addition of substrate measured after 10 mins by measuring amount of MOCAc formed by spectrofluorimetric method";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5154827";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.4167 hr";"";""
"CHEMBL5192597";"";"None";"1057.26";"None";"None";"7";"COC(=O)[C@@H]1CCCN1C(=O)[C@@H](Cc1ccc(O)cc1)N(C)C(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)C[C@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(N)=O)N(C)C(=O)[C@@H](NC(=O)OCc1ccccc1)C(C)C";"IC50";"'='";"0.178";"nM";"9.75";"";"";"UO_0000065";"9.22";"None";"None";"None";"0";"CHEMBL5158466";"Inhibition of recombinant human liver Cathepsin D using Mca-Gly-Lys-Pro-Ile-Leu-Phe-Phe-Arg-Leu-Lys-(Dnp)-D-Arg-NH2 as substrate incubated for 120 mins by fluorescence assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5154724";"1";"Scientific Literature";"Bioorg Med Chem";"2022";"None";"TIME = 2.0 hr";"INHIBITOR";""
"CHEMBL4782948";"";"None";"645.66";"1";"2.04";"9e";"COc1ccc(CC(=O)NC(=N)N[C@H](C(=O)Nc2cc(S(N)(=O)=O)ccc2C)C2CCCC2)cc1OC.O=C(O)C(F)(F)F";"IC50";"'='";"427.0";"nM";"6.37";"";"";"UO_0000065";"11.98";"0.24";"4.33";"3.69";"0";"CHEMBL4706202";"Inhibition of human liver Cathepsin D preincubated for 10 mins followed by substrate addition and further incubated for 2 hrs in dark by fluorimetric analysis";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4699662";"1";"Scientific Literature";"Bioorg Med Chem";"2021";"None";"TIME = 2.167 hr";"INHIBITOR";""
"CHEMBL5095248";"SEBETRALSTAT";"3.0";"491.52";"0";"2.76";"14w; KVD900";"COCc1nn(Cc2ccc(Cn3ccccc3=O)cc2)cc1C(=O)NCc1nccc(OC)c1F";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5112851";"Inhibition of human Cathepsin D preincubated for 5 mins followed by substrate addition by fluorometer analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL2581";"Cathepsin D";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5108074";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.08333 hr";"";""
